<?xml version="1.0" encoding="UTF-8" ?><extract createDate="2010-04-22"><manufacturerList><manufacturer id="ABB">Abbott Laboratories Limited</manufacturer><manufacturer id="ABH">Manufacturer name not currently available</manufacturer><manufacturer id="ABI">Abiogen Pharma</manufacturer><manufacturer id="ABP">Manufacturer name not currently available</manufacturer><manufacturer id="ABT">Albert Pharma Inc - &quot; DO NOT USE &quot;</manufacturer><manufacturer id="ACC">Accel Pharmac Inc.</manufacturer><manufacturer id="ACO">Acon Laboratories Incorporated</manufacturer><manufacturer id="ACT">Actelion Pharmaceutiques Canada Inc.</manufacturer><manufacturer id="ADI">Adria Laboratories of Canada Ltd.</manufacturer><manufacturer id="ADR">Manufacturer name not currently available</manufacturer><manufacturer id="AGO">Agouron Pharmaceuticals Canada Inc.</manufacturer><manufacturer id="AGP">Actavis Group PTC ehf</manufacturer><manufacturer id="AHA">Manufacturer name not currently available</manufacturer><manufacturer id="AKN">Akorn Pharmaceuticals Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="AKO">Manufacturer name not currently available</manufacturer><manufacturer id="ALA">Altana Pharma Inc.</manufacturer><manufacturer id="ALB">Albert Pharma Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="ALC">Alcon Canada Inc.</manufacturer><manufacturer id="ALE">Alexion Pharmaceuticals Inc.</manufacturer><manufacturer id="ALL">Allergan Inc.</manufacturer><manufacturer id="ALR">AllerPharma Inc.</manufacturer><manufacturer id="ALT">Altimed Pharmaceutical Company</manufacturer><manufacturer id="ALZ">ALZA Canada</manufacturer><manufacturer id="AMA">Amada (Nutritional Products)</manufacturer><manufacturer id="AMG">Amgen Canada Inc.</manufacturer><manufacturer id="ANC">Manufacturer name not currently available</manufacturer><manufacturer id="APP">APP Pharmaceuticals LLC</manufacturer><manufacturer id="APX">Apotex Inc.</manufacturer><manufacturer id="ASE">Astellas Pharma Canada Inc.</manufacturer><manufacturer id="AST">Astra Pharma Inc.</manufacturer><manufacturer id="ASZ">Astra Zeneca - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="ATO">Aton Pharma Inc.</manufacturer><manufacturer id="AUT">Auto Control Medical</manufacturer><manufacturer id="AVE">Aventis Pharma</manufacturer><manufacturer id="AVN">Aventis Pasteur Limited (S8)</manufacturer><manufacturer id="AVR">Advanced Vision Research, Inc. (S8)</manufacturer><manufacturer id="AXC">Axcan Pharma Inc.</manufacturer><manufacturer id="AXX">Axxess  Pharma  Inc.</manufacturer><manufacturer id="AYE">Ayerst Laboratories, Division of Ayerst, McKenna &amp; Harrison</manufacturer><manufacturer id="AZC">AstraZeneca</manufacturer><manufacturer id="BAC">Baxter Corporation - Clintec Nutrition Division (S8)</manufacturer><manufacturer id="BAH">Bayer Inc., Health Care Division</manufacturer><manufacturer id="BAK">Baker Cummins Inc</manufacturer><manufacturer id="BAL">Bayer Healthcare LLC Subsidiary of Bayer Corporation</manufacturer><manufacturer id="BAR">Barr Laboratories Inc.</manufacturer><manufacturer id="BAU">Bausch &amp; Lomb Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="BAX">Baxter Corporation</manufacturer><manufacturer id="BAY">Bayer Inc., Consumer Care Division</manufacturer><manufacturer id="BCA">Manufacturer name not currently available</manufacturer><manufacturer id="BCI">Baker Cummins Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="BDH">Manufacturer name not currently available</manufacturer><manufacturer id="BED">BD Consumer Healthcare</manufacturer><manufacturer id="BEE">Manufacturer name not currently available</manufacturer><manufacturer id="BER">Berlex Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="BEX">Berlex Canada Inc</manufacturer><manufacturer id="BFI">Axcan Pharma Inc.</manufacturer><manufacturer id="BIC">Biocodex</manufacturer><manufacturer id="BIG">Biogen Idec Canada Inc.</manufacturer><manufacturer id="BIO">Biovail Pharmaceuticals Canada</manufacturer><manufacturer id="BJH">Draxis Health Inc.</manufacturer><manufacturer id="BMS">Bristol-Myers Squibb Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="BNQ">Bioniche Pharma (Canada) Ltd.  (S8)</manufacturer><manufacturer id="BNY">Manufacturer name not currently available</manufacturer><manufacturer id="BOE">Boehringer-Ingelheim (Canada) Ltd./Ltee</manufacturer><manufacturer id="BOM">Boehringer - Mannheim Canada</manufacturer><manufacturer id="BOP">Boots Pharmaceuticals - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="BQU">Bristol Myers Squibb Canada Inc</manufacturer><manufacturer id="BRA">B. Braun Medical Inc. (S8)</manufacturer><manufacturer id="BRI">Bristol-Myers Squibb Canada Inc. Nutritional Div. Ottawa</manufacturer><manufacturer id="BSH">Bausch &amp; Lomb Canada Inc</manufacturer><manufacturer id="BSS">Bauch &amp; Lomb Surgical Inc. (S8)</manufacturer><manufacturer id="BWE">Burroughs Wellcome Inc.</manufacturer><manufacturer id="BYK">Byk Canada Inc.</manufacturer><manufacturer id="CBS">Manufacturer name not currently available</manufacturer><manufacturer id="CBV">CIBA Vision</manufacturer><manufacturer id="CDM">Canderm Pharmacal Ltd./Ltee - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="CDX">Canderm Pharmacal Ltd</manufacturer><manufacturer id="CEL">Celgene</manufacturer><manufacturer id="CEP">Cephalon Inc.</manufacturer><manufacturer id="CGP">Manufacturer name not currently available</manufacturer><manufacturer id="CGS">Ciba-Geigy Self Medication Products</manufacturer><manufacturer id="CHU">Church and Dwight Canada Corp.</manufacturer><manufacturer id="CIB">Ciba Pharmaceuticals, Division of Ciba-Geigy Canada Ltd.</manufacturer><manufacturer id="CIL">Chilcott Laboratories-Division of Warner-Lambert Canada Inc.</manufacturer><manufacturer id="CLK">Clark Laboratory - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="CLT">Clintec (Non-Formulary) - &quot; DO NOT USE&quot;</manufacturer><manufacturer id="CMA">Cosmair Canada Inc.</manufacturer><manufacturer id="CMH">Manufacturer name not currently available</manufacturer><manufacturer id="CNG">Manufacturer name not currently available</manufacturer><manufacturer id="CNN">Connaught Novo Nordisk Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="COB">Cobalt Pharmaceuticals Inc.</manufacturer><manufacturer id="COL">Columbia Laboratories</manufacturer><manufacturer id="CON">Pasteur Merieux Connaught Canada</manufacturer><manufacturer id="CPL">Clay-Park Labs Inc.</manufacturer><manufacturer id="CRY">Crystaal Corp.</manufacturer><manufacturer id="CTS">Custom Pharmaceuticals - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="CUB">Manufacturer name not currently available</manufacturer><manufacturer id="CUV">Chauvin Pharmaceuticals Limited (S8)</manufacturer><manufacturer id="CYI">Cytex Pharmaceutical Co.</manufacturer><manufacturer id="DBL">David Bull Laboratories - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="DBU">David Bull Laboratories (Canada) Inc.</manufacturer><manufacturer id="DCL">DC Labs</manufacturer><manufacturer id="DER">Dermik Laboratories Canada Inc.</manufacturer><manufacturer id="DES">Desbergers Limited</manufacturer><manufacturer id="DKT">Dioptic Laboratories, Division of Akorn Pharmaceuticals Cana</manufacturer><manufacturer id="DLU">L. P. Dey (S8)</manufacturer><manufacturer id="DME">Dupont Merck Pharma (Endo Canada Division) - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="DPC">Dominion Pharmacal</manufacturer><manufacturer id="DPL">DPT Laboratories - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="DPM">Dupont Merck Pharma - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="DPT">Dermtek Pharmaceuticals Ltd.</manufacturer><manufacturer id="DPY">Manufacturer Name currently not available</manufacturer><manufacturer id="DTC">Drug Trading Company Ltd. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="DUI">Duchesnay Inc.</manufacturer><manufacturer id="DUP">Du Pont Pharma</manufacturer><manufacturer id="EAT">Manufacturer name not currently available</manufacturer><manufacturer id="EDM">Endo Canada Division Du Pont Merck Pharma</manufacturer><manufacturer id="EFM">Manufacturer name not currently available</manufacturer><manufacturer id="ELA">Elan Pharmaceuticals, Inc.</manufacturer><manufacturer id="ELD">Manufacturer name not currently available</manufacturer><manufacturer id="EMS">EMD Serono Canada Inc.</manufacturer><manufacturer id="ENZ">Enzon Inc. (S8)</manufacturer><manufacturer id="ERF">Erfa Canada Inc.</manufacturer><manufacturer id="ETH">Ethypharm Inc.</manufacturer><manufacturer id="EUR">Euro-Pharm International Canada</manufacturer><manufacturer id="EVM">Evans Medical Ltd.</manufacturer><manufacturer id="FAB">Fabrigen Inc.</manufacturer><manufacturer id="FAU">Faulding Canada Inc.</manufacturer><manufacturer id="FEI">Ferring Inc.</manufacturer><manufacturer id="FIC">Manufacturer name not currently available</manufacturer><manufacturer id="FIS">Fisons Corporation Limited</manufacturer><manufacturer id="FLI">Boots Pharmaceuticals Ltd.</manufacturer><manufacturer id="FOU">Fournier Pharma Inc.</manufacturer><manufacturer id="FRS">Merck Frosst Canada &amp; Cie, Merck Frosst Canada &amp; Co.</manufacturer><manufacturer id="FUJ">Fujisawa Canada Inc.</manufacturer><manufacturer id="GAC">Galderma Canada Inc</manufacturer><manufacturer id="GAL">Galderma - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GCC">Manufacturer name not currently available</manufacturer><manufacturer id="GEB">Manufacturer name not currently available</manufacturer><manufacturer id="GED">GenDerm Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GEI">Geigy Pharmaceuticals,Division of Ciba-Geigy Canada Ltd.</manufacturer><manufacturer id="GEM">Genmed, A Division of Pfizer Canada Inc.</manufacturer><manufacturer id="GEN">Genpharm Inc.</manufacturer><manufacturer id="GET">Genentech Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GEZ">Genzyme - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GIL">Gilead Sciences Inc.</manufacturer><manufacturer id="GLA">Glaxo Canada Inc.</manufacturer><manufacturer id="GLC">Glenwood Laboratories Canada Ltd. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GLD">Glades, Division of Stiefel Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="GLE">Glenwood Laboratories Canada Ltd</manufacturer><manufacturer id="GLW">Glaxo Wellcome Inc.</manufacturer><manufacturer id="GPM">Manufacturer name not currently available</manufacturer><manufacturer id="GRA">Graceway Pharmaceuticals</manufacturer><manufacturer id="GSK">GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care</manufacturer><manufacturer id="GSS">GlaxoSmithKline Shire Biochem</manufacturer><manufacturer id="GWP">GW Pharma Limited</manufacturer><manufacturer id="GZM">Genzyme Canada Inc.</manufacturer><manufacturer id="HCI">Les Lab Charton, Division of Herdt &amp; Charton - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="HCM">Healthcomm International Inc. (S8)</manufacturer><manufacturer id="HER">Manufacturer name not currently available</manufacturer><manufacturer id="HIL">Hill Dermaceuticals Inc.</manufacturer><manufacturer id="HLL">Hollister Stier Laboratories LLC</manufacturer><manufacturer id="HLR">Hoffmann-La Roche Limited</manufacturer><manufacturer id="HLZ">Manufacturer name not currently available</manufacturer><manufacturer id="HMR">Hoechst Marion Roussel Canada Inc.</manufacturer><manufacturer id="HOE">Hoechst Canada Inc.,Pharmaceutical Div.(Hoechst-Roussel Cana</manufacturer><manufacturer id="HOL">Manufacturer name not currently available</manufacturer><manufacturer id="HOM">Home Diagnostics Inc</manufacturer><manufacturer id="HOR">Frank W. Horner Inc.</manufacturer><manufacturer id="HOS">Hospira Healthcare Corporation.</manufacturer><manufacturer id="HRU">Hoechst-Roussel Canada Inc.</manufacturer><manufacturer id="ICI">Manufacturer name not currently available</manufacturer><manufacturer id="ICN">ICN Canada Limited</manufacturer><manufacturer id="IMM">Immunotech Research Ltd.</manufacturer><manufacturer id="IMU">Immunex Corporation</manufacturer><manufacturer id="INF">Interfalk Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="INK">Manufacturer name not currently available</manufacturer><manufacturer id="INR">Manufacturer name not currently available</manufacturer><manufacturer id="INT">Intermune Inc. (S8)</manufacturer><manufacturer id="IOB">Iolab Canada Inc.</manufacturer><manufacturer id="IOL">Manufacturer name not currently available</manufacturer><manufacturer id="IPC">Insight Pharmaceuticals Corporation</manufacturer><manufacturer id="IPS">Ipsen Limited</manufacturer><manufacturer id="IVA">Ivax Laboratories Incorporated</manufacturer><manufacturer id="JAC">Jacobus Pharmaceutical Company Inc.</manufacturer><manufacturer id="JAM">Jamieson Laboratories Ltd.</manufacturer><manufacturer id="JAN">Janssen Pharmaceutica Inc.</manufacturer><manufacturer id="JAS">Manufacturer name not currently available</manufacturer><manufacturer id="JFO">Chiron Canada ULC (S8)</manufacturer><manufacturer id="JHP">JHP Pharmaceuticals LLC</manufacturer><manufacturer id="JNO">Janssen-Ortho Inc.</manufacturer><manufacturer id="JOU">Jouveinal Inc.</manufacturer><manufacturer id="JPC">Jamp Pharma Corporation</manufacturer><manufacturer id="KAP">Kabi Pharmacia</manufacturer><manufacturer id="KEY">Key Pharmaceuticals,Div.of Schering Canada Inc.-&quot;DO NOT USE&quot;</manufacturer><manufacturer id="KGW">Manufacturer name not currently available</manufacturer><manufacturer id="KNL">Knoll Pharma Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="KNO">Knoll Pharma Inc.</manufacturer><manufacturer id="KNR">Kenral Inc.,Division of The Upjohn Company of Canada</manufacturer><manufacturer id="KUC">Kremers-Urban (Canada) - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="KUR">Manufacturer name not currently available</manufacturer><manufacturer id="LAF">Laboratoires Fournier S.A.</manufacturer><manufacturer id="LDA">Leda Health Innovations Inc.</manufacturer><manufacturer id="LEA">Lee-Adams Lab.</manufacturer><manufacturer id="LED">Lederle Division-of Cyanamid Canada Inc.</manufacturer><manufacturer id="LEO">Leo Pharma Inc.</manufacturer><manufacturer id="LIF">Lifescan Canada Ltd.</manufacturer><manufacturer id="LIL">Eli Lilly Canada Inc.</manufacturer><manufacturer id="LIO">LIOH Inc.</manufacturer><manufacturer id="LIP">The Liposome Company Inc. (S8)</manufacturer><manufacturer id="LON">Linson Pharma Inc.</manufacturer><manufacturer id="LUI">Luitpold Pharmaceuticals Inc.</manufacturer><manufacturer id="LYP">Manufacturer name not currently available</manufacturer><manufacturer id="MAN">Paul Maney Labs., Division of Canapharm Ind. Inc.</manufacturer><manufacturer id="MAY">MAYNE PHARMA (CANADA) INC.</manufacturer><manufacturer id="MCL">McNeil Consumer Products Co.</manufacturer><manufacturer id="MCN">Manufacturer name not currently available</manufacturer><manufacturer id="MDA">Manufacturer name not currently available</manufacturer><manufacturer id="MDO">Manufacturer name not currently available</manufacturer><manufacturer id="MDP">Manufacturer name not currently available</manufacturer><manufacturer id="MEA">Meta Pharmaceuticals Inc.</manufacturer><manufacturer id="MEC">Medicis Canada Ltd.</manufacturer><manufacturer id="MED">Medisense Canada Inc.</manufacturer><manufacturer id="MEI">Medican Pharma</manufacturer><manufacturer id="MEM">Medical Mart Supplies - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="MER">Merrell Dow Pharmaceuticals (Canada) Inc.</manufacturer><manufacturer id="MET">Medican Technologies Inc.</manufacturer><manufacturer id="MEZ">Merz Pharmaceutical Gmbh</manufacturer><manufacturer id="MFC">Merck Frosst Canada Ltd.</manufacturer><manufacturer id="MFS">Merck Frosst/Schering Pharma GP</manufacturer><manufacturer id="MGI">MGI Pharma Inc.</manufacturer><manufacturer id="MIN">Mint Pharmaceuticals Inc.</manufacturer><manufacturer id="MIP">Miles Canada Inc Pharmaceutical Division - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="MIS">Miles Canada Inc.Diagnostic Division - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="MIT">Miles Canada Inc., Pharmaceuticals Division</manufacturer><manufacturer id="MJN">Mead Johnson Nutritionals</manufacturer><manufacturer id="MJO">Manufacturer name not currently available</manufacturer><manufacturer id="MJS">Mead Johnson Canada</manufacturer><manufacturer id="MMH">3M Pharmaceuticals, Division 3M Canada Inc.</manufacturer><manufacturer id="MMZ">Medical Mart Supplies Ltd</manufacturer><manufacturer id="MOG">Med-O-Gen Medical Inc.</manufacturer><manufacturer id="MPH">Mayne Pharma (Canada) Inc.  (S8)</manufacturer><manufacturer id="MPU">Merit Pharmaceuticals - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="MRR">Marion Merrell Dow Canada</manufacturer><manufacturer id="MSD">Merck Sharp &amp; Dohme Canada, Division of Merck Frosst Canada</manufacturer><manufacturer id="MYL">Mylan Pharmaceuticals ULC</manufacturer><manufacturer id="NAM">Manufacturer name not currently available</manufacturer><manufacturer id="NDA">Nadeau Laboratory Ltd.</manufacturer><manufacturer id="NEO">Manufacturer name not currently available</manufacturer><manufacturer id="NEP">Nephro-Tech, Inc. (S8)</manufacturer><manufacturer id="NES">Nestle Clinical Nutrition</manufacturer><manufacturer id="NGP">Next Generation Pharma Inc.</manufacturer><manufacturer id="NOB">Nova Biomedical Corporation.</manufacturer><manufacturer id="NON">Novartis Nutrition Corporation</manufacturer><manufacturer id="NOO">Novo Nordisk Canada Inc</manufacturer><manufacturer id="NOP">Novopharm Ltd.</manufacturer><manufacturer id="NOV">Novartis Pharma Canada Inc.</manufacturer><manufacturer id="NOW">Manufacturer name not currently available</manufacturer><manufacturer id="NPI">Nutravite Pharmaceuticals Inc.</manufacturer><manufacturer id="NRD">Nordic Laboratories Inc., Marion Merrell Dow (Canada) Inc.</manufacturer><manufacturer id="NXP">Nu-Pharm Inc.</manufacturer><manufacturer id="NYC">Nycomed Canada Inc.</manufacturer><manufacturer id="OCU">Manufacturer name not currently available</manufacturer><manufacturer id="ODN">Odan Laboratories Ltd.</manufacturer><manufacturer id="OGN">Organon Teknika Canada Inc</manufacturer><manufacturer id="OGS">Organon Sanofi-Synthelabo Canada</manufacturer><manufacturer id="OMC">Ortho McNeil</manufacturer><manufacturer id="OMG">Omega Laboratories Ltd.</manufacturer><manufacturer id="OPI">OptimaPharma, a Division of Taro Pharmaceuticals Inc.</manufacturer><manufacturer id="OPS">OPI S.A.</manufacturer><manufacturer id="ORC">Orchid Healthcare</manufacturer><manufacturer id="ORG">Organon Canada Ltd./Ltee</manufacturer><manufacturer id="ORP">Orphan Medical Inc.  (S8)</manufacturer><manufacturer id="ORT">Manufacturer name not currently available</manufacturer><manufacturer id="ORY">Oryx Pharmaceuticals Inc.</manufacturer><manufacturer id="OTK">Organon Teknika Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="OVA">Ovation Pharmaceuticals Inc.</manufacturer><manufacturer id="PAL">Paladin Labs Inc.</manufacturer><manufacturer id="PAT">Pathogenesis Canada Ltd.</manufacturer><manufacturer id="PBN">Pharmalab (1982) Inc.  (S8)</manufacturer><manufacturer id="PCO">Manufacturer name not currently available</manufacturer><manufacturer id="PDA">Parke-Davis,Division Warner-Lambert Canada Inc.</manufacturer><manufacturer id="PDL">Pro Doc Laboratories - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="PEN">Pendopharm Inc.</manufacturer><manufacturer id="PER">Perrigo International</manufacturer><manufacturer id="PFI">Pfizer Canada Inc.</manufacturer><manufacturer id="PFP">Purdue Pharma</manufacturer><manufacturer id="PFR">Purdue Frederick Inc.</manufacturer><manufacturer id="PGI">Proctor &amp; Gamble Inc.</manufacturer><manufacturer id="PGO">PanGeo Pharma (Canada) Inc.</manufacturer><manufacturer id="PGP">Proctor &amp; Gamble Pharmaceuticals Canada, Inc.</manufacturer><manufacturer id="PHA">Pharmacia Canada Inc.</manufacturer><manufacturer id="PHD">Manufacturer name not currently available</manufacturer><manufacturer id="PHE">Pharmel Inc.</manufacturer><manufacturer id="PHO">Pharmaco Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="PHR">Pharmaco Canada Inc</manufacturer><manufacturer id="PMJ">Pharmacia &amp; Upjohn</manufacturer><manufacturer id="PMS">Pharmascience Inc.</manufacturer><manufacturer id="PMT">Pharmetics Inc.  (S8)</manufacturer><manufacturer id="PMV">Pharmavite Lab. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="POU">Manufacturer name not currently available</manufacturer><manufacturer id="PPC">Pharmaceutical Partners of Canada</manufacturer><manufacturer id="PRE">Prempharm Inc.</manufacturer><manufacturer id="PRO">Proval Pharma Inc.</manufacturer><manufacturer id="PVR">Pharmavite Corporation</manufacturer><manufacturer id="PWC">Manufacturer name not currently available</manufacturer><manufacturer id="QVS">Quest Vitamins, Division of Pangeo Health Brands Inc. (S8)</manufacturer><manufacturer id="RAI">Ratiopharm Inc.  (DO NOT USE)</manufacturer><manufacturer id="RAN">Ranbaxy Pharmaceuticals Canada Inc.</manufacturer><manufacturer id="RBT">Roberts Pharmaceutical of Canada Inc.</manufacturer><manufacturer id="RCA">Reed &amp; Carnrick,Division of Block Drug Company (Canada) Ltd.</manufacturer><manufacturer id="RDC">Reddy-Cheminor Inc.</manufacturer><manufacturer id="RED">Dr Reddy&apos;s Laboratories Inc.</manufacturer><manufacturer id="RHO">Rhoxalpharma Inc.</manufacturer><manufacturer id="RHP">Rhodiapharm Inc.</manufacturer><manufacturer id="RIA">Laboratoire Riva Inc.</manufacturer><manufacturer id="RIC">Richmond Pharmaceuticals Inc.</manufacturer><manufacturer id="RIK">Manufacturer name not currently available</manufacturer><manufacturer id="RIP">Richmond Pharmaceuticals Inc</manufacturer><manufacturer id="RIV">Rivex Pharma Inc.</manufacturer><manufacturer id="ROB">Manufacturer name not currently available</manufacturer><manufacturer id="ROC">Manufacturer Name currently not available</manufacturer><manufacturer id="ROD">Roche Diagnostics, a division of Hoffmann-La Roche Limited</manufacturer><manufacturer id="ROG">Rougier Pharma, Division of Ratiopharm Inc.</manufacturer><manufacturer id="ROP">Roberts Pharmaceutical - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="ROR">Rhone-Poulenc Rorer Consumer Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="ROS">Ross Laboratories-Abbott (Nutritional Products)</manufacturer><manufacturer id="ROU">Roussel Canada Inc.(Hoechst-Roussel Canada Inc.)</manufacturer><manufacturer id="ROY">C. A. Roy Limited - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="RPH">Ratiopharm Inc.</manufacturer><manufacturer id="RPP">Rhone-Poulenc Rorer-Ethical Division</manufacturer><manufacturer id="RPR">Rhone-Poulenc Rorer Consumer Inc.</manufacturer><manufacturer id="SAB">Sabex Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="SAN">Sandoz Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="SAO">Sanofi Canada Inc.</manufacturer><manufacturer id="SAS">Sanofi - Synthelabo Canada Inc.</manufacturer><manufacturer id="SAV">Sanofi Aventis Pharma</manufacturer><manufacturer id="SAW">Sanofi Winthrop - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="SBI">Shire BioChem Inc.</manufacturer><manufacturer id="SBP">STIEFFEL BCD PHARMA</manufacturer><manufacturer id="SCC">Manufacturer name not currently available</manufacturer><manufacturer id="SCE">Schein Pharmaceutical</manufacturer><manufacturer id="SCH">Schering Canada Inc.</manufacturer><manufacturer id="SCJ">Manufacturer name not currently available</manufacturer><manufacturer id="SCK">Manufacturer name not currently available</manufacturer><manufacturer id="SCP">Schering-Plough Canada Inc.</manufacturer><manufacturer id="SDM">Shoppers Drug Mart</manufacturer><manufacturer id="SDR">Stanley Pharmaceuticals Ltd.</manufacturer><manufacturer id="SDZ">Sandoz Canada Inc.</manufacturer><manufacturer id="SEA">Searle Canada Inc.</manufacturer><manufacturer id="SEP">Sepracor Pharmaceuticals Inc.</manufacturer><manufacturer id="SER">Manufacturer name not currently available</manufacturer><manufacturer id="SEV">Servier Canada Inc.</manufacturer><manufacturer id="SHG">Shire Human Genetic Therapies Inc.</manufacturer><manufacturer id="SHI">Shire Canada Inc.</manufacturer><manufacturer id="SHL">SHS International Ltd.</manufacturer><manufacturer id="SHM">Sherwood Inc.</manufacturer><manufacturer id="SHS">SHS North America</manufacturer><manufacturer id="SIG">Sigma-Tau Pharmaceutical Inc.</manufacturer><manufacturer id="SIL">Sabex 2002 Inc</manufacturer><manufacturer id="SKB">SmithKline Beecham Consumer Healthcare.</manufacturer><manufacturer id="SKF">Seaford Pharmaceuticals Inc.  (S8)</manufacturer><manufacturer id="SLL">Manufacturer name not currently available</manufacturer><manufacturer id="SLO">Solvay Kingswood Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="SMJ">Smith Kline Beecham Pharma Inc</manufacturer><manufacturer id="SNE">Smith &amp; Nephew Inc.</manufacturer><manufacturer id="SOL">Solvay Kingswood Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="SPH">Solvay Pharma Inc.</manufacturer><manufacturer id="SQI">Squire Pharmaceuticals Inc.</manufacturer><manufacturer id="SQU">Manufacturer name not currently available</manufacturer><manufacturer id="SRO">Serono Canada Inc.</manufacturer><manufacturer id="STE">Sterimax Inc.</manufacturer><manufacturer id="STH">Sterling Health</manufacturer><manufacturer id="STI">Stiefel Canada Inc.</manufacturer><manufacturer id="STW">Manufacturer name not currently available</manufacturer><manufacturer id="SUN">Sun Pharmaceutical Inc</manufacturer><manufacturer id="SWS">Swiss Herbal Remedies Ltd.</manufacturer><manufacturer id="SYN">Syntex Inc.</manufacturer><manufacturer id="SYP">SynCare Pharmaceutical Inc.</manufacturer><manufacturer id="TAK">Takeda Pharmaceuticals North America Inc.</manufacturer><manufacturer id="TAN">Tanta Pharmaceutical Co.</manufacturer><manufacturer id="TAP">TAP Pharmaceuticals</manufacturer><manufacturer id="TAR">Taro Pharmaceuticals Inc.</manufacturer><manufacturer id="TCD">Trans Canaderm Inc.</manufacturer><manufacturer id="TCH">Technilab Inc.</manufacturer><manufacturer id="TER">Therasense Canada Inc.</manufacturer><manufacturer id="THE">Theramed Corporation</manufacturer><manufacturer id="THR">Thermor Ltd.</manufacturer><manufacturer id="TIC">Tican Pharmaceuticals Ltd.</manufacturer><manufacturer id="TKJ">TEVA Pharmaceutical Industries Ltd.</manufacturer><manufacturer id="TLI">Laboratory Trianon Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="TMP">3M Pharmaceuticals/3M Canada Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="TPH">TaroPharma, a Division of Taro Pharmaceuticals Inc.</manufacturer><manufacturer id="TRA">Manufacturer name not currently available</manufacturer><manufacturer id="TRI">Trillium Health Care Products Inc.</manufacturer><manufacturer id="TRO">Trophic Canada Ltd.</manufacturer><manufacturer id="UCB">UCB Canada Inc.</manufacturer><manufacturer id="UME">Unimed Canada Inc.</manufacturer><manufacturer id="UPJ">The Upjohn Company of Canada</manufacturer><manufacturer id="UPS">Manufacturer name not currently available</manufacturer><manufacturer id="USV">Manufacturer name not currently available</manufacturer><manufacturer id="UTC">United Therapeutics Corporation (S8)</manufacturer><manufacturer id="VAE">Valeo Pharma Inc.</manufacturer><manufacturer id="VAL">Valeant Canada Ltd.</manufacturer><manufacturer id="VHL">Vita Health Products Inc. (S8)</manufacturer><manufacturer id="VIV">Viva Pharmaceuticals</manufacturer><manufacturer id="VLH">Lundbeck Canada Inc.</manufacturer><manufacturer id="VRO">Virco Pharmaceutical (Canada) Inc.</manufacturer><manufacturer id="WAB">Waymar Pharmaceuticals Inc.</manufacturer><manufacturer id="WAM">Manufacturer name not currently available</manufacturer><manufacturer id="WAP">Wampole</manufacturer><manufacturer id="WAR">Warner Chilcott Company, Inc.</manufacturer><manufacturer id="WAT">Watson Laboratories Inc.</manufacturer><manufacturer id="WAY">Wyeth Pharmaceuticals</manufacturer><manufacturer id="WBP">Manufacturer name not currently available</manufacturer><manufacturer id="WCC">Women&apos;s Capital Corporation</manufacturer><manufacturer id="WEL">WellSpring Pharmaceutical Canada Corp.</manufacturer><manufacturer id="WHB">Whitehall-Robins Inc</manufacturer><manufacturer id="WHH">Manufacturer name not currently available</manufacturer><manufacturer id="WIN">Winthrop Laboratories</manufacturer><manufacturer id="WLA">Warner-Lambert - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="WLN">Manufacturer name not currently available</manufacturer><manufacturer id="WNP">WN Pharmaceuticals Ltd.</manufacturer><manufacturer id="WOC">Wockhardt UK Ltd.  (S8)</manufacturer><manufacturer id="WRI">Whitehall-Robins Inc. - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="WSD">Manufacturer name not currently available</manufacturer><manufacturer id="WSQ">Westwood Squibb Pharmaceuticals</manufacturer><manufacturer id="WTR">Westcan Pharmaceuticals - &quot;DO NOT USE&quot;</manufacturer><manufacturer id="WYE">Wyeth Ltd.</manufacturer><manufacturer id="XEN">Xenex Laboratories Inc.</manufacturer><manufacturer id="XXX">Manufacturer cannot be identified</manufacturer><manufacturer id="YNO">Baxter AG (S8)</manufacturer><manufacturer id="YYY">Manufacturer for Gov&apos;t Pharmacy Items</manufacturer><manufacturer id="ZEN">Zeneca Pharma Inc.</manufacturer><manufacturer id="ZIL">Zila Pharmaceuticals Inc.</manufacturer><manufacturer id="ZYN">Zymcan Pharmaceuticals Inc.</manufacturer></manufacturerList><formulary edition="4101" updateVer="Q" formularyDate="2010-04-23" createDate="2010-04-22"><pcg2 id="040000000"><name>ANTIHISTAMINICS</name><pcg6><genericName id="00005"><name>CETIRIZINE HYDROCHLORIDE</name><pcgGroup><pcg9 id="040000086"><itemNumber>0001</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="02223554" notABenefit="Y" sec3="Y"><name>Reactine</name><manufacturerId>MCL</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02231603" notABenefit="Y" sec3="Y"><name>Apo-Cetirizine</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02315955" dinStatus="N" notABenefit="Y" sec3="Y"><name>Extra Strength Allergy Relief</name><manufacturerId>PEN</manufacturerId><listingDate>2009-11-13</listingDate></drug></pcg9><pcg9 id="040000087"><itemNumber>0002</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><drug id="01900978" notABenefit="Y" sec3="Y"><name>Reactine</name><manufacturerId>MCL</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="02315963" notABenefit="Y" sec3="Y"><name>PMS-Cetirizine</name><manufacturerId>PMS</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00002"><name>DIPHENHYDRAMINE HCL</name><pcgGroup><pcg9 id="040000014" suppliedBy="L"><itemNumber>0003</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><drug id="00022756" notABenefit="Y" sec3="Y"><name>Benadryl</name><manufacturerId>PDA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="040000013" suppliedBy="L"><itemNumber>0004</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><drug id="00022764" notABenefit="Y" sec3="Y"><name>Benadryl</name><manufacturerId>PDA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01195"><name>KETOTIFEN</name><pcgGroup><pcg9 id="040000084"><itemNumber>0005</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><drug id="00577308" notABenefit="Y" sec3="Y"><name>Zaditen</name><manufacturerId>SQI</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02230730" notABenefit="Y" sec3="Y"><name>Novo-Ketotifen</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00015"><name>LORATADINE</name><pcgGroup><pcg9 id="040000061"><itemNumber>0006</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="00782696" notABenefit="Y" sec3="Y"><name>Claritin</name><manufacturerId>SCP</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02243880" notABenefit="Y" sec3="Y"><name>Apo-Loratadine</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00003"><name>PROMETHAZINE HCL</name><pcgGroup><pcg9 id="040000022"><itemNumber>0007</itemNumber><strength>2mg/mL</strength><dosageForm>O/L</dosageForm><drug id="00583979" notABenefit="Y" sec3="Y"><name>PMS-Promethazine</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01937693" notABenefit="Y" sec3="Y"><name>Phenergan</name><manufacturerId>RPR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="080000000"><name>ANTI-INFECTIVE AGENTS</name><pcg6 id="080800000"><name>ANTHELMINTICS</name><genericName id="00021"><name>MEBENDAZOLE</name><pcgGroup><pcg9 id="080800013"><itemNumber>0008</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>3.6800</price><drug id="00556734" sec3="Y"><name>Vermox</name><manufacturerId>JNO</manufacturerId><individualPrice>3.6800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00019"><name>PIPERAZINE ADIPATE</name><pcgGroup><pcg9 id="080800003"><itemNumber>0009</itemNumber><dosageForm>Gran 2g Pk</dosageForm><price>.7230</price><drug id="02100215" dinStatus="E" sec3="Y"><name>Entacyl</name><manufacturerId>SHI</manufacturerId><individualPrice>.7230</individualPrice><listingDate>1999-02-10</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081204000"><name>ANTIBIOTICS ANTIFUNGALS</name><genericName id="00023"><name>AMPHOTERICIN B</name><pcgGroup><pcg9 id="081204001"><itemNumber>0010</itemNumber><dosageForm>Inj Pd-50mg Pk</dosageForm><price>70.4000</price><drug id="00029149" sec3="Y"><name>Fungizone</name><manufacturerId>BQU</manufacturerId><individualPrice>70.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00032"><name>FLUCONAZOLE</name><pcgGroup lccId="00001"><pcg9 id="081204025"><itemNumber>0011</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>1.0513</price><drug id="02024152" sec3="Y" sec6="Y" sec12="Y"><name>Diflucan P.O.S.</name><manufacturerId>PFI</manufacturerId><individualPrice>1.0513</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="274">For the treatment of oral/esophageal candidiasis in immunocompromised patients (e.g. patients with malignancies and transplant patients) who have failed to respond to nystatin or imidazoles and when oral tablets of fluconazole cannot be tolerated.
</lccNote><lccNote seq="002" type="W">For oral candidiasis, network will limit supply to 2 weeks. For esophageal candidiasis, network will limit supply to 6 weeks.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="275">For the treatment of patients with disseminated candidiasis when oral tablets of fluconazole cannot be tolerated.</lccNote><lccNote seq="005" type="W">For disseminated candidiasis, network will limit supply to 6 weeks.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="276">For the treatment of patients with cryptococcal meningitis when oral tablets of fluconazole cannot be tolerated.</lccNote><lccNote seq="008" type="W">For cryptococcal meningitis (initial treatment), network will limit supply to 12 weeks.</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="010" reasonForUseId="277">For the treatment of patients with vulvovaginal candidiasis when oral tablets of fluconazole cannot be tolerated.</lccNote><lccNote seq="011" type="W">For vulvovaginal candidiasis, network will limit supply to one dose 150mg (Repeats no more than every 25 days).</lccNote><lccNote seq="012" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup lccId="00002"><pcg9 id="081204023"><itemNumber>0012</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>2.4814</price><dailyCost>4.9628</dailyCost><drug id="00891800" notABenefit="Y" sec3="Y"><name>Diflucan</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02236978" sec3="Y" sec6="Y" sec12="Y"><name>Novo-Fluconazole</name><manufacturerId>NOP</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>2003-04-16</listingDate></drug><drug id="02237370" sec3="Y" sec6="Y" sec12="Y"><name>Apo-Fluconazole</name><manufacturerId>APX</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>1999-09-15</listingDate></drug><drug id="02245292" sec3="Y" sec6="Y" sec12="Y"><name>Gen-Fluconazole</name><manufacturerId>GEN</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>2003-04-16</listingDate></drug><drug id="02245643" sec3="Y" sec6="Y" sec12="Y"><name>PMS-Fluconazole</name><manufacturerId>PMS</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>2003-01-30</listingDate></drug><drug id="02249294" sec3="Y" sec6="Y" sec12="Y"><name>Taro-Fluconazole</name><manufacturerId>TAR</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>2004-12-21</listingDate></drug><drug id="02281260" sec3="Y" sec6="Y" sec12="Y"><name>Co Fluconazole</name><manufacturerId>COB</manufacturerId><individualPrice>2.4814</individualPrice><dailyCost>4.9628</dailyCost><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="081204024"><itemNumber>0013</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>4.4020</price><dailyCost>4.4020</dailyCost><drug id="00891819" notABenefit="Y" sec3="Y"><name>Diflucan</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02236979" sec3="Y" sec6="Y" sec12="Y"><name>Novo-Fluconazole</name><manufacturerId>NOP</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>2003-04-16</listingDate></drug><drug id="02237371" sec3="Y" sec6="Y" sec12="Y"><name>Apo-Fluconazole</name><manufacturerId>APX</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>1999-09-15</listingDate></drug><drug id="02245293" sec3="Y" sec6="Y" sec12="Y"><name>Gen-Fluconazole</name><manufacturerId>GEN</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>2003-04-16</listingDate></drug><drug id="02245644" sec3="Y" sec6="Y" sec12="Y"><name>PMS-Fluconazole</name><manufacturerId>PMS</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>2003-01-30</listingDate></drug><drug id="02249308" sec3="Y" sec6="Y" sec12="Y"><name>Taro-Fluconazole</name><manufacturerId>TAR</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>2004-12-21</listingDate></drug><drug id="02281279" sec3="Y" sec6="Y" sec12="Y"><name>Co Fluconazole</name><manufacturerId>COB</manufacturerId><individualPrice>4.4020</individualPrice><dailyCost>4.4020</dailyCost><listingDate>2008-01-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="202">For the treatment of thrush in immunocompromised patients (i.e. patients with malignancies and transplant recipients) who are unresponsive to nystatin or imidazole preparations;</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="203">For the treatment of oroesophageal candidiasis in immunocompromised patients (i.e. patients with malignancies and transplant recipients);</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="204">For patients with disseminated candidiasis;</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="205">For the treatment of acute cryptococcal meningitis.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00027"><name>KETOCONAZOLE</name><pcgGroup><pcg9 id="081204010"><itemNumber>0014</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.9393</price><dailyCost>.9393</dailyCost><note>A low pH is necessary for absorption. Antacids, anticholinergics/antispasmodics, H2-blockers, and omeprazole may decrease absorption. Ketoconazole is a potent inhibitor of hepatic oxidation of drugs and may cause significant elevation of blood levels of astemizole, cisapride, cyclosporine, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of ketoconazole and astemizole, cisapride or terfenadine. Insulin requirements may be reduced. Hepatotoxicity occurs in approximately 1 in 1500 patients treated with ketoconazole for onychomycosis; female gender, pre-existing disease, alcoholism and greater than 2 weeks of therapy are pre-disposing factors.</note><drug id="00633836" dinStatus="E" sec3="Y"><name>Nizoral</name><manufacturerId>JAN</manufacturerId><individualPrice>1.8786</individualPrice><dailyCost>1.8786</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231061" sec3="Y"><name>Novo-Ketoconazole</name><manufacturerId>NOP</manufacturerId><individualPrice>.9393</individualPrice><dailyCost>.9393</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02237235" sec3="Y"><name>Apo-Ketoconazole</name><manufacturerId>APX</manufacturerId><individualPrice>.9393</individualPrice><dailyCost>.9393</dailyCost><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00025"><name>NYSTATIN</name><pcgGroup><pcg9 id="081204006"><itemNumber>0015</itemNumber><strength>100000U/mL</strength><dosageForm>O/L</dosageForm><price>.0592</price><dailyCost>.2368</dailyCost><drug id="00248169" notABenefit="Y" sec3="Y"><name>Mycostatin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02194201" sec3="Y"><name>Ratio-Nystatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.0592</individualPrice><dailyCost>.2368</dailyCost><listingDate>1997-10-31</listingDate></drug></pcg9><pcg9 id="081204005"><itemNumber>0016</itemNumber><strength>500000U</strength><dosageForm>Tab</dosageForm><price>.1680</price><dailyCost>.5040</dailyCost><drug id="00029416" notABenefit="Y" sec3="Y"><name>Mycostatin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02194198" sec3="Y"><name>Ratio-Nystatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.1680</individualPrice><dailyCost>.5040</dailyCost><listingDate>1997-10-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00030"><name>TERBINAFINE HCL</name><pcgGroup><pcg9 id="081204016"><itemNumber>0017</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="02031116" notABenefit="Y" sec3="Y"><name>Lamisil</name><manufacturerId>NOV</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02239893" notABenefit="Y" sec3="Y"><name>Apo-Terbinafine</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02240346" notABenefit="Y" sec3="Y"><name>Novo-Terbinafine</name><manufacturerId>NOP</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02242503" notABenefit="Y" sec3="Y"><name>Mylan-Terbinafine</name><manufacturerId>MYL</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02254727" notABenefit="Y" sec3="Y"><name>Co Terbinafine</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02262177" notABenefit="Y" sec3="Y"><name>Sandoz Terbinafine</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02294273" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Terbinafine</name><manufacturerId>PMS</manufacturerId><listingDate>2009-09-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01634"><name>VORICONAZOLE</name><pcgGroup lccId="00165"><pcg9 id="081204029"><itemNumber>0018</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>12.1057</price><drug id="02256460" sec3="Y" sec12="Y"><name>Vfend</name><manufacturerId>PFI</manufacturerId><individualPrice>12.1057</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><pcg9 id="081204030"><itemNumber>0019</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>48.4025</price><drug id="02256479" sec3="Y" sec12="Y"><name>Vfend</name><manufacturerId>PFI</manufacturerId><individualPrice>48.4025</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="399">Outpatient continuation of treatment for documented invasive aspergillosis in patients who have demonstrated a clinical response to either oral or parenteral voriconazole.

* The first prescription must be written by a physician based at the hospital where the patient was hospitalized.


Note: Limited to 3 months of reimbursement.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="081212000"><name>ANTIBIOTICS ERYTHROMYCINS</name><note>Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.</note><genericName id="00040"><name>AZITHROMYCIN</name><pcgGroup><pcg9 id="081212025"><itemNumber>0020</itemNumber><strength>100mg/5mL</strength><dosageForm>O/L-15mL Pk</dosageForm><price>8.3198</price><drug id="02223716" sec3="Y"><name>Zithromax</name><manufacturerId>PFI</manufacturerId><individualPrice>16.9562</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02274388" sec3="Y"><name>PMS-Azithromycin</name><manufacturerId>PMS</manufacturerId><individualPrice>8.3205</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02315157" dinStatus="N" sec3="Y"><name>Novo-Azithromycin Pediatric</name><manufacturerId>NOP</manufacturerId><individualPrice>8.3205</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02332388" dinStatus="N" sec3="Y"><name>Sandoz Azithromycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>8.3198</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="081212026"><itemNumber>0021</itemNumber><strength>200mg/5mL</strength><dosageForm>O/L-15mL Pk</dosageForm><price>11.7848</price><drug id="02223724" sec3="Y"><name>Zithromax</name><manufacturerId>PFI</manufacturerId><individualPrice>24.0178</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02274396" sec3="Y"><name>PMS-Azithromycin</name><manufacturerId>PMS</manufacturerId><individualPrice>11.7855</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02315165" dinStatus="N" sec3="Y"><name>Novo-Azithromycin Pediatric</name><manufacturerId>NOP</manufacturerId><individualPrice>11.7855</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02332396" dinStatus="N" sec3="Y"><name>Sandoz Azithromycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>11.7848</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="081212036"><itemNumber>0022</itemNumber><strength>200mg/5mL</strength><dosageForm>O/L-22.5mL Pk</dosageForm><price>17.6772</price><drug id="09857315" sec3="Y"><name>Zithromax</name><manufacturerId>PFI</manufacturerId><individualPrice>36.0267</individualPrice><listingDate>2009-03-02</listingDate></drug><drug id="09857316" sec3="Y"><name>PMS-Azithromycin</name><manufacturerId>PMS</manufacturerId><individualPrice>17.6783</individualPrice><listingDate>2009-03-02</listingDate></drug><drug id="09857328" dinStatus="N" sec3="Y"><name>Novo-Azithromycin Pediatric</name><manufacturerId>NOP</manufacturerId><individualPrice>17.6783</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="09857351" dinStatus="N" sec3="Y"><name>Sandoz Azithromycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>17.6772</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="081212029"><itemNumber>0023</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>2.4667</price><drug id="02212021" sec3="Y"><name>Zithromax</name><manufacturerId>PFI</manufacturerId><individualPrice>5.2281</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02247423" sec3="Y"><name>Apo-Azithromycin</name><manufacturerId>APX</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02255340" sec3="Y"><name>Co-Azithromycin</name><manufacturerId>COB</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02261634" sec3="Y"><name>PMS-Azithromycin</name><manufacturerId>PMS</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-03-01</listingDate></drug><drug id="02265826" sec3="Y"><name>Sandoz Azithromycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02267845" sec3="Y"><name>Novo-Azithromycin</name><manufacturerId>NOP</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02275287" sec3="Y"><name>Ratio-Azithromycin</name><manufacturerId>RPH</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-05-19</listingDate></drug><drug id="02278359" sec3="Y"><name>Gen-Azithromycin</name><manufacturerId>GEN</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2006-08-24</listingDate></drug><drug id="02278588" dinStatus="N" sec3="Y"><name>Phl-Azithromycin</name><manufacturerId>PHE</manufacturerId><individualPrice>2.4667</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="081212028"><itemNumber>0024</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><drug id="02231143" notABenefit="Y" sec3="Y" sec6="Y"><name>Zithromax</name><manufacturerId>PFI</manufacturerId><listingDate>1998-12-31</listingDate></drug><drug id="02256088" notABenefit="Y" sec3="Y" sec6="Y"><name>Co Azithromycin</name><manufacturerId>COB</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00039"><name>CLARITHROMYCIN</name><pcgGroup><pcg9 id="081212032"><itemNumber>0025</itemNumber><strength>500mg</strength><dosageForm>ER Tab</dosageForm><price>2.5144</price><dailyCost>5.0288</dailyCost><drug id="02244756" sec3="Y"><name>Biaxin XL</name><manufacturerId>ABB</manufacturerId><individualPrice>2.5144</individualPrice><dailyCost>5.0288</dailyCost><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="081212030"><itemNumber>0026</itemNumber><strength>125mg/5mL</strength><dosageForm>Ped Gran</dosageForm><price>.2842</price><dailyCost>2.8420</dailyCost><drug id="02146908" sec3="Y"><name>Biaxin</name><manufacturerId>ABB</manufacturerId><individualPrice>.2842</individualPrice><dailyCost>2.8420</dailyCost><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="081212031"><itemNumber>0027</itemNumber><strength>250mg/5mL</strength><dosageForm>Susp</dosageForm><price>.5712</price><dailyCost>5.7120</dailyCost><drug id="02244641" sec3="Y"><name>Biaxin</name><manufacturerId>ABB</manufacturerId><individualPrice>.5712</individualPrice><dailyCost>5.7120</dailyCost><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="081212020"><itemNumber>0028</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.7861</price><dailyCost>1.5722</dailyCost><drug id="01984853" sec3="Y"><name>Biaxin</name><manufacturerId>ABB</manufacturerId><individualPrice>1.6487</individualPrice><dailyCost>3.2974</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02247573" sec3="Y"><name>PMS-Clarithromycin</name><manufacturerId>PMS</manufacturerId><individualPrice>.7861</individualPrice><dailyCost>1.5722</dailyCost><listingDate>2007-10-03</listingDate></drug><drug id="02247818" sec3="Y"><name>Ratio-Clarithromycin</name><manufacturerId>RPH</manufacturerId><individualPrice>.7861</individualPrice><dailyCost>1.5722</dailyCost><listingDate>2007-09-04</listingDate></drug><drug id="02248856" sec3="Y"><name>Mylan-Clarithromycin</name><manufacturerId>MYL</manufacturerId><individualPrice>.7861</individualPrice><dailyCost>1.5722</dailyCost><listingDate>2007-09-04</listingDate></drug><drug id="02266539" dinStatus="N" sec3="Y"><name>Sandoz Clarithromycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7861</individualPrice><dailyCost>1.5722</dailyCost><listingDate>2008-08-28</listingDate></drug><drug id="02274744" sec3="Y"><name>Apo-Clarithromycin</name><manufacturerId>APX</manufacturerId><individualPrice>.7861</individualPrice><dailyCost>1.5722</dailyCost><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="081212024"><itemNumber>0029</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><drug id="02126710" notABenefit="Y" sec3="Y"><name>Biaxin</name><manufacturerId>ABB</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02247574" notABenefit="Y" sec3="Y"><name>PMS-Clarithromycin</name><manufacturerId>PMS</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02247819" notABenefit="Y" sec3="Y"><name>Ratio-Clarithromycin</name><manufacturerId>RPH</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02248857" notABenefit="Y" sec3="Y"><name>Mylan-Clarithromycin</name><manufacturerId>MYL</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02266547" notABenefit="Y" sec3="Y"><name>Sandoz Clarithromycin</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02274752" notABenefit="Y" sec3="Y"><name>Apo-Clarithromycin</name><manufacturerId>APX</manufacturerId><listingDate>2007-10-03</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00033"><name>ERYTHROMYCIN BASE</name><pcgGroup><pcg9 id="081212013"><itemNumber>0030</itemNumber><strength>250mg</strength><dosageForm>Ent Pel Cap</dosageForm><price>.2293</price><dailyCost>.9172</dailyCost><drug id="00607142" sec3="Y"><name>ERYC</name><manufacturerId>PFI</manufacturerId><individualPrice>.2293</individualPrice><dailyCost>.9172</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00726672" notABenefit="Y" sec3="Y"><name>Apo-Erythro E-C</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081212001"><itemNumber>0031</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.1828</price><dailyCost>.7312</dailyCost><drug id="00244635" notABenefit="Y" sec3="Y"><name>Erythromid</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00682020" sec3="Y"><name>Apo-Erythro</name><manufacturerId>APX</manufacturerId><individualPrice>.1828</individualPrice><dailyCost>.7312</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00036"><name>ERYTHROMYCIN ESTOLATE</name><pcgGroup><pcg9 id="081212006"><itemNumber>0032</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0368</price><dailyCost>.7360</dailyCost><drug id="00015474" notABenefit="Y" sec3="Y"><name>Ilosone</name><manufacturerId>LIL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00021172" dinStatus="E" sec3="Y"><name>Novo-Rythro Estolate</name><manufacturerId>NOP</manufacturerId><individualPrice>.0368</individualPrice><dailyCost>.7360</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081212007"><itemNumber>0033</itemNumber><strength>50mg/mL</strength><dosageForm>O/L</dosageForm><price>.0713</price><dailyCost>1.4260</dailyCost><drug id="00210641" notABenefit="Y" sec3="Y"><name>Ilosone</name><manufacturerId>LIL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00262595" sec3="Y"><name>Novo-Rythro Estolate</name><manufacturerId>NOP</manufacturerId><individualPrice>.0713</individualPrice><dailyCost>1.4260</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00034"><name>ERYTHROMYCIN ETHYLSUCCINATE</name><pcgGroup><pcg9 id="081212002"><itemNumber>0034</itemNumber><strength>40mg/mL</strength><dosageForm>O/L</dosageForm><price>.0669</price><dailyCost>1.0035</dailyCost><drug id="00000299" notABenefit="Y" sec3="Y"><name>EES-200</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00605859" sec3="Y"><name>Novo-Rythro Ethyl Succinate</name><manufacturerId>NOP</manufacturerId><individualPrice>.0669</individualPrice><dailyCost>1.0035</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081212009"><itemNumber>0035</itemNumber><strength>80mg/mL</strength><dosageForm>O/L</dosageForm><price>.1013</price><dailyCost>1.5195</dailyCost><drug id="00453617" notABenefit="Y" sec3="Y"><name>EES-400</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00652318" sec3="Y"><name>Novo-Rythro Ethyl Succinate</name><manufacturerId>NOP</manufacturerId><individualPrice>.1013</individualPrice><dailyCost>1.5195</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081212011"><itemNumber>0036</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>.3363</price><dailyCost>1.0089</dailyCost><drug id="00583782" notABenefit="Y" sec3="Y"><name>EES-600</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00637416" sec3="Y"><name>Apo-Erythro-ES</name><manufacturerId>APX</manufacturerId><individualPrice>.3363</individualPrice><dailyCost>1.0089</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00035"><name>ERYTHROMYCIN STEARATE</name><pcgGroup><pcg9 id="081212003"><itemNumber>0037</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.2118</price><dailyCost>.8472</dailyCost><drug id="00000434" notABenefit="Y" sec3="Y"><name>Erythrocin</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00545678" sec3="Y"><name>Apo-Erythro-S</name><manufacturerId>APX</manufacturerId><individualPrice>.2118</individualPrice><dailyCost>.8472</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081212010"><itemNumber>0038</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.5390</price><dailyCost>1.0780</dailyCost><drug id="00266515" dinStatus="E" sec3="Y"><name>Erythrocin</name><manufacturerId>ABB</manufacturerId><individualPrice>.5390</individualPrice><dailyCost>1.0780</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00688568" sec3="Y"><name>Apo-Erythro-S</name><manufacturerId>APX</manufacturerId><individualPrice>.5425</individualPrice><dailyCost>1.0850</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081216000"><name>ANTIBIOTICS PENICILLINS</name><genericName id="00050"><name>AMOXICILLIN</name><note>The activity of amoxicillin is essentially identical to ampicillin. However, amoxicillin is more completely absorbed and causes diarrhea less frequently than ampicillin. The only situation where amoxicillin should not be used to replace oral ampicillin is Shigellosis.</note><pcgGroup><pcg9 id="081216036"><itemNumber>0039</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.1750</price><dailyCost>.5250</dailyCost><drug id="00406724" sec3="Y"><name>Novamoxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1750</individualPrice><dailyCost>.5250</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00628115" notABenefit="Y" sec3="Y"><name>Apo-Amoxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00865567" notABenefit="Y" sec3="Y"><name>Nu-Amoxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02041294" notABenefit="Y" sec3="Y"><name>Amoxil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230243" notABenefit="Y" sec3="Y"><name>PMS-Amoxicillin</name><manufacturerId>PMS</manufacturerId><listingDate>2004-04-06</listingDate></drug><drug id="02238171" notABenefit="Y" sec3="Y"><name>Gen-Amoxicillin</name><manufacturerId>GEN</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081216039"><itemNumber>0040</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.3417</price><dailyCost>1.0251</dailyCost><drug id="00406716" sec3="Y"><name>Novamoxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3417</individualPrice><dailyCost>1.0251</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00628123" notABenefit="Y" sec3="Y"><name>Apo-Amoxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00865575" notABenefit="Y" sec3="Y"><name>Nu-Amoxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02041308" notABenefit="Y" sec3="Y"><name>Amoxil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230244" notABenefit="Y" sec3="Y"><name>PMS-Amoxicillin</name><manufacturerId>PMS</manufacturerId><listingDate>2004-04-06</listingDate></drug><drug id="02238172" notABenefit="Y" sec3="Y"><name>Gen-Amoxicillin</name><manufacturerId>GEN</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081216038"><itemNumber>0041</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0353</price><dailyCost>.5295</dailyCost><drug id="00452149" sec3="Y"><name>Novamoxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0353</individualPrice><dailyCost>.5295</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00628131" notABenefit="Y" sec3="Y"><name>Apo-Amoxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00865540" notABenefit="Y" sec3="Y"><name>Nu-Amoxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01934171" notABenefit="Y" sec3="Y"><name>Novamoxin (Sugar Reduced)</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02041316" notABenefit="Y" sec3="Y"><name>Amoxil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230245" notABenefit="Y" sec3="Y"><name>PMS-Amoxicillin</name><manufacturerId>PMS</manufacturerId><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="081216037"><itemNumber>0042</itemNumber><strength>50mg/mL</strength><dosageForm>O/L</dosageForm><price>.0540</price><dailyCost>.8100</dailyCost><drug id="00452130" sec3="Y"><name>Novamoxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0540</individualPrice><dailyCost>.8100</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00628158" notABenefit="Y" sec3="Y"><name>Apo-Amoxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00865559" notABenefit="Y" sec3="Y"><name>Nu-Amoxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01934163" notABenefit="Y" sec3="Y"><name>Novamoxin (Sugar Reduced)</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02042592" notABenefit="Y" sec3="Y"><name>Amoxil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230246" notABenefit="Y" sec3="Y"><name>PMS-Amoxicillin</name><manufacturerId>PMS</manufacturerId><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="081216090"><itemNumber>0043</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><drug id="02036347" notABenefit="Y" sec3="Y"><name>Novamoxin Chewable</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02041685" notABenefit="Y" sec3="Y"><name>Amoxil Chewable</name><manufacturerId>AYE</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="081216091"><itemNumber>0044</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="02036355" notABenefit="Y" sec3="Y"><name>Novamoxin Chewable</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02041286" notABenefit="Y" sec3="Y"><name>Amoxil Chewable</name><manufacturerId>AYE</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00054"><name>AMOXICILLIN &amp; CLAVULANIC ACID</name><note>Amoxicillin/clavulanic acid is not recommended as first line treatment for acute  otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to  B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.</note><pcgGroup><pcg9 id="081216054"><itemNumber>0045</itemNumber><strength>25mg &amp; 6.25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0517</price><dailyCost>.7755</dailyCost><drug id="01916882" sec3="Y"><name>Clavulin</name><manufacturerId>GSK</manufacturerId><individualPrice>.1170</individualPrice><dailyCost>1.7550</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02243986" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><individualPrice>.0517</individualPrice><dailyCost>.7755</dailyCost><listingDate>2003-01-30</listingDate></drug><drug id="02244646" sec3="Y"><name>Ratio-Aclavulanate 125F</name><manufacturerId>RPH</manufacturerId><individualPrice>.0517</individualPrice><dailyCost>.7755</dailyCost><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="081216053"><itemNumber>0046</itemNumber><strength>50mg &amp; 12.5mg/mL</strength><dosageForm>O/L</dosageForm><price>.0869</price><dailyCost>1.3035</dailyCost><drug id="01916874" sec3="Y"><name>Clavulin</name><manufacturerId>GSK</manufacturerId><individualPrice>.2011</individualPrice><dailyCost>3.0165</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02243987" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><individualPrice>.0869</individualPrice><dailyCost>1.3035</dailyCost><listingDate>2003-01-30</listingDate></drug><drug id="02244647" sec3="Y"><name>Ratio-Aclavulanate 250F</name><manufacturerId>RPH</manufacturerId><individualPrice>.0869</individualPrice><dailyCost>1.3035</dailyCost><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="081216081"><itemNumber>0047</itemNumber><strength>200mg &amp; 28.5mg/5mL</strength><dosageForm>Susp</dosageForm><price>.1440</price><drug id="02238831" sec3="Y"><name>Clavulin (BID)</name><manufacturerId>GSK</manufacturerId><individualPrice>.1440</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="081216082"><itemNumber>0048</itemNumber><strength>400mg &amp; 57mg/5mL</strength><dosageForm>Susp</dosageForm><price>.2753</price><drug id="02238830" sec3="Y"><name>Clavulin (BID)</name><manufacturerId>GSK</manufacturerId><individualPrice>.2753</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02288559" notABenefit="Y" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="081216052"><itemNumber>0049</itemNumber><strength>250mg &amp; 125mg</strength><dosageForm>Tab</dosageForm><price>.4365</price><dailyCost>1.3095</dailyCost><drug id="01916866" notABenefit="Y" sec3="Y"><name>Clavulin</name><manufacturerId>GSK</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02243350" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><individualPrice>.4365</individualPrice><dailyCost>1.3095</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02243770" sec3="Y"><name>Ratio-Aclavulanate</name><manufacturerId>RPH</manufacturerId><individualPrice>.4366</individualPrice><dailyCost>1.3098</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="081216051"><itemNumber>0050</itemNumber><strength>500mg &amp; 125mg</strength><dosageForm>Tab</dosageForm><price>.6673</price><dailyCost>2.0019</dailyCost><drug id="01916858" sec3="Y"><name>Clavulin</name><manufacturerId>GSK</manufacturerId><individualPrice>1.4802</individualPrice><dailyCost>4.4406</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02243351" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><individualPrice>.6673</individualPrice><dailyCost>2.0019</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02243771" sec3="Y"><name>Ratio-Aclavulanate</name><manufacturerId>RPH</manufacturerId><individualPrice>.6673</individualPrice><dailyCost>2.0019</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="081216080"><itemNumber>0051</itemNumber><strength>875mg &amp; 125mg</strength><dosageForm>Tab</dosageForm><price>1.0009</price><drug id="02238829" sec3="Y"><name>Clavulin (BID)</name><manufacturerId>GSK</manufacturerId><individualPrice>2.2203</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02245623" sec3="Y"><name>Apo-Amoxi Clav</name><manufacturerId>APX</manufacturerId><individualPrice>1.0009</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247021" sec3="Y"><name>Ratio-Aclavulanate</name><manufacturerId>RPH</manufacturerId><individualPrice>1.0009</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02248138" sec3="Y"><name>Novo-Clavamoxin 875</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0009</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00042"><name>AMPICILLIN</name><note>Use with caution in urinary tract infections as even E. coli is resistant in approximately 20% of cases.</note><pcgGroup><pcg9 id="081216002"><itemNumber>0052</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.3071</price><dailyCost>1.2284</dailyCost><drug id="00002003" notABenefit="Y" sec3="Y"><name>Penbritin</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00020877" sec3="Y"><name>Novo-Ampicillin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3071</individualPrice><dailyCost>1.2284</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081216001"><itemNumber>0053</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.5955</price><dailyCost>2.3820</dailyCost><drug id="00002011" notABenefit="Y" sec3="Y"><name>Penbritin</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00020885" sec3="Y"><name>Novo-Ampicillin</name><manufacturerId>NOP</manufacturerId><individualPrice>.5955</individualPrice><dailyCost>2.3820</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00043"><name>CLOXACILLIN</name><pcgGroup><pcg9 id="081216008"><itemNumber>0054</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.1850</price><dailyCost>.7400</dailyCost><drug id="00002046" notABenefit="Y" sec3="Y"><name>Orbenin</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00337765" sec3="Y"><name>Novo-Cloxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1850</individualPrice><dailyCost>.7400</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00618292" notABenefit="Y" sec3="Y"><name>Apo-Cloxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00717584" notABenefit="Y" sec3="Y"><name>Nu-Cloxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081216007"><itemNumber>0055</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.3498</price><dailyCost>1.3992</dailyCost><drug id="00002054" notABenefit="Y" sec3="Y"><name>Orbenin</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00337773" sec3="Y"><name>Novo-Cloxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3498</individualPrice><dailyCost>1.3992</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00618284" notABenefit="Y" sec3="Y"><name>Apo-Cloxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00717592" notABenefit="Y" sec3="Y"><name>Nu-Cloxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081216009"><itemNumber>0056</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0450</price><dailyCost>1.8000</dailyCost><drug id="00337757" sec3="Y"><name>Novo-Cloxin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0450</individualPrice><dailyCost>1.8000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00644633" notABenefit="Y" sec3="Y"><name>Apo-Cloxi</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00717630" notABenefit="Y" sec3="Y"><name>Nu-Cloxi</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02042975" notABenefit="Y" sec3="Y"><name>Orbenin</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00049"><name>PENICILLIN V (POTASSIUM)</name><pcgGroup><pcg9 id="081216035"><itemNumber>0057</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0535</price><dailyCost>1.0700</dailyCost><drug id="00018635" notABenefit="Y" sec3="Y"><name>Nadopen-V</name><manufacturerId>NDA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00642223" sec3="Y"><name>Apo-Pen V-K</name><manufacturerId>APX</manufacturerId><individualPrice>.0535</individualPrice><dailyCost>1.0700</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081216042"><itemNumber>0058</itemNumber><strength>60mg/mL</strength><dosageForm>O/L</dosageForm><price>.0472</price><dailyCost>.7080</dailyCost><drug id="00331945" notABenefit="Y" sec3="Y"><name>VC-K 500</name><manufacturerId>LIL</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00391603" sec3="Y"><name>Novo-Pen-VK-500</name><manufacturerId>NOP</manufacturerId><individualPrice>.0472</individualPrice><dailyCost>.7080</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00642231" notABenefit="Y" sec3="Y"><name>Apo-Pen V-K</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081216034"><itemNumber>0059</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.0710</price><dailyCost>.2840</dailyCost><drug id="00021202" sec3="Y"><name>Novo-Pen-VK-500</name><manufacturerId>NOP</manufacturerId><individualPrice>.0710</individualPrice><dailyCost>.2840</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00248843" notABenefit="Y" sec3="Y"><name>PVF-K 500</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00642215" notABenefit="Y" sec3="Y"><name>Apo-Pen V-K</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00717568" notABenefit="Y" sec3="Y"><name>Nu-Pen VK</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01429"><name>PIPERACILLIN SODIUM &amp; TAZOBACTAM SODIUM</name><pcgGroup><pcg9 id="081216101"><itemNumber>0060</itemNumber><strength>2g &amp; 250mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><drug id="02170817" notABenefit="Y" sec3="Y"><name>Tazocin</name><manufacturerId>WYE</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02308444" notABenefit="Y" sec3="Y"><name>Piperacillin &amp; Tazobactam for Injection</name><manufacturerId>APX</manufacturerId><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="081216097"><itemNumber>0061</itemNumber><strength>3g &amp; 375mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><drug id="02170795" notABenefit="Y" sec3="Y"><name>Tazocin</name><manufacturerId>WYE</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02308452" notABenefit="Y" sec3="Y"><name>Piperacillin &amp; Tazobactam for Injection</name><manufacturerId>APX</manufacturerId><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="081216102"><itemNumber>0062</itemNumber><strength>4g &amp; 500mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><drug id="02170809" notABenefit="Y" sec3="Y"><name>Tazocin</name><manufacturerId>WYE</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02308460" notABenefit="Y" sec3="Y"><name>Piperacillin &amp; Tazobactam for Injection</name><manufacturerId>APX</manufacturerId><listingDate>2008-12-03</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081224000"><name>ANTIBIOTICS TETRACYCLINES</name><genericName id="00062"><name>DOXYCYCLINE HYCLATE</name><pcgGroup><pcg9 id="081224015"><itemNumber>0063</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="00578452" dinStatus="N" notABenefit="Y" sec3="Y" sec6="Y"><name>Vibra-Tabs</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00874256" dinStatus="N" notABenefit="Y" sec3="Y" sec6="Y"><name>Apo-Doxy-Tabs</name><manufacturerId>APX</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00063"><name>MINOCYCLINE HCL</name><pcgGroup><pcg9 id="081224021"><itemNumber>0064</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><drug id="01914138" notABenefit="Y" sec3="Y"><name>Ratio-Minocycline</name><manufacturerId>RPH</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02084090" notABenefit="Y" sec3="Y"><name>Apo-Minocycline</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02108143" notABenefit="Y" sec3="Y"><name>Novo-Minocycline</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02173514" notABenefit="Y" sec3="Y"><name>Minocin</name><manufacturerId>STI</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02230735" notABenefit="Y" sec3="Y"><name>Mylan-Minocycline</name><manufacturerId>MYL</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02237313" notABenefit="Y" sec3="Y"><name>Sandoz Minocycline</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02294419" notABenefit="Y" sec3="Y"><name>PMS-Minocycline</name><manufacturerId>PMS</manufacturerId><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="081224022"><itemNumber>0065</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><drug id="01914146" notABenefit="Y" sec3="Y"><name>Ratio-Minocycline</name><manufacturerId>RPH</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02084104" notABenefit="Y" sec3="Y"><name>Apo-Minocycline</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02108151" notABenefit="Y" sec3="Y"><name>Novo-Minocycline</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02173506" notABenefit="Y" sec3="Y"><name>Minocin</name><manufacturerId>STI</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02230736" notABenefit="Y" sec3="Y"><name>Mylan-Minocycline</name><manufacturerId>MYL</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02237314" notABenefit="Y" sec3="Y"><name>Sandoz Minocycline</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02294427" notABenefit="Y" sec3="Y"><name>PMS-Minocycline</name><manufacturerId>PMS</manufacturerId><listingDate>2008-04-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00060"><name>TETRACYCLINE</name><note>Tetracycline use during tooth development (last half of pregnancy and up to age 8) may cause permanent tooth discoloration or enamel hypoplasia. These reactions are more common during long-term use. Tetracyclines should not be used in these groups unless other antibiotics are unlikely to be effective or are contraindicated.</note><pcgGroup><pcg9 id="081224002"><itemNumber>0066</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.0549</price><dailyCost>.2196</dailyCost><drug id="00024422" notABenefit="Y" sec3="Y"><name>Tetracyn</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00580929" sec3="Y"><name>Apo-Tetra</name><manufacturerId>APX</manufacturerId><individualPrice>.0549</individualPrice><dailyCost>.2196</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081228000"><name>ANTIBIOTICS OTHER ANTIBIOTICS</name><genericName id="00077"><name>CEFACLOR</name><pcgGroup><pcg9 id="081228038"><itemNumber>0067</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.9697</price><dailyCost>2.9091</dailyCost><drug id="00465186" sec3="Y"><name>Ceclor</name><manufacturerId>PHE</manufacturerId><individualPrice>1.0207</individualPrice><dailyCost>3.0621</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02185830" notABenefit="Y" sec3="Y"><name>PMS-Cefaclor</name><manufacturerId>PMS</manufacturerId><listingDate>1997-08-28</listingDate></drug><drug id="02230263" sec3="Y"><name>Apo-Cefaclor</name><manufacturerId>APX</manufacturerId><individualPrice>.9697</individualPrice><dailyCost>2.9091</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02231432" notABenefit="Y" sec3="Y"><name>Nu-Cefaclor</name><manufacturerId>NXP</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081228037"><itemNumber>0068</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>1.9300</price><dailyCost>5.7900</dailyCost><drug id="00465194" sec3="Y"><name>Ceclor</name><manufacturerId>PHE</manufacturerId><individualPrice>2.0040</individualPrice><dailyCost>6.0120</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02185849" notABenefit="Y" sec3="Y"><name>PMS-Cefaclor</name><manufacturerId>PMS</manufacturerId><listingDate>1997-08-28</listingDate></drug><drug id="02230264" sec3="Y"><name>Apo-Cefaclor</name><manufacturerId>APX</manufacturerId><individualPrice>1.9300</individualPrice><dailyCost>5.7900</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02231433" notABenefit="Y" sec3="Y"><name>Nu-Cefaclor</name><manufacturerId>NXP</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081228040"><itemNumber>0069</itemNumber><strength>25mg/mL</strength><dosageForm>Oral Susp</dosageForm><price>.1037</price><dailyCost>1.5555</dailyCost><drug id="00465208" sec3="Y"><name>Ceclor</name><manufacturerId>PHE</manufacturerId><individualPrice>.1089</individualPrice><dailyCost>1.6335</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02185857" notABenefit="Y" sec3="Y"><name>PMS-Cefaclor</name><manufacturerId>PMS</manufacturerId><listingDate>1999-04-15</listingDate></drug><drug id="02237500" dinStatus="E" sec3="Y"><name>Apo-Cefaclor</name><manufacturerId>APX</manufacturerId><individualPrice>.1037</individualPrice><dailyCost>1.5555</dailyCost><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081228039"><itemNumber>0070</itemNumber><strength>50mg/mL</strength><dosageForm>Oral Susp</dosageForm><price>.1895</price><dailyCost>2.8425</dailyCost><drug id="00465216" sec3="Y"><name>Ceclor</name><manufacturerId>PHE</manufacturerId><individualPrice>.1993</individualPrice><dailyCost>2.9895</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02185865" notABenefit="Y" sec3="Y"><name>PMS-Cefaclor</name><manufacturerId>PMS</manufacturerId><listingDate>1999-04-15</listingDate></drug><drug id="02237501" dinStatus="E" sec3="Y"><name>Apo-Cefaclor</name><manufacturerId>APX</manufacturerId><individualPrice>.1895</individualPrice><dailyCost>2.8425</dailyCost><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081228087"><itemNumber>0071</itemNumber><strength>375mg/5mL</strength><dosageForm>Oral Susp</dosageForm><price>.2872</price><drug id="00832804" sec3="Y"><name>Ceclor</name><manufacturerId>PHE</manufacturerId><individualPrice>.2872</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02185873" notABenefit="Y" sec3="Y"><name>PMS-Cefaclor</name><manufacturerId>PMS</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00076"><name>CEFADROXIL</name><pcgGroup><pcg9 id="081228036"><itemNumber>0072</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.8421</price><dailyCost>1.6842</dailyCost><drug id="00507245" notABenefit="Y" sec3="Y"><name>Duricef</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02235134" sec3="Y"><name>Novo-Cefadroxil</name><manufacturerId>NOP</manufacturerId><individualPrice>.8421</individualPrice><dailyCost>1.6842</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02240774" sec3="Y"><name>Apo-Cefadroxil</name><manufacturerId>APX</manufacturerId><individualPrice>.8421</individualPrice><dailyCost>1.6842</dailyCost><listingDate>2000-04-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00084"><name>CEFIXIME</name><pcgGroup><pcg9 id="081228054"><itemNumber>0073</itemNumber><strength>20mg/mL</strength><dosageForm>Oral Susp</dosageForm><price>.3989</price><drug id="00868965" sec3="Y"><name>Suprax</name><manufacturerId>SAV</manufacturerId><individualPrice>.3989</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081228056"><itemNumber>0074</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>3.4300</price><dailyCost>3.4300</dailyCost><drug id="00868981" sec3="Y"><name>Suprax</name><manufacturerId>SAV</manufacturerId><individualPrice>3.4300</individualPrice><dailyCost>3.4300</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00095"><name>CEFOXITIN SODIUM</name><pcgGroup><pcg9 id="081228119"><itemNumber>0075</itemNumber><strength>1g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><drug id="00663697" notABenefit="Y" sec3="Y"><name>Mefoxin</name><manufacturerId>MSD</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02291711" notABenefit="Y" sec3="Y"><name>Cefoxitin for Injection</name><manufacturerId>ORC</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="081228120"><itemNumber>0076</itemNumber><strength>2g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><drug id="00663700" notABenefit="Y" sec3="Y"><name>Mefoxin</name><manufacturerId>MSD</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02291738" notABenefit="Y" sec3="Y"><name>Cefoxitin for Injection</name><manufacturerId>ORC</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00099"><name>CEFPROZIL</name><pcgGroup><pcg9 id="081228083"><itemNumber>0077</itemNumber><strength>125mg/5mL</strength><dosageForm>Oral Susp</dosageForm><price>.0791</price><drug id="02163675" sec3="Y"><name>Cefzil</name><manufacturerId>BQU</manufacturerId><individualPrice>.1693</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02293943" sec3="Y"><name>Apo-Cefprozil</name><manufacturerId>APX</manufacturerId><individualPrice>.0791</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02303426" dinStatus="N" sec3="Y"><name>Sandoz Cefprozil</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0791</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="081228084"><itemNumber>0078</itemNumber><strength>250mg/5mL</strength><dosageForm>Oral Susp</dosageForm><price>.1581</price><drug id="02163683" sec3="Y"><name>Cefzil</name><manufacturerId>BQU</manufacturerId><individualPrice>.3385</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02293579" sec3="Y"><name>Ran-Cefprozil</name><manufacturerId>RAN</manufacturerId><individualPrice>.1581</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02293951" sec3="Y"><name>Apo-Cefprozil</name><manufacturerId>APX</manufacturerId><individualPrice>.1581</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02303434" dinStatus="N" sec3="Y"><name>Sandoz Cefprozil</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1581</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="081228085"><itemNumber>0079</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.8092</price><drug id="02163659" sec3="Y"><name>Cefzil</name><manufacturerId>BQU</manufacturerId><individualPrice>1.7327</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02292998" sec3="Y"><name>Apo-Cefprozil</name><manufacturerId>APX</manufacturerId><individualPrice>.8092</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02293528" sec3="Y"><name>Ran-Cefprozil</name><manufacturerId>RAN</manufacturerId><individualPrice>.8092</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02302179" sec3="Y"><name>Sandoz Cefprozil</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8092</individualPrice><listingDate>2008-03-25</listingDate></drug><drug id="02332035" dinStatus="N" sec3="Y"><name>Cefprozil Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.8092</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="081228086"><itemNumber>0080</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>1.5867</price><drug id="02163667" sec3="Y"><name>Cefzil</name><manufacturerId>BQU</manufacturerId><individualPrice>3.3974</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02293005" sec3="Y"><name>Apo-Cefprozil</name><manufacturerId>APX</manufacturerId><individualPrice>1.5867</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02293536" sec3="Y"><name>Ran-Cefprozil</name><manufacturerId>RAN</manufacturerId><individualPrice>1.5867</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02302187" sec3="Y"><name>Sandoz Cefprozil</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.5867</individualPrice><listingDate>2008-03-25</listingDate></drug><drug id="02332043" dinStatus="N" sec3="Y"><name>Cefprozil Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.5867</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00078"><name>CEFTRIAXONE DISODIUM</name><pcgGroup><pcg9 id="081228043"><itemNumber>0081</itemNumber><strength>0.25g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><price>5.3750</price><drug id="00657387" sec3="Y"><name>Rocephin</name><manufacturerId>HLR</manufacturerId><individualPrice>11.2860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02250276" sec3="Y"><name>Ceftriaxone Sodium for Injection, BP</name><manufacturerId>MAY</manufacturerId><individualPrice>5.3750</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02292866" dinStatus="N" sec3="Y"><name>Ceftriaxone for Injection USP</name><manufacturerId>ORC</manufacturerId><individualPrice>5.3750</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="081228045"><itemNumber>0082</itemNumber><strength>1g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><price>17.0000</price><drug id="00657417" sec3="Y"><name>Rocephin</name><manufacturerId>HLR</manufacturerId><individualPrice>35.7000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02250292" sec3="Y"><name>Ceftriaxone Sodium for Injection, BP</name><manufacturerId>MAY</manufacturerId><individualPrice>17.0000</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02287633" sec3="Y"><name>Ceftriaxone Sodium for Injection</name><manufacturerId>NOP</manufacturerId><individualPrice>17.0000</individualPrice><listingDate>2008-03-25</listingDate></drug><drug id="02292270" sec3="Y"><name>Ceftriaxone</name><manufacturerId>SDZ</manufacturerId><individualPrice>17.5000</individualPrice><listingDate>2007-05-04</listingDate></drug><drug id="02292874" sec3="Y"><name>Ceftriaxone for Injection USP</name><manufacturerId>ORC</manufacturerId><individualPrice>17.0000</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="081228046"><itemNumber>0083</itemNumber><strength>2g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><price>33.5000</price><drug id="00657409" sec3="Y"><name>Rocephin</name><manufacturerId>HLR</manufacturerId><individualPrice>68.9700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02250306" sec3="Y"><name>Ceftriaxone Sodium for Injection, BP</name><manufacturerId>MAY</manufacturerId><individualPrice>33.5000</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02292289" sec3="Y"><name>Ceftriaxone</name><manufacturerId>SDZ</manufacturerId><individualPrice>34.4850</individualPrice><listingDate>2007-05-04</listingDate></drug><drug id="02292882" sec3="Y"><name>Ceftriaxone for Injection USP</name><manufacturerId>ORC</manufacturerId><individualPrice>33.5000</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="081228121"><itemNumber>0084</itemNumber><strength>10g/Vial</strength><dosageForm>Inj Pd-1 Vial Pk</dosageForm><drug id="00851957" notABenefit="Y" sec3="Y"><name>Rocephin</name><manufacturerId>HLR</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02292904" notABenefit="Y" sec3="Y"><name>Ceftriaxone for Injection USP</name><manufacturerId>APX</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00088"><name>CEFUROXIME AXETIL</name><pcgGroup><pcg9 id="081228079"><itemNumber>0085</itemNumber><strength>125mg/5mL</strength><dosageForm>Susp</dosageForm><price>.1748</price><drug id="02212307" sec3="Y"><name>Ceftin</name><manufacturerId>GSK</manufacturerId><individualPrice>.1748</individualPrice><listingDate>1998-10-21</listingDate></drug></pcg9><pcg9 id="081228064"><itemNumber>0086</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.7237</price><dailyCost>1.4474</dailyCost><drug id="02212277" sec3="Y"><name>Ceftin</name><manufacturerId>GSK</manufacturerId><individualPrice>1.6187</individualPrice><dailyCost>3.2374</dailyCost><listingDate>1998-10-21</listingDate></drug><drug id="02242656" sec3="Y"><name>Ratio-Cefuroxime</name><manufacturerId>RPH</manufacturerId><individualPrice>.7237</individualPrice><dailyCost>1.4474</dailyCost><listingDate>2002-04-04</listingDate></drug><drug id="02244393" sec3="Y"><name>Apo-Cefuroxime</name><manufacturerId>APX</manufacturerId><individualPrice>.7237</individualPrice><dailyCost>1.4474</dailyCost><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="081228065"><itemNumber>0087</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>1.4337</price><dailyCost>2.8674</dailyCost><drug id="02212285" sec3="Y"><name>Ceftin</name><manufacturerId>GSK</manufacturerId><individualPrice>3.2067</individualPrice><dailyCost>6.4134</dailyCost><listingDate>1998-10-21</listingDate></drug><drug id="02242657" sec3="Y"><name>Ratio-Cefuroxime</name><manufacturerId>RPH</manufacturerId><individualPrice>1.4337</individualPrice><dailyCost>2.8674</dailyCost><listingDate>2002-04-04</listingDate></drug><drug id="02244394" sec3="Y"><name>Apo-Cefuroxime</name><manufacturerId>APX</manufacturerId><individualPrice>1.4337</individualPrice><dailyCost>2.8674</dailyCost><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00065"><name>CEPHALEXIN MONOHYDRATE</name><pcgGroup><pcg9 id="081228001"><itemNumber>0088</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.2250</price><dailyCost>.9000</dailyCost><drug id="00253154" notABenefit="Y" sec3="Y"><name>Ceporex</name><manufacturerId>GLA</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00342084" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2250</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081228029"><itemNumber>0089</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.4500</price><dailyCost>1.8000</dailyCost><drug id="00253146" notABenefit="Y" sec3="Y"><name>Ceporex</name><manufacturerId>GLA</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00342114" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><individualPrice>.4500</individualPrice><dailyCost>1.8000</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081228003"><itemNumber>0090</itemNumber><strength>25mg/mL</strength><dosageForm>Pd for Oral Susp</dosageForm><price>.0457</price><dailyCost>.9140</dailyCost><drug id="00015547" sec3="Y"><name>Keflex</name><manufacturerId>PHE</manufacturerId><individualPrice>.0457</individualPrice><dailyCost>.9140</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00342106" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0457</individualPrice><dailyCost>.9140</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02177811" notABenefit="Y" sec3="Y"><name>PMS-Cephalexin 125</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081228002"><itemNumber>0091</itemNumber><strength>50mg/mL</strength><dosageForm>Pd for Oral Susp</dosageForm><price>.0948</price><dailyCost>1.8960</dailyCost><drug id="00035645" sec3="Y"><name>Keflex</name><manufacturerId>PHE</manufacturerId><individualPrice>.0948</individualPrice><dailyCost>1.8960</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00342092" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0948</individualPrice><dailyCost>1.8960</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02177838" notABenefit="Y" sec3="Y"><name>PMS-Cephalexin 250</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081228034"><itemNumber>0092</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.2250</price><dailyCost>.9000</dailyCost><drug id="00403628" sec3="Y"><name>Keflex</name><manufacturerId>PHE</manufacturerId><individualPrice>.2370</individualPrice><dailyCost>.9480</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00583413" notABenefit="Y" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00768723" sec3="Y"><name>Apo-Cephalex</name><manufacturerId>APX</manufacturerId><individualPrice>.2250</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865877" notABenefit="Y" sec3="Y"><name>Nu-Cephalex</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02177781" notABenefit="Y" sec3="Y"><name>PMS-Cephalexin</name><manufacturerId>PMS</manufacturerId><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="081228028"><itemNumber>0093</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.4500</price><dailyCost>1.8000</dailyCost><drug id="00244392" sec3="Y"><name>Keflex</name><manufacturerId>PHE</manufacturerId><individualPrice>.4740</individualPrice><dailyCost>1.8960</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00583421" notABenefit="Y" sec3="Y"><name>Novo-Lexin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00768715" sec3="Y"><name>Apo-Cephalex</name><manufacturerId>APX</manufacturerId><individualPrice>.4500</individualPrice><dailyCost>1.8000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865885" notABenefit="Y" sec3="Y"><name>Nu-Cephalex</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02177803" notABenefit="Y" sec3="Y"><name>PMS-Cephalexin</name><manufacturerId>PMS</manufacturerId><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00067"><name>CLINDAMYCIN HCL</name><pcgGroup><pcg9 id="081228006"><itemNumber>0094</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.3881</price><dailyCost>3.1048</dailyCost><drug id="00030570" sec3="Y"><name>Dalacin C</name><manufacturerId>PFI</manufacturerId><individualPrice>.8868</individualPrice><dailyCost>7.0944</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02241709" sec3="Y"><name>Novo-Clindamycin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3881</individualPrice><dailyCost>3.1048</dailyCost><listingDate>2000-11-30</listingDate></drug><drug id="02245232" sec3="Y"><name>Apo-Clindamycin</name><manufacturerId>APX</manufacturerId><individualPrice>.3881</individualPrice><dailyCost>3.1048</dailyCost><listingDate>2002-07-29</listingDate></drug><drug id="02258331" sec3="Y"><name>Mylan-Clindamycin</name><manufacturerId>MYL</manufacturerId><individualPrice>.3881</individualPrice><dailyCost>3.1048</dailyCost><listingDate>2004-10-14</listingDate></drug><drug id="02294826" sec3="Y"><name>PMS-Clindamycin</name><manufacturerId>PMS</manufacturerId><individualPrice>.3881</individualPrice><dailyCost>3.1048</dailyCost><listingDate>2008-05-16</listingDate></drug></pcg9><pcg9 id="081228088"><itemNumber>0095</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.7762</price><drug id="02182866" sec3="Y"><name>Dalacin C</name><manufacturerId>PFI</manufacturerId><individualPrice>1.7736</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02241710" sec3="Y"><name>Novo-Clindamycin</name><manufacturerId>NOP</manufacturerId><individualPrice>.7762</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02245233" sec3="Y"><name>Apo-Clindamycin</name><manufacturerId>APX</manufacturerId><individualPrice>.7762</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02258358" sec3="Y"><name>Mylan-Clindamycin</name><manufacturerId>MYL</manufacturerId><individualPrice>.7762</individualPrice><listingDate>2004-10-14</listingDate></drug><drug id="02294834" sec3="Y"><name>PMS-Clindamycin</name><manufacturerId>PMS</manufacturerId><individualPrice>.7762</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00068"><name>CLINDAMYCIN PALMITATE</name><pcgGroup><pcg9 id="081228007"><itemNumber>0096</itemNumber><strength>15mg/mL</strength><dosageForm>Pd for Oral Susp</dosageForm><price>.1193</price><drug id="00225851" sec3="Y"><name>Dalacin C Flavoured Granules</name><manufacturerId>PFI</manufacturerId><individualPrice>.1193</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00069"><name>CLINDAMYCIN PHOSPHATE</name><pcgGroup><pcg9 id="081228008"><itemNumber>0097</itemNumber><strength>300mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>4.5740</price><note>Clindamycin is well absorbed by the oral route, therefore stepdown therapy from IV to oral is possible.</note><drug id="00260436" sec3="Y"><name>Dalacin C</name><manufacturerId>PFI</manufacturerId><individualPrice>7.7917</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230540" sec3="Y"><name>Clindamycin Phosphate Injection USP</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.5740</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00098"><name>SODIUM FUSIDATE</name><pcgGroup lccId="00004"><pcg9 id="081228082"><itemNumber>0098</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>1.1250</price><drug id="01934252" dinStatus="E" sec3="Y" sec12="Y"><name>Fucidin Leo</name><manufacturerId>LEO</manufacturerId><individualPrice>1.1250</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="342">As part of combination therapy, for the treatment of serious infections confirmed on culture to be caused by a strain of S. aureus or coagulase-negative staphylococci likely susceptible to fusidic acid where standard anti-staphylococcal agents are precluded because of allergy, resistance or treatment failure.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00668"><name>TOBRAMYCIN</name><pcgGroup><pcg9 id="081228094"><itemNumber>0099</itemNumber><strength>300mg/5mL</strength><dosageForm>Inh Sol-5mL Pk</dosageForm><price>50.6250</price><drug id="02239630" sec3="Y"><name>TOBI</name><manufacturerId>NOV</manufacturerId><individualPrice>50.6250</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00075"><name>TOBRAMYCIN SULFATE</name><pcgGroup><pcg9 id="081228035"><itemNumber>0100</itemNumber><strength>80mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>4.5000</price><drug id="00325449" notABenefit="Y" sec3="Y"><name>Nebcin</name><manufacturerId>LIL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02241210" sec3="Y"><name>Tobramycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.5000</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081600000"><name>ANTITUBERCULAR AGENTS</name><genericName id="00100"><name>ETHAMBUTOL HCL</name><pcgGroup><pcg9 id="081600004"><itemNumber>0101</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.0973</price><drug id="00127957" notABenefit="Y" sec3="Y"><name>Myambutol</name><manufacturerId>LED</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00247960" sec3="Y"><name>Etibi</name><manufacturerId>VAL</manufacturerId><individualPrice>.0973</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081600003"><itemNumber>0102</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.2711</price><drug id="00247979" sec3="Y"><name>Etibi</name><manufacturerId>VAL</manufacturerId><individualPrice>.2711</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02170078" notABenefit="Y" sec3="Y"><name>Myambutol</name><manufacturerId>WAY</manufacturerId><listingDate>1997-02-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00101"><name>ISONIAZID</name><pcgGroup><pcg9 id="081600010"><itemNumber>0103</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.0640</price><drug id="00272655" dinStatus="E" sec3="Y"><name>Isotamine</name><manufacturerId>VAL</manufacturerId><individualPrice>.0640</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00104"><name>PYRAZINAMIDE</name><pcgGroup><pcg9 id="081600012"><itemNumber>0104</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.4980</price><drug id="00283991" sec3="Y"><name>Tebrazid</name><manufacturerId>VAL</manufacturerId><individualPrice>.4980</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00107"><name>RIFABUTIN</name><pcgGroup lccId="00005"><pcg9 id="081600018"><itemNumber>0105</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>4.0560</price><drug id="02063786" sec3="Y" sec12="Y"><name>Mycobutin</name><manufacturerId>PFI</manufacturerId><individualPrice>4.0560</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" type="R">For the prevention of Mycobacterium Avium Intracellular (MAI) in:</lccNote><lccNote seq="002" reasonForUseId="103">Patients with a CD4+ cell count less than 200/mm3 with an AIDS-defining diagnosis;</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="104">Patients with a CD4+ cell count less than 100/mm3 without an AIDS-defining diagnosis.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00102"><name>RIFAMPIN</name><note>Except when used for prophylaxis in contacts of H. influenzae or N. meningitidis, rifampin should not be used as monotherapy, as bacterial resistance will develop quickly.</note><pcgGroup><pcg9 id="081600009"><itemNumber>0106</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.6038</price><drug id="00393444" sec3="Y"><name>Rofact</name><manufacturerId>VAL</manufacturerId><individualPrice>.6038</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02091887" sec3="Y"><name>Rifadin</name><manufacturerId>SAV</manufacturerId><individualPrice>.7707</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081600008"><itemNumber>0107</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.9503</price><drug id="00343617" sec3="Y"><name>Rofact</name><manufacturerId>VAL</manufacturerId><individualPrice>.9503</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02092808" sec3="Y"><name>Rifadin</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2129</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="081800000"><name>ANTIVIRALS</name><genericName id="01567"><name>ABACAVIR &amp; LAMIVUDINE &amp; ZIDOVUDINE</name><pcgGroup><pcg9 id="081800065"><itemNumber>0108</itemNumber><strength>300mg/150mg/300mg</strength><dosageForm>Tab</dosageForm><price>17.3102</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02244757" sec3="Y"><name>Trizivir</name><manufacturerId>GSK</manufacturerId><individualPrice>17.3102</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01426"><name>ABACAVIR SULFATE</name><pcgGroup><pcg9 id="081800054"><itemNumber>0109</itemNumber><strength>20mg/mL</strength><dosageForm>O/L</dosageForm><price>.4474</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02240358" sec3="Y"><name>Ziagen</name><manufacturerId>GSK</manufacturerId><individualPrice>.4474</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="081800053"><itemNumber>0110</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>6.8693</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02240357" sec3="Y"><name>Ziagen</name><manufacturerId>GSK</manufacturerId><individualPrice>6.8693</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01678"><name>ABACAVIR SULFATE &amp; LAMIVUDINE</name><pcgGroup><pcg9 id="081800094"><itemNumber>0111</itemNumber><strength>600mg/300mg</strength><dosageForm>Tab</dosageForm><price>22.7947</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02269341" sec3="Y"><name>Kivexa</name><manufacturerId>GSK</manufacturerId><individualPrice>22.7947</individualPrice><listingDate>2006-06-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00109"><name>ACYCLOVIR</name><pcgGroup><pcg9 id="081800019"><strength>200mg/5mL</strength><dosageForm>Susp</dosageForm><price>.2450</price><drug id="00886157" sec6="Y"><name>Zovirax</name><manufacturerId>GLW</manufacturerId><individualPrice>.2450</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081800026"><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.9395</price><drug id="02197405" sec6="Y"><name>Nu-Acyclovir</name><manufacturerId>NXP</manufacturerId><individualPrice>.9395</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="081800100"><itemNumber>0112</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><drug id="00634506" notABenefit="Y" sec3="Y" sec6="Y"><name>Zovirax</name><manufacturerId>GSK</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02078627" notABenefit="Y" sec3="Y" sec6="Y"><name>Ratio-Acyclovir</name><manufacturerId>RPH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02207621" notABenefit="Y" sec3="Y" sec6="Y"><name>Apo-Acyclovir</name><manufacturerId>APX</manufacturerId><listingDate>1998-12-31</listingDate></drug><drug id="02242784" notABenefit="Y" sec3="Y" sec6="Y"><name>Gen-Acyclovir</name><manufacturerId>GEN</manufacturerId><listingDate>2001-06-07</listingDate></drug><drug id="02285959" notABenefit="Y" sec3="Y" sec6="Y"><name>Novo-Acyclovir</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="081800027"><strength>400mg</strength><dosageForm>Tab</dosageForm><price>1.8555</price><drug id="02197413" sec6="Y"><name>Nu-Acyclovir</name><manufacturerId>NXP</manufacturerId><individualPrice>1.8555</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="081800101"><itemNumber>0113</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><drug id="01911627" notABenefit="Y" sec3="Y" sec6="Y"><name>Zovirax</name><manufacturerId>GSK</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02078635" notABenefit="Y" sec3="Y" sec6="Y"><name>Ratio-Acyclovir</name><manufacturerId>RPH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02207648" notABenefit="Y" sec3="Y" sec6="Y"><name>Apo-Acyclovir</name><manufacturerId>APX</manufacturerId><listingDate>1998-12-31</listingDate></drug><drug id="02242463" notABenefit="Y" sec3="Y" sec6="Y"><name>Gen-Acyclovir</name><manufacturerId>GEN</manufacturerId><listingDate>2001-06-07</listingDate></drug><drug id="02285967" notABenefit="Y" sec3="Y" sec6="Y"><name>Novo-Acyclovir</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00007"><pcg9 id="081800002"><itemNumber>0114</itemNumber><strength>800mg</strength><dosageForm>Tab</dosageForm><price>2.2664</price><drug id="01911635" sec3="Y" sec6="Y" sec12="Y"><name>Zovirax</name><manufacturerId>GSK</manufacturerId><individualPrice>5.0692</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02078651" sec3="Y" sec6="Y" sec12="Y"><name>Ratio-Acyclovir</name><manufacturerId>RPH</manufacturerId><individualPrice>2.2664</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02197421" sec3="Y" sec6="Y" sec12="Y"><name>Nu-Acyclovir</name><manufacturerId>NXP</manufacturerId><individualPrice>2.2664</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02207656" sec3="Y" sec6="Y" sec12="Y"><name>Apo-Acyclovir</name><manufacturerId>APX</manufacturerId><individualPrice>2.2664</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02242464" sec3="Y" sec6="Y" sec12="Y"><name>Gen-Acyclovir</name><manufacturerId>GEN</manufacturerId><individualPrice>2.2664</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02285975" sec3="Y" sec6="Y" sec12="Y"><name>Novo-Acyclovir</name><manufacturerId>NOP</manufacturerId><individualPrice>2.2664</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><lccNote seq="001" type="R">In contrast to bacterial infections, viral replication precedes clinical signs and symptoms. Since antiviral agents are only active against replicating viruses, clinical benefit in reducing severity of symptoms and duration of illness is only marginal, at best. Therefore, treatment initiated beyond the stated time frames below is of no value, and treatment of mild cases should be carefully considered, in light of the minimal benefit which will be achieved. In addition, the balance of evidence indicates that the use of acyclovir in normal hosts in an attempt to prevent post-herpetic neuralgia is of no value.</lccNote><lccNote seq="002" type="R">Where specified, treatment must begin within the time frames indicated for the product to be reimbursed. There is no benefit from the therapy begun after these time frames.</lccNote><lccNote seq="003" type="R">Acyclovir tablets will be reimbursed when prescribed for:</lccNote><lccNote seq="004" reasonForUseId="95">Herpes zoster in immunocompetent patients 50 years of age or older, up to 72 hours after appearance of lesions. Dose: 800mg 5 times/day for 7 days.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="96">Herpes zoster ophthalmicus regardless of age, up to 72 hours after appearance of lesions. Dose: 800mg 5 times/day for 7 days.</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="008" reasonForUseId="97">Herpes zoster in immunocompromised patients regardless of age and time elapsed from onset. Dose: 800mg 5 times/day for 7 days.</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="010" reasonForUseId="314">Varicella zoster in immunocompetent patients greater than or equal to 12 years of age, up to 24 hours after appearance of lesions. Dose: 20mg/kg/dose (max. 800mg) 4 times/day for 5 days.</lccNote><lccNote seq="011" type="W">Network will limit supply up to 7 days and up to 35 tablets.</lccNote><lccNote seq="012" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01614"><name>ATAZANAVIR SULFATE</name><pcgGroup><pcg9 id="081800080"><itemNumber>0115</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>10.3655</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02248610" sec3="Y"><name>Reyataz</name><manufacturerId>BQU</manufacturerId><individualPrice>10.3655</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9><pcg9 id="081800081"><itemNumber>0116</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>10.4010</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02248611" sec3="Y"><name>Reyataz</name><manufacturerId>BQU</manufacturerId><individualPrice>10.4010</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01702"><name>DARUNAVIR</name><pcgGroup><pcg9 id="081800097"><itemNumber>0117</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>7.1690</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the 
Facilitated Access mechanism. In combination with ritonavir, as part of a HIV
treatment regimen for treatment-experienced adult patients who have demonstrated
failure to at least 2 Protease Inhibitors.
</note><drug id="02284057" sec3="Y" sec6="Y"><name>Prezista</name><manufacturerId>JNO</manufacturerId><individualPrice>7.1690</individualPrice><listingDate>2007-05-04</listingDate></drug></pcg9><pcg9 id="081800338"><itemNumber>0118</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>10.0830</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism. In combination with ritonavir, as part of a HIV treatment regimen for treatment-naive adult patients.</note><drug id="02324016" dinStatus="N" sec3="Y" sec6="Y"><name>Prezista</name><manufacturerId>JNO</manufacturerId><individualPrice>10.0830</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="081800337"><itemNumber>0119</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>14.3380</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the 
Facilitated Access mechanism. In combination with ritonavir, as part of a HIV
treatment regimen for treatment-experienced adult patients who have demonstrated
failure to at least 2 Protease Inhibitors.</note><drug id="02324024" dinStatus="N" sec3="Y" sec6="Y"><name>Prezista</name><manufacturerId>JNO</manufacturerId><individualPrice>14.3380</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01391"><name>DELAVIRDINE MESYLATE</name><pcgGroup><pcg9 id="081800043"><itemNumber>0120</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.7178</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02238348" sec3="Y"><name>Rescriptor</name><manufacturerId>PFI</manufacturerId><individualPrice>.7178</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01234"><name>DIDANOSINE</name><pcgGroup><pcg9 id="081800072"><itemNumber>0121</itemNumber><strength>125mg</strength><dosageForm>Enteric Coated Cap</dosageForm><price>3.3777</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02244596" sec3="Y"><name>Videx EC</name><manufacturerId>BQU</manufacturerId><individualPrice>3.3777</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="081800073"><itemNumber>0122</itemNumber><strength>200mg</strength><dosageForm>Enteric Coated Cap</dosageForm><price>5.4040</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02244597" sec3="Y"><name>Videx EC</name><manufacturerId>BQU</manufacturerId><individualPrice>5.4040</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="081800074"><itemNumber>0123</itemNumber><strength>250mg</strength><dosageForm>Enteric Coated Cap</dosageForm><price>6.7550</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02244598" sec3="Y"><name>Videx EC</name><manufacturerId>BQU</manufacturerId><individualPrice>6.7550</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="081800075"><itemNumber>0124</itemNumber><strength>400mg</strength><dosageForm>Enteric Coated Cap</dosageForm><price>10.8300</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02244599" sec3="Y"><name>Videx EC</name><manufacturerId>BQU</manufacturerId><individualPrice>10.8300</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01416"><name>EFAVIRENZ</name><pcgGroup><pcg9 id="081800050"><itemNumber>0125</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>1.1717</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02239886" sec3="Y"><name>Sustiva</name><manufacturerId>BQU</manufacturerId><individualPrice>1.1717</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="081800052"><itemNumber>0126</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>4.6861</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02239888" sec3="Y"><name>Sustiva</name><manufacturerId>BQU</manufacturerId><individualPrice>4.6861</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="081800076"><itemNumber>0127</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>14.0583</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02246045" sec3="Y"><name>Sustiva</name><manufacturerId>BQU</manufacturerId><individualPrice>14.0583</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01732"><name>EFAVIRENZ/TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE</name><pcgGroup><pcg9 id="081800103"><itemNumber>0128</itemNumber><strength>600mg/300mg/200mg</strength><dosageForm>Tab</dosageForm><price>39.1083</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02300699" sec3="Y"><name>Atripla</name><manufacturerId>BQU</manufacturerId><individualPrice>39.1083</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01710"><name>EMTRICITABINE &amp; TENOFOVIR DISOPROXIL FUMARATE</name><pcgGroup><pcg9 id="081800099"><itemNumber>0129</itemNumber><strength>200mg &amp; 300mg</strength><dosageForm>Tab</dosageForm><price>25.0500</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02274906" sec3="Y"><name>Truvada</name><manufacturerId>GIL</manufacturerId><individualPrice>25.0500</individualPrice><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01747"><name>ETRAVIRINE</name><pcgGroup><pcg9 id="081800104"><itemNumber>0130</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>5.5535</price><note>Note:  For use in combination with an optimized regimen, for the treatment of
HIV-1 infection in treatment-experienced adult patients who have failed prior anti-retroviral therapies and have HIV-1 strains resistant to multiple antiretroviral agents, including protease inhibitors (PIs) and other non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Note:  For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism</note><drug id="02306778" dinStatus="N" sec3="Y"><name>Intelence</name><manufacturerId>JNO</manufacturerId><individualPrice>5.5535</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00114"><name>FAMCICLOVIR</name><pcgGroup><pcg9 id="081800028"><itemNumber>0131</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><drug id="02229110" notABenefit="Y" sec3="Y"><name>Famvir</name><manufacturerId>NOV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02278081" notABenefit="Y" sec3="Y"><name>PMS-Famciclovir</name><manufacturerId>PMS</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02278634" notABenefit="Y" sec3="Y"><name>Sandoz Famciclovir</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02292025" notABenefit="Y" sec3="Y"><name>Apo-Famciclovir</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02305682" notABenefit="Y" sec3="Y"><name>Co Famciclovir</name><manufacturerId>COB</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="081800029"><itemNumber>0132</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="02229129" notABenefit="Y" sec3="Y"><name>Famvir</name><manufacturerId>NOV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02278103" notABenefit="Y" sec3="Y"><name>PMS-Famciclovir</name><manufacturerId>PMS</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02278642" notABenefit="Y" sec3="Y"><name>Sandoz Famciclovir</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02292041" notABenefit="Y" sec3="Y"><name>Apo-Famciclovir</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02305690" notABenefit="Y" sec3="Y"><name>Co Famciclovir</name><manufacturerId>COB</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00008"><pcg9 id="081800011"><itemNumber>0133</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>3.2026</price><drug id="02177102" sec3="Y" sec12="Y"><name>Famvir</name><manufacturerId>NOV</manufacturerId><individualPrice>6.7624</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02278111" sec3="Y" sec12="Y"><name>PMS-Famciclovir</name><manufacturerId>PMS</manufacturerId><individualPrice>3.2026</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02278650" sec3="Y" sec12="Y"><name>Sandoz Famciclovir</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.2026</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02292068" sec3="Y" sec12="Y"><name>Apo-Famciclovir</name><manufacturerId>APX</manufacturerId><individualPrice>3.2026</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02305704" dinStatus="N" sec3="Y" sec12="Y"><name>Co Famciclovir</name><manufacturerId>COB</manufacturerId><individualPrice>3.2026</individualPrice><listingDate>2008-12-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="147">Herpes zoster in patients 50 years of age or older, up to 72 hours* after appearance of lesions. Dose: 500mg 3 times/day for 7 days.</lccNote><lccNote seq="002" type="R">*The patient must begin treatment within the time frame specified for the product to be reimbursed. There is no benefit from the therapy begun after this time frame.</lccNote><lccNote seq="003" type="W">Network will limit supply to 7 days and 21 tablets.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01636"><name>FOSAMPRENAVIR CALCIUM</name><pcgGroup><pcg9 id="081800107"><itemNumber>0134</itemNumber><strength>50mg/mL</strength><dosageForm>Oral Susp</dosageForm><price>.5790</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02261553" dinStatus="N" sec3="Y"><name>Telzir</name><manufacturerId>GSK</manufacturerId><individualPrice>.5790</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="081800093"><itemNumber>0135</itemNumber><strength>700mg</strength><dosageForm>Tab</dosageForm><price>7.9200</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02261545" sec3="Y"><name>Telzir</name><manufacturerId>GSK</manufacturerId><individualPrice>7.9200</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00108"><name>GANCICLOVIR SODIUM</name><pcgGroup lccId="00009"><pcg9 id="081800001"><itemNumber>0136</itemNumber><strength>500mg/Vial</strength><dosageForm>Pd Inj-10mL Pk</dosageForm><price>41.2140</price><drug id="02162695" sec3="Y" sec6="Y" sec12="Y"><name>Cytovene</name><manufacturerId>HLR</manufacturerId><individualPrice>41.2140</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="12">For the treatment of CMV retinitis secondary to AIDS and other immunosuppressive syndromes.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00116"><name>INDINAVIR</name><pcgGroup><pcg9 id="081800015"><itemNumber>0137</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.3467</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02229161" sec3="Y"><name>Crixivan</name><manufacturerId>MFC</manufacturerId><individualPrice>1.3467</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="081800016"><itemNumber>0138</itemNumber><strength>400mg</strength><dosageForm>Cap</dosageForm><price>2.6933</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02229196" sec3="Y"><name>Crixivan</name><manufacturerId>MFC</manufacturerId><individualPrice>2.6933</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00111"><name>LAMIVUDINE</name><pcgGroup><pcg9 id="081800005"><itemNumber>0139</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.3139</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism. Reimbursement will not be provided for the treatment of hepatitis.</note><drug id="02192691" sec3="Y"><name>3TC</name><manufacturerId>GSK</manufacturerId><individualPrice>.3139</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081800004"><itemNumber>0140</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>4.8358</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism. Reimbursement will not be provided for the treatment of hepatitis.</note><drug id="02192683" sec3="Y"><name>3TC</name><manufacturerId>GSK</manufacturerId><individualPrice>4.8358</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081800078"><itemNumber>0141</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>9.6717</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.  Reimbursement will not be provided for the treatment of hepatitis</note><drug id="02247825" sec3="Y"><name>3TC</name><manufacturerId>GSK</manufacturerId><individualPrice>9.6717</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01404"><name>LAMIVUDINE &amp; ZIDOVUDINE</name><pcgGroup><pcg9 id="081800049"><itemNumber>0142</itemNumber><strength>150mg &amp; 300mg</strength><dosageForm>Tab</dosageForm><price>10.4412</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02239213" sec3="Y"><name>Combivir</name><manufacturerId>GSK</manufacturerId><individualPrice>10.4412</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01511"><name>LOPINAVIR &amp; RITONAVIR</name><pcgGroup><pcg9 id="081800061"><itemNumber>0143</itemNumber><strength>80mg/mL &amp; 20mg/mL</strength><dosageForm>O/L</dosageForm><price>2.1649</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02243644" sec3="Y"><name>Kaletra</name><manufacturerId>ABB</manufacturerId><individualPrice>2.1649</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="081800110"><itemNumber>0144</itemNumber><strength>100mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>2.7002</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02312301" dinStatus="N" sec3="Y"><name>Kaletra</name><manufacturerId>ABB</manufacturerId><individualPrice>2.7002</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="081800098"><itemNumber>0145</itemNumber><strength>200mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>5.4490</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02285533" sec3="Y"><name>Kaletra</name><manufacturerId>ABB</manufacturerId><individualPrice>5.4490</individualPrice><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01390"><name>NELFINAVIR MESYLATE</name><pcgGroup><pcg9 id="081800042"><itemNumber>0146</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>1.8200</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02238617" sec3="Y"><name>Viracept</name><manufacturerId>PFI</manufacturerId><individualPrice>1.8200</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="081800086"><itemNumber>0147</itemNumber><strength>625mg</strength><dosageForm>Tab</dosageForm><price>4.5500</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02248761" sec3="Y"><name>Viracept</name><manufacturerId>PFI</manufacturerId><individualPrice>4.5500</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01393"><name>NEVIRAPINE</name><pcgGroup><pcg9 id="081800044"><itemNumber>0148</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>4.9383</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02238748" sec3="Y"><name>Viramune</name><manufacturerId>BOE</manufacturerId><individualPrice>4.9383</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01554"><name>OSELTAMIVIR PHOSPHATE</name><pcgGroup lccId="00143"><pcg9 id="081800064"><itemNumber>0149</itemNumber><strength>75mg</strength><dosageForm>Cap</dosageForm><price>3.9000</price><drug id="02241472" sec3="Y" sec12="Y"><name>Tamiflu</name><manufacturerId>HLR</manufacturerId><individualPrice>3.9000</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="371">For the prophylaxis (max: 75mg daily) of institutionalized individuals during confirmed* outbreaks of Influenza A or Influenza B.</lccNote><lccNote seq="002" type="N">Network will limit supply to 6 weeks.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="372">For the treatment (max: 75mg bid) of institutionalized individuals during confirmed* outbreaks due to: Influenza B or, Influenza A (as an alternative to amantadine) or, Influenza A where new cases have developed despite amantadine prophylaxis.</lccNote><lccNote seq="005" type="N">Network will limit supply to 5 days.</lccNote><lccNote seq="006" type="R">*The outbreak must be confirmed by Public Health.</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01723"><name>RALTEGRAVIR POTASSIUM</name><pcgGroup><pcg9 id="081800102"><itemNumber>0150</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>13.5000</price><note>For use in combination with an optimized regimen, for the treatment of HIV-1 infection in treatment-experienced adult patients who cannot achieve complete viral suppression on multiple prior anti-retroviral regimens AND who have one of the following:
.  HIV-1 strains with documented resistance to at least one drug in each of the major classes of anti-retrovirals: protease inhibitors (Pls), non-nucleoside reverse transcriptase inhibitors(NNRTIs)and nucleoside reverse transcriptase inhibitors (NRTIs); OR
.  serious class-effect intolerance to Pls,NNRTs and/or NRTIs precluding treatment with that antiretroviral class

NOTE: For the treatment of HIV/AIDS,the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02301881" dinStatus="N" sec3="Y" sec6="Y"><name>Isentress</name><manufacturerId>MFC</manufacturerId><individualPrice>13.5000</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00113"><name>RITONAVIR</name><pcgGroup><pcg9 id="081800010"><itemNumber>0151</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>1.4671</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02241480" sec3="Y"><name>Norvir SEC</name><manufacturerId>ABB</manufacturerId><individualPrice>1.4671</individualPrice><listingDate>2000-02-16</listingDate></drug></pcg9><pcg9 id="081800009"><itemNumber>0152</itemNumber><strength>80mg/mL</strength><dosageForm>O/L</dosageForm><price>1.1839</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02229145" sec3="Y"><name>Norvir</name><manufacturerId>ABB</manufacturerId><individualPrice>1.1839</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00110"><name>SAQUINAVIR MESYLATE</name><pcgGroup><pcg9 id="081800003"><itemNumber>0153</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.8200</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02216965" sec3="Y"><name>Invirase</name><manufacturerId>HLR</manufacturerId><individualPrice>1.8200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="081800045"><itemNumber>0154</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.0557</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02239083" dinStatus="E" sec3="Y"><name>Fortovase</name><manufacturerId>HLR</manufacturerId><individualPrice>1.0557</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="081800096"><itemNumber>0155</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>4.2000</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02279320" sec3="Y"><name>Invirase</name><manufacturerId>HLR</manufacturerId><individualPrice>4.2000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00112"><name>STAVUDINE</name><pcgGroup><pcg9 id="081800017"><itemNumber>0156</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><price>4.1185</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02216086" sec3="Y"><name>Zerit</name><manufacturerId>BQU</manufacturerId><individualPrice>4.1185</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="081800006"><itemNumber>0157</itemNumber><strength>20mg</strength><dosageForm>Cap</dosageForm><price>4.2818</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02216094" sec3="Y"><name>Zerit</name><manufacturerId>BQU</manufacturerId><individualPrice>4.2818</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="081800007"><itemNumber>0158</itemNumber><strength>30mg</strength><dosageForm>Cap</dosageForm><price>4.4672</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02216108" sec3="Y"><name>Zerit</name><manufacturerId>BQU</manufacturerId><individualPrice>4.4672</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="081800008"><itemNumber>0159</itemNumber><strength>40mg</strength><dosageForm>Cap</dosageForm><price>4.6305</price><note>For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02216116" sec3="Y"><name>Zerit</name><manufacturerId>BQU</manufacturerId><individualPrice>4.6305</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01619"><name>TENOFOVIR DISOPROXIL</name><pcgGroup><pcg9 id="081800083"><itemNumber>0160</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>17.1300</price><note>Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism.</note><drug id="02247128" sec3="Y"><name>Viread</name><manufacturerId>GIL</manufacturerId><individualPrice>17.1300</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00115"><name>VALACYCLOVIR</name><pcgGroup lccId="00010"><pcg9 id="081800012"><itemNumber>0161</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>1.6962</price><drug id="02219492" sec3="Y" sec12="Y"><name>Valtrex</name><manufacturerId>GSK</manufacturerId><individualPrice>3.3924</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02295822" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Valacyclovir</name><manufacturerId>APX</manufacturerId><individualPrice>1.6962</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02298457" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Valacyclovir</name><manufacturerId>PMS</manufacturerId><individualPrice>1.6962</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="159">Herpes zoster in patients 50 years of age or older, up to 72 hours* after appearance of lesions. Dose: 1 gram 3 times/day for 7 days.</lccNote><lccNote seq="002" type="R">*The patient must begin treatment within the time frame specified for the product to be reimbursed. There is no benefit from the therapy begun after this time frame.</lccNote><lccNote seq="003" type="W">Network will limit supply to 7 days and 42 capsules.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01581"><name>VALGANCICLOVIR</name><pcgGroup lccId="00145"><pcg9 id="081800066"><itemNumber>0162</itemNumber><strength>450mg</strength><dosageForm>Tab</dosageForm><price>22.4100</price><drug id="02245777" sec3="Y" sec12="Y"><name>Valcyte</name><manufacturerId>HLR</manufacturerId><individualPrice>22.4100</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="374">For the treatment of CMV retinitis in patients with AIDS.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01749"><name>ZANAMIVIR</name><pcgGroup lccId="00203"><pcg9 id="081800109"><itemNumber>0163</itemNumber><strength>5mg</strength><dosageForm>Pd Inh-5 Rotadisks Pk</dosageForm><price>36.5400</price><drug id="02240863" dinStatus="N" sec3="Y" sec12="Y"><name>Relenza</name><manufacturerId>GSK</manufacturerId><individualPrice>36.5400</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment or prophylaxis of institutionalized individuals during confirmed outbreaks due to influenza A or Influenza B when the predominant circulating strain is resistant to oseltamivir or for the prophylaxis of influenza A, where new cases have developed despite amantadine prophylaxis.
The outbreak must be confirmed by Public Health.</lccNote><lccNote seq="002" reasonForUseId="414">For treatment: 2 inhalations of 5mg (10mg) bid for 5 days,</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="415">For prophylaxis: 2 inhalations of 5mg (10mg) once daily for 10 days.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00144"><name>ZIDOVUDINE</name><pcgGroup><pcg9 id="081800031"><itemNumber>0164</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><drug id="01902660" notABenefit="Y" sec3="Y"><name>Retrovir</name><manufacturerId>GLW</manufacturerId><listingDate>2009-06-23</listingDate></drug><drug id="01946323" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Zidovudine</name><manufacturerId>APX</manufacturerId><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="082000000"><name>PLASMODICIDES (ANTIMALARIALS)</name><genericName id="00117"><name>CHLOROQUINE PHOSPHATE</name><pcgGroup><pcg9 id="082000001"><itemNumber>0165</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.3208</price><drug id="00021261" sec3="Y"><name>Novo-Chloroquine</name><manufacturerId>NOP</manufacturerId><individualPrice>.3208</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02017539" notABenefit="Y" sec3="Y"><name>Aralen</name><manufacturerId>SAO</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00118"><name>HYDROXYCHLOROQUINE SULFATE</name><pcgGroup><pcg9 id="082000002"><itemNumber>0166</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.2620</price><drug id="02017709" sec3="Y"><name>Plaquenil</name><manufacturerId>SAV</manufacturerId><individualPrice>.5893</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02246691" sec3="Y"><name>Apo-Hydroxyquine</name><manufacturerId>APX</manufacturerId><individualPrice>.2620</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02252600" sec3="Y"><name>Mylan-Hydroxychloroquine</name><manufacturerId>MYL</manufacturerId><individualPrice>.2620</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="082400000"><name>SULFONAMIDES</name><genericName id="00126"><name>SULFASALAZINE</name><pcgGroup><pcg9 id="082400006"><itemNumber>0167</itemNumber><strength>500mg</strength><dosageForm>Ent Tab</dosageForm><price>.2816</price><drug id="00598488" sec3="Y"><name>PMS-Sulfasalazine-E.C.</name><manufacturerId>PMS</manufacturerId><individualPrice>.2816</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02064472" sec3="Y"><name>Salazopyrin</name><manufacturerId>PFI</manufacturerId><individualPrice>.3586</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="082400005"><itemNumber>0168</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.1804</price><drug id="00598461" sec3="Y"><name>PMS-Sulfasalazine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1804</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02064480" sec3="Y"><name>Salazopyrin</name><manufacturerId>PFI</manufacturerId><individualPrice>.2354</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="083200000"><name>TRICHOMONACIDES</name><genericName id="00029"><name>METRONIDAZOLE</name><pcgGroup><pcg9 id="083200002"><itemNumber>0169</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>.4250</price><dailyCost>1.2750</dailyCost><drug id="00783137" dinStatus="E" sec3="Y"><name>PMS-Metronidazole</name><manufacturerId>PMS</manufacturerId><individualPrice>.4250</individualPrice><dailyCost>1.2750</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01926853" sec3="Y"><name>Flagyl</name><manufacturerId>SAV</manufacturerId><individualPrice>.9371</individualPrice><dailyCost>2.8113</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02248562" sec3="Y"><name>Apo-Metronidazole</name><manufacturerId>APX</manufacturerId><individualPrice>.4250</individualPrice><dailyCost>1.2750</dailyCost><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="083200001"><itemNumber>0170</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.0595</price><dailyCost>.1785</dailyCost><drug id="00545066" sec3="Y"><name>Apo-Metronidazole</name><manufacturerId>APX</manufacturerId><individualPrice>.0595</individualPrice><dailyCost>.1785</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01926896" notABenefit="Y" sec3="Y"><name>Flagyl</name><manufacturerId>RPP</manufacturerId><listingDate>2001-02-28</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="083600000"><name>URINARY ANTI-INFECTIVES</name><genericName id="00133"><name>NITROFURANTOIN</name><note>Nitrofurantoin macrocrystals may be better tolerated. Avoid use of nitrofurantoin during the last 6 weeks of pregnancy. Use with caution in patients with renal impairment.</note><pcgGroup><pcg9 id="083600013"><itemNumber>0171</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.3187</price><dailyCost>1.2748</dailyCost><drug id="01997637" notABenefit="Y" sec3="Y"><name>Macrodantin</name><manufacturerId>PGP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231015" sec3="Y"><name>Novo-Furantoin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3187</individualPrice><dailyCost>1.2748</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="083600012"><itemNumber>0172</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6110</price><dailyCost>2.4440</dailyCost><drug id="01997645" notABenefit="Y" sec3="Y"><name>Macrodantin</name><manufacturerId>PGP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231016" sec3="Y"><name>Novo-Furantoin</name><manufacturerId>NOP</manufacturerId><individualPrice>.6110</individualPrice><dailyCost>2.4440</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="083600015"><itemNumber>0173</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1670</price><dailyCost>.6680</dailyCost><drug id="00017086" notABenefit="Y" sec3="Y"><name>Nifuran</name><manufacturerId>MAN</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00319511" sec3="Y"><name>Apo-Nitrofurantoin</name><manufacturerId>APX</manufacturerId><individualPrice>.1670</individualPrice><dailyCost>.6680</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="083600008"><itemNumber>0174</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2227</price><dailyCost>.8908</dailyCost><drug id="00017094" notABenefit="Y" sec3="Y"><name>Nifuran</name><manufacturerId>MAN</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00312738" sec3="Y"><name>Apo-Nitrofurantoin</name><manufacturerId>APX</manufacturerId><individualPrice>.2227</individualPrice><dailyCost>.8908</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00135"><name>NITROFURANTOIN MONO/MICRO CRYSTALS</name><pcgGroup><pcg9 id="083600018"><itemNumber>0175</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6903</price><drug id="02063662" sec3="Y"><name>MacroBID</name><manufacturerId>PGP</manufacturerId><individualPrice>.6903</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="084000000"><name>MISCELLANEOUS ANTI-INFECTIVES</name><genericName id="01616"><name>CEFEPIME</name><pcgGroup><pcg9 id="084000065"><itemNumber>0176</itemNumber><strength>1g</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><drug id="02163632" notABenefit="Y" sec3="Y"><name>Maxipime</name><manufacturerId>BQU</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02319020" dinStatus="N" notABenefit="Y" sec3="Y"><name>Cefepime for Injection</name><manufacturerId>APX</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="084000072"><itemNumber>0177</itemNumber><strength>2g</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><drug id="02163640" notABenefit="Y" sec3="Y"><name>Maxipime</name><manufacturerId>BQU</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02319039" dinStatus="N" notABenefit="Y" sec3="Y"><name>Cefepime for Injection</name><manufacturerId>APX</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00141"><name>CIPROFLOXACIN</name><note>Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children &lt; 18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.</note><pcgGroup lccId="00011"><pcg9 id="084000050"><itemNumber>0178</itemNumber><strength>10g/100mL</strength><dosageForm>Oral Susp</dosageForm><price>.5582</price><dailyCost>5.5820</dailyCost><drug id="02237514" sec3="Y" sec12="Y"><name>Cipro</name><manufacturerId>BAY</manufacturerId><individualPrice>.5582</individualPrice><dailyCost>5.5820</dailyCost><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="084000014"><itemNumber>0179</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>1.1105</price><dailyCost>2.2210</dailyCost><drug id="02155958" sec3="Y" sec12="Y"><name>Cipro</name><manufacturerId>BAY</manufacturerId><individualPrice>2.4742</individualPrice><dailyCost>4.9484</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02161737" sec3="Y" sec12="Y"><name>Novo-Ciprofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02229521" sec3="Y" sec12="Y"><name>Apo-Ciproflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02245647" sec3="Y" sec12="Y"><name>Gen-Ciprofloxacin</name><manufacturerId>GEN</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02246825" sec3="Y" sec12="Y"><name>Ratio-Ciprofloxacin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02247339" sec3="Y" sec12="Y"><name>Co-Ciprofloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248437" sec3="Y" sec12="Y"><name>PMS-Ciprofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248756" sec3="Y" sec12="Y"><name>Sandoz Ciprofloxacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02266962" sec3="Y" sec12="Y"><name>Taro-Ciprofloxacin</name><manufacturerId>TAR</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2006-06-14</listingDate></drug><drug id="02267934" sec3="Y" sec12="Y"><name>Ran-Ciprofloxacin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02303728" sec3="Y" sec12="Y"><name>Ran-Ciproflox</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2008-03-25</listingDate></drug><drug id="02317427" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Ciprofloxacin</name><manufacturerId>MIN</manufacturerId><individualPrice>1.1505</individualPrice><dailyCost>2.3010</dailyCost><listingDate>2009-11-13</listingDate></drug><drug id="02332132" dinStatus="N" sec3="Y" sec12="Y"><name>Ciprofloxacin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1105</individualPrice><dailyCost>2.2210</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="084000015"><itemNumber>0180</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>1.2529</price><dailyCost>2.5058</dailyCost><drug id="02155966" sec3="Y" sec12="Y"><name>Cipro</name><manufacturerId>BAY</manufacturerId><individualPrice>2.7915</individualPrice><dailyCost>5.5830</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02161745" sec3="Y" sec12="Y"><name>Novo-Ciprofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02229522" sec3="Y" sec12="Y"><name>Apo-Ciproflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02245648" sec3="Y" sec12="Y"><name>Gen-Ciprofloxacin</name><manufacturerId>GEN</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02246826" sec3="Y" sec12="Y"><name>Ratio-Ciprofloxacin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02247340" sec3="Y" sec12="Y"><name>Co-Ciprofloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248438" sec3="Y" sec12="Y"><name>PMS-Ciprofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248757" sec3="Y" sec12="Y"><name>Sandoz Ciprofloxacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02266970" sec3="Y" sec12="Y"><name>Taro-Ciprofloxacin</name><manufacturerId>TAR</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2006-06-14</listingDate></drug><drug id="02267942" sec3="Y" sec12="Y"><name>Ran-Ciprofloxacin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02303736" sec3="Y" sec12="Y"><name>Ran-Ciproflox</name><manufacturerId>RAN</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2008-03-25</listingDate></drug><drug id="02317435" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Ciprofloxacin</name><manufacturerId>MIN</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2009-11-13</listingDate></drug><drug id="02332140" dinStatus="N" sec3="Y" sec12="Y"><name>Ciprofloxacin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.2529</individualPrice><dailyCost>2.5058</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="084000016"><itemNumber>0181</itemNumber><strength>750mg</strength><dosageForm>Tab</dosageForm><price>2.3631</price><dailyCost>4.7262</dailyCost><drug id="02155974" sec3="Y" sec12="Y"><name>Cipro</name><manufacturerId>BAY</manufacturerId><individualPrice>5.1118</individualPrice><dailyCost>10.2236</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02161753" sec3="Y" sec12="Y"><name>Novo-Ciprofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02229523" sec3="Y" sec12="Y"><name>Apo-Ciproflox</name><manufacturerId>APX</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02245649" sec3="Y" sec12="Y"><name>Gen-Ciprofloxacin</name><manufacturerId>GEN</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02246827" sec3="Y" sec12="Y"><name>Ratio-Ciprofloxacin</name><manufacturerId>RPH</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02247341" sec3="Y" sec12="Y"><name>Co-Ciprofloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248439" sec3="Y" sec12="Y"><name>PMS-Ciprofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02248758" sec3="Y" sec12="Y"><name>Sandoz Ciprofloxacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02267950" sec3="Y" sec12="Y"><name>Ran-Ciprofloxacin</name><manufacturerId>RAN</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02303744" sec3="Y" sec12="Y"><name>Ran-Ciproflox</name><manufacturerId>RAN</manufacturerId><individualPrice>2.3632</individualPrice><dailyCost>4.7264</dailyCost><listingDate>2008-03-25</listingDate></drug><drug id="02317443" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Ciprofloxacin</name><manufacturerId>MIN</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2009-11-13</listingDate></drug><drug id="02332159" dinStatus="N" sec3="Y" sec12="Y"><name>Ciprofloxacin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>2.3631</individualPrice><dailyCost>4.7262</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of patients with:</lccNote><lccNote seq="002" reasonForUseId="332">SST/BJ (Gram negative bacteria): 
Skin/soft tissue and bone/joint infection due to gram negative bacteria; severe diabetic foot infection; severe otitis externa; decubitus ulcers.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="333">GU Tract: 
Urinary tract infection/prostatitis/epididymitis caused by (suspected or documented) Pseudomonas; sexually transmitted diseases.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="334">COPD with risk: 
Acute bacterial exacerbation of chronic obstructive pulmonary disease (COPD) with risk factors*; bronchiectasis; pneumonic illness with cystic fibrosis.</lccNote><lccNote seq="007" type="R">*Risk factors include: poor pulmonary lung function (FEV1 below 50% predicted level), age over 65 years, co-morbid medical illness (congestive heart failure, diabetes, chronic renal failure, chronic liver disease), chronic corticosteroid use, malnutrition, prolonged duration of disease or 4 or more exacerbations per year.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="336">Step-Down: 
Step-down therapy after parenteral therapy or hospital/emergency department discharge; febrile neutropenia.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="011" reasonForUseId="350">GI: 
Traveller&apos;s diarrhea; enteric fever syndromes; Crohn&apos;s disease.</lccNote><lccNote seq="012" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="013" reasonForUseId="353">For the prophylaxis or treatment of B. anthracis exposure.</lccNote><lccNote seq="014" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="015" reasonForUseId="977">Exceptional cases of allergy or intolerance to all other appropriate therapies.</lccNote><lccNote seq="016" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01629"><name>CIPROFLOXACIN HCL &amp; CIPROFLOXACIN BASE</name><pcgGroup lccId="00161"><pcg9 id="084000066"><itemNumber>0182</itemNumber><strength>500mg</strength><dosageForm>ER Tab</dosageForm><price>2.9882</price><drug id="02247916" sec3="Y" sec12="Y"><name>Cipro XL</name><manufacturerId>BAY</manufacturerId><individualPrice>2.9882</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="394">For patients with uncomplicated urinary tract infections (acute cystitis) who have failure, intolerance or hypersensitivity to all formulary antibiotic alternatives that are listed as General Benefits.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup lccId="00162"><pcg9 id="084000067"><itemNumber>0183</itemNumber><strength>1000mg</strength><dosageForm>ER Tab</dosageForm><price>2.9882</price><drug id="02251787" sec3="Y" sec12="Y"><name>Cipro XL</name><manufacturerId>BAY</manufacturerId><individualPrice>2.9882</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="395">For patients with complicated urinary tract infections or acute uncomplicated pyelonephritis who have failure, intolerance or hypersensitivity to all formulary antibiotic alternatives that are listed as General Benefits.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01381"><name>LEVOFLOXACIN</name><pcgGroup lccId="00013"><pcg9 id="084000051"><itemNumber>0184</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>2.2200</price><drug id="02236841" sec3="Y" sec12="Y"><name>Levaquin</name><manufacturerId>JNO</manufacturerId><individualPrice>4.8152</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02248262" sec3="Y" sec12="Y"><name>Novo-Levofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2005-01-25</listingDate></drug><drug id="02284677" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Levofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02284707" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Levofloxacin</name><manufacturerId>APX</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02298635" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Levofloxacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02313979" dinStatus="N" sec3="Y" sec12="Y"><name>Gen-Levofloxacin</name><manufacturerId>GEN</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02315424" dinStatus="N" sec3="Y" sec12="Y"><name>Co Levofloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>2.2200</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><pcg9 id="084000049"><itemNumber>0185</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>2.5050</price><drug id="02236842" sec3="Y" sec12="Y"><name>Levaquin</name><manufacturerId>JNO</manufacturerId><individualPrice>5.4870</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02248263" sec3="Y" sec12="Y"><name>Novo-Levofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2005-01-25</listingDate></drug><drug id="02284685" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Levofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02284715" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Levofloxacin</name><manufacturerId>APX</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02298643" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Levofloxacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02313987" dinStatus="N" sec3="Y" sec12="Y"><name>Gen-Levofloxacin</name><manufacturerId>GEN</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02315432" dinStatus="N" sec3="Y" sec12="Y"><name>Co Levofloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>2.5050</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of patients with:</lccNote><lccNote seq="002" reasonForUseId="337">CAP with co-morbidity: 
Community acquired pneumonia with co-morbid illnesses or failure to first-line therapy.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="338">COPD with risk: 
Acute bacterial exacerbation of chronic obstructive pulmonary disease (COPD) with risk factors*; bronchiectasis.</lccNote><lccNote seq="005" type="R">*Risk factors include: poor pulmonary lung function (FEV1 below 50% predicted level), age over 65 years, co-morbid medical illness (congestive heart failure, diabetes, chronic renal failure, chronic liver disease), chronic corticosteroid use, malnutrition, prolonged duration of disease or 4 or more exacerbations per year.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="339">Step-Down: 
Step-down therapy after parenteral therapy or hospital / emergency department discharge.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="977">Exceptional cases of allergy or intolerance to all other appropriate therapies.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="084000075"><itemNumber>0186</itemNumber><strength>750mg</strength><dosageForm>Tab</dosageForm><drug id="02246804" notABenefit="Y" sec3="Y"><name>Levaquin</name><manufacturerId>JNO</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02285649" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Levofloxacin</name><manufacturerId>NOP</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02298651" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Levofloxacin</name><manufacturerId>SDZ</manufacturerId><listingDate>2009-11-13</listingDate></drug><drug id="02305585" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Levofloxacin</name><manufacturerId>PMS</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02315440" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Levofloxacin</name><manufacturerId>COB</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02325942" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Levofloxacin</name><manufacturerId>APX</manufacturerId><listingDate>2009-09-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01514"><name>LINEZOLID</name><pcgGroup lccId="00014"><pcg9 id="084000054"><itemNumber>0187</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>71.9811</price><drug id="02243684" sec3="Y" sec12="Y"><name>Zyvoxam</name><manufacturerId>PFI</manufacturerId><individualPrice>71.9811</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of patients with:</lccNote><lccNote seq="002" reasonForUseId="362">Methicillin-resistant Staphylococcus species (MRSA, MRSE) infections* in patients who are intolerant or have failed vancomycin therapy, or have contraindications to venous access.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="363">Vancomycin resistant Enterococcus species (VRE) infections* in patients switching from IV linezolid.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="364">Step-down therapy for the treatment of methicillin-resistant Staphylococcus species or vancomycin resistant Enterococcus species (VRE) infections* after parenteral therapy or hospital/ emergency department discharge.</lccNote><lccNote seq="007" type="R">* Infections must be documented and culture proven. Not approved for colonization (e.g. nares, urine, etc). Maximum 28 days supply.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00147"><name>MEFLOQUINE HCL</name><pcgGroup><pcg9 id="084000027"><itemNumber>0188</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="02018055" notABenefit="Y" sec3="Y"><name>Lariam</name><manufacturerId>HLR</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02244366" notABenefit="Y" sec3="Y"><name>Apo-Mefloquine</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01516"><name>MOXIFLOXACIN HYDROCHLORIDE</name><pcgGroup lccId="00015"><pcg9 id="084000053"><itemNumber>0189</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>5.7347</price><drug id="02242965" sec3="Y" sec12="Y"><name>Avelox</name><manufacturerId>BAY</manufacturerId><individualPrice>5.7347</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of patients with:</lccNote><lccNote seq="002" reasonForUseId="337">CAP with co-morbidity: 
Community acquired pneumonia with co-morbid illnesses or failure to first-line therapy.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="338">COPD with risk: 
Acute bacterial exacerbation of chronic obstructive pulmonary disease (COPD) with risk factors*; bronchiectasis.</lccNote><lccNote seq="005" type="R">*Risk factors include: poor pulmonary lung function (FEV1 below 50% predicted level), age over 65 years, co-morbid medical illness (congestive heart failure, diabetes, chronic renal failure, chronic liver disease), chronic corticosteroid use, malnutrition, prolonged duration of disease or 4 or more exacerbations per year.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="339">Step-Down: 
Step-down therapy after parenteral therapy or hospital / emergency department discharge.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="977">Exceptional cases of allergy or intolerance to all other appropriate therapies.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00138"><name>NORFLOXACIN</name><pcgGroup><pcg9 id="084000010"><itemNumber>0190</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>1.0898</price><dailyCost>2.1796</dailyCost><drug id="00643025" notABenefit="Y" sec3="Y"><name>Noroxin</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02229524" sec3="Y"><name>Apo-Norflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.0898</individualPrice><dailyCost>2.1796</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02237682" sec3="Y"><name>Novo-Norfloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0898</individualPrice><dailyCost>2.1796</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02246596" sec3="Y"><name>PMS-Norfloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0898</individualPrice><dailyCost>2.1796</dailyCost><listingDate>2003-04-16</listingDate></drug><drug id="02269627" sec3="Y"><name>Co Norfloxacin</name><manufacturerId>COB</manufacturerId><individualPrice>1.0898</individualPrice><dailyCost>2.1796</dailyCost><listingDate>2006-09-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00145"><name>OFLOXACIN</name><pcgGroup lccId="00016"><pcg9 id="084000037"><itemNumber>0191</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>1.3041</price><dailyCost>2.6082</dailyCost><drug id="01968424" notABenefit="Y" sec3="Y"><name>Floxin</name><manufacturerId>JNO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231529" sec3="Y" sec12="Y"><name>Apo-Oflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.3041</individualPrice><dailyCost>2.6082</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243474" sec3="Y" sec12="Y"><name>Novo-Ofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3041</individualPrice><dailyCost>2.6082</dailyCost><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="084000038"><itemNumber>0192</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>1.2161</price><dailyCost>2.4322</dailyCost><drug id="01968416" notABenefit="Y" sec3="Y"><name>Floxin</name><manufacturerId>JNO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231531" sec3="Y" sec12="Y"><name>Apo-Oflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.2161</individualPrice><dailyCost>2.4322</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243475" sec3="Y" sec12="Y"><name>Novo-Ofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.2161</individualPrice><dailyCost>2.4322</dailyCost><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="084000030"><itemNumber>0193</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>1.2161</price><dailyCost>2.4322</dailyCost><drug id="01968408" notABenefit="Y" sec3="Y"><name>Floxin</name><manufacturerId>JNO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231532" sec3="Y" sec12="Y"><name>Apo-Oflox</name><manufacturerId>APX</manufacturerId><individualPrice>1.2161</individualPrice><dailyCost>2.4322</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243476" dinStatus="E" sec3="Y" sec12="Y"><name>Novo-Ofloxacin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.2161</individualPrice><dailyCost>2.4322</dailyCost><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of patients with:</lccNote><lccNote seq="002" reasonForUseId="340">SST/BJ (Gram negative bacteria): 
Skin/soft tissue and bone/joint infection due to gram negative bacteria; severe diabetic foot infection..</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="341">GU Tract: 
Urinary tract infection / prostatitis / epididymitis; sexually transmitted disease.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="338">COPD with risk: 
Acute bacterial exacerbation of chronic obstructive pulmonary disease (COPD) with risk factors*; bronchiectasis.</lccNote><lccNote seq="007" type="R">*Risk factors include: poor pulmonary lung function (FEV1 below 50% predicted level), age over 65 years, co-morbid medical illness (congestive heart failure, diabetes, chronic renal failure, chronic liver disease), chronic corticosteroid use, malnutrition, prolonged duration of disease or 4 or more exacerbations per year.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="335">GI: 
Traveller&apos;s diarrhea; enteric fever syndromes.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="011" reasonForUseId="339">Step-Down: 
Step-down therapy after parenteral therapy or hospital / emergency department discharge.</lccNote><lccNote seq="012" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="013" reasonForUseId="977">Exceptional cases of allergy or intolerance to all other appropriate therapies.</lccNote><lccNote seq="014" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00136"><name>SULFAMETHOXAZOLE &amp; TRIMETHOPRIM</name><note>Avoid using sulfamethoxazole/trimethoprim during the last 6 weeks of pregnancy.</note><pcgGroup><pcg9 id="084000002"><itemNumber>0194</itemNumber><strength>40mg &amp; 8mg/mL</strength><dosageForm>O/L</dosageForm><price>.0198</price><dailyCost>.1980</dailyCost><drug id="00270644" notABenefit="Y" sec3="Y"><name>Septra</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00272485" notABenefit="Y" sec3="Y"><name>Bactrim Sugar Free</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00726540" sec3="Y"><name>Novo-Trimel</name><manufacturerId>NOP</manufacturerId><individualPrice>.0198</individualPrice><dailyCost>.1980</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="084000001"><itemNumber>0195</itemNumber><strength>400mg &amp; 80mg</strength><dosageForm>Tab</dosageForm><price>.0482</price><dailyCost>.1928</dailyCost><drug id="00270636" notABenefit="Y" sec3="Y"><name>Septra</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00272469" notABenefit="Y" sec3="Y"><name>Bactrim</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00445274" sec3="Y"><name>Apo-Sulfatrim</name><manufacturerId>APX</manufacturerId><individualPrice>.0482</individualPrice><dailyCost>.1928</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00510637" sec3="Y"><name>Novo-Trimel</name><manufacturerId>NOP</manufacturerId><individualPrice>.0482</individualPrice><dailyCost>.1928</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865710" sec3="Y"><name>Nu-Cotrimox</name><manufacturerId>NXP</manufacturerId><individualPrice>.0482</individualPrice><dailyCost>.1928</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="084000003"><itemNumber>0196</itemNumber><strength>800mg &amp; 160mg</strength><dosageForm>Tab</dosageForm><price>.1221</price><dailyCost>.2442</dailyCost><drug id="00368040" notABenefit="Y" sec3="Y"><name>Septra DS</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00371823" notABenefit="Y" sec3="Y"><name>Bactrim-DS</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00445282" sec3="Y"><name>Apo-Sulfatrim-DS</name><manufacturerId>APX</manufacturerId><individualPrice>.1221</individualPrice><dailyCost>.2442</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00510645" sec3="Y"><name>Novo-Trimel DS</name><manufacturerId>NOP</manufacturerId><individualPrice>.1221</individualPrice><dailyCost>.2442</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865729" sec3="Y"><name>Nu-Cotrimox</name><manufacturerId>NXP</manufacturerId><individualPrice>.1221</individualPrice><dailyCost>.2442</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00137"><name>TRIMETHOPRIM</name><pcgGroup><pcg9 id="084000007"><itemNumber>0197</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2566</price><dailyCost>.5132</dailyCost><drug id="00675229" notABenefit="Y" sec3="Y"><name>Proloprim</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02243116" sec3="Y"><name>Apo-Trimethoprim</name><manufacturerId>APX</manufacturerId><individualPrice>.2566</individualPrice><dailyCost>.5132</dailyCost><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="084000009"><itemNumber>0198</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.5273</price><dailyCost>.5273</dailyCost><drug id="00677590" notABenefit="Y" sec3="Y"><name>Proloprim</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02243117" sec3="Y"><name>Apo-Trimethoprim</name><manufacturerId>APX</manufacturerId><individualPrice>.5273</individualPrice><dailyCost>.5273</dailyCost><listingDate>2001-06-07</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="100000000"><name>ANTINEOPLASTIC AGENTS</name><pcg6><genericName id="00202"><name>ALTRETAMINE</name><pcgGroup><pcg9 id="100000095"><itemNumber>0199</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>3.3600</price><drug id="02126230" sec3="Y"><name>Hexalen</name><manufacturerId>LIL</manufacturerId><individualPrice>3.3600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00208"><name>ANASTROZOLE</name><pcgGroup lccId="00017"><pcg9 id="100000109"><itemNumber>0200</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>4.9500</price><drug id="02224135" sec3="Y" sec12="Y"><name>Arimidex</name><manufacturerId>AZC</manufacturerId><individualPrice>4.9500</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="365">For the treatment of metastatic breast cancer in hormone receptor positive post-menopausal women.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="396">As an alternative to tamoxifen for the adjuvant treatment of postmenopausal women with hormone receptor positive breast cancer.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00207"><name>BICALUTAMIDE</name><pcgGroup><pcg9 id="100000108"><itemNumber>0201</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>3.2200</price><drug id="02184478" sec3="Y"><name>Casodex</name><manufacturerId>AZC</manufacturerId><individualPrice>6.4400</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02270226" sec3="Y"><name>Novo-Bicalutamide</name><manufacturerId>NOP</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02274337" sec3="Y"><name>Co Bicalutamide</name><manufacturerId>COB</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02275589" sec3="Y"><name>PMS-Bicalutamide</name><manufacturerId>PMS</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02276089" sec3="Y"><name>Sandoz Bicalutamide</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02277700" sec3="Y"><name>Ratio-Bicalutamide</name><manufacturerId>RPH</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02296063" sec3="Y"><name>Apo-Bicalutamide</name><manufacturerId>APX</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02302403" sec3="Y"><name>Gen-Bicalutamide</name><manufacturerId>GEN</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00187"><name>BUSERELIN ACETATE</name><pcgGroup><pcg9 id="100000111"><itemNumber>0202</itemNumber><strength>6.3mg</strength><dosageForm>Implant Kit</dosageForm><price>724.6050</price><drug id="02228955" sec3="Y"><name>Suprefact Depot</name><manufacturerId>SAV</manufacturerId><individualPrice>724.6050</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="100000151"><itemNumber>0203</itemNumber><strength>9.45mg</strength><dosageForm>Implant Kit</dosageForm><price>1070.6850</price><drug id="02240749" sec3="Y"><name>Suprefact Depot</name><manufacturerId>SAV</manufacturerId><individualPrice>1070.6850</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="100000075"><itemNumber>0204</itemNumber><strength>1mg/mL</strength><dosageForm>Inj Sol-5.5mL Pk</dosageForm><price>58.6900</price><drug id="02225166" sec3="Y"><name>Suprefact</name><manufacturerId>SAV</manufacturerId><individualPrice>58.6900</individualPrice><listingDate>1999-01-08</listingDate></drug></pcg9><pcg9 id="100000076"><itemNumber>0205</itemNumber><strength>1mg/mL</strength><dosageForm>Nas Sp-10mL Pk</dosageForm><price>74.8800</price><drug id="02225158" sec3="Y"><name>Suprefact</name><manufacturerId>SAV</manufacturerId><individualPrice>74.8800</individualPrice><listingDate>1999-01-08</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00157"><name>BUSULFAN</name><pcgGroup><pcg9 id="100000005"><itemNumber>0206</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>1.4376</price><drug id="00004618" sec3="Y"><name>Myleran</name><manufacturerId>GSK</manufacturerId><individualPrice>1.4376</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01399"><name>CAPECITABINE</name><pcgGroup lccId="00018"><pcg9 id="100000136"><itemNumber>0207</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>1.8300</price><drug id="02238453" sec3="Y" sec12="Y"><name>Xeloda</name><manufacturerId>HLR</manufacturerId><individualPrice>1.8300</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="100000137"><itemNumber>0208</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>6.1000</price><drug id="02238454" sec3="Y" sec12="Y"><name>Xeloda</name><manufacturerId>HLR</manufacturerId><individualPrice>6.1000</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="346">For the first-line treatment of patients with metastatic colorectal cancer in whom combination chemotherapy is not recommended.</lccNote><lccNote seq="002" type="N">Not to be used in patients who have failed 5-flurouracil.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="360">For the treatment of metastatic breast cancer where patients have progressed 
after prior chemotherapy.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="406">For adjuvant treatment of stage 3 or high risk stage 2* colon cancer in patients who have completed surgery (within three months), who would normally be candidates for adjuvant chemotherapy with 5FU/LV.

*high risk stage 2 colon cancer is defined as one of the following:
 - obstruction,
 - perforation,
 - poorly differentiated adenocarcinoma,
 - inadequate lymph node sampling,
 - T4 tumour.
</lccNote><lccNote seq="007" type="R">LU Authorization Period: 6 Months.</lccNote><lccNote seq="008" reasonForUseId="409">As part of the CAPOX regimen for the first-line and second-line treatment of metastatic colorectal cancer</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00158"><name>CHLORAMBUCIL</name><pcgGroup><pcg9 id="100000006"><itemNumber>0209</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>1.3548</price><drug id="00004626" sec3="Y"><name>Leukeran</name><manufacturerId>GSK</manufacturerId><individualPrice>1.3548</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00204"><name>CLADRIBINE</name><pcgGroup lccId="00019"><pcg9 id="100000100"><itemNumber>0210</itemNumber><strength>1mg/mL</strength><dosageForm>Inj</dosageForm><price>56.7720</price><drug id="02022117" sec3="Y" sec12="Y"><name>Leustatin</name><manufacturerId>JNO</manufacturerId><individualPrice>56.7720</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="99">For hairy cell leukemia, as a single 7-day treatment course.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00159"><name>CYCLOPHOSPHAMIDE</name><pcgGroup><pcg9 id="100000010"><itemNumber>0211</itemNumber><strength>200mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>5.7630</price><drug id="02241797" sec3="Y"><name>Procytox</name><manufacturerId>BAX</manufacturerId><individualPrice>5.7630</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="100000009"><itemNumber>0212</itemNumber><strength>1000mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>13.4436</price><drug id="02241799" sec3="Y"><name>Procytox</name><manufacturerId>BAX</manufacturerId><individualPrice>13.4436</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="100000008"><itemNumber>0213</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.3520</price><drug id="00344877" dinStatus="E" sec3="Y"><name>Cytoxan</name><manufacturerId>BQU</manufacturerId><individualPrice>.3794</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02241795" sec3="Y"><name>Procytox</name><manufacturerId>BAX</manufacturerId><individualPrice>.3520</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="100000007"><itemNumber>0214</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.4740</price><drug id="00344885" notABenefit="Y" sec3="Y"><name>Cytoxan</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02241796" sec3="Y"><name>Procytox</name><manufacturerId>BAX</manufacturerId><individualPrice>.4740</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00180"><name>CYPROTERONE ACETATE</name><pcgGroup><pcg9 id="100000057"><itemNumber>0215</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>1.4085</price><drug id="00704431" sec3="Y"><name>Androcur</name><manufacturerId>BAY</manufacturerId><individualPrice>1.4085</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229723" sec3="Y"><name>Gen-Cyproterone</name><manufacturerId>GEN</manufacturerId><individualPrice>1.4085</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02245898" sec3="Y"><name>Apo-Cyproterone</name><manufacturerId>APX</manufacturerId><individualPrice>1.4085</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00160"><name>CYTARABINE</name><pcgGroup><pcg9 id="100000012"><itemNumber>0216</itemNumber><strength>100mg</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>10.4312</price><drug id="00386715" sec3="Y"><name>Cytosar</name><manufacturerId>PFI</manufacturerId><individualPrice>10.4312</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00161"><name>DAUNORUBICIN</name><pcgGroup><pcg9 id="100000014"><itemNumber>0217</itemNumber><dosageForm>Inj Pd-20mg Pk</dosageForm><price>85.8500</price><drug id="01926683" sec3="Y"><name>Cerubidine</name><manufacturerId>ERF</manufacturerId><individualPrice>85.8500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00174"><name>ESTRAMUSTINE PHOSPHATE DISODIUM</name><pcgGroup><pcg9 id="100000046"><itemNumber>0218</itemNumber><strength>140mg</strength><dosageForm>Cap</dosageForm><price>3.0070</price><drug id="02063794" sec3="Y"><name>Emcyt</name><manufacturerId>PFI</manufacturerId><individualPrice>3.0070</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00185"><name>ETOPOSIDE</name><pcgGroup><pcg9 id="100000072"><itemNumber>0219</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>28.7500</price><drug id="00616192" sec3="Y"><name>Vepesid</name><manufacturerId>BQU</manufacturerId><individualPrice>28.7500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01507"><name>EXEMESTANE</name><pcgGroup lccId="00020"><pcg9 id="100000162"><itemNumber>0220</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>5.0441</price><drug id="02242705" sec3="Y" sec12="Y"><name>Aromasin</name><manufacturerId>PFI</manufacturerId><individualPrice>5.0441</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="180">For the hormonal treatment of metastatic breast cancer in hormone receptor positive post-menopausal women who have disease progression following tamoxifen therapy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="407">For the sequential treatment of postmenopausal women with estrogen receptor-positive early breast cancer who have received 2-3 years of initial adjuvant tamoxifen therapy.

LU Authorization Period: Treatment period required to complete a total of
5 years of adjuvant therapy.
</lccNote></pcgGroup></genericName><genericName id="01583"><name>FLUDARABINE PHOSPHATE</name><pcgGroup lccId="00151"><pcg9 id="100000171"><itemNumber>0221</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>38.9080</price><drug id="02246226" sec3="Y" sec12="Y"><name>Fludara</name><manufacturerId>GZM</manufacturerId><individualPrice>38.9080</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="379">For second line therapy of patients with chronic lymphocytic leukemia (CLL) who have failed or are intolerant to chlorambucil.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00177"><name>FLUTAMIDE</name><pcgGroup><pcg9 id="100000050"><itemNumber>0222</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>1.3530</price><drug id="00637726" sec3="Y"><name>Euflex</name><manufacturerId>SCH</manufacturerId><individualPrice>1.3530</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230089" sec3="Y"><name>Novo-Flutamide</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3530</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02230104" sec3="Y"><name>PMS-Flutamide</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3530</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02238560" sec3="Y"><name>Apo-Flutamide</name><manufacturerId>APX</manufacturerId><individualPrice>1.3530</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00182"><name>GOSERELIN ACETATE</name><pcgGroup><pcg9 id="100000069"><itemNumber>0223</itemNumber><strength>3.6mg</strength><dosageForm>Depot Inj</dosageForm><price>381.7500</price><drug id="02049325" sec3="Y"><name>Zoladex</name><manufacturerId>AZC</manufacturerId><individualPrice>381.7500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000110"><itemNumber>0224</itemNumber><strength>10.8mg</strength><dosageForm>Depot Inj</dosageForm><price>1087.9800</price><drug id="02225905" sec3="Y"><name>Zoladex LA</name><manufacturerId>AZC</manufacturerId><individualPrice>1087.9800</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00184"><name>HYDROXYUREA</name><pcgGroup><pcg9 id="100000071"><itemNumber>0225</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><price>1.0203</price><drug id="00465283" sec3="Y"><name>Hydrea</name><manufacturerId>BQU</manufacturerId><individualPrice>1.0203</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242920" sec3="Y"><name>Gen-Hydroxyurea</name><manufacturerId>GEN</manufacturerId><individualPrice>1.0203</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02247937" sec3="Y"><name>Apo-Hydroxyurea</name><manufacturerId>APX</manufacturerId><individualPrice>1.0203</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01534"><name>IMATINIB MESYLATE</name><pcgGroup><pcg9 id="100000180"><itemNumber>0226</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>27.1062</price><note>These products must be prescribed based on the following criteria:

1)   For treatment of Philadelphia chromosome-positive chronic myeloid
leukemia (CML) in chronic phase.

The initial dose is 400 mg/day.  The dose may be increased up to a maximum of 800 mg/day in patients who do not have an adequate hematologic response at 3 months or cytogenetic response at 1 year; or if there has been loss of a previously achieved hematologic and/or cytogenetic response.

2)   For treatment of Philadelphia chromosome-positive chronic myeloid 
leukemia (CML) in blast crisis or accelerated phase. 

The initial dose is 600 mg/day.  The dose may be increased to a maximum of 800 mg/day in patients who do not have an adequate hematologic response at 3 months or cytogenetic response at 1 year; or loss of a previously achieved hematologic and/or cytogenetic response.</note><drug id="02253275" sec3="Y"><name>Gleevec</name><manufacturerId>NOV</manufacturerId><individualPrice>27.1062</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="100000177"><itemNumber>0227</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>108.4247</price><note>These products must be prescribed based on the following criteria:

1)   For treatment of Philadelphia chromosome-positive chronic myeloid 
leukemia (CML) in chronic phase.

The initial dose is 400 mg/day.  The dose may be increased up to a maximum of 800 mg/day in patients who do not have an adequate hematologic response at 3 months or cytogenetic response at 1 year; or if there has been loss of a previously achieved hematologic and/or cytogenetic response.

2)   For treatment of Philadelphia chromosome-positive chronic myeloid 
leukemia (CML) in blast crisis or accelerated phase.
 
The initial dose is 600 mg/day.  The dose may be increased to a maximum of 800 mg/day in patients who do not have an adequate hematologic response at 3 months or cytogenetic response at 1 year; or loss of a previously achieved hematologic and/or cytogenetic response.</note><drug id="02253283" sec3="Y"><name>Gleevec</name><manufacturerId>NOV</manufacturerId><individualPrice>108.4247</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00203"><name>INTERFERON ALFA-2B</name><pcgGroup lccId="00022"><pcg9 id="100000153"><itemNumber>0228</itemNumber><strength>15mu/mL</strength><dosageForm>18mu MD Pen Kit</dosageForm><price>210.0600</price><drug id="02240693" sec3="Y" sec12="Y"><name>Intron A</name><manufacturerId>SCH</manufacturerId><individualPrice>210.0600</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000154"><itemNumber>0229</itemNumber><strength>25mu/mL</strength><dosageForm>30mu MD Pen Kit</dosageForm><price>350.1000</price><drug id="02240694" sec3="Y" sec12="Y"><name>Intron A</name><manufacturerId>SCH</manufacturerId><individualPrice>350.1000</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000155"><itemNumber>0230</itemNumber><strength>50mu/mL</strength><dosageForm>60mu MD Pen Kit</dosageForm><price>700.1900</price><drug id="02240695" sec3="Y" sec12="Y"><name>Intron A</name><manufacturerId>SCH</manufacturerId><individualPrice>700.1900</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="28">For hairy cell leukemia.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="29">For Kaposi&apos;s Sarcoma.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01334"><name>LETROZOLE</name><pcgGroup lccId="00024"><pcg9 id="100000116"><itemNumber>0231</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>5.5120</price><drug id="02231384" sec3="Y" sec12="Y"><name>Femara</name><manufacturerId>NOV</manufacturerId><individualPrice>5.5120</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="365">For the treatment of metastatic breast cancer in hormone receptor positive post-menopausal women.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="403">For the treatment of hormone receptor positive early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 5 years.</lccNote><lccNote seq="005" reasonForUseId="408">As an alternative to tamoxifen for the adjuvant treatment of post-
menopausal women with hormone receptor positive early breast cancer 
for a maximum of five years.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 5 years.</lccNote></pcgGroup></genericName><genericName id="00178"><name>LEUPROLIDE ACETATE</name><pcgGroup><pcg9 id="100000084"><itemNumber>0232</itemNumber><strength>3.75mg</strength><dosageForm>Inj-Kit</dosageForm><price>337.4000</price><drug id="00884502" sec3="Y"><name>Lupron Depot PDS</name><manufacturerId>ABB</manufacturerId><individualPrice>337.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000066"><itemNumber>0233</itemNumber><strength>7.5mg</strength><dosageForm>Inj-Kit</dosageForm><price>387.9700</price><drug id="00836273" sec3="Y"><name>Lupron Depot PDS</name><manufacturerId>ABB</manufacturerId><individualPrice>387.9700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000148"><itemNumber>0234</itemNumber><strength>11.25mg</strength><dosageForm>Inj-Kit</dosageForm><price>1005.2600</price><drug id="02239834" sec3="Y"><name>Lupron Depot PDS</name><manufacturerId>ABB</manufacturerId><individualPrice>1005.2600</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000113"><itemNumber>0235</itemNumber><strength>22.5mg</strength><dosageForm>Inj-Kit</dosageForm><price>1071.0000</price><drug id="02230248" sec3="Y"><name>Lupron Depot PDS</name><manufacturerId>ABB</manufacturerId><individualPrice>1071.0000</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="100000146"><itemNumber>0236</itemNumber><strength>30mg</strength><dosageForm>Inj-Kit</dosageForm><price>1428.0000</price><drug id="02239833" sec3="Y"><name>Lupron Depot PDS</name><manufacturerId>ABB</manufacturerId><individualPrice>1428.0000</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="100000172"><itemNumber>0237</itemNumber><strength>7.5mg</strength><dosageForm>Pd Susp Inj-Pref Syr Kit</dosageForm><price>343.5800</price><drug id="02248239" sec3="Y"><name>Eligard</name><manufacturerId>SAV</manufacturerId><individualPrice>343.5800</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="100000173"><itemNumber>0238</itemNumber><strength>22.5mg</strength><dosageForm>Pd Susp Inj-Pref Syr Kit</dosageForm><price>891.0000</price><drug id="02248240" sec3="Y"><name>Eligard</name><manufacturerId>SAV</manufacturerId><individualPrice>891.0000</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="100000176"><itemNumber>0239</itemNumber><strength>30mg</strength><dosageForm>Pd Susp Inj-Pref Syr Kit</dosageForm><price>1285.2000</price><drug id="02248999" sec3="Y"><name>Eligard</name><manufacturerId>SAV</manufacturerId><individualPrice>1285.2000</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="100000181"><itemNumber>0240</itemNumber><strength>45mg</strength><dosageForm>Pd Susp Inj-Pref Syr Kit</dosageForm><price>1450.0000</price><drug id="02268892" sec3="Y"><name>Eligard</name><manufacturerId>SAV</manufacturerId><individualPrice>1450.0000</individualPrice><listingDate>2006-06-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00172"><name>LOMUSTINE (CCNU)</name><pcgGroup><pcg9 id="100000044"><itemNumber>0241</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>6.2700</price><drug id="00360430" sec3="Y"><name>CeeNU</name><manufacturerId>BQU</manufacturerId><individualPrice>6.2700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000043"><itemNumber>0242</itemNumber><strength>40mg</strength><dosageForm>Cap</dosageForm><price>10.7925</price><drug id="00360422" sec3="Y"><name>CeeNU</name><manufacturerId>BQU</manufacturerId><individualPrice>10.7925</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000042"><itemNumber>0243</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>17.8175</price><drug id="00360414" sec3="Y"><name>CeeNU</name><manufacturerId>BQU</manufacturerId><individualPrice>17.8175</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00173"><name>MEGESTROL ACETATE</name><pcgGroup><pcg9 id="100000045"><itemNumber>0244</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.0073</price><drug id="00386391" notABenefit="Y" sec3="Y"><name>Megace</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02195917" sec3="Y"><name>Apo-Megestrol</name><manufacturerId>APX</manufacturerId><individualPrice>1.0073</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000063"><itemNumber>0245</itemNumber><strength>160mg</strength><dosageForm>Tab</dosageForm><price>4.2630</price><drug id="00731323" notABenefit="Y" sec3="Y"><name>Megace</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02195925" sec3="Y"><name>Apo-Megestrol</name><manufacturerId>APX</manufacturerId><individualPrice>4.2630</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00163"><name>MELPHALAN</name><pcgGroup><pcg9 id="100000017"><itemNumber>0246</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>1.5672</price><drug id="00004715" sec3="Y"><name>Alkeran</name><manufacturerId>GSK</manufacturerId><individualPrice>1.5672</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00164"><name>MERCAPTOPURINE</name><pcgGroup><pcg9 id="100000018"><itemNumber>0247</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>3.6680</price><note>Decrease dose of mercaptopurine to 25-33% of initial dose if allopurinol used concomitantly.</note><drug id="00004723" sec3="Y"><name>Purinethol</name><manufacturerId>NOP</manufacturerId><individualPrice>3.6680</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00179"><name>METHOTREXATE</name><pcgGroup><pcg9 id="100000054"><itemNumber>0248</itemNumber><strength>20mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>12.5000</price><drug id="02182947" sec3="Y"><name>Methotrexate Sodium</name><manufacturerId>MAY</manufacturerId><individualPrice>12.5000</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="100000032"><itemNumber>0249</itemNumber><strength>50mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>12.4800</price><drug id="02170671" notABenefit="Y" sec3="Y"><name>Methotrexate</name><manufacturerId>WAY</manufacturerId><listingDate>1998-03-17</listingDate></drug><drug id="02182777" sec3="Y"><name>Methotrexate</name><manufacturerId>MAY</manufacturerId><individualPrice>12.4800</individualPrice><listingDate>2005-10-06</listingDate></drug></pcg9><pcg9 id="100000001"><itemNumber>0250</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.6325</price><drug id="02170698" sec3="Y"><name>Methotrexate</name><manufacturerId>WAY</manufacturerId><individualPrice>.6325</individualPrice><listingDate>1997-02-04</listingDate></drug><drug id="02182963" sec3="Y"><name>Apo-Methotrexate</name><manufacturerId>APX</manufacturerId><individualPrice>.6325</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02244798" sec3="Y"><name>Ratio-Methotrexate Sodium</name><manufacturerId>RPH</manufacturerId><individualPrice>.6325</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00186"><name>NILUTAMIDE</name><pcgGroup><pcg9 id="100000073"><itemNumber>0251</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>1.9679</price><drug id="02221861" sec3="Y"><name>Anandron</name><manufacturerId>SAV</manufacturerId><individualPrice>1.9679</individualPrice><listingDate>1999-01-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00165"><name>PROCARBAZINE HCL</name><pcgGroup><pcg9 id="100000021"><itemNumber>0252</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.4079</price><note>Procarbazine inhibits monoamine oxidase. Avoid alcohol and foods with high tyramine content (e.g. aged cheese, red wine, yogurt, etc.)</note><drug id="00012750" sec3="Y"><name>Matulane</name><manufacturerId>SIG</manufacturerId><individualPrice>.4079</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00181"><name>STREPTOZOCIN</name><pcgGroup><pcg9 id="100000058"><itemNumber>0253</itemNumber><dosageForm>Inj Pd-1g Pk</dosageForm><price>38.4500</price><drug id="00622141" sec3="Y"><name>Zanosar</name><manufacturerId>PFI</manufacturerId><individualPrice>38.4500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00171"><name>TAMOXIFEN CITRATE</name><pcgGroup><pcg9 id="100000040"><itemNumber>0254</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1750</price><drug id="00812404" sec3="Y"><name>Apo-Tamox</name><manufacturerId>APX</manufacturerId><individualPrice>.1750</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00851965" sec3="Y"><name>Novo-Tamoxifen</name><manufacturerId>NOP</manufacturerId><individualPrice>.1750</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926624" sec3="Y"><name>Tamofen</name><manufacturerId>SAV</manufacturerId><individualPrice>.1930</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02048477" notABenefit="Y" sec3="Y"><name>Nolvadex</name><manufacturerId>AZC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02088428" sec3="Y"><name>Gen-Tamoxifen</name><manufacturerId>GEN</manufacturerId><individualPrice>.1750</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="100000056"><itemNumber>0255</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.3500</price><drug id="00812390" sec3="Y"><name>Apo-Tamox</name><manufacturerId>APX</manufacturerId><individualPrice>.3500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00851973" sec3="Y"><name>Novo-Tamoxifen</name><manufacturerId>NOP</manufacturerId><individualPrice>.3500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926632" sec3="Y"><name>Tamofen</name><manufacturerId>SAV</manufacturerId><individualPrice>.3859</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02048485" sec3="Y"><name>Nolvadex D</name><manufacturerId>AZC</manufacturerId><individualPrice>.3600</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02089858" sec3="Y"><name>Gen-Tamoxifen</name><manufacturerId>GEN</manufacturerId><individualPrice>.3500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01449"><name>TEMOZOLOMIDE</name><pcgGroup lccId="00025"><pcg9 id="100000156"><itemNumber>0256</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>7.4174</price><drug id="02241093" sec3="Y" sec12="Y"><name>Temodal</name><manufacturerId>SCH</manufacturerId><individualPrice>7.4174</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000157"><itemNumber>0257</itemNumber><strength>20mg</strength><dosageForm>Cap</dosageForm><price>29.6694</price><drug id="02241094" sec3="Y" sec12="Y"><name>Temodal</name><manufacturerId>SCH</manufacturerId><individualPrice>29.6694</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000158"><itemNumber>0258</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>148.3468</price><drug id="02241095" sec3="Y" sec12="Y"><name>Temodal</name><manufacturerId>SCH</manufacturerId><individualPrice>148.3468</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="100000159"><itemNumber>0259</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>370.8565</price><drug id="02241096" sec3="Y" sec12="Y"><name>Temodal</name><manufacturerId>SCH</manufacturerId><individualPrice>370.8565</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="320">For patients with recurrent or progressive glioblastoma multiforme or anaplastic astrocytoma..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00166"><name>THIOGUANINE</name><pcgGroup><pcg9 id="100000023"><itemNumber>0260</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>4.1888</price><drug id="00282081" sec3="Y"><name>Lanvis</name><manufacturerId>GSK</manufacturerId><individualPrice>4.1888</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01690"><name>TRIPTORELIN PAMOATE</name><pcgGroup><pcg9 id="100000188"><itemNumber>0261</itemNumber><strength>3.75mg/Vial</strength><dosageForm>Inj Pd with Sterile Water-Vial Pk</dosageForm><price>299.4400</price><drug id="09857199" sec3="Y"><name>Trelstar (1 Month)</name><manufacturerId>PAL</manufacturerId><individualPrice>299.4400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="100000189"><itemNumber>0262</itemNumber><strength>11.25mg/Vial</strength><dosageForm>Inj Pd with Sterile Water-Vial Pk</dosageForm><price>916.8400</price><drug id="09857200" sec3="Y"><name>Trelstar LA (3 Month)</name><manufacturerId>PAL</manufacturerId><individualPrice>916.8400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="100000186"><itemNumber>0263</itemNumber><strength>3.75mg/Vial</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>299.4400</price><drug id="02240000" sec3="Y"><name>Trelstar (1 Month)</name><manufacturerId>PAL</manufacturerId><individualPrice>299.4400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="100000187"><itemNumber>0264</itemNumber><strength>11.25mg/Vial</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>916.8400</price><drug id="02243856" sec3="Y"><name>Trelstar LA (3 Month)</name><manufacturerId>PAL</manufacturerId><individualPrice>916.8400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00176"><name>VINCRISTINE SULFATE</name><pcgGroup><pcg9 id="100000049"><itemNumber>0265</itemNumber><strength>1mg/mL</strength><dosageForm>Inj Sol</dosageForm><price>7.1300</price><drug id="00611182" notABenefit="Y" sec3="Y"><name>Oncovin</name><manufacturerId>LIL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02143305" sec3="Y"><name>Vincristine Sulfate</name><manufacturerId>NOP</manufacturerId><individualPrice>7.1300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="120000000"><name>AUTONOMIC AGENTS</name><pcg6 id="120400000"><name>PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS</name><genericName id="00210"><name>BETHANECHOL CHLORIDE</name><pcgGroup><pcg9 id="120400002"><itemNumber>0266</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2734</price><drug id="01947958" sec3="Y"><name>Duvoid</name><manufacturerId>PAL</manufacturerId><individualPrice>.2734</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120400001"><itemNumber>0267</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.4429</price><drug id="01947931" sec3="Y"><name>Duvoid</name><manufacturerId>PAL</manufacturerId><individualPrice>.4429</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120400015"><itemNumber>0268</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.5834</price><drug id="01947923" sec3="Y"><name>Duvoid</name><manufacturerId>PAL</manufacturerId><individualPrice>.5834</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00211"><name>CARBACHOL</name><pcgGroup><pcg9 id="120400005"><itemNumber>0269</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.3727</price><drug id="00885568" sec3="Y"><name>Carbachol</name><manufacturerId>GLA</manufacturerId><individualPrice>.3727</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01333"><name>DONEPEZIL HCL</name><pcgGroup lccId="00026"><pcg9 id="120400017"><itemNumber>0270</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>4.8679</price><drug id="02232043" sec3="Y" sec12="Y"><name>Aricept</name><manufacturerId>PFI</manufacturerId><individualPrice>4.8679</individualPrice><listingDate>1999-06-01</listingDate></drug></pcg9><pcg9 id="120400018"><itemNumber>0271</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>4.8679</price><drug id="02232044" sec3="Y" sec12="Y"><name>Aricept</name><manufacturerId>PFI</manufacturerId><individualPrice>4.8679</individualPrice><listingDate>1999-06-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="347">Initial Trial: For patients with mild to moderate Alzheimer&apos;s Disease (Mini-Mental State Exam [MMSE] 10-26). Patients will be reimbursed for a period of up to 3 months after which continued treatment must be reassessed.

Network note: Maximum duration 3 months.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="348">Continuation: Further reimbursement will be made available to those patients whose disease has not progressed/deteriorated while on this drug. Patients must continue to have a MMSE score of 10-26.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01540"><name>GALANTAMINE HYDROBROMIDE</name><pcgGroup lccId="00027"><pcg9 id="120400031"><itemNumber>0272</itemNumber><strength>8mg</strength><dosageForm>ER Cap</dosageForm><price>4.9860</price><drug id="02266717" sec3="Y" sec12="Y"><name>Reminyl ER</name><manufacturerId>JNO</manufacturerId><individualPrice>4.9860</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><pcg9 id="120400029"><itemNumber>0273</itemNumber><strength>16mg</strength><dosageForm>ER Cap</dosageForm><price>4.9860</price><drug id="02266725" sec3="Y" sec12="Y"><name>Reminyl ER</name><manufacturerId>JNO</manufacturerId><individualPrice>4.9860</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><pcg9 id="120400030"><itemNumber>0274</itemNumber><strength>24mg</strength><dosageForm>ER Cap</dosageForm><price>4.9860</price><drug id="02266733" sec3="Y" sec12="Y"><name>Reminyl ER</name><manufacturerId>JNO</manufacturerId><individualPrice>4.9860</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="347">Initial Trial: For patients with mild to moderate Alzheimer&apos;s Disease (Mini-Mental State Exam [MMSE] 10-26). Patients will be reimbursed for a period of up to 3 months after which continued treatment must be reassessed.

Network note: Maximum duration 3 months.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="348">Continuation: Further reimbursement will be made available to those patients whose disease has not progressed/deteriorated while on this drug. Patients must continue to have a MMSE score of 10-26.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00212"><name>NEOSTIGMINE BROMIDE</name><pcgGroup><pcg9 id="120400007"><itemNumber>0275</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.4370</price><drug id="00869945" sec3="Y"><name>Prostigmin</name><manufacturerId>VAL</manufacturerId><individualPrice>.4370</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00214"><name>PYRIDOSTIGMINE BROMIDE</name><pcgGroup><pcg9 id="120400011"><itemNumber>0276</itemNumber><strength>180mg</strength><dosageForm>LA Tab</dosageForm><price>.9397</price><drug id="00869953" sec3="Y"><name>Mestinon</name><manufacturerId>VAL</manufacturerId><individualPrice>.9397</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120400010"><itemNumber>0277</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><price>.4295</price><drug id="00869961" sec3="Y"><name>Mestinon</name><manufacturerId>VAL</manufacturerId><individualPrice>.4295</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01491"><name>RIVASTIGMINE</name><pcgGroup lccId="00028"><pcg9 id="120400019"><itemNumber>0278</itemNumber><strength>1.5mg</strength><dosageForm>Cap</dosageForm><price>1.3029</price><drug id="02242115" sec3="Y" sec12="Y"><name>Exelon</name><manufacturerId>NOV</manufacturerId><individualPrice>2.6059</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02305984" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Rivastigmine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02306034" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Rivastigmine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02311283" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Rivastigmine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02324563" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Rivastigmine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02332809" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Rivastigmine</name><manufacturerId>MYL</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02336715" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Rivastigmine</name><manufacturerId>APX</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="120400020"><itemNumber>0279</itemNumber><strength>3mg</strength><dosageForm>Cap</dosageForm><price>1.3029</price><drug id="02242116" sec3="Y" sec12="Y"><name>Exelon</name><manufacturerId>NOV</manufacturerId><individualPrice>2.6059</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02305992" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Rivastigmine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02306042" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Rivastigmine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02311291" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Rivastigmine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02324571" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Rivastigmine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02332817" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Rivastigmine</name><manufacturerId>MYL</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02336723" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Rivastigmine</name><manufacturerId>APX</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="120400021"><itemNumber>0280</itemNumber><strength>4.5mg</strength><dosageForm>Cap</dosageForm><price>1.3029</price><drug id="02242117" sec3="Y" sec12="Y"><name>Exelon</name><manufacturerId>NOV</manufacturerId><individualPrice>2.6059</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02306018" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Rivastigmine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02306050" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Rivastigmine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02311305" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Rivastigmine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02324598" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Rivastigmine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02332825" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Rivastigmine</name><manufacturerId>MYL</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02336731" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Rivastigmine</name><manufacturerId>APX</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="120400022"><itemNumber>0281</itemNumber><strength>6mg</strength><dosageForm>Cap</dosageForm><price>1.3029</price><drug id="02242118" sec3="Y" sec12="Y"><name>Exelon</name><manufacturerId>NOV</manufacturerId><individualPrice>2.6059</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02306026" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Rivastigmine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02306069" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Rivastigmine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02311313" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Rivastigmine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02324601" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Rivastigmine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02332833" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Rivastigmine</name><manufacturerId>MYL</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02336758" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Rivastigmine</name><manufacturerId>APX</manufacturerId><individualPrice>1.3029</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="347">Initial Trial: For patients with mild to moderate Alzheimer&apos;s Disease (Mini-Mental State Exam [MMSE] 10-26). Patients will be reimbursed for a period of up to 3 months after which continued treatment must be reassessed.

Network note: Maximum duration 3 months.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="348">Continuation: Further reimbursement will be made available to those patients whose disease has not progressed/deteriorated while on this drug. Patients must continue to have a MMSE score of 10-26.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="120800000"><name>PARASYMPATHOLYTIC (CHOLINERGIC BLOCKING) AGENTS</name><note>Anticholinergic agents should be used with extreme caution in the elderly due to age- related central nervous system adverse effects (e.g., confusion, paranoia, hallucinations). Avoid in patients with dementia as drug-induced memory impairment is common. (This does not apply to ipratropium bromide).</note><genericName id="00215"><name>BENZTROPINE MESYLATE</name><pcgGroup><pcg9 id="120800003"><itemNumber>0282</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0450</price><drug id="00016357" notABenefit="Y" sec3="Y"><name>Cogentin</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00426857" sec3="Y"><name>Apo-Benztropine</name><manufacturerId>APX</manufacturerId><individualPrice>.0450</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00223"><name>ETHOPROPAZINE HCL</name><pcgGroup><pcg9 id="120800021"><itemNumber>0283</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2200</price><drug id="01927744" sec3="Y"><name>Parsitan</name><manufacturerId>ERF</manufacturerId><individualPrice>.2200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00226"><name>FLAVOXATE HCL</name><pcgGroup><pcg9 id="120800038"><itemNumber>0284</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><drug id="00728179" notABenefit="Y" sec3="Y"><name>Urispas</name><manufacturerId>PAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02244842" notABenefit="Y" sec3="Y"><name>Apo-Flavoxate</name><manufacturerId>APX</manufacturerId><listingDate>2002-07-29</listingDate></drug><drug id="02245480" notABenefit="Y" sec3="Y"><name>PMS-Flavoxate</name><manufacturerId>PMS</manufacturerId><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00227"><name>IPRATROPIUM BROMIDE</name><pcgGroup lccId="00030"><pcg9 id="120800039"><itemNumber>0285</itemNumber><strength>250mcg/mL</strength><dosageForm>Inh Sol-20mL Pk</dosageForm><price>8.7850</price><drug id="00731439" notABenefit="Y" sec3="Y"><name>Atrovent</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02097141" sec3="Y" sec12="Y"><name>Ratio-Ipratropium</name><manufacturerId>RPH</manufacturerId><individualPrice>8.7850</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02126222" sec3="Y" sec12="Y"><name>Apo-Ipravent Inhalation Solution</name><manufacturerId>APX</manufacturerId><individualPrice>8.7850</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02210479" sec3="Y" sec12="Y"><name>Novo-Ipramide</name><manufacturerId>NOP</manufacturerId><individualPrice>8.7850</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02231136" sec3="Y" sec12="Y"><name>PMS-Ipratropium</name><manufacturerId>PMS</manufacturerId><individualPrice>8.7850</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02239131" sec3="Y" sec12="Y"><name>Gen-Ipratropium</name><manufacturerId>GEN</manufacturerId><individualPrice>8.7850</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="256">Patients who have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="257">Patients with cystic fibrosis in whom nebulizer therapy is indicated;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="258">Patients with severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="259">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00031"><pcg9 id="120800047"><itemNumber>0286</itemNumber><strength>125mcg/mL</strength><dosageForm>Inh Sol-2mL UDV Pk</dosageForm><price>.6590</price><drug id="02026759" notABenefit="Y" sec3="Y"><name>Atrovent UDV</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02097176" sec3="Y" sec12="Y"><name>Ratio-Ipratropium UDV</name><manufacturerId>RPH</manufacturerId><individualPrice>.6590</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231135" sec3="Y" sec12="Y"><name>PMS-Ipratropium</name><manufacturerId>PMS</manufacturerId><individualPrice>.6590</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="120800046"><itemNumber>0287</itemNumber><strength>250mcg/mL</strength><dosageForm>Inh Sol-2mL UDV Pk</dosageForm><price>1.3180</price><drug id="01950681" notABenefit="Y" sec3="Y"><name>Atrovent UDV</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02097168" sec3="Y" sec12="Y"><name>Ratio-Ipratropium UDV</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3180</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02216221" sec3="Y" sec12="Y"><name>Gen-Ipratropium</name><manufacturerId>GEN</manufacturerId><individualPrice>1.3180</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02231245" sec3="Y" sec12="Y"><name>PMS-Ipratropium</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3180</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="265">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="266">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="267">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="268">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="120800056"><itemNumber>0288</itemNumber><strength>20mcg/Metered Dose</strength><dosageForm>Inh-200 Dose Pk</dosageForm><price>18.3400</price><drug id="02247686" sec3="Y"><name>Atrovent HFA</name><manufacturerId>BOE</manufacturerId><individualPrice>18.3400</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01365"><name>IPRATROPIUM BROMIDE/SALBUTAMOL</name><pcgGroup lccId="00029"><pcg9 id="120800050"><itemNumber>0289</itemNumber><strength>500mcg/2.5mg/2.5mL</strength><dosageForm>Inh Sol-2.5mL Pk</dosageForm><price>.7340</price><drug id="02231675" sec3="Y" sec12="Y"><name>Combivent UDV</name><manufacturerId>BOE</manufacturerId><individualPrice>1.5075</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02243789" sec3="Y" sec12="Y"><name>Ratio-IPRA SAL UDV</name><manufacturerId>RPH</manufacturerId><individualPrice>.7340</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02272695" sec3="Y" sec12="Y"><name>Gen-Combo Sterinebs</name><manufacturerId>GEN</manufacturerId><individualPrice>.7340</individualPrice><listingDate>2006-01-24</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="256">Patients who have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="257">Patients with cystic fibrosis in whom nebulizer therapy is indicated;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="258">Patients with severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="259">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00225"><name>OXYBUTYNIN CHLORIDE</name><pcgGroup><pcg9 id="120800034"><itemNumber>0290</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>.0444</price><drug id="01924753" notABenefit="Y" sec3="Y"><name>Ditropan</name><manufacturerId>JNO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02223376" sec3="Y"><name>PMS-Oxybutynin</name><manufacturerId>PMS</manufacturerId><individualPrice>.0444</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="120800033"><itemNumber>0291</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1973</price><drug id="01924761" notABenefit="Y" sec3="Y"><name>Ditropan</name><manufacturerId>PGP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02158590" sec3="Y"><name>Nu-Oxybutyn</name><manufacturerId>NXP</manufacturerId><individualPrice>.1973</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163543" sec3="Y"><name>Apo-Oxybutynin</name><manufacturerId>APX</manufacturerId><individualPrice>.1973</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230394" sec3="Y"><name>Novo-Oxybutynin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1973</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02230800" sec3="Y"><name>Gen-Oxybutynin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1973</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02240550" sec3="Y"><name>PMS-Oxybutynin</name><manufacturerId>PMS</manufacturerId><individualPrice>.1973</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00220"><name>PROCYCLIDINE HCL</name><pcgGroup><pcg9 id="120800014"><itemNumber>0292</itemNumber><strength>0.5mg/mL</strength><dosageForm>O/L</dosageForm><price>.0307</price><drug id="00004405" dinStatus="E" sec3="Y"><name>Kemadrin</name><manufacturerId>BWE</manufacturerId><individualPrice>.0307</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120800037"><itemNumber>0293</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.0555</price><drug id="00649392" sec3="Y"><name>PMS-Procyclidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0555</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120800013"><itemNumber>0294</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0255</price><drug id="00004758" notABenefit="Y" sec3="Y"><name>Kemadrin</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00587354" sec3="Y"><name>PMS-Procyclidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0255</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01592"><name>TIOTROPIUM BROMIDE MONOHYDRATE</name><pcgGroup><pcg9 id="120800054"><itemNumber>0295</itemNumber><strength>18mcg</strength><dosageForm>Cap</dosageForm><price>2.1000</price><drug id="02246793" sec3="Y"><name>Spiriva</name><manufacturerId>BOE</manufacturerId><individualPrice>2.1000</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00222"><name>TRIHEXYPHENIDYL HCL</name><pcgGroup><pcg9 id="120800018"><itemNumber>0296</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0369</price><drug id="00015040" notABenefit="Y" sec3="Y"><name>Artane</name><manufacturerId>LED</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00545058" sec3="Y"><name>Apo-Trihex</name><manufacturerId>APX</manufacturerId><individualPrice>.0369</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="120800017"><itemNumber>0297</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0668</price><drug id="00015059" notABenefit="Y" sec3="Y"><name>Artane</name><manufacturerId>LED</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00545074" sec3="Y"><name>Apo-Trihex</name><manufacturerId>APX</manufacturerId><individualPrice>.0668</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00818"><name>TRIMEBUTINE MALEATE</name><pcgGroup><pcg9 id="120800062"><itemNumber>0298</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="00587869" notABenefit="Y" sec3="Y"><name>Modulon</name><manufacturerId>AXC</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02245663" notABenefit="Y" sec3="Y"><name>Apo-Trimebutine</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="120800061"><itemNumber>0299</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><drug id="00803499" notABenefit="Y" sec3="Y"><name>Modulon</name><manufacturerId>AXC</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02245664" notABenefit="Y" sec3="Y"><name>Apo-Trimebutine</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="121200000"><name>SYMPATHOMIMETIC (ADRENERGIC) AGENTS</name><note>Solutions for use in nebulizers are more expensive than metered dose inhalers (MDI) and turbuhalers, and for most patients, there is no significant benefit. The only indication for this mode of administration is for selected patient groups, such as those noted in the Limited Use clinical criteria for solutions for use in nebulizers, who are unable to use other formulations. Even children who are unable to coordinate actuation of a MDI and inhalation can usually use a spacer or turbuhaler. Special fittings are available for patients with severe arthritis who have difficulty using a standard MDI.</note><genericName id="01568"><name>BUDESONIDE &amp; FORMOTEROL FUMARATE DIHYDRATE</name><pcgGroup lccId="00032"><pcg9 id="121200087"><itemNumber>0300</itemNumber><strength>100mcg/6mcg</strength><dosageForm>Pd Inh-120 Dose Pk</dosageForm><price>60.0000</price><drug id="02245385" sec3="Y" sec12="Y"><name>Symbicort 100 Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>60.0000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="121200088"><itemNumber>0301</itemNumber><strength>200mcg/6mcg</strength><dosageForm>Pd Inh-120 Dose Pk</dosageForm><price>78.0000</price><drug id="02245386" sec3="Y" sec12="Y"><name>Symbicort 200 Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>78.0000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="330">For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00236"><name>EPINEPHRINE HCL</name><pcgGroup><pcg9 id="121200005"><itemNumber>0302</itemNumber><strength>30mg/30mL</strength><dosageForm>Inj Sol-30mL Pk</dosageForm><price>21.0500</price><drug id="00155357" sec3="Y"><name>Adrenalin</name><manufacturerId>ERF</manufacturerId><individualPrice>21.0500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01345"><name>FORMOTEROL FUMARATE</name><pcgGroup lccId="00036"><pcg9 id="121200075"><itemNumber>0303</itemNumber><strength>12mcg/Cap</strength><dosageForm>Inh Pd-Device Pk</dosageForm><price>46.9500</price><drug id="02230898" sec3="Y" sec12="Y"><name>Foradil</name><manufacturerId>NOV</manufacturerId><individualPrice>46.9500</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="132">For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.</lccNote><lccNote seq="002" type="N">This drug is not for relief of acute symptoms.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01396"><name>FORMOTEROL FUMARATE DIHYDRATE</name><pcgGroup lccId="00037"><pcg9 id="121200082"><itemNumber>0304</itemNumber><strength>6mcg/Metered Dose</strength><dosageForm>Pd Inh-60 Dose Pk</dosageForm><price>32.7000</price><drug id="02237225" sec3="Y" sec12="Y"><name>Oxeze Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>32.7000</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="121200078"><itemNumber>0305</itemNumber><strength>12mcg/Metered Dose</strength><dosageForm>Pd Inh-60 Dose Pk</dosageForm><price>43.5500</price><drug id="02237224" sec3="Y" sec12="Y"><name>Oxeze Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>43.5500</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="132">For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.</lccNote><lccNote seq="002" type="N">This drug is not for relief of acute symptoms.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00237"><name>ISOPROTERENOL HCL</name><pcgGroup lccId="00038"><pcg9 id="121200009"><itemNumber>0306</itemNumber><strength>0.5%</strength><dosageForm>Inh Sol-10mL Pk</dosageForm><price>8.4700</price><drug id="02017652" dinStatus="E" sec3="Y" sec12="Y"><name>Isuprel</name><manufacturerId>SAO</manufacturerId><individualPrice>8.4700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="260">Children aged 6 years or less;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="261">Patients who have a tracheostomy;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="262">Patients with cystic fibrosis in whom nebulizer therapy is indicated;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="263">Patients with severe mental or physical disabilities;</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="010" reasonForUseId="264">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="011" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00241"><name>ORCIPRENALINE SULFATE</name><pcgGroup><pcg9 id="121200016"><itemNumber>0307</itemNumber><strength>2mg/mL</strength><dosageForm>O/L</dosageForm><price>.0302</price><drug id="00249920" notABenefit="Y" sec3="Y"><name>Alupent</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02192675" sec3="Y"><name>Tanta Orciprenaline</name><manufacturerId>TAN</manufacturerId><individualPrice>.0302</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02236783" sec3="Y"><name>Apo-Orciprenaline</name><manufacturerId>APX</manufacturerId><individualPrice>.0302</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00238"><name>PSEUDOEPHEDRINE HCL</name><pcgGroup><pcg9 id="121200011"><itemNumber>0308</itemNumber><strength>6mg/mL</strength><dosageForm>O/L</dosageForm><drug id="00004561" notABenefit="Y" sec3="Y"><name>Sudafed</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00425516" notABenefit="Y" sec3="Y"><name>Robidrine</name><manufacturerId>WHB</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="121200010"><itemNumber>0309</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><drug id="00004766" notABenefit="Y" sec3="Y"><name>Sudafed</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00342726" notABenefit="Y" sec3="Y"><name>Robidrine</name><manufacturerId>WHB</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00239"><name>SALBUTAMOL</name><pcgGroup lccId="00040"><pcg9 id="121200048"><itemNumber>0310</itemNumber><strength>1mg/mL</strength><dosageForm>Inh Sol- 2.5mL Pk</dosageForm><price>.4828</price><drug id="01926934" sec3="Y" sec12="Y"><name>Gen-Salbutamol Sterinebs P.F.</name><manufacturerId>GEN</manufacturerId><individualPrice>.4828</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01986864" sec3="Y" sec12="Y"><name>Ratio-Salbutamol Respirator Sol P.F.</name><manufacturerId>RPH</manufacturerId><individualPrice>.4828</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02208229" sec3="Y" sec12="Y"><name>PMS-Salbutamol</name><manufacturerId>PMS</manufacturerId><individualPrice>.4828</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02213419" sec3="Y" sec12="Y"><name>Ventolin Nebules P.F.</name><manufacturerId>GSK</manufacturerId><individualPrice>1.0335</individualPrice><listingDate>1998-10-21</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="265">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="266">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="267">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="268">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00041"><pcg9 id="121200070"><itemNumber>0311</itemNumber><strength>2mg/mL</strength><dosageForm>Inh Sol- 2.5mL Pk</dosageForm><price>.9173</price><drug id="02173360" sec3="Y" sec12="Y"><name>Gen-Salbutamol</name><manufacturerId>GEN</manufacturerId><individualPrice>.9173</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02208237" sec3="Y" sec12="Y"><name>PMS-Salbutamol</name><manufacturerId>PMS</manufacturerId><individualPrice>.9173</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02213427" sec3="Y" sec12="Y"><name>Ventolin Nebules P.F.</name><manufacturerId>GSK</manufacturerId><individualPrice>1.9630</individualPrice><listingDate>2006-06-15</listingDate></drug><drug id="02239366" sec3="Y" sec12="Y"><name>Ratio-Salbutamol</name><manufacturerId>RPH</manufacturerId><individualPrice>.9173</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="265">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="266">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="267">Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="268">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00042"><pcg9 id="121200025"><itemNumber>0312</itemNumber><strength>5mg/mL</strength><dosageForm>Inh Sol-10mL Pk</dosageForm><price>4.6850</price><drug id="00860808" sec3="Y" sec12="Y"><name>Ratio-Salbutamol Respirator Sol</name><manufacturerId>RPH</manufacturerId><individualPrice>4.6850</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02069571" sec3="Y" sec12="Y"><name>PMS-Salbutamol Respirator Solution</name><manufacturerId>PMS</manufacturerId><individualPrice>4.6850</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02154412" sec3="Y" sec12="Y"><name>Sandoz Salbutamol</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.6850</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213486" sec3="Y" sec12="Y"><name>Ventolin</name><manufacturerId>GSK</manufacturerId><individualPrice>10.0300</individualPrice><listingDate>1998-04-03</listingDate></drug><drug id="02232987" sec3="Y" sec12="Y"><name>Gen-Salbutamol</name><manufacturerId>GEN</manufacturerId><individualPrice>4.6850</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="256">Patients who have a tracheostomy;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="257">Patients with cystic fibrosis in whom nebulizer therapy is indicated;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="258">Patients with severe mental or physical disabilities;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="259">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="121200012"><itemNumber>0313</itemNumber><strength>100mcg/Metered Dose</strength><dosageForm>Inh-200 dose Pk</dosageForm><price>6.5000</price><drug id="00790419" notABenefit="Y" sec3="Y"><name>Apo-Salvent</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00851841" notABenefit="Y" sec3="Y"><name>Ratio-Salbutamol Inhaler</name><manufacturerId>RPH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00874086" notABenefit="Y" sec3="Y"><name>Novo-Salmol</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02213478" notABenefit="Y" sec3="Y"><name>Ventolin</name><manufacturerId>GLW</manufacturerId><listingDate>1997-07-12</listingDate></drug><drug id="02232570" notABenefit="Y" sec3="Y"><name>Airomir HFA</name><manufacturerId>MMH</manufacturerId><listingDate>1998-12-31</listingDate></drug><drug id="02241497" dinStatus="N" sec3="Y"><name>Ventolin HFA</name><manufacturerId>GSK</manufacturerId><individualPrice>6.5000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02244914" dinStatus="E" sec3="Y"><name>Ratio-Salbutamol HFA</name><manufacturerId>RPH</manufacturerId><individualPrice>6.5000</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02245669" sec3="Y"><name>Apo-Salvent CFC Free</name><manufacturerId>APX</manufacturerId><individualPrice>6.5000</individualPrice><listingDate>2003-01-01</listingDate></drug></pcg9><pcg9 id="121200037"><itemNumber>0314</itemNumber><strength>0.4mg/mL</strength><dosageForm>O/L</dosageForm><price>.0476</price><drug id="02091186" sec3="Y"><name>PMS-Salbutamol</name><manufacturerId>PMS</manufacturerId><individualPrice>.0476</individualPrice><listingDate>2004-12-21</listingDate></drug><drug id="02212390" notABenefit="Y" sec3="Y"><name>Ventolin</name><manufacturerId>GSK</manufacturerId><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="121200013"><itemNumber>0315</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1274</price><drug id="01961039" notABenefit="Y" sec3="Y"><name>Ventolin</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02146843" sec3="Y"><name>Apo-Salvent</name><manufacturerId>APX</manufacturerId><individualPrice>.1274</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="121200021"><itemNumber>0316</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.2134</price><drug id="01932691" notABenefit="Y" sec3="Y"><name>Ventolin</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02146851" sec3="Y"><name>Apo-Salvent</name><manufacturerId>APX</manufacturerId><individualPrice>.2134</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00254"><name>SALMETEROL XINAFOATE</name><pcgGroup lccId="00043"><pcg9 id="121200069"><itemNumber>0317</itemNumber><strength>50mcg/Blister</strength><dosageForm>Diskhaler-60 Disk Pk</dosageForm><price>56.1000</price><drug id="02214261" sec3="Y" sec12="Y"><name>SereVent Diskhaler Disks</name><manufacturerId>GSK</manufacturerId><individualPrice>56.1000</individualPrice><listingDate>1997-07-12</listingDate></drug></pcg9><pcg9 id="121200077"><itemNumber>0318</itemNumber><strength>50mcg</strength><dosageForm>Pd Inh-60 Dose Pk</dosageForm><price>56.1000</price><drug id="02231129" sec3="Y" sec12="Y"><name>SereVent Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>56.1000</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="132">For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.</lccNote><lccNote seq="002" type="N">This drug is not for relief of acute symptoms.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="391">For patients with moderate to severe COPD with persistent respiratory symptoms despite an adequate trial of, or an intolerance to, a regularly scheduled short-acting bronchodilator AND a long-acting anticholinergic.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01460"><name>SALMETEROL XINAFOATE &amp; FLUTICASONE PROPIONATE</name><pcgGroup lccId="00044"><pcg9 id="121200085"><itemNumber>0319</itemNumber><strength>25/125mcg/Metered Dose</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>95.9900</price><drug id="02245126" sec3="Y" sec12="Y"><name>Advair 125</name><manufacturerId>GSK</manufacturerId><individualPrice>95.9900</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="121200086"><itemNumber>0320</itemNumber><strength>25/250mcg/Metered Dose</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>136.2700</price><drug id="02245127" sec3="Y" sec12="Y"><name>Advair 250</name><manufacturerId>GSK</manufacturerId><individualPrice>136.2700</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="121200083"><itemNumber>0321</itemNumber><strength>50/100mcg</strength><dosageForm>Inh-60 Dose Pk</dosageForm><price>80.1900</price><drug id="02240835" sec3="Y" sec12="Y"><name>Advair Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>80.1900</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="121200080"><itemNumber>0322</itemNumber><strength>50/250mcg</strength><dosageForm>Inh-60 Dose Pk</dosageForm><price>95.9900</price><drug id="02240836" sec3="Y" sec12="Y"><name>Advair Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>95.9900</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="121200081"><itemNumber>0323</itemNumber><strength>50/500mcg</strength><dosageForm>Inh-60 Dose Pk</dosageForm><price>136.2700</price><drug id="02240837" sec3="Y" sec12="Y"><name>Advair Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>136.2700</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="330">For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00245"><name>TERBUTALINE SULFATE</name><pcgGroup><pcg9 id="121200047"><itemNumber>0324</itemNumber><strength>0.5mg/Dose</strength><dosageForm>Inh-200 Dose Pk</dosageForm><price>14.7000</price><drug id="00786616" sec3="Y"><name>Bricanyl Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>14.7000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="121600000"><name>SYMPATHOLYTIC (ADRENERGIC BLOCKING) AGENTS</name><note>Ergotamine is the drug of choice in the treatment of acute attacks of migraine. It may also alleviate or prevent acute attacks of cluster headache in some patients. The addition of caffeine or pentobarbital have not been proven to result in greater efficacy.</note><genericName id="00258"><name>ERGOTAMINE TARTRATE &amp; CAFFEINE</name><pcgGroup><pcg9 id="121600003"><itemNumber>0325</itemNumber><strength>1mg &amp; 100mg</strength><dosageForm>Tab</dosageForm><price>.7902</price><drug id="00176095" sec3="Y"><name>Cafergot</name><manufacturerId>NOV</manufacturerId><individualPrice>.7902</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="122000000"><name>SKELETAL MUSCLE RELAXANTS</name><note>Muscle relaxants, other than baclofen and dantrolene sodium, are not indicated for spasticity due to cerebral palsy, multiple sclerosis, spinal cord injury, etc.</note><genericName id="00271"><name>BACLOFEN</name><pcgGroup><pcg9 id="122000003"><itemNumber>0326</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2311</price><drug id="00455881" sec3="Y"><name>Lioresal</name><manufacturerId>NOV</manufacturerId><individualPrice>.6379</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02063735" sec3="Y"><name>PMS-Baclofen</name><manufacturerId>PMS</manufacturerId><individualPrice>.2311</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02088398" sec3="Y"><name>Gen-Baclofen</name><manufacturerId>GEN</manufacturerId><individualPrice>.2311</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02136090" sec3="Y"><name>Nu-Baclo</name><manufacturerId>NXP</manufacturerId><individualPrice>.2311</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02139332" sec3="Y"><name>Apo-Baclofen</name><manufacturerId>APX</manufacturerId><individualPrice>.2311</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02236507" sec3="Y"><name>Ratio-Baclofen</name><manufacturerId>RPH</manufacturerId><individualPrice>.2311</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="122000006"><itemNumber>0327</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.4498</price><drug id="00636576" sec3="Y"><name>Lioresal DS</name><manufacturerId>NOV</manufacturerId><individualPrice>1.2415</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02063743" sec3="Y"><name>PMS-Baclofen</name><manufacturerId>PMS</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02088401" sec3="Y"><name>Gen-Baclofen</name><manufacturerId>GEN</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02136104" sec3="Y"><name>Nu-Baclo</name><manufacturerId>NXP</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02139391" sec3="Y"><name>Apo-Baclofen</name><manufacturerId>APX</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02236508" sec3="Y"><name>Ratio-Baclofen</name><manufacturerId>RPH</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00272"><name>CYCLOBENZAPRINE HCL</name><pcgGroup><pcg9 id="122000005"><itemNumber>0328</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="00782742" notABenefit="Y" sec3="Y"><name>Flexeril</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02080052" notABenefit="Y" sec3="Y"><name>Novo-Cycloprine</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02171848" notABenefit="Y" sec3="Y"><name>Nu-Cyclobenzaprine</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02177145" notABenefit="Y" sec3="Y"><name>Apo-Cyclobenzaprine</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02212048" notABenefit="Y" sec3="Y"><name>PMS-Cyclobenzaprine</name><manufacturerId>PMS</manufacturerId><listingDate>1996-12-19</listingDate></drug><drug id="02231353" notABenefit="Y" sec3="Y"><name>Gen-Cycloprine</name><manufacturerId>GEN</manufacturerId><listingDate>1998-12-31</listingDate></drug><drug id="02236506" notABenefit="Y" sec3="Y"><name>Ratio-Cyclobenzaprine</name><manufacturerId>RPH</manufacturerId><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00270"><name>DANTROLENE SODIUM</name><pcgGroup><pcg9 id="122000002"><itemNumber>0329</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.3780</price><drug id="01997602" sec3="Y"><name>Dantrium</name><manufacturerId>JHP</manufacturerId><individualPrice>.3780</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="122000001"><itemNumber>0330</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.7684</price><drug id="01997653" sec3="Y"><name>Dantrium</name><manufacturerId>JHP</manufacturerId><individualPrice>.7684</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00273"><name>ORPHENADRINE CITRATE</name><pcgGroup><pcg9 id="122000007"><itemNumber>0331</itemNumber><strength>60mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><drug id="01966162" notABenefit="Y" sec3="Y"><name>Norflex</name><manufacturerId>MMH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02229731" notABenefit="Y" sec3="Y"><name>Orphenadrine</name><manufacturerId>CYI</manufacturerId><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01453"><name>TIZANIDINE HCL</name><pcgGroup><pcg9 id="122000025"><itemNumber>0332</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><drug id="02239170" notABenefit="Y" sec3="Y"><name>Zanaflex</name><manufacturerId>ELA</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02259893" notABenefit="Y" sec3="Y"><name>Apo-Tizanidine</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02272059" notABenefit="Y" sec3="Y"><name>Gen-Tizanidine</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="200000000"><name>BLOOD FORMATION AND COAGULATION</name><pcg6 id="200400000"><name>ANTIANEMIA DRUGS</name><genericName id="00282"><name>FERROUS FUMARATE</name><pcgGroup><pcg9 id="200400013"><itemNumber>0333</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.1234</price><drug id="01923420" sec3="Y"><name>Palafer</name><manufacturerId>GSK</manufacturerId><individualPrice>.2013</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02237556" sec3="Y"><name>Euro-Fer</name><manufacturerId>EUR</manufacturerId><individualPrice>.1234</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="200400003"><itemNumber>0334</itemNumber><strength>60mg/mL</strength><dosageForm>O/L</dosageForm><price>.0857</price><drug id="01923439" sec3="Y"><name>Palafer</name><manufacturerId>GSK</manufacturerId><individualPrice>.0857</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00283"><name>FERROUS GLUCONATE</name><pcgGroup><pcg9 id="200400004" suppliedBy="L"><itemNumber>0335</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.0212</price><drug id="00021458" selfMed="Y" sec3="Y"><name>Novo-Ferrogluc</name><manufacturerId>NOP</manufacturerId><individualPrice>.0212</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00031097" notABenefit="Y" sec3="Y"><name>Ferrous Gluconate</name><manufacturerId>JPC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00545031" selfMed="Y" sec3="Y"><name>Apo-Ferrous Gluconate</name><manufacturerId>APX</manufacturerId><individualPrice>.0212</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00284"><name>FERROUS SULFATE</name><pcgGroup><pcg9 id="200400007"><itemNumber>0336</itemNumber><strength>75mg/mL</strength><dosageForm>O/L</dosageForm><price>.2436</price><drug id="00762954" sec3="Y"><name>Fer-In-Sol</name><manufacturerId>MJS</manufacturerId><individualPrice>.2436</individualPrice><listingDate>1997-01-03</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="201200000"><name>COAGULANTS AND ANTI-COAGULANTS</name><genericName id="00298"><name>DALTEPARIN SODIUM</name><pcgGroup lccId="00045"><pcg9 id="201200038"><itemNumber>0337</itemNumber><strength>2500IU/0.2mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>5.1376</price><drug id="02132621" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>5.1376</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="201200040"><itemNumber>0338</itemNumber><strength>5000IU/0.2mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>10.2752</price><drug id="02132648" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>10.2752</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="201200064"><itemNumber>0339</itemNumber><strength>10000IU/0.4mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>20.5504</price><drug id="09853790" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>20.5504</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="201200065"><itemNumber>0340</itemNumber><strength>12500IU/0.5mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>25.6880</price><drug id="09853820" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>25.6880</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="201200066"><itemNumber>0341</itemNumber><strength>15000IU/0.6mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>30.8256</price><drug id="09853880" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>30.8256</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="201200067"><itemNumber>0342</itemNumber><strength>18000IU/0.72mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>36.9907</price><drug id="09853910" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>36.9907</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="201200037"><itemNumber>0343</itemNumber><strength>10000IU/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>16.2240</price><drug id="02132664" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>16.2240</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="201200043"><itemNumber>0344</itemNumber><strength>25000IU/mL</strength><dosageForm>Multidose 3.8mL Pk</dosageForm><price>154.1280</price><drug id="02231171" sec3="Y" sec12="Y"><name>Fragmin</name><manufacturerId>PFI</manufacturerId><individualPrice>154.1280</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="186">For acute treatment of deep venous thrombosis (DVT), for a maximum of three weeks;</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="187">For DVT in pregnant or lactating females;</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="188">For DVT in patients whom treatment with warfarin is not tolerated, or contraindicated;</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="189">For DVT in patients who have failed treatment with warfarin.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01229"><name>ENOXAPARIN</name><pcgGroup lccId="00046"><pcg9 id="201200070"><itemNumber>0345</itemNumber><strength>100mg/mL</strength><dosageForm>Inj Sol-3mLVial Pk</dosageForm><price>61.5000</price><drug id="02236564" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>61.5000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200071"><itemNumber>0346</itemNumber><strength>30mg/0.3mL</strength><dosageForm>Pref Syr-0.3mL Pk</dosageForm><price>6.1900</price><drug id="02012472" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>6.1900</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200055"><itemNumber>0347</itemNumber><strength>40mg/0.4mL</strength><dosageForm>Pref Syr-0.4mL Pk</dosageForm><price>8.2000</price><drug id="02236883" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>8.2000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200056"><itemNumber>0348</itemNumber><strength>60mg/0.6mL</strength><dosageForm>Pref Syr-0.6mL Pk</dosageForm><price>12.3000</price><drug id="09852468" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>12.3000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200057"><itemNumber>0349</itemNumber><strength>80mg/0.8mL</strength><dosageForm>Pref Syr-0.8mL Pk</dosageForm><price>16.4000</price><drug id="09852476" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>16.4000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200073"><itemNumber>0350</itemNumber><strength>120mg/0.8mL</strength><dosageForm>Pref Syr-0.8mL Pk</dosageForm><price>24.6000</price><drug id="09857137" sec3="Y" sec12="Y"><name>Lovenox HP</name><manufacturerId>SAV</manufacturerId><individualPrice>24.6000</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="201200058"><itemNumber>0351</itemNumber><strength>100mg/mL</strength><dosageForm>Pref Syr-1mL Pk</dosageForm><price>20.5000</price><drug id="09852484" sec3="Y" sec12="Y"><name>Lovenox</name><manufacturerId>SAV</manufacturerId><individualPrice>20.5000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="201200074"><itemNumber>0352</itemNumber><strength>150mg/mL</strength><dosageForm>Pref Syr-1mL Pk</dosageForm><price>30.7500</price><drug id="02242692" sec3="Y" sec12="Y"><name>Lovenox HP</name><manufacturerId>SAV</manufacturerId><individualPrice>30.7500</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="186">For acute treatment of deep venous thrombosis (DVT), for a maximum of three weeks;</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="187">For DVT in pregnant or lactating females;</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="188">For DVT in patients whom treatment with warfarin is not tolerated, or contraindicated;</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="189">For DVT in patients who have failed treatment with warfarin.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="323">For the acute treatment of pulmonary embolism, maximum of three weeks.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01576"><name>FONDAPARINUX SODIUM</name><pcgGroup lccId="00148"><pcg9 id="201200072"><itemNumber>0353</itemNumber><strength>2.5mg</strength><dosageForm>Inj-0.5mL Pk</dosageForm><price>15.4320</price><drug id="02245531" sec3="Y" sec12="Y"><name>Arixtra</name><manufacturerId>GSK</manufacturerId><individualPrice>15.4320</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="378">For the post-operative prophylaxis of venous thromboembolic events in patients undergoing orthopedic surgery of the lower limbs such as hip fracture, hip replacement or knee surgery.</lccNote><lccNote seq="002" type="N">Limited to 9 days of reimbursement.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00290"><name>HEPARIN SODIUM</name><pcgGroup><pcg9 id="201200002"><itemNumber>0354</itemNumber><strength>10000USP U/10mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>3.5875</price><drug id="00740519" sec3="Y"><name>Hepalean</name><manufacturerId>ORG</manufacturerId><individualPrice>3.5875</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="201200003"><itemNumber>0355</itemNumber><strength>50000USP U/5mL</strength><dosageForm>Inj Sol-5mL Pk</dosageForm><price>6.0373</price><drug id="00740497" sec3="Y"><name>Hepalean</name><manufacturerId>ORG</manufacturerId><individualPrice>6.0373</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01409"><name>NADROPARIN CALCIUM</name><pcgGroup lccId="00047"><pcg9 id="201200050"><itemNumber>0356</itemNumber><strength>9500IU/mL</strength><dosageForm>Pref Syr-0.3mL Pk</dosageForm><price>9.1290</price><drug id="09853936" sec3="Y" sec12="Y"><name>Fraxiparine</name><manufacturerId>GSK</manufacturerId><individualPrice>9.1290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="201200051"><itemNumber>0357</itemNumber><strength>9500IU/mL</strength><dosageForm>Pref Syr-0.4mL Pk</dosageForm><price>9.1290</price><drug id="09853944" sec3="Y" sec12="Y"><name>Fraxiparine</name><manufacturerId>GSK</manufacturerId><individualPrice>9.1290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="201200052"><itemNumber>0358</itemNumber><strength>9500IU/mL</strength><dosageForm>Pref Syr-0.6mL Pk</dosageForm><price>9.1290</price><drug id="09853952" sec3="Y" sec12="Y"><name>Fraxiparine</name><manufacturerId>GSK</manufacturerId><individualPrice>9.1290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="201200059"><itemNumber>0359</itemNumber><strength>19000IU/mL</strength><dosageForm>Pref Syr-0.6mL Pk</dosageForm><price>18.2580</price><drug id="02240114" sec3="Y" sec12="Y"><name>Fraxiparine Forte</name><manufacturerId>GSK</manufacturerId><individualPrice>18.2580</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="201200053"><itemNumber>0360</itemNumber><strength>9500IU/mL</strength><dosageForm>Pref Syr-0.8mL Pk</dosageForm><price>9.1290</price><drug id="09853979" sec3="Y" sec12="Y"><name>Fraxiparine</name><manufacturerId>GSK</manufacturerId><individualPrice>9.1290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="201200060"><itemNumber>0361</itemNumber><strength>19000IU/mL</strength><dosageForm>Pref Syr-0.8mL Pk</dosageForm><price>18.2580</price><drug id="09854100" sec3="Y" sec12="Y"><name>Fraxiparine Forte</name><manufacturerId>GSK</manufacturerId><individualPrice>18.2580</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="201200054"><itemNumber>0362</itemNumber><strength>9500IU/mL</strength><dosageForm>Pref Syr-1.0mL Pk</dosageForm><price>9.1290</price><drug id="09853987" sec3="Y" sec12="Y"><name>Fraxiparine</name><manufacturerId>GSK</manufacturerId><individualPrice>9.1290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="201200061"><itemNumber>0363</itemNumber><strength>19000IU/mL</strength><dosageForm>Pref Syr-1.0mL Pk</dosageForm><price>18.2580</price><drug id="09854118" sec3="Y" sec12="Y"><name>Fraxiparine Forte</name><manufacturerId>GSK</manufacturerId><individualPrice>18.2580</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="186">For acute treatment of deep venous thrombosis (DVT), for a maximum of three weeks;</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="187">For DVT in pregnant or lactating females;</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="188">For DVT in patients whom treatment with warfarin is not tolerated, or contraindicated;</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="189">For DVT in patients who have failed treatment with warfarin.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01756"><name>RIVAROXABAN</name><pcgGroup><pcg9 id="201200079"><itemNumber>0364</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>8.8598</price><note>Note: For the prevention of venous thromboembolic events in patients who have undergone elective total hip replacement (THR) or total knee replacement (TKR) surgery.

NETWORK NOTE: Limited to 14 days of reimbursement and to 1 claim in a 120 day period.</note><drug id="02316986" dinStatus="N" sec3="Y"><name>Xarelto</name><manufacturerId>BAH</manufacturerId><individualPrice>8.8598</individualPrice><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00299"><name>TINZAPARIN SODIUM</name><pcgGroup lccId="00048"><pcg9 id="201200039"><itemNumber>0365</itemNumber><strength>10000IU/mL</strength><dosageForm>Inj - 2mL Pk</dosageForm><price>32.0000</price><drug id="02167840" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>32.0000</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="201200042"><itemNumber>0366</itemNumber><strength>20000IU/mL</strength><dosageForm>Inj - 2mL Pk</dosageForm><price>65.0000</price><drug id="02229515" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>65.0000</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="201200044"><itemNumber>0367</itemNumber><strength>3500IU/0.35mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>5.6450</price><drug id="02229755" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>5.6450</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="201200045"><itemNumber>0368</itemNumber><strength>4500IU/0.45mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>7.2580</price><drug id="09853898" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>7.2580</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="201200046"><itemNumber>0369</itemNumber><strength>10000IU/0.5mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>16.4800</price><drug id="02231478" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>16.4800</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="201200047"><itemNumber>0370</itemNumber><strength>14000IU/0.7mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>23.0700</price><drug id="09853901" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>23.0700</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="201200048"><itemNumber>0371</itemNumber><strength>18000IU/0.9mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>29.6600</price><drug id="09853928" sec3="Y" sec12="Y"><name>Innohep</name><manufacturerId>LEO</manufacturerId><individualPrice>29.6600</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="186">For acute treatment of deep venous thrombosis (DVT), for a maximum of three weeks;</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="187">For DVT in pregnant or lactating females;</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="188">For DVT in patients whom treatment with warfarin is not tolerated, or contraindicated;</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="189">For DVT in patients who have failed treatment with warfarin.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="323">For the acute treatment of pulmonary embolism, maximum of three weeks.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00292"><name>WARFARIN</name><note>The use of International Normalized Ratio (INR) instead of Prothrombin Time results to control warfarin dosing is strongly recommended. Prothrombin Time results can vary three-fold depending on the reagent used; INR corrects for this and substantially improves safety and efficacy of warfarin therapy.</note><pcgGroup><pcg9 id="201200026"><itemNumber>0372</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.1415</price><drug id="01918311" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.3182</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242680" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242924" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244462" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265273" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="201200027"><itemNumber>0373</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1496</price><drug id="01918338" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.3365</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242681" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1496</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242925" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1496</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244463" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1496</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265281" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1496</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="201200010"><itemNumber>0374</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.1198</price><drug id="01918346" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.2694</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242682" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1198</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242926" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1198</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244464" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1198</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265303" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1198</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="201200062"><itemNumber>0375</itemNumber><strength>3mg</strength><dosageForm>Tab</dosageForm><price>.1855</price><drug id="02240205" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.4172</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242683" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2002-04-04</listingDate></drug><drug id="02245618" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265311" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2005-09-16</listingDate></drug><drug id="02287498" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1910</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="201200028"><itemNumber>0376</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.1855</price><drug id="02007959" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.4172</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242684" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242927" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244465" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265338" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1855</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="201200035"><itemNumber>0377</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1200</price><drug id="01918354" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.2699</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242685" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.1200</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242928" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.1200</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244466" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.1200</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02265346" sec3="Y"><name>Novo-Warfarin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1200</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="201200077"><itemNumber>0378</itemNumber><strength>6mg</strength><dosageForm>Tab</dosageForm><drug id="02240206" notABenefit="Y" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02242686" notABenefit="Y" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02287501" notABenefit="Y" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="201200008"><itemNumber>0379</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2153</price><drug id="01918362" sec3="Y"><name>Coumadin</name><manufacturerId>BQU</manufacturerId><individualPrice>.4843</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242687" sec3="Y"><name>Taro-Warfarin</name><manufacturerId>TAR</manufacturerId><individualPrice>.2153</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02242929" sec3="Y"><name>Apo-Warfarin</name><manufacturerId>APX</manufacturerId><individualPrice>.2153</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244467" sec3="Y"><name>Gen-Warfarin</name><manufacturerId>GEN</manufacturerId><individualPrice>.2153</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="201600000"><name>HEMATOPOIETIC AGENTS</name><genericName id="01573"><name>DARBEPOETIN ALFA</name><pcgGroup><pcg9 id="201600013"><itemNumber>0380</itemNumber><strength>150mcg/0.3mL</strength><dosageForm>Pref Syr-0.3mL Pk</dosageForm><price>402.0000</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Darbepoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Aranesp are recommended by the Committee to Evaluate Drugs :

I.    200mcg q2weekly x 6 weeks, then increase to 300mcg q2weekly if inadequate    response;      OR
II.   500mcg q3weekly x maximum duration of 3 cycles, then decrease to 300mcg      q3weekly for maintenance;     OR
III.  150mcg qweekly</note><drug id="02246360" sec3="Y"><name>Aranesp</name><manufacturerId>AMG</manufacturerId><individualPrice>402.0000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="201600037"><itemNumber>0381</itemNumber><strength>200mcg/0.4mL</strength><dosageForm>Pref Syr-0.4mL Pk</dosageForm><price>536.0000</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Darbepoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Aranesp are recommended by the Committee to Evaluate Drugs :

I.    200mcg q2weekly x 6 weeks, then increase to 300mcg q2weekly if inadequate response;      OR
II.   500mcg q3weekly x maximum duration of 3 cycles, then decrease to 300mcg q3weekly for maintenance;     OR
III.  150mcg qweekly</note><drug id="09857185" sec3="Y"><name>Aranesp</name><manufacturerId>AMG</manufacturerId><individualPrice>536.0000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="201600038"><itemNumber>0382</itemNumber><strength>300mcg/0.6mL</strength><dosageForm>Pref Syr-0.6mL Pk</dosageForm><price>828.0000</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Darbepoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Aranesp are recommended by the Committee to Evaluate Drugs :

I.    200mcg q2weekly x 6 weeks, then increase to 300mcg q2weekly if inadequate response;      OR
II.   500mcg q3weekly x maximum duration of 3 cycles, then decrease to 300mcg q3weekly for maintenance;     OR
III.  150mcg qweekly</note><drug id="09857186" sec3="Y"><name>Aranesp</name><manufacturerId>AMG</manufacturerId><individualPrice>828.0000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="201600039"><itemNumber>0383</itemNumber><strength>500mcg/1.0mL</strength><dosageForm>Pref Syr-1.0mL Pk</dosageForm><price>1380.0000</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Darbepoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Aranesp are recommended by the Committee to Evaluate Drugs :

I.    200mcg q2weekly x 6 weeks, then increase to 300mcg q2weekly if inadequate response;      OR
II.   500mcg q3weekly x maximum duration of 3 cycles, then decrease to 300mcg q3weekly for maintenance;     OR
III.  150mcg qweekly</note><drug id="09857187" sec3="Y"><name>Aranesp</name><manufacturerId>AMG</manufacturerId><individualPrice>1380.0000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00304"><name>EPOETIN ALFA</name><pcgGroup><pcg9 id="201600002"><itemNumber>0384</itemNumber><strength>10,000IU/mL</strength><dosageForm>Pref Syr - 1mL Pk</dosageForm><price>142.5000</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Erythropoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Eprex are recommended by the Committee to Evaluate Drugs:
 
I.  150 IU/kg subcutaneously 3 times a week for 4 weeks. If no response, the dose may be increased to 300 IU/kg subcutaneously 3 times a week;      OR
II.  40,000 IU once weekly. If no response after 4 weeks, the dose may be increased to 60,000 IU once weekly for 4 weeks.</note><drug id="02231587" sec3="Y"><name>Eprex</name><manufacturerId>JNO</manufacturerId><individualPrice>142.5000</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="201600006"><itemNumber>0385</itemNumber><strength>40,000IU/mL</strength><dosageForm>Pref Syr - 1mL Pk</dosageForm><price>401.8500</price><note>These products must be prescribed based on the following criteria:

For the treatment of chemotherapy-induced anemia in patients with malignant cancer undergoing myelosuppressive chemotherapy with a hemoglobin count of less than 100g/L and MCV level between 75fL and 120fL.

Note: Erythropoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.  

The following dosage regimens for Eprex are recommended by the Committee to Evaluate Drugs:
 
I.  150 IU/kg subcutaneously 3 times a week for 4 weeks. If no response, the dose may be increased to 300 IU/kg subcutaneously 3 times a week;      OR
II.  40,000 IU once weekly. If no response after 4 weeks, the dose may be increased to 60,000 IU once weekly for 4 weeks.</note><drug id="02240722" sec3="Y"><name>Eprex</name><manufacturerId>JNO</manufacturerId><individualPrice>401.8500</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="201600046"><itemNumber>0386</itemNumber><strength>20,000IU/0.5mL</strength><dosageForm>Pref Syr-0.5mL Pk</dosageForm><price>267.9000</price><note>For patients with malignant cancer undergoing myelosuppressive chemotherapy with hemoglobin count less than 100g/L and MCV level between 75fL and 120fL.

Note: Erythropoietin therapy should be re-assessed after 3 months of therapy and should not be continued for those patients who do not respond to therapy      (i.e. Hgb level has not improved by at least 15g/L or transfusions were required after first 2 weeks of therapy) or who are no longer anemic.
</note><drug id="02243239" dinStatus="N" sec3="Y"><name>Eprex</name><manufacturerId>JNO</manufacturerId><individualPrice>267.9000</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="202400000"><name>HEMORRHEOLOGIC AGENTS</name><genericName id="00306"><name>PENTOXIFYLLINE</name><pcgGroup lccId="00049"><pcg9 id="202400001"><itemNumber>0387</itemNumber><strength>400mg</strength><dosageForm>SR Tab</dosageForm><price>.3046</price><drug id="01968432" sec3="Y" sec12="Y"><name>Ratio-Pentoxifylline</name><manufacturerId>RPH</manufacturerId><individualPrice>.3046</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02221977" sec3="Y" sec12="Y"><name>Trental</name><manufacturerId>SAV</manufacturerId><individualPrice>.7795</individualPrice><listingDate>1999-01-07</listingDate></drug><drug id="02230090" sec3="Y" sec12="Y"><name>Apo-Pentoxifylline</name><manufacturerId>APX</manufacturerId><individualPrice>.3046</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02230401" sec3="Y" sec12="Y"><name>Nu-Pentoxifylline</name><manufacturerId>NXP</manufacturerId><individualPrice>.3046</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="76">For the treatment of patients with critical limb ischemia (with arterial ulcers, gangrene and/or rest pain) and documented arterial vascular disease.</lccNote><lccNote seq="002" type="N">Limited Use form must specify if arterial ulcers, gangrene and/or rest pain are present.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName></pcg6></pcg2><pcg2 id="240000000"><name>CARDIOVASCULAR DRUGS</name><pcg6 id="240400000"><name>CARDIAC DRUGS</name><genericName id="00325"><name>ACEBUTOLOL HCL</name><pcgGroup><pcg9 id="240400084"><itemNumber>0388</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.1294</price><dailyCost>.2588</dailyCost><drug id="01910140" sec3="Y"><name>Rhotral</name><manufacturerId>SAV</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01926543" sec3="Y"><name>Sectral</name><manufacturerId>SAV</manufacturerId><individualPrice>.3146</individualPrice><dailyCost>.6292</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02036290" notABenefit="Y" sec3="Y"><name>Monitan</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02147602" sec3="Y"><name>Apo-Acebutolol</name><manufacturerId>APX</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02165546" sec3="Y"><name>Nu-Acebutolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02204517" sec3="Y"><name>Novo-Acebutolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02237721" sec3="Y"><name>Gen-Acebutolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02237885" sec3="Y"><name>Gen-Acebutolol (Type S)</name><manufacturerId>GEN</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02257599" sec3="Y"><name>Sandoz Acebutolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1294</individualPrice><dailyCost>.2588</dailyCost><listingDate>2005-01-25</listingDate></drug></pcg9><pcg9 id="240400085"><itemNumber>0389</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.1936</price><dailyCost>.3872</dailyCost><drug id="01910159" sec3="Y"><name>Rhotral</name><manufacturerId>SAV</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01926551" sec3="Y"><name>Sectral</name><manufacturerId>SAV</manufacturerId><individualPrice>.4708</individualPrice><dailyCost>.9416</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02036436" notABenefit="Y" sec3="Y"><name>Monitan</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02147610" sec3="Y"><name>Apo-Acebutolol</name><manufacturerId>APX</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02165554" sec3="Y"><name>Nu-Acebutolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02204525" sec3="Y"><name>Novo-Acebutolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02237722" sec3="Y"><name>Gen-Acebutolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02237886" sec3="Y"><name>Gen-Acebutolol (Type S)</name><manufacturerId>GEN</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02257602" sec3="Y"><name>Sandoz Acebutolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1936</individualPrice><dailyCost>.3872</dailyCost><listingDate>2005-01-25</listingDate></drug></pcg9><pcg9 id="240400116"><itemNumber>0390</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.3847</price><dailyCost>.7694</dailyCost><drug id="01910167" sec3="Y"><name>Rhotral</name><manufacturerId>SAV</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01926578" sec3="Y"><name>Sectral</name><manufacturerId>SAV</manufacturerId><individualPrice>.9862</individualPrice><dailyCost>1.9724</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02036444" notABenefit="Y" sec3="Y"><name>Monitan</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02147629" sec3="Y"><name>Apo-Acebutolol</name><manufacturerId>APX</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02165562" sec3="Y"><name>Nu-Acebutolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02204533" sec3="Y"><name>Novo-Acebutolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02237723" sec3="Y"><name>Gen-Acebutolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02237887" sec3="Y"><name>Gen-Acebutolol (Type S)</name><manufacturerId>GEN</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02257610" sec3="Y"><name>Sandoz Acebutolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3847</individualPrice><dailyCost>.7694</dailyCost><listingDate>2005-01-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00323"><name>AMIODARONE HCL</name><pcgGroup><pcg9 id="240400072"><itemNumber>0391</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>1.0295</price><note>The manufacturer recommends that treatment with amiodarone be initiated in hospital and continued in a monitored environment under the care of a cardiologist, or internist with equivalent experience in such care.</note><drug id="02036282" sec3="Y"><name>Cordarone</name><manufacturerId>WAY</manufacturerId><individualPrice>2.0589</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239835" sec3="Y"><name>Novo-Amiodarone</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02240071" sec3="Y"><name>Ratio-Amiodarone</name><manufacturerId>RPH</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240604" sec3="Y"><name>Mylan-Amiodarone</name><manufacturerId>MYL</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02242472" sec3="Y"><name>PMS-Amiodarone</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02243836" sec3="Y"><name>Sandoz Amiodarone</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246194" sec3="Y"><name>Apo-Amiodarone</name><manufacturerId>APX</manufacturerId><individualPrice>1.0295</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00328"><name>AMLODIPINE</name><pcgGroup><pcg9 id="240400120"><itemNumber>0392</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.6656</price><dailyCost>.6656</dailyCost><drug id="00878928" sec3="Y"><name>Norvasc</name><manufacturerId>PFI</manufacturerId><individualPrice>1.3565</individualPrice><dailyCost>1.3565</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02250497" dinStatus="N" sec3="Y"><name>Novo-Amlodipine</name><manufacturerId>NOP</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02259605" dinStatus="N" sec3="Y"><name>Ratio-Amlodipine</name><manufacturerId>RPH</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02272113" dinStatus="N" sec3="Y"><name>Mylan-Amlodipine</name><manufacturerId>MYL</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02273373" dinStatus="N" sec3="Y"><name>Apo-Amlodipine</name><manufacturerId>APX</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02280132" dinStatus="N" sec3="Y"><name>Gd-Amlodipine</name><manufacturerId>GEM</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02284065" dinStatus="N" sec3="Y"><name>PMS-Amlodipine</name><manufacturerId>PMS</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02284383" dinStatus="N" sec3="Y"><name>Sandoz Amlodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02297485" dinStatus="N" sec3="Y"><name>Co Amlodipine</name><manufacturerId>COB</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02321858" dinStatus="N" sec3="Y"><name>Ran-Amlodipine</name><manufacturerId>RAN</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02326779" dinStatus="N" sec3="Y"><name>Phl-Amlodipine</name><manufacturerId>PHE</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02331071" dinStatus="N" sec3="Y"><name>Jamp-Amlodipine</name><manufacturerId>JPC</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2010-04-23</listingDate></drug><drug id="02331934" dinStatus="N" sec3="Y"><name>Amlodipine Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.6656</individualPrice><dailyCost>.6656</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240400121"><itemNumber>0393</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.9880</price><dailyCost>.9880</dailyCost><drug id="00878936" sec3="Y"><name>Norvasc</name><manufacturerId>PFI</manufacturerId><individualPrice>2.0135</individualPrice><dailyCost>2.0135</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02250500" dinStatus="N" sec3="Y"><name>Novo-Amlodipine</name><manufacturerId>NOP</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02259613" dinStatus="N" sec3="Y"><name>Ratio-Amlodipine</name><manufacturerId>RPH</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02272121" dinStatus="N" sec3="Y"><name>Mylan-Amlodipine</name><manufacturerId>MYL</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02273381" dinStatus="N" sec3="Y"><name>Apo-Amlodipine</name><manufacturerId>APX</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02280140" dinStatus="N" sec3="Y"><name>Gd-Amlodipine</name><manufacturerId>GEM</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02284073" dinStatus="N" sec3="Y"><name>PMS-Amlodipine</name><manufacturerId>PMS</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02284391" dinStatus="N" sec3="Y"><name>Sandoz Amlodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02297493" dinStatus="N" sec3="Y"><name>Co Amlodipine</name><manufacturerId>COB</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02321866" dinStatus="N" sec3="Y"><name>Ran-Amlodipine</name><manufacturerId>RAN</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02326787" dinStatus="N" sec3="Y"><name>Phl-Amlodipine</name><manufacturerId>PHE</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2009-09-30</listingDate></drug><drug id="02331098" dinStatus="N" sec3="Y"><name>Jamp-Amlodipine</name><manufacturerId>JPC</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2010-04-23</listingDate></drug><drug id="02331942" dinStatus="N" sec3="Y"><name>Amlodipine Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.9880</individualPrice><dailyCost>.9880</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00324"><name>ATENOLOL</name><pcgGroup><pcg9 id="240400079"><itemNumber>0394</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2790</price><dailyCost>.2790</dailyCost><drug id="00773689" sec3="Y"><name>Apo-Atenol</name><manufacturerId>APX</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886114" sec3="Y"><name>Nu-Atenol</name><manufacturerId>NXP</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01912062" sec3="Y"><name>Novo-Atenol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02039532" sec3="Y"><name>Tenormin</name><manufacturerId>AZC</manufacturerId><individualPrice>.5746</individualPrice><dailyCost>.5746</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02146894" sec3="Y"><name>Gen-Atenolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02171791" sec3="Y"><name>Ratio-Atenolol</name><manufacturerId>RPH</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231731" sec3="Y"><name>Sandoz Atenolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02237600" sec3="Y"><name>PMS-Atenolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02255545" sec3="Y"><name>Co-Atenolol</name><manufacturerId>COB</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>2004-10-14</listingDate></drug><drug id="02267985" sec3="Y"><name>Ran-Atenolol</name><manufacturerId>RAN</manufacturerId><individualPrice>.2790</individualPrice><dailyCost>.2790</dailyCost><listingDate>2006-03-01</listingDate></drug></pcg9><pcg9 id="240400078"><itemNumber>0395</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.4586</price><dailyCost>.4586</dailyCost><drug id="00773697" sec3="Y"><name>Apo-Atenol</name><manufacturerId>APX</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886122" sec3="Y"><name>Nu-Atenol</name><manufacturerId>NXP</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01912054" sec3="Y"><name>Novo-Atenol</name><manufacturerId>NOP</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02039540" sec3="Y"><name>Tenormin</name><manufacturerId>AZC</manufacturerId><individualPrice>.9446</individualPrice><dailyCost>.9446</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02147432" sec3="Y"><name>Gen-Atenolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02171805" sec3="Y"><name>Ratio-Atenolol</name><manufacturerId>RPH</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231733" sec3="Y"><name>Sandoz Atenolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02237601" sec3="Y"><name>PMS-Atenolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02255553" sec3="Y"><name>Co-Atenolol</name><manufacturerId>COB</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>2004-10-14</listingDate></drug><drug id="02267993" sec3="Y"><name>Ran-Atenolol</name><manufacturerId>RAN</manufacturerId><individualPrice>.4586</individualPrice><dailyCost>.4586</dailyCost><listingDate>2006-03-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01508"><name>BISOPROLOL FUMARATE</name><pcgGroup><pcg9 id="240400157"><itemNumber>0396</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1750</price><drug id="02241148" dinStatus="E" sec3="Y"><name>Monocor</name><manufacturerId>BIO</manufacturerId><individualPrice>.3974</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02247439" sec3="Y"><name>Sandoz Bisoprolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1750</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02256134" sec3="Y"><name>Apo-Bisoprolol</name><manufacturerId>APX</manufacturerId><individualPrice>.1750</individualPrice><listingDate>2004-11-16</listingDate></drug><drug id="02267470" sec3="Y"><name>Novo-Bisoprolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1750</individualPrice><listingDate>2005-08-19</listingDate></drug><drug id="02302632" sec3="Y"><name>PMS-Bisoprolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.1750</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="240400158"><itemNumber>0397</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2900</price><drug id="02241149" dinStatus="E" sec3="Y"><name>Monocor</name><manufacturerId>CRY</manufacturerId><individualPrice>.5800</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02247440" sec3="Y"><name>Sandoz Bisoprolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02256177" sec3="Y"><name>Apo-Bisoprolol</name><manufacturerId>APX</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2004-11-16</listingDate></drug><drug id="02267489" sec3="Y"><name>Novo-Bisoprolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2005-08-19</listingDate></drug><drug id="02302640" sec3="Y"><name>PMS-Bisoprolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00334"><name>CARVEDILOL</name><pcgGroup lccId="00050"><pcg9 id="240400140"><itemNumber>0398</itemNumber><strength>3.125mg</strength><dosageForm>Tab</dosageForm><price>.6350</price><dailyCost>1.2700</dailyCost><drug id="02229650" notABenefit="Y" sec3="Y"><name>Coreg</name><manufacturerId>GSK</manufacturerId><listingDate>1997-04-10</listingDate></drug><drug id="02245914" sec3="Y" sec12="Y"><name>PMS-Carvedilol</name><manufacturerId>PMS</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02247933" sec3="Y" sec12="Y"><name>Apo-Carvedilol</name><manufacturerId>APX</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02248752" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Carvedilol</name><manufacturerId>PHE</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02252309" sec3="Y" sec12="Y"><name>Ratio-Carvedilol</name><manufacturerId>RPH</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02268027" sec3="Y" sec12="Y"><name>Ran-Carvedilol</name><manufacturerId>RAN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2005-12-06</listingDate></drug><drug id="02338068" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Carvedilol</name><manufacturerId>ZYN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240400141"><itemNumber>0399</itemNumber><strength>6.25mg</strength><dosageForm>Tab</dosageForm><price>.6350</price><dailyCost>1.2700</dailyCost><drug id="02229651" notABenefit="Y" sec3="Y"><name>Coreg</name><manufacturerId>GSK</manufacturerId><listingDate>1997-04-10</listingDate></drug><drug id="02245915" sec3="Y" sec12="Y"><name>PMS-Carvedilol</name><manufacturerId>PMS</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02247934" sec3="Y" sec12="Y"><name>Apo-Carvedilol</name><manufacturerId>APX</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02248753" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Carvedilol</name><manufacturerId>PHE</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02252317" sec3="Y" sec12="Y"><name>Ratio-Carvedilol</name><manufacturerId>RPH</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02268035" sec3="Y" sec12="Y"><name>Ran-Carvedilol</name><manufacturerId>RAN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2005-12-06</listingDate></drug><drug id="02338092" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Carvedilol</name><manufacturerId>ZYN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240400142"><itemNumber>0400</itemNumber><strength>12.5mg</strength><dosageForm>Tab</dosageForm><price>.6350</price><dailyCost>1.2700</dailyCost><drug id="02229652" notABenefit="Y" sec3="Y"><name>Coreg</name><manufacturerId>GSK</manufacturerId><listingDate>1997-04-10</listingDate></drug><drug id="02245916" sec3="Y" sec12="Y"><name>PMS-Carvedilol</name><manufacturerId>PMS</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02247935" sec3="Y" sec12="Y"><name>Apo-Carvedilol</name><manufacturerId>APX</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02248754" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Carvedilol</name><manufacturerId>PHE</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02252325" sec3="Y" sec12="Y"><name>Ratio-Carvedilol</name><manufacturerId>RPH</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02268043" sec3="Y" sec12="Y"><name>Ran-Carvedilol</name><manufacturerId>RAN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2005-12-06</listingDate></drug><drug id="02338106" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Carvedilol</name><manufacturerId>ZYN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240400143"><itemNumber>0401</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.6350</price><dailyCost>1.2700</dailyCost><drug id="02229653" notABenefit="Y" sec3="Y"><name>Coreg</name><manufacturerId>GSK</manufacturerId><listingDate>1997-04-10</listingDate></drug><drug id="02245917" sec3="Y" sec12="Y"><name>PMS-Carvedilol</name><manufacturerId>PMS</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02247936" sec3="Y" sec12="Y"><name>Apo-Carvedilol</name><manufacturerId>APX</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02248755" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Carvedilol</name><manufacturerId>PHE</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02252333" sec3="Y" sec12="Y"><name>Ratio-Carvedilol</name><manufacturerId>RPH</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2004-07-20</listingDate></drug><drug id="02268051" sec3="Y" sec12="Y"><name>Ran-Carvedilol</name><manufacturerId>RAN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2005-12-06</listingDate></drug><drug id="02338114" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Carvedilol</name><manufacturerId>ZYN</manufacturerId><individualPrice>.6350</individualPrice><dailyCost>1.2700</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" type="R">For patients with:</lccNote><lccNote seq="002" reasonForUseId="183">a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotension converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and 
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00307"><name>DIGOXIN</name><note>Digoxin toxicity is common and serious: digoxin levels should be monitored in the elderly, after adding drugs that affect urea clearance including diuretics, particularly spironolactone; verapamil and quinidine also interact significantly with digoxin. Dose should be reduced in renal impairment and in elderly patients. Chronic therapy should be re-evaluated.</note><pcgGroup><pcg9 id="240400004"><itemNumber>0402</itemNumber><strength>0.05mg/mL</strength><dosageForm>O/L</dosageForm><price>.3561</price><drug id="02242320" sec3="Y"><name>Lanoxin</name><manufacturerId>PMS</manufacturerId><individualPrice>.3561</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="240400090"><itemNumber>0403</itemNumber><strength>0.0625mg</strength><dosageForm>Tab</dosageForm><price>.2177</price><drug id="02242321" sec3="Y"><name>Lanoxin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2177</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="240400003"><itemNumber>0404</itemNumber><strength>0.125mg</strength><dosageForm>Tab</dosageForm><price>.1030</price><drug id="02242322" sec3="Y"><name>Lanoxin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2060</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02281228" dinStatus="E" sec3="Y"><name>Apo-Digoxin</name><manufacturerId>APX</manufacturerId><individualPrice>.1030</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9><pcg9 id="240400002"><itemNumber>0405</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.1030</price><drug id="02242323" sec3="Y"><name>Lanoxin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2060</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02281201" dinStatus="E" sec3="Y"><name>Apo-Digoxin</name><manufacturerId>APX</manufacturerId><individualPrice>.1030</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00320"><name>DILTIAZEM HCL</name><pcgGroup><pcg9 id="240400161"><itemNumber>0406</itemNumber><strength>120mg</strength><dosageForm>ER Tab</dosageForm><price>.7911</price><drug id="02256738" sec3="Y"><name>Tiazac XC</name><manufacturerId>BIO</manufacturerId><individualPrice>.7911</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="240400162"><itemNumber>0407</itemNumber><strength>180mg</strength><dosageForm>ER Tab</dosageForm><price>1.0501</price><drug id="02256746" sec3="Y"><name>Tiazac XC</name><manufacturerId>BIO</manufacturerId><individualPrice>1.0501</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="240400163"><itemNumber>0408</itemNumber><strength>240mg</strength><dosageForm>ER Tab</dosageForm><price>1.3929</price><drug id="02256754" sec3="Y"><name>Tiazac XC</name><manufacturerId>BIO</manufacturerId><individualPrice>1.3929</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="240400164"><itemNumber>0409</itemNumber><strength>300mg</strength><dosageForm>ER Tab</dosageForm><price>1.3929</price><drug id="02256762" sec3="Y"><name>Tiazac XC</name><manufacturerId>BIO</manufacturerId><individualPrice>1.3929</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="240400165"><itemNumber>0410</itemNumber><strength>360mg</strength><dosageForm>ER Tab</dosageForm><price>1.3929</price><drug id="02256770" sec3="Y"><name>Tiazac XC</name><manufacturerId>BIO</manufacturerId><individualPrice>1.3929</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9><pcg9 id="240400133"><itemNumber>0411</itemNumber><strength>120mg</strength><dosageForm>LA Cap</dosageForm><price>.6366</price><dailyCost>.6366</dailyCost><drug id="02097249" sec3="Y"><name>Cardizem CD</name><manufacturerId>BIO</manufacturerId><individualPrice>1.4537</individualPrice><dailyCost>1.4537</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02229781" sec3="Y"><name>Ratio-Diltiazem CD</name><manufacturerId>RPH</manufacturerId><individualPrice>.6366</individualPrice><dailyCost>.6366</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02230997" sec3="Y"><name>Apo-Diltiaz CD</name><manufacturerId>APX</manufacturerId><individualPrice>.6366</individualPrice><dailyCost>.6366</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02242538" sec3="Y"><name>Novo-Diltazem CD</name><manufacturerId>NOP</manufacturerId><individualPrice>.6366</individualPrice><dailyCost>.6366</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02243338" sec3="Y"><name>Sandoz Diltiazem CD</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6366</individualPrice><dailyCost>.6366</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02254808" dinStatus="E" sec3="Y"><name>Gen-Diltiazem CD</name><manufacturerId>GEN</manufacturerId><individualPrice>.6366</individualPrice><dailyCost>.6366</dailyCost><listingDate>2004-09-14</listingDate></drug></pcg9><pcg9 id="240400123"><itemNumber>0412</itemNumber><strength>180mg</strength><dosageForm>LA Cap</dosageForm><price>.8450</price><dailyCost>.8450</dailyCost><drug id="02097257" sec3="Y"><name>Cardizem CD</name><manufacturerId>BIO</manufacturerId><individualPrice>1.9297</individualPrice><dailyCost>1.9297</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02229782" sec3="Y"><name>Ratio-Diltiazem CD</name><manufacturerId>RPH</manufacturerId><individualPrice>.8450</individualPrice><dailyCost>.8450</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02230998" sec3="Y"><name>Apo-Diltiaz CD</name><manufacturerId>APX</manufacturerId><individualPrice>.8450</individualPrice><dailyCost>.8450</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02242539" sec3="Y"><name>Novo-Diltazem CD</name><manufacturerId>NOP</manufacturerId><individualPrice>.8450</individualPrice><dailyCost>.8450</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02243339" sec3="Y"><name>Sandoz Diltiazem CD</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8450</individualPrice><dailyCost>.8450</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02254816" dinStatus="E" sec3="Y"><name>Gen-Diltiazem CD</name><manufacturerId>GEN</manufacturerId><individualPrice>.8450</individualPrice><dailyCost>.8450</dailyCost><listingDate>2004-09-14</listingDate></drug></pcg9><pcg9 id="240400122"><itemNumber>0413</itemNumber><strength>240mg</strength><dosageForm>LA Cap</dosageForm><price>1.1208</price><dailyCost>1.1208</dailyCost><drug id="02097265" sec3="Y"><name>Cardizem CD</name><manufacturerId>BIO</manufacturerId><individualPrice>2.5596</individualPrice><dailyCost>2.5596</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02229783" sec3="Y"><name>Ratio-Diltiazem CD</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1208</individualPrice><dailyCost>1.1208</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02230999" sec3="Y"><name>Apo-Diltiaz CD</name><manufacturerId>APX</manufacturerId><individualPrice>1.1208</individualPrice><dailyCost>1.1208</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02242540" sec3="Y"><name>Novo-Diltazem CD</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1208</individualPrice><dailyCost>1.1208</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02243340" sec3="Y"><name>Sandoz Diltiazem CD</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1208</individualPrice><dailyCost>1.1208</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02254824" dinStatus="E" sec3="Y"><name>Gen-Diltiazem CD</name><manufacturerId>GEN</manufacturerId><individualPrice>1.1208</individualPrice><dailyCost>1.1208</dailyCost><listingDate>2004-09-14</listingDate></drug></pcg9><pcg9 id="240400134"><itemNumber>0414</itemNumber><strength>300mg</strength><dosageForm>LA Cap</dosageForm><price>1.4010</price><dailyCost>1.4010</dailyCost><drug id="02097273" sec3="Y"><name>Cardizem CD</name><manufacturerId>BIO</manufacturerId><individualPrice>3.1995</individualPrice><dailyCost>3.1995</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02229526" sec3="Y"><name>Apo-Diltiaz CD</name><manufacturerId>APX</manufacturerId><individualPrice>1.4010</individualPrice><dailyCost>1.4010</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02229784" sec3="Y"><name>Ratio-Diltiazem CD</name><manufacturerId>RPH</manufacturerId><individualPrice>1.4010</individualPrice><dailyCost>1.4010</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02242541" sec3="Y"><name>Novo-Diltazem CD</name><manufacturerId>NOP</manufacturerId><individualPrice>1.4010</individualPrice><dailyCost>1.4010</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02243341" sec3="Y"><name>Sandoz Diltiazem CD</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.4010</individualPrice><dailyCost>1.4010</dailyCost><listingDate>2001-10-11</listingDate></drug><drug id="02254832" dinStatus="E" sec3="Y"><name>Gen-Diltiazem CD</name><manufacturerId>GEN</manufacturerId><individualPrice>1.4010</individualPrice><dailyCost>1.4010</dailyCost><listingDate>2004-09-14</listingDate></drug></pcg9><pcg9 id="240400109"><itemNumber>0415</itemNumber><strength>60mg</strength><dosageForm>LA Cap</dosageForm><price>.6369</price><dailyCost>.6369</dailyCost><drug id="02097214" notABenefit="Y" sec3="Y"><name>Cardizem-SR</name><manufacturerId>CRY</manufacturerId><listingDate>1998-09-18</listingDate></drug><drug id="02222957" dinStatus="E" sec3="Y"><name>Apo-Diltiaz SR</name><manufacturerId>APX</manufacturerId><individualPrice>.6369</individualPrice><dailyCost>.6369</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240400110"><itemNumber>0416</itemNumber><strength>90mg</strength><dosageForm>LA Cap</dosageForm><price>.8453</price><dailyCost>.8453</dailyCost><drug id="02097222" notABenefit="Y" sec3="Y"><name>Cardizem-SR</name><manufacturerId>CRY</manufacturerId><listingDate>2001-10-11</listingDate></drug><drug id="02222965" dinStatus="E" sec3="Y"><name>Apo-Diltiaz SR</name><manufacturerId>APX</manufacturerId><individualPrice>.8453</individualPrice><dailyCost>.8453</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240400111"><itemNumber>0417</itemNumber><strength>120mg</strength><dosageForm>LA Cap</dosageForm><price>1.1213</price><dailyCost>1.1213</dailyCost><drug id="02097230" notABenefit="Y" sec3="Y"><name>Cardizem-SR</name><manufacturerId>CRY</manufacturerId><listingDate>2001-10-11</listingDate></drug><drug id="02222973" dinStatus="E" sec3="Y"><name>Apo-Diltiaz SR</name><manufacturerId>APX</manufacturerId><individualPrice>1.1213</individualPrice><dailyCost>1.1213</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240400145"><itemNumber>0418</itemNumber><strength>120mg</strength><dosageForm>SR Cap</dosageForm><price>.4043</price><dailyCost>.4043</dailyCost><drug id="02231150" sec3="Y"><name>Tiazac</name><manufacturerId>BIO</manufacturerId><individualPrice>.8533</individualPrice><dailyCost>.8533</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02245918" sec3="Y"><name>Sandoz Diltiazem T</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4043</individualPrice><dailyCost>.4043</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02271605" sec3="Y"><name>Novo-Diltiazem HCL ER</name><manufacturerId>NOP</manufacturerId><individualPrice>.4043</individualPrice><dailyCost>.4043</dailyCost><listingDate>2006-03-01</listingDate></drug><drug id="02291037" dinStatus="N" sec3="Y"><name>Apo-Diltiaz TZ</name><manufacturerId>APX</manufacturerId><individualPrice>.4043</individualPrice><dailyCost>.4043</dailyCost><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240400146"><itemNumber>0419</itemNumber><strength>180mg</strength><dosageForm>SR Cap</dosageForm><price>.5366</price><dailyCost>.5366</dailyCost><drug id="02231151" sec3="Y"><name>Tiazac</name><manufacturerId>BIO</manufacturerId><individualPrice>1.1556</individualPrice><dailyCost>1.1556</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02245919" sec3="Y"><name>Sandoz Diltiazem T</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5366</individualPrice><dailyCost>.5366</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02271613" sec3="Y"><name>Novo-Diltiazem HCL ER</name><manufacturerId>NOP</manufacturerId><individualPrice>.5366</individualPrice><dailyCost>.5366</dailyCost><listingDate>2006-03-01</listingDate></drug><drug id="02291045" dinStatus="N" sec3="Y"><name>Apo-Diltiaz TZ</name><manufacturerId>APX</manufacturerId><individualPrice>.5366</individualPrice><dailyCost>.5366</dailyCost><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240400147"><itemNumber>0420</itemNumber><strength>240mg</strength><dosageForm>SR Cap</dosageForm><price>.7118</price><dailyCost>.7118</dailyCost><drug id="02231152" sec3="Y"><name>Tiazac</name><manufacturerId>BIO</manufacturerId><individualPrice>1.5328</individualPrice><dailyCost>1.5328</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02245920" sec3="Y"><name>Sandoz Diltiazem T</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7118</individualPrice><dailyCost>.7118</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02271621" sec3="Y"><name>Novo-Diltiazem HCL ER</name><manufacturerId>NOP</manufacturerId><individualPrice>.7118</individualPrice><dailyCost>.7118</dailyCost><listingDate>2006-03-01</listingDate></drug><drug id="02291053" dinStatus="N" sec3="Y"><name>Apo-Diltiaz TZ</name><manufacturerId>APX</manufacturerId><individualPrice>.7118</individualPrice><dailyCost>.7118</dailyCost><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240400148"><itemNumber>0421</itemNumber><strength>300mg</strength><dosageForm>SR Cap</dosageForm><price>.8897</price><dailyCost>.8897</dailyCost><drug id="02231154" sec3="Y"><name>Tiazac</name><manufacturerId>BIO</manufacturerId><individualPrice>1.8878</individualPrice><dailyCost>1.8878</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02245921" sec3="Y"><name>Sandoz Diltiazem T</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8897</individualPrice><dailyCost>.8897</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02271648" sec3="Y"><name>Novo-Diltiazem HCL ER</name><manufacturerId>NOP</manufacturerId><individualPrice>.8897</individualPrice><dailyCost>.8897</dailyCost><listingDate>2006-03-01</listingDate></drug><drug id="02291061" dinStatus="N" sec3="Y"><name>Apo-Diltiaz TZ</name><manufacturerId>APX</manufacturerId><individualPrice>.8897</individualPrice><dailyCost>.8897</dailyCost><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240400149"><itemNumber>0422</itemNumber><strength>360mg</strength><dosageForm>SR Cap</dosageForm><price>1.0732</price><dailyCost>1.0732</dailyCost><drug id="02231155" sec3="Y"><name>Tiazac</name><manufacturerId>BIO</manufacturerId><individualPrice>2.3112</individualPrice><dailyCost>2.3112</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02245922" sec3="Y"><name>Sandoz Diltiazem T</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.0732</individualPrice><dailyCost>1.0732</dailyCost><listingDate>2006-01-24</listingDate></drug><drug id="02271656" sec3="Y"><name>Novo-Diltiazem HCL ER</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0732</individualPrice><dailyCost>1.0732</dailyCost><listingDate>2006-03-01</listingDate></drug><drug id="02291088" dinStatus="N" sec3="Y"><name>Apo-Diltiaz TZ</name><manufacturerId>APX</manufacturerId><individualPrice>1.0732</individualPrice><dailyCost>1.0732</dailyCost><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240400054"><itemNumber>0423</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.1866</price><drug id="00771376" sec3="Y"><name>Apo-Diltiaz</name><manufacturerId>APX</manufacturerId><individualPrice>.1866</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00862924" sec3="Y"><name>Novo-Diltazem</name><manufacturerId>NOP</manufacturerId><individualPrice>.1866</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00886068" sec3="Y"><name>Nu-Diltiaz</name><manufacturerId>NXP</manufacturerId><individualPrice>.1866</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02097370" dinStatus="E" sec3="Y"><name>Cardizem</name><manufacturerId>BIO</manufacturerId><individualPrice>.3941</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400053"><itemNumber>0424</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><price>.3273</price><drug id="00771384" sec3="Y"><name>Apo-Diltiaz</name><manufacturerId>APX</manufacturerId><individualPrice>.3273</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00862932" sec3="Y"><name>Novo-Diltazem</name><manufacturerId>NOP</manufacturerId><individualPrice>.3273</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00886076" sec3="Y"><name>Nu-Diltiaz</name><manufacturerId>NXP</manufacturerId><individualPrice>.3273</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02097389" dinStatus="E" sec3="Y"><name>Cardizem</name><manufacturerId>BIO</manufacturerId><individualPrice>.6912</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00313"><name>DISOPYRAMIDE</name><pcgGroup><pcg9 id="240400019"><itemNumber>0425</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.2673</price><drug id="02030799" notABenefit="Y" sec3="Y"><name>Norpace</name><manufacturerId>RBT</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02224801" sec3="Y"><name>Rythmodan</name><manufacturerId>SAV</manufacturerId><individualPrice>.2673</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="240400020"><itemNumber>0426</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.3778</price><drug id="02030802" notABenefit="Y" sec3="Y"><name>Norpace</name><manufacturerId>RBT</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02224828" sec3="Y"><name>Rythmodan</name><manufacturerId>SAV</manufacturerId><individualPrice>.3778</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00327"><name>FLECAINIDE ACETATE</name><pcgGroup><pcg9 id="240400119"><itemNumber>0427</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3956</price><drug id="01966197" sec3="Y"><name>Tambocor</name><manufacturerId>GRA</manufacturerId><individualPrice>.5379</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02275538" sec3="Y"><name>Apo-Flecainide</name><manufacturerId>APX</manufacturerId><individualPrice>.3956</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="240400095"><itemNumber>0428</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.7912</price><drug id="01966200" sec3="Y"><name>Tambocor</name><manufacturerId>GRA</manufacturerId><individualPrice>1.0760</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02275546" sec3="Y"><name>Apo-Flecainide</name><manufacturerId>APX</manufacturerId><individualPrice>.7912</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00315"><name>METOPROLOL TARTRATE</name><pcgGroup><pcg9 id="240400069"><itemNumber>0429</itemNumber><strength>100mg</strength><dosageForm>LA Tab</dosageForm><price>.1415</price><drug id="00658855" sec3="Y"><name>Lopresor SR</name><manufacturerId>NOV</manufacturerId><individualPrice>.2972</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02285169" sec3="Y"><name>Apo-Metoprolol SR</name><manufacturerId>APX</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02303396" dinStatus="N" sec3="Y"><name>Sandoz Metoprolol SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1415</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="240400044"><itemNumber>0430</itemNumber><strength>200mg</strength><dosageForm>LA Tab</dosageForm><price>.2568</price><drug id="00534560" sec3="Y"><name>Lopresor SR</name><manufacturerId>NOV</manufacturerId><individualPrice>.5392</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02285177" sec3="Y"><name>Apo-Metoprolol SR</name><manufacturerId>APX</manufacturerId><individualPrice>.2568</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02303418" dinStatus="N" sec3="Y"><name>Sandoz Metoprolol SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2568</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="240400037"><itemNumber>0431</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.0968</price><dailyCost>.1936</dailyCost><drug id="00397423" sec3="Y"><name>Lopresor</name><manufacturerId>NOV</manufacturerId><individualPrice>.2495</individualPrice><dailyCost>.4990</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00402605" notABenefit="Y" sec3="Y"><name>Betaloc</name><manufacturerId>AZC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00618632" sec3="Y"><name>Apo-Metoprolol</name><manufacturerId>APX</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00648035" sec3="Y"><name>Novo-Metoprol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00749354" sec3="Y"><name>Apo-Metoprolol (Type L)</name><manufacturerId>APX</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00842648" sec3="Y"><name>Novo-Metoprol (Uncoated)</name><manufacturerId>NOP</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865605" sec3="Y"><name>Nu-Metop</name><manufacturerId>NXP</manufacturerId><individualPrice>.1080</individualPrice><dailyCost>.2160</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02174545" sec3="Y"><name>Mylan-Metoprolol (Type L)</name><manufacturerId>MYL</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02230803" sec3="Y"><name>PMS-Metoprolol-L</name><manufacturerId>PMS</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02247875" sec3="Y"><name>Sandoz Metoprolol (Type L)</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0968</individualPrice><dailyCost>.1936</dailyCost><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="240400036"><itemNumber>0432</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.1747</price><dailyCost>.3494</dailyCost><drug id="00397431" sec3="Y"><name>Lopresor</name><manufacturerId>NOV</manufacturerId><individualPrice>.5442</individualPrice><dailyCost>1.0884</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00402540" notABenefit="Y" sec3="Y"><name>Betaloc</name><manufacturerId>AZC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00618640" sec3="Y"><name>Apo-Metoprolol</name><manufacturerId>APX</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00648043" sec3="Y"><name>Novo-Metoprol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00751170" sec3="Y"><name>Apo-Metoprolol (Type L)</name><manufacturerId>APX</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00842656" sec3="Y"><name>Novo-Metoprol (Uncoated)</name><manufacturerId>NOP</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865613" sec3="Y"><name>Nu-Metop</name><manufacturerId>NXP</manufacturerId><individualPrice>.1830</individualPrice><dailyCost>.3660</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02174553" sec3="Y"><name>Mylan-Metoprolol (Type L)</name><manufacturerId>MYL</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02230804" sec3="Y"><name>PMS-Metoprolol-L</name><manufacturerId>PMS</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02247876" sec3="Y"><name>Sandoz Metoprolol (Type L)</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1747</individualPrice><dailyCost>.3494</dailyCost><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00321"><name>MEXILETINE HCL</name><pcgGroup><pcg9 id="240400064"><itemNumber>0433</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.8162</price><drug id="00599956" notABenefit="Y" sec3="Y"><name>Mexitil</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230359" sec3="Y"><name>Novo-Mexiletine</name><manufacturerId>NOP</manufacturerId><individualPrice>.8162</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240400063"><itemNumber>0434</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.0930</price><drug id="00599964" notABenefit="Y" sec3="Y"><name>Mexitil</name><manufacturerId>BOE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230360" sec3="Y"><name>Novo-Mexiletine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0930</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00308"><name>NADOLOL</name><pcgGroup><pcg9 id="240400058"><itemNumber>0435</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.2465</price><dailyCost>.2465</dailyCost><drug id="00607126" notABenefit="Y" sec3="Y"><name>Corgard</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00782505" sec3="Y"><name>Apo-Nadol</name><manufacturerId>APX</manufacturerId><individualPrice>.2465</individualPrice><dailyCost>.2465</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02126753" sec3="Y"><name>Novo-Nadolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2465</individualPrice><dailyCost>.2465</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400042"><itemNumber>0436</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>.3515</price><dailyCost>.7030</dailyCost><drug id="00463256" notABenefit="Y" sec3="Y"><name>Corgard</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00782467" sec3="Y"><name>Apo-Nadol</name><manufacturerId>APX</manufacturerId><individualPrice>.3515</individualPrice><dailyCost>.7030</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02126761" sec3="Y"><name>Novo-Nadolol</name><manufacturerId>NOP</manufacturerId><individualPrice>.3515</individualPrice><dailyCost>.7030</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400008"><itemNumber>0437</itemNumber><strength>160mg</strength><dosageForm>Tab</dosageForm><price>.6595</price><dailyCost>.6595</dailyCost><drug id="00523372" notABenefit="Y" sec3="Y"><name>Corgard</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00782475" sec3="Y"><name>Apo-Nadol</name><manufacturerId>APX</manufacturerId><individualPrice>.6595</individualPrice><dailyCost>.6595</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00318"><name>NIFEDIPINE</name><pcgGroup><pcg9 id="240400081"><itemNumber>0438</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.3679</price><drug id="00725110" sec3="Y"><name>Apo-Nifed</name><manufacturerId>APX</manufacturerId><individualPrice>.3679</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02155869" notABenefit="Y" sec3="Y"><name>Adalat</name><manufacturerId>BAH</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400049"><itemNumber>0439</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.4877</price><note>Rapid absorption of liquid nifedipine from pulvules can cause severe hypotension and aggravation of myocardial or cerebral ischemia.</note><drug id="00755907" sec3="Y"><name>Apo-Nifed</name><manufacturerId>APX</manufacturerId><individualPrice>.4877</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02155877" notABenefit="Y" sec3="Y"><name>Adalat</name><manufacturerId>BAH</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00309"><name>PROCAINAMIDE HCL</name><pcgGroup><pcg9 id="240400067"><itemNumber>0440</itemNumber><strength>250mg</strength><dosageForm>LA Tab</dosageForm><price>.4500</price><drug id="00638692" sec3="Y"><name>Procan SR</name><manufacturerId>ERF</manufacturerId><individualPrice>.4500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400066"><itemNumber>0441</itemNumber><strength>500mg</strength><dosageForm>LA Tab</dosageForm><price>.6377</price><drug id="00638676" sec3="Y"><name>Procan SR</name><manufacturerId>ERF</manufacturerId><individualPrice>.6377</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400065"><itemNumber>0442</itemNumber><strength>750mg</strength><dosageForm>LA Tab</dosageForm><price>1.0250</price><drug id="00638684" sec3="Y"><name>Procan SR</name><manufacturerId>ERF</manufacturerId><individualPrice>1.0250</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00326"><name>PROPAFENONE HCL</name><pcgGroup><pcg9 id="240400091"><itemNumber>0443</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.3395</price><drug id="00603708" sec3="Y"><name>Rythmol</name><manufacturerId>ABB</manufacturerId><individualPrice>1.1862</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243324" sec3="Y"><name>Apo-Propafenone</name><manufacturerId>APX</manufacturerId><individualPrice>.3395</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02245372" sec3="Y"><name>Mylan-Propafenone</name><manufacturerId>MYL</manufacturerId><individualPrice>.3395</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02294559" sec3="Y"><name>PMS-Propafenone</name><manufacturerId>PMS</manufacturerId><individualPrice>.3395</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="240400092"><itemNumber>0444</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.5985</price><drug id="00603716" sec3="Y"><name>Rythmol</name><manufacturerId>ABB</manufacturerId><individualPrice>2.0909</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243325" sec3="Y"><name>Apo-Propafenone</name><manufacturerId>APX</manufacturerId><individualPrice>.5985</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02245373" sec3="Y"><name>Mylan-Propafenone</name><manufacturerId>MYL</manufacturerId><individualPrice>.5985</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02294575" sec3="Y"><name>PMS-Propafenone</name><manufacturerId>PMS</manufacturerId><individualPrice>.5985</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00310"><name>PROPRANOLOL</name><pcgGroup><pcg9 id="240400013"><itemNumber>0445</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0192</price><drug id="00402788" sec3="Y"><name>Apo-Propranolol</name><manufacturerId>APX</manufacturerId><individualPrice>.0192</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00496480" sec3="Y"><name>Novo-Pranol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0192</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00582255" sec3="Y"><name>PMS-Propranolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.0192</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042177" notABenefit="Y" sec3="Y"><name>Inderal</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400059"><itemNumber>0446</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.0346</price><drug id="00663719" sec3="Y"><name>Apo-Propranolol</name><manufacturerId>APX</manufacturerId><individualPrice>.0346</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00740675" sec3="Y"><name>Novo-Pranol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0346</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042193" notABenefit="Y" sec3="Y"><name>Inderal</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400012"><itemNumber>0447</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.0348</price><dailyCost>.0696</dailyCost><drug id="00402753" sec3="Y"><name>Apo-Propranolol</name><manufacturerId>APX</manufacturerId><individualPrice>.0348</individualPrice><dailyCost>.0696</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00496499" sec3="Y"><name>Novo-Pranol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0348</individualPrice><dailyCost>.0696</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00582263" sec3="Y"><name>PMS-Propranolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.0348</individualPrice><dailyCost>.0696</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02042207" notABenefit="Y" sec3="Y"><name>Inderal-40</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400015"><itemNumber>0448</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>.0585</price><dailyCost>.1170</dailyCost><drug id="00402761" sec3="Y"><name>Apo-Propranolol</name><manufacturerId>APX</manufacturerId><individualPrice>.0585</individualPrice><dailyCost>.1170</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00496502" sec3="Y"><name>Novo-Pranol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0585</individualPrice><dailyCost>.1170</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00582271" sec3="Y"><name>PMS-Propranolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.0585</individualPrice><dailyCost>.1170</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02042215" notABenefit="Y" sec3="Y"><name>Inderal</name><manufacturerId>WAY</manufacturerId><listingDate>1997-02-04</listingDate></drug></pcg9><pcg9 id="240400041"><itemNumber>0449</itemNumber><strength>120mg</strength><dosageForm>Tab</dosageForm><price>.3091</price><dailyCost>.6182</dailyCost><drug id="00504335" sec3="Y"><name>Apo-Propranolol</name><manufacturerId>APX</manufacturerId><individualPrice>.3091</individualPrice><dailyCost>.6182</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02042223" notABenefit="Y" sec3="Y"><name>Inderal</name><manufacturerId>WAY</manufacturerId><listingDate>1997-02-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00322"><name>SOTALOL HCL</name><pcgGroup><pcg9 id="240400131"><itemNumber>0450</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><drug id="00897272" notABenefit="Y" sec3="Y"><name>Sotacor</name><manufacturerId>BQU</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02084228" notABenefit="Y" sec3="Y"><name>Ratio-Sotalol</name><manufacturerId>RPH</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02210428" notABenefit="Y" sec3="Y"><name>Apo-Sotalol</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02229778" notABenefit="Y" sec3="Y"><name>Gen-Sotalol</name><manufacturerId>GEN</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02231181" notABenefit="Y" sec3="Y"><name>Novo-Sotalol</name><manufacturerId>NOP</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02238326" notABenefit="Y" sec3="Y"><name>PMS-Sotalol</name><manufacturerId>PMS</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02257831" notABenefit="Y" sec3="Y"><name>Sandoz Sotalol</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02270625" notABenefit="Y" sec3="Y"><name>Co Sotalol</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="240400068"><itemNumber>0451</itemNumber><strength>160mg</strength><dosageForm>Tab</dosageForm><price>.6492</price><drug id="00483923" notABenefit="Y" sec3="Y"><name>Sotacor</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02084236" sec3="Y"><name>Ratio-Sotalol</name><manufacturerId>RPH</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163772" sec3="Y"><name>Nu-Sotalol</name><manufacturerId>NXP</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02167794" sec3="Y"><name>Apo-Sotalol</name><manufacturerId>APX</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229779" sec3="Y"><name>Gen-Sotalol</name><manufacturerId>GEN</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02231182" sec3="Y"><name>Novo-Sotalol</name><manufacturerId>NOP</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02234013" sec3="Y"><name>Rhoxal-Sotalol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6492</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02238327" sec3="Y"><name>PMS-Sotalol</name><manufacturerId>PMS</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02257858" sec3="Y"><name>Sandoz Sotalol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6492</individualPrice><listingDate>2005-01-25</listingDate></drug><drug id="02270633" sec3="Y"><name>Co Sotalol</name><manufacturerId>COB</manufacturerId><individualPrice>.6492</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00314"><name>TIMOLOL MALEATE</name><pcgGroup><pcg9 id="240400023"><itemNumber>0452</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1649</price><dailyCost>.3298</dailyCost><drug id="00353914" notABenefit="Y" sec3="Y"><name>Blocadren</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00755842" sec3="Y"><name>Apo-Timol</name><manufacturerId>APX</manufacturerId><individualPrice>.1649</individualPrice><dailyCost>.3298</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01947796" sec3="Y"><name>Novo-Timol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1649</individualPrice><dailyCost>.3298</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02044609" sec3="Y"><name>Nu-Timolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.1649</individualPrice><dailyCost>.3298</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400022"><itemNumber>0453</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2572</price><dailyCost>.5144</dailyCost><drug id="00353922" notABenefit="Y" sec3="Y"><name>Blocadren</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00755850" sec3="Y"><name>Apo-Timol</name><manufacturerId>APX</manufacturerId><individualPrice>.2572</individualPrice><dailyCost>.5144</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01947818" sec3="Y"><name>Novo-Timol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2572</individualPrice><dailyCost>.5144</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02044617" sec3="Y"><name>Nu-Timolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.2572</individualPrice><dailyCost>.5144</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240400043"><itemNumber>0454</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.5005</price><dailyCost>1.0010</dailyCost><drug id="00495611" notABenefit="Y" sec3="Y"><name>Blocadren</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00755869" sec3="Y"><name>Apo-Timol</name><manufacturerId>APX</manufacturerId><individualPrice>.5005</individualPrice><dailyCost>1.0010</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01947826" sec3="Y"><name>Novo-Timol</name><manufacturerId>NOP</manufacturerId><individualPrice>.5005</individualPrice><dailyCost>1.0010</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02044625" sec3="Y"><name>Nu-Timolol</name><manufacturerId>NXP</manufacturerId><individualPrice>.5005</individualPrice><dailyCost>1.0010</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00319"><name>VERAPAMIL HCL</name><pcgGroup><pcg9 id="240400051"><itemNumber>0455</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>.2735</price><dailyCost>.8205</dailyCost><drug id="00554316" notABenefit="Y" sec3="Y"><name>Isoptin</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00782483" sec3="Y"><name>Apo-Verap</name><manufacturerId>APX</manufacturerId><individualPrice>.2735</individualPrice><dailyCost>.8205</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886033" sec3="Y"><name>Nu-Verap</name><manufacturerId>NXP</manufacturerId><individualPrice>.2735</individualPrice><dailyCost>.8205</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02237921" sec3="Y"><name>Gen-Verapamil</name><manufacturerId>GEN</manufacturerId><individualPrice>.2735</individualPrice><dailyCost>.8205</dailyCost><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="240400050"><itemNumber>0456</itemNumber><strength>120mg</strength><dosageForm>Tab</dosageForm><price>.4250</price><dailyCost>1.2750</dailyCost><drug id="00554324" notABenefit="Y" sec3="Y"><name>Isoptin</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00782491" sec3="Y"><name>Apo-Verap</name><manufacturerId>APX</manufacturerId><individualPrice>.4250</individualPrice><dailyCost>1.2750</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886041" sec3="Y"><name>Nu-Verap</name><manufacturerId>NXP</manufacturerId><individualPrice>.4250</individualPrice><dailyCost>1.2750</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02237922" sec3="Y"><name>Gen-Verapamil</name><manufacturerId>GEN</manufacturerId><individualPrice>.4250</individualPrice><dailyCost>1.2750</dailyCost><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="240600000"><name>ANTILIPEMIC DRUGS</name><note>Nicotinic acid is the most cost-effective therapy for hyperlipidemia and is tolerated in approximately 80% of patients with adequate warning about expected flushing which disappears after five days in most cases; regular ASA will substantially reduce flushing. Bile acid sequestrants are more costly than fibrates or HMG-CoA reductase inhibitors.</note><genericName id="01685"><name>AMLODIPINE BESYLATE / ATORVASTATIN CALCIUM</name><pcgGroup><pcg9 id="240600056"><itemNumber>0457</itemNumber><strength>5mg/10mg</strength><dosageForm>Tab</dosageForm><price>2.3206</price><note>Note:  Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273233" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>2.3206</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600057"><itemNumber>0458</itemNumber><strength>5mg/20mg</strength><dosageForm>Tab</dosageForm><price>2.7366</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273241" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>2.7366</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600058"><itemNumber>0459</itemNumber><strength>5mg/40mg</strength><dosageForm>Tab</dosageForm><price>2.8926</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273268" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>2.8926</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600059"><itemNumber>0460</itemNumber><strength>5mg/80mg</strength><dosageForm>Tab</dosageForm><price>2.8926</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273276" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>2.8926</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600060"><itemNumber>0461</itemNumber><strength>10mg/10mg</strength><dosageForm>Tab</dosageForm><price>2.4500</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273284" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>2.4500</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600061"><itemNumber>0462</itemNumber><strength>10mg/20mg</strength><dosageForm>Tab</dosageForm><price>3.0544</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273292" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>3.0544</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600062"><itemNumber>0463</itemNumber><strength>10mg/40mg</strength><dosageForm>Tab</dosageForm><price>3.2000</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273306" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>3.2000</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600063"><itemNumber>0464</itemNumber><strength>10mg/80mg</strength><dosageForm>Tab</dosageForm><price>3.2000</price><note>Note:   Patients should be stabilized on a statin or a calcium channel blocker before being initiated on Caduet.</note><drug id="02273314" sec3="Y"><name>Caduet</name><manufacturerId>PFI</manufacturerId><individualPrice>3.2000</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00347"><name>ATORVASTATIN CALCIUM</name><pcgGroup><pcg9 id="240600036"><itemNumber>0465</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>1.6640</price><drug id="02230711" sec3="Y"><name>Lipitor</name><manufacturerId>PFI</manufacturerId><individualPrice>1.6640</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="240600034"><itemNumber>0466</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>2.0800</price><drug id="02230713" sec3="Y"><name>Lipitor</name><manufacturerId>PFI</manufacturerId><individualPrice>2.0800</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="240600037"><itemNumber>0467</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>2.2360</price><drug id="02230714" sec3="Y"><name>Lipitor</name><manufacturerId>PFI</manufacturerId><individualPrice>2.2360</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="240600045"><itemNumber>0468</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>2.2360</price><drug id="02243097" sec3="Y"><name>Lipitor</name><manufacturerId>PFI</manufacturerId><individualPrice>2.2360</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00346"><name>BEZAFIBRATE</name><pcgGroup><pcg9 id="240600027"><itemNumber>0469</itemNumber><strength>400mg</strength><dosageForm>SR Tab</dosageForm><price>1.7440</price><drug id="02083523" sec3="Y"><name>Bezalip</name><manufacturerId>AGP</manufacturerId><individualPrice>1.7440</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240600026"><itemNumber>0470</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.8833</price><drug id="02084082" notABenefit="Y" sec3="Y"><name>Bezalip</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02240331" sec3="Y"><name>PMS-Bezafibrate</name><manufacturerId>PMS</manufacturerId><individualPrice>.8833</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00336"><name>CHOLESTYRAMINE RESIN</name><pcgGroup><pcg9 id="240600003"><itemNumber>0471</itemNumber><dosageForm>Oral Pd-Pouch Pk</dosageForm><price>1.3167</price><drug id="00464880" notABenefit="Y" sec3="Y"><name>Questran 9g Pk</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00890960" sec3="Y"><name>PMS-Cholestyramine Sugar Free 5g Pk</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3167</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01918486" notABenefit="Y" sec3="Y"><name>Questran Light 4g Pk</name><manufacturerId>BQU</manufacturerId><listingDate>2004-07-20</listingDate></drug><drug id="02210320" sec3="Y"><name>PMS-Cholestyramine 9g Pk</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3167</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00335"><name>CLOFIBRATE</name><pcgGroup><pcg9 id="240600001"><itemNumber>0472</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><drug id="00002038" notABenefit="Y" sec3="Y"><name>Atromid-S</name><manufacturerId>AYE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00337382" notABenefit="Y" sec3="Y"><name>Novo-Fibrate</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00338"><name>COLESTIPOL HCL</name><note>Combining psyllium with Colestid therapy improves the efficacy, and decreases costs, of antilipemic treatment.</note><pcgGroup><pcg9 id="240600009"><itemNumber>0473</itemNumber><dosageForm>Gran-5g Pk</dosageForm><price>.8850</price><drug id="00642975" sec3="Y"><name>Colestid Regular</name><manufacturerId>PFI</manufacturerId><individualPrice>.8850</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240600029"><itemNumber>0474</itemNumber><dosageForm>Gran-7.5g Pk</dosageForm><price>.8672</price><drug id="02132699" sec3="Y"><name>Colestid Orange</name><manufacturerId>PFI</manufacturerId><individualPrice>.8672</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01607"><name>EZETIMIBE</name><pcgGroup lccId="00150"><pcg9 id="240600049"><itemNumber>0475</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>1.7248</price><drug id="02247521" sec3="Y" sec12="Y"><name>Ezetrol</name><manufacturerId>MFS</manufacturerId><individualPrice>1.7248</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="380">For use in combination with a HMG-CoA reductase inhibitor (&apos;statin&apos;) in patients with hypercholesterolemia who have not reached target LDL levels despite the use of maximally tolerated doses.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="381">For use as monotherapy in the management of hypercholesterolemia in patients who are intolerant to HMG-CoA reductase inhibitors or where HMG-CoA reductase inhibitors are contraindicated.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00342"><name>FENOFIBRATE</name><pcgGroup><pcg9 id="240600018"><itemNumber>0476</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6105</price><drug id="00885827" notABenefit="Y" sec3="Y"><name>Lipidil</name><manufacturerId>JOU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02225980" sec3="Y"><name>Apo-Fenofibrate</name><manufacturerId>APX</manufacturerId><individualPrice>.6105</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="240600067"><itemNumber>0477</itemNumber><strength>67mg</strength><dosageForm>Cap</dosageForm><drug id="02230283" notABenefit="Y" sec3="Y"><name>Lipidil Micro</name><manufacturerId>FOU</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243180" notABenefit="Y" sec3="Y"><name>Apo-Feno-Micro</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243551" notABenefit="Y" sec3="Y"><name>Novo-Fenofibrate Micronized</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="240600030"><itemNumber>0478</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.0890</price><drug id="02146959" sec3="Y"><name>Lipidil Micro</name><manufacturerId>SPH</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239864" sec3="Y"><name>Apo-Feno-Micro</name><manufacturerId>APX</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240210" sec3="Y"><name>Mylan-Fenofibrate Micro</name><manufacturerId>MYL</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02243552" sec3="Y"><name>Novo-Fenofibrate Micronized</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>2002-04-04</listingDate></drug><drug id="02250039" sec3="Y"><name>Ratio-Fenofibrate MC</name><manufacturerId>RPH</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02273551" sec3="Y"><name>PMS-Fenofibrate Micro</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0890</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="240600046"><itemNumber>0479</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="02241601" notABenefit="Y" sec3="Y"><name>Lipidil Supra</name><manufacturerId>LAF</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02246859" notABenefit="Y" sec3="Y"><name>Apo-Feno-Super</name><manufacturerId>APX</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02288044" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Fenofibrate S</name><manufacturerId>SDZ</manufacturerId><listingDate>2009-08-18</listingDate></drug><drug id="02289083" notABenefit="Y" sec3="Y"><name>Novo-Fenofibrate-S</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="240600043"><itemNumber>0480</itemNumber><strength>160mg</strength><dosageForm>Tab</dosageForm><price>.5500</price><drug id="02241602" sec3="Y"><name>Lipidil Supra</name><manufacturerId>SPH</manufacturerId><individualPrice>1.2463</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02246860" sec3="Y"><name>Apo-Feno-Super</name><manufacturerId>APX</manufacturerId><individualPrice>.5500</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02250004" dinStatus="E" sec3="Y"><name>Fenomax</name><manufacturerId>ORY</manufacturerId><individualPrice>.5500</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02288052" sec3="Y"><name>Sandoz Fenofibrate S</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5500</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02289091" sec3="Y"><name>Novo-Fenofibrate-S</name><manufacturerId>NOP</manufacturerId><individualPrice>.5500</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="240600054"><itemNumber>0481</itemNumber><strength>48mg</strength><dosageForm>Tab</dosageForm><price>.4100</price><drug id="02269074" sec3="Y"><name>Lipidil EZ</name><manufacturerId>FOU</manufacturerId><individualPrice>.4100</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="240600055"><itemNumber>0482</itemNumber><strength>145mg</strength><dosageForm>Tab</dosageForm><price>1.0500</price><drug id="02269082" sec3="Y"><name>Lipidil EZ</name><manufacturerId>FOU</manufacturerId><individualPrice>1.0500</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00345"><name>FLUVASTATIN SODIUM</name><pcgGroup><pcg9 id="240600024"><itemNumber>0483</itemNumber><strength>20mg</strength><dosageForm>Cap</dosageForm><price>.8510</price><drug id="02061562" sec3="Y"><name>Lescol</name><manufacturerId>NOV</manufacturerId><individualPrice>.8510</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240600025"><itemNumber>0484</itemNumber><strength>40mg</strength><dosageForm>Cap</dosageForm><price>1.1949</price><drug id="02061570" sec3="Y"><name>Lescol</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1949</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240600050"><itemNumber>0485</itemNumber><strength>80mg</strength><dosageForm>ER Tab</dosageForm><price>1.4414</price><drug id="02250527" sec3="Y"><name>Lescol XL</name><manufacturerId>NOV</manufacturerId><individualPrice>1.4414</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00337"><name>GEMFIBROZIL</name><pcgGroup><pcg9 id="240600007"><itemNumber>0486</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.2352</price><drug id="00599026" sec3="Y"><name>Lopid</name><manufacturerId>PFI</manufacturerId><individualPrice>.5358</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01979574" sec3="Y"><name>Apo-Gemfibrozil</name><manufacturerId>APX</manufacturerId><individualPrice>.2352</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02185407" sec3="Y"><name>Mylan-Gemfibrozil</name><manufacturerId>MYL</manufacturerId><individualPrice>.2352</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02239951" sec3="Y"><name>PMS-Gemfibrozil</name><manufacturerId>PMS</manufacturerId><individualPrice>.2352</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02241704" sec3="Y"><name>Novo-Gemfibrozil</name><manufacturerId>NOP</manufacturerId><individualPrice>.2352</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="240600068"><itemNumber>0487</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><drug id="00659606" notABenefit="Y" sec3="Y"><name>Lopid</name><manufacturerId>PFI</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="01979582" notABenefit="Y" sec3="Y"><name>Apo-Gemfibrozil</name><manufacturerId>APX</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02142074" notABenefit="Y" sec3="Y"><name>Novo-Gemfibrozil</name><manufacturerId>NOP</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02230183" notABenefit="Y" sec3="Y"><name>PMS-Gemfibrozil</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02230476" notABenefit="Y" sec3="Y"><name>Mylan-Gemfibrozil</name><manufacturerId>MYL</manufacturerId><listingDate>2008-02-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00339"><name>LOVASTATIN</name><pcgGroup><pcg9 id="240600011"><itemNumber>0488</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.8657</price><drug id="00795860" sec3="Y"><name>Mevacor</name><manufacturerId>MFC</manufacturerId><individualPrice>1.9675</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02220172" sec3="Y"><name>Apo-Lovastatin</name><manufacturerId>APX</manufacturerId><individualPrice>.8657</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02243127" sec3="Y"><name>Gen-Lovastatin</name><manufacturerId>GEN</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02245822" sec3="Y"><name>Ratio-Lovastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246013" sec3="Y"><name>PMS-Lovastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246542" sec3="Y"><name>Novo-Lovastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247056" sec3="Y"><name>Sandoz Lovastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02248572" sec3="Y"><name>Co-Lovastatin</name><manufacturerId>COB</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02267969" sec3="Y"><name>Ran-Lovastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>.8657</individualPrice><listingDate>2005-12-06</listingDate></drug></pcg9><pcg9 id="240600015"><itemNumber>0489</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.5968</price><drug id="00795852" sec3="Y"><name>Mevacor</name><manufacturerId>MFC</manufacturerId><individualPrice>3.5939</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02220180" sec3="Y"><name>Apo-Lovastatin</name><manufacturerId>APX</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02243129" sec3="Y"><name>Gen-Lovastatin</name><manufacturerId>GEN</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02245823" sec3="Y"><name>Ratio-Lovastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246014" sec3="Y"><name>PMS-Lovastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246543" sec3="Y"><name>Novo-Lovastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247057" sec3="Y"><name>Sandoz Lovastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02248573" sec3="Y"><name>Co-Lovastatin</name><manufacturerId>COB</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02267977" sec3="Y"><name>Ran-Lovastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.5968</individualPrice><listingDate>2005-12-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01479"><name>NIACIN</name><pcgGroup><pcg9 id="240600051"><itemNumber>0490</itemNumber><strength>500mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note:  For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin(defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred),   are unable to continue taking crystalline niacin because of intractable and 
intolerable side effects.</note><drug id="02262347" dinStatus="N" sec3="Y"><name>Niaspan</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240600069"><itemNumber>0491</itemNumber><strength>500mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note: For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin (defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred), are unable to continue taking crystalline niacin because of intractable and intolerable side effects.</note><drug id="02309254" dinStatus="N" sec3="Y"><name>Niaspan FCT</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="240600052"><itemNumber>0492</itemNumber><strength>750mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note:  For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin(defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred),   are unable to continue taking crystalline niacin because of intractable and 
intolerable side effects.</note><drug id="02262355" dinStatus="N" sec3="Y"><name>Niaspan</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240600070"><itemNumber>0493</itemNumber><strength>750mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note: For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin (defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred), are unable to continue taking crystalline niacin because of intractable and intolerable side effects.</note><drug id="02309262" dinStatus="N" sec3="Y"><name>Niaspan FCT</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="240600053"><itemNumber>0494</itemNumber><strength>1000mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note:  For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin(defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred),   are unable to continue taking crystalline niacin because of intractable and 
intolerable side effects.</note><drug id="02262339" dinStatus="N" sec3="Y"><name>Niaspan</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="240600071"><itemNumber>0495</itemNumber><strength>1000mg</strength><dosageForm>ER Tab</dosageForm><price>1.2214</price><note>Note: For the treatment of dyslipidemia in patients who, after an adequate trial of crystalline niacin (defined as at least 1 month duration during which time appropriate dose titration, use of ASA and patient counseling have occurred), are unable to continue taking crystalline niacin because of intractable and intolerable side effects.</note><drug id="02309289" dinStatus="N" sec3="Y"><name>Niaspan FCT</name><manufacturerId>SEP</manufacturerId><individualPrice>1.2214</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00340"><name>PRAVASTATIN SODIUM</name><pcgGroup><pcg9 id="240600013"><itemNumber>0496</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.7567</price><drug id="00893749" sec3="Y"><name>Pravachol</name><manufacturerId>BQU</manufacturerId><individualPrice>.7567</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243506" sec3="Y"><name>Apo-Pravastatin</name><manufacturerId>APX</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244350" sec3="Y"><name>Nu-Pravastatin</name><manufacturerId>NXP</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246930" sec3="Y"><name>Ratio-Pravastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247008" sec3="Y"><name>Novo-Pravastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247655" sec3="Y"><name>PMS-Pravastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247856" sec3="Y"><name>Sandoz Pravastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248182" sec3="Y"><name>Co Pravastatin</name><manufacturerId>COB</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02257092" sec3="Y"><name>Mylan-Pravastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02284421" sec3="Y"><name>Ran-Pravastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>.7567</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02317451" notABenefit="Y" sec3="Y"><name>Mint-Pravastatin</name><manufacturerId>MIN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02330954" notABenefit="Y" sec3="Y"><name>Jamp-Pravastatin</name><manufacturerId>JPC</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02332191" notABenefit="Y" sec3="Y"><name>Pravastatin Tablets</name><manufacturerId>RAN</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600014"><itemNumber>0497</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.8925</price><drug id="00893757" sec3="Y"><name>Pravachol</name><manufacturerId>BQU</manufacturerId><individualPrice>.8925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243507" sec3="Y"><name>Apo-Pravastatin</name><manufacturerId>APX</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244351" sec3="Y"><name>Nu-Pravastatin</name><manufacturerId>NXP</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246931" sec3="Y"><name>Ratio-Pravastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247009" sec3="Y"><name>Novo-Pravastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247656" sec3="Y"><name>PMS-Pravastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247857" sec3="Y"><name>Sandoz Pravastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248183" sec3="Y"><name>Co Pravastatin</name><manufacturerId>COB</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02257106" sec3="Y"><name>Mylan-Pravastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02284448" sec3="Y"><name>Ran-Pravastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>.8925</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02317478" notABenefit="Y" sec3="Y"><name>Mint-Pravastatin</name><manufacturerId>MIN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02330962" notABenefit="Y" sec3="Y"><name>Jamp-Pravastatin</name><manufacturerId>JPC</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02332205" notABenefit="Y" sec3="Y"><name>Pravastatin Tablets</name><manufacturerId>RAN</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600035"><itemNumber>0498</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.0750</price><drug id="02222051" sec3="Y"><name>Pravachol</name><manufacturerId>BQU</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02243508" sec3="Y"><name>Apo-Pravastatin</name><manufacturerId>APX</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244352" sec3="Y"><name>Nu-Pravastatin</name><manufacturerId>NXP</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246932" sec3="Y"><name>Ratio-Pravastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247010" sec3="Y"><name>Novo-Pravastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02247657" sec3="Y"><name>PMS-Pravastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247858" sec3="Y"><name>Sandoz Pravastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248184" sec3="Y"><name>Co Pravastatin</name><manufacturerId>COB</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02257114" sec3="Y"><name>Mylan-Pravastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02284456" sec3="Y"><name>Ran-Pravastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.0750</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02317486" notABenefit="Y" sec3="Y"><name>Mint-Pravastatin</name><manufacturerId>MIN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02330970" notABenefit="Y" sec3="Y"><name>Jamp-Pravastatin</name><manufacturerId>JPC</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02332213" notABenefit="Y" sec3="Y"><name>Pravastatin Tablets</name><manufacturerId>RAN</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01590"><name>ROSUVASTATIN CALCIUM</name><pcgGroup><pcg9 id="240600066"><itemNumber>0499</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>1.2900</price><drug id="02265540" sec3="Y"><name>Crestor</name><manufacturerId>AZC</manufacturerId><individualPrice>1.2900</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="240600044"><itemNumber>0500</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>1.3600</price><drug id="02247162" sec3="Y"><name>Crestor</name><manufacturerId>AZC</manufacturerId><individualPrice>1.3600</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="240600047"><itemNumber>0501</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>1.7000</price><drug id="02247163" sec3="Y"><name>Crestor</name><manufacturerId>AZC</manufacturerId><individualPrice>1.7000</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="240600048"><itemNumber>0502</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.9900</price><drug id="02247164" sec3="Y"><name>Crestor</name><manufacturerId>AZC</manufacturerId><individualPrice>1.9900</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00341"><name>SIMVASTATIN</name><pcgGroup><pcg9 id="240600017"><itemNumber>0503</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.4500</price><drug id="00884324" sec3="Y"><name>Zocor</name><manufacturerId>MFC</manufacturerId><individualPrice>1.0225</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02246582" sec3="Y"><name>Mylan-Simvastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247011" sec3="Y"><name>Apo-Simvastatin</name><manufacturerId>APX</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247067" sec3="Y"><name>Ratio-Simvastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248103" sec3="Y"><name>Co-Simvastatin</name><manufacturerId>COB</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02250144" sec3="Y"><name>Novo-Simvastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02269252" sec3="Y"><name>PMS-Simvastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02281546" dinStatus="N" sec3="Y"><name>Phl-Simvastatin</name><manufacturerId>PHE</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02329131" dinStatus="N" sec3="Y"><name>Ran-Simvastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331020" dinStatus="N" sec3="Y"><name>Jamp-Simvastatin</name><manufacturerId>JPC</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02331969" dinStatus="N" sec3="Y"><name>Simvastatin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600016"><itemNumber>0504</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.8900</price><drug id="00884332" sec3="Y"><name>Zocor</name><manufacturerId>MFC</manufacturerId><individualPrice>2.0232</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02246583" sec3="Y"><name>Mylan-Simvastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247012" sec3="Y"><name>Apo-Simvastatin</name><manufacturerId>APX</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247068" sec3="Y"><name>Ratio-Simvastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247828" sec3="Y"><name>Sandoz Simvastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248104" sec3="Y"><name>Co-Simvastatin</name><manufacturerId>COB</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02250152" sec3="Y"><name>Novo-Simvastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02265885" sec3="Y"><name>Taro-Simvastatin</name><manufacturerId>TAR</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2005-10-06</listingDate></drug><drug id="02269260" sec3="Y"><name>PMS-Simvastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02281554" dinStatus="N" sec3="Y"><name>Phl-Simvastatin</name><manufacturerId>PHE</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02329158" dinStatus="N" sec3="Y"><name>Ran-Simvastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331039" dinStatus="N" sec3="Y"><name>Jamp-Simvastatin</name><manufacturerId>JPC</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02331985" dinStatus="N" sec3="Y"><name>Simvastatin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.8900</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600028"><itemNumber>0505</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>1.1000</price><drug id="00884340" sec3="Y"><name>Zocor</name><manufacturerId>MFC</manufacturerId><individualPrice>2.5004</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02246737" sec3="Y"><name>Mylan-Simvastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247013" sec3="Y"><name>Apo-Simvastatin</name><manufacturerId>APX</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247069" sec3="Y"><name>Ratio-Simvastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247830" sec3="Y"><name>Sandoz Simvastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248105" sec3="Y"><name>Co-Simvastatin</name><manufacturerId>COB</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02250160" sec3="Y"><name>Novo-Simvastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02265893" sec3="Y"><name>Taro-Simvastatin</name><manufacturerId>TAR</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2005-10-06</listingDate></drug><drug id="02269279" sec3="Y"><name>PMS-Simvastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02281562" dinStatus="N" sec3="Y"><name>Phl-Simvastatin</name><manufacturerId>PHE</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02329166" dinStatus="N" sec3="Y"><name>Ran-Simvastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331047" dinStatus="N" sec3="Y"><name>Jamp-Simvastatin</name><manufacturerId>JPC</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02331993" dinStatus="N" sec3="Y"><name>Simvastatin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600032"><itemNumber>0506</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.1000</price><drug id="00884359" sec3="Y"><name>Zocor</name><manufacturerId>MFC</manufacturerId><individualPrice>2.5004</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02246584" sec3="Y"><name>Mylan-Simvastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247014" sec3="Y"><name>Apo-Simvastatin</name><manufacturerId>APX</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247070" sec3="Y"><name>Ratio-Simvastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247831" sec3="Y"><name>Sandoz Simvastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248106" sec3="Y"><name>Co-Simvastatin</name><manufacturerId>COB</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02250179" sec3="Y"><name>Novo-Simvastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02265907" sec3="Y"><name>Taro-Simvastatin</name><manufacturerId>TAR</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2005-10-06</listingDate></drug><drug id="02269287" sec3="Y"><name>PMS-Simvastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02281570" dinStatus="N" sec3="Y"><name>Phl-Simvastatin</name><manufacturerId>PHE</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02329174" dinStatus="N" sec3="Y"><name>Ran-Simvastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331055" dinStatus="N" sec3="Y"><name>Jamp-Simvastatin</name><manufacturerId>JPC</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332000" dinStatus="N" sec3="Y"><name>Simvastatin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240600040"><itemNumber>0507</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>1.1000</price><drug id="02240332" sec3="Y"><name>Zocor</name><manufacturerId>MFC</manufacturerId><individualPrice>2.5004</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02246585" sec3="Y"><name>Mylan-Simvastatin</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247015" sec3="Y"><name>Apo-Simvastatin</name><manufacturerId>APX</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02247071" sec3="Y"><name>Ratio-Simvastatin</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247833" sec3="Y"><name>Sandoz Simvastatin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248107" sec3="Y"><name>Co-Simvastatin</name><manufacturerId>COB</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02250187" sec3="Y"><name>Novo-Simvastatin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02269295" sec3="Y"><name>PMS-Simvastatin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2006-04-04</listingDate></drug><drug id="02281589" dinStatus="N" sec3="Y"><name>Phl-Simvastatin</name><manufacturerId>PHE</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02329182" dinStatus="N" sec3="Y"><name>Ran-Simvastatin</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331063" dinStatus="N" sec3="Y"><name>Jamp-Simvastatin</name><manufacturerId>JPC</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332019" dinStatus="N" sec3="Y"><name>Simvastatin Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="240800000"><name>HYPOTENSIVE DRUGS (FOR DIURETICS SEE 40:28)</name><genericName id="01741"><name>ALISKIREN</name><pcgGroup><pcg9 id="240800275"><itemNumber>0508</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>1.1857</price><note>NOTE:  For patients with moderate hypertension who have not achieved blood pressure targets while on maximally optimized therapy with a thiazide-diuretic AND an Angiotensin Converting Enzyme Inhibitor (ACE-I)
or a thiazide-diuretic AND Angiotensin II Receptor Blocker (ARB).</note><drug id="02302063" dinStatus="N" sec3="Y"><name>Rasilez</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1857</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="240800276"><itemNumber>0509</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>1.1857</price><note>NOTE:  For patients with moderate hypertension who have not achieved blood pressure targets while on maximally optimized therapy with a thiazide-diuretic AND an Angiotensin Converting Enzyme Inhibitor (ACE-I)
or a thiazide-diuretic AND Angiotensin II Receptor Blocker (ARB).</note><drug id="02302071" dinStatus="N" sec3="Y"><name>Rasilez</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1857</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00369"><name>ATENOLOL &amp; CHLORTHALIDONE</name><pcgGroup><pcg9 id="240800107"><itemNumber>0510</itemNumber><strength>50 &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.3195</price><drug id="02049961" sec3="Y"><name>Tenoretic 50/25</name><manufacturerId>AZC</manufacturerId><individualPrice>.6389</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02248763" sec3="Y"><name>Apo-Atenidone</name><manufacturerId>APX</manufacturerId><individualPrice>.3195</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02302918" sec3="Y"><name>Novo-Atenolthalidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.3195</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="240800108"><itemNumber>0511</itemNumber><strength>100 &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.5236</price><drug id="02049988" sec3="Y"><name>Tenoretic 100/25</name><manufacturerId>AZC</manufacturerId><individualPrice>1.0471</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02248764" sec3="Y"><name>Apo-Atenidone</name><manufacturerId>APX</manufacturerId><individualPrice>.5236</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02302926" sec3="Y"><name>Novo-Atenolthalidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.5236</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00381"><name>BENAZEPRIL</name><pcgGroup><pcg9 id="240800186"><itemNumber>0512</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.4722</price><dailyCost>.4722</dailyCost><drug id="00885835" sec3="Y"><name>Lotensin</name><manufacturerId>NOV</manufacturerId><individualPrice>.7436</individualPrice><dailyCost>.7436</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02290332" sec3="Y"><name>Apo-Benazepril</name><manufacturerId>APX</manufacturerId><individualPrice>.4722</individualPrice><dailyCost>.4722</dailyCost><listingDate>2007-10-03</listingDate></drug></pcg9><pcg9 id="240800187"><itemNumber>0513</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.5583</price><dailyCost>.5583</dailyCost><drug id="00885843" sec3="Y"><name>Lotensin</name><manufacturerId>NOV</manufacturerId><individualPrice>.8793</individualPrice><dailyCost>.8793</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02290340" sec3="Y"><name>Apo-Benazepril</name><manufacturerId>APX</manufacturerId><individualPrice>.5583</individualPrice><dailyCost>.5583</dailyCost><listingDate>2007-10-03</listingDate></drug></pcg9><pcg9 id="240800188"><itemNumber>0514</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.5460</price><dailyCost>.5460</dailyCost><drug id="00885851" sec3="Y"><name>Lotensin</name><manufacturerId>NOV</manufacturerId><individualPrice>1.0089</individualPrice><dailyCost>1.0089</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02273918" sec3="Y"><name>Apo-Benazepril</name><manufacturerId>APX</manufacturerId><individualPrice>.5460</individualPrice><dailyCost>.5460</dailyCost><listingDate>2006-06-14</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01422"><name>CANDESARTAN CILEXETIL</name><pcgGroup><pcg9 id="240800260"><itemNumber>0515</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.6800</price><drug id="02239090" sec3="Y"><name>Atacand</name><manufacturerId>AZC</manufacturerId><individualPrice>.6800</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9><pcg9 id="240800235"><itemNumber>0516</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>1.1400</price><drug id="02239091" sec3="Y"><name>Atacand</name><manufacturerId>AZC</manufacturerId><individualPrice>1.1400</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="240800234"><itemNumber>0517</itemNumber><strength>16mg</strength><dosageForm>Tab</dosageForm><price>1.1400</price><drug id="02239092" sec3="Y"><name>Atacand</name><manufacturerId>AZC</manufacturerId><individualPrice>1.1400</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="240800279"><itemNumber>0518</itemNumber><strength>32mg</strength><dosageForm>Tab</dosageForm><price>1.1400</price><drug id="02311658" dinStatus="N" sec3="Y"><name>Atacand</name><manufacturerId>AZC</manufacturerId><individualPrice>1.1400</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01558"><name>CANDESARTAN CILEXETIL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800248"><itemNumber>0519</itemNumber><strength>16mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>1.1400</price><drug id="02244021" sec3="Y"><name>Atacand Plus</name><manufacturerId>AZC</manufacturerId><individualPrice>1.1400</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00363"><name>CAPTOPRIL</name><pcgGroup><pcg9 id="240800130"><itemNumber>0520</itemNumber><strength>12.5mg</strength><dosageForm>Tab</dosageForm><price>.2120</price><dailyCost>.6360</dailyCost><drug id="00695661" notABenefit="Y" sec3="Y"><name>Capoten</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00893595" sec3="Y"><name>Apo-Capto</name><manufacturerId>APX</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913824" sec3="Y"><name>Nu-Capto</name><manufacturerId>NXP</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01942964" sec3="Y"><name>Novo-Captopril</name><manufacturerId>NOP</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02163551" sec3="Y"><name>Gen-Captopril</name><manufacturerId>GEN</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02230203" sec3="Y"><name>PMS-Captopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02242788" dinStatus="E" sec3="Y"><name>Captopril</name><manufacturerId>ZYN</manufacturerId><individualPrice>.2120</individualPrice><dailyCost>.6360</dailyCost><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="240800078"><itemNumber>0521</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.3000</price><dailyCost>.9000</dailyCost><drug id="00546283" sec3="Y"><name>Capoten</name><manufacturerId>BQU</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00893609" sec3="Y"><name>Apo-Capto</name><manufacturerId>APX</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913832" sec3="Y"><name>Nu-Capto</name><manufacturerId>NXP</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01942972" sec3="Y"><name>Novo-Captopril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02163578" sec3="Y"><name>Gen-Captopril</name><manufacturerId>GEN</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02230204" sec3="Y"><name>PMS-Captopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02242789" dinStatus="E" sec3="Y"><name>Captopril</name><manufacturerId>ZYN</manufacturerId><individualPrice>.3000</individualPrice><dailyCost>.9000</dailyCost><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="240800077"><itemNumber>0522</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.5590</price><dailyCost>1.6770</dailyCost><drug id="00546291" sec3="Y"><name>Capoten</name><manufacturerId>BQU</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00893617" sec3="Y"><name>Apo-Capto</name><manufacturerId>APX</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913840" sec3="Y"><name>Nu-Capto</name><manufacturerId>NXP</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01942980" sec3="Y"><name>Novo-Captopril</name><manufacturerId>NOP</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02163586" sec3="Y"><name>Gen-Captopril</name><manufacturerId>GEN</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02230205" sec3="Y"><name>PMS-Captopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02242790" dinStatus="E" sec3="Y"><name>Captopril</name><manufacturerId>ZYN</manufacturerId><individualPrice>.5590</individualPrice><dailyCost>1.6770</dailyCost><listingDate>2001-06-07</listingDate></drug></pcg9><pcg9 id="240800076"><itemNumber>0523</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>1.0395</price><drug id="00546305" notABenefit="Y" sec3="Y"><name>Capoten</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00893625" sec3="Y"><name>Apo-Capto</name><manufacturerId>APX</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913859" sec3="Y"><name>Nu-Capto</name><manufacturerId>NXP</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01942999" sec3="Y"><name>Novo-Captopril</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163594" sec3="Y"><name>Gen-Captopril</name><manufacturerId>GEN</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230206" sec3="Y"><name>PMS-Captopril</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02242791" dinStatus="E" sec3="Y"><name>Captopril</name><manufacturerId>ZYN</manufacturerId><individualPrice>1.0395</individualPrice><listingDate>2001-06-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00382"><name>CILAZAPRIL</name><pcgGroup><pcg9 id="240800189"><itemNumber>0524</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.2950</price><drug id="01911465" sec3="Y"><name>Inhibace</name><manufacturerId>HLR</manufacturerId><individualPrice>.6229</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02266350" sec3="Y"><name>Novo-Cilazapril</name><manufacturerId>NOP</manufacturerId><individualPrice>.2950</individualPrice><listingDate>2005-06-13</listingDate></drug><drug id="02280442" sec3="Y"><name>PMS-Cilazapril</name><manufacturerId>PMS</manufacturerId><individualPrice>.2950</individualPrice><listingDate>2006-08-24</listingDate></drug><drug id="02283778" sec3="Y"><name>Mylan-Cilazapril</name><manufacturerId>MYL</manufacturerId><individualPrice>.2950</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02291134" sec3="Y"><name>Apo-Cilazapril</name><manufacturerId>APX</manufacturerId><individualPrice>.2950</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="240800190"><itemNumber>0525</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.3400</price><dailyCost>.3400</dailyCost><drug id="01911473" sec3="Y"><name>Inhibace</name><manufacturerId>HLR</manufacturerId><individualPrice>.7179</individualPrice><dailyCost>.7179</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02266369" sec3="Y"><name>Novo-Cilazapril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3400</individualPrice><dailyCost>.3400</dailyCost><listingDate>2005-06-13</listingDate></drug><drug id="02280450" sec3="Y"><name>PMS-Cilazapril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3400</individualPrice><dailyCost>.3400</dailyCost><listingDate>2006-08-24</listingDate></drug><drug id="02283786" sec3="Y"><name>Mylan-Cilazapril</name><manufacturerId>MYL</manufacturerId><individualPrice>.3400</individualPrice><dailyCost>.3400</dailyCost><listingDate>2006-09-06</listingDate></drug><drug id="02285215" sec3="Y"><name>Co Cilazapril</name><manufacturerId>COB</manufacturerId><individualPrice>.3400</individualPrice><dailyCost>.3400</dailyCost><listingDate>2007-04-02</listingDate></drug><drug id="02291142" sec3="Y"><name>Apo-Cilazapril</name><manufacturerId>APX</manufacturerId><individualPrice>.3400</individualPrice><dailyCost>.3400</dailyCost><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="240800191"><itemNumber>0526</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.3950</price><dailyCost>.3950</dailyCost><drug id="01911481" sec3="Y"><name>Inhibace</name><manufacturerId>HLR</manufacturerId><individualPrice>.8341</individualPrice><dailyCost>.8341</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02266377" sec3="Y"><name>Novo-Cilazapril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2005-06-13</listingDate></drug><drug id="02280469" sec3="Y"><name>PMS-Cilazapril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2006-08-24</listingDate></drug><drug id="02283794" sec3="Y"><name>Mylan-Cilazapril</name><manufacturerId>MYL</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2006-09-06</listingDate></drug><drug id="02285223" sec3="Y"><name>Co Cilazapril</name><manufacturerId>COB</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2007-04-02</listingDate></drug><drug id="02291150" sec3="Y"><name>Apo-Cilazapril</name><manufacturerId>APX</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2007-03-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01436"><name>CILAZAPRIL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800236"><itemNumber>0527</itemNumber><strength>5mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>.4170</price><drug id="02181479" sec3="Y"><name>Inhibace Plus</name><manufacturerId>HLR</manufacturerId><individualPrice>.8339</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02284987" sec3="Y"><name>Apo-Cilazapril/HCTZ</name><manufacturerId>APX</manufacturerId><individualPrice>.4170</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02313731" dinStatus="N" sec3="Y"><name>Novo-Cilazapril/HCTZ</name><manufacturerId>NOP</manufacturerId><individualPrice>.4170</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00355"><name>CLONIDINE HCL</name><note>Significant rebound hypertension can occur after missing even one or two doses; this drug should be avoided in patients with cardiovascular fragility or suspected problems with compliance.</note><pcgGroup><pcg9 id="240800171"><itemNumber>0528</itemNumber><strength>0.025mg</strength><dosageForm>Tab</dosageForm><drug id="00519251" notABenefit="Y" sec3="Y"><name>Dixarit</name><manufacturerId>BOE</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02248732" notABenefit="Y" sec3="Y"><name>Apo-Clonidine</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02304163" notABenefit="Y" sec3="Y"><name>Novo-Clonidine</name><manufacturerId>NOP</manufacturerId><listingDate>2008-05-16</listingDate></drug></pcg9><pcg9 id="240800022"><itemNumber>0529</itemNumber><strength>0.1mg</strength><dosageForm>Tab</dosageForm><price>.1358</price><dailyCost>.5432</dailyCost><drug id="00259527" sec3="Y"><name>Catapres</name><manufacturerId>BOE</manufacturerId><individualPrice>.1853</individualPrice><dailyCost>.7412</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00868949" sec3="Y"><name>Apo-Clonidine</name><manufacturerId>APX</manufacturerId><individualPrice>.1358</individualPrice><dailyCost>.5432</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913786" sec3="Y"><name>Nu-Clonidine</name><manufacturerId>NXP</manufacturerId><individualPrice>.1358</individualPrice><dailyCost>.5432</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02046121" sec3="Y"><name>Novo-Clonidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1358</individualPrice><dailyCost>.5432</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800021"><itemNumber>0530</itemNumber><strength>0.2mg</strength><dosageForm>Tab</dosageForm><price>.2424</price><dailyCost>.9696</dailyCost><drug id="00291889" sec3="Y"><name>Catapres</name><manufacturerId>BOE</manufacturerId><individualPrice>.3306</individualPrice><dailyCost>1.3224</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00868957" sec3="Y"><name>Apo-Clonidine</name><manufacturerId>APX</manufacturerId><individualPrice>.2424</individualPrice><dailyCost>.9696</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913220" sec3="Y"><name>Nu-Clonidine</name><manufacturerId>NXP</manufacturerId><individualPrice>.2424</individualPrice><dailyCost>.9696</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02046148" sec3="Y"><name>Novo-Clonidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.2424</individualPrice><dailyCost>.9696</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00375"><name>DOXAZOSIN MESYLATE</name><pcgGroup><pcg9 id="240800168"><itemNumber>0531</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.2750</price><dailyCost>.2750</dailyCost><drug id="01958100" sec3="Y"><name>Cardura-1</name><manufacturerId>AZC</manufacturerId><individualPrice>.5665</individualPrice><dailyCost>.5665</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02240498" sec3="Y"><name>Mylan-Doxazosin</name><manufacturerId>MYL</manufacturerId><individualPrice>.2750</individualPrice><dailyCost>.2750</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02240588" sec3="Y"><name>Apo-Doxazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.2750</individualPrice><dailyCost>.2750</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02242728" sec3="Y"><name>Novo-Doxazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2750</individualPrice><dailyCost>.2750</dailyCost><listingDate>2001-03-07</listingDate></drug><drug id="02244527" sec3="Y"><name>PMS-Doxazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2750</individualPrice><dailyCost>.2750</dailyCost><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="240800169"><itemNumber>0532</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.3300</price><dailyCost>.3300</dailyCost><drug id="01958097" sec3="Y"><name>Cardura-2</name><manufacturerId>AZC</manufacturerId><individualPrice>.6795</individualPrice><dailyCost>.6795</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02240499" sec3="Y"><name>Mylan-Doxazosin</name><manufacturerId>MYL</manufacturerId><individualPrice>.3300</individualPrice><dailyCost>.3300</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02240589" sec3="Y"><name>Apo-Doxazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.3300</individualPrice><dailyCost>.3300</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02242729" sec3="Y"><name>Novo-Doxazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3300</individualPrice><dailyCost>.3300</dailyCost><listingDate>2001-03-07</listingDate></drug><drug id="02244528" sec3="Y"><name>PMS-Doxazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.3300</individualPrice><dailyCost>.3300</dailyCost><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="240800170"><itemNumber>0533</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.4290</price><dailyCost>.4290</dailyCost><drug id="01958119" sec3="Y"><name>Cardura-4</name><manufacturerId>AZC</manufacturerId><individualPrice>.8835</individualPrice><dailyCost>.8835</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02240500" sec3="Y"><name>Mylan-Doxazosin</name><manufacturerId>MYL</manufacturerId><individualPrice>.4290</individualPrice><dailyCost>.4290</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02240590" sec3="Y"><name>Apo-Doxazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.4290</individualPrice><dailyCost>.4290</dailyCost><listingDate>2000-01-17</listingDate></drug><drug id="02242730" sec3="Y"><name>Novo-Doxazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.4290</individualPrice><dailyCost>.4290</dailyCost><listingDate>2001-03-07</listingDate></drug><drug id="02244529" sec3="Y"><name>PMS-Doxazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.4290</individualPrice><dailyCost>.4290</dailyCost><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00368"><name>ENALAPRIL MALEATE</name><pcgGroup><pcg9 id="240800149"><itemNumber>0534</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.3617</price><dailyCost>.3617</dailyCost><drug id="00851795" sec3="Y"><name>Vasotec</name><manufacturerId>MFC</manufacturerId><individualPrice>.3617</individualPrice><dailyCost>.3617</dailyCost><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>1996-10-01</listingDate></drug><drug id="02020025" notABenefit="Y" sec3="Y"><name>Apo-Enalapril</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02291878" notABenefit="Y" sec3="Y"><name>Co Enalapril</name><manufacturerId>COB</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299933" notABenefit="Y" sec3="Y"><name>Sandoz Enalapril</name><manufacturerId>SDZ</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299984" notABenefit="Y" sec3="Y"><name>Ratio-Enalapril</name><manufacturerId>RPH</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300036" notABenefit="Y" sec3="Y"><name>Gen-Enalapril</name><manufacturerId>GEN</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300079" notABenefit="Y" sec3="Y"><name>PMS-Enalapril</name><manufacturerId>PMS</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-02-12</listingDate></drug><drug id="02300117" notABenefit="Y" sec3="Y"><name>Taro-Enalapril</name><manufacturerId>TAR</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-01-15</listingDate></drug><drug id="02300680" notABenefit="Y" sec3="Y"><name>Novo-Enalapril</name><manufacturerId>NOP</manufacturerId><note>** Each tablet is made with 2.5mg of enalapril maleate that is  
   equivalent to 2mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-05-16</listingDate></drug></pcg9><pcg9 id="240800105"><itemNumber>0535</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.4279</price><dailyCost>.4279</dailyCost><drug id="00708879" sec3="Y"><name>Vasotec</name><manufacturerId>MFC</manufacturerId><individualPrice>.4279</individualPrice><dailyCost>.4279</dailyCost><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>1996-10-01</listingDate></drug><drug id="02019884" notABenefit="Y" sec3="Y"><name>Apo-Enalapril</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02233005" notABenefit="Y" sec3="Y"><name>Novo-Enalapril</name><manufacturerId>NOP</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-05-16</listingDate></drug><drug id="02291886" notABenefit="Y" sec3="Y"><name>Co Enalapril</name><manufacturerId>COB</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299941" notABenefit="Y" sec3="Y"><name>Sandoz Enalapril</name><manufacturerId>SDZ</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299992" notABenefit="Y" sec3="Y"><name>Ratio-Enalapril</name><manufacturerId>RPH</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300044" notABenefit="Y" sec3="Y"><name>Gen-Enalapril</name><manufacturerId>GEN</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300087" notABenefit="Y" sec3="Y"><name>PMS-Enalapril</name><manufacturerId>PMS</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-02-12</listingDate></drug><drug id="02300125" notABenefit="Y" sec3="Y"><name>Taro-Enalapril</name><manufacturerId>TAR</manufacturerId><note>** Each tablet is made with 5mg of enalapril maleate that is  
   equivalent to 4mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800104"><itemNumber>0536</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.5142</price><dailyCost>.5142</dailyCost><drug id="00670901" sec3="Y"><name>Vasotec</name><manufacturerId>MFC</manufacturerId><individualPrice>.5142</individualPrice><dailyCost>.5142</dailyCost><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>1996-10-01</listingDate></drug><drug id="02019892" notABenefit="Y" sec3="Y"><name>Apo-Enalapril</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02233006" notABenefit="Y" sec3="Y"><name>Novo-Enalapril</name><manufacturerId>NOP</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-05-16</listingDate></drug><drug id="02291894" notABenefit="Y" sec3="Y"><name>Co Enalapril</name><manufacturerId>COB</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299968" notABenefit="Y" sec3="Y"><name>Sandoz Enalapril</name><manufacturerId>SDZ</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300001" notABenefit="Y" sec3="Y"><name>Ratio-Enalapril</name><manufacturerId>RPH</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300052" notABenefit="Y" sec3="Y"><name>Gen-Enalapril</name><manufacturerId>GEN</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300095" notABenefit="Y" sec3="Y"><name>PMS-Enalapril</name><manufacturerId>PMS</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-02-12</listingDate></drug><drug id="02300133" notABenefit="Y" sec3="Y"><name>Taro-Enalapril</name><manufacturerId>TAR</manufacturerId><note>** Each tablet is made with 10mg of enalapril maleate that is  
   equivalent to 8mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800103"><itemNumber>0537</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.6204</price><dailyCost>.6204</dailyCost><drug id="00670928" sec3="Y"><name>Vasotec</name><manufacturerId>MFC</manufacturerId><individualPrice>.6204</individualPrice><dailyCost>.6204</dailyCost><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>1996-10-01</listingDate></drug><drug id="02019906" notABenefit="Y" sec3="Y"><name>Apo-Enalapril</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02233007" notABenefit="Y" sec3="Y"><name>Novo-Enalapril</name><manufacturerId>NOP</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-05-16</listingDate></drug><drug id="02291908" notABenefit="Y" sec3="Y"><name>Co Enalapril</name><manufacturerId>COB</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02299976" notABenefit="Y" sec3="Y"><name>Sandoz Enalapril</name><manufacturerId>SDZ</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300028" notABenefit="Y" sec3="Y"><name>Ratio-Enalapril</name><manufacturerId>RPH</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300060" notABenefit="Y" sec3="Y"><name>Gen-Enalapril</name><manufacturerId>GEN</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2007-12-19</listingDate></drug><drug id="02300109" notABenefit="Y" sec3="Y"><name>PMS-Enalapril</name><manufacturerId>PMS</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-02-12</listingDate></drug><drug id="02300141" notABenefit="Y" sec3="Y"><name>Taro-Enalapril</name><manufacturerId>TAR</manufacturerId><note>** Each tablet is made with 20mg of enalapril maleate that is  
   equivalent to 16mg of enalapril sodium, in the finished tablets.</note><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01561"><name>EPROSARTAN MESYLATE</name><pcgGroup><pcg9 id="240800247"><itemNumber>0538</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.7003</price><drug id="02240432" sec3="Y"><name>Teveten</name><manufacturerId>SPH</manufacturerId><individualPrice>.7003</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="240800252"><itemNumber>0539</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>1.0510</price><drug id="02243942" sec3="Y"><name>Teveten</name><manufacturerId>SPH</manufacturerId><individualPrice>1.0510</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01632"><name>EPROSARTAN MESYLATE &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800259"><itemNumber>0540</itemNumber><strength>600mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>1.0510</price><drug id="02253631" sec3="Y"><name>Teveten Plus</name><manufacturerId>SPH</manufacturerId><individualPrice>1.0510</individualPrice><listingDate>2005-05-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00372"><name>FELODIPINE</name><note>Grapefruit juice or erythromycin triple the blood levels of felodipine and markedly increase both efficacy and adverse effects. Other dihydropyridines are affected to differing degrees by grapefruit juice.</note><pcgGroup><pcg9 id="240800202"><itemNumber>0541</itemNumber><strength>2.5mg</strength><dosageForm>ER Tab</dosageForm><price>.5087</price><drug id="02057778" sec3="Y"><name>Plendil</name><manufacturerId>AZC</manufacturerId><individualPrice>.5087</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800164"><itemNumber>0542</itemNumber><strength>5mg</strength><dosageForm>ER Tab</dosageForm><price>.4620</price><dailyCost>.4620</dailyCost><drug id="00851779" sec3="Y"><name>Plendil</name><manufacturerId>AZC</manufacturerId><individualPrice>.6797</individualPrice><dailyCost>.6797</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02280264" sec3="Y"><name>Sandoz Felodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4620</individualPrice><dailyCost>.4620</dailyCost><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="240800165"><itemNumber>0543</itemNumber><strength>10mg</strength><dosageForm>ER Tab</dosageForm><price>.6925</price><dailyCost>.6925</dailyCost><drug id="00851787" sec3="Y"><name>Plendil</name><manufacturerId>AZC</manufacturerId><individualPrice>1.0197</individualPrice><dailyCost>1.0197</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02280272" sec3="Y"><name>Sandoz Felodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6925</individualPrice><dailyCost>.6925</dailyCost><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="240800201"><itemNumber>0544</itemNumber><strength>2.5mg</strength><dosageForm>SR Tab</dosageForm><price>.5301</price><drug id="02221985" sec3="Y"><name>Renedil</name><manufacturerId>SAV</manufacturerId><individualPrice>.5301</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9><pcg9 id="240800154"><itemNumber>0545</itemNumber><strength>5mg</strength><dosageForm>SR Tab</dosageForm><price>.4620</price><dailyCost>.4620</dailyCost><drug id="02221993" sec3="Y"><name>Renedil</name><manufacturerId>SAV</manufacturerId><individualPrice>.7228</individualPrice><dailyCost>.7228</dailyCost><listingDate>1999-01-07</listingDate></drug><drug id="09857203" sec3="Y"><name>Sandoz Felodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4620</individualPrice><dailyCost>.4620</dailyCost><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="240800155"><itemNumber>0546</itemNumber><strength>10mg</strength><dosageForm>SR Tab</dosageForm><price>.6925</price><dailyCost>.6925</dailyCost><drug id="02222000" sec3="Y"><name>Renedil</name><manufacturerId>SAV</manufacturerId><individualPrice>1.0834</individualPrice><dailyCost>1.0834</dailyCost><listingDate>1999-01-07</listingDate></drug><drug id="09857204" sec3="Y"><name>Sandoz Felodipine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6925</individualPrice><dailyCost>.6925</dailyCost><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00373"><name>FOSINOPRIL SODIUM</name><pcgGroup><pcg9 id="240800156"><itemNumber>0547</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3950</price><dailyCost>.3950</dailyCost><drug id="01907107" sec3="Y"><name>Monopril</name><manufacturerId>BQU</manufacturerId><individualPrice>.8710</individualPrice><dailyCost>.8710</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02247802" sec3="Y"><name>Novo-Fosinopril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02255944" sec3="Y"><name>PMS-Fosinopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2005-07-14</listingDate></drug><drug id="02262401" sec3="Y"><name>Mylan-Fosinopril</name><manufacturerId>MYL</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2005-01-25</listingDate></drug><drug id="02266008" sec3="Y"><name>Apo-Fosinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2005-07-14</listingDate></drug><drug id="02294524" dinStatus="N" sec3="Y"><name>Ran-Fosinopril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02331004" dinStatus="N" sec3="Y"><name>Jamp-Fosinopril</name><manufacturerId>JPC</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2010-04-23</listingDate></drug><drug id="02332566" dinStatus="N" sec3="Y"><name>Fosinopril Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.3950</individualPrice><dailyCost>.3950</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240800157"><itemNumber>0548</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.4750</price><dailyCost>.4750</dailyCost><drug id="01907115" sec3="Y"><name>Monopril</name><manufacturerId>BQU</manufacturerId><individualPrice>1.0475</individualPrice><dailyCost>1.0475</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02247803" sec3="Y"><name>Novo-Fosinopril</name><manufacturerId>NOP</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2004-04-06</listingDate></drug><drug id="02255952" sec3="Y"><name>PMS-Fosinopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2005-07-14</listingDate></drug><drug id="02262428" sec3="Y"><name>Mylan-Fosinopril</name><manufacturerId>MYL</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2005-01-25</listingDate></drug><drug id="02266016" sec3="Y"><name>Apo-Fosinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2005-07-14</listingDate></drug><drug id="02294532" dinStatus="N" sec3="Y"><name>Ran-Fosinopril</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2010-03-02</listingDate></drug><drug id="02331012" dinStatus="N" sec3="Y"><name>Jamp-Fosinopril</name><manufacturerId>JPC</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2010-04-23</listingDate></drug><drug id="02332574" dinStatus="N" sec3="Y"><name>Fosinopril Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><dailyCost>.4750</dailyCost><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00350"><name>HYDRALAZINE HCL</name><pcgGroup><pcg9 id="240800044"><itemNumber>0549</itemNumber><strength>20mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>11.6500</price><drug id="00723754" sec3="Y"><name>Apresoline</name><manufacturerId>STE</manufacturerId><individualPrice>11.6500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800010"><itemNumber>0550</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1026</price><dailyCost>.4104</dailyCost><drug id="00005525" notABenefit="Y" sec3="Y"><name>Apresoline</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441619" sec3="Y"><name>Apo-Hydralazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1026</individualPrice><dailyCost>.4104</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800041"><itemNumber>0551</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1644</price><dailyCost>.6576</dailyCost><drug id="00005533" notABenefit="Y" sec3="Y"><name>Apresoline</name><manufacturerId>STE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441627" sec3="Y"><name>Apo-Hydralazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1644</individualPrice><dailyCost>.6576</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800008"><itemNumber>0552</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2527</price><dailyCost>1.0108</dailyCost><drug id="00005541" notABenefit="Y" sec3="Y"><name>Apresoline</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441635" sec3="Y"><name>Apo-Hydralazine</name><manufacturerId>APX</manufacturerId><individualPrice>.2527</individualPrice><dailyCost>1.0108</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00759481" sec3="Y"><name>Novo-Hylazin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2527</individualPrice><dailyCost>1.0108</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01402"><name>IRBESARTAN</name><pcgGroup><pcg9 id="240800231"><itemNumber>0553</itemNumber><strength>75mg</strength><dosageForm>Tab</dosageForm><price>1.2098</price><drug id="02237923" sec3="Y"><name>Avapro</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2098</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="240800232"><itemNumber>0554</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>1.2098</price><drug id="02237924" sec3="Y"><name>Avapro</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2098</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="240800233"><itemNumber>0555</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>1.2098</price><drug id="02237925" sec3="Y"><name>Avapro</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2098</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01500"><name>IRBESARTAN &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800242"><itemNumber>0556</itemNumber><strength>150 &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>1.2098</price><drug id="02241818" sec3="Y"><name>Avalide</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2098</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="240800243"><itemNumber>0557</itemNumber><strength>300 &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>1.2098</price><drug id="02241819" sec3="Y"><name>Avalide</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2098</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="240800263"><itemNumber>0558</itemNumber><strength>300 &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>1.2015</price><drug id="02280213" sec3="Y"><name>Avalide</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2015</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00367"><name>LABETALOL HCL</name><pcgGroup><pcg9 id="240800093"><itemNumber>0559</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2765</price><drug id="02106272" sec3="Y"><name>Trandate</name><manufacturerId>PAL</manufacturerId><individualPrice>.2765</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="240800094"><itemNumber>0560</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.4888</price><drug id="02106280" sec3="Y"><name>Trandate</name><manufacturerId>PAL</manufacturerId><individualPrice>.4888</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00371"><name>LISINOPRIL</name><pcgGroup><pcg9 id="240800146"><itemNumber>0561</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2694</price><dailyCost>.2694</dailyCost><drug id="00839388" sec3="Y"><name>Prinivil</name><manufacturerId>MFC</manufacturerId><individualPrice>.5713</individualPrice><dailyCost>.5713</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02256797" sec3="Y"><name>Ratio-Lisinopril P</name><manufacturerId>RPH</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285061" sec3="Y"><name>Novo-Lisinopril (Type P)</name><manufacturerId>NOP</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="09853685" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="09857272" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="240800147"><itemNumber>0562</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3237</price><dailyCost>.3237</dailyCost><drug id="00839396" sec3="Y"><name>Prinivil</name><manufacturerId>MFC</manufacturerId><individualPrice>.6864</individualPrice><dailyCost>.6864</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02256800" sec3="Y"><name>Ratio-Lisinopril P</name><manufacturerId>RPH</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285088" sec3="Y"><name>Novo-Lisinopril (Type P)</name><manufacturerId>NOP</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="09853960" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="09857286" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="240800148"><itemNumber>0563</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.3890</price><dailyCost>.3890</dailyCost><drug id="00839418" sec3="Y"><name>Prinivil</name><manufacturerId>MFC</manufacturerId><individualPrice>.8253</individualPrice><dailyCost>.8253</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02256819" sec3="Y"><name>Ratio-Lisinopril P</name><manufacturerId>RPH</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285096" sec3="Y"><name>Novo-Lisinopril (Type P)</name><manufacturerId>NOP</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="09854010" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="09857287" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="240800150"><itemNumber>0564</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2694</price><dailyCost>.2694</dailyCost><drug id="02049333" sec3="Y"><name>Zestril</name><manufacturerId>AZC</manufacturerId><individualPrice>.5388</individualPrice><dailyCost>.5388</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02217481" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>1997-08-28</listingDate></drug><drug id="02271443" sec3="Y"><name>Co Lisinopril</name><manufacturerId>COB</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02274833" sec3="Y"><name>Mylan-Lisinopril</name><manufacturerId>MYL</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285118" sec3="Y"><name>Novo-Lisinopril (Type Z)</name><manufacturerId>NOP</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02289199" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02292203" sec3="Y"><name>PMS-Lisinopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02294230" sec3="Y"><name>Ran-Lisinopril</name><manufacturerId>RAN</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02299879" sec3="Y"><name>Ratio-Lisinopril Z</name><manufacturerId>RPH</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02332167" dinStatus="N" sec3="Y"><name>Lisinopril Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.2694</individualPrice><dailyCost>.2694</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800151"><itemNumber>0565</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3237</price><dailyCost>.3237</dailyCost><drug id="02049376" sec3="Y"><name>Zestril</name><manufacturerId>AZC</manufacturerId><individualPrice>.6474</individualPrice><dailyCost>.6474</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02217503" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02271451" sec3="Y"><name>Co Lisinopril</name><manufacturerId>COB</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02274841" sec3="Y"><name>Mylan-Lisinopril</name><manufacturerId>MYL</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285126" sec3="Y"><name>Novo-Lisinopril (Type Z)</name><manufacturerId>NOP</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02289202" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02292211" sec3="Y"><name>PMS-Lisinopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02294249" sec3="Y"><name>Ran-Lisinopril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02299887" sec3="Y"><name>Ratio-Lisinopril Z</name><manufacturerId>RPH</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02332175" dinStatus="N" sec3="Y"><name>Lisinopril Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.3237</individualPrice><dailyCost>.3237</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800152"><itemNumber>0566</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.3890</price><dailyCost>.3890</dailyCost><drug id="02049384" sec3="Y"><name>Zestril</name><manufacturerId>AZC</manufacturerId><individualPrice>.7779</individualPrice><dailyCost>.7779</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02217511" sec3="Y"><name>Apo-Lisinopril</name><manufacturerId>APX</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2001-06-07</listingDate></drug><drug id="02271478" sec3="Y"><name>Co Lisinopril</name><manufacturerId>COB</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02274868" sec3="Y"><name>Mylan-Lisinopril</name><manufacturerId>MYL</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02285134" sec3="Y"><name>Novo-Lisinopril (Type Z)</name><manufacturerId>NOP</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02289229" sec3="Y"><name>Sandoz Lisinopril</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02292238" sec3="Y"><name>PMS-Lisinopril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02294257" sec3="Y"><name>Ran-Lisinopril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02299895" sec3="Y"><name>Ratio-Lisinopril Z</name><manufacturerId>RPH</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2007-12-19</listingDate></drug><drug id="02332183" dinStatus="N" sec3="Y"><name>Lisinopril Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.3890</individualPrice><dailyCost>.3890</dailyCost><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00383"><name>LISINOPRIL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800207"><itemNumber>0567</itemNumber><strength>10mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.4168</price><drug id="02103729" sec3="Y"><name>Zestoretic</name><manufacturerId>AZC</manufacturerId><individualPrice>.8335</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02261979" sec3="Y"><name>Apo-Lisinopril/HCTZ</name><manufacturerId>APX</manufacturerId><individualPrice>.4168</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02297736" sec3="Y"><name>Mylan-Lisinopril HCTZ</name><manufacturerId>MYL</manufacturerId><individualPrice>.4168</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02301768" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type Z)</name><manufacturerId>NOP</manufacturerId><individualPrice>.4168</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02302365" sec3="Y"><name>Sandoz Lisinopril HCT</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4168</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800214"><itemNumber>0568</itemNumber><strength>10mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.3334</price><drug id="02108194" sec3="Y"><name>Prinzide</name><manufacturerId>MFC</manufacturerId><individualPrice>.7074</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02302136" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type P)</name><manufacturerId>NOP</manufacturerId><individualPrice>.3334</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800196"><itemNumber>0569</itemNumber><strength>20mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.4006</price><drug id="00884413" sec3="Y"><name>Prinzide</name><manufacturerId>MFC</manufacturerId><individualPrice>.8500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02302144" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type P)</name><manufacturerId>NOP</manufacturerId><individualPrice>.4006</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800215"><itemNumber>0570</itemNumber><strength>20mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.5008</price><drug id="02045737" sec3="Y"><name>Zestoretic</name><manufacturerId>AZC</manufacturerId><individualPrice>1.0016</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02261987" sec3="Y"><name>Apo-Lisinopril/HCTZ</name><manufacturerId>APX</manufacturerId><individualPrice>.5008</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02297744" sec3="Y"><name>Mylan-Lisinopril HCTZ</name><manufacturerId>MYL</manufacturerId><individualPrice>.5008</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02301776" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type Z)</name><manufacturerId>NOP</manufacturerId><individualPrice>.5008</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02302373" sec3="Y"><name>Sandoz Lisinopril HCT</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5008</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="240800274"><itemNumber>0571</itemNumber><strength>20mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><drug id="02045729" notABenefit="Y" sec3="Y"><name>Zestoretic</name><manufacturerId>AZC</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02261995" notABenefit="Y" sec3="Y"><name>Apo-Lisinopril/HCTZ</name><manufacturerId>APX</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02297752" notABenefit="Y" sec3="Y"><name>Mylan-Lisinopril HCTZ</name><manufacturerId>MYL</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02301784" notABenefit="Y" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type Z)</name><manufacturerId>NOP</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02302381" notABenefit="Y" sec3="Y"><name>Sandoz Lisinopril HCT</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="240800273"><itemNumber>0572</itemNumber><strength>20mg/25mg</strength><dosageForm>Tab</dosageForm><drug id="00884421" notABenefit="Y" sec3="Y"><name>Prinzide</name><manufacturerId>MFC</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02302152" notABenefit="Y" sec3="Y"><name>Novo-Lisinopril/HCTZ (Type P)</name><manufacturerId>NOP</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00387"><name>LOSARTAN POTASSIUM</name><pcgGroup><pcg9 id="240800212"><itemNumber>0573</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>1.2500</price><drug id="02182815" sec3="Y"><name>Cozaar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800216"><itemNumber>0574</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>1.2500</price><drug id="02182874" sec3="Y"><name>Cozaar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800230"><itemNumber>0575</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>1.2500</price><drug id="02182882" sec3="Y"><name>Cozaar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2500</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01378"><name>LOSARTAN POTASSIUM &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800282"><itemNumber>0576</itemNumber><strength>100mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>1.2135</price><drug id="02297841" dinStatus="N" sec3="Y"><name>Hyzaar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2135</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="240800226"><itemNumber>0577</itemNumber><strength>50mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>1.2500</price><drug id="02230047" sec3="Y"><name>Hyzaar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2500</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="240800241"><itemNumber>0578</itemNumber><strength>100mg/25mg</strength><dosageForm>Tab</dosageForm><price>1.2500</price><drug id="02241007" sec3="Y"><name>Hyzaar DS</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2500</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00353"><name>METHYLDOPA</name><pcgGroup><pcg9 id="240800023"><itemNumber>0579</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><price>.0989</price><dailyCost>.3956</dailyCost><drug id="00016551" notABenefit="Y" sec3="Y"><name>Aldomet</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00360252" sec3="Y"><name>Apo-Methyldopa</name><manufacturerId>APX</manufacturerId><individualPrice>.0989</individualPrice><dailyCost>.3956</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800013"><itemNumber>0580</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.1433</price><dailyCost>.5732</dailyCost><drug id="00016578" notABenefit="Y" sec3="Y"><name>Aldomet</name><manufacturerId>MSD</manufacturerId><listingDate>2002-11-22</listingDate></drug><drug id="00360260" sec3="Y"><name>Apo-Methyldopa</name><manufacturerId>APX</manufacturerId><individualPrice>.1433</individualPrice><dailyCost>.5732</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800045"><itemNumber>0581</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.2537</price><dailyCost>.5074</dailyCost><drug id="00016586" notABenefit="Y" sec3="Y"><name>Aldomet</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00426830" sec3="Y"><name>Apo-Methyldopa</name><manufacturerId>APX</manufacturerId><individualPrice>.2537</individualPrice><dailyCost>.5074</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00362"><name>MINOXIDIL</name><pcgGroup><pcg9 id="240800072"><itemNumber>0582</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.3420</price><drug id="00514497" sec3="Y"><name>Loniten</name><manufacturerId>PFI</manufacturerId><individualPrice>.3420</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800071"><itemNumber>0583</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.7540</price><drug id="00514500" sec3="Y"><name>Loniten</name><manufacturerId>PFI</manufacturerId><individualPrice>.7540</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00318"><name>NIFEDIPINE</name><pcgGroup><pcg9 id="240800227"><itemNumber>0584</itemNumber><strength>20mg</strength><dosageForm>ER Tab</dosageForm><price>1.2341</price><drug id="02237618" sec3="Y"><name>Adalat XL</name><manufacturerId>BAY</manufacturerId><individualPrice>1.2341</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="240800158"><itemNumber>0585</itemNumber><strength>30mg</strength><dosageForm>ER Tab</dosageForm><price>1.2341</price><dailyCost>1.2341</dailyCost><drug id="02155907" sec3="Y"><name>Adalat XL</name><manufacturerId>BAY</manufacturerId><individualPrice>1.2341</individualPrice><dailyCost>1.2341</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800159"><itemNumber>0586</itemNumber><strength>60mg</strength><dosageForm>ER Tab</dosageForm><price>.9374</price><dailyCost>.9374</dailyCost><drug id="02155990" sec3="Y"><name>Adalat XL</name><manufacturerId>BAY</manufacturerId><individualPrice>1.8747</individualPrice><dailyCost>1.8747</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02321149" dinStatus="N" sec3="Y"><name>Mylan-Nifedipine Extended Release</name><manufacturerId>MYL</manufacturerId><individualPrice>.9374</individualPrice><dailyCost>.9374</dailyCost><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="240800129"><itemNumber>0587</itemNumber><strength>10mg</strength><dosageForm>LA Tab</dosageForm><price>.4432</price><dailyCost>.8864</dailyCost><drug id="02155885" notABenefit="Y" sec3="Y"><name>Adalat PA 10</name><manufacturerId>BAH</manufacturerId><listingDate>1997-08-28</listingDate></drug><drug id="02197448" dinStatus="E" sec3="Y"><name>Apo-Nifed PA</name><manufacturerId>APX</manufacturerId><individualPrice>.4432</individualPrice><dailyCost>.8864</dailyCost><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240800125"><itemNumber>0588</itemNumber><strength>20mg</strength><dosageForm>LA Tab</dosageForm><price>.6930</price><dailyCost>1.3860</dailyCost><drug id="02155893" notABenefit="Y" sec3="Y"><name>Adalat PA 20</name><manufacturerId>BAH</manufacturerId><listingDate>1997-08-28</listingDate></drug><drug id="02181525" dinStatus="E" sec3="Y"><name>Apo-Nifed PA</name><manufacturerId>APX</manufacturerId><individualPrice>.6930</individualPrice><dailyCost>1.3860</dailyCost><listingDate>1997-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01768"><name>OLMESARTAN MEDOXOMIL</name><pcgGroup><pcg9 id="240800284"><itemNumber>0589</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><drug id="02318660" dinStatus="N" sec3="Y"><name>Olmetec</name><manufacturerId>SCP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240800285"><itemNumber>0590</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><drug id="02318679" dinStatus="N" sec3="Y"><name>Olmetec</name><manufacturerId>SCP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01769"><name>OLMESARTAN MEDOXOMIL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800286"><itemNumber>0591</itemNumber><strength>20mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><drug id="02319616" dinStatus="N" sec3="Y"><name>Olmetec Plus</name><manufacturerId>SCP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240800287"><itemNumber>0592</itemNumber><strength>40mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><drug id="02319624" dinStatus="N" sec3="Y"><name>Olmetec Plus</name><manufacturerId>SCP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="240800288"><itemNumber>0593</itemNumber><strength>40mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><drug id="02319632" dinStatus="N" sec3="Y"><name>Olmetec Plus</name><manufacturerId>SCP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00386"><name>PERINDOPRIL ERBUMINE</name><pcgGroup><pcg9 id="240800208"><itemNumber>0594</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.6233</price><drug id="02123274" sec3="Y"><name>Coversyl</name><manufacturerId>SEV</manufacturerId><individualPrice>.6233</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800209"><itemNumber>0595</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.7800</price><drug id="02123282" sec3="Y"><name>Coversyl</name><manufacturerId>SEV</manufacturerId><individualPrice>.7800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800257"><itemNumber>0596</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>1.0920</price><drug id="02246624" sec3="Y"><name>Coversyl</name><manufacturerId>SEV</manufacturerId><individualPrice>1.0920</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02289296" notABenefit="Y" sec3="Y"><name>Apo-Perindopril</name><manufacturerId>APX</manufacturerId><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01699"><name>PERINDOPRIL ERBUMINE &amp; INDAPAMIDE</name><pcgGroup><pcg9 id="240800265"><itemNumber>0597</itemNumber><strength>2mg &amp; 0.625mg</strength><dosageForm>Tab</dosageForm><price>.8207</price><drug id="02246568" sec3="Y"><name>Coversyl Plus LD</name><manufacturerId>SEV</manufacturerId><individualPrice>.8207</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><pcg9 id="240800264"><itemNumber>0598</itemNumber><strength>4mg &amp; 1.25mg</strength><dosageForm>Tab</dosageForm><price>.9763</price><drug id="02246569" sec3="Y"><name>Coversyl Plus</name><manufacturerId>SEV</manufacturerId><individualPrice>.9763</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><pcg9 id="240800283"><itemNumber>0599</itemNumber><strength>8mg &amp; 2.5mg</strength><dosageForm>Tab</dosageForm><price>1.0920</price><drug id="02321653" dinStatus="N" sec3="Y"><name>Coversyl Plus HD</name><manufacturerId>SEV</manufacturerId><individualPrice>1.0920</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00359"><name>PINDOLOL</name><pcgGroup><pcg9 id="240800058"><itemNumber>0600</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2023</price><dailyCost>.4046</dailyCost><drug id="00417270" sec3="Y"><name>Visken</name><manufacturerId>NOV</manufacturerId><individualPrice>.5442</individualPrice><dailyCost>1.0884</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00755877" sec3="Y"><name>Apo-Pindol</name><manufacturerId>APX</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00869007" sec3="Y"><name>Novo-Pindol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886149" sec3="Y"><name>Nu-Pindol</name><manufacturerId>NXP</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02057808" sec3="Y"><name>Gen-Pindolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231536" sec3="Y"><name>PMS-Pindolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02261782" sec3="Y"><name>Sandoz Pindolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2023</individualPrice><dailyCost>.4046</dailyCost><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="240800057"><itemNumber>0601</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3490</price><dailyCost>.6980</dailyCost><drug id="00443174" sec3="Y"><name>Visken</name><manufacturerId>NOV</manufacturerId><individualPrice>.9293</individualPrice><dailyCost>1.8586</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00755885" sec3="Y"><name>Apo-Pindol</name><manufacturerId>APX</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00869015" sec3="Y"><name>Novo-Pindol</name><manufacturerId>NOP</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886009" sec3="Y"><name>Nu-Pindol</name><manufacturerId>NXP</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02057816" sec3="Y"><name>Gen-Pindolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231537" sec3="Y"><name>PMS-Pindolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02261790" sec3="Y"><name>Sandoz Pindolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3490</individualPrice><dailyCost>.6980</dailyCost><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="240800056"><itemNumber>0602</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.5128</price><dailyCost>1.0256</dailyCost><drug id="00417289" sec3="Y"><name>Visken</name><manufacturerId>NOV</manufacturerId><individualPrice>1.3481</individualPrice><dailyCost>2.6962</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00755893" sec3="Y"><name>Apo-Pindol</name><manufacturerId>APX</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00869023" sec3="Y"><name>Novo-Pindol</name><manufacturerId>NOP</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886130" sec3="Y"><name>Nu-Pindol</name><manufacturerId>NXP</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02057824" sec3="Y"><name>Gen-Pindolol</name><manufacturerId>GEN</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02231539" sec3="Y"><name>PMS-Pindolol</name><manufacturerId>PMS</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02261804" sec3="Y"><name>Sandoz Pindolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5128</individualPrice><dailyCost>1.0256</dailyCost><listingDate>2006-07-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00365"><name>PINDOLOL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800086"><itemNumber>0603</itemNumber><strength>10mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.8341</price><drug id="00568627" sec3="Y"><name>Viskazide 10/25</name><manufacturerId>NOV</manufacturerId><individualPrice>.8341</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800085"><itemNumber>0604</itemNumber><strength>10mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>.8341</price><drug id="00568635" sec3="Y"><name>Viskazide 10/50</name><manufacturerId>NOV</manufacturerId><individualPrice>.8341</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00366"><name>PRAZOSIN HCL</name><pcgGroup><pcg9 id="240800089"><itemNumber>0605</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.1371</price><dailyCost>.2742</dailyCost><drug id="00560952" sec3="Y"><name>Minipress</name><manufacturerId>PFI</manufacturerId><individualPrice>.2743</individualPrice><dailyCost>.5486</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00882801" sec3="Y"><name>Apo-Prazo</name><manufacturerId>APX</manufacturerId><individualPrice>.1371</individualPrice><dailyCost>.2742</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913794" sec3="Y"><name>Nu-Prazo</name><manufacturerId>NXP</manufacturerId><individualPrice>.1371</individualPrice><dailyCost>.2742</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01934198" sec3="Y"><name>Novo-Prazin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1371</individualPrice><dailyCost>.2742</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800088"><itemNumber>0606</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1862</price><dailyCost>.3724</dailyCost><drug id="00560960" sec3="Y"><name>Minipress</name><manufacturerId>PFI</manufacturerId><individualPrice>.3725</individualPrice><dailyCost>.7450</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00882828" sec3="Y"><name>Apo-Prazo</name><manufacturerId>APX</manufacturerId><individualPrice>.1862</individualPrice><dailyCost>.3724</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913808" sec3="Y"><name>Nu-Prazo</name><manufacturerId>NXP</manufacturerId><individualPrice>.1862</individualPrice><dailyCost>.3724</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01934201" sec3="Y"><name>Novo-Prazin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1862</individualPrice><dailyCost>.3724</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800087"><itemNumber>0607</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2560</price><dailyCost>.5120</dailyCost><drug id="00560979" sec3="Y"><name>Minipress</name><manufacturerId>PFI</manufacturerId><individualPrice>.5121</individualPrice><dailyCost>1.0242</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00882836" sec3="Y"><name>Apo-Prazo</name><manufacturerId>APX</manufacturerId><individualPrice>.2560</individualPrice><dailyCost>.5120</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01913816" sec3="Y"><name>Nu-Prazo</name><manufacturerId>NXP</manufacturerId><individualPrice>.2560</individualPrice><dailyCost>.5120</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01934228" sec3="Y"><name>Novo-Prazin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2560</individualPrice><dailyCost>.5120</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00374"><name>QUINAPRIL HCL</name><pcgGroup><pcg9 id="240800160"><itemNumber>0608</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.8706</price><dailyCost>.8706</dailyCost><drug id="01947664" sec3="Y"><name>Accupril</name><manufacturerId>PFI</manufacturerId><individualPrice>.8706</individualPrice><dailyCost>.8706</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800161"><itemNumber>0609</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.8706</price><dailyCost>.8706</dailyCost><drug id="01947672" sec3="Y"><name>Accupril</name><manufacturerId>PFI</manufacturerId><individualPrice>.8706</individualPrice><dailyCost>.8706</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800162"><itemNumber>0610</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.8706</price><dailyCost>.8706</dailyCost><drug id="01947680" sec3="Y"><name>Accupril</name><manufacturerId>PFI</manufacturerId><individualPrice>.8706</individualPrice><dailyCost>.8706</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="240800163"><itemNumber>0611</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.8706</price><dailyCost>.8706</dailyCost><drug id="01947699" sec3="Y"><name>Accupril</name><manufacturerId>PFI</manufacturerId><individualPrice>.8706</individualPrice><dailyCost>.8706</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01459"><name>QUINAPRIL HCL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800239"><itemNumber>0612</itemNumber><strength>10mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.8705</price><drug id="02237367" sec3="Y"><name>Accuretic</name><manufacturerId>PFI</manufacturerId><individualPrice>.8705</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="240800240"><itemNumber>0613</itemNumber><strength>20mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.8705</price><drug id="02237368" sec3="Y"><name>Accuretic</name><manufacturerId>PFI</manufacturerId><individualPrice>.8705</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="240800256"><itemNumber>0614</itemNumber><strength>20mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.8665</price><drug id="02237369" sec3="Y"><name>Accuretic</name><manufacturerId>PFI</manufacturerId><individualPrice>.8665</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00385"><name>RAMIPRIL</name><pcgGroup><pcg9 id="240800203"><itemNumber>0615</itemNumber><strength>1.25mg</strength><dosageForm>Cap</dosageForm><price>.3250</price><drug id="02221829" sec3="Y"><name>Altace</name><manufacturerId>SAV</manufacturerId><individualPrice>.6933</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02251515" sec3="Y"><name>Apo-Ramipril</name><manufacturerId>APX</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02287692" sec3="Y"><name>Ratio-Ramipril</name><manufacturerId>RPH</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02295369" dinStatus="N" sec3="Y"><name>PMS-Ramipril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02295482" sec3="Y"><name>Co Ramipril</name><manufacturerId>COB</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02299372" dinStatus="N" sec3="Y"><name>Ramipril</name><manufacturerId>RIA</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02301148" dinStatus="N" sec3="Y"><name>Gen-Ramipril</name><manufacturerId>GEN</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310503" dinStatus="N" sec3="Y"><name>Ran-Ramipril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02331101" dinStatus="N" sec3="Y"><name>Jamp-Ramipril</name><manufacturerId>JPC</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332299" dinStatus="N" sec3="Y"><name>Ramipril Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800204"><itemNumber>0616</itemNumber><strength>2.5mg</strength><dosageForm>Cap</dosageForm><price>.3750</price><drug id="02221837" sec3="Y"><name>Altace</name><manufacturerId>SAV</manufacturerId><individualPrice>.7999</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02247917" dinStatus="N" sec3="Y"><name>PMS-Ramipril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02247945" sec3="Y"><name>Novo-Ramipril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02251531" sec3="Y"><name>Apo-Ramipril</name><manufacturerId>APX</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02255316" dinStatus="N" sec3="Y"><name>Ramipril</name><manufacturerId>RIA</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02287706" sec3="Y"><name>Ratio-Ramipril</name><manufacturerId>RPH</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02295490" sec3="Y"><name>Co Ramipril</name><manufacturerId>COB</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-12-19</listingDate></drug><drug id="02301156" dinStatus="N" sec3="Y"><name>Gen-Ramipril</name><manufacturerId>GEN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310511" dinStatus="N" sec3="Y"><name>Ran-Ramipril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02331128" dinStatus="N" sec3="Y"><name>Jamp-Ramipril</name><manufacturerId>JPC</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332302" dinStatus="N" sec3="Y"><name>Ramipril Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800205"><itemNumber>0617</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.3750</price><drug id="02221845" sec3="Y"><name>Altace</name><manufacturerId>SAV</manufacturerId><individualPrice>.7999</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02247918" dinStatus="N" sec3="Y"><name>PMS-Ramipril</name><manufacturerId>PMS</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02247946" sec3="Y"><name>Novo-Ramipril</name><manufacturerId>NOP</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02251574" sec3="Y"><name>Apo-Ramipril</name><manufacturerId>APX</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02255324" dinStatus="N" sec3="Y"><name>Ramipril</name><manufacturerId>RIA</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02287714" sec3="Y"><name>Ratio-Ramipril</name><manufacturerId>RPH</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02295504" sec3="Y"><name>Co Ramipril</name><manufacturerId>COB</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2007-12-19</listingDate></drug><drug id="02301164" dinStatus="N" sec3="Y"><name>Gen-Ramipril</name><manufacturerId>GEN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310538" dinStatus="N" sec3="Y"><name>Ran-Ramipril</name><manufacturerId>RAN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02331136" dinStatus="N" sec3="Y"><name>Jamp-Ramipril</name><manufacturerId>JPC</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332310" dinStatus="N" sec3="Y"><name>Ramipril Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.3750</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800206"><itemNumber>0618</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.4750</price><drug id="02221853" sec3="Y"><name>Altace</name><manufacturerId>SAV</manufacturerId><individualPrice>1.0132</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02247919" dinStatus="N" sec3="Y"><name>PMS-Ramipril</name><manufacturerId>PMS</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02247947" sec3="Y"><name>Novo-Ramipril</name><manufacturerId>NOP</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02251582" sec3="Y"><name>Apo-Ramipril</name><manufacturerId>APX</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02255332" dinStatus="N" sec3="Y"><name>Ramipril</name><manufacturerId>RIA</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02287722" sec3="Y"><name>Ratio-Ramipril</name><manufacturerId>RPH</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02295512" sec3="Y"><name>Co Ramipril</name><manufacturerId>COB</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02301172" dinStatus="N" sec3="Y"><name>Gen-Ramipril</name><manufacturerId>GEN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310546" dinStatus="N" sec3="Y"><name>Ran-Ramipril</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02331144" dinStatus="N" sec3="Y"><name>Jamp-Ramipril</name><manufacturerId>JPC</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02332329" dinStatus="N" sec3="Y"><name>Ramipril Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="240800280"><itemNumber>0619</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><drug id="02281112" notABenefit="Y" sec3="Y"><name>Altace</name><manufacturerId>SAV</manufacturerId><listingDate>2009-06-23</listingDate></drug><drug id="02311194" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ratio-Ramipril</name><manufacturerId>RPH</manufacturerId><listingDate>2009-06-23</listingDate></drug><drug id="02325381" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Ramipril</name><manufacturerId>APX</manufacturerId><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01705"><name>RAMIPRIL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800266"><itemNumber>0620</itemNumber><strength>2.5mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.7500</price><drug id="02283131" sec3="Y"><name>Altace HCT</name><manufacturerId>SAV</manufacturerId><individualPrice>.7500</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="240800267"><itemNumber>0621</itemNumber><strength>5mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.7650</price><drug id="02283158" sec3="Y"><name>Altace HCT</name><manufacturerId>SAV</manufacturerId><individualPrice>.7650</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="240800269"><itemNumber>0622</itemNumber><strength>5mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.7650</price><drug id="02283174" sec3="Y"><name>Altace HCT</name><manufacturerId>SAV</manufacturerId><individualPrice>.7650</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="240800268"><itemNumber>0623</itemNumber><strength>10mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>.9689</price><drug id="02283166" sec3="Y"><name>Altace HCT</name><manufacturerId>SAV</manufacturerId><individualPrice>.9689</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="240800270"><itemNumber>0624</itemNumber><strength>10mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.9689</price><drug id="02283182" sec3="Y"><name>Altace HCT</name><manufacturerId>SAV</manufacturerId><individualPrice>.9689</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01435"><name>TELMISARTAN</name><pcgGroup><pcg9 id="240800237"><itemNumber>0625</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>1.1296</price><drug id="02240769" sec3="Y"><name>Micardis</name><manufacturerId>BOE</manufacturerId><individualPrice>1.1296</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="240800238"><itemNumber>0626</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>1.1296</price><drug id="02240770" sec3="Y"><name>Micardis</name><manufacturerId>BOE</manufacturerId><individualPrice>1.1296</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01559"><name>TELMISARTAN &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800281"><itemNumber>0627</itemNumber><strength>80mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>1.1296</price><drug id="02318709" dinStatus="N" sec3="Y"><name>Micardis Plus</name><manufacturerId>BOE</manufacturerId><individualPrice>1.1296</individualPrice><listingDate>2009-11-13</listingDate></drug></pcg9><pcg9 id="240800249"><itemNumber>0628</itemNumber><strength>80mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>1.1296</price><drug id="02244344" sec3="Y"><name>Micardis Plus</name><manufacturerId>BOE</manufacturerId><individualPrice>1.1296</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00370"><name>TERAZOSIN HCL</name><pcgGroup><pcg9 id="240800131"><itemNumber>0629</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.2770</price><dailyCost>.2770</dailyCost><drug id="00818658" sec3="Y"><name>Hytrin</name><manufacturerId>ABB</manufacturerId><individualPrice>.7341</individualPrice><dailyCost>.7341</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02218941" sec3="Y"><name>Ratio-Terazosin</name><manufacturerId>RPH</manufacturerId><individualPrice>.2770</individualPrice><dailyCost>.2770</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02230805" sec3="Y"><name>Novo-Terazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2770</individualPrice><dailyCost>.2770</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02233047" sec3="Y"><name>Nu-Terazosin</name><manufacturerId>NXP</manufacturerId><individualPrice>.2770</individualPrice><dailyCost>.2770</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02234502" sec3="Y"><name>Apo-Terazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.2770</individualPrice><dailyCost>.2770</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243518" sec3="Y"><name>PMS-Terazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2770</individualPrice><dailyCost>.2770</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="240800132"><itemNumber>0630</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.3521</price><dailyCost>.3521</dailyCost><drug id="00818682" sec3="Y"><name>Hytrin</name><manufacturerId>ABB</manufacturerId><individualPrice>.9331</individualPrice><dailyCost>.9331</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02218968" sec3="Y"><name>Ratio-Terazosin</name><manufacturerId>RPH</manufacturerId><individualPrice>.3521</individualPrice><dailyCost>.3521</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02230806" sec3="Y"><name>Novo-Terazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3521</individualPrice><dailyCost>.3521</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02233048" sec3="Y"><name>Nu-Terazosin</name><manufacturerId>NXP</manufacturerId><individualPrice>.3521</individualPrice><dailyCost>.3521</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02234503" sec3="Y"><name>Apo-Terazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.3521</individualPrice><dailyCost>.3521</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243519" sec3="Y"><name>PMS-Terazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.3521</individualPrice><dailyCost>.3521</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="240800133"><itemNumber>0631</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.4782</price><dailyCost>.4782</dailyCost><drug id="00818666" sec3="Y"><name>Hytrin</name><manufacturerId>ABB</manufacturerId><individualPrice>1.2672</individualPrice><dailyCost>1.2672</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02218976" sec3="Y"><name>Ratio-Terazosin</name><manufacturerId>RPH</manufacturerId><individualPrice>.4782</individualPrice><dailyCost>.4782</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02230807" sec3="Y"><name>Novo-Terazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.4782</individualPrice><dailyCost>.4782</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02233049" sec3="Y"><name>Nu-Terazosin</name><manufacturerId>NXP</manufacturerId><individualPrice>.4782</individualPrice><dailyCost>.4782</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02234504" sec3="Y"><name>Apo-Terazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.4782</individualPrice><dailyCost>.4782</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243520" sec3="Y"><name>PMS-Terazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.4782</individualPrice><dailyCost>.4782</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="240800213"><itemNumber>0632</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.7000</price><dailyCost>.7000</dailyCost><drug id="00818674" sec3="Y"><name>Hytrin</name><manufacturerId>ABB</manufacturerId><individualPrice>1.8549</individualPrice><dailyCost>1.8549</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02218984" sec3="Y"><name>Ratio-Terazosin</name><manufacturerId>RPH</manufacturerId><individualPrice>.7000</individualPrice><dailyCost>.7000</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02230808" sec3="Y"><name>Novo-Terazosin</name><manufacturerId>NOP</manufacturerId><individualPrice>.7000</individualPrice><dailyCost>.7000</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02233050" sec3="Y"><name>Nu-Terazosin</name><manufacturerId>NXP</manufacturerId><individualPrice>.7000</individualPrice><dailyCost>.7000</dailyCost><listingDate>1999-04-15</listingDate></drug><drug id="02234505" sec3="Y"><name>Apo-Terazosin</name><manufacturerId>APX</manufacturerId><individualPrice>.7000</individualPrice><dailyCost>.7000</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02243521" sec3="Y"><name>PMS-Terazosin</name><manufacturerId>PMS</manufacturerId><individualPrice>.7000</individualPrice><dailyCost>.7000</dailyCost><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01398"><name>TRANDOLAPRIL</name><pcgGroup><pcg9 id="240800228"><itemNumber>0633</itemNumber><strength>1mg</strength><dosageForm>Cap</dosageForm><price>.6901</price><drug id="02231459" sec3="Y"><name>Mavik</name><manufacturerId>ABB</manufacturerId><individualPrice>.6901</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240800229"><itemNumber>0634</itemNumber><strength>2mg</strength><dosageForm>Cap</dosageForm><price>.7931</price><drug id="02231460" sec3="Y"><name>Mavik</name><manufacturerId>ABB</manufacturerId><individualPrice>.7931</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="240800258"><itemNumber>0635</itemNumber><strength>4mg</strength><dosageForm>Cap</dosageForm><price>.9785</price><drug id="02239267" sec3="Y"><name>Mavik</name><manufacturerId>ABB</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01362"><name>VALSARTAN</name><pcgGroup><pcg9 id="240800254"><itemNumber>0636</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>1.1832</price><drug id="02244781" sec3="Y"><name>Diovan</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1832</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="240800255"><itemNumber>0637</itemNumber><strength>160mg</strength><dosageForm>Tab</dosageForm><price>1.1832</price><drug id="02244782" sec3="Y"><name>Diovan</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1832</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="240800272"><itemNumber>0638</itemNumber><strength>320mg</strength><dosageForm>Tab</dosageForm><price>1.1371</price><drug id="02289504" sec3="Y"><name>Diovan</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1371</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01490"><name>VALSARTAN &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="240800244"><itemNumber>0639</itemNumber><strength>80mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>1.1832</price><drug id="02241900" sec3="Y"><name>Diovan-HCT</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1832</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="240800245"><itemNumber>0640</itemNumber><strength>160mg/12.5mg</strength><dosageForm>Tab</dosageForm><price>1.1832</price><drug id="02241901" sec3="Y"><name>Diovan-HCT</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1832</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="240800253"><itemNumber>0641</itemNumber><strength>160mg/25mg</strength><dosageForm>Tab</dosageForm><price>1.1832</price><drug id="02246955" sec3="Y"><name>Diovan-HCT</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1832</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="240800277"><itemNumber>0642</itemNumber><strength>320mg &amp; 12.5mg</strength><dosageForm>Tab</dosageForm><price>1.1646</price><drug id="02308908" dinStatus="N" sec3="Y"><name>Diovan-HCT</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1646</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="240800278"><itemNumber>0643</itemNumber><strength>320mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>1.1646</price><drug id="02308916" dinStatus="N" sec3="Y"><name>Diovan-HCT</name><manufacturerId>NOV</manufacturerId><individualPrice>1.1646</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00319"><name>VERAPAMIL HCL</name><pcgGroup><pcg9 id="240800271"><itemNumber>0644</itemNumber><strength>120mg</strength><dosageForm>LA Tab</dosageForm><drug id="01907123" notABenefit="Y" sec3="Y"><name>Isoptin SR</name><manufacturerId>ABB</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02210347" notABenefit="Y" sec3="Y"><name>Gen-Verapamil SR</name><manufacturerId>GEN</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02246893" notABenefit="Y" sec3="Y"><name>Apo-Verap SR</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="240800197"><itemNumber>0645</itemNumber><strength>180mg</strength><dosageForm>LA Tab</dosageForm><price>.5204</price><dailyCost>.5204</dailyCost><drug id="01934317" sec3="Y"><name>Isoptin SR</name><manufacturerId>ABB</manufacturerId><individualPrice>1.5222</individualPrice><dailyCost>1.5222</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02210355" sec3="Y"><name>Gen-Verapamil SR</name><manufacturerId>GEN</manufacturerId><individualPrice>.5204</individualPrice><dailyCost>.5204</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02246894" sec3="Y"><name>Apo-Verap SR</name><manufacturerId>APX</manufacturerId><individualPrice>.5204</individualPrice><dailyCost>.5204</dailyCost><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="240800128"><itemNumber>0646</itemNumber><strength>240mg</strength><dosageForm>LA Tab</dosageForm><price>.6940</price><dailyCost>.6940</dailyCost><drug id="00742554" sec3="Y"><name>Isoptin SR</name><manufacturerId>ABB</manufacturerId><individualPrice>2.0300</individualPrice><dailyCost>2.0300</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02210363" sec3="Y"><name>Gen-Verapamil SR</name><manufacturerId>GEN</manufacturerId><individualPrice>.6940</individualPrice><dailyCost>.6940</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02211920" sec3="Y"><name>Novo-Veramil SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.6940</individualPrice><dailyCost>.6940</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02237791" sec3="Y"><name>PMS-Verapamil SR</name><manufacturerId>PMS</manufacturerId><individualPrice>.6940</individualPrice><dailyCost>.6940</dailyCost><listingDate>2000-04-17</listingDate></drug><drug id="02246895" sec3="Y"><name>Apo-Verap SR</name><manufacturerId>APX</manufacturerId><individualPrice>.6940</individualPrice><dailyCost>.6940</dailyCost><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="241200000"><name>VASODILATING DRUGS</name><note>Pharmacologic tolerance (tachyphylaxis) may lead to loss of efficacy with chronic multiple (qid) daily dosing of nitrates. Continued relief of angina may require adjustment of dosage interval (e.g., tid).</note><genericName id="00393"><name>BETAHISTINE DIHYDROCHLORIDE</name><pcgGroup><pcg9 id="241200080"><itemNumber>0647</itemNumber><strength>16mg</strength><dosageForm>Tab</dosageForm><drug id="02243878" notABenefit="Y" sec3="Y"><name>Serc</name><manufacturerId>SPH</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02280191" notABenefit="Y" sec3="Y"><name>Novo-Betahistine</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="241200087"><itemNumber>0648</itemNumber><strength>24mg</strength><dosageForm>Tab</dosageForm><drug id="02247998" notABenefit="Y" sec3="Y"><name>Serc</name><manufacturerId>SPH</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02280205" notABenefit="Y" sec3="Y"><name>Novo-Betahistine</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00394"><name>DIPYRIDAMOLE</name><pcgGroup><pcg9 id="241200081"><itemNumber>0649</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><drug id="00067385" notABenefit="Y" sec3="Y"><name>Persantine</name><manufacturerId>BOE</manufacturerId><listingDate>2009-03-02</listingDate></drug><drug id="00895644" notABenefit="Y" sec3="Y"><name>Apo-Dipyridamole</name><manufacturerId>APX</manufacturerId><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="241200090"><itemNumber>0650</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="00067393" notABenefit="Y" sec3="Y"><name>Persantine</name><manufacturerId>BOE</manufacturerId><listingDate>2009-03-02</listingDate></drug><drug id="00895652" notABenefit="Y" sec3="Y"><name>Apo-Dipyridamole</name><manufacturerId>APX</manufacturerId><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="241200091"><itemNumber>0651</itemNumber><strength>75mg</strength><dosageForm>Tab</dosageForm><drug id="00452092" notABenefit="Y" sec3="Y"><name>Persantine</name><manufacturerId>BOE</manufacturerId><listingDate>2009-03-02</listingDate></drug><drug id="00895660" notABenefit="Y" sec3="Y"><name>Apo-Dipyridamole</name><manufacturerId>APX</manufacturerId><listingDate>2009-03-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00400"><name>DIPYRIDAMOLE &amp; ACETYLSALICYLIC ACID</name><pcgGroup lccId="00062"><pcg9 id="241200078"><itemNumber>0652</itemNumber><strength>200mg/25mg</strength><dosageForm>Cap</dosageForm><price>.8230</price><drug id="02242119" sec3="Y" sec12="Y"><name>Aggrenox</name><manufacturerId>BOE</manufacturerId><individualPrice>.8230</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="349">For the secondary prevention of stroke.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00389"><name>ISOSORBIDE DINITRATE</name><pcgGroup><pcg9 id="241200018"><itemNumber>0653</itemNumber><strength>20mg</strength><dosageForm>LA Tab</dosageForm><drug id="00740721" notABenefit="Y" sec3="Y"><name>Cedocard SR</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00786683" notABenefit="Y" sec3="Y"><name>Coradur-SR</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200002"><itemNumber>0654</itemNumber><strength>5mg</strength><dosageForm>SL Tab</dosageForm><price>.0621</price><drug id="00670944" sec3="Y"><name>Apo-ISDN</name><manufacturerId>APX</manufacturerId><individualPrice>.0621</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042606" notABenefit="Y" sec3="Y"><name>Isordil</name><manufacturerId>WAY</manufacturerId><listingDate>1997-02-04</listingDate></drug></pcg9><pcg9 id="241200006"><itemNumber>0655</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0365</price><drug id="00441686" sec3="Y"><name>Apo-ISDN</name><manufacturerId>APX</manufacturerId><individualPrice>.0365</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042622" notABenefit="Y" sec3="Y"><name>Isordil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200005"><itemNumber>0656</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.0857</price><drug id="00441694" sec3="Y"><name>Apo-ISDN</name><manufacturerId>APX</manufacturerId><individualPrice>.0857</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042614" notABenefit="Y" sec3="Y"><name>Isordil</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00401"><name>ISOSORBIDE-5-MONONITRATE</name><pcgGroup><pcg9 id="241200088"><itemNumber>0657</itemNumber><strength>60mg</strength><dosageForm>ER Tab</dosageForm><drug id="02126559" notABenefit="Y" sec3="Y"><name>Imdur</name><manufacturerId>AZC</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02272830" notABenefit="Y" sec3="Y"><name>Apo-ISMN</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02301288" notABenefit="Y" sec3="Y"><name>PMS-ISMN</name><manufacturerId>PMS</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00402"><name>NIMODIPINE</name><pcgGroup lccId="00063"><pcg9 id="241200062"><itemNumber>0658</itemNumber><strength>30mg</strength><dosageForm>SG Cap</dosageForm><price>6.2465</price><drug id="02155923" dinStatus="E" sec3="Y" sec12="Y"><name>Nimotop</name><manufacturerId>BAY</manufacturerId><individualPrice>6.2465</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="42">As adjunctive therapy to improve the neurologic outcome following subarachnoid haemorrhage during the acute management period (within 4 days of haemorrhage).</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="43">As prophylaxis of ischemia if surgery is delayed.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00390"><name>NITROGLYCERIN</name><pcgGroup><pcg9 id="241200073"><itemNumber>0659</itemNumber><strength>2%</strength><dosageForm>Oint</dosageForm><price>.6263</price><drug id="01926454" sec3="Y"><name>Nitrol</name><manufacturerId>PAL</manufacturerId><individualPrice>.6263</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200034"><itemNumber>0660</itemNumber><strength>0.4mg/Hr/20 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.7130</price><drug id="00852384" sec3="Y"><name>Transderm-Nitro</name><manufacturerId>NOV</manufacturerId><individualPrice>.7130</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="241200071"><itemNumber>0661</itemNumber><strength>0.4mg/Hr/20 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6400</price><drug id="01911902" sec3="Y"><name>Nitro-Dur</name><manufacturerId>SCH</manufacturerId><individualPrice>.6400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200059"><itemNumber>0662</itemNumber><strength>0.6mg/Hr/30 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.7130</price><drug id="02046156" sec3="Y"><name>Transderm-Nitro</name><manufacturerId>NOV</manufacturerId><individualPrice>.7130</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="241200072"><itemNumber>0663</itemNumber><strength>0.6mg/Hr/30 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6400</price><drug id="01911929" sec3="Y"><name>Nitro-Dur</name><manufacturerId>SCH</manufacturerId><individualPrice>.6400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200063"><itemNumber>0664</itemNumber><strength>0.4mg/Hr/13.3 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6593</price><drug id="02163527" sec3="Y"><name>Minitran</name><manufacturerId>GRA</manufacturerId><individualPrice>.6593</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200067"><itemNumber>0665</itemNumber><strength>0.4mg/Hr/14 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6400</price><drug id="02230733" sec3="Y"><name>Trinipatch</name><manufacturerId>PAL</manufacturerId><individualPrice>.6400</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="241200064"><itemNumber>0666</itemNumber><strength>0.6mg/Hr/20 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6597</price><drug id="02163535" sec3="Y"><name>Minitran</name><manufacturerId>GRA</manufacturerId><individualPrice>.6597</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200068"><itemNumber>0667</itemNumber><strength>0.6mg/Hr/21 Sq Cm</strength><dosageForm>Patch</dosageForm><price>.6400</price><drug id="02230734" sec3="Y"><name>Trinipatch</name><manufacturerId>PAL</manufacturerId><individualPrice>.6400</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="241200004"><itemNumber>0668</itemNumber><strength>0.3mg</strength><dosageForm>SL Tab</dosageForm><price>.1191</price><drug id="00037613" sec3="Y"><name>Nitrostat</name><manufacturerId>PFI</manufacturerId><individualPrice>.1191</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200003" suppliedBy="L"><itemNumber>0669</itemNumber><strength>0.6mg</strength><dosageForm>SL Tab</dosageForm><price>.1191</price><drug id="00037621" selfMed="Y" sec3="Y"><name>Nitrostat</name><manufacturerId>PFI</manufacturerId><individualPrice>.1191</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="241200017"><itemNumber>0670</itemNumber><strength>0.4mg/Metered Dose</strength><dosageForm>Spray-200 Dose Pk</dosageForm><price>8.4600</price><drug id="01926721" notABenefit="Y" sec3="Y"><name>Nitrolingual</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02243588" sec3="Y"><name>Gen-Nitro SL</name><manufacturerId>GEN</manufacturerId><individualPrice>8.4600</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="241200069"><itemNumber>0671</itemNumber><strength>0.4mg/Metered Dose</strength><dosageForm>Spray-200 Dose Pk</dosageForm><price>13.9900</price><drug id="02231441" sec3="Y"><name>Nitrolingual Pump Spray</name><manufacturerId>SAV</manufacturerId><individualPrice>13.9900</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="280000000"><name>CENTRAL NERVOUS SYSTEM DRUGS</name><pcg6 id="280804000"><name>ANALGESICS NONSTEROIDAL ANTI-INFLAMMATORY AGENTS</name><note>NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.</note><genericName id="00404"><name>ACETYLSALICYLIC ACID</name><pcgGroup><pcg9 id="280804002" suppliedBy="L"><itemNumber>0672</itemNumber><strength>325mg</strength><dosageForm>Ent Tab</dosageForm><price>.0280</price><drug id="00010332" selfMed="Y" sec3="Y"><name>Entrophen</name><manufacturerId>PEN</manufacturerId><individualPrice>.0280</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00216666" notABenefit="Y" sec3="Y"><name>Novasen</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804003" suppliedBy="L"><itemNumber>0673</itemNumber><strength>650mg</strength><dosageForm>Ent Tab</dosageForm><price>.0862</price><drug id="00010340" selfMed="Y" sec3="Y"><name>Entrophen</name><manufacturerId>PEN</manufacturerId><individualPrice>.0862</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00229296" notABenefit="Y" sec3="Y"><name>Novasen</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804001" suppliedBy="L"><itemNumber>0674</itemNumber><strength>325mg</strength><dosageForm>Tab</dosageForm><price>.0585</price><drug id="00036145" notABenefit="Y" sec3="Y"><name>ASA</name><manufacturerId>RPR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00040851" selfMed="Y" sec3="Y"><name>PMS-ASA</name><manufacturerId>PMS</manufacturerId><individualPrice>.0585</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01430"><name>CELECOXIB</name><pcgGroup lccId="00064"><pcg9 id="280804075"><itemNumber>0675</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6624</price><drug id="02239941" sec3="Y" sec12="Y"><name>Celebrex</name><manufacturerId>PFI</manufacturerId><individualPrice>.6624</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="280804076"><itemNumber>0676</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>1.3247</price><drug id="02239942" sec3="Y" sec12="Y"><name>Celebrex</name><manufacturerId>PFI</manufacturerId><individualPrice>1.3247</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><lccNote seq="001" type="T">Osteoarthritis</lccNote><lccNote seq="002" reasonForUseId="316">For patients who have failed an adequate trial of acetaminophen (e.g. acetaminophen 1g QID for several weeks) and have had:</lccNote><lccNote seq="003" type="R">History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS.</lccNote><lccNote seq="004" type="N">The maximum daily dose of celecoxib which will be reimbursed for the treatment of osteoarthritis is 200mg.</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" type="T">Rheumatoid arthritis</lccNote><lccNote seq="007" reasonForUseId="317">For patients who have had:</lccNote><lccNote seq="008" type="R">History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS.</lccNote><lccNote seq="009" type="N">The maximum daily dose of celecoxib which will be reimbursed for the treatment of rheumatoid arthritis is 400mg.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01721"><name>DICLOFENAC POTASSIUM</name><pcgGroup><pcg9 id="280804099"><itemNumber>0677</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="00881635" notABenefit="Y" sec3="Y"><name>Voltaren Rapide</name><manufacturerId>NOV</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02239355" notABenefit="Y" sec3="Y"><name>Novo-Difenac-K</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02239753" notABenefit="Y" sec3="Y"><name>PMS-Diclofenac K</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02243433" notABenefit="Y" sec3="Y"><name>Apo-Diclo Rapide</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02261774" notABenefit="Y" sec3="Y"><name>Sandoz Diclofenac Rapide</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00425"><name>DICLOFENAC SODIUM</name><pcgGroup><pcg9 id="280804005"><itemNumber>0678</itemNumber><strength>25mg</strength><dosageForm>Ent Tab</dosageForm><price>.1563</price><drug id="00514004" notABenefit="Y" sec3="Y"><name>Voltaren</name><manufacturerId>GEI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00808539" sec3="Y"><name>Novo-Difenac</name><manufacturerId>NOP</manufacturerId><individualPrice>.1563</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00839175" sec3="Y"><name>Apo-Diclo</name><manufacturerId>APX</manufacturerId><individualPrice>.1563</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00886017" sec3="Y"><name>Nu-Diclo</name><manufacturerId>NXP</manufacturerId><individualPrice>.1902</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02302616" dinStatus="N" sec3="Y"><name>PMS-Diclofenac</name><manufacturerId>PMS</manufacturerId><individualPrice>.1563</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9><pcg9 id="280804006"><itemNumber>0679</itemNumber><strength>50mg</strength><dosageForm>Ent Tab</dosageForm><price>.3125</price><drug id="00514012" sec3="Y"><name>Voltaren</name><manufacturerId>NOV</manufacturerId><individualPrice>.8256</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00808547" sec3="Y"><name>Novo-Difenac</name><manufacturerId>NOP</manufacturerId><individualPrice>.3125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00839183" sec3="Y"><name>Apo-Diclo</name><manufacturerId>APX</manufacturerId><individualPrice>.3125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00886025" sec3="Y"><name>Nu-Diclo</name><manufacturerId>NXP</manufacturerId><individualPrice>.3125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02302624" dinStatus="N" sec3="Y"><name>PMS-Diclofenac</name><manufacturerId>PMS</manufacturerId><individualPrice>.3125</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9><pcg9 id="280804058"><itemNumber>0680</itemNumber><strength>75mg</strength><dosageForm>LA Tab</dosageForm><price>.4865</price><drug id="00782459" notABenefit="Y" sec3="Y"><name>Voltaren SR</name><manufacturerId>NOV</manufacturerId><listingDate>1998-08-26</listingDate></drug><drug id="02158582" sec3="Y"><name>Novo-Difenac SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.5706</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02162814" sec3="Y"><name>Apo-Diclo SR</name><manufacturerId>APX</manufacturerId><individualPrice>.5706</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231504" sec3="Y"><name>PMS-Diclofenac-SR</name><manufacturerId>PMS</manufacturerId><individualPrice>.5706</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02261901" sec3="Y"><name>Sandoz Diclofenac SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="280804059"><itemNumber>0681</itemNumber><strength>100mg</strength><dosageForm>LA Tab</dosageForm><price>.6502</price><drug id="00590827" notABenefit="Y" sec3="Y"><name>Voltaren SR</name><manufacturerId>NOV</manufacturerId><listingDate>1998-08-26</listingDate></drug><drug id="02048698" sec3="Y"><name>Novo-Difenac SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.7874</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02091194" sec3="Y"><name>Apo-Diclo SR</name><manufacturerId>APX</manufacturerId><individualPrice>.7874</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231505" sec3="Y"><name>PMS-Diclofenac-SR</name><manufacturerId>PMS</manufacturerId><individualPrice>.7874</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02261944" sec3="Y"><name>Sandoz Diclofenac SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6502</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="280804007"><itemNumber>0682</itemNumber><strength>50mg</strength><dosageForm>Sup</dosageForm><price>.4950</price><drug id="00632724" sec3="Y"><name>Voltaren</name><manufacturerId>NOV</manufacturerId><individualPrice>1.2397</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231506" sec3="Y"><name>PMS-Diclofenac</name><manufacturerId>PMS</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02261928" dinStatus="N" sec3="Y"><name>Sandoz Diclofenac</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="280804008"><itemNumber>0683</itemNumber><strength>100mg</strength><dosageForm>Sup</dosageForm><price>.6665</price><drug id="00632732" sec3="Y"><name>Voltaren</name><manufacturerId>NOV</manufacturerId><individualPrice>1.6687</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231508" sec3="Y"><name>PMS-Diclofenac</name><manufacturerId>PMS</manufacturerId><individualPrice>.6665</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02261936" dinStatus="N" sec3="Y"><name>Sandoz Diclofenac</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6665</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00460"><name>DICLOFENAC SODIUM &amp; MISOPROSTOL</name><pcgGroup><pcg9 id="280804049"><itemNumber>0684</itemNumber><strength>50mg &amp; 200mcg</strength><dosageForm>Tab</dosageForm><price>.5871</price><drug id="01917056" sec3="Y"><name>Arthrotec 50</name><manufacturerId>PFI</manufacturerId><individualPrice>.5871</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804056"><itemNumber>0685</itemNumber><strength>75mg &amp; 200mcg</strength><dosageForm>Tab</dosageForm><price>.7991</price><drug id="02229837" sec3="Y"><name>Arthrotec 75</name><manufacturerId>PFI</manufacturerId><individualPrice>.7991</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00431"><name>DIFLUNISAL</name><pcgGroup><pcg9 id="280804009"><itemNumber>0686</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.2824</price><drug id="00587699" notABenefit="Y" sec3="Y"><name>Dolobid</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02039486" sec3="Y"><name>Apo-Diflunisal</name><manufacturerId>APX</manufacturerId><individualPrice>.2824</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02048493" sec3="Y"><name>Novo-Diflunisal</name><manufacturerId>NOP</manufacturerId><individualPrice>.2824</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804010"><itemNumber>0687</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.5363</price><drug id="00576131" notABenefit="Y" sec3="Y"><name>Dolobid</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02039494" sec3="Y"><name>Apo-Diflunisal</name><manufacturerId>APX</manufacturerId><individualPrice>.5363</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00465"><name>ETODOLAC</name><pcgGroup><pcg9 id="280804057"><itemNumber>0688</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><drug id="02142023" notABenefit="Y" sec3="Y"><name>Ultradol</name><manufacturerId>PGP</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02232317" notABenefit="Y" sec3="Y"><name>Apo-Etodolac</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="280804051"><itemNumber>0689</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><drug id="02142031" notABenefit="Y" sec3="Y"><name>Ultradol</name><manufacturerId>PGP</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02232318" notABenefit="Y" sec3="Y"><name>Apo-Etodolac</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00435"><name>FLOCTAFENINE</name><pcgGroup><pcg9 id="280804013"><itemNumber>0690</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.4175</price><drug id="02017628" notABenefit="Y" sec3="Y"><name>Idarac</name><manufacturerId>SAO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02244680" sec3="Y"><name>Apo-Floctafenine</name><manufacturerId>APX</manufacturerId><individualPrice>.4175</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="280804014"><itemNumber>0691</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.8123</price><drug id="02017636" notABenefit="Y" sec3="Y"><name>Idarac</name><manufacturerId>SAO</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02244681" sec3="Y"><name>Apo-Floctafenine</name><manufacturerId>APX</manufacturerId><individualPrice>.8123</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00433"><name>FLURBIPROFEN</name><pcgGroup><pcg9 id="280804017"><itemNumber>0692</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2221</price><drug id="00647942" sec3="Y"><name>Ansaid</name><manufacturerId>PFI</manufacturerId><individualPrice>.5329</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01912046" sec3="Y"><name>Apo-Flurbiprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.2221</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02020661" sec3="Y"><name>Nu-Flurbiprofen</name><manufacturerId>NXP</manufacturerId><individualPrice>.2221</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100509" sec3="Y"><name>Novo-Flurprofen</name><manufacturerId>NOP</manufacturerId><individualPrice>.2221</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804018"><itemNumber>0693</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.3039</price><drug id="00600792" sec3="Y"><name>Ansaid</name><manufacturerId>PFI</manufacturerId><individualPrice>.6976</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01912038" sec3="Y"><name>Apo-Flurbiprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.3039</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02020688" sec3="Y"><name>Nu-Flurbiprofen</name><manufacturerId>NXP</manufacturerId><individualPrice>.3039</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100517" sec3="Y"><name>Novo-Flurprofen</name><manufacturerId>NOP</manufacturerId><individualPrice>.3039</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00407"><name>IBUPROFEN</name><pcgGroup><pcg9 id="280804019"><itemNumber>0694</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.0243</price><drug id="00252409" notABenefit="Y" sec3="Y"><name>Motrin</name><manufacturerId>UPJ</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00441643" sec3="Y"><name>Apo-Ibuprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.0243</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00629324" sec3="Y"><name>Novo-Profen</name><manufacturerId>NOP</manufacturerId><individualPrice>.0243</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804020"><itemNumber>0695</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.0284</price><drug id="00327794" notABenefit="Y" sec3="Y"><name>Motrin</name><manufacturerId>UPJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441651" sec3="Y"><name>Apo-Ibuprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.0284</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804021"><itemNumber>0696</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.0372</price><drug id="00364142" sec3="Y"><name>Motrin</name><manufacturerId>UPJ</manufacturerId><individualPrice>.1871</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00506052" sec3="Y"><name>Apo-Ibuprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.0372</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00629340" sec3="Y"><name>Novo-Profen</name><manufacturerId>NOP</manufacturerId><individualPrice>.0372</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804022"><itemNumber>0697</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>.0465</price><drug id="00484911" notABenefit="Y" sec3="Y"><name>Motrin</name><manufacturerId>UPJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00585114" sec3="Y"><name>Apo-Ibuprofen</name><manufacturerId>APX</manufacturerId><individualPrice>.0465</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00629359" sec3="Y"><name>Novo-Profen</name><manufacturerId>NOP</manufacturerId><individualPrice>.0465</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00408"><name>INDOMETHACIN</name><pcgGroup><pcg9 id="280804023"><itemNumber>0698</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.0871</price><drug id="00016039" notABenefit="Y" sec3="Y"><name>Indocid</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00337420" sec3="Y"><name>Novo-Methacin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0871</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00611158" sec3="Y"><name>Apo-Indomethacin</name><manufacturerId>APX</manufacturerId><individualPrice>.0871</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865850" sec3="Y"><name>Nu-Indo</name><manufacturerId>NXP</manufacturerId><individualPrice>.0871</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804024"><itemNumber>0699</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.1511</price><drug id="00016047" notABenefit="Y" sec3="Y"><name>Indocid</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00337439" sec3="Y"><name>Novo-Methacin</name><manufacturerId>NOP</manufacturerId><individualPrice>.1511</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00611166" sec3="Y"><name>Apo-Indomethacin</name><manufacturerId>APX</manufacturerId><individualPrice>.1511</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865869" sec3="Y"><name>Nu-Indo</name><manufacturerId>NXP</manufacturerId><individualPrice>.1511</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804025"><itemNumber>0700</itemNumber><strength>50mg</strength><dosageForm>Sup</dosageForm><price>.8200</price><drug id="00594466" notABenefit="Y" sec3="Y"><name>Indocid</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02231799" sec3="Y"><name>Sab-Indomethacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8200</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="280804026"><itemNumber>0701</itemNumber><strength>100mg</strength><dosageForm>Sup</dosageForm><price>.8919</price><drug id="00016233" notABenefit="Y" sec3="Y"><name>Indocid</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01934139" sec3="Y"><name>Ratio-Indomethacin</name><manufacturerId>RPH</manufacturerId><individualPrice>.8919</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231800" sec3="Y"><name>Sab-Indomethacin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8919</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00420"><name>KETOPROFEN</name><pcgGroup><pcg9 id="280804027"><itemNumber>0702</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.3373</price><drug id="00790427" sec3="Y"><name>Apo-Keto</name><manufacturerId>APX</manufacturerId><individualPrice>.3373</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926403" notABenefit="Y" sec3="Y"><name>Orudis</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804028"><itemNumber>0703</itemNumber><strength>50mg</strength><dosageForm>Ent Tab</dosageForm><price>.3373</price><drug id="00790435" sec3="Y"><name>Apo-Keto-E</name><manufacturerId>APX</manufacturerId><individualPrice>.3373</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926381" notABenefit="Y" sec3="Y"><name>Orudis E-50</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804029"><itemNumber>0704</itemNumber><strength>100mg</strength><dosageForm>Ent Tab</dosageForm><price>.6823</price><drug id="00761680" notABenefit="Y" sec3="Y"><name>Rhodis-EC</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00842664" sec3="Y"><name>Apo-Keto-E</name><manufacturerId>APX</manufacturerId><individualPrice>.6823</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926365" notABenefit="Y" sec3="Y"><name>Orudis E-100</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804060"><itemNumber>0705</itemNumber><strength>200mg</strength><dosageForm>LA Tab</dosageForm><price>1.3890</price><drug id="01926373" notABenefit="Y" sec3="Y"><name>Orudis SR-200</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02172577" sec3="Y"><name>Apo-Keto SR</name><manufacturerId>APX</manufacturerId><individualPrice>1.3890</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280804030"><itemNumber>0706</itemNumber><strength>100mg</strength><dosageForm>Sup</dosageForm><price>.9930</price><drug id="01926411" notABenefit="Y" sec3="Y"><name>Orudis</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02015951" sec3="Y"><name>PMS-Ketoprofen</name><manufacturerId>PMS</manufacturerId><individualPrice>.9930</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00442"><name>KETOROLAC TROMETHAMINE</name><pcgGroup><pcg9 id="280804105"><itemNumber>0707</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="02162660" notABenefit="Y" sec3="Y"><name>Toradol</name><manufacturerId>HLR</manufacturerId><listingDate>2008-10-01</listingDate></drug><drug id="02229080" notABenefit="Y" sec3="Y"><name>Apo-Ketorolac</name><manufacturerId>APX</manufacturerId><listingDate>2008-10-01</listingDate></drug><drug id="02230201" notABenefit="Y" sec3="Y"><name>Novo-Ketorolac</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00427"><name>MEFENAMIC ACID</name><pcgGroup><pcg9 id="280804031"><itemNumber>0708</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.2626</price><drug id="00155225" notABenefit="Y" sec3="Y"><name>Ponstan</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02229452" sec3="Y"><name>Apo-Mefenamic</name><manufacturerId>APX</manufacturerId><individualPrice>.2626</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02229569" sec3="Y"><name>Nu-Mefenamic</name><manufacturerId>NXP</manufacturerId><individualPrice>.2626</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02231208" dinStatus="E" sec3="Y"><name>PMS-Mefenamic Acid</name><manufacturerId>PMS</manufacturerId><individualPrice>.2626</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01501"><name>MELOXICAM</name><pcgGroup><pcg9 id="280804083"><itemNumber>0709</itemNumber><strength>7.5mg</strength><dosageForm>Tab</dosageForm><price>.3900</price><drug id="02242785" sec3="Y"><name>Mobicox</name><manufacturerId>BOE</manufacturerId><individualPrice>.8011</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02247889" sec3="Y"><name>Ratio-Meloxicam</name><manufacturerId>RPH</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248267" sec3="Y"><name>PMS-Meloxicam</name><manufacturerId>PMS</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248973" sec3="Y"><name>Apo-Meloxicam</name><manufacturerId>APX</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02250012" sec3="Y"><name>Co-Meloxicam</name><manufacturerId>COB</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02255987" sec3="Y"><name>Gen-Meloxicam</name><manufacturerId>GEN</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02258315" sec3="Y"><name>Novo-Meloxicam</name><manufacturerId>NOP</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2004-11-16</listingDate></drug></pcg9><pcg9 id="280804084"><itemNumber>0710</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.4500</price><drug id="02242786" sec3="Y"><name>Mobicox</name><manufacturerId>BOE</manufacturerId><individualPrice>.9243</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02248031" sec3="Y"><name>Ratio-Meloxicam</name><manufacturerId>RPH</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248268" sec3="Y"><name>PMS-Meloxicam</name><manufacturerId>PMS</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248974" sec3="Y"><name>Apo-Meloxicam</name><manufacturerId>APX</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02250020" sec3="Y"><name>Co-Meloxicam</name><manufacturerId>COB</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02255995" sec3="Y"><name>Gen-Meloxicam</name><manufacturerId>GEN</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02258323" sec3="Y"><name>Novo-Meloxicam</name><manufacturerId>NOP</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2004-11-16</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00456"><name>NABUMETONE</name><pcgGroup><pcg9 id="280804072"><itemNumber>0711</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><drug id="02083531" notABenefit="Y" sec3="Y"><name>Relafen</name><manufacturerId>GSK</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02238639" notABenefit="Y" sec3="Y"><name>Apo-Nabumetone</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02240867" notABenefit="Y" sec3="Y"><name>Novo-Nabumetone</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02242912" notABenefit="Y" sec3="Y"><name>Sandoz Nabumetone</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02244563" notABenefit="Y" sec3="Y"><name>Mylan-Nabumetone</name><manufacturerId>MYL</manufacturerId><listingDate>2007-07-12</listingDate></drug></pcg9><pcg9 id="280804085"><itemNumber>0712</itemNumber><strength>750mg</strength><dosageForm>Tab</dosageForm><drug id="02083558" notABenefit="Y" sec3="Y"><name>Relafen</name><manufacturerId>GSK</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02240868" notABenefit="Y" sec3="Y"><name>Novo-Nabumetone</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00416"><name>NAPROXEN</name><pcgGroup><pcg9 id="280804100"><itemNumber>0713</itemNumber><strength>250mg</strength><dosageForm>Ent Tab</dosageForm><drug id="02162792" notABenefit="Y" sec3="Y"><name>Naprosyn E</name><manufacturerId>HLR</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243312" notABenefit="Y" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02243431" notABenefit="Y" sec3="Y"><name>Gen-Naproxen EC</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02246699" notABenefit="Y" sec3="Y"><name>Apo-Naproxen EC</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="280804101"><itemNumber>0714</itemNumber><strength>375mg</strength><dosageForm>Ent Tab</dosageForm><drug id="02162415" notABenefit="Y" sec3="Y"><name>Naprosyn E</name><manufacturerId>HLR</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243313" notABenefit="Y" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02243432" notABenefit="Y" sec3="Y"><name>Gen-Naproxen EC</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02246700" notABenefit="Y" sec3="Y"><name>Apo-Naproxen EC</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02294702" notABenefit="Y" sec3="Y"><name>PMS-Naproxen EC</name><manufacturerId>PMS</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="280804102"><itemNumber>0715</itemNumber><strength>500mg</strength><dosageForm>Ent Tab</dosageForm><drug id="02162423" notABenefit="Y" sec3="Y"><name>Naprosyn E</name><manufacturerId>HLR</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02241024" notABenefit="Y" sec3="Y"><name>Gen-Naproxen EC</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243314" notABenefit="Y" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02246701" notABenefit="Y" sec3="Y"><name>Apo-Naproxen EC</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02294710" notABenefit="Y" sec3="Y"><name>PMS-Naproxen EC</name><manufacturerId>PMS</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="280804054"><itemNumber>0716</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0614</price><drug id="02162431" sec3="Y"><name>Naprosyn</name><manufacturerId>HLR</manufacturerId><individualPrice>.0614</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804066"><itemNumber>0717</itemNumber><strength>750mg</strength><dosageForm>SR Tab</dosageForm><price>1.0048</price><drug id="02162466" notABenefit="Y" sec3="Y"><name>Naprosyn SR</name><manufacturerId>HLR</manufacturerId><listingDate>2000-04-17</listingDate></drug><drug id="02177072" sec3="Y"><name>Apo-Naproxen SR</name><manufacturerId>APX</manufacturerId><individualPrice>1.0048</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="280804037"><itemNumber>0718</itemNumber><strength>500mg</strength><dosageForm>Sup</dosageForm><price>.4775</price><drug id="02017237" sec3="Y"><name>PMS-Naproxen</name><manufacturerId>PMS</manufacturerId><individualPrice>.4775</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02162458" notABenefit="Y" sec3="Y"><name>Naprosyn</name><manufacturerId>HLR</manufacturerId><listingDate>2000-04-17</listingDate></drug><drug id="02230477" dinStatus="E" sec3="Y"><name>Naproxen</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4775</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="280804033"><itemNumber>0719</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><price>.0781</price><drug id="00299413" notABenefit="Y" sec3="Y"><name>Naprosyn</name><manufacturerId>SYN</manufacturerId><listingDate>2001-02-28</listingDate></drug><drug id="00522678" sec3="Y"><name>Apo-Naproxen</name><manufacturerId>APX</manufacturerId><individualPrice>.0781</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804034"><itemNumber>0720</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.1068</price><drug id="00522651" sec3="Y"><name>Apo-Naproxen</name><manufacturerId>APX</manufacturerId><individualPrice>.1068</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00565350" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><individualPrice>.1068</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865648" sec3="Y"><name>Nu-Naprox</name><manufacturerId>NXP</manufacturerId><individualPrice>.1068</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02162474" notABenefit="Y" sec3="Y"><name>Naprosyn</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804035"><itemNumber>0721</itemNumber><strength>375mg</strength><dosageForm>Tab</dosageForm><price>.1458</price><drug id="00600806" sec3="Y"><name>Apo-Naproxen</name><manufacturerId>APX</manufacturerId><individualPrice>.1458</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00627097" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><individualPrice>.1458</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865656" sec3="Y"><name>Nu-Naprox</name><manufacturerId>NXP</manufacturerId><individualPrice>.1458</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02162482" notABenefit="Y" sec3="Y"><name>Naprosyn</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804036"><itemNumber>0722</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.2110</price><drug id="00589861" sec3="Y"><name>Novo-Naprox</name><manufacturerId>NOP</manufacturerId><individualPrice>.2110</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00592277" sec3="Y"><name>Apo-Naproxen</name><manufacturerId>APX</manufacturerId><individualPrice>.2110</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865664" sec3="Y"><name>Nu-Naprox</name><manufacturerId>NXP</manufacturerId><individualPrice>.2110</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02162490" notABenefit="Y" sec3="Y"><name>Naprosyn</name><manufacturerId>HLR</manufacturerId><listingDate>2000-04-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00446"><name>NAPROXEN SODIUM</name><pcgGroup><pcg9 id="280804103"><itemNumber>0723</itemNumber><strength>275mg</strength><dosageForm>Tab</dosageForm><drug id="00784354" notABenefit="Y" sec3="Y"><name>Apo-Napro-Na</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02162725" notABenefit="Y" sec3="Y"><name>Anaprox</name><manufacturerId>HLR</manufacturerId><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="280804104"><itemNumber>0724</itemNumber><strength>550mg</strength><dosageForm>Tab</dosageForm><drug id="01940309" notABenefit="Y" sec3="Y"><name>Apo-Napro-Na DS</name><manufacturerId>APX</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02162717" notABenefit="Y" sec3="Y"><name>Anaprox DS</name><manufacturerId>HLR</manufacturerId><listingDate>2007-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01317"><name>OXAPROZIN.</name><pcgGroup><pcg9 id="280804055"><itemNumber>0725</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><drug id="02027860" notABenefit="Y" sec3="Y"><name>Daypro</name><manufacturerId>HLR</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02243661" notABenefit="Y" sec3="Y"><name>Apo-Oxaprozin</name><manufacturerId>APX</manufacturerId><listingDate>2007-07-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00429"><name>PIROXICAM</name><pcgGroup><pcg9 id="280804038"><itemNumber>0726</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.4147</price><drug id="00525596" notABenefit="Y" sec3="Y"><name>Feldene</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00642886" sec3="Y"><name>Apo-Piroxicam</name><manufacturerId>APX</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00695718" sec3="Y"><name>Novo-Pirocam</name><manufacturerId>NOP</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865761" sec3="Y"><name>Nu-Pirox</name><manufacturerId>NXP</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171813" sec3="Y"><name>Gen-Piroxicam</name><manufacturerId>GEN</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804039"><itemNumber>0727</itemNumber><strength>20mg</strength><dosageForm>Cap</dosageForm><price>.7158</price><drug id="00525618" notABenefit="Y" sec3="Y"><name>Feldene</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00642894" sec3="Y"><name>Apo-Piroxicam</name><manufacturerId>APX</manufacturerId><individualPrice>.7158</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00695696" sec3="Y"><name>Novo-Pirocam</name><manufacturerId>NOP</manufacturerId><individualPrice>.7158</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865788" sec3="Y"><name>Nu-Pirox</name><manufacturerId>NXP</manufacturerId><individualPrice>.7158</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171821" sec3="Y"><name>Gen-Piroxicam</name><manufacturerId>GEN</manufacturerId><individualPrice>.7158</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804041"><itemNumber>0728</itemNumber><strength>20mg</strength><dosageForm>Sup</dosageForm><price>1.6460</price><drug id="00632716" notABenefit="Y" sec3="Y"><name>Feldene</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02154463" sec3="Y"><name>PMS-Piroxicam</name><manufacturerId>PMS</manufacturerId><individualPrice>1.6460</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00422"><name>SULINDAC</name><pcgGroup><pcg9 id="280804042"><itemNumber>0729</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.3824</price><drug id="00456888" notABenefit="Y" sec3="Y"><name>Clinoril</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00745588" sec3="Y"><name>Novo-Sundac</name><manufacturerId>NOP</manufacturerId><individualPrice>.3824</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00778354" sec3="Y"><name>Apo-Sulin</name><manufacturerId>APX</manufacturerId><individualPrice>.3824</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042576" sec3="Y"><name>Nu-Sulindac</name><manufacturerId>NXP</manufacturerId><individualPrice>.3824</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804043"><itemNumber>0730</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.4840</price><drug id="00432369" notABenefit="Y" sec3="Y"><name>Clinoril</name><manufacturerId>FRS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00745596" sec3="Y"><name>Novo-Sundac</name><manufacturerId>NOP</manufacturerId><individualPrice>.4840</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00778362" sec3="Y"><name>Apo-Sulin</name><manufacturerId>APX</manufacturerId><individualPrice>.4840</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042584" sec3="Y"><name>Nu-Sulindac</name><manufacturerId>NXP</manufacturerId><individualPrice>.4840</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00434"><name>TIAPROFENIC ACID</name><pcgGroup><pcg9 id="280804044"><itemNumber>0731</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.3437</price><drug id="01989782" notABenefit="Y" sec3="Y"><name>Surgam</name><manufacturerId>HRU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02136112" sec3="Y"><name>Apo-Tiaprofenic</name><manufacturerId>APX</manufacturerId><individualPrice>.3437</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02179679" sec3="Y"><name>Novo-Tiaprofenic</name><manufacturerId>NOP</manufacturerId><individualPrice>.3437</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280804045"><itemNumber>0732</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.3258</price><drug id="02136120" sec3="Y"><name>Apo-Tiaprofenic</name><manufacturerId>APX</manufacturerId><individualPrice>.3258</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02179687" sec3="Y"><name>Novo-Tiaprofenic</name><manufacturerId>NOP</manufacturerId><individualPrice>.3258</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02221950" notABenefit="Y" sec3="Y"><name>Surgam</name><manufacturerId>SAV</manufacturerId><listingDate>1999-01-07</listingDate></drug><drug id="02230828" sec3="Y"><name>PMS-Tiaprofenic</name><manufacturerId>PMS</manufacturerId><individualPrice>.3258</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="280808000"><name>ANALGESICS OPIATE AGONISTS</name><note>Narcotic analgesics can produce dependence and may be abused. Physical dependence, psychological dependence and tolerance may develop. Prescribers are cautioned about ordering these drugs for patients with a history of either emotional disturbances or drug abuse, including alcohol.</note><genericName id="00421"><name>ACETAMINOPHEN &amp; CODEINE PHOSPHATE</name><pcgGroup><pcg9 id="280808001"><itemNumber>0733</itemNumber><strength>160mg &amp; 8mg/5mL</strength><dosageForm>O/L</dosageForm><price>.0586</price><drug id="00816027" sec3="Y"><name>PMS-Acetaminophen With Codeine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0586</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02163942" notABenefit="Y" sec3="Y"><name>Tylenol With Codeine</name><manufacturerId>JNO</manufacturerId><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="280808002"><itemNumber>0734</itemNumber><strength>300mg &amp; 30mg</strength><dosageForm>Tab</dosageForm><price>.1300</price><drug id="00608882" sec3="Y"><name>Ratio-Emtec</name><manufacturerId>RPH</manufacturerId><individualPrice>.1300</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00666130" notABenefit="Y" sec3="Y"><name>Empracet-30</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808003"><itemNumber>0735</itemNumber><strength>300mg &amp; 60mg</strength><dosageForm>Tab</dosageForm><price>.1384</price><drug id="00621463" sec3="Y"><name>Ratio-Lenoltec No.4</name><manufacturerId>RPH</manufacturerId><individualPrice>.1384</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163918" sec3="Y"><name>Tylenol No.4</name><manufacturerId>JNO</manufacturerId><individualPrice>.1384</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00415"><name>ACETAMINOPHEN COMPOUND WITH CODEINE</name><pcgGroup><pcg9 id="280808004"><itemNumber>0736</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.0476</price><drug id="00293504" notABenefit="Y" sec3="Y"><name>Atasol-15</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00653241" sec3="Y"><name>Ratio-Lenoltec No.2</name><manufacturerId>RPH</manufacturerId><individualPrice>.0476</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163934" sec3="Y"><name>Tylenol No.2</name><manufacturerId>JNO</manufacturerId><individualPrice>.0476</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808005"><itemNumber>0737</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.0524</price><drug id="00293512" notABenefit="Y" sec3="Y"><name>Atasol-30</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00653276" sec3="Y"><name>Ratio-Lenoltec No.3</name><manufacturerId>RPH</manufacturerId><individualPrice>.0524</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163926" sec3="Y"><name>Tylenol No.3</name><manufacturerId>JNO</manufacturerId><individualPrice>.0524</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01743"><name>ACETYLSALICYLIC ACID &amp; BUTALBITAL &amp; CAFFEINE</name><pcgGroup><pcg9 id="280808136"><itemNumber>0738</itemNumber><strength>330mg &amp; 50mg &amp; 40mg</strength><dosageForm>Cap</dosageForm><drug id="00226327" notABenefit="Y" sec3="Y"><name>Fiorinal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="00608238" notABenefit="Y" sec3="Y"><name>Ratio-Tecnal</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01744"><name>ACETYLSALICYLIC ACID &amp; BUTALBITAL &amp; CAFFEINE &amp; CODEINE PHOSPHATE</name><pcgGroup><pcg9 id="280808168"><itemNumber>0739</itemNumber><strength>330mg &amp; 50mg &amp; 40mg &amp; 15mg</strength><dosageForm>Cap</dosageForm><drug id="00176192" notABenefit="Y" sec3="Y"><name>Fiorinal C1/4</name><manufacturerId>NOV</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="00608203" notABenefit="Y" sec3="Y"><name>Ratio-Tecnal C1/4</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="280808138"><itemNumber>0740</itemNumber><strength>330mg &amp; 50mg &amp; 40mg &amp; 30mg</strength><dosageForm>Cap</dosageForm><drug id="00176206" notABenefit="Y" sec3="Y"><name>Fiorinal C1/2</name><manufacturerId>NOV</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="00608181" notABenefit="Y" sec3="Y"><name>Ratio-Tecnal C1/2</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00405"><name>ACETYLSALICYLIC ACID COMPOUND WITH CODEINE</name><pcgGroup><pcg9 id="280808007"><itemNumber>0741</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.1730</price><drug id="02238645" sec3="Y"><name>292</name><manufacturerId>PEN</manufacturerId><individualPrice>.1730</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00406"><name>CODEINE PHOSPHATE</name><pcgGroup><pcg9 id="280808009"><itemNumber>0742</itemNumber><strength>5mg/mL</strength><dosageForm>O/L</dosageForm><price>.0196</price><drug id="00779474" sec3="Y"><name>Ratio-Codeine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0196</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808010"><itemNumber>0743</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.0542</price><drug id="00593435" sec3="Y"><name>Ratio-Codeine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0542</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00779458" sec3="Y"><name>Codeine</name><manufacturerId>ROG</manufacturerId><individualPrice>.0542</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808011"><itemNumber>0744</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.0773</price><drug id="00593451" sec3="Y"><name>Ratio-Codeine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0773</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00462"><name>CODEINE SULFATE TRIHYDRATE &amp; MONOHYDRATE</name><pcgGroup lccId="00066"><pcg9 id="280808101"><itemNumber>0745</itemNumber><strength>50mg</strength><dosageForm>CR Tab</dosageForm><price>.3050</price><drug id="02230302" sec3="Y" sec12="Y"><name>Codeine Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.3050</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="280808107"><itemNumber>0746</itemNumber><strength>100mg</strength><dosageForm>CR Tab</dosageForm><price>.6100</price><drug id="02163748" sec3="Y" sec12="Y"><name>Codeine Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.6100</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="280808108"><itemNumber>0747</itemNumber><strength>150mg</strength><dosageForm>CR Tab</dosageForm><price>.9220</price><drug id="02163780" sec3="Y" sec12="Y"><name>Codeine Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.9220</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="280808109"><itemNumber>0748</itemNumber><strength>200mg</strength><dosageForm>CR Tab</dosageForm><price>1.2200</price><drug id="02163799" sec3="Y" sec12="Y"><name>Codeine Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.2200</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="201">For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a listed long-acting opioid.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00466"><name>FENTANYL TRANSDERMAL SYSTEM</name><pcgGroup><pcg9 id="280808169"><itemNumber>0749</itemNumber><strength>12mcg/hr</strength><dosageForm>Trans Patch</dosageForm><drug id="02280345" notABenefit="Y" sec3="Y"><name>Duragesic 12</name><manufacturerId>JNO</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="02311925" notABenefit="Y" sec3="Y"><name>Ratio-Fentanyl</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="02327112" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Fentanyl MTX Patch</name><manufacturerId>SDZ</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02330105" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ran-Fentanyl Matrix Patch</name><manufacturerId>RAN</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00067"><pcg9 id="280808079"><itemNumber>0750</itemNumber><strength>25mcg/hr</strength><dosageForm>Trans Patch</dosageForm><price>4.2500</price><drug id="01937383" sec3="Y" sec12="Y"><name>Duragesic 25</name><manufacturerId>JNO</manufacturerId><individualPrice>10.4520</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02249391" sec3="Y" sec12="Y"><name>Ran-Fentanyl</name><manufacturerId>RAN</manufacturerId><individualPrice>4.2500</individualPrice><listingDate>2006-10-23</listingDate></drug><drug id="02275813" notABenefit="Y" sec3="Y"><name>Duragesic Mat</name><manufacturerId>JNO</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02282941" sec3="Y" sec12="Y"><name>Ratio-Fentanyl</name><manufacturerId>RPH</manufacturerId><individualPrice>4.2500</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02314630" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Fentanyl</name><manufacturerId>NOP</manufacturerId><individualPrice>4.2500</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02327120" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Fentanyl MTX Patch</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.2500</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02330113" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Fentanyl Matrix Patch</name><manufacturerId>RAN</manufacturerId><individualPrice>4.2500</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="280808080"><itemNumber>0751</itemNumber><strength>50mcg/hr</strength><dosageForm>Trans Patch</dosageForm><price>8.0000</price><drug id="01937391" sec3="Y" sec12="Y"><name>Duragesic 50</name><manufacturerId>JNO</manufacturerId><individualPrice>19.6680</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02249413" sec3="Y" sec12="Y"><name>Ran-Fentanyl</name><manufacturerId>RAN</manufacturerId><individualPrice>8.0000</individualPrice><listingDate>2006-10-23</listingDate></drug><drug id="02275821" notABenefit="Y" sec3="Y"><name>Duragesic Mat</name><manufacturerId>JNO</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02282968" sec3="Y" sec12="Y"><name>Ratio-Fentanyl</name><manufacturerId>RPH</manufacturerId><individualPrice>8.0000</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02314649" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Fentanyl</name><manufacturerId>NOP</manufacturerId><individualPrice>8.0000</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02327147" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Fentanyl MTX Patch</name><manufacturerId>SDZ</manufacturerId><individualPrice>8.0000</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02330121" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Fentanyl Matrix Patch</name><manufacturerId>RAN</manufacturerId><individualPrice>8.0000</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="280808081"><itemNumber>0752</itemNumber><strength>75mcg/hr</strength><dosageForm>Trans Patch</dosageForm><price>11.2500</price><drug id="01937405" sec3="Y" sec12="Y"><name>Duragesic 75</name><manufacturerId>JNO</manufacturerId><individualPrice>27.6620</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02249421" sec3="Y" sec12="Y"><name>Ran-Fentanyl</name><manufacturerId>RAN</manufacturerId><individualPrice>11.2500</individualPrice><listingDate>2006-10-23</listingDate></drug><drug id="02275848" notABenefit="Y" sec3="Y"><name>Duragesic Mat</name><manufacturerId>JNO</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02282976" sec3="Y" sec12="Y"><name>Ratio-Fentanyl</name><manufacturerId>RPH</manufacturerId><individualPrice>11.2500</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02314657" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Fentanyl</name><manufacturerId>NOP</manufacturerId><individualPrice>11.2500</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02327155" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Fentanyl MTX Patch</name><manufacturerId>SDZ</manufacturerId><individualPrice>11.2500</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02330148" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Fentanyl Matrix Patch</name><manufacturerId>RAN</manufacturerId><individualPrice>11.2500</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="280808082"><itemNumber>0753</itemNumber><strength>100mcg/hr</strength><dosageForm>Trans Patch</dosageForm><price>14.0000</price><drug id="01937413" sec3="Y" sec12="Y"><name>Duragesic 100</name><manufacturerId>JNO</manufacturerId><individualPrice>34.4320</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02249448" sec3="Y" sec12="Y"><name>Ran-Fentanyl</name><manufacturerId>RAN</manufacturerId><individualPrice>14.0000</individualPrice><listingDate>2006-10-23</listingDate></drug><drug id="02275856" notABenefit="Y" sec3="Y"><name>Duragesic Mat</name><manufacturerId>JNO</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02282984" sec3="Y" sec12="Y"><name>Ratio-Fentanyl</name><manufacturerId>RPH</manufacturerId><individualPrice>14.0000</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02314665" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Fentanyl</name><manufacturerId>NOP</manufacturerId><individualPrice>14.0000</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02327163" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Fentanyl MTX Patch</name><manufacturerId>SDZ</manufacturerId><individualPrice>14.0000</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02330156" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Fentanyl Matrix Patch</name><manufacturerId>RAN</manufacturerId><individualPrice>14.0000</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="201">For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a listed long-acting opioid.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00432"><name>HYDROMORPHONE HCL</name><pcgGroup><pcg9 id="280808097"><itemNumber>0754</itemNumber><strength>3mg</strength><dosageForm>CR Cap</dosageForm><price>.6510</price><drug id="02125323" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.6510</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808098"><itemNumber>0755</itemNumber><strength>6mg</strength><dosageForm>CR Cap</dosageForm><price>.9770</price><drug id="02125331" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.9770</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808099"><itemNumber>0756</itemNumber><strength>12mg</strength><dosageForm>CR Cap</dosageForm><price>1.6920</price><drug id="02125366" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.6920</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808123"><itemNumber>0757</itemNumber><strength>18mg</strength><dosageForm>CR Cap</dosageForm><price>2.4400</price><drug id="02243562" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>2.4400</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="280808100"><itemNumber>0758</itemNumber><strength>24mg</strength><dosageForm>CR Cap</dosageForm><price>3.1240</price><drug id="02125382" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>3.1240</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808102"><itemNumber>0759</itemNumber><strength>30mg</strength><dosageForm>CR Cap</dosageForm><price>3.7420</price><drug id="02125390" sec3="Y"><name>Hydromorph Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>3.7420</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="280808073"><itemNumber>0760</itemNumber><strength>20mg/mL</strength><dosageForm>Inj</dosageForm><price>3.6680</price><drug id="02145936" sec3="Y"><name>Hydromorphone HP-20</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.6680</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02146118" sec3="Y"><name>Dilaudid-HP-Plus</name><manufacturerId>ABB</manufacturerId><individualPrice>3.6680</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808014"><itemNumber>0761</itemNumber><strength>2mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>.9450</price><drug id="00627100" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.9500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02145901" sec3="Y"><name>Hydromorphone</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9450</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="280808015"><itemNumber>0762</itemNumber><strength>10mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>2.3380</price><drug id="00622133" sec3="Y"><name>Dilaudid-HP</name><manufacturerId>ABB</manufacturerId><individualPrice>2.3380</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02145928" sec3="Y"><name>Hydromorphone HP-10</name><manufacturerId>SDZ</manufacturerId><individualPrice>2.3380</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808072"><itemNumber>0763</itemNumber><strength>50mg/mL</strength><dosageForm>Inj-1mL Pk</dosageForm><price>9.7335</price><drug id="02145863" sec3="Y"><name>Dilaudid-XP</name><manufacturerId>ABB</manufacturerId><individualPrice>9.7335</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02146126" sec3="Y"><name>Hydromorphone HP-50</name><manufacturerId>SDZ</manufacturerId><individualPrice>9.7335</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="280808013"><itemNumber>0764</itemNumber><strength>1mg/mL</strength><dosageForm>Oral Sol</dosageForm><price>.0652</price><drug id="00786535" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0931</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916386" sec3="Y"><name>PMS-Hydromorphone</name><manufacturerId>PMS</manufacturerId><individualPrice>.0652</individualPrice><listingDate>2006-01-24</listingDate></drug></pcg9><pcg9 id="280808074"><itemNumber>0765</itemNumber><strength>250mg</strength><dosageForm>Pd Vial Pk</dosageForm><price>67.5750</price><drug id="02085895" sec3="Y"><name>Dilaudid Sterile Powder</name><manufacturerId>ABB</manufacturerId><individualPrice>67.5750</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808016"><itemNumber>0766</itemNumber><strength>3mg</strength><dosageForm>Sup</dosageForm><price>2.6000</price><drug id="00125105" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>2.6000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808017"><itemNumber>0767</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.0959</price><drug id="00705438" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0959</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00885444" sec3="Y"><name>PMS-Hydromorphone</name><manufacturerId>PMS</manufacturerId><individualPrice>.0959</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="280808018"><itemNumber>0768</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1417</price><drug id="00125083" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.1417</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00885436" sec3="Y"><name>PMS-Hydromorphone</name><manufacturerId>PMS</manufacturerId><individualPrice>.1417</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="280808019"><itemNumber>0769</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.2240</price><drug id="00125121" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.2240</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00885401" sec3="Y"><name>PMS-Hydromorphone</name><manufacturerId>PMS</manufacturerId><individualPrice>.2240</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="280808020"><itemNumber>0770</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>.3528</price><drug id="00786543" sec3="Y"><name>Dilaudid</name><manufacturerId>ABB</manufacturerId><individualPrice>.3528</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00885428" sec3="Y"><name>PMS-Hydromorphone</name><manufacturerId>PMS</manufacturerId><individualPrice>.3528</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00410"><name>MEPERIDINE HCL</name><pcgGroup lccId="00068"><pcg9 id="280808027"><itemNumber>0771</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1439</price><drug id="02138018" sec3="Y" sec12="Y"><name>Demerol</name><manufacturerId>SAV</manufacturerId><individualPrice>.1439</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="270">Limited to 2 weeks supply for acute pain.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00426"><name>MORPHINE HCL</name><pcgGroup><pcg9 id="280808028"><itemNumber>0772</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>.0200</price><drug id="00486582" notABenefit="Y" sec3="Y"><name>M.O.S.</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00607762" sec3="Y"><name>Ratio-Morphine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808029"><itemNumber>0773</itemNumber><strength>5mg/mL</strength><dosageForm>O/L</dosageForm><price>.0842</price><drug id="00514217" notABenefit="Y" sec3="Y"><name>M.O.S.</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00607770" sec3="Y"><name>Ratio-Morphine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0842</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808030"><itemNumber>0774</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.1838</price><drug id="00632503" sec3="Y"><name>M.O.S.</name><manufacturerId>VAL</manufacturerId><individualPrice>.1838</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00690783" sec3="Y"><name>Ratio-Morphine</name><manufacturerId>RPH</manufacturerId><individualPrice>.1838</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808031"><itemNumber>0775</itemNumber><strength>20mg/mL</strength><dosageForm>O/L</dosageForm><price>.5240</price><drug id="00632481" dinStatus="E" sec3="Y"><name>M.O.S.</name><manufacturerId>VAL</manufacturerId><individualPrice>.5240</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00690791" sec3="Y"><name>Ratio-Morphine</name><manufacturerId>RPH</manufacturerId><individualPrice>.5241</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808033"><itemNumber>0776</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1700</price><drug id="00690198" sec3="Y"><name>M.O.S.-10</name><manufacturerId>VAL</manufacturerId><individualPrice>.1700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808034"><itemNumber>0777</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.3243</price><drug id="00690201" sec3="Y"><name>M.O.S.-20</name><manufacturerId>VAL</manufacturerId><individualPrice>.3243</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808036"><itemNumber>0778</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><price>.5851</price><drug id="00690244" sec3="Y"><name>M.O.S.-60</name><manufacturerId>VAL</manufacturerId><individualPrice>.5851</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00411"><name>MORPHINE SULFATE</name><pcgGroup><pcg9 id="280808068"><itemNumber>0779</itemNumber><strength>10mg</strength><dosageForm>ER Cap</dosageForm><price>.2900</price><drug id="02019930" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>.2900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808086"><itemNumber>0780</itemNumber><strength>15mg</strength><dosageForm>ER Cap</dosageForm><price>.3350</price><drug id="02177749" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>.3350</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="280808069"><itemNumber>0781</itemNumber><strength>30mg</strength><dosageForm>ER Cap</dosageForm><price>.5000</price><drug id="02019949" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>.5000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808070"><itemNumber>0782</itemNumber><strength>60mg</strength><dosageForm>ER Cap</dosageForm><price>.8875</price><drug id="02019957" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>.8875</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808071"><itemNumber>0783</itemNumber><strength>100mg</strength><dosageForm>ER Cap</dosageForm><price>1.9100</price><drug id="02019965" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>1.9100</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808087"><itemNumber>0784</itemNumber><strength>200mg</strength><dosageForm>ER Cap</dosageForm><price>3.8198</price><drug id="02177757" sec3="Y"><name>M-Eslon</name><manufacturerId>ETH</manufacturerId><individualPrice>3.8198</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="280808040"><itemNumber>0785</itemNumber><strength>15mg/mL</strength><dosageForm>Inj Sol Amp</dosageForm><price>.9000</price><drug id="00392561" sec3="Y"><name>Morphine Sulfate</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9000</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="00850330" notABenefit="Y" sec3="Y"><name>Morphine Sulfate Injection USP</name><manufacturerId>HOS</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808041"><itemNumber>0786</itemNumber><strength>50mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>3.2200</price><drug id="00617288" sec3="Y"><name>Morphine HP-50</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808042"><itemNumber>0787</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>.0200</price><drug id="00591467" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.0200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808043"><itemNumber>0788</itemNumber><strength>5mg/mL</strength><dosageForm>O/L</dosageForm><price>.0803</price><drug id="00591475" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.0803</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808046"><itemNumber>0789</itemNumber><strength>20mg/mL</strength><dosageForm>Oral Drops</dosageForm><price>.3857</price><drug id="00621935" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.3857</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808125"><itemNumber>0790</itemNumber><strength>10mg</strength><dosageForm>SR Cap</dosageForm><price>.3604</price><drug id="02242163" sec3="Y"><name>Kadian</name><manufacturerId>ABB</manufacturerId><individualPrice>.3604</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="280808093"><itemNumber>0791</itemNumber><strength>20mg</strength><dosageForm>SR Cap</dosageForm><price>.7004</price><drug id="02184435" sec3="Y"><name>Kadian</name><manufacturerId>ABB</manufacturerId><individualPrice>.7004</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="280808094"><itemNumber>0792</itemNumber><strength>50mg</strength><dosageForm>SR Cap</dosageForm><price>1.3248</price><drug id="02184443" sec3="Y"><name>Kadian</name><manufacturerId>ABB</manufacturerId><individualPrice>1.3248</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="280808095"><itemNumber>0793</itemNumber><strength>100mg</strength><dosageForm>SR Cap</dosageForm><price>2.3106</price><drug id="02184451" sec3="Y"><name>Kadian</name><manufacturerId>ABB</manufacturerId><individualPrice>2.3106</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="280808053"><itemNumber>0794</itemNumber><strength>15mg</strength><dosageForm>SR Tab</dosageForm><price>.2977</price><drug id="02015439" sec3="Y"><name>MS Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>.6620</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244790" sec3="Y"><name>Ratio-Morphine SR</name><manufacturerId>RPH</manufacturerId><individualPrice>.2977</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02245284" sec3="Y"><name>PMS-Morphine Sulfate</name><manufacturerId>PMS</manufacturerId><individualPrice>.2977</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02302764" dinStatus="N" sec3="Y"><name>Novo-Morphine SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.2977</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="280808055"><itemNumber>0795</itemNumber><strength>60mg</strength><dosageForm>SR Tab</dosageForm><price>.7924</price><drug id="02014300" sec3="Y"><name>MS Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.7620</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244792" sec3="Y"><name>Ratio-Morphine SR</name><manufacturerId>RPH</manufacturerId><individualPrice>.7924</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02245286" sec3="Y"><name>PMS-Morphine Sulfate</name><manufacturerId>PMS</manufacturerId><individualPrice>.7924</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02302780" sec3="Y"><name>Novo-Morphine SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.7924</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="280808056"><itemNumber>0796</itemNumber><strength>100mg</strength><dosageForm>SR Tab</dosageForm><price>1.2909</price><drug id="02014319" sec3="Y"><name>MS Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>2.6860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245287" dinStatus="N" sec3="Y"><name>PMS-Morphine Sulfate SR</name><manufacturerId>PMS</manufacturerId><individualPrice>1.2909</individualPrice><listingDate>2008-06-27</listingDate></drug><drug id="02302799" sec3="Y"><name>Novo-Morphine SR</name><manufacturerId>NOP</manufacturerId><individualPrice>1.2909</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="280808057"><itemNumber>0797</itemNumber><strength>200mg</strength><dosageForm>SR Tab</dosageForm><price>2.3999</price><drug id="02014327" sec3="Y"><name>MS Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>4.9940</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245288" dinStatus="N" sec3="Y"><name>PMS-Morphine Sulfate SR</name><manufacturerId>PMS</manufacturerId><individualPrice>2.3999</individualPrice><listingDate>2008-06-27</listingDate></drug><drug id="02302802" sec3="Y"><name>Novo-Morphine SR</name><manufacturerId>NOP</manufacturerId><individualPrice>2.3999</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="280808054"><itemNumber>0798</itemNumber><strength>30mg</strength><dosageForm>SR/ER Tab</dosageForm><price>.4495</price><drug id="02014297" sec3="Y"><name>MS Contin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.0000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244791" sec3="Y"><name>Ratio-Morphine SR</name><manufacturerId>RPH</manufacturerId><individualPrice>.4495</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02245285" sec3="Y"><name>PMS-Morphine Sulfate</name><manufacturerId>PMS</manufacturerId><individualPrice>.4495</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02302772" dinStatus="N" sec3="Y"><name>Novo-Morphine SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.4495</individualPrice><listingDate>2009-06-23</listingDate></drug></pcg9><pcg9 id="280808051"><itemNumber>0799</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.3350</price><drug id="02014238" sec3="Y"><name>MS-IR</name><manufacturerId>PFP</manufacturerId><individualPrice>.3350</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808052"><itemNumber>0800</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.4300</price><drug id="02014254" sec3="Y"><name>MS-IR</name><manufacturerId>PFP</manufacturerId><individualPrice>.4300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808047"><itemNumber>0801</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1100</price><drug id="00594652" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.1100</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808048"><itemNumber>0802</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1700</price><drug id="00594644" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.1700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808049"><itemNumber>0803</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.2250</price><drug id="00594636" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.2250</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280808050"><itemNumber>0804</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3450</price><drug id="00675962" sec3="Y"><name>Statex</name><manufacturerId>PMS</manufacturerId><individualPrice>.3450</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00448"><name>OXYCODONE HCL</name><pcgGroup lccId="00069"><pcg9 id="280808088"><itemNumber>0805</itemNumber><strength>10mg</strength><dosageForm>SR Tab</dosageForm><price>.8680</price><drug id="02202441" sec3="Y" sec12="Y"><name>Oxycontin</name><manufacturerId>PFP</manufacturerId><individualPrice>.8680</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="280808089"><itemNumber>0806</itemNumber><strength>20mg</strength><dosageForm>SR Tab</dosageForm><price>1.3000</price><drug id="02202468" sec3="Y" sec12="Y"><name>Oxycontin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.3000</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="280808090"><itemNumber>0807</itemNumber><strength>40mg</strength><dosageForm>SR Tab</dosageForm><price>2.2560</price><drug id="02202476" sec3="Y" sec12="Y"><name>Oxycontin</name><manufacturerId>PFP</manufacturerId><individualPrice>2.2560</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="280808091"><itemNumber>0808</itemNumber><strength>80mg</strength><dosageForm>SR Tab</dosageForm><price>4.1640</price><drug id="02202484" sec3="Y" sec12="Y"><name>Oxycontin</name><manufacturerId>PFP</manufacturerId><individualPrice>4.1640</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="201">For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a listed long-acting opioid.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="280808119"><itemNumber>0809</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><drug id="00789739" dinStatus="N" notABenefit="Y" sec3="Y"><name>Supeudol</name><manufacturerId>SDZ</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02231934" notABenefit="Y" sec3="Y"><name>Oxy.IR</name><manufacturerId>PFP</manufacturerId><listingDate>2009-01-30</listingDate></drug><drug id="02319977" notABenefit="Y" sec3="Y"><name>PMS-Oxycodone</name><manufacturerId>PMS</manufacturerId><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="280808120"><itemNumber>0810</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="00443948" dinStatus="N" notABenefit="Y" sec3="Y"><name>Supeudol</name><manufacturerId>SDZ</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02240131" notABenefit="Y" sec3="Y"><name>Oxy.IR</name><manufacturerId>PFP</manufacturerId><listingDate>2009-01-30</listingDate></drug><drug id="02319985" notABenefit="Y" sec3="Y"><name>PMS-Oxycodone</name><manufacturerId>PMS</manufacturerId><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="280808121"><itemNumber>0811</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><drug id="02240132" notABenefit="Y" sec3="Y"><name>OXY.IR</name><manufacturerId>PFP</manufacturerId><listingDate>2008-10-01</listingDate></drug><drug id="02262983" notABenefit="Y" sec3="Y"><name>Supeudol</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-10-01</listingDate></drug><drug id="02319993" notABenefit="Y" sec3="Y"><name>PMS-Oxycodone</name><manufacturerId>PMS</manufacturerId><listingDate>2009-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00424"><name>OXYCODONE HCL &amp; ACETAMINOPHEN</name><pcgGroup><pcg9 id="280808064"><itemNumber>0812</itemNumber><strength>5mg &amp; 325mg</strength><dosageForm>Tab</dosageForm><price>.1285</price><drug id="00608165" sec3="Y"><name>Ratio-Oxycocet</name><manufacturerId>RPH</manufacturerId><individualPrice>.1285</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916475" notABenefit="Y" sec3="Y"><name>Percocet</name><manufacturerId>BQU</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="01916548" sec3="Y"><name>Endocet</name><manufacturerId>BQU</manufacturerId><individualPrice>.1285</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245758" dinStatus="N" sec3="Y"><name>PMS-Oxycodone-Acetaminophen</name><manufacturerId>PMS</manufacturerId><individualPrice>.1285</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02307898" dinStatus="N" sec3="Y"><name>Novo-Oxycodone Acet</name><manufacturerId>NOP</manufacturerId><individualPrice>.1285</individualPrice><listingDate>2008-10-01</listingDate></drug><drug id="02324628" dinStatus="N" sec3="Y"><name>Apo-Oxycodone/Acet</name><manufacturerId>APX</manufacturerId><individualPrice>.1285</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00418"><name>OXYCODONE HCL &amp; ACETYLSALICYLIC ACID</name><pcgGroup><pcg9 id="280808065"><itemNumber>0813</itemNumber><strength>5mg &amp; 325mg</strength><dosageForm>Tab</dosageForm><price>.2576</price><drug id="00608157" sec3="Y"><name>Ratio-Oxycodan</name><manufacturerId>RPH</manufacturerId><individualPrice>.2576</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916572" notABenefit="Y" sec3="Y"><name>Percodan</name><manufacturerId>BQU</manufacturerId><listingDate>2008-12-23</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="280892000"><name>ANALGESICS MISCELLANEOUS ANALGESICS AND ANTIPYRETICS</name><genericName id="00403"><name>ACETAMINOPHEN</name><pcgGroup><pcg9 id="280892002"><itemNumber>0814</itemNumber><strength>80mg/mL</strength><dosageForm>O/L</dosageForm><price>.1197</price><drug id="00631353" notABenefit="Y" sec3="Y"><name>Atasol</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00642401" notABenefit="Y" sec3="Y"><name>Tempra</name><manufacturerId>MJS</manufacturerId><listingDate>1999-01-01</listingDate></drug><drug id="02027801" sec3="Y"><name>Pediatrix</name><manufacturerId>RPH</manufacturerId><individualPrice>.1197</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="280892003"><itemNumber>0815</itemNumber><strength>120mg</strength><dosageForm>Sup</dosageForm><price>.5367</price><drug id="01919385" notABenefit="Y" sec3="Y"><name>Abenol</name><manufacturerId>PEN</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230434" sec3="Y"><name>ACET 120</name><manufacturerId>PMS</manufacturerId><individualPrice>.5367</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="280892004"><itemNumber>0816</itemNumber><strength>325mg</strength><dosageForm>Sup</dosageForm><price>.6625</price><drug id="01919393" notABenefit="Y" sec3="Y"><name>Abenol</name><manufacturerId>PEN</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230436" sec3="Y"><name>ACET 325</name><manufacturerId>PMS</manufacturerId><individualPrice>.6625</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="280892005"><itemNumber>0817</itemNumber><strength>650mg</strength><dosageForm>Sup</dosageForm><price>.7608</price><drug id="01919407" notABenefit="Y" sec3="Y"><name>Abenol</name><manufacturerId>PEN</manufacturerId><listingDate>2007-01-02</listingDate></drug><drug id="02230437" sec3="Y"><name>ACET 650</name><manufacturerId>PMS</manufacturerId><individualPrice>.7608</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="280892006" suppliedBy="L"><itemNumber>0818</itemNumber><strength>325mg</strength><dosageForm>Tab</dosageForm><price>.0114</price><drug id="00293482" notABenefit="Y" sec3="Y"><name>Atasol</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00389218" selfMed="Y" sec3="Y"><name>Novo-Gesic</name><manufacturerId>NOP</manufacturerId><individualPrice>.0114</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00544981" selfMed="Y" sec3="Y"><name>Apo-Acetaminophen</name><manufacturerId>APX</manufacturerId><individualPrice>.0114</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00589241" selfMed="Y" sec3="Y"><name>Acetaminophen</name><manufacturerId>DPC</manufacturerId><individualPrice>.0114</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01928260" dinStatus="E" selfMed="Y" sec3="Y"><name>Panadol</name><manufacturerId>STH</manufacturerId><individualPrice>.0344</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="280892007" suppliedBy="L"><itemNumber>0819</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.0149</price><drug id="00013668" notABenefit="Y" sec3="Y"><name>Atasol Forte</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00482323" selfMed="Y" sec3="Y"><name>Novo-Gesic Forte</name><manufacturerId>NOP</manufacturerId><individualPrice>.0149</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00545007" selfMed="Y" sec3="Y"><name>Apo-Acetaminophen</name><manufacturerId>APX</manufacturerId><individualPrice>.0149</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00589233" selfMed="Y" sec3="Y"><name>Acetaminophen Extra Strength</name><manufacturerId>DPC</manufacturerId><individualPrice>.0149</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01766"><name>TRAMADOL HCL &amp; ACETAMINOPHEN</name><pcgGroup><pcg9 id="280892010"><itemNumber>0820</itemNumber><strength>37.5mg &amp; 325mg</strength><dosageForm>Tab</dosageForm><drug id="02264846" notABenefit="Y" sec3="Y"><name>Tramacet</name><manufacturerId>JNO</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02336790" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Tramadol/Acet</name><manufacturerId>APX</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="281200000"><name>ANTICONVULSANTS</name><genericName id="00476"><name>CARBAMAZEPINE</name><pcgGroup><pcg9 id="281200049"><itemNumber>0821</itemNumber><strength>100mg</strength><dosageForm>Chew Tab</dosageForm><price>.0612</price><drug id="00369810" sec3="Y"><name>Tegretol</name><manufacturerId>NOV</manufacturerId><individualPrice>.1518</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231542" sec3="Y"><name>PMS-Carbamazepine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0612</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02244403" sec3="Y"><name>Taro-Carbamazepine</name><manufacturerId>TAR</manufacturerId><individualPrice>.0612</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02261855" sec3="Y"><name>Sandoz Carbamazepine Chewtabs</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0612</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="281200050"><itemNumber>0822</itemNumber><strength>200mg</strength><dosageForm>Chew Tab</dosageForm><price>.1207</price><drug id="00665088" sec3="Y"><name>Tegretol</name><manufacturerId>NOV</manufacturerId><individualPrice>.2995</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231540" sec3="Y"><name>PMS-Carbamazepine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1207</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02244404" sec3="Y"><name>Taro-Carbamazepine</name><manufacturerId>TAR</manufacturerId><individualPrice>.1207</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02261863" sec3="Y"><name>Sandoz Carbamazepine Chewtabs</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1207</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00070"><pcg9 id="281200065"><itemNumber>0823</itemNumber><strength>200mg</strength><dosageForm>LA Tab</dosageForm><price>.1498</price><drug id="00773611" sec3="Y" sec12="Y"><name>Tegretol CR</name><manufacturerId>NOV</manufacturerId><individualPrice>.3718</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231543" sec3="Y" sec12="Y"><name>PMS-Carbamazepine CR</name><manufacturerId>PMS</manufacturerId><individualPrice>.1498</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02241882" sec3="Y" sec12="Y"><name>Mylan-Carbamazepine CR</name><manufacturerId>MYL</manufacturerId><individualPrice>.1498</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02261839" sec3="Y" sec12="Y"><name>Sandoz Carbamazepine CR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1498</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="281200066"><itemNumber>0824</itemNumber><strength>400mg</strength><dosageForm>LA Tab</dosageForm><price>.2996</price><drug id="00755583" sec3="Y" sec12="Y"><name>Tegretol CR</name><manufacturerId>NOV</manufacturerId><individualPrice>.7435</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231544" sec3="Y" sec12="Y"><name>PMS-Carbamazepine CR</name><manufacturerId>PMS</manufacturerId><individualPrice>.2996</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02241883" sec3="Y" sec12="Y"><name>Mylan-Carbamazepine CR</name><manufacturerId>MYL</manufacturerId><individualPrice>.2996</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02261847" sec3="Y" sec12="Y"><name>Sandoz Carbamazepine CR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2996</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="67">For patients who have been tried on conventional carbamazepine with unsatisfactory results due to adverse effects or poor control of symptoms.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="281200067"><itemNumber>0825</itemNumber><strength>100mg/5mL</strength><dosageForm>Oral Susp</dosageForm><price>.0717</price><drug id="02194333" sec3="Y"><name>Tegretol</name><manufacturerId>NOV</manufacturerId><individualPrice>.0717</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="281200015"><itemNumber>0826</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.0795</price><drug id="00010405" notABenefit="Y" sec3="Y"><name>Tegretol</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00402699" sec3="Y"><name>Apo-Carbamazepine</name><manufacturerId>APX</manufacturerId><individualPrice>.0795</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00782718" sec3="Y"><name>Novo-Carbamaz</name><manufacturerId>NOP</manufacturerId><individualPrice>.0795</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042568" sec3="Y"><name>Nu-Carbamazepine</name><manufacturerId>NXP</manufacturerId><individualPrice>.0795</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00488"><name>CLOBAZAM</name><pcgGroup lccId="00071"><pcg9 id="281200061"><itemNumber>0827</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1709</price><drug id="02221799" sec3="Y" sec12="Y"><name>Frisium</name><manufacturerId>OVA</manufacturerId><individualPrice>.4393</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02238334" sec3="Y" sec12="Y"><name>Novo-Clobazam</name><manufacturerId>NOP</manufacturerId><individualPrice>.1709</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238797" sec3="Y" sec12="Y"><name>Ratio-Clobazam</name><manufacturerId>RPH</manufacturerId><individualPrice>.1709</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02244474" sec3="Y" sec12="Y"><name>PMS-Clobazam</name><manufacturerId>PMS</manufacturerId><individualPrice>.1709</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02244638" sec3="Y" sec12="Y"><name>Apo-Clobazam</name><manufacturerId>APX</manufacturerId><individualPrice>.1709</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="23">As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="N">Because a large number of patients will become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00479"><name>CLONAZEPAM</name><pcgGroup><pcg9 id="281200032"><itemNumber>0828</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.0925</price><drug id="00382825" sec3="Y"><name>Rivotril</name><manufacturerId>HLR</manufacturerId><individualPrice>.1981</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02048701" sec3="Y"><name>PMS-Clonazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02103656" sec3="Y"><name>Ratio-Clonazepam</name><manufacturerId>RPH</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02173344" sec3="Y"><name>Nu-Clonazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177889" sec3="Y"><name>Apo-Clonazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02207818" sec3="Y"><name>PMS-Clonazepam-R</name><manufacturerId>PMS</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230950" sec3="Y"><name>Mylan-Clonazepam</name><manufacturerId>MYL</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02233960" sec3="Y"><name>Sandoz Clonazepam</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0925</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02239024" sec3="Y"><name>Novo-Clonazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.0925</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02270641" sec3="Y"><name>Co Clonazepam</name><manufacturerId>COB</manufacturerId><individualPrice>.0925</individualPrice><listingDate>2006-06-14</listingDate></drug></pcg9><pcg9 id="281200031"><itemNumber>0829</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1595</price><drug id="00382841" sec3="Y"><name>Rivotril</name><manufacturerId>HLR</manufacturerId><individualPrice>.3417</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02048736" sec3="Y"><name>PMS-Clonazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02103737" sec3="Y"><name>Ratio-Clonazepam</name><manufacturerId>RPH</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02173352" sec3="Y"><name>Nu-Clonazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177897" sec3="Y"><name>Apo-Clonazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230951" sec3="Y"><name>Mylan-Clonazepam</name><manufacturerId>MYL</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02233985" sec3="Y"><name>Sandoz Clonazepam</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1595</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02239025" sec3="Y"><name>Novo-Clonazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.1595</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02270676" sec3="Y"><name>Co Clonazepam</name><manufacturerId>COB</manufacturerId><individualPrice>.1595</individualPrice><listingDate>2006-06-14</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00483"><name>DIVALPROEX SODIUM</name><pcgGroup><pcg9 id="281200047"><itemNumber>0830</itemNumber><strength>125mg</strength><dosageForm>Ent Tab</dosageForm><price>.1093</price><drug id="00596418" sec3="Y"><name>Epival</name><manufacturerId>ABB</manufacturerId><individualPrice>.2896</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239517" sec3="Y"><name>Nu-Divalproex</name><manufacturerId>NXP</manufacturerId><individualPrice>.1093</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02239698" sec3="Y"><name>Apo-Divalproex</name><manufacturerId>APX</manufacturerId><individualPrice>.1093</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02239701" sec3="Y"><name>Novo-Divalproex</name><manufacturerId>NOP</manufacturerId><individualPrice>.1093</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02244138" sec3="Y"><name>PMS-Divalproex</name><manufacturerId>PMS</manufacturerId><individualPrice>.1093</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02265133" sec3="Y"><name>Gen-Divalproex</name><manufacturerId>GEN</manufacturerId><individualPrice>.1093</individualPrice><listingDate>2005-04-28</listingDate></drug></pcg9><pcg9 id="281200046"><itemNumber>0831</itemNumber><strength>250mg</strength><dosageForm>Ent Tab</dosageForm><price>.1964</price><drug id="00596426" sec3="Y"><name>Epival</name><manufacturerId>ABB</manufacturerId><individualPrice>.5205</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239518" sec3="Y"><name>Nu-Divalproex</name><manufacturerId>NXP</manufacturerId><individualPrice>.1964</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02239699" sec3="Y"><name>Apo-Divalproex</name><manufacturerId>APX</manufacturerId><individualPrice>.1964</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02239702" sec3="Y"><name>Novo-Divalproex</name><manufacturerId>NOP</manufacturerId><individualPrice>.1964</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02244139" sec3="Y"><name>PMS-Divalproex</name><manufacturerId>PMS</manufacturerId><individualPrice>.1964</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02265141" sec3="Y"><name>Gen-Divalproex</name><manufacturerId>GEN</manufacturerId><individualPrice>.1964</individualPrice><listingDate>2005-04-28</listingDate></drug></pcg9><pcg9 id="281200045"><itemNumber>0832</itemNumber><strength>500mg</strength><dosageForm>Ent Tab</dosageForm><price>.3931</price><drug id="00596434" sec3="Y"><name>Epival</name><manufacturerId>ABB</manufacturerId><individualPrice>1.0416</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239519" sec3="Y"><name>Nu-Divalproex</name><manufacturerId>NXP</manufacturerId><individualPrice>.3931</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02239700" sec3="Y"><name>Apo-Divalproex</name><manufacturerId>APX</manufacturerId><individualPrice>.3931</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02239703" sec3="Y"><name>Novo-Divalproex</name><manufacturerId>NOP</manufacturerId><individualPrice>.3931</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02244140" sec3="Y"><name>PMS-Divalproex</name><manufacturerId>PMS</manufacturerId><individualPrice>.3931</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02265168" sec3="Y"><name>Gen-Divalproex</name><manufacturerId>GEN</manufacturerId><individualPrice>.3931</individualPrice><listingDate>2005-04-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00473"><name>ETHOSUXIMIDE</name><pcgGroup><pcg9 id="281200008"><itemNumber>0833</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.3300</price><drug id="00022799" sec3="Y"><name>Zarontin</name><manufacturerId>ERF</manufacturerId><individualPrice>.3300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281200009"><itemNumber>0834</itemNumber><strength>50mg/mL</strength><dosageForm>O/L</dosageForm><price>.0660</price><drug id="00023485" sec3="Y"><name>Zarontin</name><manufacturerId>ERF</manufacturerId><individualPrice>.0660</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00487"><name>GABAPENTIN</name><pcgGroup lccId="00072"><pcg9 id="281200062"><itemNumber>0835</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.2000</price><drug id="02084260" sec3="Y" sec12="Y"><name>Neurontin</name><manufacturerId>PFI</manufacturerId><individualPrice>.4239</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243446" sec3="Y" sec12="Y"><name>PMS-Gabapentin</name><manufacturerId>PMS</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02244304" sec3="Y" sec12="Y"><name>Apo-Gabapentin</name><manufacturerId>APX</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02244513" sec3="Y" sec12="Y"><name>Novo-Gabapentin</name><manufacturerId>NOP</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246314" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Gabapentin</name><manufacturerId>PHE</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02248259" sec3="Y" sec12="Y"><name>Mylan-Gabapentin</name><manufacturerId>MYL</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02256142" sec3="Y" sec12="Y"><name>Co-Gabapentin</name><manufacturerId>COB</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2005-03-31</listingDate></drug><drug id="02260883" sec3="Y" sec12="Y"><name>Ratio-Gabapentin</name><manufacturerId>RPH</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2005-07-14</listingDate></drug><drug id="02304775" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Gabapentin</name><manufacturerId>ZYN</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02319055" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Gabapentin</name><manufacturerId>RAN</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02332582" dinStatus="N" sec3="Y" sec12="Y"><name>Gabapentin Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.2000</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281200063"><itemNumber>0836</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.4865</price><drug id="02084279" sec3="Y" sec12="Y"><name>Neurontin</name><manufacturerId>PFI</manufacturerId><individualPrice>1.0311</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243447" sec3="Y" sec12="Y"><name>PMS-Gabapentin</name><manufacturerId>PMS</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02244305" sec3="Y" sec12="Y"><name>Apo-Gabapentin</name><manufacturerId>APX</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02244514" sec3="Y" sec12="Y"><name>Novo-Gabapentin</name><manufacturerId>NOP</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246315" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Gabapentin</name><manufacturerId>PHE</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02248260" sec3="Y" sec12="Y"><name>Mylan-Gabapentin</name><manufacturerId>MYL</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02256150" sec3="Y" sec12="Y"><name>Co-Gabapentin</name><manufacturerId>COB</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2005-03-31</listingDate></drug><drug id="02260891" sec3="Y" sec12="Y"><name>Ratio-Gabapentin</name><manufacturerId>RPH</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2005-07-14</listingDate></drug><drug id="02304783" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Gabapentin</name><manufacturerId>ZYN</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02319063" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Gabapentin</name><manufacturerId>RAN</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02332590" dinStatus="N" sec3="Y" sec12="Y"><name>Gabapentin Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.4865</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281200064"><itemNumber>0837</itemNumber><strength>400mg</strength><dosageForm>Cap</dosageForm><price>.5798</price><drug id="02084287" sec3="Y" sec12="Y"><name>Neurontin</name><manufacturerId>PFI</manufacturerId><individualPrice>1.2288</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243448" sec3="Y" sec12="Y"><name>PMS-Gabapentin</name><manufacturerId>PMS</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02244306" sec3="Y" sec12="Y"><name>Apo-Gabapentin</name><manufacturerId>APX</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02244515" sec3="Y" sec12="Y"><name>Novo-Gabapentin</name><manufacturerId>NOP</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02246316" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Gabapentin</name><manufacturerId>PHE</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02248261" sec3="Y" sec12="Y"><name>Mylan-Gabapentin</name><manufacturerId>MYL</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02256169" sec3="Y" sec12="Y"><name>Co-Gabapentin</name><manufacturerId>COB</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2005-03-31</listingDate></drug><drug id="02260905" sec3="Y" sec12="Y"><name>Ratio-Gabapentin</name><manufacturerId>RPH</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2005-07-14</listingDate></drug><drug id="02304791" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Gabapentin</name><manufacturerId>ZYN</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02319071" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Gabapentin</name><manufacturerId>RAN</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02332604" dinStatus="N" sec3="Y" sec12="Y"><name>Gabapentin Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.5798</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="136">As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="N">Because a large number of patients may become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="281200122"><itemNumber>0838</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><drug id="02239717" notABenefit="Y" sec3="Y"><name>Neurontin</name><manufacturerId>PFI</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02248457" notABenefit="Y" sec3="Y"><name>Novo-Gabapentin</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02255898" notABenefit="Y" sec3="Y"><name>PMS-Gabapentin</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02260913" notABenefit="Y" sec3="Y"><name>Ratio-Gabapentin</name><manufacturerId>RPH</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02293358" notABenefit="Y" sec3="Y"><name>Apo-Gabapentin</name><manufacturerId>APX</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="281200123"><itemNumber>0839</itemNumber><strength>800mg</strength><dosageForm>Tab</dosageForm><drug id="02239718" notABenefit="Y" sec3="Y"><name>Neurontin</name><manufacturerId>PFI</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02247346" notABenefit="Y" sec3="Y"><name>Novo-Gabapentin</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02255901" notABenefit="Y" sec3="Y"><name>PMS-Gabapentin</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02260921" notABenefit="Y" sec3="Y"><name>Ratio-Gabapentin</name><manufacturerId>RPH</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02293366" notABenefit="Y" sec3="Y"><name>Apo-Gabapentin</name><manufacturerId>APX</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00486"><name>LAMOTRIGINE</name><pcgGroup lccId="00073"><pcg9 id="281200055"><itemNumber>0840</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1658</price><drug id="02142082" sec3="Y" sec12="Y"><name>Lamictal</name><manufacturerId>GSK</manufacturerId><individualPrice>.3742</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243352" sec3="Y" sec12="Y"><name>Ratio-Lamotrigine</name><manufacturerId>RPH</manufacturerId><individualPrice>.1658</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02245208" sec3="Y" sec12="Y"><name>Apo-Lamotrigine</name><manufacturerId>APX</manufacturerId><individualPrice>.1658</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246897" sec3="Y" sec12="Y"><name>PMS-Lamotrigine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1658</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248232" sec3="Y" sec12="Y"><name>Novo-Lamotrigine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1658</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02265494" sec3="Y" sec12="Y"><name>Mylan-Lamotrigine</name><manufacturerId>MYL</manufacturerId><individualPrice>.1658</individualPrice><listingDate>2005-07-14</listingDate></drug></pcg9><pcg9 id="281200059"><itemNumber>0841</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.6630</price><drug id="02142104" sec3="Y" sec12="Y"><name>Lamictal</name><manufacturerId>GSK</manufacturerId><individualPrice>1.4940</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02243353" sec3="Y" sec12="Y"><name>Ratio-Lamotrigine</name><manufacturerId>RPH</manufacturerId><individualPrice>.6630</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02245209" sec3="Y" sec12="Y"><name>Apo-Lamotrigine</name><manufacturerId>APX</manufacturerId><individualPrice>.6630</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246898" sec3="Y" sec12="Y"><name>PMS-Lamotrigine</name><manufacturerId>PMS</manufacturerId><individualPrice>.6630</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248233" sec3="Y" sec12="Y"><name>Novo-Lamotrigine</name><manufacturerId>NOP</manufacturerId><individualPrice>.6630</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02265508" sec3="Y" sec12="Y"><name>Mylan-Lamotrigine</name><manufacturerId>MYL</manufacturerId><individualPrice>.6630</individualPrice><listingDate>2005-07-14</listingDate></drug></pcg9><pcg9 id="281200060"><itemNumber>0842</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.9945</price><drug id="02142112" sec3="Y" sec12="Y"><name>Lamictal</name><manufacturerId>GSK</manufacturerId><individualPrice>2.2018</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245210" sec3="Y" sec12="Y"><name>Apo-Lamotrigine</name><manufacturerId>APX</manufacturerId><individualPrice>.9945</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246899" sec3="Y" sec12="Y"><name>PMS-Lamotrigine</name><manufacturerId>PMS</manufacturerId><individualPrice>.9945</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02246963" sec3="Y" sec12="Y"><name>Ratio-Lamotrigine</name><manufacturerId>RPH</manufacturerId><individualPrice>.9945</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248234" sec3="Y" sec12="Y"><name>Novo-Lamotrigine</name><manufacturerId>NOP</manufacturerId><individualPrice>.9945</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02265516" sec3="Y" sec12="Y"><name>Mylan-Lamotrigine</name><manufacturerId>MYL</manufacturerId><individualPrice>.9945</individualPrice><listingDate>2005-07-14</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="136">As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="N">Because a large number of patients may become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01603"><name>LEVETIRACETAM</name><pcgGroup><pcg9 id="281200091"><itemNumber>0843</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="02247027" notABenefit="Y" sec3="Y"><name>Keppra</name><manufacturerId>VLH</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02274183" notABenefit="Y" sec3="Y"><name>Co Levetiracetam</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02285924" notABenefit="Y" sec3="Y"><name>Apo-Levetiracetam</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02296101" notABenefit="Y" sec3="Y"><name>PMS-Levetiracetam</name><manufacturerId>PMS</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="281200092"><itemNumber>0844</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><drug id="02247028" notABenefit="Y" sec3="Y"><name>Keppra</name><manufacturerId>VLH</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02274191" notABenefit="Y" sec3="Y"><name>Co Levetiracetam</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02285932" notABenefit="Y" sec3="Y"><name>Apo-Levetiracetam</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02296128" notABenefit="Y" sec3="Y"><name>PMS-Levetiracetam</name><manufacturerId>PMS</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="281200093"><itemNumber>0845</itemNumber><strength>750mg</strength><dosageForm>Tab</dosageForm><drug id="02247029" notABenefit="Y" sec3="Y"><name>Keppra</name><manufacturerId>VLH</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02274205" notABenefit="Y" sec3="Y"><name>Co Levetiracetam</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02285940" notABenefit="Y" sec3="Y"><name>Apo-Levetiracetam</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02296136" notABenefit="Y" sec3="Y"><name>PMS-Levetiracetam</name><manufacturerId>PMS</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00475"><name>METHSUXIMIDE</name><pcgGroup><pcg9 id="281200013"><itemNumber>0846</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>1.0500</price><drug id="00022802" sec3="Y"><name>Celontin</name><manufacturerId>ERF</manufacturerId><individualPrice>1.0500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01593"><name>OXCARBAZEPINE</name><pcgGroup><pcg9 id="281200087"><itemNumber>0847</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><drug id="02242067" notABenefit="Y" sec3="Y"><name>Trileptal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02284294" notABenefit="Y" sec3="Y"><name>Apo-Oxcarbazepine</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281200088"><itemNumber>0848</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><drug id="02242068" notABenefit="Y" sec3="Y"><name>Trileptal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02284308" notABenefit="Y" sec3="Y"><name>Apo-Oxcarbazepine</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281200089"><itemNumber>0849</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><drug id="02242069" notABenefit="Y" sec3="Y"><name>Trileptal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02284316" notABenefit="Y" sec3="Y"><name>Apo-Oxcarbazepine</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00471"><name>PHENYTOIN (DIPHENYLHYDANTOIN)</name><pcgGroup><pcg9 id="281200003"><itemNumber>0850</itemNumber><strength>6mg/mL</strength><dosageForm>O/L</dosageForm><price>.0406</price><drug id="00023442" sec3="Y"><name>Dilantin</name><manufacturerId>PFI</manufacturerId><individualPrice>.0406</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281200002"><itemNumber>0851</itemNumber><strength>25mg/mL</strength><dosageForm>O/L</dosageForm><price>.0323</price><drug id="00023450" sec3="Y"><name>Dilantin</name><manufacturerId>PFI</manufacturerId><individualPrice>.0480</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02250896" sec3="Y"><name>Taro-Phenytoin</name><manufacturerId>TAR</manufacturerId><individualPrice>.0323</individualPrice><listingDate>2005-11-08</listingDate></drug></pcg9><pcg9 id="281200001"><itemNumber>0852</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.0738</price><drug id="00023698" sec3="Y"><name>Dilantin</name><manufacturerId>PFI</manufacturerId><individualPrice>.0738</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00472"><name>PHENYTOIN (DIPHENYLHYDANTOIN) SODIUM</name><pcgGroup><pcg9 id="281200005"><itemNumber>0853</itemNumber><strength>30mg</strength><dosageForm>Cap</dosageForm><price>.0538</price><drug id="00022772" sec3="Y"><name>Dilantin</name><manufacturerId>PFI</manufacturerId><individualPrice>.0538</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281200004"><itemNumber>0854</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.0747</price><drug id="00022780" sec3="Y"><name>Dilantin</name><manufacturerId>PFI</manufacturerId><individualPrice>.0747</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00477"><name>PRIMIDONE</name><pcgGroup><pcg9 id="281200025"><itemNumber>0855</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><price>.0553</price><drug id="00399310" sec3="Y"><name>Apo-Primidone</name><manufacturerId>APX</manufacturerId><individualPrice>.0553</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042363" notABenefit="Y" sec3="Y"><name>Mysoline</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281200024"><itemNumber>0856</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.0870</price><drug id="00396761" sec3="Y"><name>Apo-Primidone</name><manufacturerId>APX</manufacturerId><individualPrice>.0870</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02042355" notABenefit="Y" sec3="Y"><name>Mysoline</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00490"><name>TOPIRAMATE</name><pcgGroup lccId="00074"><pcg9 id="281200079"><itemNumber>0857</itemNumber><strength>15mg</strength><dosageForm>Sprinkle Cap</dosageForm><price>1.1420</price><drug id="02239907" sec3="Y" sec12="Y"><name>Topamax Sprinkle</name><manufacturerId>JNO</manufacturerId><individualPrice>1.1420</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="281200080"><itemNumber>0858</itemNumber><strength>25mg</strength><dosageForm>Sprinkle Cap</dosageForm><price>1.1990</price><drug id="02239908" sec3="Y" sec12="Y"><name>Topamax Sprinkle</name><manufacturerId>JNO</manufacturerId><individualPrice>1.1990</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="321">In children age 16 and under, as adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00075"><pcg9 id="281200069"><itemNumber>0859</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.5250</price><drug id="02230893" sec3="Y" sec12="Y"><name>Topamax</name><manufacturerId>JNO</manufacturerId><individualPrice>1.2512</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02248860" sec3="Y" sec12="Y"><name>Novo-Topiramate</name><manufacturerId>NOP</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02256827" sec3="Y" sec12="Y"><name>Ratio-Topiramate</name><manufacturerId>RPH</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02260050" sec3="Y" sec12="Y"><name>Sandoz Topiramate</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02262991" sec3="Y" sec12="Y"><name>PMS-Topiramate</name><manufacturerId>PMS</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02263351" sec3="Y" sec12="Y"><name>Gen-Topiramate</name><manufacturerId>GEN</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02271184" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Topiramate</name><manufacturerId>PHE</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02279614" sec3="Y" sec12="Y"><name>Apo-Topiramate</name><manufacturerId>APX</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02287765" sec3="Y" sec12="Y"><name>Co Topiramate</name><manufacturerId>COB</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02315645" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Topiramate</name><manufacturerId>MIN</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2009-03-02</listingDate></drug><drug id="02325136" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Topiramate</name><manufacturerId>ZYN</manufacturerId><individualPrice>.5250</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281200070"><itemNumber>0860</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.9950</price><drug id="02230894" sec3="Y" sec12="Y"><name>Topamax</name><manufacturerId>JNO</manufacturerId><individualPrice>2.3715</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02248861" sec3="Y" sec12="Y"><name>Novo-Topiramate</name><manufacturerId>NOP</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02256835" sec3="Y" sec12="Y"><name>Ratio-Topiramate</name><manufacturerId>RPH</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02260069" sec3="Y" sec12="Y"><name>Sandoz Topiramate</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02263009" sec3="Y" sec12="Y"><name>PMS-Topiramate</name><manufacturerId>PMS</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02263378" sec3="Y" sec12="Y"><name>Gen-Topiramate</name><manufacturerId>GEN</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02271192" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Topiramate</name><manufacturerId>PHE</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02279630" sec3="Y" sec12="Y"><name>Apo-Topiramate</name><manufacturerId>APX</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02287773" sec3="Y" sec12="Y"><name>Co Topiramate</name><manufacturerId>COB</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02315653" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Topiramate</name><manufacturerId>MIN</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2009-03-02</listingDate></drug><drug id="02325144" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Topiramate</name><manufacturerId>ZYN</manufacturerId><individualPrice>.9950</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281200071"><itemNumber>0861</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>1.5750</price><drug id="02230896" sec3="Y" sec12="Y"><name>Topamax</name><manufacturerId>JNO</manufacturerId><individualPrice>3.5415</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02248862" sec3="Y" sec12="Y"><name>Novo-Topiramate</name><manufacturerId>NOP</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02256843" sec3="Y" sec12="Y"><name>Ratio-Topiramate</name><manufacturerId>RPH</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02263017" sec3="Y" sec12="Y"><name>PMS-Topiramate</name><manufacturerId>PMS</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02263386" sec3="Y" sec12="Y"><name>Gen-Topiramate</name><manufacturerId>GEN</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02267837" sec3="Y" sec12="Y"><name>Sandoz Topiramate</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2005-11-08</listingDate></drug><drug id="02271206" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Topiramate</name><manufacturerId>PHE</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02279649" sec3="Y" sec12="Y"><name>Apo-Topiramate</name><manufacturerId>APX</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02287781" sec3="Y" sec12="Y"><name>Co Topiramate</name><manufacturerId>COB</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02315661" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Topiramate</name><manufacturerId>MIN</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2009-03-02</listingDate></drug><drug id="02325152" dinStatus="N" sec3="Y" sec12="Y"><name>Zym-Topiramate</name><manufacturerId>ZYN</manufacturerId><individualPrice>1.5750</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="223">As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="N">Because a large number of patients may become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00481"><name>VALPROATE SODIUM</name><pcgGroup><pcg9 id="281200040"><itemNumber>0862</itemNumber><strength>50mg/mL</strength><dosageForm>O/L</dosageForm><price>.0458</price><drug id="00443832" sec3="Y"><name>Depakene</name><manufacturerId>ABB</manufacturerId><individualPrice>.1138</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02140063" sec3="Y"><name>Ratio-Valproic</name><manufacturerId>RPH</manufacturerId><individualPrice>.0458</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02236807" sec3="Y"><name>PMS-Valproic Acid</name><manufacturerId>PMS</manufacturerId><individualPrice>.0458</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238370" sec3="Y"><name>Apo-Valproic</name><manufacturerId>APX</manufacturerId><individualPrice>.0458</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00482"><name>VALPROIC ACID</name><pcgGroup><pcg9 id="281200041"><itemNumber>0863</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.2062</price><drug id="00443840" sec3="Y"><name>Depakene</name><manufacturerId>ABB</manufacturerId><individualPrice>.5464</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100630" sec3="Y"><name>Novo-Valproic</name><manufacturerId>NOP</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02140047" sec3="Y"><name>Ratio-Valproic</name><manufacturerId>RPH</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02184648" sec3="Y"><name>Mylan-Valproic</name><manufacturerId>MYL</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230768" sec3="Y"><name>PMS-Valproic Acid</name><manufacturerId>PMS</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02237830" sec3="Y"><name>Nu-Valproic</name><manufacturerId>NXP</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238048" sec3="Y"><name>Apo-Valproic</name><manufacturerId>APX</manufacturerId><individualPrice>.2062</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02239714" sec3="Y"><name>Sandoz Valproic</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2062</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="281200042"><itemNumber>0864</itemNumber><strength>500mg</strength><dosageForm>Ent Cap</dosageForm><price>.4125</price><drug id="00507989" notABenefit="Y" sec3="Y"><name>Depakene</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02140055" sec3="Y"><name>Ratio-Valproic EC</name><manufacturerId>RPH</manufacturerId><individualPrice>.4125</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02229628" sec3="Y"><name>PMS-Valproic Acid</name><manufacturerId>PMS</manufacturerId><individualPrice>.4125</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02239713" dinStatus="E" sec3="Y"><name>Sandoz Valproic</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4125</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00485"><name>VIGABATRIN</name><pcgGroup lccId="00076"><pcg9 id="281200054"><itemNumber>0865</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.9110</price><drug id="02065819" sec3="Y" sec12="Y"><name>Sabril</name><manufacturerId>OVA</manufacturerId><individualPrice>.9110</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="136">As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.</lccNote><lccNote seq="002" type="N">Because a large number of patients may become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="281604000"><name>PSYCHOTHERAPEUTIC AGENTS ANTIDEPRESSANTS</name><genericName id="00491"><name>AMITRIPTYLINE</name><pcgGroup><pcg9 id="281604003"><itemNumber>0866</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0435</price><drug id="00016322" notABenefit="Y" sec3="Y"><name>Elavil</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335053" sec3="Y"><name>Apo-Amitriptyline</name><manufacturerId>APX</manufacturerId><individualPrice>.0435</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604002"><itemNumber>0867</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.0829</price><drug id="00016330" notABenefit="Y" sec3="Y"><name>Elavil</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335061" sec3="Y"><name>Apo-Amitriptyline</name><manufacturerId>APX</manufacturerId><individualPrice>.0829</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604001"><itemNumber>0868</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1540</price><drug id="00016349" notABenefit="Y" sec3="Y"><name>Elavil</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335088" sec3="Y"><name>Apo-Amitriptyline</name><manufacturerId>APX</manufacturerId><individualPrice>.1540</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01383"><name>BUPROPION HCL</name><pcgGroup lccId="00077"><pcg9 id="281604102"><itemNumber>0869</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2667</price><drug id="02237824" dinStatus="E" sec3="Y" sec12="Y"><name>Wellbutrin SR</name><manufacturerId>BIO</manufacturerId><individualPrice>.6188</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02275074" sec3="Y" sec12="Y"><name>Sandoz Bupropion SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2667</individualPrice><listingDate>2006-08-24</listingDate></drug><drug id="02285657" sec3="Y" sec12="Y"><name>Ratio-Bupropion SR</name><manufacturerId>RPH</manufacturerId><individualPrice>.2667</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="281604103"><itemNumber>0870</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.4000</price><drug id="02237825" sec3="Y" sec12="Y"><name>Wellbutrin SR</name><manufacturerId>BIO</manufacturerId><individualPrice>.9192</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02275082" sec3="Y" sec12="Y"><name>Sandoz Bupropion SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2006-08-24</listingDate></drug><drug id="02285665" sec3="Y" sec12="Y"><name>Ratio-Bupropion SR</name><manufacturerId>RPH</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02313421" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Bupropion SR</name><manufacturerId>PMS</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="281604120"><itemNumber>0871</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.5346</price><drug id="02275090" sec3="Y" sec12="Y"><name>Wellbutrin XL</name><manufacturerId>BIO</manufacturerId><individualPrice>.5346</individualPrice><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="281604121"><itemNumber>0872</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>1.0691</price><drug id="02275104" sec3="Y" sec12="Y"><name>Wellbutrin XL</name><manufacturerId>BIO</manufacturerId><individualPrice>1.0691</individualPrice><listingDate>2007-11-10</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="315">For the treatment of depression.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01421"><name>CITALOPRAM HYDROBROMIDE</name><pcgGroup><pcg9 id="281604096"><itemNumber>0873</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.6250</price><drug id="02239607" sec3="Y"><name>Celexa</name><manufacturerId>VLH</manufacturerId><individualPrice>1.3317</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02246056" sec3="Y"><name>Apo-Citalopram</name><manufacturerId>APX</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02246594" sec3="Y"><name>Gen-Citalopram</name><manufacturerId>GEN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248010" sec3="Y"><name>PMS-Citalopram</name><manufacturerId>PMS</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248050" sec3="Y"><name>Co-Citalopram</name><manufacturerId>COB</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248170" sec3="Y"><name>Sandoz Citalopram</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248944" dinStatus="N" sec3="Y"><name>Phl-Citalopram</name><manufacturerId>PHE</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02252112" sec3="Y"><name>Ratio-Citalopram</name><manufacturerId>RPH</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02285622" sec3="Y"><name>Ran-Citalo</name><manufacturerId>RAN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2007-05-04</listingDate></drug><drug id="02293218" sec3="Y"><name>Novo-Citalopram</name><manufacturerId>NOP</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02304686" dinStatus="N" sec3="Y"><name>Mint-Citalopram</name><manufacturerId>MIN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02306239" dinStatus="N" sec3="Y"><name>Citalopram-Odan</name><manufacturerId>ODN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2008-10-01</listingDate></drug><drug id="02313405" dinStatus="N" sec3="Y"><name>Jamp-Citalopram</name><manufacturerId>JPC</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-01-30</listingDate></drug><drug id="02322781" dinStatus="N" sec3="Y"><name>Ng-Citalopram</name><manufacturerId>NGP</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331950" dinStatus="N" sec3="Y"><name>Citalopram Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281604097"><itemNumber>0874</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.6250</price><drug id="02239608" sec3="Y"><name>Celexa</name><manufacturerId>VLH</manufacturerId><individualPrice>1.3317</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02246057" sec3="Y"><name>Apo-Citalopram</name><manufacturerId>APX</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02246595" sec3="Y"><name>Gen-Citalopram</name><manufacturerId>GEN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248011" sec3="Y"><name>PMS-Citalopram</name><manufacturerId>PMS</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248051" sec3="Y"><name>Co-Citalopram</name><manufacturerId>COB</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248171" sec3="Y"><name>Sandoz Citalopram</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02248945" dinStatus="N" sec3="Y"><name>Phl-Citalopram</name><manufacturerId>PHE</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02252120" sec3="Y"><name>Ratio-Citalopram</name><manufacturerId>RPH</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02285630" sec3="Y"><name>Ran-Citalo</name><manufacturerId>RAN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2007-05-04</listingDate></drug><drug id="02293226" sec3="Y"><name>Novo-Citalopram</name><manufacturerId>NOP</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02304694" dinStatus="N" sec3="Y"><name>Mint-Citalopram</name><manufacturerId>MIN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02306247" dinStatus="N" sec3="Y"><name>Citalopram-Odan</name><manufacturerId>ODN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2008-10-01</listingDate></drug><drug id="02313413" dinStatus="N" sec3="Y"><name>Jamp-Citalopram</name><manufacturerId>JPC</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-01-30</listingDate></drug><drug id="02322803" dinStatus="N" sec3="Y"><name>Ng-Citalopram</name><manufacturerId>NGP</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2009-11-13</listingDate></drug><drug id="02331977" dinStatus="N" sec3="Y"><name>Citalopram Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.6250</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00492"><name>CLOMIPRAMINE HCL</name><pcgGroup><pcg9 id="281604026"><itemNumber>0875</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1290</price><drug id="00330566" sec3="Y"><name>Anafranil</name><manufacturerId>ORY</manufacturerId><individualPrice>.2581</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02040786" sec3="Y"><name>Apo-Clomipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.1290</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244816" sec3="Y"><name>Co-Clomipramine</name><manufacturerId>COB</manufacturerId><individualPrice>.1290</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="281604005"><itemNumber>0876</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1758</price><drug id="00324019" sec3="Y"><name>Anafranil</name><manufacturerId>ORY</manufacturerId><individualPrice>.3516</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02040778" sec3="Y"><name>Apo-Clomipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.1758</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244817" sec3="Y"><name>Co-Clomipramine</name><manufacturerId>COB</manufacturerId><individualPrice>.1758</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="281604035"><itemNumber>0877</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3237</price><drug id="00402591" sec3="Y"><name>Anafranil</name><manufacturerId>ORY</manufacturerId><individualPrice>.6474</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02040751" sec3="Y"><name>Apo-Clomipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.3237</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244818" sec3="Y"><name>Co-Clomipramine</name><manufacturerId>COB</manufacturerId><individualPrice>.3237</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00493"><name>DESIPRAMINE</name><pcgGroup><pcg9 id="281604007"><itemNumber>0878</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1729</price><drug id="00010448" notABenefit="Y" sec3="Y"><name>Pertofrane</name><manufacturerId>GEI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01946269" sec3="Y"><name>PMS-Desipramine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1885</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01948784" dinStatus="E" sec3="Y"><name>Ratio-Desipramine</name><manufacturerId>RPH</manufacturerId><individualPrice>.1729</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099128" notABenefit="Y" sec3="Y"><name>Norpramin</name><manufacturerId>SAV</manufacturerId><listingDate>1999-01-07</listingDate></drug><drug id="02211947" sec3="Y"><name>Nu-Desipramine</name><manufacturerId>NXP</manufacturerId><individualPrice>.1885</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02216256" sec3="Y"><name>Apo-Desipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.1729</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="281604006"><itemNumber>0879</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3048</price><drug id="01946277" sec3="Y"><name>PMS-Desipramine</name><manufacturerId>PMS</manufacturerId><individualPrice>.3048</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01948792" dinStatus="E" sec3="Y"><name>Ratio-Desipramine</name><manufacturerId>RPH</manufacturerId><individualPrice>.3048</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099136" notABenefit="Y" sec3="Y"><name>Norpramin</name><manufacturerId>SAV</manufacturerId><listingDate>1999-01-07</listingDate></drug><drug id="02211955" sec3="Y"><name>Nu-Desipramine</name><manufacturerId>NXP</manufacturerId><individualPrice>.3048</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02216264" sec3="Y"><name>Apo-Desipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.3048</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="281604034"><itemNumber>0880</itemNumber><strength>75mg</strength><dosageForm>Tab</dosageForm><price>.4696</price><drug id="01946242" sec3="Y"><name>PMS-Desipramine</name><manufacturerId>PMS</manufacturerId><individualPrice>.4696</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099144" notABenefit="Y" sec3="Y"><name>Norpramin</name><manufacturerId>HMR</manufacturerId><listingDate>1999-01-07</listingDate></drug><drug id="02211963" sec3="Y"><name>Nu-Desipramine</name><manufacturerId>NXP</manufacturerId><individualPrice>.4696</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02216272" sec3="Y"><name>Apo-Desipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.4696</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00494"><name>DOXEPIN HCL</name><pcgGroup><pcg9 id="281604010"><itemNumber>0881</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.1889</price><drug id="00024325" sec3="Y"><name>Sinequan</name><manufacturerId>ERF</manufacturerId><individualPrice>.3212</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02049996" sec3="Y"><name>Apo-Doxepin</name><manufacturerId>APX</manufacturerId><individualPrice>.1889</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604009"><itemNumber>0882</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.2140</price><drug id="00024333" sec3="Y"><name>Sinequan</name><manufacturerId>ERF</manufacturerId><individualPrice>.3940</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02050005" sec3="Y"><name>Apo-Doxepin</name><manufacturerId>APX</manufacturerId><individualPrice>.2140</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604008"><itemNumber>0883</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.3971</price><drug id="00024341" sec3="Y"><name>Sinequan</name><manufacturerId>ERF</manufacturerId><individualPrice>.7308</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02050013" sec3="Y"><name>Apo-Doxepin</name><manufacturerId>APX</manufacturerId><individualPrice>.3971</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604028"><itemNumber>0884</itemNumber><strength>75mg</strength><dosageForm>Cap</dosageForm><price>.3916</price><drug id="00400750" sec3="Y"><name>Sinequan</name><manufacturerId>ERF</manufacturerId><individualPrice>1.0493</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913441" sec3="Y"><name>Novo-Doxepin</name><manufacturerId>NOP</manufacturerId><individualPrice>.3916</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02050021" sec3="Y"><name>Apo-Doxepin</name><manufacturerId>APX</manufacturerId><individualPrice>.3916</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604027"><itemNumber>0885</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.5160</price><drug id="00326925" sec3="Y"><name>Sinequan</name><manufacturerId>ERF</manufacturerId><individualPrice>1.3800</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913468" sec3="Y"><name>Novo-Doxepin</name><manufacturerId>NOP</manufacturerId><individualPrice>.5160</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02050048" sec3="Y"><name>Apo-Doxepin</name><manufacturerId>APX</manufacturerId><individualPrice>.5160</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604044"><itemNumber>0886</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.7109</price><drug id="00584274" notABenefit="Y" sec3="Y"><name>Sinequan</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01913476" sec3="Y"><name>Novo-Doxepin</name><manufacturerId>NOP</manufacturerId><individualPrice>.7109</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01745"><name>DULOXETINE</name><pcgGroup><pcg9 id="281604123"><itemNumber>0887</itemNumber><strength>30mg</strength><dosageForm>DR Cap</dosageForm><price>1.8264</price><drug id="02301482" dinStatus="N" sec3="Y"><name>Cymbalta</name><manufacturerId>LIL</manufacturerId><individualPrice>1.8264</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="281604124"><itemNumber>0888</itemNumber><strength>60mg</strength><dosageForm>DR Cap</dosageForm><price>3.6525</price><drug id="02301490" dinStatus="N" sec3="Y"><name>Cymbalta</name><manufacturerId>LIL</manufacturerId><individualPrice>3.6525</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01714"><name>ESCITALOPRAM</name><pcgGroup><pcg9 id="281604118"><itemNumber>0889</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>1.6284</price><drug id="02263238" dinStatus="N" sec3="Y"><name>Cipralex</name><manufacturerId>VLH</manufacturerId><individualPrice>1.6284</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="281604119"><itemNumber>0890</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>1.7337</price><drug id="02263254" dinStatus="N" sec3="Y"><name>Cipralex</name><manufacturerId>VLH</manufacturerId><individualPrice>1.7337</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00505"><name>FLUOXETINE HCL</name><note>Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.</note><pcgGroup><pcg9 id="281604122"><itemNumber>0891</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><drug id="02018985" notABenefit="Y" sec3="Y"><name>Prozac</name><manufacturerId>LIL</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02177579" notABenefit="Y" sec3="Y"><name>PMS-Fluoxetine</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02216353" notABenefit="Y" sec3="Y"><name>Apo-Fluoxetine</name><manufacturerId>APX</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02216582" notABenefit="Y" sec3="Y"><name>Novo-Fluoxetine</name><manufacturerId>NOP</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02223481" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Fluoxetine</name><manufacturerId>PHE</manufacturerId><listingDate>2009-11-19</listingDate></drug><drug id="02237813" notABenefit="Y" sec3="Y"><name>Gen-Fluoxetine</name><manufacturerId>GEN</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02241371" notABenefit="Y" sec3="Y"><name>Ratio-Fluoxetine</name><manufacturerId>RPH</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02243486" notABenefit="Y" sec3="Y"><name>Sandoz Fluoxetine</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="281604051"><itemNumber>0892</itemNumber><strength>20mg</strength><dosageForm>Cap</dosageForm><price>.8025</price><drug id="00636622" sec3="Y"><name>Prozac</name><manufacturerId>LIL</manufacturerId><individualPrice>1.8393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177587" sec3="Y"><name>PMS-Fluoxetine</name><manufacturerId>PMS</manufacturerId><individualPrice>.8025</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02192764" sec3="Y"><name>Nu-Fluoxetine</name><manufacturerId>NXP</manufacturerId><individualPrice>.8025</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02216361" sec3="Y"><name>Apo-Fluoxetine</name><manufacturerId>APX</manufacturerId><individualPrice>.8025</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02216590" sec3="Y"><name>Novo-Fluoxetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.8025</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02223503" dinStatus="N" sec3="Y"><name>Phl-Fluoxetine</name><manufacturerId>PHE</manufacturerId><individualPrice>.8025</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02237814" sec3="Y"><name>Gen-Fluoxetine</name><manufacturerId>GEN</manufacturerId><individualPrice>.8025</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02241374" sec3="Y"><name>Ratio-Fluoxetine</name><manufacturerId>RPH</manufacturerId><individualPrice>.8025</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02242178" sec3="Y"><name>Co-Fluoxetine</name><manufacturerId>COB</manufacturerId><individualPrice>.8025</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02243487" sec3="Y"><name>Sandoz Fluoxetine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8025</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00506"><name>FLUVOXAMINE MALEATE</name><note>Fluvoxamine therapy should be discontinued for 2 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluvoxamine.</note><pcgGroup><pcg9 id="281604058"><itemNumber>0893</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3930</price><drug id="01919342" sec3="Y"><name>Luvox</name><manufacturerId>SPH</manufacturerId><individualPrice>.8420</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02218453" sec3="Y"><name>Ratio-Fluvoxamine</name><manufacturerId>RPH</manufacturerId><individualPrice>.3930</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231192" sec3="Y"><name>Nu-Fluvoxamine</name><manufacturerId>NXP</manufacturerId><individualPrice>.3930</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02231329" sec3="Y"><name>Apo-Fluvoxamine</name><manufacturerId>APX</manufacturerId><individualPrice>.3930</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02239953" sec3="Y"><name>Novo-Fluvoxamine</name><manufacturerId>NOP</manufacturerId><individualPrice>.3930</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240682" sec3="Y"><name>PMS-Fluvoxamine</name><manufacturerId>PMS</manufacturerId><individualPrice>.3930</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02247054" sec3="Y"><name>Sandoz Fluvoxamine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3930</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02255529" sec3="Y"><name>Co-Fluvoxamine</name><manufacturerId>COB</manufacturerId><individualPrice>.3930</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9><pcg9 id="281604059"><itemNumber>0894</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.7065</price><drug id="01919369" sec3="Y"><name>Luvox</name><manufacturerId>SPH</manufacturerId><individualPrice>1.5133</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02218461" sec3="Y"><name>Ratio-Fluvoxamine</name><manufacturerId>RPH</manufacturerId><individualPrice>.7065</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231193" sec3="Y"><name>Nu-Fluvoxamine</name><manufacturerId>NXP</manufacturerId><individualPrice>.7065</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02231330" sec3="Y"><name>Apo-Fluvoxamine</name><manufacturerId>APX</manufacturerId><individualPrice>.7065</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02239954" sec3="Y"><name>Novo-Fluvoxamine</name><manufacturerId>NOP</manufacturerId><individualPrice>.7065</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240683" sec3="Y"><name>PMS-Fluvoxamine</name><manufacturerId>PMS</manufacturerId><individualPrice>.7065</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02247055" sec3="Y"><name>Sandoz Fluvoxamine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7065</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02255537" sec3="Y"><name>Co-Fluvoxamine</name><manufacturerId>COB</manufacturerId><individualPrice>.7065</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00495"><name>IMIPRAMINE</name><pcgGroup><pcg9 id="281604013"><itemNumber>0895</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1370</price><drug id="00010464" notABenefit="Y" sec3="Y"><name>Tofranil</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00360201" sec3="Y"><name>Apo-Imipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.1370</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604012"><itemNumber>0896</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.2353</price><drug id="00010472" notABenefit="Y" sec3="Y"><name>Tofranil</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00312797" sec3="Y"><name>Apo-Imipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.2353</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604011"><itemNumber>0897</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.3807</price><drug id="00010480" sec3="Y"><name>Tofranil</name><manufacturerId>NOV</manufacturerId><individualPrice>.5076</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00326852" sec3="Y"><name>Apo-Imipramine</name><manufacturerId>APX</manufacturerId><individualPrice>.3807</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00502"><name>MAPROTILINE HCL</name><pcgGroup><pcg9 id="281604031"><itemNumber>0898</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.5493</price><drug id="00360481" notABenefit="Y" sec3="Y"><name>Ludiomil</name><manufacturerId>CIB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02158612" sec3="Y"><name>Novo-Maprotiline</name><manufacturerId>NOP</manufacturerId><individualPrice>.5493</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604030"><itemNumber>0899</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>1.0401</price><drug id="00360503" notABenefit="Y" sec3="Y"><name>Ludiomil</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02158620" sec3="Y"><name>Novo-Maprotiline</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0401</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604032"><itemNumber>0900</itemNumber><strength>75mg</strength><dosageForm>Tab</dosageForm><price>1.4204</price><drug id="00360511" notABenefit="Y" sec3="Y"><name>Ludiomil</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02158639" sec3="Y"><name>Novo-Maprotiline</name><manufacturerId>NOP</manufacturerId><individualPrice>1.4204</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01529"><name>MIRTAZAPINE</name><pcgGroup><pcg9 id="281604112"><itemNumber>0901</itemNumber><strength>15mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>.1950</price><drug id="02248542" sec3="Y"><name>Remeron RD</name><manufacturerId>ORG</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2005-02-22</listingDate></drug><drug id="02279894" sec3="Y"><name>Novo-Mirtazapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>.1950</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="281604113"><itemNumber>0902</itemNumber><strength>30mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>.3900</price><drug id="02248543" sec3="Y"><name>Remeron RD</name><manufacturerId>ORG</manufacturerId><individualPrice>.7800</individualPrice><listingDate>2005-02-22</listingDate></drug><drug id="02279908" sec3="Y"><name>Novo-Mirtazapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>.3900</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="281604114"><itemNumber>0903</itemNumber><strength>45mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>.5850</price><drug id="02248544" sec3="Y"><name>Remeron RD</name><manufacturerId>ORG</manufacturerId><individualPrice>1.1700</individualPrice><listingDate>2005-02-22</listingDate></drug><drug id="02279916" sec3="Y"><name>Novo-Mirtazapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>.5850</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="281604107"><itemNumber>0904</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.6200</price><drug id="02243910" sec3="Y"><name>Remeron</name><manufacturerId>ORG</manufacturerId><individualPrice>1.2400</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02248762" sec3="Y"><name>PMS-Mirtazapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02250608" sec3="Y"><name>Sandoz Mirtazapine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02252279" dinStatus="N" sec3="Y"><name>Phl-Mirtazapine</name><manufacturerId>PHE</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02256118" sec3="Y"><name>Mylan-Mirtazapine</name><manufacturerId>MYL</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2004-09-14</listingDate></drug><drug id="02259354" sec3="Y"><name>Novo-Mirtazapine</name><manufacturerId>NOP</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2004-12-21</listingDate></drug><drug id="02267292" dinStatus="E" sec3="Y"><name>Sandoz Mirtazapine FC</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2005-12-06</listingDate></drug><drug id="02270927" sec3="Y"><name>Ratio-Mirtazapine</name><manufacturerId>RPH</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02274361" sec3="Y"><name>Co Mirtazapine</name><manufacturerId>COB</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02286629" sec3="Y"><name>Apo-Mirtazapine</name><manufacturerId>APX</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02325187" dinStatus="N" sec3="Y"><name>Zym-Mirtazapine</name><manufacturerId>ZYN</manufacturerId><individualPrice>.6200</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00509"><name>MOCLOBEMIDE</name><pcgGroup><pcg9 id="281604066"><itemNumber>0905</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2520</price><drug id="00899348" notABenefit="Y" sec3="Y"><name>Manerix</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02232148" sec3="Y"><name>Apo-Moclobemide</name><manufacturerId>APX</manufacturerId><individualPrice>.2520</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02239746" sec3="Y"><name>Novo-Moclobemide</name><manufacturerId>NOP</manufacturerId><individualPrice>.2520</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="281604067"><itemNumber>0906</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.2900</price><drug id="00899356" sec3="Y"><name>Manerix</name><manufacturerId>HLR</manufacturerId><individualPrice>.6058</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02232150" sec3="Y"><name>Apo-Moclobemide</name><manufacturerId>APX</manufacturerId><individualPrice>.2900</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02239747" sec3="Y"><name>Novo-Moclobemide</name><manufacturerId>NOP</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02243218" sec3="Y"><name>PMS-Moclobemide</name><manufacturerId>PMS</manufacturerId><individualPrice>.2900</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="281604084"><itemNumber>0907</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.5695</price><drug id="02166747" sec3="Y"><name>Manerix</name><manufacturerId>HLR</manufacturerId><individualPrice>1.1896</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02239748" sec3="Y"><name>Novo-Moclobemide</name><manufacturerId>NOP</manufacturerId><individualPrice>.5695</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240456" sec3="Y"><name>Apo-Moclobemide</name><manufacturerId>APX</manufacturerId><individualPrice>.5695</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02243219" sec3="Y"><name>PMS-Moclobemide</name><manufacturerId>PMS</manufacturerId><individualPrice>.5695</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00497"><name>NORTRIPTYLINE</name><pcgGroup><pcg9 id="281604016"><itemNumber>0908</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.1000</price><drug id="00015229" sec3="Y"><name>Aventyl</name><manufacturerId>PHE</manufacturerId><individualPrice>.2000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177692" sec3="Y"><name>PMS-Nortriptyline</name><manufacturerId>PMS</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02223139" sec3="Y"><name>Nu-Nortriptyline</name><manufacturerId>NXP</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02223511" sec3="Y"><name>Apo-Nortriptyline</name><manufacturerId>APX</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02231686" dinStatus="E" sec3="Y"><name>Gen-Nortriptyline</name><manufacturerId>GEN</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231781" sec3="Y"><name>Novo-Nortriptyline</name><manufacturerId>NOP</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02240789" dinStatus="E" sec3="Y"><name>Ratio-Nortriptyline</name><manufacturerId>RPH</manufacturerId><individualPrice>.1000</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="281604015"><itemNumber>0909</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.2022</price><drug id="00015237" sec3="Y"><name>Aventyl</name><manufacturerId>PHE</manufacturerId><individualPrice>.4043</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177706" sec3="Y"><name>PMS-Nortriptyline</name><manufacturerId>PMS</manufacturerId><individualPrice>.2022</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02223147" sec3="Y"><name>Nu-Nortriptyline</name><manufacturerId>NXP</manufacturerId><individualPrice>.2022</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02223538" sec3="Y"><name>Apo-Nortriptyline</name><manufacturerId>APX</manufacturerId><individualPrice>.2022</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02231687" dinStatus="E" sec3="Y"><name>Gen-Nortriptyline</name><manufacturerId>GEN</manufacturerId><individualPrice>.2022</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231782" sec3="Y"><name>Novo-Nortriptyline</name><manufacturerId>NOP</manufacturerId><individualPrice>.2022</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02240790" dinStatus="E" sec3="Y"><name>Ratio-Nortriptyline</name><manufacturerId>RPH</manufacturerId><individualPrice>.2022</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00511"><name>PAROXETINE HCL</name><pcgGroup><pcg9 id="281604094"><itemNumber>0910</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="02027887" notABenefit="Y" sec3="Y"><name>Paxil</name><manufacturerId>SMJ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02240907" notABenefit="Y" sec3="Y"><name>Apo-Paroxetine</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02247750" notABenefit="Y" sec3="Y"><name>PMS-Paroxetine</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02247810" notABenefit="Y" sec3="Y"><name>Ratio-Paroxetine</name><manufacturerId>RPH</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02248012" notABenefit="Y" sec3="Y"><name>Gen-Paroxetine</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02248450" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Paroxetine</name><manufacturerId>PHE</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02248556" notABenefit="Y" sec3="Y"><name>Novo-Paroxetine</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02262746" notABenefit="Y" sec3="Y"><name>Co Paroxetine</name><manufacturerId>COB</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02269422" notABenefit="Y" sec3="Y"><name>Sandoz Paroxetine</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="281604078"><itemNumber>0911</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.7950</price><drug id="01940481" sec3="Y"><name>Paxil</name><manufacturerId>GSK</manufacturerId><individualPrice>1.8056</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02240908" sec3="Y"><name>Apo-Paroxetine</name><manufacturerId>APX</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247751" sec3="Y"><name>PMS-Paroxetine</name><manufacturerId>PMS</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247811" sec3="Y"><name>Ratio-Paroxetine</name><manufacturerId>RPH</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248013" sec3="Y"><name>Gen-Paroxetine</name><manufacturerId>GEN</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248451" dinStatus="N" sec3="Y"><name>Phl-Paroxetine</name><manufacturerId>PHE</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02248557" sec3="Y"><name>Novo-Paroxetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02262754" sec3="Y"><name>Co-Paroxetine</name><manufacturerId>COB</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2005-04-28</listingDate></drug><drug id="02269430" dinStatus="N" sec3="Y"><name>Sandoz Paroxetine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7950</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9><pcg9 id="281604079"><itemNumber>0912</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.8450</price><drug id="01940473" sec3="Y"><name>Paxil</name><manufacturerId>GSK</manufacturerId><individualPrice>1.9183</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02240909" sec3="Y"><name>Apo-Paroxetine</name><manufacturerId>APX</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247752" sec3="Y"><name>PMS-Paroxetine</name><manufacturerId>PMS</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247812" sec3="Y"><name>Ratio-Paroxetine</name><manufacturerId>RPH</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248014" sec3="Y"><name>Gen-Paroxetine</name><manufacturerId>GEN</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248452" dinStatus="N" sec3="Y"><name>Phl-Paroxetine</name><manufacturerId>PHE</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02248558" sec3="Y"><name>Novo-Paroxetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02262762" sec3="Y"><name>Co-Paroxetine</name><manufacturerId>COB</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2005-04-28</listingDate></drug><drug id="02269449" dinStatus="N" sec3="Y"><name>Sandoz Paroxetine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8450</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00498"><name>PHENELZINE SULFATE</name><pcgGroup><pcg9 id="281604017"><itemNumber>0913</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.3667</price><note>Consult the scientific literature regarding cautions and contraindications prior to prescribing and/or dispensing irreversible monoamine oxidase inhibitors.</note><drug id="00476552" maO="Y" sec3="Y"><name>Nardil</name><manufacturerId>ERF</manufacturerId><individualPrice>.3667</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00507"><name>SERTRALINE HCL</name><note>Sertraline therapy should be discontinued for 2 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting sertraline.</note><pcgGroup><pcg9 id="281604093"><itemNumber>0914</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.4000</price><drug id="02132702" sec3="Y"><name>Zoloft</name><manufacturerId>PFI</manufacturerId><individualPrice>.8152</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02238280" sec3="Y"><name>Apo-Sertraline</name><manufacturerId>APX</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240485" sec3="Y"><name>Novo-Sertraline</name><manufacturerId>NOP</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02242519" sec3="Y"><name>Mylan-Sertraline</name><manufacturerId>MYL</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02244838" sec3="Y"><name>PMS-Sertraline</name><manufacturerId>PMS</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245159" sec3="Y"><name>Sandoz Sertraline</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245787" sec3="Y"><name>Ratio-Sertraline</name><manufacturerId>RPH</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02245824" dinStatus="N" sec3="Y"><name>Phl-Sertraline</name><manufacturerId>PHE</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02287390" sec3="Y"><name>Co Sertraline</name><manufacturerId>COB</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><pcg9 id="281604060"><itemNumber>0915</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.8000</price><drug id="01962817" sec3="Y"><name>Zoloft</name><manufacturerId>PFI</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02238281" sec3="Y"><name>Apo-Sertraline</name><manufacturerId>APX</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240484" sec3="Y"><name>Novo-Sertraline</name><manufacturerId>NOP</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02242520" sec3="Y"><name>Mylan-Sertraline</name><manufacturerId>MYL</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02244839" sec3="Y"><name>PMS-Sertraline</name><manufacturerId>PMS</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245160" sec3="Y"><name>Sandoz Sertraline</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245788" sec3="Y"><name>Ratio-Sertraline</name><manufacturerId>RPH</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02245825" dinStatus="N" sec3="Y"><name>Phl-Sertraline</name><manufacturerId>PHE</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02287404" sec3="Y"><name>Co Sertraline</name><manufacturerId>COB</manufacturerId><individualPrice>.8000</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><pcg9 id="281604061"><itemNumber>0916</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.8750</price><drug id="01962779" sec3="Y"><name>Zoloft</name><manufacturerId>PFI</manufacturerId><individualPrice>1.7833</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02238282" sec3="Y"><name>Apo-Sertraline</name><manufacturerId>APX</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02240481" sec3="Y"><name>Novo-Sertraline</name><manufacturerId>NOP</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02242521" sec3="Y"><name>Mylan-Sertraline</name><manufacturerId>MYL</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02244840" sec3="Y"><name>PMS-Sertraline</name><manufacturerId>PMS</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245161" sec3="Y"><name>Sandoz Sertraline</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245789" sec3="Y"><name>Ratio-Sertraline</name><manufacturerId>RPH</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02245826" dinStatus="N" sec3="Y"><name>Phl-Sertraline</name><manufacturerId>PHE</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02287412" sec3="Y"><name>Co Sertraline</name><manufacturerId>COB</manufacturerId><individualPrice>.8750</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00500"><name>TRANYLCYPROMINE SULFATE</name><pcgGroup><pcg9 id="281604020"><itemNumber>0917</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3682</price><note>Consult the scientific literature regarding cautions and contraindications prior to prescribing and/or dispensing irreversible monoamine oxidase inhibitors.</note><drug id="01919598" maO="Y" sec3="Y"><name>Parnate</name><manufacturerId>GSK</manufacturerId><individualPrice>.3682</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00504"><name>TRAZODONE HYDROCHLORIDE</name><pcgGroup><pcg9 id="281604040"><itemNumber>0918</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2214</price><drug id="00579351" sec3="Y"><name>Desyrel</name><manufacturerId>BQU</manufacturerId><individualPrice>.2214</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01937227" sec3="Y"><name>PMS-Trazodone</name><manufacturerId>PMS</manufacturerId><individualPrice>.2214</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02144263" sec3="Y"><name>Novo-Trazodone</name><manufacturerId>NOP</manufacturerId><individualPrice>.2214</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02147637" sec3="Y"><name>Apo-Trazodone</name><manufacturerId>APX</manufacturerId><individualPrice>.2214</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231683" sec3="Y"><name>Gen-Trazodone</name><manufacturerId>GEN</manufacturerId><individualPrice>.2214</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02277344" sec3="Y"><name>Ratio-Trazodone</name><manufacturerId>RPH</manufacturerId><individualPrice>.2214</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="281604041"><itemNumber>0919</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.3956</price><drug id="00579378" sec3="Y"><name>Desyrel</name><manufacturerId>BQU</manufacturerId><individualPrice>.3956</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01937235" sec3="Y"><name>PMS-Trazodone</name><manufacturerId>PMS</manufacturerId><individualPrice>.3956</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02144271" sec3="Y"><name>Novo-Trazodone</name><manufacturerId>NOP</manufacturerId><individualPrice>.3956</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02147645" sec3="Y"><name>Apo-Trazodone</name><manufacturerId>APX</manufacturerId><individualPrice>.3956</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231684" sec3="Y"><name>Gen-Trazodone</name><manufacturerId>GEN</manufacturerId><individualPrice>.3956</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02277352" sec3="Y"><name>Ratio-Trazodone</name><manufacturerId>RPH</manufacturerId><individualPrice>.3956</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="281604050"><itemNumber>0920</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.5812</price><drug id="00702277" dinStatus="E" sec3="Y"><name>Desyrel Dividose</name><manufacturerId>BQU</manufacturerId><individualPrice>.5812</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02144298" sec3="Y"><name>Novo-Trazodone</name><manufacturerId>NOP</manufacturerId><individualPrice>.5812</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02147653" sec3="Y"><name>Apo-Trazodone D</name><manufacturerId>APX</manufacturerId><individualPrice>.5812</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02277360" sec3="Y"><name>Ratio-Trazodone</name><manufacturerId>RPH</manufacturerId><individualPrice>.5812</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00501"><name>TRIMIPRAMINE</name><pcgGroup><pcg9 id="281604033"><itemNumber>0921</itemNumber><strength>75mg</strength><dosageForm>Cap</dosageForm><price>.7314</price><drug id="00761656" notABenefit="Y" sec3="Y"><name>Rhotrimine</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01926349" notABenefit="Y" sec3="Y"><name>Surmontil</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02070987" sec3="Y"><name>Apo-Trimip</name><manufacturerId>APX</manufacturerId><individualPrice>.7314</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604024"><itemNumber>0922</itemNumber><strength>12.5mg</strength><dosageForm>Tab</dosageForm><price>.2156</price><drug id="00740799" sec3="Y"><name>Apo-Trimip</name><manufacturerId>APX</manufacturerId><individualPrice>.2156</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926357" notABenefit="Y" sec3="Y"><name>Surmontil</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604023"><itemNumber>0923</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.2776</price><drug id="00740802" sec3="Y"><name>Apo-Trimip</name><manufacturerId>APX</manufacturerId><individualPrice>.2776</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926322" notABenefit="Y" sec3="Y"><name>Surmontil</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604022"><itemNumber>0924</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.5434</price><drug id="00740810" sec3="Y"><name>Apo-Trimip</name><manufacturerId>APX</manufacturerId><individualPrice>.5434</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926330" notABenefit="Y" sec3="Y"><name>Surmontil</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281604021"><itemNumber>0925</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.9273</price><drug id="00740829" sec3="Y"><name>Apo-Trimip</name><manufacturerId>APX</manufacturerId><individualPrice>.9273</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00761648" notABenefit="Y" sec3="Y"><name>Rhotrimine</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01926284" notABenefit="Y" sec3="Y"><name>Surmontil</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00513"><name>VENLAFAXINE  HCL</name><pcgGroup><pcg9 id="281604087"><itemNumber>0926</itemNumber><strength>37.5mg</strength><dosageForm>ER Cap</dosageForm><price>.4200</price><drug id="02237279" sec3="Y"><name>Effexor XR</name><manufacturerId>WAY</manufacturerId><individualPrice>.8824</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02273969" sec3="Y"><name>Ratio-Venlafaxine XR</name><manufacturerId>RPH</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02275023" sec3="Y"><name>Novo-Venlafaxine XR</name><manufacturerId>NOP</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02278545" sec3="Y"><name>PMS-Venlafaxine XR</name><manufacturerId>PMS</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02304317" sec3="Y"><name>Co Venlafaxine XR</name><manufacturerId>COB</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2008-04-09</listingDate></drug><drug id="02310279" dinStatus="N" sec3="Y"><name>Gen-Venlafaxine XR</name><manufacturerId>GEN</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310317" dinStatus="N" sec3="Y"><name>Sandoz Venlafaxine XR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02331683" dinStatus="N" sec3="Y"><name>Apo-Venlafaxine XR</name><manufacturerId>APX</manufacturerId><individualPrice>.4200</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281604088"><itemNumber>0927</itemNumber><strength>75mg</strength><dosageForm>ER Cap</dosageForm><price>.8399</price><drug id="02237280" sec3="Y"><name>Effexor XR</name><manufacturerId>WAY</manufacturerId><individualPrice>1.7647</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02273977" sec3="Y"><name>Ratio-Venlafaxine XR</name><manufacturerId>RPH</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02275031" sec3="Y"><name>Novo-Venlafaxine XR</name><manufacturerId>NOP</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02278553" sec3="Y"><name>PMS-Venlafaxine XR</name><manufacturerId>PMS</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02304325" sec3="Y"><name>Co Venlafaxine XR</name><manufacturerId>COB</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2008-04-09</listingDate></drug><drug id="02310287" dinStatus="N" sec3="Y"><name>Gen-Venlafaxine XR</name><manufacturerId>GEN</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310325" dinStatus="N" sec3="Y"><name>Sandoz Venlafaxine XR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02331691" dinStatus="N" sec3="Y"><name>Apo-Venlafaxine XR</name><manufacturerId>APX</manufacturerId><individualPrice>.8399</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281604089"><itemNumber>0928</itemNumber><strength>150mg</strength><dosageForm>ER Cap</dosageForm><price>.8868</price><drug id="02237282" sec3="Y"><name>Effexor XR</name><manufacturerId>WAY</manufacturerId><individualPrice>1.8633</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02273985" sec3="Y"><name>Ratio-Venlafaxine XR</name><manufacturerId>RPH</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02275058" sec3="Y"><name>Novo-Venlafaxine XR</name><manufacturerId>NOP</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02278561" sec3="Y"><name>PMS-Venlafaxine XR</name><manufacturerId>PMS</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="02304333" sec3="Y"><name>Co Venlafaxine XR</name><manufacturerId>COB</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2008-04-09</listingDate></drug><drug id="02310295" dinStatus="N" sec3="Y"><name>Gen-Venlafaxine XR</name><manufacturerId>GEN</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02310333" dinStatus="N" sec3="Y"><name>Sandoz Venlafaxine XR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02331705" dinStatus="N" sec3="Y"><name>Apo-Venlafaxine XR</name><manufacturerId>APX</manufacturerId><individualPrice>.8868</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="281608000"><name>PSYCHOTHERAPEUTIC AGENTS TRANQUILIZERS</name><genericName id="00540"><name>ALPRAZOLAM</name><pcgGroup><pcg9 id="281608119"><itemNumber>0929</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.0760</price><drug id="00548359" sec3="Y"><name>Xanax</name><manufacturerId>PFI</manufacturerId><individualPrice>.2532</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865397" sec3="Y"><name>Apo-Alpraz</name><manufacturerId>APX</manufacturerId><individualPrice>.0760</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913239" sec3="Y"><name>Nu-Alpraz</name><manufacturerId>NXP</manufacturerId><individualPrice>.0760</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913484" sec3="Y"><name>Novo-Alprazol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0760</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02137534" sec3="Y"><name>Gen-Alprazolam</name><manufacturerId>GEN</manufacturerId><individualPrice>.0760</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608118"><itemNumber>0930</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.0920</price><drug id="00548367" sec3="Y"><name>Xanax</name><manufacturerId>PFI</manufacturerId><individualPrice>.3027</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865400" sec3="Y"><name>Apo-Alpraz</name><manufacturerId>APX</manufacturerId><individualPrice>.0920</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913247" sec3="Y"><name>Nu-Alpraz</name><manufacturerId>NXP</manufacturerId><individualPrice>.0920</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913492" sec3="Y"><name>Novo-Alprazol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0920</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02137542" sec3="Y"><name>Gen-Alprazolam</name><manufacturerId>GEN</manufacturerId><individualPrice>.0920</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608233"><itemNumber>0931</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><drug id="00723770" notABenefit="Y" sec3="Y"><name>Xanax</name><manufacturerId>PFI</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02229813" notABenefit="Y" sec3="Y"><name>Gen-Alprazolam</name><manufacturerId>GEN</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02243611" notABenefit="Y" sec3="Y"><name>Apo-Alpraz</name><manufacturerId>APX</manufacturerId><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="281608234"><itemNumber>0932</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><drug id="00813958" notABenefit="Y" sec3="Y"><name>Xanax TS</name><manufacturerId>PFI</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02229814" notABenefit="Y" sec3="Y"><name>Gen-Alprazolam</name><manufacturerId>GEN</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02243612" notABenefit="Y" sec3="Y"><name>Apo-Alpraz TS</name><manufacturerId>APX</manufacturerId><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00541"><name>BROMAZEPAM</name><pcgGroup><pcg9 id="281608146"><itemNumber>0933</itemNumber><strength>1.5mg</strength><dosageForm>Tab</dosageForm><price>.0515</price><drug id="00682314" dinStatus="E" sec3="Y"><name>Lectopam</name><manufacturerId>HLR</manufacturerId><individualPrice>.1082</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171856" sec3="Y"><name>Nu-Bromazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.0515</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177153" sec3="Y"><name>Apo-Bromazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0515</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02192705" sec3="Y"><name>Gen-Bromazepam</name><manufacturerId>GEN</manufacturerId><individualPrice>.0515</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608123"><itemNumber>0934</itemNumber><strength>3mg</strength><dosageForm>Tab</dosageForm><price>.0700</price><drug id="00518123" sec3="Y"><name>Lectopam</name><manufacturerId>HLR</manufacturerId><individualPrice>.1499</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171864" sec3="Y"><name>Nu-Bromazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177161" sec3="Y"><name>Apo-Bromazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02192713" sec3="Y"><name>Gen-Bromazepam</name><manufacturerId>GEN</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230584" sec3="Y"><name>Novo-Bromazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="281608122"><itemNumber>0935</itemNumber><strength>6mg</strength><dosageForm>Tab</dosageForm><price>.1022</price><drug id="00518131" sec3="Y"><name>Lectopam</name><manufacturerId>HLR</manufacturerId><individualPrice>.2190</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171872" sec3="Y"><name>Nu-Bromazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.1022</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177188" sec3="Y"><name>Apo-Bromazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.1022</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02192721" sec3="Y"><name>Gen-Bromazepam</name><manufacturerId>GEN</manufacturerId><individualPrice>.1022</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230585" sec3="Y"><name>Novo-Bromazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.1022</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00515"><name>CHLORDIAZEPOXIDE</name><pcgGroup><pcg9 id="281608003"><itemNumber>0936</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.0679</price><drug id="00012629" notABenefit="Y" sec3="Y"><name>Librium</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00522724" sec3="Y"><name>Apo-Chlordiazepoxide</name><manufacturerId>APX</manufacturerId><individualPrice>.0679</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608002"><itemNumber>0937</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.1070</price><drug id="00012637" notABenefit="Y" sec3="Y"><name>Librium</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00522988" sec3="Y"><name>Apo-Chlordiazepoxide</name><manufacturerId>APX</manufacturerId><individualPrice>.1070</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608001"><itemNumber>0938</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.1658</price><drug id="00012645" notABenefit="Y" sec3="Y"><name>Librium</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00522996" sec3="Y"><name>Apo-Chlordiazepoxide</name><manufacturerId>APX</manufacturerId><individualPrice>.1658</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00517"><name>CHLORPROMAZINE</name><pcgGroup><pcg9 id="281608009"><itemNumber>0939</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1365</price><drug id="00232823" sec3="Y"><name>Novo-Chlorpromazine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1365</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01929917" notABenefit="Y" sec3="Y"><name>Largactil</name><manufacturerId>RPP</manufacturerId><listingDate>1999-07-22</listingDate></drug></pcg9><pcg9 id="281608008"><itemNumber>0940</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1565</price><drug id="00232807" sec3="Y"><name>Novo-Chlorpromazine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1565</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01929925" notABenefit="Y" sec3="Y"><name>Largactil</name><manufacturerId>RPP</manufacturerId><listingDate>1999-07-22</listingDate></drug></pcg9><pcg9 id="281608007"><itemNumber>0941</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.3200</price><drug id="00232831" sec3="Y"><name>Novo-Chlorpromazine</name><manufacturerId>NOP</manufacturerId><individualPrice>.3200</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01929933" notABenefit="Y" sec3="Y"><name>Largactil</name><manufacturerId>RPP</manufacturerId><listingDate>1999-07-22</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00519"><name>CLORAZEPATE DIPOTASSIUM</name><pcgGroup><pcg9 id="281608022"><itemNumber>0942</itemNumber><strength>3.75mg</strength><dosageForm>Cap</dosageForm><price>.0694</price><drug id="00264938" notABenefit="Y" sec3="Y"><name>Tranxene</name><manufacturerId>ABB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00860689" sec3="Y"><name>Apo-Clorazepate</name><manufacturerId>APX</manufacturerId><individualPrice>.0694</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608021"><itemNumber>0943</itemNumber><strength>7.5mg</strength><dosageForm>Cap</dosageForm><price>.0953</price><drug id="00264946" dinStatus="E" sec3="Y"><name>Tranxene</name><manufacturerId>ABB</manufacturerId><individualPrice>.1905</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00860700" sec3="Y"><name>Apo-Clorazepate</name><manufacturerId>APX</manufacturerId><individualPrice>.0953</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608020"><itemNumber>0944</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><price>.1715</price><drug id="00264911" dinStatus="E" sec3="Y"><name>Tranxene</name><manufacturerId>ABB</manufacturerId><individualPrice>.3430</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00860697" sec3="Y"><name>Apo-Clorazepate</name><manufacturerId>APX</manufacturerId><individualPrice>.1715</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00544"><name>CLOZAPINE</name><pcgGroup><pcg9 id="281608157"><itemNumber>0945</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><drug id="00894737" notABenefit="Y" sec3="Y"><name>Clozaril</name><manufacturerId>NOV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02247243" notABenefit="Y" sec3="Y"><name>Gen-Clozapine</name><manufacturerId>GEN</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02248034" notABenefit="Y" sec3="Y"><name>Apo-Clozapine</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="281608158"><itemNumber>0946</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="00894745" notABenefit="Y" sec3="Y"><name>Clozaril</name><manufacturerId>NOV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02247244" notABenefit="Y" sec3="Y"><name>Gen-Clozapine</name><manufacturerId>GEN</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02248035" notABenefit="Y" sec3="Y"><name>Apo-Clozapine</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00520"><name>DIAZEPAM</name><pcgGroup><pcg9 id="281608201"><itemNumber>0947</itemNumber><strength>5mg/mL</strength><dosageForm>Rect Gel-2x 5mg Pk</dosageForm><price>142.1700</price><drug id="02238162" sec3="Y"><name>Diastat</name><manufacturerId>VAL</manufacturerId><individualPrice>142.1700</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="281608202"><itemNumber>0948</itemNumber><strength>5mg/mL</strength><dosageForm>Rect Gel-2x10mg Pk</dosageForm><price>142.1700</price><drug id="09853340" sec3="Y"><name>Diastat</name><manufacturerId>VAL</manufacturerId><individualPrice>142.1700</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="281608203"><itemNumber>0949</itemNumber><strength>5mg/mL</strength><dosageForm>Rect Gel-2x15mg Pk</dosageForm><price>142.1700</price><drug id="09853430" sec3="Y"><name>Diastat</name><manufacturerId>VAL</manufacturerId><individualPrice>142.1700</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="281608025"><itemNumber>0950</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0508</price><drug id="00013277" notABenefit="Y" sec3="Y"><name>Valium</name><manufacturerId>HLR</manufacturerId><listingDate>2005-02-22</listingDate></drug><drug id="00405329" sec3="Y"><name>Apo-Diazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0508</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608024"><itemNumber>0951</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0650</price><drug id="00013285" notABenefit="Y" sec3="Y"><name>Valium</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00362158" sec3="Y"><name>Apo-Diazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0650</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608023"><itemNumber>0952</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0867</price><drug id="00013293" notABenefit="Y" sec3="Y"><name>Valium</name><manufacturerId>HLR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00405337" sec3="Y"><name>Apo-Diazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0867</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00539"><name>FLUPENTHIXOL DECANOATE</name><pcgGroup><pcg9 id="281608250"><itemNumber>0953</itemNumber><strength>200mg/2mL</strength><dosageForm>Inj  Sol-2mL Pk</dosageForm><drug id="09857337" notABenefit="Y" sec3="Y"><name>Fluanxol Depot</name><manufacturerId>VLH</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608251"><itemNumber>0954</itemNumber><strength>200mg/10mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><drug id="09857339" notABenefit="Y" sec3="Y"><name>Fluanxol Depot</name><manufacturerId>VLH</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608111"><itemNumber>0955</itemNumber><strength>20mg/mL</strength><dosageForm>Inj Sol-1mL Amp Pk</dosageForm><price>7.1860</price><drug id="02156032" sec3="Y"><name>Fluanxol Depot</name><manufacturerId>VLH</manufacturerId><individualPrice>7.1860</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608110"><itemNumber>0956</itemNumber><strength>100mg/mL</strength><dosageForm>Inj Sol-1mL Amp Pk</dosageForm><price>35.9300</price><drug id="02156040" sec3="Y"><name>Fluanxol Depot</name><manufacturerId>VLH</manufacturerId><individualPrice>35.9300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00542"><name>FLUPENTHIXOL DIHYDROCHLORIDE</name><pcgGroup><pcg9 id="281608134"><itemNumber>0957</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.2483</price><drug id="02156008" sec3="Y"><name>Fluanxol</name><manufacturerId>VLH</manufacturerId><individualPrice>.2483</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608130"><itemNumber>0958</itemNumber><strength>3mg</strength><dosageForm>Tab</dosageForm><price>.5362</price><drug id="02156016" sec3="Y"><name>Fluanxol</name><manufacturerId>VLH</manufacturerId><individualPrice>.5362</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00534"><name>FLUPHENAZINE DECANOATE</name><pcgGroup><pcg9 id="281608151"><itemNumber>0959</itemNumber><strength>100mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>29.7800</price><drug id="00755575" sec3="Y"><name>Modecate Concentrate</name><manufacturerId>BQU</manufacturerId><individualPrice>29.7800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608094"><itemNumber>0960</itemNumber><strength>125mg/5mL</strength><dosageForm>Inj Susp-5mL Pk</dosageForm><price>23.1600</price><drug id="00349917" notABenefit="Y" sec3="Y"><name>Modecate</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02091275" sec3="Y"><name>PMS-Fluphenazine Decanoate</name><manufacturerId>PMS</manufacturerId><individualPrice>23.1600</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00521"><name>FLUPHENAZINE HCL</name><pcgGroup><pcg9 id="281608030"><itemNumber>0961</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.1739</price><drug id="00029378" notABenefit="Y" sec3="Y"><name>Moditen HCL</name><manufacturerId>BQU</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00405345" sec3="Y"><name>Apo-Fluphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1739</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608029"><itemNumber>0962</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.2252</price><drug id="00029386" notABenefit="Y" sec3="Y"><name>Moditen HCL</name><manufacturerId>BQU</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00410632" sec3="Y"><name>Apo-Fluphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.2252</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608028"><itemNumber>0963</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1720</price><drug id="00029408" notABenefit="Y" sec3="Y"><name>Moditen HCL</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00405361" sec3="Y"><name>Apo-Fluphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1720</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00523"><name>HALOPERIDOL</name><pcgGroup><pcg9 id="281608038"><itemNumber>0964</itemNumber><strength>5mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>4.0000</price><drug id="00017574" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00808652" sec3="Y"><name>Haloperidol</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.0000</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="281608036"><itemNumber>0965</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.0360</price><drug id="00017655" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363685" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0360</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00396796" sec3="Y"><name>Apo-Haloperidol</name><manufacturerId>APX</manufacturerId><individualPrice>.0360</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608035"><itemNumber>0966</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.0614</price><drug id="00017663" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363677" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0614</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00396818" sec3="Y"><name>Apo-Haloperidol</name><manufacturerId>APX</manufacturerId><individualPrice>.0614</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608034"><itemNumber>0967</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1050</price><drug id="00017671" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363669" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1050</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00396826" sec3="Y"><name>Apo-Haloperidol</name><manufacturerId>APX</manufacturerId><individualPrice>.1050</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608033"><itemNumber>0968</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1487</price><drug id="00017698" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363650" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1487</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00396834" sec3="Y"><name>Apo-Haloperidol</name><manufacturerId>APX</manufacturerId><individualPrice>.1487</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608101"><itemNumber>0969</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1330</price><drug id="00381772" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00463698" sec3="Y"><name>Apo-Haloperidol</name><manufacturerId>APX</manufacturerId><individualPrice>.1330</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00713449" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1330</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608112"><itemNumber>0970</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.6304</price><drug id="00499579" notABenefit="Y" sec3="Y"><name>Haldol</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00768820" sec3="Y"><name>Novo-Peridol</name><manufacturerId>NOP</manufacturerId><individualPrice>.6304</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00543"><name>HALOPERIDOL DECANOATE</name><pcgGroup><pcg9 id="281608132"><itemNumber>0971</itemNumber><strength>100mg/mL Oily</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>11.6648</price><drug id="00599093" notABenefit="Y" sec3="Y"><name>Haldol-LA</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02130300" sec3="Y"><name>Haloperidol LA</name><manufacturerId>SDZ</manufacturerId><individualPrice>11.6648</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="281608141"><itemNumber>0972</itemNumber><strength>50mg/mL Oily</strength><dosageForm>Inj Sol-5mL Pk</dosageForm><price>30.2500</price><drug id="00599085" notABenefit="Y" sec3="Y"><name>Haldol-LA</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02130297" sec3="Y"><name>Haloperidol LA</name><manufacturerId>SDZ</manufacturerId><individualPrice>30.2500</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="281608140"><itemNumber>0973</itemNumber><strength>100mg/mL Oily</strength><dosageForm>Inj Sol-5mL Pk</dosageForm><price>58.3240</price><drug id="00980803" notABenefit="Y" sec3="Y"><name>Haldol-LA</name><manufacturerId>OMC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="09853758" sec3="Y"><name>Haloperidol LA</name><manufacturerId>SDZ</manufacturerId><individualPrice>58.3240</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00524"><name>HYDROXYZINE HCL</name><pcgGroup><pcg9 id="281608041"><itemNumber>0974</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><drug id="00024376" notABenefit="Y" sec3="Y"><name>Atarax</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00646059" notABenefit="Y" sec3="Y"><name>Apo-Hydroxyzine</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00738824" notABenefit="Y" sec3="Y"><name>Novo-Hydroxyzin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01927876" notABenefit="Y" sec3="Y"><name>Multipax</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608040"><itemNumber>0975</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><drug id="00024384" notABenefit="Y" sec3="Y"><name>Atarax</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00646024" notABenefit="Y" sec3="Y"><name>Apo-Hydroxyzine</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00738832" notABenefit="Y" sec3="Y"><name>Novo-Hydroxyzin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01938835" notABenefit="Y" sec3="Y"><name>Multipax</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608039"><itemNumber>0976</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><drug id="00024392" notABenefit="Y" sec3="Y"><name>Atarax</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00646016" notABenefit="Y" sec3="Y"><name>Apo-Hydroxyzine</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00738840" notABenefit="Y" sec3="Y"><name>Novo-Hydroxyzin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01927884" notABenefit="Y" sec3="Y"><name>Multipax</name><manufacturerId>RPP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00536"><name>LORAZEPAM</name><pcgGroup><pcg9 id="281608136"><itemNumber>0977</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.0359</price><drug id="00655740" sec3="Y"><name>Apo-Lorazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0359</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00711101" sec3="Y"><name>Novo-Lorazem</name><manufacturerId>NOP</manufacturerId><individualPrice>.0359</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00728187" sec3="Y"><name>PMS-Lorazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.0359</individualPrice><listingDate>2002-04-04</listingDate></drug><drug id="00865672" sec3="Y"><name>Nu-Loraz</name><manufacturerId>NXP</manufacturerId><individualPrice>.0359</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02041413" sec3="Y"><name>Ativan</name><manufacturerId>WAY</manufacturerId><individualPrice>.0359</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608098"><itemNumber>0978</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.0447</price><drug id="00637742" sec3="Y"><name>Novo-Lorazem</name><manufacturerId>NOP</manufacturerId><individualPrice>.0447</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00655759" sec3="Y"><name>Apo-Lorazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0447</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00728195" sec3="Y"><name>PMS-Lorazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.0447</individualPrice><listingDate>2002-04-04</listingDate></drug><drug id="00865680" sec3="Y"><name>Nu-Loraz</name><manufacturerId>NXP</manufacturerId><individualPrice>.0447</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02041421" sec3="Y"><name>Ativan</name><manufacturerId>WAY</manufacturerId><individualPrice>.0447</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608099"><itemNumber>0979</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0699</price><drug id="00637750" sec3="Y"><name>Novo-Lorazem</name><manufacturerId>NOP</manufacturerId><individualPrice>.0699</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00655767" sec3="Y"><name>Apo-Lorazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0699</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00728209" sec3="Y"><name>PMS-Lorazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.0699</individualPrice><listingDate>2002-04-04</listingDate></drug><drug id="00865699" sec3="Y"><name>Nu-Loraz</name><manufacturerId>NXP</manufacturerId><individualPrice>.0699</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02041448" sec3="Y"><name>Ativan</name><manufacturerId>WAY</manufacturerId><individualPrice>.0699</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00555"><name>LOXAPINE SUCCINATE</name><pcgGroup><pcg9 id="281608241"><itemNumber>0980</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1500</price><drug id="02170019" notABenefit="Y" sec3="Y"><name>Loxapac</name><manufacturerId>WAY</manufacturerId><listingDate>1998-03-17</listingDate></drug><drug id="02230837" sec3="Y"><name>PMS-Loxapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1500</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="281608242"><itemNumber>0981</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2498</price><drug id="02170027" notABenefit="Y" sec3="Y"><name>Loxapac</name><manufacturerId>WAY</manufacturerId><listingDate>1998-11-19</listingDate></drug><drug id="02230838" sec3="Y"><name>PMS-Loxapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.2498</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="281608243"><itemNumber>0982</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.3872</price><drug id="02170132" notABenefit="Y" sec3="Y"><name>Loxapac</name><manufacturerId>WAY</manufacturerId><listingDate>1998-11-19</listingDate></drug><drug id="02230839" sec3="Y"><name>PMS-Loxapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.3872</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="281608244"><itemNumber>0983</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.5162</price><drug id="02170035" notABenefit="Y" sec3="Y"><name>Loxapac</name><manufacturerId>WAY</manufacturerId><listingDate>1998-03-17</listingDate></drug><drug id="02230840" sec3="Y"><name>PMS-Loxapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.5162</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00553"><name>OLANZAPINE</name><pcgGroup><pcg9 id="281608249"><itemNumber>0984</itemNumber><strength>20mg</strength><dosageForm>Rapid Dissolve Tab</dosageForm><drug id="02243089" notABenefit="Y" sec3="Y"><name>Zyprexa Zydis</name><manufacturerId>LIL</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02321386" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Olanzapine OD</name><manufacturerId>NOP</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02327597" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Olanzapine ODT</name><manufacturerId>COB</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02327805" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Olanzapine ODT</name><manufacturerId>SDZ</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608206"><itemNumber>0985</itemNumber><strength>5mg</strength><dosageForm>Rapid Dissolve Tab</dosageForm><price>1.7870</price><drug id="02243086" sec3="Y"><name>Zyprexa Zydis</name><manufacturerId>LIL</manufacturerId><individualPrice>3.5746</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02303191" dinStatus="N" sec3="Y"><name>PMS-Olanzapine ODT</name><manufacturerId>PMS</manufacturerId><individualPrice>1.7870</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02321343" dinStatus="N" sec3="Y"><name>Novo-Olanzapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>1.7870</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02327562" dinStatus="N" sec3="Y"><name>Co Olanzapine ODT</name><manufacturerId>COB</manufacturerId><individualPrice>1.7870</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02327775" dinStatus="N" sec3="Y"><name>Sandoz Olanzapine ODT</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.7873</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608207"><itemNumber>0986</itemNumber><strength>10mg</strength><dosageForm>Rapid Dissolve Tab</dosageForm><price>3.5714</price><drug id="02243087" sec3="Y"><name>Zyprexa Zydis</name><manufacturerId>LIL</manufacturerId><individualPrice>7.1429</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02303205" dinStatus="N" sec3="Y"><name>PMS-Olanzapine ODT</name><manufacturerId>PMS</manufacturerId><individualPrice>3.5714</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02321351" dinStatus="N" sec3="Y"><name>Novo-Olanzapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>3.5714</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02327570" dinStatus="N" sec3="Y"><name>Co Olanzapine ODT</name><manufacturerId>COB</manufacturerId><individualPrice>3.5714</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02327783" dinStatus="N" sec3="Y"><name>Sandoz Olanzapine ODT</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.5714</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608225"><itemNumber>0987</itemNumber><strength>15mg</strength><dosageForm>Rapid Dissolve Tab</dosageForm><price>5.3553</price><drug id="02243088" sec3="Y"><name>Zyprexa Zydis</name><manufacturerId>LIL</manufacturerId><individualPrice>10.7111</individualPrice><listingDate>2005-02-22</listingDate></drug><drug id="02303213" dinStatus="N" sec3="Y"><name>PMS-Olanzapine ODT</name><manufacturerId>PMS</manufacturerId><individualPrice>5.3553</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02321378" dinStatus="N" sec3="Y"><name>Novo-Olanzapine OD</name><manufacturerId>NOP</manufacturerId><individualPrice>5.3553</individualPrice><listingDate>2010-03-02</listingDate></drug><drug id="02327589" dinStatus="N" sec3="Y"><name>Co Olanzapine ODT</name><manufacturerId>COB</manufacturerId><individualPrice>5.3553</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02327791" dinStatus="N" sec3="Y"><name>Sandoz Olanzapine ODT</name><manufacturerId>SDZ</manufacturerId><individualPrice>5.3555</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608248"><itemNumber>0988</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><drug id="02238851" notABenefit="Y" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02325713" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02333015" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="281608195"><itemNumber>0989</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.8438</price><drug id="02229250" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><individualPrice>1.7972</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02276712" sec3="Y"><name>Novo-Olanzapine</name><manufacturerId>NOP</manufacturerId><individualPrice>.8438</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02281791" dinStatus="N" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><individualPrice>.8438</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02303116" dinStatus="N" sec3="Y"><name>PMS-Olanzapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.8438</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02325659" dinStatus="N" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><individualPrice>.8438</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608187"><itemNumber>0990</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>1.6875</price><drug id="02229269" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><individualPrice>3.5944</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02276720" sec3="Y"><name>Novo-Olanzapine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.6875</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02281805" dinStatus="N" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><individualPrice>1.6875</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02303159" dinStatus="N" sec3="Y"><name>PMS-Olanzapine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.6875</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02325667" dinStatus="N" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><individualPrice>1.6875</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608188"><itemNumber>0991</itemNumber><strength>7.5mg</strength><dosageForm>Tab</dosageForm><price>2.5313</price><drug id="02229277" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><individualPrice>5.3916</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02276739" sec3="Y"><name>Novo-Olanzapine</name><manufacturerId>NOP</manufacturerId><individualPrice>2.5313</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02281813" dinStatus="N" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><individualPrice>2.5313</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02303167" dinStatus="N" sec3="Y"><name>PMS-Olanzapine</name><manufacturerId>PMS</manufacturerId><individualPrice>2.5313</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02325675" dinStatus="N" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><individualPrice>2.5313</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608189"><itemNumber>0992</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>3.3750</price><drug id="02229285" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><individualPrice>7.1888</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02276747" sec3="Y"><name>Novo-Olanzapine</name><manufacturerId>NOP</manufacturerId><individualPrice>3.3750</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02281821" dinStatus="N" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><individualPrice>3.3750</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02303175" dinStatus="N" sec3="Y"><name>PMS-Olanzapine</name><manufacturerId>PMS</manufacturerId><individualPrice>3.3750</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02325683" dinStatus="N" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><individualPrice>3.3750</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608211"><itemNumber>0993</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>5.0625</price><drug id="02238850" sec3="Y"><name>Zyprexa</name><manufacturerId>LIL</manufacturerId><individualPrice>10.7831</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02276755" sec3="Y"><name>Novo-Olanzapine</name><manufacturerId>NOP</manufacturerId><individualPrice>5.0625</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02281848" dinStatus="N" sec3="Y"><name>Apo-Olanzapine</name><manufacturerId>APX</manufacturerId><individualPrice>5.0625</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02303183" dinStatus="N" sec3="Y"><name>PMS-Olanzapine</name><manufacturerId>PMS</manufacturerId><individualPrice>5.0625</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02325691" dinStatus="N" sec3="Y"><name>Co Olanzapine</name><manufacturerId>COB</manufacturerId><individualPrice>5.0625</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00528"><name>OXAZEPAM</name><pcgGroup><pcg9 id="281608052"><itemNumber>0994</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0350</price><drug id="00402680" sec3="Y"><name>Apo-Oxazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0350</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02043653" notABenefit="Y" sec3="Y"><name>Serax</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608051"><itemNumber>0995</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><price>.0550</price><drug id="00402745" sec3="Y"><name>Apo-Oxazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0550</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02043661" notABenefit="Y" sec3="Y"><name>Serax</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608050"><itemNumber>0996</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.0750</price><drug id="00402737" sec3="Y"><name>Apo-Oxazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0750</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02043688" notABenefit="Y" sec3="Y"><name>Serax</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01759"><name>PALIPERIDONE</name><pcgGroup><pcg9 id="281608245"><itemNumber>0997</itemNumber><strength>3mg</strength><dosageForm>ER Tab</dosageForm><price>3.4780</price><drug id="02300273" dinStatus="N" sec3="Y"><name>Invega</name><manufacturerId>JNO</manufacturerId><individualPrice>3.4780</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="281608246"><itemNumber>0998</itemNumber><strength>6mg</strength><dosageForm>ER Tab</dosageForm><price>5.2060</price><drug id="02300281" dinStatus="N" sec3="Y"><name>Invega</name><manufacturerId>JNO</manufacturerId><individualPrice>5.2060</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="281608247"><itemNumber>0999</itemNumber><strength>9mg</strength><dosageForm>ER Tab</dosageForm><price>6.9450</price><drug id="02300303" dinStatus="N" sec3="Y"><name>Invega</name><manufacturerId>JNO</manufacturerId><individualPrice>6.9450</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00527"><name>PERICYAZINE</name><pcgGroup><pcg9 id="281608054"><itemNumber>1000</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.2251</price><drug id="01926780" sec3="Y"><name>Neuleptil</name><manufacturerId>ERF</manufacturerId><individualPrice>.2251</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608053"><itemNumber>1001</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.3856</price><drug id="01926772" sec3="Y"><name>Neuleptil</name><manufacturerId>ERF</manufacturerId><individualPrice>.3856</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608049"><itemNumber>1002</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.3780</price><drug id="01926756" sec3="Y"><name>Neuleptil</name><manufacturerId>ERF</manufacturerId><individualPrice>.3780</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00529"><name>PERPHENAZINE</name><pcgGroup><pcg9 id="281608057"><itemNumber>1003</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0626</price><drug id="00028290" notABenefit="Y" sec3="Y"><name>Trilafon</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335134" sec3="Y"><name>Apo-Perphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.0626</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608056"><itemNumber>1004</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.0758</price><drug id="00028304" notABenefit="Y" sec3="Y"><name>Trilafon</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335126" sec3="Y"><name>Apo-Perphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.0758</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608055"><itemNumber>1005</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>.0832</price><drug id="00028312" notABenefit="Y" sec3="Y"><name>Trilafon</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335118" sec3="Y"><name>Apo-Perphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.0832</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608097"><itemNumber>1006</itemNumber><strength>16mg</strength><dosageForm>Tab</dosageForm><price>.1274</price><drug id="00028320" notABenefit="Y" sec3="Y"><name>Trilafon</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00335096" sec3="Y"><name>Apo-Perphenazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1274</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00535"><name>PIMOZIDE</name><pcgGroup><pcg9 id="281608096"><itemNumber>1007</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.2279</price><drug id="00313815" sec3="Y"><name>Orap</name><manufacturerId>PHE</manufacturerId><individualPrice>.2279</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245432" sec3="Y"><name>Apo-Pimozide</name><manufacturerId>APX</manufacturerId><individualPrice>.2279</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="281608095"><itemNumber>1008</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.4136</price><drug id="00313823" sec3="Y"><name>Orap</name><manufacturerId>PHE</manufacturerId><individualPrice>.4136</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245433" sec3="Y"><name>Apo-Pimozide</name><manufacturerId>APX</manufacturerId><individualPrice>.4136</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00538"><name>PIPOTIAZINE PALMITATE</name><pcgGroup><pcg9 id="281608107"><itemNumber>1009</itemNumber><strength>25mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>15.5000</price><drug id="01926667" sec3="Y"><name>Piportil L4</name><manufacturerId>SAV</manufacturerId><individualPrice>15.5000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608135"><itemNumber>1010</itemNumber><strength>50mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>26.2800</price><drug id="00990507" sec3="Y"><name>Piportil L4</name><manufacturerId>SAV</manufacturerId><individualPrice>26.2800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608106"><itemNumber>1011</itemNumber><strength>100mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>49.9000</price><drug id="01926675" sec3="Y"><name>Piportil L4</name><manufacturerId>SAV</manufacturerId><individualPrice>49.9000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00530"><name>PROCHLORPERAZINE</name><pcgGroup><pcg9 id="281608066"><itemNumber>1012</itemNumber><strength>10mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>1.4000</price><drug id="00789747" sec3="Y"><name>Prochlorperazine Mesylate</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.4000</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="01927779" notABenefit="Y" sec3="Y"><name>Stemetil</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608063"><itemNumber>1013</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1055</price><drug id="00886440" sec3="Y"><name>Apo-Prochlorazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1055</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="01927752" notABenefit="Y" sec3="Y"><name>Stemetil</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608062"><itemNumber>1014</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1290</price><drug id="00886432" sec3="Y"><name>Apo-Prochlorazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1290</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="01927760" notABenefit="Y" sec3="Y"><name>Stemetil</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01361"><name>QUETIAPINE</name><pcgGroup><pcg9 id="281608235"><itemNumber>1015</itemNumber><strength>50mg</strength><dosageForm>ER Tab</dosageForm><price>.9800</price><drug id="02300184" dinStatus="N" sec3="Y"><name>Seroquel XR</name><manufacturerId>AZC</manufacturerId><individualPrice>.9800</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281608236"><itemNumber>1016</itemNumber><strength>200mg</strength><dosageForm>ER Tab</dosageForm><price>2.6200</price><drug id="02300192" dinStatus="N" sec3="Y"><name>Seroquel XR</name><manufacturerId>AZC</manufacturerId><individualPrice>2.6200</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281608237"><itemNumber>1017</itemNumber><strength>300mg</strength><dosageForm>ER Tab</dosageForm><price>3.8600</price><drug id="02300206" dinStatus="N" sec3="Y"><name>Seroquel XR</name><manufacturerId>AZC</manufacturerId><individualPrice>3.8600</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281608238"><itemNumber>1018</itemNumber><strength>400mg</strength><dosageForm>ER Tab</dosageForm><price>5.2400</price><drug id="02300214" dinStatus="N" sec3="Y"><name>Seroquel XR</name><manufacturerId>AZC</manufacturerId><individualPrice>5.2400</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281608191"><itemNumber>1019</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.2470</price><drug id="02236951" sec3="Y"><name>Seroquel</name><manufacturerId>AZC</manufacturerId><individualPrice>.4940</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02284235" dinStatus="N" sec3="Y"><name>Novo-Quetiapine</name><manufacturerId>NOP</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02296551" dinStatus="N" sec3="Y"><name>PMS-Quetiapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02307804" dinStatus="N" sec3="Y"><name>Gen-Quetiapine</name><manufacturerId>GEN</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02311704" dinStatus="N" sec3="Y"><name>Ratio-Quetiapine</name><manufacturerId>RPH</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02313901" dinStatus="N" sec3="Y"><name>Apo-Quetiapine</name><manufacturerId>APX</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02313995" dinStatus="N" sec3="Y"><name>Sandoz Quetiapine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02316080" dinStatus="N" sec3="Y"><name>Co Quetiapine</name><manufacturerId>COB</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02330415" dinStatus="N" sec3="Y"><name>Jamp-Quetiapine</name><manufacturerId>JPC</manufacturerId><individualPrice>.2470</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608192"><itemNumber>1020</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.6590</price><drug id="02236952" sec3="Y"><name>Seroquel</name><manufacturerId>AZC</manufacturerId><individualPrice>1.3180</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02284243" dinStatus="N" sec3="Y"><name>Novo-Quetiapine</name><manufacturerId>NOP</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02296578" dinStatus="N" sec3="Y"><name>PMS-Quetiapine</name><manufacturerId>PMS</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02307812" dinStatus="N" sec3="Y"><name>Gen-Quetiapine</name><manufacturerId>GEN</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02311712" dinStatus="N" sec3="Y"><name>Ratio-Quetiapine</name><manufacturerId>RPH</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02313928" dinStatus="N" sec3="Y"><name>Apo-Quetiapine</name><manufacturerId>APX</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02314002" dinStatus="N" sec3="Y"><name>Sandoz Quetiapine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02316099" dinStatus="N" sec3="Y"><name>Co Quetiapine</name><manufacturerId>COB</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02330423" dinStatus="N" sec3="Y"><name>Jamp-Quetiapine</name><manufacturerId>JPC</manufacturerId><individualPrice>.6590</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608209"><itemNumber>1021</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><drug id="02240862" notABenefit="Y" sec3="Y"><name>Seroquel</name><manufacturerId>AZC</manufacturerId><listingDate>2002-04-04</listingDate></drug><drug id="02284251" notABenefit="Y" sec3="Y"><name>Novo-Quetiapine</name><manufacturerId>NOP</manufacturerId><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="281608193"><itemNumber>1022</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>1.3233</price><drug id="02236953" sec3="Y"><name>Seroquel</name><manufacturerId>AZC</manufacturerId><individualPrice>2.6467</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02284278" dinStatus="N" sec3="Y"><name>Novo-Quetiapine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02296594" dinStatus="N" sec3="Y"><name>PMS-Quetiapine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02307839" dinStatus="N" sec3="Y"><name>Gen-Quetiapine</name><manufacturerId>GEN</manufacturerId><individualPrice>1.3234</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02311747" dinStatus="N" sec3="Y"><name>Ratio-Quetiapine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.3234</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02313936" dinStatus="N" sec3="Y"><name>Apo-Quetiapine</name><manufacturerId>APX</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02314010" dinStatus="N" sec3="Y"><name>Sandoz Quetiapine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02316110" dinStatus="N" sec3="Y"><name>Co Quetiapine</name><manufacturerId>COB</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02330458" dinStatus="N" sec3="Y"><name>Jamp-Quetiapine</name><manufacturerId>JPC</manufacturerId><individualPrice>1.3233</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608210"><itemNumber>1023</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>1.9312</price><drug id="02244107" sec3="Y"><name>Seroquel</name><manufacturerId>AZC</manufacturerId><individualPrice>3.8625</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02284286" dinStatus="N" sec3="Y"><name>Novo-Quetiapine</name><manufacturerId>NOP</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02296608" dinStatus="N" sec3="Y"><name>PMS-Quetiapine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02307847" dinStatus="N" sec3="Y"><name>Gen-Quetiapine</name><manufacturerId>GEN</manufacturerId><individualPrice>1.9313</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02311755" dinStatus="N" sec3="Y"><name>Ratio-Quetiapine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.9313</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02313944" dinStatus="N" sec3="Y"><name>Apo-Quetiapine</name><manufacturerId>APX</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02314029" dinStatus="N" sec3="Y"><name>Sandoz Quetiapine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02316129" dinStatus="N" sec3="Y"><name>Co Quetiapine</name><manufacturerId>COB</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2008-12-03</listingDate></drug><drug id="02330466" dinStatus="N" sec3="Y"><name>Jamp-Quetiapine</name><manufacturerId>JPC</manufacturerId><individualPrice>1.9312</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00546"><name>RISPERIDONE</name><pcgGroup><pcg9 id="281608194"><itemNumber>1024</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>.5520</price><drug id="02236950" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>1.3720</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02279266" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.5520</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02280396" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.5520</individualPrice><listingDate>2006-09-06</listingDate></drug></pcg9><pcg9 id="281608217"><itemNumber>1025</itemNumber><strength>0.5mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>.7450</price><drug id="02247704" sec3="Y"><name>Risperdal M-Tab</name><manufacturerId>JNO</manufacturerId><individualPrice>.7450</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="281608216"><itemNumber>1026</itemNumber><strength>1mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>1.0300</price><drug id="02247705" sec3="Y"><name>Risperdal M-Tab</name><manufacturerId>JNO</manufacturerId><individualPrice>1.0300</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="281608218"><itemNumber>1027</itemNumber><strength>2mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>2.0375</price><drug id="02247706" sec3="Y"><name>Risperdal M-Tab</name><manufacturerId>JNO</manufacturerId><individualPrice>2.0375</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="281608229"><itemNumber>1028</itemNumber><strength>3mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>3.0550</price><drug id="02268086" sec3="Y"><name>Risperdal M-Tab</name><manufacturerId>JNO</manufacturerId><individualPrice>3.0550</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9><pcg9 id="281608230"><itemNumber>1029</itemNumber><strength>4mg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>4.0850</price><drug id="02268094" sec3="Y"><name>Risperdal M-Tab</name><manufacturerId>JNO</manufacturerId><individualPrice>4.0850</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9><pcg9 id="281608226"><itemNumber>1030</itemNumber><strength>25mg</strength><dosageForm>Pd for Inj-Vial Pk</dosageForm><price>156.5500</price><note>NOTE: For the treatment of schizophrenia or schizoaffective disorders in patient who have:
A history of non-adherence; AND
Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; AND
Inadequate control or significant side-effects from one or more conventional depot
antipsychotic agents.</note><drug id="02255707" dinStatus="N" sec3="Y"><name>Risperdal Consta</name><manufacturerId>JNO</manufacturerId><individualPrice>156.5500</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="281608227"><itemNumber>1031</itemNumber><strength>37.5mg</strength><dosageForm>Pd for Inj-Vial Pk</dosageForm><price>234.8200</price><note>NOTE: For the treatment of schizophrenia or schizoaffective disorders in patient who have:
A history of non-adherence; AND
Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; AND
Inadequate control or significant side-effects from one or more conventional depot
antipsychotic agents.</note><drug id="02255723" dinStatus="N" sec3="Y"><name>Risperdal Consta</name><manufacturerId>JNO</manufacturerId><individualPrice>234.8200</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="281608228"><itemNumber>1032</itemNumber><strength>50mg</strength><dosageForm>Pd for Inj-Vial Pk</dosageForm><price>313.0900</price><note>NOTE: For the treatment of schizophrenia or schizoaffective disorders in patient who have:
A history of non-adherence; AND
Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; AND
Inadequate control or significant side-effects from one or more conventional depot
antipsychotic agents.</note><drug id="02255758" dinStatus="N" sec3="Y"><name>Risperdal Consta</name><manufacturerId>JNO</manufacturerId><individualPrice>313.0900</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="281608198"><itemNumber>1033</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.2075</price><drug id="02240551" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>.5257</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02252007" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258439" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264757" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02280906" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282119" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282240" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282585" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282690" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303485" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02303655" dinStatus="N" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02328305" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332051" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.2075</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608200"><itemNumber>1034</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.3475</price><drug id="02240552" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>.8806</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02252015" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258447" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264188" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02264765" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02280914" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282127" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282259" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282593" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303493" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02303663" dinStatus="N" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02328313" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332078" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.3475</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608174"><itemNumber>1035</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.4800</price><drug id="02025280" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>1.2165</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02252023" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258455" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264196" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02264773" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02279800" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02280922" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282135" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282267" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282607" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303507" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02328321" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332086" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.4800</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608175"><itemNumber>1036</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.9583</price><drug id="02025299" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>2.4285</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02252031" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258463" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264218" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02264781" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02279819" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02280930" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282143" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282275" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282615" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303515" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02328348" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332094" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.9583</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608176"><itemNumber>1037</itemNumber><strength>3mg</strength><dosageForm>Tab</dosageForm><price>1.4375</price><drug id="02025302" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>3.6430</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02252058" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258471" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264226" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02264803" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02279827" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02280949" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282151" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282283" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282623" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303523" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02328364" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332108" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.4375</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="281608177"><itemNumber>1038</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>1.9167</price><drug id="02025310" sec3="Y"><name>Risperdal</name><manufacturerId>JNO</manufacturerId><individualPrice>4.8575</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02252066" sec3="Y"><name>PMS-Risperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02258498" dinStatus="N" sec3="Y"><name>Phl-Risperidone</name><manufacturerId>PHE</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2009-11-19</listingDate></drug><drug id="02264234" sec3="Y"><name>Novo-Risperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02264811" sec3="Y"><name>Ratio-Risperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02279835" sec3="Y"><name>Sandoz Risperidone</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02280957" sec3="Y"><name>Ran-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282178" sec3="Y"><name>Apo-Risperidone</name><manufacturerId>APX</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282291" sec3="Y"><name>Gen-Risperidone</name><manufacturerId>GEN</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02282631" sec3="Y"><name>Co Risperidone</name><manufacturerId>COB</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2006-09-06</listingDate></drug><drug id="02303531" dinStatus="N" sec3="Y"><name>Zym-Risperidone</name><manufacturerId>ZYN</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2010-04-23</listingDate></drug><drug id="02328372" dinStatus="N" sec3="Y"><name>Rbx-Risperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02332116" dinStatus="N" sec3="Y"><name>Risperidone Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.9167</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00533"><name>THIOTHIXENE</name><pcgGroup><pcg9 id="281608092"><itemNumber>1039</itemNumber><strength>2mg</strength><dosageForm>Cap</dosageForm><price>.3100</price><drug id="00024430" sec3="Y"><name>Navane</name><manufacturerId>ERF</manufacturerId><individualPrice>.3100</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608091"><itemNumber>1040</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.4400</price><drug id="00024449" sec3="Y"><name>Navane</name><manufacturerId>ERF</manufacturerId><individualPrice>.4400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608090"><itemNumber>1041</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.5500</price><drug id="00024457" sec3="Y"><name>Navane</name><manufacturerId>ERF</manufacturerId><individualPrice>.5500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00532"><name>TRIFLUOPERAZINE</name><pcgGroup><pcg9 id="281608082"><itemNumber>1042</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.1340</price><drug id="00345539" sec3="Y"><name>Apo-Trifluoperazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1340</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01918206" notABenefit="Y" sec3="Y"><name>Stelazine</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608081"><itemNumber>1043</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.1758</price><drug id="00312754" sec3="Y"><name>Apo-Trifluoperazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1758</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01918214" notABenefit="Y" sec3="Y"><name>Stelazine</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608080"><itemNumber>1044</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2328</price><drug id="00312746" sec3="Y"><name>Apo-Trifluoperazine</name><manufacturerId>APX</manufacturerId><individualPrice>.2328</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01918222" notABenefit="Y" sec3="Y"><name>Stelazine</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="281608079"><itemNumber>1045</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2790</price><drug id="00326836" sec3="Y"><name>Apo-Trifluoperazine</name><manufacturerId>APX</manufacturerId><individualPrice>.2790</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01918230" notABenefit="Y" sec3="Y"><name>Stelazine</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="281612000"><name>PSYCHOTHERAPEUTIC AGENTS OTHER PSYCHOTROPICS</name><genericName id="00554"><name>LITHIUM CARBONATE</name><pcgGroup><pcg9 id="281612008"><itemNumber>1046</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.0422</price><drug id="00461733" sec3="Y"><name>Carbolith</name><manufacturerId>VAL</manufacturerId><individualPrice>.0844</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02216132" sec3="Y"><name>PMS-Lithium Carbonate</name><manufacturerId>PMS</manufacturerId><individualPrice>.0422</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02242837" sec3="Y"><name>Apo-Lithium Carbonate</name><manufacturerId>APX</manufacturerId><individualPrice>.0422</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="281612014"><itemNumber>1047</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.0413</price><drug id="02013231" sec3="Y"><name>Lithane</name><manufacturerId>ERF</manufacturerId><individualPrice>.1282</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="09857532" sec3="Y"><name>Apo-Lithium Carbonate</name><manufacturerId>APX</manufacturerId><individualPrice>.0413</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="281612002"><itemNumber>1048</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.0443</price><drug id="00236683" sec3="Y"><name>Carbolith</name><manufacturerId>VAL</manufacturerId><individualPrice>.0886</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02216140" sec3="Y"><name>PMS-Lithium Carbonate</name><manufacturerId>PMS</manufacturerId><individualPrice>.0443</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02242838" sec3="Y"><name>Apo-Lithium Carbonate</name><manufacturerId>APX</manufacturerId><individualPrice>.0443</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="281612016"><itemNumber>1049</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.0471</price><drug id="00406775" sec3="Y"><name>Lithane</name><manufacturerId>ERF</manufacturerId><individualPrice>.1277</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="09857540" sec3="Y"><name>Apo-Lithium Carbonate</name><manufacturerId>APX</manufacturerId><individualPrice>.0471</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="281612027"><itemNumber>1050</itemNumber><strength>300mg</strength><dosageForm>ER Tab</dosageForm><drug id="00590665" notABenefit="Y" sec3="Y"><name>Duralith</name><manufacturerId>JNO</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00558"><name>TRYPTOPHAN</name><pcgGroup><pcg9 id="281612028"><itemNumber>1051</itemNumber><strength>500mg</strength><dosageForm>Cap</dosageForm><drug id="00718149" notABenefit="Y" sec3="Y"><name>Tryptan</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02240334" notABenefit="Y" sec3="Y"><name>Ratio-Tryptophan</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02241023" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Tryptophan</name><manufacturerId>PMS</manufacturerId><listingDate>2009-04-01</listingDate></drug><drug id="02248540" notABenefit="Y" sec3="Y"><name>Apo-Tryptophan</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281612029"><itemNumber>1052</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><drug id="02029456" notABenefit="Y" sec3="Y"><name>Tryptan</name><manufacturerId>VAL</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02240333" notABenefit="Y" sec3="Y"><name>Ratio-Tryptophan</name><manufacturerId>RPH</manufacturerId><listingDate>2008-12-03</listingDate></drug><drug id="02240445" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Tryptophan</name><manufacturerId>PMS</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02248538" notABenefit="Y" sec3="Y"><name>Apo-Tryptophan</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="281612030"><itemNumber>1053</itemNumber><strength>1g</strength><dosageForm>Tab</dosageForm><drug id="00654531" notABenefit="Y" sec3="Y"><name>Tryptan</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230202" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Tryptophan</name><manufacturerId>PMS</manufacturerId><listingDate>1999-04-15</listingDate></drug><drug id="02237250" notABenefit="Y" sec3="Y"><name>Ratio-Tryptophan</name><manufacturerId>RPH</manufacturerId><listingDate>2000-04-17</listingDate></drug><drug id="02248539" notABenefit="Y" sec3="Y"><name>Apo-Tryptophan</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="282000000"><name>C.N.S. STIMULANTS</name><note>Stimulant medication should only be used when diagnostic criteria for narcolepsy or attention deficit disorder have been met and when stimulant medication has been demonstrated to produce clinical benefits. The use of conventional-release medication should almost always precede the use of extended-release preparations.</note><genericName id="00559"><name>DEXAMPHETAMINE SULFATE</name><pcgGroup><pcg9 id="282000003"><itemNumber>1054</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.5635</price><drug id="01924516" sec3="Y"><name>Dexedrine</name><manufacturerId>PAL</manufacturerId><individualPrice>.5635</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00560"><name>METHYLPHENIDATE HCL</name><pcgGroup><pcg9 id="282000032"><itemNumber>1055</itemNumber><strength>10mg</strength><dosageForm>ER Cap</dosageForm><price>.6600</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277166" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>.6600</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000033"><itemNumber>1056</itemNumber><strength>15mg</strength><dosageForm>ER Cap</dosageForm><price>.9450</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277131" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>.9450</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000034"><itemNumber>1057</itemNumber><strength>20mg</strength><dosageForm>ER Cap</dosageForm><price>1.2200</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277158" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.2200</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000035"><itemNumber>1058</itemNumber><strength>30mg</strength><dosageForm>ER Cap</dosageForm><price>1.6750</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277174" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>1.6750</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000036"><itemNumber>1059</itemNumber><strength>40mg</strength><dosageForm>ER Cap</dosageForm><price>2.1350</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277182" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>2.1350</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000037"><itemNumber>1060</itemNumber><strength>50mg</strength><dosageForm>ER Cap</dosageForm><price>2.5880</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277190" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>2.5880</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000038"><itemNumber>1061</itemNumber><strength>60mg</strength><dosageForm>ER Cap</dosageForm><price>3.0000</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277204" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>3.0000</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000041"><itemNumber>1062</itemNumber><strength>80mg</strength><dosageForm>ER Cap</dosageForm><price>3.9700</price><note>Note:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or       who have problems with inattention that interfere with learning
   AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry,        pediatrics or a general practitioner with expertise in ADHD
   AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate 
   slow release (SR) or Dexedrine IR or Dexedrine SR (Spansules), and have            experienced unsatisfactory results due to poor symptom control, side effects,      administrative barriers, or societal barriers.
      Administrative barriers include:
      . inability of a school to dose the child at lunch;
      . the school lunch hour does not coincide with the dosing schedule;
      . poor compliance with noon or afternoon doses;
      . the patient is unable to swallow tablets.
      Societal barriers include:
      . the patient or patient&apos;s caregiver(s) has(have) a history of substance             abuse or diversion of listed immediate-release alternatives;
      . the patient or patient&apos;s caregiver(s) is/are at risk of substance abuse or         diversion of listed immediate-release alternatives.
          
</note><drug id="02277212" dinStatus="N" sec3="Y"><name>Biphentin</name><manufacturerId>PFP</manufacturerId><individualPrice>3.9700</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="282000006"><itemNumber>1063</itemNumber><strength>20mg</strength><dosageForm>ER Tab</dosageForm><price>.2820</price><drug id="00632775" sec3="Y"><name>Ritalin SR</name><manufacturerId>NOV</manufacturerId><individualPrice>.5921</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02266687" sec3="Y"><name>Apo-Methylphenidate SR</name><manufacturerId>APX</manufacturerId><individualPrice>.2820</individualPrice><listingDate>2006-07-19</listingDate></drug><drug id="02320312" dinStatus="N" sec3="Y"><name>Sandoz Methylphenidate SR</name><manufacturerId>SDZ</manufacturerId><individualPrice>.2820</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="282000028"><itemNumber>1064</itemNumber><strength>18mg</strength><dosageForm>SR Tab</dosageForm><price>1.0197</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02247732" dinStatus="N" sec3="Y"><name>Concerta</name><manufacturerId>JNO</manufacturerId><individualPrice>2.0985</individualPrice><listingDate>2009-04-01</listingDate></drug><drug id="02315068" dinStatus="N" sec3="Y"><name>Novo-Methylphenidate ER-C</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0197</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="282000031"><itemNumber>1065</itemNumber><strength>27mg</strength><dosageForm>SR Tab</dosageForm><price>1.1768</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02250241" dinStatus="N" sec3="Y"><name>Concerta</name><manufacturerId>JNO</manufacturerId><individualPrice>2.4218</individualPrice><listingDate>2009-04-01</listingDate></drug><drug id="02315076" dinStatus="N" sec3="Y"><name>Novo-Methylphenidate ER-C</name><manufacturerId>NOP</manufacturerId><individualPrice>1.1768</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="282000029"><itemNumber>1066</itemNumber><strength>36mg</strength><dosageForm>SR Tab</dosageForm><price>1.3339</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02247733" dinStatus="N" sec3="Y"><name>Concerta</name><manufacturerId>JNO</manufacturerId><individualPrice>2.7451</individualPrice><listingDate>2009-04-01</listingDate></drug><drug id="02315084" dinStatus="N" sec3="Y"><name>Novo-Methylphenidate ER-C</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3339</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="282000030"><itemNumber>1067</itemNumber><strength>54mg</strength><dosageForm>SR Tab</dosageForm><price>1.6480</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02247734" dinStatus="N" sec3="Y"><name>Concerta</name><manufacturerId>JNO</manufacturerId><individualPrice>3.3915</individualPrice><listingDate>2009-04-01</listingDate></drug><drug id="02315092" dinStatus="N" sec3="Y"><name>Novo-Methylphenidate ER-C</name><manufacturerId>NOP</manufacturerId><individualPrice>1.6480</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="282000004"><itemNumber>1068</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1262</price><drug id="00005606" sec3="Y"><name>Ritalin</name><manufacturerId>NOV</manufacturerId><individualPrice>.3264</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00584991" sec3="Y"><name>PMS-Methylphenidate</name><manufacturerId>PMS</manufacturerId><individualPrice>.1262</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02249324" sec3="Y"><name>Apo-Methylphenidate</name><manufacturerId>APX</manufacturerId><individualPrice>.1262</individualPrice><listingDate>2005-03-31</listingDate></drug></pcg9><pcg9 id="282000039"><itemNumber>1069</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><drug id="00005614" notABenefit="Y" sec3="Y"><name>Ritalin</name><manufacturerId>NOV</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="00585009" notABenefit="Y" sec3="Y"><name>PMS-Methylphenidate</name><manufacturerId>PMS</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02249332" notABenefit="Y" sec3="Y"><name>Apo-Methylphenidate</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01752"><name>MIXED SALT AMPHETAMINE</name><pcgGroup><pcg9 id="282000042"><itemNumber>1070</itemNumber><strength>5mg</strength><dosageForm>ER Cap</dosageForm><price>1.9795</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248808" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>1.9795</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="282000043"><itemNumber>1071</itemNumber><strength>10mg</strength><dosageForm>ER Cap</dosageForm><price>2.2495</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248809" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>2.2495</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="282000044"><itemNumber>1072</itemNumber><strength>15mg</strength><dosageForm>ER Cap</dosageForm><price>2.5196</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248810" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>2.5196</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="282000045"><itemNumber>1073</itemNumber><strength>20mg</strength><dosageForm>ER Cap</dosageForm><price>2.7897</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248811" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>2.7897</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="282000046"><itemNumber>1074</itemNumber><strength>25mg</strength><dosageForm>ER Cap</dosageForm><price>3.0598</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248812" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>3.0598</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="282000047"><itemNumber>1075</itemNumber><strength>30mg</strength><dosageForm>ER Cap</dosageForm><price>3.3300</price><note>Notes:  Patients &gt; 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or psychosocial needs, and who meet the following:

   1)   Patients who demonstrate significant and problematic disruptive behaviour          or who have problems with  
        inattention that interfere with learning; AND
   2)   Prescribed by or in consultation with a specialist in pediatric                    psychiatry, pediatrics or a general practitioner  
        with expertise in ADHD; AND
   3)   Have been tried on methylphenidate immediate release (IR) or                       methylphenidate slow release (SR) or
        Dexedrine IR or Dexedrine SR (Spansules), and have experienced                     unsatisfactory results due to poor
        symptom control, side effects, administrative barriers, or societal                barriers.
             Administrative barriers include: 
             .   inability of a school to dose the child at lunch;
             .   the school lunch hour does not coincide with the dosing schedule;
             .   poor compliance with noon or afternoon doses;
             .   the patient is unable to swallow tablets.
                 Societal barriers include:
             .   the patient or patient&apos;s caregiver(s) has(have) a history of                       substance abuse or diversion of listed immediate-release                           alternatives;
             .   the patient or patient&apos;s caregiver(s) is/are at risk of substance                  abuse or diversion of listed immediate-release alternatives.</note><drug id="02248813" dinStatus="N" sec3="Y"><name>Adderall XR</name><manufacturerId>SHI</manufacturerId><individualPrice>3.3300</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01448"><name>MODAFINIL</name><pcgGroup><pcg9 id="282000040"><itemNumber>1076</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="02239665" notABenefit="Y" sec3="Y"><name>Alertec</name><manufacturerId>BJH</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02285398" notABenefit="Y" sec3="Y"><name>Apo-Modafinil</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01765"><name>SIBUTRAMINE HCL MONOHYDRATE</name><pcgGroup><pcg9 id="282000048"><itemNumber>1077</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><drug id="02243163" notABenefit="Y" sec3="Y"><name>Meridia</name><manufacturerId>ABB</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02337614" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Sibutramine</name><manufacturerId>APX</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="282000049"><itemNumber>1078</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><drug id="02243164" notABenefit="Y" sec3="Y"><name>Meridia</name><manufacturerId>ABB</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02337622" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Sibutramine</name><manufacturerId>APX</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="282400000"><name>SEDATIVES AND HYPNOTICS</name><note>Sedatives and hypnotics are indicated for short-term therapy only.</note><genericName id="00570"><name>AMOBARBITAL SODIUM</name><pcgGroup><pcg9 id="282400004"><itemNumber>1079</itemNumber><strength>60mg</strength><dosageForm>Cap</dosageForm><price>.0960</price><drug id="00015148" dinStatus="E" sec3="Y"><name>Amytal Sodium</name><manufacturerId>LIL</manufacturerId><individualPrice>.0960</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="282400003"><itemNumber>1080</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>.2114</price><drug id="00015156" dinStatus="E" sec3="Y"><name>Amytal Sodium</name><manufacturerId>LIL</manufacturerId><individualPrice>.2114</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00581"><name>BUSPIRONE HYDROCHLORIDE</name><pcgGroup><pcg9 id="282400166"><itemNumber>1081</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="00603821" notABenefit="Y" sec3="Y"><name>Buspar</name><manufacturerId>BQU</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02211076" notABenefit="Y" sec3="Y"><name>Apo-Buspirone</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-16</listingDate></drug><drug id="02230874" notABenefit="Y" sec3="Y"><name>Gen-Buspirone</name><manufacturerId>GEN</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02230942" notABenefit="Y" sec3="Y"><name>PMS-Buspirone</name><manufacturerId>PMS</manufacturerId><listingDate>2007-11-16</listingDate></drug><drug id="02231492" notABenefit="Y" sec3="Y"><name>Novo-Buspirone</name><manufacturerId>NOP</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02237858" notABenefit="Y" sec3="Y"><name>Ratio-Buspirone</name><manufacturerId>RPH</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00573"><name>FLURAZEPAM</name><pcgGroup><pcg9 id="282400016"><itemNumber>1082</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><price>.0810</price><drug id="00012696" notABenefit="Y" sec3="Y"><name>Dalmane</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00521698" sec3="Y"><name>Apo-Flurazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0810</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="282400015"><itemNumber>1083</itemNumber><strength>30mg</strength><dosageForm>Cap</dosageForm><price>.0930</price><drug id="00012718" notABenefit="Y" sec3="Y"><name>Dalmane</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00521701" sec3="Y"><name>Apo-Flurazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0930</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00574"><name>METHOTRIMEPRAZINE</name><pcgGroup><pcg9 id="282400022"><itemNumber>1084</itemNumber><strength>25mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>3.2000</price><drug id="01927698" sec3="Y"><name>Nozinan</name><manufacturerId>SAV</manufacturerId><individualPrice>3.2000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="282400041"><itemNumber>1085</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.0685</price><drug id="01927647" notABenefit="Y" sec3="Y"><name>Nozinan</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02238403" sec3="Y"><name>Apo-Methoprazine</name><manufacturerId>APX</manufacturerId><individualPrice>.0685</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="282400019"><itemNumber>1086</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0528</price><drug id="01927655" notABenefit="Y" sec3="Y"><name>Nozinan</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02232903" sec3="Y"><name>PMS-Methotrimeprazine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0528</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238404" sec3="Y"><name>Apo-Methoprazine</name><manufacturerId>APX</manufacturerId><individualPrice>.0528</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="282400018"><itemNumber>1087</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1131</price><drug id="01927663" notABenefit="Y" sec3="Y"><name>Nozinan</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02232904" dinStatus="E" sec3="Y"><name>PMS-Methotrimeprazine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1131</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238405" sec3="Y"><name>Apo-Methoprazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1131</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="282400017"><itemNumber>1088</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1541</price><drug id="01927671" notABenefit="Y" sec3="Y"><name>Nozinan</name><manufacturerId>SAV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02232905" sec3="Y"><name>PMS-Methotrimeprazine</name><manufacturerId>PMS</manufacturerId><individualPrice>.1541</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02238406" sec3="Y"><name>Apo-Methoprazine</name><manufacturerId>APX</manufacturerId><individualPrice>.1541</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00580"><name>NITRAZEPAM</name><pcgGroup><pcg9 id="282400165"><itemNumber>1089</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0680</price><drug id="00511528" sec3="Y"><name>Mogadon</name><manufacturerId>VAL</manufacturerId><individualPrice>.1428</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229654" sec3="Y"><name>Nitrazadon</name><manufacturerId>VAL</manufacturerId><individualPrice>.0680</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02234003" sec3="Y"><name>Sandoz Nitrazepam</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0680</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02245230" sec3="Y"><name>Apo-Nitrazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0680</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="282400164"><itemNumber>1090</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1017</price><drug id="00511536" sec3="Y"><name>Mogadon</name><manufacturerId>VAL</manufacturerId><individualPrice>.2137</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229655" sec3="Y"><name>Nitrazadon</name><manufacturerId>VAL</manufacturerId><individualPrice>.1017</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02234007" sec3="Y"><name>Sandoz Nitrazepam</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1017</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02245231" sec3="Y"><name>Apo-Nitrazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.1017</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00576"><name>PENTOBARBITAL SODIUM</name><pcgGroup><pcg9 id="282400027"><itemNumber>1091</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.2038</price><drug id="00000086" dinStatus="E" sec3="Y"><name>Nembutal</name><manufacturerId>ABB</manufacturerId><individualPrice>.2038</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00579"><name>TEMAZEPAM</name><pcgGroup><pcg9 id="282400063"><itemNumber>1092</itemNumber><strength>15mg</strength><dosageForm>Cap</dosageForm><price>.0875</price><drug id="00604453" sec3="Y"><name>Restoril</name><manufacturerId>ORY</manufacturerId><individualPrice>.1750</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02223570" sec3="Y"><name>Nu-Temazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.0875</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02225964" sec3="Y"><name>Apo-Temazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.0875</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02230095" sec3="Y"><name>Novo-Temazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.0875</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02231615" dinStatus="E" sec3="Y"><name>Gen-Temazepam</name><manufacturerId>GEN</manufacturerId><individualPrice>.0875</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02243023" sec3="Y"><name>Ratio-Temazepam</name><manufacturerId>RPH</manufacturerId><individualPrice>.0875</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244814" sec3="Y"><name>Co-Temazepam</name><manufacturerId>COB</manufacturerId><individualPrice>.0875</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02273039" sec3="Y"><name>PMS-Temazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.0875</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="282400062"><itemNumber>1093</itemNumber><strength>30mg</strength><dosageForm>Cap</dosageForm><price>.1053</price><drug id="00604461" sec3="Y"><name>Restoril</name><manufacturerId>ORY</manufacturerId><individualPrice>.2105</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02223589" sec3="Y"><name>Nu-Temazepam</name><manufacturerId>NXP</manufacturerId><individualPrice>.1053</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02225972" sec3="Y"><name>Apo-Temazepam</name><manufacturerId>APX</manufacturerId><individualPrice>.1053</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02230102" sec3="Y"><name>Novo-Temazepam</name><manufacturerId>NOP</manufacturerId><individualPrice>.1053</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02231616" dinStatus="E" sec3="Y"><name>Gen-Temazepam</name><manufacturerId>GEN</manufacturerId><individualPrice>.1053</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02243024" sec3="Y"><name>Ratio-Temazepam</name><manufacturerId>RPH</manufacturerId><individualPrice>.1053</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02244815" sec3="Y"><name>Co-Temazepam</name><manufacturerId>COB</manufacturerId><individualPrice>.1053</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02273047" sec3="Y"><name>PMS-Temazepam</name><manufacturerId>PMS</manufacturerId><individualPrice>.1053</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00578"><name>TRIAZOLAM</name><pcgGroup><pcg9 id="282400057"><itemNumber>1094</itemNumber><strength>0.125mg</strength><dosageForm>Tab</dosageForm><price>.1181</price><drug id="00512559" notABenefit="Y" sec3="Y"><name>Halcion</name><manufacturerId>UPJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00808563" sec3="Y"><name>Apo-Triazo</name><manufacturerId>APX</manufacturerId><individualPrice>.1181</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01995227" sec3="Y"><name>Gen-Triazolam</name><manufacturerId>GEN</manufacturerId><individualPrice>.1181</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="282400056"><itemNumber>1095</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.2086</price><drug id="00443158" notABenefit="Y" sec3="Y"><name>Halcion</name><manufacturerId>PFI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00808571" sec3="Y"><name>Apo-Triazo</name><manufacturerId>APX</manufacturerId><individualPrice>.2090</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913506" sec3="Y"><name>Gen-Triazolam</name><manufacturerId>GEN</manufacturerId><individualPrice>.2086</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00585"><name>ZOPICLONE</name><pcgGroup><pcg9 id="282400064"><itemNumber>1096</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><drug id="02216167" notABenefit="Y" sec3="Y"><name>Imovane</name><manufacturerId>SAV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02243426" notABenefit="Y" sec3="Y"><name>PMS-Zopiclone</name><manufacturerId>PMS</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02245077" notABenefit="Y" sec3="Y"><name>Apo-Zopiclone</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02246534" notABenefit="Y" sec3="Y"><name>Ratio-Zopiclone</name><manufacturerId>RPH</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02251450" notABenefit="Y" sec3="Y"><name>Novo-Zopiclone</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02257572" notABenefit="Y" sec3="Y"><name>Sandoz Zopiclone</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02267918" notABenefit="Y" sec3="Y"><name>Ran-Zopiclone</name><manufacturerId>RAN</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02271931" notABenefit="Y" sec3="Y"><name>Co Zopiclone</name><manufacturerId>COB</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02294052" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Zopiclone</name><manufacturerId>PHE</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02296616" notABenefit="Y" sec3="Y"><name>Mylan-Zopiclone</name><manufacturerId>MYL</manufacturerId><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="282400179"><itemNumber>1097</itemNumber><strength>7.5mg</strength><dosageForm>Tab</dosageForm><drug id="01926799" notABenefit="Y" sec3="Y"><name>Imovane</name><manufacturerId>SAV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02008203" notABenefit="Y" sec3="Y"><name>Rhovane</name><manufacturerId>SAV</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02218313" notABenefit="Y" sec3="Y"><name>Apo-Zopiclone</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02238596" notABenefit="Y" sec3="Y"><name>Mylan-Zopiclone</name><manufacturerId>MYL</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02240606" notABenefit="Y" sec3="Y"><name>PMS-Zopiclone</name><manufacturerId>PMS</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02242481" notABenefit="Y" sec3="Y"><name>Ratio-Zopiclone</name><manufacturerId>RPH</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02251469" notABenefit="Y" sec3="Y"><name>Novo-Zopiclone</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02257580" notABenefit="Y" sec3="Y"><name>Sandoz Zopiclone</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02267926" notABenefit="Y" sec3="Y"><name>Ran-Zopiclone</name><manufacturerId>RAN</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02271958" notABenefit="Y" sec3="Y"><name>Co Zopiclone</name><manufacturerId>COB</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02294060" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Zopiclone</name><manufacturerId>PHE</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="289200000"><name>MISCELLANEOUS CENTRAL NERVOUS SYSTEM DRUGS</name><genericName id="01536"><name>ENTACAPONE</name><pcgGroup lccId="00142"><pcg9 id="289200014"><itemNumber>1098</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>1.6039</price><drug id="02243763" sec3="Y" sec12="Y"><name>Comtan</name><manufacturerId>NOV</manufacturerId><individualPrice>1.6039</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="367">For the treatment of patients with Parkinson&apos;s disease with 25% of the waking day in the off state despite maximally tolerated doses of levodopa.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01763"><name>MEMANTINE HCL</name><pcgGroup><pcg9 id="289200037"><itemNumber>1099</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><drug id="02260638" notABenefit="Y" sec3="Y"><name>Ebixa</name><manufacturerId>VLH</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02320908" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ratio-Memantine</name><manufacturerId>RPH</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02321130" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Memantine</name><manufacturerId>PMS</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01505"><name>NARATRIPTAN HYDROCHLORIDE</name><pcgGroup><pcg9 id="289200004"><itemNumber>1100</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><drug id="02237820" notABenefit="Y" sec3="Y"><name>Amerge</name><manufacturerId>GSK</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02314290" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Naratriptan</name><manufacturerId>NOP</manufacturerId><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="289200005"><itemNumber>1101</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><drug id="02237821" notABenefit="Y" sec3="Y"><name>Amerge</name><manufacturerId>GSK</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02314304" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Naratriptan</name><manufacturerId>NOP</manufacturerId><listingDate>2010-03-02</listingDate></drug><drug id="02322323" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Naratriptan</name><manufacturerId>SDZ</manufacturerId><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00260"><name>PIZOTYLINE</name><pcgGroup><pcg9 id="289200030"><itemNumber>1102</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.3799</price><drug id="00329320" sec3="Y"><name>Sandomigran</name><manufacturerId>PAL</manufacturerId><individualPrice>.3799</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="289200031"><itemNumber>1103</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.6308</price><drug id="00511552" sec3="Y"><name>Sandomigran DS</name><manufacturerId>PAL</manufacturerId><individualPrice>.6308</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01364"><name>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</name><pcgGroup><pcg9 id="289200001"><itemNumber>1104</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>1.0513</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole, Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02237145" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>1.0513</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="289200023"><itemNumber>1105</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.4950</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02269309" sec3="Y"><name>Novo-Pramipexole</name><manufacturerId>NOP</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02290111" sec3="Y"><name>PMS-Pramipexole</name><manufacturerId>PMS</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02292378" sec3="Y"><name>Apo-Pramipexole</name><manufacturerId>APX</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02297302" dinStatus="N" sec3="Y"><name>Co Pramipexole</name><manufacturerId>COB</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02315262" dinStatus="N" sec3="Y"><name>Sandoz Pramipexole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4950</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="09857268" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>1.0513</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="289200011"><itemNumber>1106</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><drug id="02241594" notABenefit="Y" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02269317" notABenefit="Y" sec3="Y"><name>Novo-Pramipexole</name><manufacturerId>NOP</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02290138" notABenefit="Y" sec3="Y"><name>PMS-Pramipexole</name><manufacturerId>PMS</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02292386" notABenefit="Y" sec3="Y"><name>Apo-Pramipexole</name><manufacturerId>APX</manufacturerId><listingDate>2007-09-04</listingDate></drug><drug id="02297310" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Pramipexole</name><manufacturerId>COB</manufacturerId><listingDate>2009-06-23</listingDate></drug><drug id="02315270" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Pramipexole</name><manufacturerId>SDZ</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="289200002"><itemNumber>1107</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>2.1028</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole, Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02237146" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>2.1028</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="289200024"><itemNumber>1108</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02269325" sec3="Y"><name>Novo-Pramipexole</name><manufacturerId>NOP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02290146" sec3="Y"><name>PMS-Pramipexole</name><manufacturerId>PMS</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02292394" sec3="Y"><name>Apo-Pramipexole</name><manufacturerId>APX</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02297329" dinStatus="N" sec3="Y"><name>Co Pramipexole</name><manufacturerId>COB</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02315289" dinStatus="N" sec3="Y"><name>Sandoz Pramipexole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="09857269" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>2.1028</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="289200003"><itemNumber>1109</itemNumber><strength>1.5mg</strength><dosageForm>Tab</dosageForm><price>2.1028</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole, Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02237147" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>2.1028</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="289200025"><itemNumber>1110</itemNumber><strength>1.5mg</strength><dosageForm>Tab</dosageForm><price>.9900</price><note>NOTE:  Mirapex is indicated for both the symptomatic treatment of idiopathic
Parkinson&apos;s Disease and moderate to severe idiopathic Restless Legs Syndrome 
under the manufacturer&apos;s Drug Indentification Number (DIN). Mirapex has also been
assigned a Product Indentification Number (PIN) for the indication of Parkinson&apos;s
Disease specifically. Apo-Pramipexole, Novo-Pramipexole, PMS-Pramipexole Sandoz Pramipexole and Co Pramipexole products are interchangeable with Mirapex for the treatment of Parkinson&apos;s Disease.</note><drug id="02269333" sec3="Y"><name>Novo-Pramipexole</name><manufacturerId>NOP</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02290154" sec3="Y"><name>PMS-Pramipexole</name><manufacturerId>PMS</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02292408" sec3="Y"><name>Apo-Pramipexole</name><manufacturerId>APX</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02297337" dinStatus="N" sec3="Y"><name>Co Pramipexole</name><manufacturerId>COB</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02315297" dinStatus="N" sec3="Y"><name>Sandoz Pramipexole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9900</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="09857270" sec3="Y"><name>Mirapex</name><manufacturerId>BOE</manufacturerId><individualPrice>2.1028</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00265"><name>SUMATRIPTAN SUCCINATE</name><pcgGroup><pcg9 id="289200012"><itemNumber>1111</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><drug id="02256428" notABenefit="Y" sec3="Y"><name>PMS-Sumatriptan</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02257882" notABenefit="Y" sec3="Y"><name>Co Sumatriptan</name><manufacturerId>COB</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02268906" notABenefit="Y" sec3="Y"><name>Gen-Sumatriptan</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="09857299" notABenefit="Y" sec3="Y"><name>Imitrex</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="289200026"><itemNumber>1112</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><drug id="02239738" notABenefit="Y" sec3="Y"><name>Imitrex DF</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02286815" notABenefit="Y" sec3="Y"><name>Novo-Sumatriptan DF</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="289200009"><itemNumber>1113</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="02163764" notABenefit="Y" sec3="Y"><name>Imitrex</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02256436" notABenefit="Y" sec3="Y"><name>PMS-Sumatriptan</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02257890" notABenefit="Y" sec3="Y"><name>Co Sumatriptan</name><manufacturerId>COB</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02263025" notABenefit="Y" sec3="Y"><name>Sandoz Sumatriptan</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02268388" notABenefit="Y" sec3="Y"><name>Apo-Sumatriptan</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02268914" notABenefit="Y" sec3="Y"><name>Gen-Sumatriptan</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02271583" notABenefit="Y" sec3="Y"><name>Ratio-Sumatriptan</name><manufacturerId>RPH</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="289200027"><itemNumber>1114</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="02212153" notABenefit="Y" sec3="Y"><name>Imitrex DF</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02286823" notABenefit="Y" sec3="Y"><name>Novo-Sumatriptan DF</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="289200006"><itemNumber>1115</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="01950614" notABenefit="Y" sec3="Y"><name>Imitrex</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02256444" notABenefit="Y" sec3="Y"><name>PMS-Sumatriptan</name><manufacturerId>PMS</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02257904" notABenefit="Y" sec3="Y"><name>Co Sumatriptan</name><manufacturerId>COB</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02263033" notABenefit="Y" sec3="Y"><name>Sandoz Sumatriptan</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02268396" notABenefit="Y" sec3="Y"><name>Apo-Sumatriptan</name><manufacturerId>APX</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02268922" notABenefit="Y" sec3="Y"><name>Gen-Sumatriptan</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02271591" notABenefit="Y" sec3="Y"><name>Ratio-Sumatriptan</name><manufacturerId>RPH</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="289200028"><itemNumber>1116</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="02212161" notABenefit="Y" sec3="Y"><name>Imitrex DF</name><manufacturerId>GSK</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02286831" notABenefit="Y" sec3="Y"><name>Novo-Sumatriptan DF</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="360000000"><name>DIAGNOSTIC AGENTS</name><pcg6 id="360400000"><name>ADRENAL INSUFFICIENCY</name><genericName id="00587"><name>COSYNTROPIN ZINC HYDROXIDE</name><pcgGroup><pcg9 id="360400003"><itemNumber>1117</itemNumber><strength>1mg/mL</strength><dosageForm>Inj Susp-1mL Pk</dosageForm><price>30.7900</price><drug id="00253952" sec3="Y"><name>Synacthen Depot</name><manufacturerId>NOV</manufacturerId><individualPrice>30.7900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="400000000"><name>ELECTROLYTIC, CALORIC  AND WATER BALANCE</name><pcg6 id="401200000"><name>REPLACEMENT AGENTS</name><genericName id="00613"><name>CALCIUM CARBONATE</name><pcgGroup><pcg9 id="401200017"><itemNumber>1118</itemNumber><strength>Eq to 250mg Elemental Calcium</strength><dosageForm>Tab</dosageForm><drug id="00645958" notABenefit="Y" sec3="Y"><name>Calcium-250</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00682047" notABenefit="Y" sec3="Y"><name>Apo-Cal 250</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02042983" notABenefit="Y" sec3="Y"><name>Os-Cal 250</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="401200016"><itemNumber>1119</itemNumber><strength>Eq to 500mg Elemental Calcium</strength><dosageForm>Tab</dosageForm><drug id="00645923" notABenefit="Y" sec3="Y"><name>Calcium-500</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00682039" notABenefit="Y" sec3="Y"><name>Apo-Cal 500</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02042991" notABenefit="Y" sec3="Y"><name>Os-Cal 500</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00615"><name>CALCIUM GLUCONATE</name><pcgGroup><pcg9 id="401200020"><itemNumber>1120</itemNumber><strength>Eq to 60mg Elemental Calcium</strength><dosageForm>Tab</dosageForm><drug id="00179698" notABenefit="Y" sec3="Y"><name>Calcium Gluconate</name><manufacturerId>SDR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00241717" notABenefit="Y" sec3="Y"><name>Calcium Gluconate</name><manufacturerId>RPR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441473" notABenefit="Y" sec3="Y"><name>Calcium Gluconate</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00618"><name>CALCIUM LACTATE</name><pcgGroup><pcg9 id="401200024"><itemNumber>1121</itemNumber><strength>Eq to 84mg Elemental Calcium</strength><dosageForm>Tab</dosageForm><drug id="00021253" notABenefit="Y" sec3="Y"><name>Calcium Lactate</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00179671" notABenefit="Y" sec3="Y"><name>Calcium Lactate</name><manufacturerId>SDR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00619"><name>ELECTROLYTE &amp; DEXTROSE</name><pcgGroup><pcg9 id="401200037"><itemNumber>1122</itemNumber><dosageForm>O/L</dosageForm><price>.0074</price><drug id="00630365" sec3="Y"><name>Pedialyte Regular</name><manufacturerId>ABB</manufacturerId><individualPrice>.0074</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00981095" sec3="Y"><name>Pedialyte Flavored</name><manufacturerId>ABB</manufacturerId><individualPrice>.0074</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="401200038"><itemNumber>1123</itemNumber><dosageForm>Oral Pd-1 Sach Pk</dosageForm><price>.7950</price><drug id="01931563" sec3="Y"><name>Gastrolyte</name><manufacturerId>SAV</manufacturerId><individualPrice>.7950</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00621"><name>PEG-ELECTROLYTES</name><pcgGroup><pcg9 id="401200040"><itemNumber>1124</itemNumber><dosageForm>Pd-4L Pk</dosageForm><price>16.4500</price><drug id="00677442" notABenefit="Y" sec3="Y"><name>Colyte</name><manufacturerId>ZYN</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00777838" sec3="Y"><name>PegLyte</name><manufacturerId>PMS</manufacturerId><individualPrice>16.4500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00622"><name>POLYETHYLENE GLYCOL &amp; ELECTROLYTES</name><pcgGroup><pcg9 id="401200041"><itemNumber>1125</itemNumber><dosageForm>Pd-1 Kit</dosageForm><price>16.1700</price><drug id="02147793" sec3="Y"><name>Klean-Prep</name><manufacturerId>RIV</manufacturerId><individualPrice>16.1700</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00610"><name>POTASSIUM CHLORIDE</name><pcgGroup><pcg9 id="401200005" suppliedBy="L"><itemNumber>1126</itemNumber><strength>1.33mEq/mL</strength><dosageForm>O/L</dosageForm><price>.0102</price><drug id="01918303" selfMed="Y" sec3="Y"><name>K-10</name><manufacturerId>GSK</manufacturerId><individualPrice>.0154</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02063859" notABenefit="Y" sec3="Y"><name>Kaochlor-10</name><manufacturerId>PMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02166372" notABenefit="Y" sec3="Y"><name>Roychlor</name><manufacturerId>WAB</manufacturerId><listingDate>1997-01-08</listingDate></drug><drug id="02238604" selfMed="Y" sec3="Y"><name>PMS-Potassium Chloride</name><manufacturerId>PMS</manufacturerId><individualPrice>.0102</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="401200008"><itemNumber>1127</itemNumber><strength>25mEq/Pouch</strength><dosageForm>Oral Pd-7.8g Pk</dosageForm><price>.4783</price><drug id="02089580" dinStatus="E" sec3="Y"><name>K-Lyte/Cl</name><manufacturerId>WEL</manufacturerId><individualPrice>.4783</individualPrice><listingDate>1998-11-17</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="401800000"><name>POTASSIUM-REMOVING RESINS</name><genericName id="00631"><name>POLYSTYRENE SODIUM SULFONATE</name><pcgGroup><pcg9 id="401800001"><itemNumber>1128</itemNumber><strength>1mEq/g</strength><dosageForm>Oral Pd-454g Pk</dosageForm><price>79.7700</price><drug id="02026961" sec3="Y"><name>Kayexalate</name><manufacturerId>SAV</manufacturerId><individualPrice>79.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="402800000"><name>DIURETICS</name><note>The Canadian Hypertension Society Consensus Conference recommends lower doses of diuretics for treatment of hypertension, particularly in the elderly, to avoid dose-related adverse effects. Hydrochlorothiazide, 25 to 50mg daily, or other diuretics in equivalent amounts are recommended.</note><genericName id="00638"><name>AMILORIDE HCL</name><pcgGroup><pcg9 id="402800031"><itemNumber>1129</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.2717</price><drug id="00487805" notABenefit="Y" sec3="Y"><name>Midamor</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02249510" sec3="Y"><name>Apo-Amiloride</name><manufacturerId>APX</manufacturerId><individualPrice>.2717</individualPrice><listingDate>2004-08-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00639"><name>AMILORIDE HCL &amp; HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="402800032"><itemNumber>1130</itemNumber><strength>5mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>.1917</price><dailyCost>.0958</dailyCost><drug id="00487813" notABenefit="Y" sec3="Y"><name>Moduret</name><manufacturerId>PRE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00784400" sec3="Y"><name>Apo-Amilzide</name><manufacturerId>APX</manufacturerId><individualPrice>.1917</individualPrice><dailyCost>.0958</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00886106" sec3="Y"><name>Nu-Amilzide</name><manufacturerId>NXP</manufacturerId><individualPrice>.1917</individualPrice><dailyCost>.0958</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="01937219" sec3="Y"><name>Novamilor</name><manufacturerId>NOP</manufacturerId><individualPrice>.1917</individualPrice><dailyCost>.0958</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02257378" sec3="Y"><name>Gen-Amilazide</name><manufacturerId>GEN</manufacturerId><individualPrice>.1917</individualPrice><dailyCost>.0958</dailyCost><listingDate>2006-05-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00632"><name>CHLORTHALIDONE</name><pcgGroup><pcg9 id="402800007"><itemNumber>1131</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.1242</price><dailyCost>.1242</dailyCost><drug id="00010413" notABenefit="Y" sec3="Y"><name>Hygroton</name><manufacturerId>GEI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00360279" sec3="Y"><name>Apo-Chlorthalidone</name><manufacturerId>APX</manufacturerId><individualPrice>.1242</individualPrice><dailyCost>.1242</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="402800006"><itemNumber>1132</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.0397</price><drug id="00010421" notABenefit="Y" sec3="Y"><name>Hygroton</name><manufacturerId>GEI</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="00360287" sec3="Y"><name>Apo-Chlorthalidone</name><manufacturerId>APX</manufacturerId><individualPrice>.0397</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00351"><name>FUROSEMIDE</name><pcgGroup><pcg9 id="402800030"><itemNumber>1133</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.2639</price><drug id="02224720" sec3="Y"><name>Lasix</name><manufacturerId>SAV</manufacturerId><individualPrice>.2639</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9><pcg9 id="402800019"><itemNumber>1134</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.0373</price><drug id="00337730" sec3="Y"><name>Novo-Semide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0373</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00396788" sec3="Y"><name>Apo-Furosemide</name><manufacturerId>APX</manufacturerId><individualPrice>.0373</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02224690" sec3="Y"><name>Lasix</name><manufacturerId>SAV</manufacturerId><individualPrice>.0838</individualPrice><listingDate>1999-01-06</listingDate></drug></pcg9><pcg9 id="402800009"><itemNumber>1135</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.0558</price><drug id="00337749" sec3="Y"><name>Novo-Semide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0558</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00362166" sec3="Y"><name>Apo-Furosemide</name><manufacturerId>APX</manufacturerId><individualPrice>.0558</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02224704" sec3="Y"><name>Lasix</name><manufacturerId>SAV</manufacturerId><individualPrice>.1286</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00078"><pcg9 id="402800043"><itemNumber>1136</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>2.8869</price><drug id="02224755" sec3="Y" sec12="Y"><name>Lasix Special</name><manufacturerId>SAV</manufacturerId><individualPrice>2.8869</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="33">For patients with severely impaired renal function refractory to conventional dosages of the drug.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00352"><name>HYDROCHLOROTHIAZIDE</name><pcgGroup><pcg9 id="402800050"><itemNumber>1137</itemNumber><strength>12.5mg</strength><dosageForm>Tab</dosageForm><drug id="02274086" notABenefit="Y" sec3="Y"><name>PMS-Hydrochlorothiazide</name><manufacturerId>PMS</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02327856" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Hydro</name><manufacturerId>APX</manufacturerId><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="402800012"><itemNumber>1138</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.0313</price><dailyCost>.0313</dailyCost><drug id="00016500" notABenefit="Y" sec3="Y"><name>HydroDIURIL</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00021474" sec3="Y"><name>Novo-Hydrazide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0313</individualPrice><dailyCost>.0313</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00326844" sec3="Y"><name>Apo-Hydro 25</name><manufacturerId>APX</manufacturerId><individualPrice>.0313</individualPrice><dailyCost>.0313</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02247386" sec3="Y"><name>PMS-Hydrochlorothiazide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0313</individualPrice><dailyCost>.0313</dailyCost><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="402800011"><itemNumber>1139</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.0434</price><drug id="00016519" notABenefit="Y" sec3="Y"><name>HydroDIURIL</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00021482" sec3="Y"><name>Novo-Hydrazide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0434</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00312800" sec3="Y"><name>Apo-Hydro 50</name><manufacturerId>APX</manufacturerId><individualPrice>.0434</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02247387" sec3="Y"><name>PMS-Hydrochlorothiazide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0434</individualPrice><listingDate>2007-09-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00636"><name>HYDROCHLOROTHIAZIDE &amp; SPIRONOLACTONE</name><pcgGroup><pcg9 id="402800024"><itemNumber>1140</itemNumber><strength>25mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.1057</price><dailyCost>.0528</dailyCost><drug id="00180408" sec3="Y"><name>Aldactazide-25</name><manufacturerId>PFI</manufacturerId><individualPrice>.1331</individualPrice><dailyCost>.0665</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00613231" sec3="Y"><name>Novo-Spirozine-25</name><manufacturerId>NOP</manufacturerId><individualPrice>.1057</individualPrice><dailyCost>.0528</dailyCost><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="402800037"><itemNumber>1141</itemNumber><strength>50mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>.2236</price><drug id="00594377" sec3="Y"><name>Aldactazide-50</name><manufacturerId>PFI</manufacturerId><individualPrice>.2823</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00657182" sec3="Y"><name>Novo-Spirozine-50</name><manufacturerId>NOP</manufacturerId><individualPrice>.2236</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00637"><name>HYDROCHLOROTHIAZIDE &amp; TRIAMTERENE</name><pcgGroup><pcg9 id="402800025"><itemNumber>1142</itemNumber><strength>25mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>.0608</price><dailyCost>.0608</dailyCost><drug id="00441775" sec3="Y"><name>Apo-Triazide</name><manufacturerId>APX</manufacturerId><individualPrice>.0608</individualPrice><dailyCost>.0608</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00532657" sec3="Y"><name>Novo-Triamzide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0608</individualPrice><dailyCost>.0608</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="00865532" notABenefit="Y" sec3="Y"><name>Nu-Triazide</name><manufacturerId>NXP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01919547" notABenefit="Y" sec3="Y"><name>Dyazide</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00641"><name>INDAPAMIDE</name><pcgGroup><pcg9 id="402800040"><itemNumber>1143</itemNumber><strength>1.25mg</strength><dosageForm>Tab</dosageForm><price>.1490</price><drug id="02179709" sec3="Y"><name>Lozide</name><manufacturerId>SEV</manufacturerId><individualPrice>.2979</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02227339" sec3="Y"><name>Indapamide Hemihydrate</name><manufacturerId>SEV</manufacturerId><individualPrice>.1877</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02239619" sec3="Y"><name>PMS-Indapamide</name><manufacturerId>PMS</manufacturerId><individualPrice>.1490</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02240067" sec3="Y"><name>Mylan-Indapamide</name><manufacturerId>MYL</manufacturerId><individualPrice>.1490</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02245246" sec3="Y"><name>Apo-Indapamide</name><manufacturerId>APX</manufacturerId><individualPrice>.1490</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="402800036"><itemNumber>1144</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.2364</price><dailyCost>.2364</dailyCost><drug id="00564966" sec3="Y"><name>Lozide</name><manufacturerId>SEV</manufacturerId><individualPrice>.4727</individualPrice><dailyCost>.4727</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02049341" sec3="Y"><name>Indapamide</name><manufacturerId>SEV</manufacturerId><individualPrice>.2977</individualPrice><dailyCost>.2977</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02153483" sec3="Y"><name>Mylan-Indapamide</name><manufacturerId>MYL</manufacturerId><individualPrice>.2364</individualPrice><dailyCost>.2364</dailyCost><listingDate>1996-10-01</listingDate></drug><drug id="02223597" sec3="Y"><name>Nu-Indapamide</name><manufacturerId>NXP</manufacturerId><individualPrice>.2364</individualPrice><dailyCost>.2364</dailyCost><listingDate>1997-04-10</listingDate></drug><drug id="02223678" sec3="Y"><name>Apo-Indapamide</name><manufacturerId>APX</manufacturerId><individualPrice>.2364</individualPrice><dailyCost>.2364</dailyCost><listingDate>1996-12-19</listingDate></drug><drug id="02231184" sec3="Y"><name>Novo-Indapamide</name><manufacturerId>NOP</manufacturerId><individualPrice>.2364</individualPrice><dailyCost>.2364</dailyCost><listingDate>1998-12-31</listingDate></drug><drug id="02239620" sec3="Y"><name>PMS-Indapamide</name><manufacturerId>PMS</manufacturerId><individualPrice>.2364</individualPrice><dailyCost>.2364</dailyCost><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00640"><name>METOLAZONE</name><pcgGroup><pcg9 id="402800035"><itemNumber>1145</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.1865</price><drug id="00888400" sec3="Y"><name>Zaroxolyn</name><manufacturerId>SAV</manufacturerId><individualPrice>.1865</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00642"><name>MIDODRINE HCL</name><pcgGroup lccId="00079"><pcg9 id="402800041"><itemNumber>1146</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.3378</price><drug id="01934392" sec3="Y" sec12="Y"><name>Amatine</name><manufacturerId>SHI</manufacturerId><individualPrice>.4610</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02278677" sec3="Y" sec12="Y"><name>Apo-Midodrine</name><manufacturerId>APX</manufacturerId><individualPrice>.3378</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9><pcg9 id="402800042"><itemNumber>1147</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.5630</price><drug id="01934406" sec3="Y" sec12="Y"><name>Amatine</name><manufacturerId>SHI</manufacturerId><individualPrice>.7684</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02278685" sec3="Y" sec12="Y"><name>Apo-Midodrine</name><manufacturerId>APX</manufacturerId><individualPrice>.5630</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="01">For the treatment of patients disabled by moderate to severe neurogenic orthostatic hypotension (i.e. drop in systolic BP less than or equal to 20mm Hg from supine to standing position), in whom conventional nonpharmacologic and pharmacologic (i.e. fludrocortisone) therapies have proven ineffective or are poorly tolerated.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00634"><name>SPIRONOLACTONE</name><note>Spironolactone can double digoxin blood levels within two weeks, and commonly causes mastalgia and gynaecomastia in men.</note><pcgGroup><pcg9 id="402800014"><itemNumber>1148</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.1038</price><drug id="00028606" sec3="Y"><name>Aldactone</name><manufacturerId>PFI</manufacturerId><individualPrice>.1331</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00613215" sec3="Y"><name>Novo-Spiroton</name><manufacturerId>NOP</manufacturerId><individualPrice>.1038</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="402800021"><itemNumber>1149</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.2417</price><drug id="00285455" sec3="Y"><name>Aldactone</name><manufacturerId>PFI</manufacturerId><individualPrice>.3138</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00613223" sec3="Y"><name>Novo-Spiroton</name><manufacturerId>NOP</manufacturerId><individualPrice>.2417</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="404000000"><name>URICOSURIC DRUGS</name><genericName id="00648"><name>PROBENECID</name><pcgGroup><pcg9 id="404000001"><itemNumber>1150</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.1884</price><drug id="00016616" notABenefit="Y" sec3="Y"><name>Benemid</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00294926" sec3="Y"><name>Benuryl</name><manufacturerId>VAL</manufacturerId><individualPrice>.1884</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00649"><name>SULFINPYRAZONE</name><pcgGroup><pcg9 id="404000002"><itemNumber>1151</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.2997</price><drug id="00010529" notABenefit="Y" sec3="Y"><name>Anturan</name><manufacturerId>GEI</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00441767" sec3="Y"><name>Apo-Sulfinpyrazone</name><manufacturerId>APX</manufacturerId><individualPrice>.2997</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="480000000"><name>COUGH PREPARATIONS</name><pcg6 id="480400000"><name>ANTITUSSIVES</name><genericName id="00650"><name>DEXTROMETHORPHAN HBR</name><pcgGroup><pcg9 id="480400010" suppliedBy="L"><itemNumber>1152</itemNumber><strength>3mg/mL</strength><dosageForm>O/L</dosageForm><price>.0088</price><drug id="00391069" notABenefit="Y" sec3="Y"><name>DM-Syrup</name><manufacturerId>PDA</manufacturerId><listingDate>2006-06-15</listingDate></drug><drug id="01928783" selfMed="Y" sec3="Y"><name>Koffex DM</name><manufacturerId>ROG</manufacturerId><individualPrice>.0088</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00441"><name>HYDROCODONE BITARTRATE</name><pcgGroup><pcg9 id="480400007"><itemNumber>1153</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>.1107</price><drug id="01916580" sec3="Y"><name>Hycodan</name><manufacturerId>BQU</manufacturerId><individualPrice>.1107</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="480800000"><name>EXPECTORANTS</name><genericName id="00660"><name>GUAIFENESIN</name><pcgGroup><pcg9 id="480800003" suppliedBy="L"><itemNumber>1154</itemNumber><strength>20mg/mL</strength><dosageForm>O/L</dosageForm><drug id="00026468" notABenefit="Y" sec3="Y"><name>Robitussin</name><manufacturerId>WHB</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00026794" notABenefit="Y" sec3="Y"><name>Guaifenesin</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00990930" notABenefit="Y" sec3="Y"><name>Guaifenesin Sugar Free</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="520000000"><name>EYE, EAR, NOSE AND THROAT PREPARATIONS</name><pcg6 id="520404000"><name>ANTI-INFECTIVES ANTIBIOTICS</name><genericName id="00151"><name>CHLORAMPHENICOL</name><pcgGroup><pcg9 id="520404016"><itemNumber>1155</itemNumber><strength>0.25%</strength><dosageForm>Oph Sol</dosageForm><price>.5280</price><drug id="01980556" sec3="Y"><name>Pentamycetin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5280</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00090"><name>FRAMYCETIN SULFATE</name><pcgGroup><pcg9 id="520404011"><itemNumber>1156</itemNumber><strength>0.5%</strength><dosageForm>Oph Oint-5g Pk</dosageForm><price>19.1300</price><drug id="02224895" sec3="Y"><name>Soframycin</name><manufacturerId>ERF</manufacturerId><individualPrice>19.1300</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><pcg9 id="520404010"><itemNumber>1157</itemNumber><strength>0.5%</strength><dosageForm>Oph Sol</dosageForm><price>1.3075</price><drug id="02224887" sec3="Y"><name>Soframycin</name><manufacturerId>ERF</manufacturerId><individualPrice>1.3075</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00667"><name>FRAMYCETIN SULFATE &amp; GRAMICIDIN &amp; DEXAMETHASONE</name><pcgGroup><pcg9 id="520404012"><itemNumber>1158</itemNumber><strength>5mg &amp; 50mcg &amp; 0.5mg/mL</strength><dosageForm>Oph/Ot Sol</dosageForm><price>.9800</price><note>The risk of ototoxicity with topical aminoglycoside may increase with prolonged therapy. Topical use of antibiotics increases the likelihood of development of bacterial resistance, especially with prolonged use, sometimes rendering the systemic use of this antibiotic class useless in these patients.</note><drug id="02224623" sec3="Y"><name>Sofracort</name><manufacturerId>SAV</manufacturerId><individualPrice>1.7874</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02247920" sec3="Y"><name>Sandoz Opticort</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9800</individualPrice><listingDate>2005-12-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00670"><name>GENTAMICIN &amp; BETAMETHASONE SODIUM PHOSPHATE</name><pcgGroup><pcg9 id="520404025"><itemNumber>1159</itemNumber><strength>3mg &amp; 1mg/mL</strength><dosageForm>Oph/Ot Drops</dosageForm><price>1.1965</price><note>The risk of ototoxicity with topical aminoglycoside may increase with prolonged therapy. Topical use of antibiotics increases the likelihood of development of bacterial resistance, especially with prolonged use, sometimes rendering the systemic use of this antibiotic class useless in these patients.</note><drug id="00682217" sec3="Y"><name>Garasone</name><manufacturerId>SCH</manufacturerId><individualPrice>1.2813</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02244999" sec3="Y"><name>Sandoz Pentasone</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1965</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00070"><name>GENTAMICIN SULFATE</name><pcgGroup><pcg9 id="520404014"><itemNumber>1160</itemNumber><strength>0.3%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>4.0000</price><drug id="00028339" sec3="Y"><name>Garamycin</name><manufacturerId>SCH</manufacturerId><individualPrice>4.0000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520404018"><itemNumber>1161</itemNumber><strength>0.3%</strength><dosageForm>Oph Sol</dosageForm><price>.4060</price><drug id="00436771" dinStatus="E" sec3="Y"><name>Alcomicin</name><manufacturerId>ALC</manufacturerId><individualPrice>.5300</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00512192" sec3="Y"><name>Garamycin</name><manufacturerId>SCH</manufacturerId><individualPrice>.4060</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520404019"><itemNumber>1162</itemNumber><strength>0.3%</strength><dosageForm>Ot Sol</dosageForm><price>1.0320</price><drug id="00512184" sec3="Y"><name>Garamycin</name><manufacturerId>SCH</manufacturerId><individualPrice>1.0320</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229441" sec3="Y"><name>Sandoz Gentamicin</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.0320</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00665"><name>POLYMYXIN B SULFATE &amp; BACITRACIN (ZINC)</name><pcgGroup><pcg9 id="520404006"><itemNumber>1163</itemNumber><strength>10000U &amp; 500U/g</strength><dosageForm>Oph Oint 3.5g Pk</dosageForm><price>5.5400</price><drug id="02239157" sec3="Y"><name>Polysporin</name><manufacturerId>PFI</manufacturerId><individualPrice>5.5400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00666"><name>POLYMYXIN B SULFATE &amp; GRAMICIDIN</name><pcgGroup><pcg9 id="520404007"><itemNumber>1164</itemNumber><strength>10000U &amp; 0.025mg/mL</strength><dosageForm>Oph/Ot Sol</dosageForm><price>.6920</price><drug id="02239156" sec3="Y"><name>Polysporin</name><manufacturerId>PFI</manufacturerId><individualPrice>.6920</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00675"><name>POLYMYXIN B SULFATE &amp; NEOMYCIN SULFATE &amp; HYDROCORTISONE</name><pcgGroup><pcg9 id="520404034"><itemNumber>1165</itemNumber><strength>10000U &amp; 5mg &amp; 10mg/mL</strength><dosageForm>Ot Sol</dosageForm><price>1.2810</price><drug id="01912828" sec3="Y"><name>Cortisporin</name><manufacturerId>GSK</manufacturerId><individualPrice>1.2810</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00668"><name>TOBRAMYCIN</name><pcgGroup><pcg9 id="520404024"><itemNumber>1166</itemNumber><strength>0.3%</strength><dosageForm>Oph Oint</dosageForm><price>2.3629</price><drug id="00614254" sec3="Y"><name>Tobrex</name><manufacturerId>ALC</manufacturerId><individualPrice>2.3629</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520404020"><itemNumber>1167</itemNumber><strength>0.3%</strength><dosageForm>Oph Sol</dosageForm><price>.8333</price><drug id="00513962" sec3="Y"><name>Tobrex</name><manufacturerId>ALC</manufacturerId><individualPrice>1.6660</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239577" sec3="Y"><name>PMS-Tobramycin</name><manufacturerId>PMS</manufacturerId><individualPrice>.8333</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02241755" sec3="Y"><name>Sandoz Tobramycin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8333</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00674"><name>TOBRAMYCIN &amp; DEXAMETHASONE</name><pcgGroup><pcg9 id="520404032"><itemNumber>1168</itemNumber><strength>0.3% &amp; 0.1%</strength><dosageForm>Oph Oint</dosageForm><price>2.9143</price><drug id="00778915" sec3="Y"><name>TobraDex</name><manufacturerId>ALC</manufacturerId><individualPrice>2.9143</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520404031"><itemNumber>1169</itemNumber><strength>0.3% &amp; 0.1%</strength><dosageForm>Oph Susp</dosageForm><price>1.9680</price><drug id="00778907" sec3="Y"><name>TobraDex</name><manufacturerId>ALC</manufacturerId><individualPrice>1.9680</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="520408000"><name>ANTI-INFECTIVES SULFONAMIDES</name><genericName id="00681"><name>SULFACETAMIDE (SODIUM)</name><pcgGroup><pcg9 id="520408003"><itemNumber>1170</itemNumber><strength>10%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>3.3400</price><drug id="00252522" dinStatus="E" sec3="Y"><name>Cetamide</name><manufacturerId>ALC</manufacturerId><individualPrice>3.3400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="520412000"><name>ANTI-INFECTIVES OTHER ANTI-INFECTIVES</name><genericName id="00141"><name>CIPROFLOXACIN</name><note>Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children &lt; 18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.</note><pcgGroup><pcg9 id="520412012"><itemNumber>1171</itemNumber><strength>0.3%</strength><dosageForm>Oph Sol-5mL Pk</dosageForm><drug id="01945270" notABenefit="Y" sec3="Y"><name>Ciloxan</name><manufacturerId>ALC</manufacturerId><listingDate>2009-01-30</listingDate></drug><drug id="02253933" notABenefit="Y" sec3="Y"><name>PMS-Ciprofloxacin</name><manufacturerId>PMS</manufacturerId><listingDate>2009-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00145"><name>OFLOXACIN</name><pcgGroup lccId="00080"><pcg9 id="520412008"><itemNumber>1172</itemNumber><strength>0.3%</strength><dosageForm>Oph Sol</dosageForm><price>.7080</price><drug id="02143291" sec3="Y" sec12="Y"><name>Ocuflox</name><manufacturerId>ALL</manufacturerId><individualPrice>2.4460</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02248398" sec3="Y" sec12="Y"><name>Apo-Ofloxacin</name><manufacturerId>APX</manufacturerId><individualPrice>.7080</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02252570" sec3="Y" sec12="Y"><name>PMS-Ofloxacin</name><manufacturerId>PMS</manufacturerId><individualPrice>.7080</individualPrice><listingDate>2007-10-03</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="170">For the treatment of conjunctivitis caused by susceptible strain(s) of Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae and Hemophilus influenzae which is/are resistant or unresponsive to listed alternative agents.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00684"><name>TRIFLURIDINE</name><pcgGroup><pcg9 id="520412007"><itemNumber>1173</itemNumber><strength>1%</strength><dosageForm>Oph Sol</dosageForm><price>3.0387</price><note>Administration of trifluridine for periods exceeding 21 days should be avoided because of potential ocular toxicity.</note><drug id="00687456" sec3="Y"><name>Viroptic</name><manufacturerId>THE</manufacturerId><individualPrice>3.0387</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="520800000"><name>ANTI-INFLAMMATORY AGENTS</name><note>Topical corticosteroid can reactivate pre-existing viral keratitis. These agents should be used with caution in patients with a history of previous corneal ulceration. In some patients, prolonged use of these agents can result in significant problems such as increased intraocular pressure.</note><genericName id="00687"><name>BECLOMETHASONE DIPROPIONATE</name><pcgGroup><pcg9 id="520800028"><itemNumber>1174</itemNumber><strength>50mcg</strength><dosageForm>Nas Sp-200 Dose Pk</dosageForm><price>12.2600</price><drug id="02172712" sec3="Y"><name>Gen-Beclo AQ</name><manufacturerId>GEN</manufacturerId><individualPrice>12.2600</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02213702" notABenefit="Y" sec3="Y"><name>Beconase Aqueous</name><manufacturerId>GLW</manufacturerId><listingDate>1998-03-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00696"><name>BUDESONIDE</name><pcgGroup><pcg9 id="520800038"><itemNumber>1175</itemNumber><strength>100mcg/Metered Dose</strength><dosageForm>Nas Aero 200 Dose</dosageForm><price>22.7000</price><drug id="02035324" sec3="Y"><name>Rhinocort Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>22.7000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520800039"><itemNumber>1176</itemNumber><strength>64mcg/Metered Dose</strength><dosageForm>Nas Sp-120 Dose Pk</dosageForm><price>10.2000</price><drug id="02231923" sec3="Y"><name>Rhinocort Aqua</name><manufacturerId>AZC</manufacturerId><individualPrice>10.2000</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="520800032"><itemNumber>1177</itemNumber><strength>100mcg/Metered Dose</strength><dosageForm>Nas Sp-165 Dose Pk</dosageForm><price>12.7400</price><drug id="01974432" notABenefit="Y" sec3="Y"><name>Rhinocort Aqua</name><manufacturerId>AST</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230648" sec3="Y"><name>Gen-Budesonide AQ</name><manufacturerId>GEN</manufacturerId><individualPrice>12.7400</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00685"><name>DEXAMETHASONE</name><pcgGroup><pcg9 id="520800015"><itemNumber>1178</itemNumber><strength>0.1%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>8.3500</price><drug id="00042579" sec3="Y"><name>Maxidex</name><manufacturerId>ALC</manufacturerId><individualPrice>8.3500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520800014"><itemNumber>1179</itemNumber><strength>0.1%</strength><dosageForm>Oph Susp</dosageForm><price>1.5400</price><drug id="00042560" sec3="Y"><name>Maxidex</name><manufacturerId>ALC</manufacturerId><individualPrice>1.5400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00686"><name>FLUMETHASONE PIVALATE &amp; IODOCHLORHYDROXYQUIN</name><pcgGroup><pcg9 id="520800012"><itemNumber>1180</itemNumber><strength>0.02% &amp; 1%</strength><dosageForm>Ot Sol</dosageForm><price>1.4500</price><drug id="00074454" sec3="Y"><name>Locacorten-Vioform</name><manufacturerId>PAL</manufacturerId><individualPrice>1.4500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00692"><name>FLUNISOLIDE</name><pcgGroup><pcg9 id="520800024"><itemNumber>1181</itemNumber><strength>0.025%</strength><dosageForm>Nas Sp-25mL Pk</dosageForm><price>14.8500</price><drug id="02162687" dinStatus="E" sec3="Y"><name>Rhinalar</name><manufacturerId>IVA</manufacturerId><individualPrice>19.8000</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02239288" sec3="Y"><name>Apo-Flunisolide</name><manufacturerId>APX</manufacturerId><individualPrice>14.8500</individualPrice><listingDate>2004-08-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00690"><name>FLUOROMETHOLONE</name><pcgGroup><pcg9 id="520800021"><itemNumber>1182</itemNumber><strength>0.1%</strength><dosageForm>Oph Susp</dosageForm><price>3.0580</price><drug id="00247855" sec3="Y"><name>FML</name><manufacturerId>ALL</manufacturerId><individualPrice>3.0580</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00693"><name>FLUOROMETHOLONE ACETATE</name><pcgGroup><pcg9 id="520800026"><itemNumber>1183</itemNumber><strength>0.1%</strength><dosageForm>Oph Susp</dosageForm><price>1.7400</price><drug id="00756784" sec3="Y"><name>Flarex</name><manufacturerId>ALC</manufacturerId><individualPrice>1.7400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00255"><name>FLUTICASONE PROPIONATE</name><pcgGroup><pcg9 id="520800035"><itemNumber>1184</itemNumber><strength>50mcg/Actuation</strength><dosageForm>Nas Sp-120 Dose Pk</dosageForm><drug id="02213672" notABenefit="Y" sec3="Y"><name>Flonase</name><manufacturerId>GSK</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02294745" notABenefit="Y" sec3="Y"><name>Apo-Fluticasone</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02296071" notABenefit="Y" sec3="Y"><name>Ratio-Fluticasone</name><manufacturerId>RPH</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00442"><name>KETOROLAC TROMETHAMINE</name><pcgGroup><pcg9 id="520800030"><itemNumber>1185</itemNumber><strength>0.5%</strength><dosageForm>Oph Sol</dosageForm><price>1.6000</price><drug id="01968300" sec3="Y"><name>Acular</name><manufacturerId>ALL</manufacturerId><individualPrice>3.3600</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245821" sec3="Y"><name>Apo-Ketorolac</name><manufacturerId>APX</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02247461" sec3="Y"><name>Ratio-Ketorolac</name><manufacturerId>RPH</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00697"><name>LODOXAMIDE TROMETHAMINE</name><pcgGroup><pcg9 id="520800034"><itemNumber>1186</itemNumber><strength>0.1%</strength><dosageForm>Oph Sol</dosageForm><price>1.0250</price><drug id="00893560" sec3="Y"><name>Alomide</name><manufacturerId>ALC</manufacturerId><individualPrice>1.0250</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00688"><name>PREDNISOLONE ACETATE</name><pcgGroup><pcg9 id="520800020"><itemNumber>1187</itemNumber><strength>0.12%</strength><dosageForm>Oph Susp</dosageForm><price>1.7960</price><drug id="00299405" sec3="Y"><name>Pred Mild</name><manufacturerId>ALL</manufacturerId><individualPrice>1.7960</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="520800017"><itemNumber>1188</itemNumber><strength>1%</strength><dosageForm>Oph Susp</dosageForm><price>1.9400</price><drug id="00301175" notABenefit="Y" sec3="Y"><name>Pred Forte</name><manufacturerId>ALL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00700401" sec3="Y"><name>Ratio-Prednisolone</name><manufacturerId>RPH</manufacturerId><individualPrice>1.9400</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02023768" notABenefit="Y" sec3="Y"><name>Diopred</name><manufacturerId>SDZ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="521600000"><name>LOCAL ANESTHETICS</name><genericName id="00699"><name>BENZYDAMINE HCL</name><pcgGroup lccId="00081"><pcg9 id="521600002"><itemNumber>1189</itemNumber><strength>0.15%</strength><dosageForm>Oral Rinse</dosageForm><price>.0290</price><drug id="01966065" sec3="Y" sec12="Y"><name>Tantum</name><manufacturerId>GRA</manufacturerId><individualPrice>.1325</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229777" sec3="Y" sec12="Y"><name>PMS-Benzydamine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0290</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02229799" sec3="Y" sec12="Y"><name>Novo-Benzydamine</name><manufacturerId>NOP</manufacturerId><individualPrice>.0290</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02230170" sec3="Y" sec12="Y"><name>Ratio-Benzydamine</name><manufacturerId>RPH</manufacturerId><individualPrice>.0290</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02239044" sec3="Y" sec12="Y"><name>Apo-Benzydamine</name><manufacturerId>APX</manufacturerId><individualPrice>.0290</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="240">For the symptomatic relief of treatment induced mucositis in cancer patients.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00698"><name>LIDOCAINE HCL</name><pcgGroup><pcg9 id="521600001"><itemNumber>1190</itemNumber><strength>2%</strength><dosageForm>O/L</dosageForm><price>.0875</price><drug id="00001686" sec3="Y"><name>Xylocaine Viscous</name><manufacturerId>AZC</manufacturerId><individualPrice>.0875</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="522000000"><name>MIOTICS</name><genericName id="00211"><name>CARBACHOL</name><pcgGroup><pcg9 id="522000002"><itemNumber>1191</itemNumber><strength>1.5%</strength><dosageForm>Oph Sol</dosageForm><price>.6733</price><drug id="00000655" sec3="Y"><name>Isopto Carbachol</name><manufacturerId>ALC</manufacturerId><individualPrice>.6733</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="522000001"><itemNumber>1192</itemNumber><strength>3%</strength><dosageForm>Oph Sol</dosageForm><price>.8100</price><drug id="00000663" sec3="Y"><name>Isopto Carbachol</name><manufacturerId>ALC</manufacturerId><individualPrice>.8100</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00702"><name>PILOCARPINE HCL</name><pcgGroup><pcg9 id="522000028"><itemNumber>1193</itemNumber><strength>4%</strength><dosageForm>Oph Gel</dosageForm><price>2.4980</price><drug id="00575240" sec3="Y"><name>Pilopine HS</name><manufacturerId>ALC</manufacturerId><individualPrice>2.4980</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="522000012"><itemNumber>1194</itemNumber><strength>1%</strength><dosageForm>Oph Sol</dosageForm><price>.2047</price><drug id="00000841" sec3="Y"><name>Isopto Carpine</name><manufacturerId>ALC</manufacturerId><individualPrice>.2047</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02023725" notABenefit="Y" sec3="Y"><name>Diocarpine</name><manufacturerId>DKT</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="522000011"><itemNumber>1195</itemNumber><strength>2%</strength><dosageForm>Oph Sol</dosageForm><price>.2360</price><drug id="00000868" sec3="Y"><name>Isopto Carpine</name><manufacturerId>ALC</manufacturerId><individualPrice>.2360</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02023741" notABenefit="Y" sec3="Y"><name>Diocarpine</name><manufacturerId>DKT</manufacturerId><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="522000009"><itemNumber>1196</itemNumber><strength>4%</strength><dosageForm>Oph Sol</dosageForm><price>.2667</price><drug id="00000884" sec3="Y"><name>Isopto Carpine</name><manufacturerId>ALC</manufacturerId><individualPrice>.2667</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="522000008"><itemNumber>1197</itemNumber><strength>6%</strength><dosageForm>Oph Sol</dosageForm><price>.4580</price><drug id="00000892" dinStatus="E" sec3="Y"><name>Isopto Carpine</name><manufacturerId>ALC</manufacturerId><individualPrice>.4580</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="522400000"><name>MYDRIATICS</name><genericName id="00232"><name>ATROPINE SULFATE</name><pcgGroup><pcg9 id="522400010"><itemNumber>1198</itemNumber><strength>1%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>5.0500</price><drug id="00252484" dinStatus="E" sec3="Y"><name>Atropine Sulfate</name><manufacturerId>ALC</manufacturerId><individualPrice>5.0500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="522400002"><itemNumber>1199</itemNumber><strength>1%</strength><dosageForm>Oph Sol</dosageForm><price>.6000</price><drug id="00035017" sec3="Y"><name>Isopto Atropine</name><manufacturerId>ALC</manufacturerId><individualPrice>.6000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01948598" notABenefit="Y" sec3="Y"><name>Atropine</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="523200000"><name>VASOCONSTRICTORS</name><genericName id="00712"><name>NAPHAZOLINE HCL</name><pcgGroup><pcg9 id="523200001"><itemNumber>1200</itemNumber><strength>0.1%</strength><dosageForm>Oph Sol</dosageForm><drug id="00001147" notABenefit="Y" sec3="Y"><name>Albalon</name><manufacturerId>ALL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00390283" notABenefit="Y" sec3="Y"><name>Naphcon Forte</name><manufacturerId>ALC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00750786" notABenefit="Y" sec3="Y"><name>Opcon</name><manufacturerId>BSH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00759880" notABenefit="Y" sec3="Y"><name>Vasocon</name><manufacturerId>IOB</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="523600000"><name>OTHER EYE, EAR, NOSE AND THROAT AGENTS</name><genericName id="00717"><name>ACETAZOLAMIDE</name><pcgGroup><pcg9 id="523600001"><itemNumber>1201</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.1237</price><drug id="00545015" sec3="Y"><name>Apo-Acetazolamide</name><manufacturerId>APX</manufacturerId><individualPrice>.1237</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02238072" notABenefit="Y" sec3="Y"><name>Diamox</name><manufacturerId>WAY</manufacturerId><listingDate>2000-11-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00720"><name>BETAXOLOL HCL</name><pcgGroup><pcg9 id="523600064"><itemNumber>1202</itemNumber><strength>0.25%</strength><dosageForm>Oph Susp</dosageForm><price>2.2280</price><drug id="01908448" sec3="Y"><name>Betoptic S</name><manufacturerId>ALC</manufacturerId><individualPrice>2.2280</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01579"><name>BIMATOPROST</name><pcgGroup lccId="00152"><pcg9 id="523600104"><itemNumber>1203</itemNumber><strength>0.03%</strength><dosageForm>Oph Sol</dosageForm><price>10.8100</price><drug id="02245860" sec3="Y" sec12="Y"><name>Lumigan</name><manufacturerId>ALL</manufacturerId><individualPrice>10.8100</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01360"><name>BRIMONIDINE</name><pcgGroup lccId="00082"><pcg9 id="523600107"><itemNumber>1204</itemNumber><strength>0.15%</strength><dosageForm>Oph Sol</dosageForm><price>1.7325</price><drug id="02248151" sec3="Y" sec12="Y"><name>Alphagan P</name><manufacturerId>ALL</manufacturerId><individualPrice>2.3100</individualPrice><listingDate>2004-11-04</listingDate></drug><drug id="02301334" sec3="Y" sec12="Y"><name>Apo-Brimonidine P</name><manufacturerId>APX</manufacturerId><individualPrice>1.7325</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9><pcg9 id="523600090"><itemNumber>1205</itemNumber><strength>0.2%</strength><dosageForm>Oph Sol</dosageForm><price>1.6500</price><drug id="02236876" sec3="Y" sec12="Y"><name>Alphagan</name><manufacturerId>ALL</manufacturerId><individualPrice>3.3000</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02243026" sec3="Y" sec12="Y"><name>Ratio-Brimonidine</name><manufacturerId>RPH</manufacturerId><individualPrice>1.6500</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02246284" sec3="Y" sec12="Y"><name>PMS-Brimonidine</name><manufacturerId>PMS</manufacturerId><individualPrice>1.6500</individualPrice><listingDate>2005-12-06</listingDate></drug><drug id="02260077" sec3="Y" sec12="Y"><name>Apo-Brimonidine</name><manufacturerId>APX</manufacturerId><individualPrice>1.6500</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02305429" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Brimonidine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.6500</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01623"><name>BRIMONIDINE TARTRATE &amp; TIMOLOL MALEATE</name><pcgGroup lccId="00156"><pcg9 id="523600115"><itemNumber>1206</itemNumber><strength>0.2% &amp; 0.5%</strength><dosageForm>Oph Sol-10mL Pk</dosageForm><price>40.1200</price><drug id="09857298" dinStatus="N" sec3="Y" sec12="Y"><name>Combigan</name><manufacturerId>ALL</manufacturerId><individualPrice>40.1200</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="310">As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="393">For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01423"><name>BRINZOLAMIDE</name><pcgGroup lccId="00083"><pcg9 id="523600096"><itemNumber>1207</itemNumber><strength>1%</strength><dosageForm>Oph Susp</dosageForm><price>3.2200</price><drug id="02238873" sec3="Y" sec12="Y"><name>Azopt</name><manufacturerId>ALC</manufacturerId><individualPrice>3.2200</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00740"><name>DEXTRAN 70 &amp; HYDROXYPROPYL METHYLCELLULOSE</name><pcgGroup lccId="00085"><pcg9 id="523600072"><itemNumber>1208</itemNumber><strength>0.1%/0.3%</strength><dosageForm>Oph-Sol</dosageForm><price>.2800</price><drug id="00390291" sec3="Y" sec12="Y"><name>Tears Naturale</name><manufacturerId>ALC</manufacturerId><individualPrice>.2800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00741"><name>DEXTRAN 70 &amp; HYDROXYPROPYL METHYLCELLULOSE &amp; POLYQUAD</name><pcgGroup lccId="00084"><pcg9 id="523600073"><itemNumber>1209</itemNumber><strength>0.1%/0.3%/0.001%</strength><dosageForm>Oph-Sol</dosageForm><price>.2880</price><drug id="00743445" sec3="Y" sec12="Y"><name>Tears Naturale II</name><manufacturerId>ALC</manufacturerId><individualPrice>.2880</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00425"><name>DICLOFENAC SODIUM</name><pcgGroup><pcg9 id="523600065"><itemNumber>1210</itemNumber><strength>0.1%</strength><dosageForm>Oph Sol</dosageForm><price>3.1600</price><drug id="01940414" sec3="Y"><name>Voltaren Ophtha</name><manufacturerId>NOV</manufacturerId><individualPrice>3.1600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00743"><name>DORZOLAMIDE HCL</name><pcgGroup lccId="00086"><pcg9 id="523600083"><itemNumber>1211</itemNumber><strength>2%</strength><dosageForm>Oph Sol</dosageForm><price>3.7500</price><drug id="02216205" sec3="Y" sec12="Y"><name>Trusopt</name><manufacturerId>MFC</manufacturerId><individualPrice>3.7500</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01431"><name>DORZOLAMIDE HCL &amp; TIMOLOL MALEATE</name><pcgGroup lccId="00087"><pcg9 id="523600098"><itemNumber>1212</itemNumber><strength>2% &amp; 0.5%</strength><dosageForm>Oph Sol</dosageForm><price>5.6820</price><drug id="02240113" sec3="Y" sec12="Y"><name>Cosopt</name><manufacturerId>MFC</manufacturerId><individualPrice>5.6820</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="523600113"><itemNumber>1213</itemNumber><strength>2% &amp; 0.5%</strength><dosageForm>Oph Sol-0.2mL Pk</dosageForm><price>.4735</price><drug id="02258692" dinStatus="N" sec3="Y" sec12="Y"><name>Cosopt Preservative free</name><manufacturerId>MFC</manufacturerId><individualPrice>.4735</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="310">As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="393">For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00227"><name>IPRATROPIUM BROMIDE</name><pcgGroup lccId="00088"><pcg9 id="523600082"><itemNumber>1214</itemNumber><strength>0.03%</strength><dosageForm>Nasal Spray</dosageForm><price>.4640</price><drug id="02163705" sec3="Y" sec12="Y"><name>Atrovent</name><manufacturerId>BOE</manufacturerId><individualPrice>.9930</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02239627" sec3="Y" sec12="Y"><name>PMS-Ipratropium</name><manufacturerId>PMS</manufacturerId><individualPrice>.4640</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="03">For the treatment of non-allergic vasomotor rhinitis</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="523600117"><itemNumber>1215</itemNumber><strength>0.06%</strength><dosageForm>Nasal Spray</dosageForm><drug id="02163713" notABenefit="Y" sec3="Y"><name>Atrovent</name><manufacturerId>BOE</manufacturerId><listingDate>2009-06-23</listingDate></drug><drug id="02246084" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Ipravent</name><manufacturerId>APX</manufacturerId><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01339"><name>LATANOPROST</name><pcgGroup lccId="00089"><pcg9 id="523600088"><itemNumber>1216</itemNumber><strength>0.005%</strength><dosageForm>Oph Sol-2.5mL Pk</dosageForm><price>27.0400</price><drug id="02231493" sec3="Y" sec12="Y"><name>Xalatan</name><manufacturerId>PFI</manufacturerId><individualPrice>27.0400</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01624"><name>LATANOPROST &amp; TIMOLOL MALEATE</name><pcgGroup lccId="00157"><pcg9 id="523600108"><itemNumber>1217</itemNumber><strength>50mcg/mL &amp; 5mg/mL</strength><dosageForm>Oph Sol-2.5mL Pk</dosageForm><price>30.6000</price><drug id="02246619" sec3="Y" sec12="Y"><name>Xalacom</name><manufacturerId>PFI</manufacturerId><individualPrice>30.6000</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="310">As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="393">For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00719"><name>LEVOBUNOLOL HCL</name><pcgGroup><pcg9 id="523600045"><itemNumber>1218</itemNumber><strength>0.25%</strength><dosageForm>Oph Sol</dosageForm><price>.9334</price><drug id="02031159" sec3="Y"><name>Ratio-Levobunolol</name><manufacturerId>RPH</manufacturerId><individualPrice>.9334</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02241715" sec3="Y"><name>Sandoz Levobunolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9334</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="523600035"><itemNumber>1219</itemNumber><strength>0.5%</strength><dosageForm>Oph Sol</dosageForm><price>1.2345</price><drug id="00637661" sec3="Y"><name>Betagan</name><manufacturerId>ALL</manufacturerId><individualPrice>3.2900</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02031167" sec3="Y"><name>Ratio-Levobunolol</name><manufacturerId>RPH</manufacturerId><individualPrice>1.2345</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02237991" sec3="Y"><name>PMS-Levobunolol</name><manufacturerId>PMS</manufacturerId><individualPrice>1.2345</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02241574" sec3="Y"><name>Apo-Levobunolol</name><manufacturerId>APX</manufacturerId><individualPrice>1.2345</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02241716" sec3="Y"><name>Sandoz Levobunolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.2345</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00722"><name>METHAZOLAMIDE</name><pcgGroup><pcg9 id="523600043"><itemNumber>1220</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.4817</price><drug id="02238071" notABenefit="Y" sec3="Y"><name>Neptazane</name><manufacturerId>WAY</manufacturerId><listingDate>1999-12-16</listingDate></drug><drug id="02245882" sec3="Y"><name>Apo-Methazolamide</name><manufacturerId>APX</manufacturerId><individualPrice>.4817</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00738"><name>METHYLCELLULOSE</name><pcgGroup lccId="00090"><pcg9 id="523600067" suppliedBy="L"><itemNumber>1221</itemNumber><strength>0.5%</strength><dosageForm>Oph-Sol</dosageForm><price>.3407</price><drug id="00000809" sec3="Y" sec12="Y"><name>Isopto Tears</name><manufacturerId>ALC</manufacturerId><individualPrice>.3407</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="523600068" suppliedBy="L"><itemNumber>1222</itemNumber><strength>1%</strength><dosageForm>Oph-Sol</dosageForm><price>.4220</price><drug id="00000817" sec3="Y" sec12="Y"><name>Isopto Tears</name><manufacturerId>ALC</manufacturerId><individualPrice>.4220</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00739"><name>PETROLATUM/MINERAL OIL</name><pcgGroup lccId="00091"><pcg9 id="523600070"><itemNumber>1223</itemNumber><strength>55%/42.5%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>6.9800</price><drug id="00210889" sec3="Y" sec12="Y"><name>Lacri-Lube</name><manufacturerId>ALL</manufacturerId><individualPrice>6.9800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="523600076"><itemNumber>1224</itemNumber><strength>80%/20%</strength><dosageForm>Oph Oint-3.5g Pk</dosageForm><price>4.5800</price><drug id="02125706" sec3="Y" sec12="Y"><name>Duolube</name><manufacturerId>BSH</manufacturerId><individualPrice>4.5800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00736"><name>POLYVINYL ALCOHOL</name><pcgGroup lccId="00093"><pcg9 id="523600078"><itemNumber>1225</itemNumber><strength>1%</strength><dosageForm>Oph-Sol</dosageForm><price>.3127</price><drug id="02133253" sec3="Y" sec12="Y"><name>Hypotears</name><manufacturerId>NOV</manufacturerId><individualPrice>.3127</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="523600069"><itemNumber>1226</itemNumber><strength>1.4%</strength><dosageForm>Oph-Sol</dosageForm><price>.6373</price><drug id="00045616" sec3="Y" sec12="Y"><name>Liquifilm Tears</name><manufacturerId>ALL</manufacturerId><individualPrice>.6373</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00742"><name>POLYVINYL ALCOHOL &amp; POLYVINYLPYRROLIDONE</name><pcgGroup lccId="00092"><pcg9 id="523600075"><itemNumber>1227</itemNumber><dosageForm>Oph-Sol</dosageForm><price>.3553</price><drug id="00579408" sec3="Y" sec12="Y"><name>Tears Plus</name><manufacturerId>ALL</manufacturerId><individualPrice>.3553</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="49">For patients with objective evidence of keratoconjunctivitis sicca as confirmed by filamentary keratopathy on slit lamp examination or biopsy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01726"><name>RANIBIZUMAB</name><pcgGroup><pcg9 id="523600114"><itemNumber>1228</itemNumber><strength>10mg/mL</strength><dosageForm>Inj Sol-0.23mL Vial Pk</dosageForm><price>1575.0000</price><note>Note: For the treatment of patients with new onset (&lt;3 months) neovascular (wet)
age-related macular degeneration (AMD) in a verteporfin PDT (Visudyne)-naive eye.

Initial diagnosis should be confirmed by an appropriate diagnostic procedure and
administration should be done by a qualified ophthalmologist experienced in Intravitreal injections.

Patients receiving concurrent administration of verteporfin PDT (Visudyne) are not eligible for reimbursement.

Treatment should be initiated with a loading phase of one injection per month for three consecutive months, followed by a maintenance phase.

During the maintenance phase, patients should be monitored for best corrected visual acuity or continued disease activity.  If there is clinical or diagnostic evidence of disease activity such as a loss of greater than 5 letters in visual acuity (Early Treatment Diabetic Retinopathy Score (ETDRS) chart or one Snellen line equivalent), Lucentis may be administered. The interval between two doses should not be shorter than one month.</note><drug id="02296810" sec3="Y"><name>Lucentis</name><manufacturerId>NOV</manufacturerId><individualPrice>1575.0000</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00718"><name>SODIUM CROMOGLYCATE</name><pcgGroup><pcg9 id="523600032"><itemNumber>1229</itemNumber><strength>2%</strength><dosageForm>Nas Sol-26mL Pk</dosageForm><price>13.7600</price><drug id="00605255" notABenefit="Y" sec3="Y"><name>Rynacrom</name><manufacturerId>FIS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01950541" sec3="Y"><name>Cromolyn</name><manufacturerId>PMS</manufacturerId><individualPrice>13.7600</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231390" sec3="Y"><name>Apo-Cromolyn</name><manufacturerId>APX</manufacturerId><individualPrice>13.7600</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="523600019"><itemNumber>1230</itemNumber><strength>2%</strength><dosageForm>Oph Sol</dosageForm><price>.9500</price><drug id="02009277" sec3="Y"><name>Cromolyn</name><manufacturerId>PMS</manufacturerId><individualPrice>.9500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230621" sec3="Y"><name>Opticrom</name><manufacturerId>ALL</manufacturerId><individualPrice>.9980</individualPrice><listingDate>1998-02-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00314"><name>TIMOLOL MALEATE</name><pcgGroup><pcg9 id="523600080"><itemNumber>1231</itemNumber><strength>0.25%</strength><dosageForm>Oph Gellan Sol</dosageForm><price>1.9560</price><note>Timolol maleate can potentiate bronchospasm in asthmatic patients and should not be used in patients with a history of asthma.</note><drug id="02171880" sec3="Y"><name>Timoptic-XE</name><manufacturerId>MFC</manufacturerId><individualPrice>3.7040</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242275" sec3="Y"><name>Timolol Maleate-EX</name><manufacturerId>ALC</manufacturerId><individualPrice>1.9560</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9><pcg9 id="523600081"><itemNumber>1232</itemNumber><strength>0.5%</strength><dosageForm>Oph Gellan Sol</dosageForm><price>2.3400</price><note>Timolol maleate can potentiate bronchospasm in asthmatic patients and should not be used in patients with a history of asthma.</note><drug id="02171899" sec3="Y"><name>Timoptic-XE</name><manufacturerId>MFC</manufacturerId><individualPrice>4.4320</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242276" sec3="Y"><name>Timolol Maleate-EX</name><manufacturerId>ALC</manufacturerId><individualPrice>2.3400</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9><pcg9 id="523600021"><itemNumber>1233</itemNumber><strength>0.25%</strength><dosageForm>Oph Sol</dosageForm><price>1.2780</price><note>Timolol maleate can potentiate bronchospasm in asthmatic patients and should not be used in patients with a history of asthma.</note><drug id="00451193" notABenefit="Y" sec3="Y"><name>Timoptic</name><manufacturerId>MFC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00755826" sec3="Y"><name>Apo-Timop</name><manufacturerId>APX</manufacturerId><individualPrice>1.2780</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00893773" sec3="Y"><name>Gen-Timolol</name><manufacturerId>GEN</manufacturerId><individualPrice>1.2780</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02083353" sec3="Y"><name>PMS-Timolol</name><manufacturerId>PMS</manufacturerId><individualPrice>1.2780</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02166712" sec3="Y"><name>Sandoz Timolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.2780</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="523600022"><itemNumber>1234</itemNumber><strength>0.5%</strength><dosageForm>Oph Sol</dosageForm><price>1.5125</price><note>Timolol maleate can potentiate bronchospasm in asthmatic patients and should not be used in patients with a history of asthma.</note><drug id="00451207" sec3="Y"><name>Timoptic</name><manufacturerId>MFC</manufacturerId><individualPrice>3.4700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00755834" sec3="Y"><name>Apo-Timop</name><manufacturerId>APX</manufacturerId><individualPrice>1.5125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00893781" sec3="Y"><name>Gen-Timolol</name><manufacturerId>GEN</manufacturerId><individualPrice>1.5125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02083345" sec3="Y"><name>PMS-Timolol</name><manufacturerId>PMS</manufacturerId><individualPrice>1.5125</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02166720" sec3="Y"><name>Sandoz Timolol</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.5125</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01746"><name>TIMOLOL MALEATE &amp; TRAVOPROST</name><pcgGroup lccId="00198"><pcg9 id="523600130"><itemNumber>1235</itemNumber><strength>0.5% &amp; 0.004%</strength><dosageForm>Oph Sol- 5mL Pk</dosageForm><price>61.2000</price><drug id="09857333" dinStatus="N" sec3="Y" sec12="Y"><name>DuoTrav</name><manufacturerId>ALC</manufacturerId><individualPrice>61.2000</individualPrice><listingDate>2009-11-13</listingDate></drug></pcg9><pcg9 id="523600116"><itemNumber>1236</itemNumber><strength>0.5% &amp; 0.004%</strength><dosageForm>Oph Sol-2.5mL Pk</dosageForm><price>30.6000</price><drug id="02278251" dinStatus="N" sec3="Y" sec12="Y"><name>DuoTrav</name><manufacturerId>ALC</manufacturerId><individualPrice>30.6000</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="310">As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="393">For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01557"><name>TRAVOPROST</name><pcgGroup lccId="00094"><pcg9 id="523600103"><itemNumber>1237</itemNumber><strength>0.004%</strength><dosageForm>Oph Sol</dosageForm><price>10.8160</price><drug id="02244896" sec3="Y" sec12="Y"><name>Travatan</name><manufacturerId>ALC</manufacturerId><individualPrice>10.8160</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="523600118"><itemNumber>1238</itemNumber><strength>0.004%</strength><dosageForm>Oph Sol-2.5mL Pk</dosageForm><price>27.0400</price><drug id="02318008" dinStatus="N" sec3="Y" sec12="Y"><name>Travatan Z</name><manufacturerId>ALC</manufacturerId><individualPrice>27.0400</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="523600119"><itemNumber>1239</itemNumber><strength>0.004%</strength><dosageForm>Oph Sol-5mL Pk</dosageForm><price>54.0800</price><drug id="09857332" dinStatus="N" sec3="Y" sec12="Y"><name>Travatan Z</name><manufacturerId>ALC</manufacturerId><individualPrice>54.0800</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="171">As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="172">As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="387">For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective..</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName></pcg6></pcg2><pcg2 id="560000000"><name>GASTROINTESTINAL DRUGS</name><pcg6 id="560400000"><name>ANTACIDS AND ADSORBENTS</name><genericName id="00748"><name>ALUMINUM HYDROXIDE &amp; MAGNESIUM HYDROXIDE</name><pcgGroup><pcg9 id="560400007" suppliedBy="L" dpp="Y"><itemNumber>1240</itemNumber><strength>40mg &amp; 40mg/mL</strength><dosageForm>O/L</dosageForm><drug id="00261173" notABenefit="Y" selfMed="Y" sec3="Y"><name>Neutralca-S</name><manufacturerId>DES</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02163136" notABenefit="Y" selfMed="Y" sec3="Y"><name>Maalox</name><manufacturerId>NOV</manufacturerId><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="560400016" dpp="Y"><itemNumber>1241</itemNumber><strength>120mg &amp; 60mg/mL</strength><dosageForm>O/L</dosageForm><drug id="00491217" notABenefit="Y" sec3="Y"><name>Diovol EX</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02162369" notABenefit="Y" sec3="Y"><name>Maalox TC</name><manufacturerId>NOV</manufacturerId><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="560400005" dpp="Y"><itemNumber>1242</itemNumber><strength>400mg &amp; 400mg</strength><dosageForm>Tab</dosageForm><drug id="00483605" notABenefit="Y" sec3="Y"><name>Gelusil Extra Strength</name><manufacturerId>PDA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02208253" notABenefit="Y" sec3="Y"><name>Maalox</name><manufacturerId>NOV</manufacturerId><listingDate>1998-03-17</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="560800000"><name>ANTIDIARRHEA AGENTS</name><genericName id="00761"><name>DIPHENOXYLATE HYDROCHLORIDE &amp; ATROPINE SULFATE</name><pcgGroup lccId="00095"><pcg9 id="560800016"><itemNumber>1243</itemNumber><strength>2.5mg &amp; 0.025mg</strength><dosageForm>Tab</dosageForm><price>.4532</price><drug id="00036323" sec3="Y" sec12="Y"><name>Lomotil</name><manufacturerId>PFI</manufacturerId><individualPrice>.4532</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of diarrhea associated with:</lccNote><lccNote seq="002" reasonForUseId="110">An ileostomy or a colostomy;.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="111">Bowel resection, including short bowel syndrome;</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="112">Inflammatory Bowel Diseases, i.e. Crohn&apos;s Disease and Ulcerative Colitis;</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="008" reasonForUseId="113">Cancer, including chemotherapy or radiation therapy;</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="010" reasonForUseId="114">HIV/AIDS;</lccNote><lccNote seq="011" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="012" reasonForUseId="115">Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;</lccNote><lccNote seq="013" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="014" reasonForUseId="224">Fecal incontinence.</lccNote><lccNote seq="015" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00760"><name>LOPERAMIDE HCL</name><pcgGroup lccId="00096"><pcg9 id="560800015"><itemNumber>1244</itemNumber><strength>2mg</strength><dosageForm>Caplet</dosageForm><price>.1903</price><drug id="00860743" sec3="Y" sec12="Y"><name>Imodium</name><manufacturerId>JAN</manufacturerId><individualPrice>.3806</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02132591" sec3="Y" sec12="Y"><name>Novo-Loperamide</name><manufacturerId>NOP</manufacturerId><individualPrice>.1903</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02212005" sec3="Y" sec12="Y"><name>Apo-Loperamide</name><manufacturerId>APX</manufacturerId><individualPrice>.1903</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02228351" sec3="Y" sec12="Y"><name>PMS-Loperamide</name><manufacturerId>PMS</manufacturerId><individualPrice>.1903</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02229552" notABenefit="Y" sec3="Y"><name>Diarr-eze</name><manufacturerId>PMS</manufacturerId><listingDate>1999-04-15</listingDate></drug><drug id="02257564" sec3="Y" sec12="Y"><name>Sandoz Loperamide</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1903</individualPrice><listingDate>2005-04-28</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of diarrhea associated with:</lccNote><lccNote seq="002" reasonForUseId="110">An ileostomy or a colostomy;.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="004" reasonForUseId="111">Bowel resection, including short bowel syndrome;</lccNote><lccNote seq="005" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="006" reasonForUseId="112">Inflammatory Bowel Diseases, i.e. Crohn&apos;s Disease and Ulcerative Colitis;</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="008" reasonForUseId="113">Cancer, including chemotherapy or radiation therapy;</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="010" reasonForUseId="114">HIV/AIDS;</lccNote><lccNote seq="011" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="012" reasonForUseId="115">Acute diarrhea in patients in congregated housing, i.e. Long Term Care Facilities (LTCF), or for patients receiving Home Care;</lccNote><lccNote seq="013" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="014" reasonForUseId="224">Fecal incontinence.</lccNote><lccNote seq="015" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="561200000"><name>CATHARTICS</name><note>Cathartics (laxatives) should only be used after failure of simpler measures. A high fibre diet, adequate hydration and a review of potentially constipating drugs is often effective in relieving constipation.</note><genericName id="00768"><name>BISACODYL</name><pcgGroup><pcg9 id="561200001" suppliedBy="L"><itemNumber>1245</itemNumber><strength>5mg</strength><dosageForm>Ent Tab</dosageForm><price>.0450</price><drug id="00254142" selfMed="Y" sec3="Y"><name>Dulcolax</name><manufacturerId>BOE</manufacturerId><individualPrice>.1860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00545023" selfMed="Y" sec3="Y"><name>Apo-Bisacodyl</name><manufacturerId>APX</manufacturerId><individualPrice>.0450</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200003"><itemNumber>1246</itemNumber><strength>5mg</strength><dosageForm>Sup</dosageForm><price>1.0933</price><drug id="00003867" sec3="Y"><name>Dulcolax</name><manufacturerId>BOE</manufacturerId><individualPrice>1.0933</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200002" suppliedBy="L"><itemNumber>1247</itemNumber><strength>10mg</strength><dosageForm>Sup</dosageForm><price>.4681</price><drug id="00003875" selfMed="Y" sec3="Y"><name>Dulcolax</name><manufacturerId>BOE</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00404802" selfMed="Y" sec3="Y"><name>Ratio-Bisacodyl</name><manufacturerId>RPH</manufacturerId><individualPrice>.4681</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00776"><name>DOCUSATE CALCIUM (DIOCTYL CALCIUM SULFOSUCCINATE)</name><pcgGroup><pcg9 id="561200027"><itemNumber>1248</itemNumber><strength>240mg</strength><dosageForm>Cap</dosageForm><price>.1287</price><drug id="00664553" sec3="Y"><name>PMS-Docusate Calcium</name><manufacturerId>PMS</manufacturerId><individualPrice>.1287</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02224666" notABenefit="Y" sec3="Y"><name>Surfak</name><manufacturerId>HMR</manufacturerId><listingDate>1999-01-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00770"><name>DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE)</name><pcgGroup><pcg9 id="561200008" suppliedBy="L"><itemNumber>1249</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.0383</price><drug id="00716731" selfMed="Y" sec3="Y"><name>Docusate Sodium</name><manufacturerId>TAR</manufacturerId><individualPrice>.0383</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01994344" selfMed="Y" sec3="Y"><name>Soflax</name><manufacturerId>PMS</manufacturerId><individualPrice>.0383</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02106256" selfMed="Y" sec3="Y"><name>Colace</name><manufacturerId>WEL</manufacturerId><individualPrice>.1310</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9><pcg9 id="561200009"><itemNumber>1250</itemNumber><strength>4mg/mL</strength><dosageForm>O/L</dosageForm><price>.0232</price><drug id="02006758" sec3="Y"><name>Soflax Syrup</name><manufacturerId>PMS</manufacturerId><individualPrice>.0232</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02086018" sec3="Y"><name>Colace</name><manufacturerId>WEL</manufacturerId><individualPrice>.0232</individualPrice><listingDate>1998-11-19</listingDate></drug></pcg9><pcg9 id="561200010"><itemNumber>1251</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.1770</price><drug id="02090163" sec3="Y"><name>Colace</name><manufacturerId>WEL</manufacturerId><individualPrice>.1770</individualPrice><listingDate>1998-11-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00777"><name>GRAIN &amp; CITRUS FIBRE</name><pcgGroup><pcg9 id="561200037" suppliedBy="L"><itemNumber>1252</itemNumber><dosageForm>Tab</dosageForm><price>.0565</price><drug id="00595829" selfMed="Y" sec3="Y"><name>Novo-Fibre</name><manufacturerId>NOP</manufacturerId><individualPrice>.0565</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00779768" notABenefit="Y" sec3="Y"><name>Fibyrax</name><manufacturerId>LED</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00779"><name>LACTULOSE</name><pcgGroup><pcg9 id="561200044"><itemNumber>1253</itemNumber><strength>40%</strength><dosageForm>Jelly-Unidose Pk</dosageForm><price>.4534</price><drug id="00739561" dinStatus="E" sec3="Y"><name>GEL-OSE</name><manufacturerId>JOU</manufacturerId><individualPrice>.4534</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200047"><itemNumber>1254</itemNumber><strength>667mg/mL</strength><dosageForm>O/L</dosageForm><price>.0147</price><drug id="00703486" sec3="Y"><name>PMS-Lactulose</name><manufacturerId>PMS</manufacturerId><individualPrice>.0147</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01675"><name>MAGNESIUM OXIDE &amp; CITRIC ACID &amp; SODIUM PICOSULFATE</name><pcgGroup><pcg9 id="561200088"><itemNumber>1255</itemNumber><strength>3.5g/12g/10mg</strength><dosageForm>Pd for Sol-2X12g  Sachet Pk</dosageForm><price>12.0000</price><drug id="02254794" sec3="Y"><name>Pico-Salax</name><manufacturerId>FEI</manufacturerId><individualPrice>12.0000</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00772"><name>MINERAL OIL</name><pcgGroup><pcg9 id="561200016"><itemNumber>1256</itemNumber><dosageForm>Enema</dosageForm><price>.0326</price><drug id="00107875" sec3="Y"><name>Fleet</name><manufacturerId>MFC</manufacturerId><individualPrice>.0326</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00773"><name>PSYLLIUM MUCILLOID</name><pcgGroup><pcg9 id="561200017" suppliedBy="L"><itemNumber>1257</itemNumber><dosageForm>Oral Pd</dosageForm><price>.0175</price><drug id="00599875" selfMed="Y" sec3="Y"><name>Mucillium</name><manufacturerId>PMS</manufacturerId><individualPrice>.0175</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02174812" selfMed="Y" sec3="Y"><name>Metamucil Fibre Therapy-Original Texture</name><manufacturerId>PGI</manufacturerId><individualPrice>.0246</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00774"><name>SENNOSIDES A &amp; B</name><pcgGroup><pcg9 id="561200021"><itemNumber>1258</itemNumber><strength>1.7mg/mL</strength><dosageForm>Syrup</dosageForm><price>.0318</price><drug id="00367729" sec3="Y"><name>Senokot</name><manufacturerId>PFP</manufacturerId><individualPrice>.0318</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200018" suppliedBy="L"><itemNumber>1259</itemNumber><strength>8.6mg</strength><dosageForm>Tab</dosageForm><price>.0595</price><drug id="00026158" selfMed="Y" sec3="Y"><name>Senokot</name><manufacturerId>PFP</manufacturerId><individualPrice>.0595</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00604402" notABenefit="Y" sec3="Y"><name>Glysennid</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200022" suppliedBy="L"><itemNumber>1260</itemNumber><strength>12mg</strength><dosageForm>Tab</dosageForm><price>.0745</price><drug id="00027502" dinStatus="E" selfMed="Y" sec3="Y"><name>Glysennid</name><manufacturerId>NOV</manufacturerId><individualPrice>.0745</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00775"><name>SODIUM BIPHOSPHATE &amp; SODIUM PHOSPHATE</name><pcgGroup><pcg9 id="561200024"><itemNumber>1261</itemNumber><strength>160mg &amp; 60mg/mL</strength><dosageForm>Ped Rect Sol</dosageForm><price>.0440</price><drug id="00108065" dinStatus="E" sec3="Y"><name>Fleet</name><manufacturerId>MFC</manufacturerId><individualPrice>.0440</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561200023" suppliedBy="L"><itemNumber>1262</itemNumber><strength>160mg &amp; 60mg/mL</strength><dosageForm>Rect Sol</dosageForm><price>.0205</price><drug id="00009911" dinStatus="E" selfMed="Y" sec3="Y"><name>Fleet</name><manufacturerId>MFC</manufacturerId><individualPrice>.0236</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02096900" selfMed="Y" sec3="Y"><name>Enemol</name><manufacturerId>DPC</manufacturerId><individualPrice>.0205</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00778"><name>SODIUM CITRATE &amp; SODIUM LAURYL SULFOACETATE</name><pcgGroup><pcg9 id="561200040"><itemNumber>1263</itemNumber><dosageForm>Micro Enema-5mL Pk</dosageForm><price>.9152</price><drug id="02063905" sec3="Y"><name>Microlax</name><manufacturerId>PFI</manufacturerId><individualPrice>.9152</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="561600000"><name>DIGESTANTS</name><genericName id="00795"><name>PANCRELIPASE EQUIVALENT TO LIPASE &amp; AMYLASE &amp; PROTEASE</name><pcgGroup lccId="00097"><pcg9 id="561600022"><itemNumber>1264</itemNumber><strength>8000 &amp; 30000 &amp; 30000 USP Units</strength><dosageForm>Cap</dosageForm><price>.1828</price><drug id="00263818" sec3="Y" sec12="Y"><name>Cotazym</name><manufacturerId>ORG</manufacturerId><individualPrice>.1828</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561600031"><itemNumber>1265</itemNumber><strength>4000 &amp; 11000 &amp; 11000 USP Units</strength><dosageForm>Ent Microsph Cap</dosageForm><price>.1795</price><drug id="02181215" sec3="Y" sec12="Y"><name>Cotazym ECS 4</name><manufacturerId>ORG</manufacturerId><individualPrice>.1795</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="561600023"><itemNumber>1266</itemNumber><strength>8000 &amp; 30000 &amp; 30000 USP Units</strength><dosageForm>Ent Microsph Cap</dosageForm><price>.3299</price><drug id="00502790" sec3="Y" sec12="Y"><name>Cotazym ECS 8</name><manufacturerId>ORG</manufacturerId><individualPrice>.3299</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="561600014"><itemNumber>1267</itemNumber><strength>20000 &amp; 55000 &amp; 55000 USP Units</strength><dosageForm>Ent Microsph Cap</dosageForm><price>.8648</price><drug id="00821373" sec3="Y" sec12="Y"><name>Cotazym ECS 20</name><manufacturerId>ORG</manufacturerId><individualPrice>.8648</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="124">Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection);</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="125">Replacement therapy for pancreatic insufficiency due to chronic pancreatitis;</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="126">Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas;</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="007" reasonForUseId="225">Replacement therapy for pancreatic insufficiency due to cystic fibrosis.</lccNote><lccNote seq="008" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00098"><pcg9 id="561600026"><itemNumber>1268</itemNumber><strength>4000 &amp; 12000 &amp; 12000 USP Units</strength><dosageForm>Ent Microsph Cap</dosageForm><price>.4349</price><drug id="00789445" sec3="Y" sec12="Y"><name>Pancrease MT4</name><manufacturerId>JNO</manufacturerId><individualPrice>.4349</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="124">Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection);</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="125">Replacement therapy for pancreatic insufficiency due to chronic pancreatitis;</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="126">Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas;</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00097"><pcg9 id="561600033"><itemNumber>1269</itemNumber><strength>5000 &amp; 16600 &amp; 18750 USP Units</strength><dosageForm>Ent Minimicrosph Cap</dosageForm><price>.1703</price><drug id="02239007" sec3="Y" sec12="Y"><name>Creon 5</name><manufacturerId>SPH</manufacturerId><individualPrice>.1703</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="561600030"><itemNumber>1270</itemNumber><strength>10000 &amp; 33200 &amp; 37500 USP Units</strength><dosageForm>Ent Minimicrosph Cap</dosageForm><price>.2723</price><drug id="02200104" sec3="Y" sec12="Y"><name>Creon 10</name><manufacturerId>SPH</manufacturerId><individualPrice>.2723</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="561600032"><itemNumber>1271</itemNumber><strength>20000 &amp; 66400 &amp; 75000 USP Units</strength><dosageForm>Ent Minimicrosph Cap</dosageForm><price>.7923</price><drug id="02239008" sec3="Y" sec12="Y"><name>Creon 20</name><manufacturerId>SPH</manufacturerId><individualPrice>.7923</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="561600025"><itemNumber>1272</itemNumber><strength>25000 &amp; 74000 &amp; 62500 USP Units</strength><dosageForm>Ent Minimicrosph Cap</dosageForm><price>.8507</price><drug id="01985205" sec3="Y" sec12="Y"><name>Creon 25</name><manufacturerId>SPH</manufacturerId><individualPrice>.8507</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="124">Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection);</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="125">Replacement therapy for pancreatic insufficiency due to chronic pancreatitis;</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="126">Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas;</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="007" reasonForUseId="225">Replacement therapy for pancreatic insufficiency due to cystic fibrosis.</lccNote><lccNote seq="008" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00098"><pcg9 id="561600028"><itemNumber>1273</itemNumber><strength>16800 &amp; 70000 &amp; 70000 USP U/0.7g</strength><dosageForm>Pd-114g Pk</dosageForm><price>38.7700</price><drug id="02230020" dinStatus="E" sec3="Y" sec12="Y"><name>Viokase</name><manufacturerId>BFI</manufacturerId><individualPrice>38.7700</individualPrice><listingDate>1997-03-14</listingDate></drug></pcg9><pcg9 id="561600029"><itemNumber>1274</itemNumber><strength>8000 &amp; 30000 &amp; 30000 USP Units</strength><dosageForm>Tab</dosageForm><price>.1628</price><drug id="02230019" dinStatus="E" sec3="Y" sec12="Y"><name>Viokase</name><manufacturerId>BFI</manufacturerId><individualPrice>.1628</individualPrice><listingDate>1997-03-14</listingDate></drug></pcg9><pcg9 id="561600034"><itemNumber>1275</itemNumber><strength>16mg</strength><dosageForm>Tab</dosageForm><price>.3256</price><drug id="02241933" dinStatus="E" sec3="Y" sec12="Y"><name>Viokase 16</name><manufacturerId>BFI</manufacturerId><individualPrice>.3256</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="124">Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection);</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="125">Replacement therapy for pancreatic insufficiency due to chronic pancreatitis;</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="126">Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas;</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="562200000"><name>ANTIEMETICS AND ANTINAUSEANTS</name><genericName id="01485"><name>DELTA-9-TETRAHYDROCANNABINOL</name><pcgGroup lccId="00191"><pcg9 id="562200020"><itemNumber>1276</itemNumber><strength>2.5mg</strength><dosageForm>Cap</dosageForm><price>1.9718</price><drug id="00611190" sec3="Y" sec12="Y"><name>Marinol</name><manufacturerId>SPH</manufacturerId><individualPrice>1.9718</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="562200021"><itemNumber>1277</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>3.9435</price><drug id="00611204" sec3="Y" sec12="Y"><name>Marinol</name><manufacturerId>SPH</manufacturerId><individualPrice>3.9435</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="40">For the treatment of emesis associated with cancer chemotherapy in patients who are unresponsive to conventional antiemetic therapy:</lccNote><lccNote seq="002" type="R">Initial dose -5mg/m.sq. given 1 to 3 hours before administration of chemotherapy;</lccNote><lccNote seq="003" type="R">Repeat doses -5mg/m.sq. every 2 to 4 hours after chemotherapy as needed, usually for 1 to 2 days: no more than 4 to 6 doses should be given in a single day.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="345">For the treatment of AIDS-related anorexia associated with weight loss and prescription is from a prescriber approved for the Facilitated Access mechanism (see Part VI of the Formulary/CDI binder).</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00803"><name>DIMENHYDRINATE</name><pcgGroup><pcg9 id="562200002" suppliedBy="L"><itemNumber>1278</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="00013803" notABenefit="Y" sec3="Y"><name>Gravol Filmkote</name><manufacturerId>HOR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00021423" notABenefit="Y" sec3="Y"><name>Novo-Dimenate</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363766" notABenefit="Y" sec3="Y"><name>Apo-Dimenhydrinate</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00586331" notABenefit="Y" sec3="Y"><name>PMS-Dimenhydrinate</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01366"><name>DOLASETRON MESYLATE</name><pcgGroup lccId="00100"><pcg9 id="562200026"><itemNumber>1279</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>14.2792</price><drug id="02231378" sec3="Y" sec12="Y"><name>Anzemet</name><manufacturerId>SAV</manufacturerId><individualPrice>14.2792</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="562200027"><itemNumber>1280</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>28.5583</price><drug id="02231379" sec3="Y" sec12="Y"><name>Anzemet</name><manufacturerId>SAV</manufacturerId><individualPrice>28.5583</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="229">For the treatment of emesis in cancer patients receiving highly emetogenic chemotherapy..</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="230">For patients receiving intravenous chemotherapy who have not experienced adequate control with other available anti-emetics.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="231">For patients receiving intravenous chemotherapy who experience intolerable side effects with other anti-emetics.</lccNote><lccNote seq="006" type="N">The therapeutic value of Anzemet more than 24 hours after the last dose of chemotherapy is unproven.</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00811"><name>DOXYLAMINE SUCCINATE AND PYRIDOXINE HCL</name><pcgGroup><pcg9 id="562200030"><itemNumber>1281</itemNumber><strength>10mg &amp; 10mg</strength><dosageForm>SR Tab</dosageForm><price>1.2000</price><drug id="00609129" sec3="Y"><name>Diclectin</name><manufacturerId>DUI</manufacturerId><individualPrice>1.2000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00810"><name>GRANISETRON HCL</name><pcgGroup lccId="00101"><pcg9 id="562200024"><itemNumber>1282</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>13.5000</price><drug id="02185881" sec3="Y" sec12="Y"><name>Kytril</name><manufacturerId>HLR</manufacturerId><individualPrice>18.0000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02308894" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Granisetron</name><manufacturerId>APX</manufacturerId><individualPrice>13.5000</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="91">For the treatment of emesis in cancer patients receiving highly emetogenic chemotherapy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="92">For patients receiving intravenous chemotherapy or radiation therapy who have not experienced adequate control with other available anti-emetics.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="93">For patients receiving intravenous chemotherapy or radiation therapy who experience intolerable side effects with other anti- emetics.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="326">For the treatment of emesis in patients receiving radiation therapy which consists of single fraction treatment to the abdominal cavity, hemi-body irradiation and total body irradiation.</lccNote><lccNote seq="008" type="N">The therapeutic value of Kytril more than 24 hours after the last dose of chemotherapy is unproven.</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00804"><name>MECLIZINE HCL</name><pcgGroup><pcg9 id="562200008"><itemNumber>1283</itemNumber><strength>25mg</strength><dosageForm>Tab</dosageForm><price>.2919</price><drug id="00220442" sec3="Y"><name>Bonamine</name><manufacturerId>PFI</manufacturerId><individualPrice>.2919</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00805"><name>NABILONE</name><pcgGroup><pcg9 id="562200034"><itemNumber>1284</itemNumber><strength>0.5mg</strength><dosageForm>Cap</dosageForm><price>3.1026</price><drug id="02256193" sec3="Y"><name>Cesamet</name><manufacturerId>VAL</manufacturerId><individualPrice>3.1026</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><pcg9 id="562200011"><itemNumber>1285</itemNumber><strength>1mg</strength><dosageForm>Cap</dosageForm><price>6.2050</price><drug id="00548375" sec3="Y"><name>Cesamet</name><manufacturerId>VAL</manufacturerId><individualPrice>6.2050</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00807"><name>ONDANSETRON HCL DIHYDRATE</name><pcgGroup><pcg9 id="562200041"><itemNumber>1286</itemNumber><strength>2mg/mL</strength><dosageForm>Inj Sol-20mL Vial Pk</dosageForm><drug id="02265532" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ondansetron Injection</name><manufacturerId>NOP</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="09857325" notABenefit="Y" sec3="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="562200014"><itemNumber>1287</itemNumber><strength>2mg/mL</strength><dosageForm>Inj Sol-2mL Vial Pk</dosageForm><drug id="02213745" notABenefit="Y" sec3="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02265524" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ondansetron Injection</name><manufacturerId>NOP</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="562200040"><itemNumber>1288</itemNumber><strength>2mg/mL</strength><dosageForm>Inj Sol-4mL Vial Pk</dosageForm><drug id="09857323" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ondansetron Injection</name><manufacturerId>NOP</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="09857324" notABenefit="Y" sec3="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00809"><name>ONDANSETRON HYDROCHLORIDE</name><pcgGroup lccId="00102"><pcg9 id="562200025"><itemNumber>1289</itemNumber><strength>4mg/5mL</strength><dosageForm>O/L</dosageForm><price>1.4614</price><drug id="02229639" sec3="Y" sec12="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><individualPrice>2.0442</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02291967" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Ondansetron</name><manufacturerId>APX</manufacturerId><individualPrice>1.4614</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="562200022"><itemNumber>1290</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>5.9884</price><drug id="02213567" sec3="Y" sec12="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><individualPrice>13.3980</individualPrice><listingDate>1997-01-20</listingDate></drug><drug id="02258188" sec3="Y" sec12="Y"><name>PMS-Ondansetron</name><manufacturerId>PMS</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02264056" sec3="Y" sec12="Y"><name>Novo-Ondansetron</name><manufacturerId>NOP</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2006-07-19</listingDate></drug><drug id="02274310" sec3="Y" sec12="Y"><name>Sandoz Ondansetron</name><manufacturerId>SDZ</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2006-07-19</listingDate></drug><drug id="02278529" sec3="Y" sec12="Y"><name>Ratio-Ondansetron</name><manufacturerId>RPH</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02278618" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Ondansetron</name><manufacturerId>PHE</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02288184" sec3="Y" sec12="Y"><name>Apo-Ondansetron</name><manufacturerId>APX</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02296349" dinStatus="N" sec3="Y" sec12="Y"><name>Co Ondansetron</name><manufacturerId>COB</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02297868" sec3="Y" sec12="Y"><name>Gen-Ondansetron</name><manufacturerId>GEN</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02305259" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Ondansetron</name><manufacturerId>MIN</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2008-12-23</listingDate></drug><drug id="02306212" dinStatus="N" sec3="Y" sec12="Y"><name>Ondansetron-Odan</name><manufacturerId>ODN</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2008-10-01</listingDate></drug><drug id="02312247" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Ondansetron</name><manufacturerId>RAN</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2008-12-23</listingDate></drug><drug id="02313685" dinStatus="N" sec3="Y" sec12="Y"><name>Jamp-Ondansetron</name><manufacturerId>JPC</manufacturerId><individualPrice>5.9884</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="562200029"><itemNumber>1291</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>13.0890</price><drug id="02239372" sec3="Y" sec12="Y"><name>Zofran ODT</name><manufacturerId>GSK</manufacturerId><individualPrice>13.0890</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="562200023"><itemNumber>1292</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>9.1402</price><drug id="02213575" sec3="Y" sec12="Y"><name>Zofran</name><manufacturerId>GSK</manufacturerId><individualPrice>20.4440</individualPrice><listingDate>1997-01-20</listingDate></drug><drug id="02258196" sec3="Y" sec12="Y"><name>PMS-Ondansetron</name><manufacturerId>PMS</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02264064" sec3="Y" sec12="Y"><name>Novo-Ondansetron</name><manufacturerId>NOP</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2006-07-19</listingDate></drug><drug id="02274329" sec3="Y" sec12="Y"><name>Sandoz Ondansetron</name><manufacturerId>SDZ</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02278537" sec3="Y" sec12="Y"><name>Ratio-Ondansetron</name><manufacturerId>RPH</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2006-06-14</listingDate></drug><drug id="02278626" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Ondansetron</name><manufacturerId>PHE</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02288192" sec3="Y" sec12="Y"><name>Apo-Ondansetron</name><manufacturerId>APX</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02296357" dinStatus="N" sec3="Y" sec12="Y"><name>Co Ondansetron</name><manufacturerId>COB</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02297876" sec3="Y" sec12="Y"><name>Gen-Ondansetron</name><manufacturerId>GEN</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02305267" dinStatus="N" sec3="Y" sec12="Y"><name>Mint-Ondansetron</name><manufacturerId>MIN</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2008-12-23</listingDate></drug><drug id="02306220" dinStatus="N" sec3="Y" sec12="Y"><name>Ondansetron-Odan</name><manufacturerId>ODN</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2008-10-01</listingDate></drug><drug id="02312255" dinStatus="N" sec3="Y" sec12="Y"><name>Ran-Ondansetron</name><manufacturerId>RAN</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2008-12-23</listingDate></drug><drug id="02313693" dinStatus="N" sec3="Y" sec12="Y"><name>Jamp-Ondansetron</name><manufacturerId>JPC</manufacturerId><individualPrice>9.1402</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="562200031"><itemNumber>1293</itemNumber><strength>8mg</strength><dosageForm>Tab</dosageForm><price>19.9720</price><drug id="02239373" sec3="Y" sec12="Y"><name>Zofran ODT</name><manufacturerId>GSK</manufacturerId><individualPrice>19.9720</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="215">For the treatment of emesis in cancer patients receiving highly emetogenic chemotherapy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="216">For patients receiving intravenous chemotherapy or radiation therapy who have not experienced adequate control with other available anti-emetics.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="217">For patients receiving intravenous chemotherapy or radiation therapy who experience intolerable side effects with other anti- emetics.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="218">For the treatment of emesis in patients receiving radiation therapy which consists of single fraction treatment to the abdominal cavity, hemi-body irradiation and total body irradiation.</lccNote><lccNote seq="008" type="N">The therapeutic value of Zofran more than 24 hours after the last dose of chemotherapy is unproven.</lccNote><lccNote seq="009" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="564000000"><name>MISCELLANEOUS G.I. DRUGS</name><genericName id="00821"><name>5-AMINOSALICYLIC ACID</name><pcgGroup><pcg9 id="564000049"><itemNumber>1294</itemNumber><strength>500mg</strength><dosageForm>Del-Release Tab</dosageForm><price>.5569</price><drug id="02099683" sec3="Y"><name>Pentasa</name><manufacturerId>FEI</manufacturerId><individualPrice>.5569</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000107"><itemNumber>1295</itemNumber><strength>1.2g</strength><dosageForm>Delayed &amp; ER Tab</dosageForm><price>1.4972</price><drug id="02297558" dinStatus="N" sec3="Y"><name>Mezavant</name><manufacturerId>SHI</manufacturerId><individualPrice>1.4972</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="564000075"><itemNumber>1296</itemNumber><strength>1g/100mL</strength><dosageForm>Enema</dosageForm><price>3.7000</price><drug id="02153521" sec3="Y"><name>Pentasa</name><manufacturerId>FEI</manufacturerId><individualPrice>3.7000</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="564000077"><itemNumber>1297</itemNumber><strength>4g/100mL</strength><dosageForm>Enema</dosageForm><price>4.4600</price><drug id="02153556" sec3="Y"><name>Pentasa</name><manufacturerId>FEI</manufacturerId><individualPrice>4.4600</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="564000045"><itemNumber>1298</itemNumber><strength>500mg</strength><dosageForm>Ent Tab</dosageForm><price>.4928</price><drug id="02112787" sec3="Y"><name>Salofalk</name><manufacturerId>BFI</manufacturerId><individualPrice>.4928</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000048"><itemNumber>1299</itemNumber><strength>500mg</strength><dosageForm>Ent Tab</dosageForm><price>.6145</price><drug id="01914030" sec3="Y"><name>Mesasal</name><manufacturerId>GSK</manufacturerId><individualPrice>.6145</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000034"><itemNumber>1300</itemNumber><strength>4g</strength><dosageForm>Rect Susp-Pk</dosageForm><price>5.9600</price><drug id="02112809" sec3="Y"><name>Salofalk</name><manufacturerId>BFI</manufacturerId><individualPrice>5.9600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000039"><itemNumber>1301</itemNumber><strength>500mg</strength><dosageForm>Sup</dosageForm><price>1.0893</price><drug id="02112760" sec3="Y"><name>Salofalk</name><manufacturerId>BFI</manufacturerId><individualPrice>1.0893</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000074"><itemNumber>1302</itemNumber><strength>1g</strength><dosageForm>Sup</dosageForm><price>1.6000</price><drug id="02153564" sec3="Y"><name>Pentasa</name><manufacturerId>FEI</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="564000100"><itemNumber>1303</itemNumber><strength>1000mg</strength><dosageForm>Sup</dosageForm><price>1.6000</price><drug id="02242146" sec3="Y"><name>Salofalk</name><manufacturerId>BFI</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><pcg9 id="564000030"><itemNumber>1304</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.2549</price><drug id="01997580" sec3="Y"><name>Asacol</name><manufacturerId>PGP</manufacturerId><individualPrice>.5200</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02171929" dinStatus="N" sec3="Y"><name>Novo-5-ASA</name><manufacturerId>NOP</manufacturerId><individualPrice>.2549</individualPrice><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="564000101"><itemNumber>1305</itemNumber><strength>800mg</strength><dosageForm>Tab</dosageForm><price>1.0100</price><drug id="02267217" sec3="Y"><name>Asacol</name><manufacturerId>PGP</manufacturerId><individualPrice>1.0100</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00822"><name>BETAMETHASONE DISODIUM PHOSPHATE</name><pcgGroup><pcg9 id="564000031"><itemNumber>1306</itemNumber><strength>5mg/100mL</strength><dosageForm>Enema-100mL Pk</dosageForm><price>9.3271</price><drug id="02060884" sec3="Y"><name>Betnesol</name><manufacturerId>PAL</manufacturerId><individualPrice>9.3271</individualPrice><listingDate>1998-11-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00812"><name>CIMETIDINE</name><note>Cimetidine is less expensive than alternatives, and is effective and well tolerated in most patients. Adequate acid suppression can be achieved by giving cimetidine as opposed to using other longer acting H2-antagonists. Long-term use of these drugs for prevention of recurrent peptic ulcers should be reviewed; specific cure of Helicobacter pylori infection with antibiotics is a more effective and less costly approach.</note><pcgGroup><pcg9 id="564000008"><itemNumber>1307</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.0737</price><drug id="00582409" dinStatus="E" sec3="Y"><name>Novo-Cimetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.0737</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00584215" sec3="Y"><name>Apo-Cimetidine</name><manufacturerId>APX</manufacturerId><individualPrice>.0737</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865796" sec3="Y"><name>Nu-Cimet</name><manufacturerId>NXP</manufacturerId><individualPrice>.0737</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916793" notABenefit="Y" sec3="Y"><name>Tagamet</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000003"><itemNumber>1308</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.0860</price><drug id="00487872" sec3="Y"><name>Apo-Cimetidine</name><manufacturerId>APX</manufacturerId><individualPrice>.0860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00582417" sec3="Y"><name>Novo-Cimetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.0860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865818" sec3="Y"><name>Nu-Cimet</name><manufacturerId>NXP</manufacturerId><individualPrice>.0860</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916815" notABenefit="Y" sec3="Y"><name>Tagamet</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02227444" sec3="Y"><name>Gen-Cimetidine</name><manufacturerId>GEN</manufacturerId><individualPrice>.0860</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="564000011"><itemNumber>1309</itemNumber><strength>400mg</strength><dosageForm>Tab</dosageForm><price>.1350</price><drug id="00600059" sec3="Y"><name>Apo-Cimetidine</name><manufacturerId>APX</manufacturerId><individualPrice>.1350</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00603678" sec3="Y"><name>Novo-Cimetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1350</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865826" sec3="Y"><name>Nu-Cimet</name><manufacturerId>NXP</manufacturerId><individualPrice>.1350</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916785" notABenefit="Y" sec3="Y"><name>Tagamet</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02227452" sec3="Y"><name>Gen-Cimetidine</name><manufacturerId>GEN</manufacturerId><individualPrice>.1350</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="564000012"><itemNumber>1310</itemNumber><strength>600mg</strength><dosageForm>Tab</dosageForm><price>.1720</price><drug id="00600067" sec3="Y"><name>Apo-Cimetidine</name><manufacturerId>APX</manufacturerId><individualPrice>.1720</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00603686" sec3="Y"><name>Novo-Cimetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.1720</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865834" sec3="Y"><name>Nu-Cimet</name><manufacturerId>NXP</manufacturerId><individualPrice>.1720</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916777" notABenefit="Y" sec3="Y"><name>Tagamet</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02227460" sec3="Y"><name>Gen-Cimetidine</name><manufacturerId>GEN</manufacturerId><individualPrice>.1720</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="564000019"><itemNumber>1311</itemNumber><strength>800mg</strength><dosageForm>Tab</dosageForm><price>.2530</price><drug id="00663727" dinStatus="E" sec3="Y"><name>Novo-Cimetine</name><manufacturerId>NOP</manufacturerId><individualPrice>.2530</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00749494" sec3="Y"><name>Apo-Cimetidine</name><manufacturerId>APX</manufacturerId><individualPrice>.2530</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01916769" notABenefit="Y" sec3="Y"><name>Tagamet</name><manufacturerId>SMJ</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00824"><name>DOMPERIDONE MALEATE</name><pcgGroup><pcg9 id="564000043"><itemNumber>1312</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1496</price><drug id="00855820" notABenefit="Y" sec3="Y"><name>Motilium</name><manufacturerId>JAN</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01912070" sec3="Y"><name>Ratio-Domperidone</name><manufacturerId>RPH</manufacturerId><individualPrice>.1496</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02103613" sec3="Y"><name>Apo-Domperidone</name><manufacturerId>APX</manufacturerId><individualPrice>.1496</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02157195" sec3="Y"><name>Novo-Domperidone</name><manufacturerId>NOP</manufacturerId><individualPrice>.1496</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02231477" sec3="Y"><name>Nu-Domperidone</name><manufacturerId>NXP</manufacturerId><individualPrice>.1496</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02236466" sec3="Y"><name>PMS-Domperidone</name><manufacturerId>PMS</manufacturerId><individualPrice>.1496</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02268078" sec3="Y"><name>Ran-Domperidone</name><manufacturerId>RAN</manufacturerId><individualPrice>.1496</individualPrice><listingDate>2006-03-01</listingDate></drug><drug id="02278669" notABenefit="Y" sec3="Y"><name>Gen-Domperidone</name><manufacturerId>GEN</manufacturerId><listingDate>2008-04-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00819"><name>FAMOTIDINE</name><note>Cimetidine is less expensive than alternatives, and is effective and well tolerated in most patients. Adequate acid suppression can be achieved by giving cimetidine as opposed to using other longer acting H2-antagonists. Long-term use of these drugs for prevention of recurrent peptic ulcers should be reviewed; specific cure of Helicobacter pylori infection with antibiotics is a more effective and less costly approach.</note><pcgGroup><pcg9 id="564000025"><itemNumber>1313</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.4679</price><drug id="00710121" sec3="Y"><name>Pepcid</name><manufacturerId>MFC</manufacturerId><individualPrice>1.0632</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01953842" sec3="Y"><name>Apo-Famotidine</name><manufacturerId>APX</manufacturerId><individualPrice>.4679</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02022133" sec3="Y"><name>Novo-Famotidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.4679</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02024195" sec3="Y"><name>Nu-Famotidine</name><manufacturerId>NXP</manufacturerId><individualPrice>.4679</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02196018" sec3="Y"><name>Mylan-Famotidine</name><manufacturerId>MYL</manufacturerId><individualPrice>.4679</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000024"><itemNumber>1314</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><price>.8423</price><drug id="00710113" sec3="Y"><name>Pepcid</name><manufacturerId>MFC</manufacturerId><individualPrice>1.9336</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01953834" sec3="Y"><name>Apo-Famotidine</name><manufacturerId>APX</manufacturerId><individualPrice>.8423</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02022141" sec3="Y"><name>Novo-Famotidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.8423</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02024209" sec3="Y"><name>Nu-Famotidine</name><manufacturerId>NXP</manufacturerId><individualPrice>.8423</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02196026" sec3="Y"><name>Mylan-Famotidine</name><manufacturerId>MYL</manufacturerId><individualPrice>.8423</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00823"><name>HYDROCORTISONE</name><pcgGroup><pcg9 id="564000032"><itemNumber>1315</itemNumber><strength>100mg/60mL</strength><dosageForm>Enema-60mL Pk</dosageForm><price>5.1429</price><drug id="00230316" sec3="Y"><name>Hycort</name><manufacturerId>VAL</manufacturerId><individualPrice>5.1429</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02112736" sec3="Y"><name>Cortenema</name><manufacturerId>BFI</manufacturerId><individualPrice>6.1600</individualPrice><listingDate>1997-05-08</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01023"><name>HYDROCORTISONE ACETATE</name><pcgGroup><pcg9 id="564000081"><itemNumber>1316</itemNumber><strength>10%</strength><dosageForm>Rect Aero-15g Pk</dosageForm><price>81.7500</price><drug id="00579335" sec3="Y"><name>Cortifoam</name><manufacturerId>PAL</manufacturerId><individualPrice>81.7500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00779"><name>LACTULOSE</name><pcgGroup><pcg9 id="564000004"><itemNumber>1317</itemNumber><strength>666.7mg/mL</strength><dosageForm>O/L</dosageForm><price>.0145</price><drug id="00854409" sec3="Y"><name>Ratio-Lactulose</name><manufacturerId>RPH</manufacturerId><individualPrice>.0145</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02091925" notABenefit="Y" sec3="Y"><name>Cephulac</name><manufacturerId>MRR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02242814" sec3="Y"><name>Apo-Lactulose Solution</name><manufacturerId>APX</manufacturerId><individualPrice>.0145</individualPrice><listingDate>2005-03-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00835"><name>LANSOPRAZOLE</name><pcgGroup lccId="00103"><pcg9 id="564000072"><itemNumber>1318</itemNumber><strength>15mg</strength><dosageForm>DR Cap</dosageForm><price>1.0000</price><drug id="02165503" sec3="Y" sec12="Y"><name>Prevacid</name><manufacturerId>ABB</manufacturerId><individualPrice>2.0000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02280515" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Lansoprazole</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0000</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02293811" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Lansoprazole</name><manufacturerId>APX</manufacturerId><individualPrice>1.0000</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="564000073"><itemNumber>1319</itemNumber><strength>30mg</strength><dosageForm>DR Cap</dosageForm><price>1.0000</price><drug id="02165511" sec3="Y" sec12="Y"><name>Prevacid</name><manufacturerId>ABB</manufacturerId><individualPrice>2.0000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02280523" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Lansoprazole</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0000</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02293838" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Lansoprazole</name><manufacturerId>APX</manufacturerId><individualPrice>1.0000</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="293">Gastroesophageal Reflux Disease (GERD)

For the treatment of erosive GERD or upper GI malignancy;
OR
For the treatment of non-erosive GERD after failure of H2-receptor antagonist therapy.

Patients with GERD should be reassessed within 6 months after initial treatment with a PPI.  The reassessment could include confirmation of need for PPI with endoscopy, a trial of PPI withdrawal, or step-down therapy to H2-receptor antagonist therapy.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="295">H. pylori-positive Peptic Ulcers

For the treatment of H. pylori-positive peptic ulcers where H. pylori is documented, by serology, urea breath test or endoscopy, for a one-week course in combination with antimicrobial therapy.  Retreatment of H. pylori-positive peptic ulcers must be documented by persistent H. pylori infection on urea breath test or endoscopy.

Maximum duration: 7 days (for retreatment, a four-week period must elapse since the end of the previous treatment).</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="297">Confirmed Peptic Ulcers or NSAID-induced Ulcer Prophylaxis:

For the treatment of confirmed peptic ulcers and NSAID-induced ulcers;
OR
For the prophylaxis of NSAID-induced ulcers for patients at increased risk of GI bleeding.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="401">Other Gastrointestinal Disorders

For the treatment of gastroduodenal Crohns disease, short-gut syndrome, scleroderma, or pancreatitis.

Note: There is a lack of published evidence to support double-dose PPI therapy in these settings</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="402">Severe Conditions:

For the treatment  of severe esophagitis, Zollinger-Ellison syndrome, esophageal stricture, persistent symptoms of GERD or persistent erosive esophagitis, or upon hospital discharge following a gastrointestinal bleed.

For patients receiving double-dose therapy, the need to continue treatment at higher doses should be reassessed after eight weeks. For re-treatment at higher doses, a four-week period should have elapsed from the end of the previous treatment. Reassessment could include a procedural assessment of the condition or step-down therapy to lower-dose proton pump inhibitor (PPI) therapy.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01411"><name>LANSOPRAZOLE &amp; CLARITHROMYCIN &amp; AMOXICILLIN</name><pcgGroup lccId="00104"><pcg9 id="564000091"><itemNumber>1320</itemNumber><strength>30mg &amp; 500mg &amp; 500mg</strength><dosageForm>Tab/Cap Pk</dosageForm><price>82.2000</price><drug id="02238525" sec3="Y" sec12="Y"><name>Hp-PAC</name><manufacturerId>ABB</manufacturerId><individualPrice>82.2000</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="306">a) For the treatment of  H. pylori-positive peptic ulcers where H. pylori is documented, by serology, breath test or endoscopy, for a one week course.
Maximum duration: 7 days.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="307">b) For the retreatment of  H. pylori-positive peptic ulcers where  H. pylori recurrence or persistence is documented, by breath test or endoscopy, for a one week course.
Maximum duration: 7 days (after a four-week period has elapsed since the end of the previous treatment)</lccNote><lccNote seq="004" type="R">Retreatment decisions should be based upon positive symptoms and positive endoscopy or positive urea breath test. Retreatment should not be based on a positive serology test, as serology tests may remain positive indefinitely. An alternative antibiotic regimen is recommended when initial therapy fails due to concerns of antimicrobial resistance.</lccNote><lccNote seq="005" type="W">Network will limit supply to 7 days. Network will verify that retreatments are reimbursed only after a four-week period has elapsed since the end of the previous treatment.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00813"><name>METOCLOPRAMIDE HCL</name><pcgGroup><pcg9 id="564000015"><itemNumber>1321</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0556</price><drug id="00842826" sec3="Y"><name>Apo-Metoclop</name><manufacturerId>APX</manufacturerId><individualPrice>.0556</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099195" notABenefit="Y" sec3="Y"><name>Maxeran</name><manufacturerId>HMR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02143275" sec3="Y"><name>Nu-Metoclopramide</name><manufacturerId>NXP</manufacturerId><individualPrice>.0556</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230431" sec3="Y"><name>PMS-Metoclopramide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0556</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="564000005"><itemNumber>1322</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.0583</price><drug id="00842834" sec3="Y"><name>Apo-Metoclop</name><manufacturerId>APX</manufacturerId><individualPrice>.0583</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099209" notABenefit="Y" sec3="Y"><name>Maxeran</name><manufacturerId>HMR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02143283" sec3="Y"><name>Nu-Metoclopramide</name><manufacturerId>NXP</manufacturerId><individualPrice>.0583</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230432" sec3="Y"><name>PMS-Metoclopramide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0583</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00817"><name>MISOPROSTOL</name><pcgGroup><pcg9 id="564000029"><itemNumber>1323</itemNumber><strength>100mcg</strength><dosageForm>Tab</dosageForm><price>.2584</price><drug id="00813966" notABenefit="Y" sec3="Y"><name>Cytotec</name><manufacturerId>SEA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02244022" sec3="Y"><name>Apo-Misoprostol</name><manufacturerId>APX</manufacturerId><individualPrice>.2584</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="564000022"><itemNumber>1324</itemNumber><strength>200mcg</strength><dosageForm>Tab</dosageForm><price>.4303</price><drug id="00632600" notABenefit="Y" sec3="Y"><name>Cytotec</name><manufacturerId>SEA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02244023" sec3="Y"><name>Apo-Misoprostol</name><manufacturerId>APX</manufacturerId><individualPrice>.4303</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00820"><name>NIZATIDINE</name><note>Cimetidine is less expensive than alternatives, and is effective and well tolerated in most patients. Adequate acid suppression can be achieved by giving cimetidine as opposed to using other longer acting H2-antagonists. Long-term use of these drugs for prevention of recurrent peptic ulcers should be reviewed; specific cure of Helicobacter pylori infection with antibiotics is a more effective and less costly approach.</note><pcgGroup><pcg9 id="564000027"><itemNumber>1325</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>.4196</price><drug id="00778338" sec3="Y"><name>Axid</name><manufacturerId>PHE</manufacturerId><individualPrice>.8392</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177714" sec3="Y"><name>PMS-Nizatidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.4196</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02220156" sec3="Y"><name>Apo-Nizatidine</name><manufacturerId>APX</manufacturerId><individualPrice>.4196</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02240457" sec3="Y"><name>Novo-Nizatidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.4196</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02246046" sec3="Y"><name>Gen-Nizatidine</name><manufacturerId>GEN</manufacturerId><individualPrice>.4196</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="564000028"><itemNumber>1326</itemNumber><strength>300mg</strength><dosageForm>Cap</dosageForm><price>.7603</price><drug id="00778346" sec3="Y"><name>Axid</name><manufacturerId>PHE</manufacturerId><individualPrice>1.5206</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02177722" sec3="Y"><name>PMS-Nizatidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.7603</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02220164" sec3="Y"><name>Apo-Nizatidine</name><manufacturerId>APX</manufacturerId><individualPrice>.7603</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02240458" sec3="Y"><name>Novo-Nizatidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.7603</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02246047" sec3="Y"><name>Gen-Nizatidine</name><manufacturerId>GEN</manufacturerId><individualPrice>.7603</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00826"><name>OLSALAZINE SODIUM</name><pcgGroup><pcg9 id="564000047"><itemNumber>1327</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>.4961</price><drug id="02063808" sec3="Y"><name>Dipentum</name><manufacturerId>UCB</manufacturerId><individualPrice>.4961</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00836"><name>OMEPRAZOLE</name><pcgGroup><pcg9 id="564000087"><itemNumber>1328</itemNumber><strength>10mg</strength><drug id="02230737" notABenefit="Y" sec3="Y"><name>Losec DR Tab</name><manufacturerId>AZC</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="09857350" dinStatus="N" notABenefit="Y" sec3="Y"><name>Mylan-Omeprazole DR Cap</name><manufacturerId>MYL</manufacturerId><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00168"><pcg9 id="564000070"><itemNumber>1329</itemNumber><strength>20mg</strength><price>1.1000</price><drug id="02190915" sec3="Y" sec12="Y"><name>Losec DR Tab</name><manufacturerId>AZC</manufacturerId><individualPrice>2.2000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245058" sec3="Y" sec12="Y"><name>Apo-Omeprazole Cap</name><manufacturerId>APX</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02260867" sec3="Y" sec12="Y"><name>Ratio-Omeprazole DR Tab</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02296446" sec3="Y" sec12="Y"><name>Sandoz Omeprazole  DR Cap</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="09857341" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Omeprazole DR Cap</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="09857342" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Omeprazole DR Cap</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="564000105"><itemNumber>1330</itemNumber><strength>20mg</strength><price>1.1000</price><drug id="00846503" notABenefit="Y" sec3="Y"><name>Losec DR Cap</name><manufacturerId>AST</manufacturerId><listingDate>2004-07-20</listingDate></drug><drug id="02320851" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Omeprazole DR Cap</name><manufacturerId>PMS</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-06-23</listingDate></drug><drug id="02329433" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Omeprazole DR Cap</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="09857285" sec3="Y" sec12="Y"><name>Apo-Omeprazole Cap</name><manufacturerId>APX</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2007-11-10</listingDate></drug><drug id="09857314" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Omeprazole DR Cap</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="293">Gastroesophageal Reflux Disease (GERD)

For the treatment of erosive GERD or upper GI malignancy;
OR
For the treatment of non-erosive GERD after failure of H2-receptor antagonist therapy.

Patients with GERD should be reassessed within 6 months after initial treatment with a PPI.  The reassessment could include confirmation of need for PPI with endoscopy, a trial of PPI withdrawal, or step-down therapy to H2-receptor antagonist therapy.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="297">Confirmed Peptic Ulcers or NSAID-induced Ulcer Prophylaxis:

For the treatment of confirmed peptic ulcers and NSAID-induced ulcers;
OR
For the prophylaxis of NSAID-induced ulcers for patients at increased risk of GI bleeding.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="401">Other Gastrointestinal Disorders

For the treatment of gastroduodenal Crohns disease, short-gut syndrome, scleroderma, or pancreatitis.

Note: There is a lack of published evidence to support double-dose PPI therapy in these settings</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="402">Severe Conditions:

For the treatment  of severe esophagitis, Zollinger-Ellison syndrome, esophageal stricture, persistent symptoms of GERD or persistent erosive esophagitis, or upon hospital discharge following a gastrointestinal bleed.

For patients receiving double-dose therapy, the need to continue treatment at higher doses should be reassessed after eight weeks. For re-treatment at higher doses, a four-week period should have elapsed from the end of the previous treatment. Reassessment could include a procedural assessment of the condition or step-down therapy to lower-dose proton pump inhibitor (PPI) therapy.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="564000094"><itemNumber>1331</itemNumber><strength>10mg</strength><dosageForm>DR Cap</dosageForm><drug id="02119579" notABenefit="Y" sec3="Y"><name>Losec</name><manufacturerId>AZC</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02296438" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Omeprazole</name><manufacturerId>SDZ</manufacturerId><listingDate>2009-05-20</listingDate></drug><drug id="02329425" dinStatus="N" notABenefit="Y" sec3="Y"><name>Mylan-Omeprazole</name><manufacturerId>MYL</manufacturerId><listingDate>2009-11-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01645"><name>OMEPRAZOLE MAGNESIUM</name><pcgGroup lccId="00167"><pcg9 id="564000079"><itemNumber>1332</itemNumber><strength>20mg</strength><price>1.1000</price><drug id="09857195" sec3="Y" sec12="Y"><name>Losec DR Tab</name><manufacturerId>AZC</manufacturerId><individualPrice>2.2000</individualPrice><listingDate>2006-10-23</listingDate></drug><drug id="09857267" sec3="Y" sec12="Y"><name>Ratio-Omeprazole DR Tab</name><manufacturerId>RPH</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="09857343" dinStatus="N" sec3="Y" sec12="Y"><name>Mylan-Omeprazole DR Cap</name><manufacturerId>MYL</manufacturerId><individualPrice>1.1000</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><lccNote seq="003" reasonForUseId="295">H. pylori-positive Peptic Ulcers

For the treatment of H. pylori-positive peptic ulcers where H. pylori is documented, by serology, urea breath test or endoscopy, for a one-week course in combination with antimicrobial therapy.  Retreatment of H. pylori-positive peptic ulcers must be documented by persistent H. pylori infection on urea breath test or endoscopy.

Maximum duration: 7 days (for retreatment, a four-week period must elapse since the end of the previous treatment).</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01320"><name>PANTOPRAZOLE SODIUM</name><pcgGroup><pcg9 id="564000106"><itemNumber>1333</itemNumber><strength>20mg</strength><dosageForm>Ent Tab</dosageForm><drug id="02241804" notABenefit="Y" sec3="Y"><name>Pantoloc</name><manufacturerId>NYC</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02285479" notABenefit="Y" sec3="Y"><name>Novo-Pantoprazole</name><manufacturerId>NOP</manufacturerId><listingDate>2008-08-28</listingDate></drug><drug id="02292912" notABenefit="Y" sec3="Y"><name>Apo-Pantoprazole</name><manufacturerId>APX</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02301075" notABenefit="Y" sec3="Y"><name>Sandoz Pantoprazole</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02305038" notABenefit="Y" sec3="Y"><name>Ran-Pantoprazole</name><manufacturerId>RAN</manufacturerId><listingDate>2008-11-04</listingDate></drug><drug id="02307863" notABenefit="Y" sec3="Y"><name>PMS-Pantoprazole</name><manufacturerId>PMS</manufacturerId><listingDate>2008-12-23</listingDate></drug><drug id="02308681" notABenefit="Y" sec3="Y"><name>Ratio-Pantoprazole</name><manufacturerId>RPH</manufacturerId><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00106"><pcg9 id="564000080"><itemNumber>1334</itemNumber><strength>40mg</strength><dosageForm>Ent Tab</dosageForm><price>.9785</price><drug id="02229453" sec3="Y" sec12="Y"><name>Pantoloc</name><manufacturerId>NYC</manufacturerId><individualPrice>2.0742</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02285487" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Pantoprazole</name><manufacturerId>NOP</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-06-27</listingDate></drug><drug id="02292920" sec3="Y" sec12="Y"><name>Apo-Pantoprazole</name><manufacturerId>APX</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-05-16</listingDate></drug><drug id="02299585" dinStatus="N" sec3="Y" sec12="Y"><name>Gen-Pantoprazole</name><manufacturerId>GEN</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02300486" dinStatus="N" sec3="Y" sec12="Y"><name>Co Pantoprazole</name><manufacturerId>COB</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02301083" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Pantoprazole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02305046" sec3="Y" sec12="Y"><name>Ran-Pantoprazole</name><manufacturerId>RAN</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-04-09</listingDate></drug><drug id="02307871" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Pantoprazole</name><manufacturerId>PMS</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02308703" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Pantoprazole</name><manufacturerId>RPH</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02309866" dinStatus="N" sec3="Y" sec12="Y"><name>Phl-Pantoprazole</name><manufacturerId>PHE</manufacturerId><individualPrice>.9785</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="293">Gastroesophageal Reflux Disease (GERD)

For the treatment of erosive GERD or upper GI malignancy;
OR
For the treatment of non-erosive GERD after failure of H2-receptor antagonist therapy.

Patients with GERD should be reassessed within 6 months after initial treatment with a PPI.  The reassessment could include confirmation of need for PPI with endoscopy, a trial of PPI withdrawal, or step-down therapy to H2-receptor antagonist therapy.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="295">H. pylori-positive Peptic Ulcers

For the treatment of H. pylori-positive peptic ulcers where H. pylori is documented, by serology, urea breath test or endoscopy, for a one-week course in combination with antimicrobial therapy.  Retreatment of H. pylori-positive peptic ulcers must be documented by persistent H. pylori infection on urea breath test or endoscopy.

Maximum duration: 7 days (for retreatment, a four-week period must elapse since the end of the previous treatment).</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="297">Confirmed Peptic Ulcers or NSAID-induced Ulcer Prophylaxis:

For the treatment of confirmed peptic ulcers and NSAID-induced ulcers;
OR
For the prophylaxis of NSAID-induced ulcers for patients at increased risk of GI bleeding.

Note: There is a lack of published evidence to support double-dose PPI therapy in this setting.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="401">Other Gastrointestinal Disorders

For the treatment of gastroduodenal Crohns disease, short-gut syndrome, scleroderma, or pancreatitis.

Note: There is a lack of published evidence to support double-dose PPI therapy in these settings</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" reasonForUseId="402">Severe Conditions:

For the treatment  of severe esophagitis, Zollinger-Ellison syndrome, esophageal stricture, persistent symptoms of GERD or persistent erosive esophagitis, or upon hospital discharge following a gastrointestinal bleed.

For patients receiving double-dose therapy, the need to continue treatment at higher doses should be reassessed after eight weeks. For re-treatment at higher doses, a four-week period should have elapsed from the end of the previous treatment. Reassessment could include a procedural assessment of the condition or step-down therapy to lower-dose proton pump inhibitor (PPI) therapy.</lccNote><lccNote seq="010" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01560"><name>RABEPRAZOLE SODIUM</name><pcgGroup><pcg9 id="564000098"><itemNumber>1335</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.3250</price><drug id="02243796" sec3="Y"><name>Pariet</name><manufacturerId>JNO</manufacturerId><individualPrice>.6688</individualPrice><listingDate>2002-07-29</listingDate></drug><drug id="02296632" sec3="Y"><name>Novo-Rabeprazole EC</name><manufacturerId>NOP</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02298074" sec3="Y"><name>Ran-Rabeprazole</name><manufacturerId>RAN</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02310805" dinStatus="N" sec3="Y"><name>PMS-Rabeprazole EC</name><manufacturerId>PMS</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02314177" dinStatus="N" sec3="Y"><name>Sandoz Rabeprazole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3250</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9><pcg9 id="564000104"><itemNumber>1336</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.6500</price><drug id="02243797" sec3="Y"><name>Pariet</name><manufacturerId>JNO</manufacturerId><individualPrice>1.3377</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02296640" sec3="Y"><name>Novo-Rabeprazole EC</name><manufacturerId>NOP</manufacturerId><individualPrice>.6500</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02298082" sec3="Y"><name>Ran-Rabeprazole</name><manufacturerId>RAN</manufacturerId><individualPrice>.6500</individualPrice><listingDate>2008-01-15</listingDate></drug><drug id="02310813" dinStatus="N" sec3="Y"><name>PMS-Rabeprazole EC</name><manufacturerId>PMS</manufacturerId><individualPrice>.6500</individualPrice><listingDate>2008-08-28</listingDate></drug><drug id="02314185" dinStatus="N" sec3="Y"><name>Sandoz Rabeprazole</name><manufacturerId>SDZ</manufacturerId><individualPrice>.6500</individualPrice><listingDate>2008-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00815"><name>RANITIDINE HCL</name><note>Cimetidine is less expensive than alternatives, and is effective and well tolerated in most patients. Adequate acid suppression can be achieved by giving cimetidine as opposed to using other longer acting H2-antagonists. Long-term use of these drugs for prevention of recurrent peptic ulcers should be reviewed; specific cure of Helicobacter pylori infection with antibiotics is a more effective and less costly approach.</note><pcgGroup><pcg9 id="564000014"><itemNumber>1337</itemNumber><strength>50mg/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>2.7990</price><drug id="02212366" sec3="Y"><name>Zantac</name><manufacturerId>GSK</manufacturerId><individualPrice>2.7990</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="564000038"><itemNumber>1338</itemNumber><strength>15mg/mL</strength><dosageForm>Oral Sol</dosageForm><price>.0932</price><drug id="02212374" sec3="Y"><name>Zantac</name><manufacturerId>GSK</manufacturerId><individualPrice>.2085</individualPrice><listingDate>1997-01-20</listingDate></drug><drug id="02242940" sec3="Y"><name>Novo-Ranidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.0932</individualPrice><listingDate>2004-12-21</listingDate></drug><drug id="02280833" sec3="Y"><name>Apo-Ranitidine</name><manufacturerId>APX</manufacturerId><individualPrice>.0932</individualPrice><listingDate>2007-09-04</listingDate></drug></pcg9><pcg9 id="564000010"><itemNumber>1339</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>.1800</price><drug id="00733059" sec3="Y"><name>Apo-Ranitidine</name><manufacturerId>APX</manufacturerId><individualPrice>.4042</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00828564" sec3="Y"><name>Novo-Ranidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.4042</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00828823" sec3="Y"><name>Ratio-Ranitidine</name><manufacturerId>RPH</manufacturerId><individualPrice>.4042</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865737" sec3="Y"><name>Nu-Ranit</name><manufacturerId>NXP</manufacturerId><individualPrice>.4042</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02207761" sec3="Y"><name>Mylan-Ranitidine</name><manufacturerId>MYL</manufacturerId><individualPrice>.4042</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02212331" sec3="Y"><name>Zantac</name><manufacturerId>GSK</manufacturerId><individualPrice>.1800</individualPrice><listingDate>1997-07-12</listingDate></drug><drug id="02242453" sec3="Y"><name>PMS-Ranitidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.4042</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02243229" sec3="Y"><name>Sandoz Ranitidine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4042</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02248570" sec3="Y"><name>Co-Ranitidine</name><manufacturerId>COB</manufacturerId><individualPrice>.4042</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02336480" notABenefit="Y" sec3="Y"><name>Ran-Ranitidine</name><manufacturerId>RAN</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="564000020"><itemNumber>1340</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.3600</price><drug id="00733067" sec3="Y"><name>Apo-Ranitidine</name><manufacturerId>APX</manufacturerId><individualPrice>.7787</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00828556" sec3="Y"><name>Novo-Ranidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.7787</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00828688" sec3="Y"><name>Ratio-Ranitidine</name><manufacturerId>RPH</manufacturerId><individualPrice>.7787</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00865745" sec3="Y"><name>Nu-Ranit</name><manufacturerId>NXP</manufacturerId><individualPrice>.7787</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02207788" sec3="Y"><name>Mylan-Ranitidine</name><manufacturerId>MYL</manufacturerId><individualPrice>.7787</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02212358" sec3="Y"><name>Zantac</name><manufacturerId>GSK</manufacturerId><individualPrice>.3600</individualPrice><listingDate>1998-03-17</listingDate></drug><drug id="02242454" sec3="Y"><name>PMS-Ranitidine</name><manufacturerId>PMS</manufacturerId><individualPrice>.7787</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02243230" sec3="Y"><name>Sandoz Ranitidine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.7787</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02248571" sec3="Y"><name>Co-Ranitidine</name><manufacturerId>COB</manufacturerId><individualPrice>.7787</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02336502" notABenefit="Y" sec3="Y"><name>Ran-Ranitidine</name><manufacturerId>RAN</manufacturerId><listingDate>2010-01-05</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00814"><name>SUCRALFATE</name><pcgGroup><pcg9 id="564000050"><itemNumber>1341</itemNumber><strength>1g/5mL</strength><dosageForm>Oral Susp</dosageForm><price>.0951</price><drug id="02103567" sec3="Y"><name>Sulcrate Suspension Plus</name><manufacturerId>BFI</manufacturerId><individualPrice>.0951</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="564000009"><itemNumber>1342</itemNumber><strength>1g</strength><dosageForm>Tab</dosageForm><price>.2335</price><drug id="02045702" sec3="Y"><name>Novo-Sucralate</name><manufacturerId>NOP</manufacturerId><individualPrice>.2335</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100622" sec3="Y"><name>Sulcrate</name><manufacturerId>BFI</manufacturerId><individualPrice>.5235</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02125250" sec3="Y"><name>Apo-Sucralfate</name><manufacturerId>APX</manufacturerId><individualPrice>.2335</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02134829" sec3="Y"><name>Nu-Sucralfate</name><manufacturerId>NXP</manufacturerId><individualPrice>.2335</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02238209" sec3="Y"><name>PMS-Sucralfate</name><manufacturerId>PMS</manufacturerId><individualPrice>.2335</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="600000000"><name>GOLD COMPOUNDS</name><pcg6><genericName id="00838"><name>AURANOFIN</name><pcgGroup><pcg9 id="600000005"><itemNumber>1343</itemNumber><strength>3mg</strength><dosageForm>Cap</dosageForm><price>2.0047</price><drug id="01916823" sec3="Y"><name>Ridaura</name><manufacturerId>PAL</manufacturerId><individualPrice>2.0047</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00837"><name>SODIUM AUROTHIOMALATE</name><pcgGroup><pcg9 id="600000004"><itemNumber>1344</itemNumber><strength>10mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>6.3100</price><drug id="01927620" sec3="Y"><name>Myochrysine</name><manufacturerId>SAV</manufacturerId><individualPrice>11.5102</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245456" sec3="Y"><name>Sodium Aurothiomalate</name><manufacturerId>SDZ</manufacturerId><individualPrice>6.3100</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="600000003"><itemNumber>1345</itemNumber><strength>25mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>7.6567</price><drug id="01927612" sec3="Y"><name>Myochrysine</name><manufacturerId>SAV</manufacturerId><individualPrice>13.9505</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245457" sec3="Y"><name>Sodium Aurothiomalate</name><manufacturerId>SDZ</manufacturerId><individualPrice>7.6567</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9><pcg9 id="600000002"><itemNumber>1346</itemNumber><strength>50mg/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>11.8900</price><drug id="01927604" sec3="Y"><name>Myochrysine</name><manufacturerId>SAV</manufacturerId><individualPrice>21.6804</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245458" sec3="Y"><name>Sodium Aurothiomalate</name><manufacturerId>SDZ</manufacturerId><individualPrice>11.8900</individualPrice><listingDate>2005-09-16</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="640000000"><name>HEAVY METAL ANTAGONISTS</name><pcg6><genericName id="00841"><name>DEFEROXAMINE MESYLATE</name><pcgGroup><pcg9 id="640000016"><itemNumber>1347</itemNumber><strength>2g/Vial</strength><dosageForm>Inj Pd-2g Vial Pk</dosageForm><drug id="01981250" notABenefit="Y" sec3="Y"><name>Desferal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02243450" notABenefit="Y" sec3="Y"><name>PMS-Deferoxamine</name><manufacturerId>PMS</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="640000017"><itemNumber>1348</itemNumber><strength>500mg/Vial</strength><dosageForm>Inj Pd-500mg Vial Pk</dosageForm><drug id="01981242" notABenefit="Y" sec3="Y"><name>Desferal</name><manufacturerId>NOV</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02242055" notABenefit="Y" sec3="Y"><name>PMS-Deferoxamine</name><manufacturerId>PMS</manufacturerId><listingDate>2008-01-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00840"><name>PENICILLAMINE</name><pcgGroup><pcg9 id="640000003"><itemNumber>1349</itemNumber><strength>250mg</strength><dosageForm>Cap</dosageForm><price>3.2965</price><drug id="00016055" sec3="Y"><name>Cuprimine</name><manufacturerId>ATO</manufacturerId><individualPrice>3.2965</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="680000000"><name>HORMONES AND SUBSTITUTES</name><pcg6 id="680400000"><name>CORTICOSTEROIDS</name><note>The general direction of the therapy of asthma has been toward the use of anti- inflammatory agents, especially inhaled steroids, which are not associated with systemic side effects to the same degree as oral steroids. The proper technique of inhalation or use of a spacer is very important to the efficacy of these agents. Physicians and pharmacists should ensure that patients are appropriately instructed in the use of these devices.</note><genericName id="00687"><name>BECLOMETHASONE DIPROPIONATE</name><pcgGroup><pcg9 id="680400082"><itemNumber>1350</itemNumber><strength>50mcg/Metered Dose</strength><dosageForm>Aero Inh-200 Dose Pk</dosageForm><price>30.0200</price><drug id="02242029" sec3="Y"><name>QVAR</name><manufacturerId>GRA</manufacturerId><individualPrice>30.0200</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9><pcg9 id="680400083"><itemNumber>1351</itemNumber><strength>100mcg/Metered Dose</strength><dosageForm>Aero Inh-200 Dose Pk</dosageForm><price>59.8600</price><drug id="02242030" sec3="Y"><name>QVAR</name><manufacturerId>GRA</manufacturerId><individualPrice>59.8600</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00696"><name>BUDESONIDE</name><pcgGroup lccId="00107"><pcg9 id="680400072"><itemNumber>1352</itemNumber><strength>0.125mg/mL</strength><dosageForm>Inh Susp</dosageForm><price>.2063</price><drug id="02229099" sec3="Y" sec12="Y"><name>Pulmicort Nebuamp</name><manufacturerId>AZC</manufacturerId><individualPrice>.2063</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="680400077"><itemNumber>1353</itemNumber><strength>0.25mg/mL</strength><dosageForm>Inh Susp</dosageForm><price>.4125</price><drug id="01978918" sec3="Y" sec12="Y"><name>Pulmicort Nebuamp</name><manufacturerId>AZC</manufacturerId><individualPrice>.4125</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680400078"><itemNumber>1354</itemNumber><strength>0.5mg/mL</strength><dosageForm>Inh Susp</dosageForm><price>.8250</price><drug id="01978926" sec3="Y" sec12="Y"><name>Pulmicort Nebuamp</name><manufacturerId>AZC</manufacturerId><individualPrice>.8250</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" type="R">For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.</lccNote><lccNote seq="002" reasonForUseId="260">Children aged 6 years or less;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="261">Patients who have a tracheostomy;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="262">Patients with cystic fibrosis in whom nebulizer therapy is indicated;</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="008" reasonForUseId="263">Patients with severe mental or physical disabilities;</lccNote><lccNote seq="009" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="010" reasonForUseId="264">Patients who have previously used nebulizer therapy within the last 12 month period.</lccNote><lccNote seq="011" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="680400051"><itemNumber>1355</itemNumber><strength>100mcg/Metered Dose</strength><dosageForm>Pd Inh-200 Dose Pk</dosageForm><price>30.4000</price><drug id="00852074" sec3="Y"><name>Pulmicort Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>30.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680400052"><itemNumber>1356</itemNumber><strength>200mcg/Metered Dose</strength><dosageForm>Pd Inh-200 Dose Pk</dosageForm><price>60.8500</price><drug id="00851752" sec3="Y"><name>Pulmicort Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>60.8500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680400053"><itemNumber>1357</itemNumber><strength>400mcg/Metered Dose</strength><dosageForm>Pd Inh-200 Dose Pk</dosageForm><price>109.5000</price><drug id="00851760" sec3="Y"><name>Pulmicort Turbuhaler</name><manufacturerId>AZC</manufacturerId><individualPrice>109.5000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01698"><name>CICLESONIDE</name><pcgGroup><pcg9 id="680400093"><itemNumber>1358</itemNumber><strength>100mcg/Actuation</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>43.0700</price><drug id="02285606" sec3="Y"><name>Alvesco</name><manufacturerId>NYC</manufacturerId><individualPrice>43.0700</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="680400094"><itemNumber>1359</itemNumber><strength>200mcg/Actuation</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>71.1600</price><drug id="02285614" sec3="Y"><name>Alvesco</name><manufacturerId>NYC</manufacturerId><individualPrice>71.1600</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="680400095"><itemNumber>1360</itemNumber><strength>50mcg/Actuation</strength><dosageForm>Metered Dose Nas Sp-120 Dose Pk</dosageForm><price>24.3400</price><drug id="02303671" dinStatus="N" sec3="Y"><name>Omnaris</name><manufacturerId>NYC</manufacturerId><individualPrice>24.3400</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00685"><name>DEXAMETHASONE</name><pcgGroup><pcg9 id="680400022"><itemNumber>1361</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><price>.1564</price><drug id="00016462" notABenefit="Y" sec3="Y"><name>Decadron</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01964976" sec3="Y"><name>PMS-Dexamethasone</name><manufacturerId>PMS</manufacturerId><individualPrice>.1564</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02240684" sec3="Y"><name>Ratio-Dexamethasone</name><manufacturerId>RPH</manufacturerId><individualPrice>.1564</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02261081" sec3="Y"><name>Apo-Dexamethasone</name><manufacturerId>APX</manufacturerId><individualPrice>.1564</individualPrice><listingDate>2005-04-28</listingDate></drug></pcg9><pcg9 id="680400031"><itemNumber>1362</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.6092</price><drug id="00354309" notABenefit="Y" sec3="Y"><name>Decadron</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01964070" sec3="Y"><name>PMS-Dexamethasone</name><manufacturerId>PMS</manufacturerId><individualPrice>.6092</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02240687" sec3="Y"><name>Ratio-Dexamethasone</name><manufacturerId>RPH</manufacturerId><individualPrice>.6092</individualPrice><listingDate>2000-07-17</listingDate></drug><drug id="02250055" sec3="Y"><name>Apo-Dexamethasone</name><manufacturerId>APX</manufacturerId><individualPrice>.6092</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00843"><name>DEXAMETHASONE 21-PHOSPHATE</name><pcgGroup><pcg9 id="680400005"><itemNumber>1363</itemNumber><strength>4mg/mL</strength><dosageForm>Inj Sol</dosageForm><price>1.6900</price><drug id="00213624" notABenefit="Y" sec3="Y"><name>Decadron</name><manufacturerId>MSD</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00664227" sec3="Y"><name>Dexamethasone Sodium</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.6900</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="01977547" sec3="Y"><name>Dexamethasone Sodium</name><manufacturerId>CYI</manufacturerId><individualPrice>1.6900</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00844"><name>FLUDROCORTISONE ACETATE</name><pcgGroup><pcg9 id="680400006"><itemNumber>1364</itemNumber><strength>0.1mg</strength><dosageForm>Tab</dosageForm><price>.2419</price><drug id="02086026" sec3="Y"><name>Florinef</name><manufacturerId>PAL</manufacturerId><individualPrice>.2419</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00255"><name>FLUTICASONE PROPIONATE</name><pcgGroup><pcg9 id="680400086"><itemNumber>1365</itemNumber><strength>50mcg/Metered Dose</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>23.9292</price><drug id="02244291" sec3="Y"><name>Flovent HFA</name><manufacturerId>GSK</manufacturerId><individualPrice>23.9292</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="680400087"><itemNumber>1366</itemNumber><strength>125mcg/Metered Dose</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>41.2800</price><drug id="02244292" sec3="Y"><name>Flovent HFA</name><manufacturerId>GSK</manufacturerId><individualPrice>41.2800</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="680400088"><itemNumber>1367</itemNumber><strength>250mcg/Metered Dose</strength><dosageForm>Inh-120 Dose Pk</dosageForm><price>82.5400</price><drug id="02244293" sec3="Y"><name>Flovent HFA</name><manufacturerId>GSK</manufacturerId><individualPrice>82.5400</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="680400079"><itemNumber>1368</itemNumber><strength>250mcg/Blister</strength><dosageForm>Pd Inh-60 Dose Pk</dosageForm><price>41.2800</price><drug id="02237246" sec3="Y"><name>Flovent Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>41.2800</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="680400080"><itemNumber>1369</itemNumber><strength>500mcg/Blister</strength><dosageForm>Pd Inh-60 Dose Pk</dosageForm><price>82.5400</price><drug id="02237247" sec3="Y"><name>Flovent Diskus</name><manufacturerId>GSK</manufacturerId><individualPrice>82.5400</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00823"><name>HYDROCORTISONE</name><pcgGroup><pcg9 id="680400057"><itemNumber>1370</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.1524</price><drug id="00030910" sec3="Y"><name>Cortef</name><manufacturerId>PFI</manufacturerId><individualPrice>.1524</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="680400007"><itemNumber>1371</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>.2750</price><drug id="00030929" sec3="Y"><name>Cortef</name><manufacturerId>PFI</manufacturerId><individualPrice>.2750</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00845"><name>METHYLPREDNISOLONE</name><pcgGroup><pcg9 id="680400014"><itemNumber>1372</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><price>.3314</price><drug id="00030988" sec3="Y"><name>Medrol</name><manufacturerId>PFI</manufacturerId><individualPrice>.3314</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00848"><name>METHYLPREDNISOLONE ACETATE</name><pcgGroup><pcg9 id="680400025"><itemNumber>1373</itemNumber><strength>40mg/mL</strength><dosageForm>Inj Susp-1mL Pk</dosageForm><price>3.2250</price><drug id="00030759" sec3="Y"><name>Depo-Medrol</name><manufacturerId>PFI</manufacturerId><individualPrice>4.7811</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245400" dinStatus="N" sec3="Y"><name>Methylprednisolone Acetate Inj Susp USP</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.2250</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="680400024"><itemNumber>1374</itemNumber><strength>80mg/mL</strength><dosageForm>Inj Susp-1mL Pk</dosageForm><price>6.4500</price><drug id="00030767" sec3="Y"><name>Depo-Medrol</name><manufacturerId>PFI</manufacturerId><individualPrice>9.1710</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245406" dinStatus="N" sec3="Y"><name>Methylprednisolone Acetate Inj Susp USP</name><manufacturerId>SDZ</manufacturerId><individualPrice>6.4500</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="680400026"><itemNumber>1375</itemNumber><strength>100mg/5mL</strength><dosageForm>Inj Susp-5mL Pk</dosageForm><price>10.7095</price><drug id="01934325" sec3="Y"><name>Depo-Medrol</name><manufacturerId>PFI</manufacturerId><individualPrice>10.7095</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00691"><name>PREDNISOLONE SODIUM PHOSPHATE</name><pcgGroup><pcg9 id="680400071"><itemNumber>1376</itemNumber><strength>6.7mg/5mL</strength><dosageForm>O/L</dosageForm><price>.0671</price><drug id="02230619" sec3="Y"><name>Pediapred Oral Liquid</name><manufacturerId>SAV</manufacturerId><individualPrice>.1223</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02245532" sec3="Y"><name>PMS-Prednisolone</name><manufacturerId>PMS</manufacturerId><individualPrice>.0671</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00846"><name>PREDNISONE</name><pcgGroup><pcg9 id="680400037"><itemNumber>1377</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.1035</price><drug id="00271373" sec3="Y"><name>Winpred</name><manufacturerId>VAL</manufacturerId><individualPrice>.1035</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00598194" sec3="Y"><name>Apo-Prednisone</name><manufacturerId>APX</manufacturerId><individualPrice>.1072</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680400018"><itemNumber>1378</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0220</price><drug id="00021695" sec3="Y"><name>Novo-Prednisone</name><manufacturerId>NOP</manufacturerId><individualPrice>.0220</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00210188" notABenefit="Y" sec3="Y"><name>Deltasone</name><manufacturerId>UPJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00312770" sec3="Y"><name>Apo-Prednisone</name><manufacturerId>APX</manufacturerId><individualPrice>.0220</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680400029"><itemNumber>1379</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.0913</price><drug id="00232378" sec3="Y"><name>Novo-Prednisone</name><manufacturerId>NOP</manufacturerId><individualPrice>.0913</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00252417" notABenefit="Y" sec3="Y"><name>Deltasone</name><manufacturerId>UPJ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00550957" sec3="Y"><name>Apo-Prednisone</name><manufacturerId>APX</manufacturerId><individualPrice>.0913</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00695"><name>TRIAMCINOLONE ACETONIDE</name><pcgGroup><pcg9 id="680400036"><itemNumber>1380</itemNumber><strength>40mg/mL</strength><dosageForm>Inj Susp-1mL Pk</dosageForm><price>4.7700</price><drug id="00990876" sec3="Y"><name>Kenalog-40</name><manufacturerId>BQU</manufacturerId><individualPrice>7.3000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229550" sec3="Y"><name>Triamcinolone Acetonide</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.7700</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9><pcg9 id="680400035"><itemNumber>1381</itemNumber><strength>50mg/5mL</strength><dosageForm>Inj Susp-5mL Pk</dosageForm><price>10.2800</price><drug id="01999761" sec3="Y"><name>Kenalog-10</name><manufacturerId>BQU</manufacturerId><individualPrice>15.7500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02229540" sec3="Y"><name>Triamcinolone Acetonide</name><manufacturerId>SDZ</manufacturerId><individualPrice>10.2800</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9><pcg9 id="680400034"><itemNumber>1382</itemNumber><strength>200mg/5mL</strength><dosageForm>Inj Susp-5mL Pk</dosageForm><price>16.7100</price><drug id="01999869" sec3="Y"><name>Kenalog-40</name><manufacturerId>BQU</manufacturerId><individualPrice>25.6000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="09857128" sec3="Y"><name>Triamcinolone Acetonide</name><manufacturerId>SDZ</manufacturerId><individualPrice>16.7100</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="680800000"><name>ANDROGENS</name><genericName id="00860"><name>DANAZOL</name><pcgGroup><pcg9 id="680800017"><itemNumber>1383</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>.8663</price><drug id="02018144" sec3="Y"><name>Cyclomen</name><manufacturerId>SAV</manufacturerId><individualPrice>.8663</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680800018"><itemNumber>1384</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>1.2854</price><drug id="02018152" sec3="Y"><name>Cyclomen</name><manufacturerId>SAV</manufacturerId><individualPrice>1.2854</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="680800015"><itemNumber>1385</itemNumber><strength>200mg</strength><dosageForm>Cap</dosageForm><price>2.0541</price><drug id="02018160" sec3="Y"><name>Cyclomen</name><manufacturerId>SAV</manufacturerId><individualPrice>2.0541</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01630"><name>TESTOSTERONE</name><pcgGroup lccId="00160"><pcg9 id="680800030"><itemNumber>1386</itemNumber><strength>1%</strength><dosageForm>2.5g Foil Packet</dosageForm><price>2.1263</price><drug id="02245345" sec3="Y" sec12="Y"><name>Androgel</name><manufacturerId>SPH</manufacturerId><individualPrice>2.1263</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="680800031"><itemNumber>1387</itemNumber><strength>1%</strength><dosageForm>5.0g Foil Packet</dosageForm><price>3.7600</price><drug id="02245346" sec3="Y" sec12="Y"><name>Androgel</name><manufacturerId>SPH</manufacturerId><individualPrice>3.7600</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="680800033"><itemNumber>1388</itemNumber><strength>1%</strength><dosageForm>Top Gel-5g Pk</dosageForm><price>3.3840</price><drug id="02280248" dinStatus="N" sec3="Y" sec12="Y"><name>Testim</name><manufacturerId>PAL</manufacturerId><individualPrice>3.3840</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><pcg9 id="680800029"><itemNumber>1389</itemNumber><strength>12.2mg</strength><dosageForm>Transdermal Patch</dosageForm><price>1.9720</price><drug id="02239653" sec3="Y" sec12="Y"><name>Androderm</name><manufacturerId>PAL</manufacturerId><individualPrice>1.9720</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="397">For male patients with confirmed low morning serum testosterone levels associated with documented, symptomatic hypothalamic, pituitary or testicular disease, or in HIV-infected patients.

Note: Older males with nonspecific symptoms of fatigue, malaise, depression who have a low normal random testosterone level do not satisfy these criteria.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00858"><name>TESTOSTERONE CYPIONATE</name><pcgGroup lccId="00175"><pcg9 id="680800013"><itemNumber>1390</itemNumber><strength>100mg/mL Oily</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>27.4768</price><drug id="00030783" sec3="Y" sec12="Y"><name>Depo-Testosterone</name><manufacturerId>PFI</manufacturerId><individualPrice>27.4768</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="397">For male patients with confirmed low morning serum testosterone levels associated with documented, symptomatic hypothalamic, pituitary or testicular disease, or in HIV-infected patients.

Note: Older males with nonspecific symptoms of fatigue, malaise, depression who have a low normal random testosterone level do not satisfy these criteria.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00859"><name>TESTOSTERONE ENANTHATE</name><pcgGroup lccId="00176"><pcg9 id="680800014"><itemNumber>1391</itemNumber><strength>1000mg/5mL Oily</strength><dosageForm>Inj Sol-5mL Pk</dosageForm><price>47.7500</price><drug id="00029246" sec3="Y" sec12="Y"><name>Delatestryl</name><manufacturerId>THE</manufacturerId><individualPrice>47.7500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="397">For male patients with confirmed low morning serum testosterone levels associated with documented, symptomatic hypothalamic, pituitary or testicular disease, or in HIV-infected patients.

Note: Older males with nonspecific symptoms of fatigue, malaise, depression who have a low normal random testosterone level do not satisfy these criteria.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00866"><name>TESTOSTERONE UNDECANOATE</name><pcgGroup lccId="00177"><pcg9 id="680800025"><itemNumber>1392</itemNumber><strength>40mg</strength><dosageForm>Cap</dosageForm><price>.5640</price><drug id="00782327" sec3="Y" sec12="Y"><name>Andriol</name><manufacturerId>ORG</manufacturerId><individualPrice>.9400</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02322498" dinStatus="N" sec3="Y" sec12="Y"><name>PMS-Testosterone</name><manufacturerId>PMS</manufacturerId><individualPrice>.5640</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="397">For male patients with confirmed low morning serum testosterone levels associated with documented, symptomatic hypothalamic, pituitary or testicular disease, or in HIV-infected patients.

Note: Older males with nonspecific symptoms of fatigue, malaise, depression who have a low normal random testosterone level do not satisfy these criteria.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="681600000"><name>ESTROGENS</name><genericName id="00869"><name>CONJUGATED ESTROGENS</name><pcgGroup lccId="00172"><pcg9 id="681600005"><itemNumber>1393</itemNumber><strength>0.625mg</strength><dosageForm>Tab</dosageForm><price>.0774</price><drug id="00265470" sec3="Y" sec12="Y"><name>C.E.S.</name><manufacturerId>VAL</manufacturerId><individualPrice>.0774</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02043408" notABenefit="Y" sec3="Y"><name>Premarin</name><manufacturerId>WAY</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="398">For short-term use in women who are experiencing symptoms of menopause.

Note: Recent evidence has demonstrated that use of hormone replacement therapy (HRT) increases the rate of coronary events, breast cancer, dementia, stroke, venous thromboembolism and referrals for abnormal vaginal bleeding. These risks should be discussed with patients and reviewed periodically.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="681600007"><itemNumber>1394</itemNumber><strength>0.625mg/g</strength><dosageForm>Vag Cr</dosageForm><price>.6093</price><drug id="02043440" sec3="Y"><name>Premarin</name><manufacturerId>WAY</manufacturerId><individualPrice>.6093</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00875"><name>ESTRADIOL</name><pcgGroup><pcg9 id="681600041"><itemNumber>1395</itemNumber><strength>2mg</strength><dosageForm>Vag Ring</dosageForm><price>61.8000</price><drug id="02168898" sec3="Y"><name>Estring</name><manufacturerId>PFI</manufacturerId><individualPrice>61.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00880"><name>ESTRADIOL 17-B</name><pcgGroup><pcg9 id="681600071"><itemNumber>1396</itemNumber><strength>25mcg</strength><dosageForm>Vag Tab</dosageForm><price>3.0607</price><drug id="02241332" sec3="Y"><name>Vagifem</name><manufacturerId>NOO</manufacturerId><individualPrice>3.0607</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00874"><name>ESTROPIPATE (CALCULATED AS SODIUM ESTRONE SULFATE 1.25MG)</name><pcgGroup lccId="00173"><pcg9 id="681600034"><itemNumber>1397</itemNumber><strength>1.5mg</strength><dosageForm>Tab</dosageForm><price>.2804</price><drug id="02089769" sec3="Y" sec12="Y"><name>Ogen 1.25</name><manufacturerId>PFI</manufacturerId><individualPrice>.2804</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="398">For short-term use in women who are experiencing symptoms of menopause.

Note: Recent evidence has demonstrated that use of hormone replacement therapy (HRT) increases the rate of coronary events, breast cancer, dementia, stroke, venous thromboembolism and referrals for abnormal vaginal bleeding. These risks should be discussed with patients and reviewed periodically.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00873"><name>ESTROPIPATE (CALCULATED AS SODIUM ESTRONE SULFATE 2.5MG)</name><pcgGroup lccId="00174"><pcg9 id="681600033"><itemNumber>1398</itemNumber><strength>3mg</strength><dosageForm>Tab</dosageForm><price>.4434</price><drug id="02089777" sec3="Y" sec12="Y"><name>Ogen 2.5</name><manufacturerId>PFI</manufacturerId><individualPrice>.4434</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="398">For short-term use in women who are experiencing symptoms of menopause.

Note: Recent evidence has demonstrated that use of hormone replacement therapy (HRT) increases the rate of coronary events, breast cancer, dementia, stroke, venous thromboembolism and referrals for abnormal vaginal bleeding. These risks should be discussed with patients and reviewed periodically.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName></pcg6><pcg6 id="682002000"><name>ANTI-DIABETIC AGENTS ORAL ANTI-DIABETIC AGENTS</name><note>An adequate trial of diet and exercise therapy alone is essential before any hypoglycaemic agent is prescribed in non-insulin dependent diabetes mellitus. When indicated (i.e., fasting plasma glucose remains &gt; 10mmol/L), drug therapy should be considered as a supplement to continuing caloric restriction and exercise.</note><genericName id="00892"><name>ACARBOSE</name><pcgGroup lccId="00113"><pcg9 id="682002011"><itemNumber>1399</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2588</price><drug id="02190885" insOH="Y" sec3="Y" sec12="Y"><name>Glucobay</name><manufacturerId>BAY</manufacturerId><individualPrice>.2588</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="682002012"><itemNumber>1400</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.3584</price><drug id="02190893" insOH="Y" sec3="Y" sec12="Y"><name>Glucobay</name><manufacturerId>BAY</manufacturerId><individualPrice>.3584</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of non-insulin-dependent diabetes mellitus (NIDDM):</lccNote><lccNote seq="002" reasonForUseId="175">In patients who cannot tolerate or have failed treatment with other oral hypoglycemic agents or in whom other oral hypoglycemic agents are contraindicated;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="176">In patients who require combination therapy with more than one oral hypoglycemic agent to control their serum glucose concentrations.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00891"><name>GLICLAZIDE</name><pcgGroup><pcg9 id="682002025"><itemNumber>1401</itemNumber><strength>30mg</strength><dosageForm>SR Tab</dosageForm><price>.1405</price><drug id="02242987" insOH="Y" sec3="Y"><name>Diamicron MR</name><manufacturerId>SEV</manufacturerId><individualPrice>.1405</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02297795" dinStatus="N" insOH="Y" sec3="Y"><name>Apo-Gliclazide MR</name><manufacturerId>APX</manufacturerId><individualPrice>.1405</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9><pcg9 id="682002010"><itemNumber>1402</itemNumber><strength>80mg</strength><dosageForm>Tab</dosageForm><price>.1863</price><drug id="00765996" insOH="Y" sec3="Y"><name>Diamicron</name><manufacturerId>SEV</manufacturerId><individualPrice>.3725</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02229519" insOH="Y" sec3="Y"><name>Mylan-Gliclazide</name><manufacturerId>MYL</manufacturerId><individualPrice>.1863</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02238103" insOH="Y" sec3="Y"><name>Novo-Gliclazide</name><manufacturerId>NOP</manufacturerId><individualPrice>.1863</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02245247" insOH="Y" sec3="Y"><name>Apo-Gliclazide</name><manufacturerId>APX</manufacturerId><individualPrice>.1863</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02294400" dinStatus="N" insOH="Y" sec3="Y"><name>PMS-Gliclazide</name><manufacturerId>PMS</manufacturerId><individualPrice>.1863</individualPrice><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01695"><name>GLIMEPIRIDE</name><pcgGroup><pcg9 id="682002031"><itemNumber>1403</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><drug id="02245272" notABenefit="Y" sec3="Y"><name>Amaryl</name><manufacturerId>SAV</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02269589" notABenefit="Y" sec3="Y"><name>Sandoz Glimepiride</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02273101" notABenefit="Y" sec3="Y"><name>Ratio-Glimepiride</name><manufacturerId>RPH</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02273756" notABenefit="Y" sec3="Y"><name>Novo-Glimepiride</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02274248" dinStatus="E" notABenefit="Y" sec3="Y"><name>Co Glimepiride</name><manufacturerId>COB</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02279061" dinStatus="E" notABenefit="Y" sec3="Y"><name>Gen-Glimepiride</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02295377" notABenefit="Y" sec3="Y"><name>Apo-Glimepiride</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="682002032"><itemNumber>1404</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><drug id="02245273" notABenefit="Y" sec3="Y"><name>Amaryl</name><manufacturerId>SAV</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02269597" notABenefit="Y" sec3="Y"><name>Sandoz Glimepiride</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02273128" notABenefit="Y" sec3="Y"><name>Ratio-Glimepiride</name><manufacturerId>RPH</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02273764" notABenefit="Y" sec3="Y"><name>Novo-Glimepiride</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02274256" dinStatus="E" notABenefit="Y" sec3="Y"><name>Co Glimepiride</name><manufacturerId>COB</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02279088" dinStatus="E" notABenefit="Y" sec3="Y"><name>Gen-Glimepiride</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02295385" notABenefit="Y" sec3="Y"><name>Apo-Glimepiride</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9><pcg9 id="682002033"><itemNumber>1405</itemNumber><strength>4mg</strength><dosageForm>Tab</dosageForm><drug id="02245274" notABenefit="Y" sec3="Y"><name>Amaryl</name><manufacturerId>SAV</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02269619" notABenefit="Y" sec3="Y"><name>Sandoz Glimepiride</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02273136" notABenefit="Y" sec3="Y"><name>Ratio-Glimepiride</name><manufacturerId>RPH</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02273772" notABenefit="Y" sec3="Y"><name>Novo-Glimepiride</name><manufacturerId>NOP</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02274272" dinStatus="E" notABenefit="Y" sec3="Y"><name>Co Glimepiride</name><manufacturerId>COB</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02279126" dinStatus="E" notABenefit="Y" sec3="Y"><name>Gen-Glimepiride</name><manufacturerId>GEN</manufacturerId><listingDate>2007-06-06</listingDate></drug><drug id="02295393" notABenefit="Y" sec3="Y"><name>Apo-Glimepiride</name><manufacturerId>APX</manufacturerId><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00888"><name>GLYBURIDE</name><pcgGroup><pcg9 id="682002009"><itemNumber>1406</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.0393</price><drug id="00720933" insOH="Y" sec3="Y"><name>Euglucon</name><manufacturerId>PMS</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00808733" insOH="Y" sec3="Y"><name>Gen-Glybe</name><manufacturerId>GEN</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01900927" insOH="Y" sec3="Y"><name>Ratio-Glyburide</name><manufacturerId>RPH</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913654" insOH="Y" sec3="Y"><name>Apo-Glyburide</name><manufacturerId>APX</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913670" insOH="Y" sec3="Y"><name>Novo-Glyburide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02020734" insOH="Y" sec3="Y"><name>Nu-Glyburide</name><manufacturerId>NXP</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02224550" insOH="Y" sec3="Y"><name>Diabeta</name><manufacturerId>SAV</manufacturerId><individualPrice>.1283</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02236733" insOH="Y" sec3="Y"><name>PMS-Glyburide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0393</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02248008" insOH="Y" sec3="Y"><name>Sandoz Glyburide</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0393</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="682002004"><itemNumber>1407</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0683</price><drug id="00720941" insOH="Y" sec3="Y"><name>Euglucon</name><manufacturerId>PMS</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00808741" insOH="Y" sec3="Y"><name>Gen-Glybe</name><manufacturerId>GEN</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01900935" insOH="Y" sec3="Y"><name>Ratio-Glyburide</name><manufacturerId>RPH</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913662" insOH="Y" sec3="Y"><name>Apo-Glyburide</name><manufacturerId>APX</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01913689" insOH="Y" sec3="Y"><name>Novo-Glyburide</name><manufacturerId>NOP</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02020742" insOH="Y" sec3="Y"><name>Nu-Glyburide</name><manufacturerId>NXP</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02224569" insOH="Y" sec3="Y"><name>Diabeta</name><manufacturerId>SAV</manufacturerId><individualPrice>.2297</individualPrice><listingDate>1999-01-06</listingDate></drug><drug id="02236734" insOH="Y" sec3="Y"><name>PMS-Glyburide</name><manufacturerId>PMS</manufacturerId><individualPrice>.0683</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02248009" insOH="Y" sec3="Y"><name>Sandoz Glyburide</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0683</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00890"><name>METFORMIN HCL</name><pcgGroup><pcg9 id="682002008"><itemNumber>1408</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>.0965</price><drug id="02045710" insOH="Y" sec3="Y"><name>Novo-Metformin</name><manufacturerId>NOP</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02099233" insOH="Y" sec3="Y"><name>Glucophage</name><manufacturerId>SAV</manufacturerId><individualPrice>.2346</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02148765" insOH="Y" sec3="Y"><name>Mylan-Metformin</name><manufacturerId>MYL</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02162822" insOH="Y" sec3="Y"><name>Nu-Metformin</name><manufacturerId>NXP</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02167786" insOH="Y" sec3="Y"><name>Apo-Metformin</name><manufacturerId>APX</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02223562" insOH="Y" sec3="Y"><name>PMS-Metformin</name><manufacturerId>PMS</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02233999" insOH="Y" sec3="Y"><name>Rhoxal-Metformin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0965</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02242794" insOH="Y" sec3="Y"><name>Zym-Metformin</name><manufacturerId>ZYN</manufacturerId><individualPrice>.1216</individualPrice><listingDate>2001-10-11</listingDate></drug><drug id="02242974" insOH="Y" sec3="Y"><name>Ratio-Metformin</name><manufacturerId>RPH</manufacturerId><individualPrice>.0965</individualPrice><listingDate>2001-06-07</listingDate></drug><drug id="02246820" insOH="Y" sec3="Y"><name>Sandoz Metformin FC</name><manufacturerId>SDZ</manufacturerId><individualPrice>.0965</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02257726" insOH="Y" sec3="Y"><name>Co-Metformin</name><manufacturerId>COB</manufacturerId><individualPrice>.0965</individualPrice><listingDate>2004-12-21</listingDate></drug><drug id="02269031" insOH="Y" sec3="Y"><name>Ran-Metformin</name><manufacturerId>RAN</manufacturerId><individualPrice>.0965</individualPrice><listingDate>2006-03-01</listingDate></drug></pcg9><pcg9 id="682002022"><itemNumber>1409</itemNumber><strength>850mg</strength><dosageForm>Tab</dosageForm><drug id="02162849" notABenefit="Y" sec3="Y"><name>Glucophage</name><manufacturerId>SAV</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02229656" notABenefit="Y" sec3="Y"><name>Mylan-Metformin</name><manufacturerId>MYL</manufacturerId><listingDate>2008-04-09</listingDate></drug><drug id="02242589" notABenefit="Y" sec3="Y"><name>PMS-Metformin</name><manufacturerId>PMS</manufacturerId><listingDate>2008-04-09</listingDate></drug><drug id="02242931" notABenefit="Y" sec3="Y"><name>Ratio-Metformin</name><manufacturerId>RPH</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02246821" notABenefit="Y" sec3="Y"><name>Sandoz Metformin FC</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02246965" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Metformin</name><manufacturerId>PHE</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02257734" notABenefit="Y" sec3="Y"><name>Co Metformin</name><manufacturerId>COB</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02269058" notABenefit="Y" sec3="Y"><name>Ran-Metformin</name><manufacturerId>RAN</manufacturerId><listingDate>2008-04-09</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01504"><name>PIOGLITAZONE HCL</name><pcgGroup><pcg9 id="682002019"><itemNumber>1410</itemNumber><strength>15mg</strength><dosageForm>Tab</dosageForm><drug id="02242572" notABenefit="Y" sec3="Y"><name>Actos</name><manufacturerId>TAK</manufacturerId><listingDate>2006-10-23</listingDate></drug><drug id="02274914" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Pioglitazone</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02297906" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Pioglitazone</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02298279" dinStatus="N" notABenefit="Y" sec3="Y"><name>Gen-Pioglitazone</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02301423" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ratio-Pioglitazone</name><manufacturerId>RPH</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302861" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Pioglitazone</name><manufacturerId>COB</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302942" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Pioglitazone</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02303124" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Pioglitazone</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02303442" dinStatus="N" notABenefit="Y" sec3="Y"><name>Accel Pioglitazone</name><manufacturerId>ACC</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02307669" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Pioglitazone</name><manufacturerId>PHE</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02320754" dinStatus="N" notABenefit="Y" sec3="Y"><name>Zym-Pioglitazone</name><manufacturerId>ZYN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02326477" dinStatus="N" notABenefit="Y" sec3="Y"><name>Mint-Pioglitazone</name><manufacturerId>MIN</manufacturerId><listingDate>2009-11-19</listingDate></drug></pcg9><pcg9 id="682002020"><itemNumber>1411</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><drug id="02242573" notABenefit="Y" sec3="Y"><name>Actos</name><manufacturerId>TAK</manufacturerId><listingDate>2006-10-23</listingDate></drug><drug id="02274922" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Pioglitazone</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02297914" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Pioglitazone</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02298287" dinStatus="N" notABenefit="Y" sec3="Y"><name>Gen-Pioglitazone</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02301431" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ratio-Pioglitazone</name><manufacturerId>RPH</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302888" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Pioglitazone</name><manufacturerId>COB</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302950" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Pioglitazone</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02303132" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Pioglitazone</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02303450" dinStatus="N" notABenefit="Y" sec3="Y"><name>Accel Pioglitazone</name><manufacturerId>ACC</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02307677" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Pioglitazone</name><manufacturerId>PHE</manufacturerId><listingDate>2010-01-05</listingDate></drug><drug id="02320762" dinStatus="N" notABenefit="Y" sec3="Y"><name>Zym-Pioglitazone</name><manufacturerId>ZYN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02326485" dinStatus="N" notABenefit="Y" sec3="Y"><name>Mint-Pioglitazone</name><manufacturerId>MIN</manufacturerId><listingDate>2009-11-19</listingDate></drug></pcg9><pcg9 id="682002021"><itemNumber>1412</itemNumber><strength>45mg</strength><dosageForm>Tab</dosageForm><drug id="02242574" notABenefit="Y" sec3="Y"><name>Actos</name><manufacturerId>TAK</manufacturerId><listingDate>2006-10-23</listingDate></drug><drug id="02274930" dinStatus="N" notABenefit="Y" sec3="Y"><name>Novo-Pioglitazone</name><manufacturerId>NOP</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02297922" dinStatus="N" notABenefit="Y" sec3="Y"><name>Sandoz Pioglitazone</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02298295" dinStatus="N" notABenefit="Y" sec3="Y"><name>Gen-Pioglitazone</name><manufacturerId>GEN</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02301458" dinStatus="N" notABenefit="Y" sec3="Y"><name>Ratio-Pioglitazone</name><manufacturerId>RPH</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302896" dinStatus="N" notABenefit="Y" sec3="Y"><name>Co Pioglitazone</name><manufacturerId>COB</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02302977" dinStatus="N" notABenefit="Y" sec3="Y"><name>Apo-Pioglitazone</name><manufacturerId>APX</manufacturerId><listingDate>2008-01-15</listingDate></drug><drug id="02303140" dinStatus="N" notABenefit="Y" sec3="Y"><name>PMS-Pioglitazone</name><manufacturerId>PMS</manufacturerId><listingDate>2008-02-12</listingDate></drug><drug id="02303469" dinStatus="N" notABenefit="Y" sec3="Y"><name>Accel Pioglitazone</name><manufacturerId>ACC</manufacturerId><listingDate>2009-09-30</listingDate></drug><drug id="02307723" dinStatus="N" notABenefit="Y" sec3="Y"><name>Phl-Pioglitazone</name><manufacturerId>PHE</manufacturerId><listingDate>2009-11-19</listingDate></drug><drug id="02320770" dinStatus="N" notABenefit="Y" sec3="Y"><name>Zym-Pioglitazone</name><manufacturerId>ZYN</manufacturerId><listingDate>2010-04-23</listingDate></drug><drug id="02326493" dinStatus="N" notABenefit="Y" sec3="Y"><name>Mint-Pioglitazone</name><manufacturerId>MIN</manufacturerId><listingDate>2009-11-19</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682010000"><name>ANTI-DIABETIC AGENTS INSULINS (RAPID ACTING)</name><genericName id="00899"><name>INSULIN (ZINC CRYSTALLINE) HUMAN BIOSYNTHETIC (RDNA ORIGIN)</name><pcgGroup><pcg9 id="682010009"><itemNumber>1413</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>20.8000</price><drug id="00586714" insOH="Y" sec3="Y"><name>Humulin Regular</name><manufacturerId>LIL</manufacturerId><individualPrice>20.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682010018"><itemNumber>1414</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>40.8300</price><drug id="09853766" insOH="Y" sec3="Y"><name>Humulin R</name><manufacturerId>LIL</manufacturerId><individualPrice>40.8300</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01575"><name>INSULIN ASPART</name><pcgGroup lccId="00146"><pcg9 id="682010023"><itemNumber>1415</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>27.7900</price><drug id="02245397" insOH="Y" sec3="Y" sec12="Y"><name>NovoRapid</name><manufacturerId>NOO</manufacturerId><individualPrice>27.7900</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="682010022"><itemNumber>1416</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>55.6400</price><drug id="02244353" insOH="Y" sec3="Y" sec12="Y"><name>NovoRapid Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>55.6400</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="388">For the treatment of patients with Type 1 diabetes mellitus.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="389">For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="390">For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on a less intensive regimen of regular insulin (1-2 injections per day).</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01758"><name>INSULIN GLULISINE (DNA ORIGIN)</name><pcgGroup><pcg9 id="682010029"><itemNumber>1417</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-10mL Vial</dosageForm><price>23.7200</price><note>Note:  For the treatment of patients with Type 1 diabetes mellitus.
For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.
For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on less intensive regimen of regular insulin (1-2 injections per day).
</note><drug id="02279460" dinStatus="N" insOH="Y" sec3="Y"><name>Apidra</name><manufacturerId>SAV</manufacturerId><individualPrice>23.7200</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="682010028"><itemNumber>1418</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>47.4700</price><note>Note:  For the treatment of patients with Type 1 diabetes mellitus.
For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.
For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on less intensive regimen of regular insulin (1-2 injections per day).
</note><drug id="02294346" dinStatus="N" insOH="Y" sec3="Y"><name>Apidra</name><manufacturerId>SAV</manufacturerId><individualPrice>47.4700</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00900"><name>INSULIN HUMAN BIOSYNTHETIC</name><pcgGroup><pcg9 id="682010013"><itemNumber>1419</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>20.4000</price><drug id="02024233" insOH="Y" sec3="Y"><name>Novolin ge Toronto</name><manufacturerId>NOO</manufacturerId><individualPrice>20.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682010019"><itemNumber>1420</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>40.0300</price><drug id="09853774" insOH="Y" sec3="Y"><name>Novolin ge Toronto Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>40.0300</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01373"><name>INSULIN LISPRO</name><pcgGroup><pcg9 id="682010015"><itemNumber>1421</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>26.8500</price><note>Note:
For the treatment of patients with Type 1 diabetes mellitus.

For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.

For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on less intensive regimen of regular insulin (1-2 injections per day).</note><drug id="02229704" insOH="Y" sec3="Y"><name>Humalog</name><manufacturerId>LIL</manufacturerId><individualPrice>26.8500</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="682010020"><itemNumber>1422</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>53.7500</price><note>Note:
For the treatment of patients with Type 1 diabetes mellitus.

For the treatment of patients with Type 2 diabetes mellitus using insulin in an intensive regimen with 3 or more injections per day or an insulin pump.

For the treatment of patients with Type 2 diabetes mellitus who are either experiencing recurrent hypoglycemia OR are unable to achieve adequate post-prandial glucose control while on less intensive regimen of regular insulin (1-2 injections per day).</note><drug id="09853715" insOH="Y" sec3="Y"><name>Humalog</name><manufacturerId>LIL</manufacturerId><individualPrice>53.7500</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682012000"><name>ANTI-DIABETIC AGENTS INSULINS (INTERMEDIATE ACTING)</name><genericName id="00910"><name>INSULIN (ISOPHANE) HUMAN BIOSYNTHETIC</name><pcgGroup><pcg9 id="682012013"><itemNumber>1423</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Susp-10mL Pk</dosageForm><price>20.4000</price><drug id="02024225" insOH="Y" sec3="Y"><name>Novolin ge NPH</name><manufacturerId>NOO</manufacturerId><individualPrice>20.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682012017"><itemNumber>1424</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>39.8800</price><drug id="09853782" insOH="Y" sec3="Y"><name>Novolin ge NPH Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>39.8800</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00908"><name>INSULIN (ISOPHANE) HUMAN BIOSYNTHETIC (RDNA ORIGIN)</name><pcgGroup><pcg9 id="682012007"><itemNumber>1425</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Susp-10mL Pk</dosageForm><price>20.8000</price><drug id="00587737" insOH="Y" sec3="Y"><name>Humulin NPH</name><manufacturerId>LIL</manufacturerId><individualPrice>20.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682012018"><itemNumber>1426</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>40.8300</price><drug id="09853804" insOH="Y" sec3="Y"><name>Humulin N</name><manufacturerId>LIL</manufacturerId><individualPrice>40.8300</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682014000"><name>ANTI-DIABETIC AGENTS INSULINS (LONG ACTING)</name><genericName id="01755"><name>INSULIN DETEMIR</name><pcgGroup><pcg9 id="682014007"><itemNumber>1427</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>98.4800</price><drug id="02271842" dinStatus="N" insOH="Y" sec3="Y"><name>Levemir Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>98.4800</individualPrice><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01667"><name>INSULIN GLARGINE</name><pcgGroup><pcg9 id="682014009"><itemNumber>1428</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-10mL Vial Pk</dosageForm><price>57.9100</price><drug id="02245689" dinStatus="N" insOH="Y" sec3="Y"><name>Lantus-(Vial)</name><manufacturerId>SAV</manufacturerId><individualPrice>57.9100</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="682014008"><itemNumber>1429</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>86.8700</price><drug id="02251930" dinStatus="N" insOH="Y" sec3="Y"><name>Lantus-(Cartridge)</name><manufacturerId>SAV</manufacturerId><individualPrice>86.8700</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="682014010"><itemNumber>1430</itemNumber><strength>100U/mL</strength><dosageForm>Inj Sol-5x3mL Pk</dosageForm><price>86.8700</price><drug id="02294338" dinStatus="N" insOH="Y" sec3="Y"><name>Lantus Solostar</name><manufacturerId>SAV</manufacturerId><individualPrice>86.8700</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682016000"><name>ANTI-DIABETIC AGENTS INSULINS (PRE-MIXED)</name><genericName id="00927"><name>INSULIN (30% NEUTRAL &amp; 70% ISOPHANE) HUMAN BIOSYNTHETIC</name><pcgGroup><pcg9 id="682016016"><itemNumber>1431</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Susp-10mL Pk</dosageForm><price>20.4000</price><drug id="02024217" insOH="Y" sec3="Y"><name>Novolin ge 30/70</name><manufacturerId>NOO</manufacturerId><individualPrice>20.4000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682016027"><itemNumber>1432</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>39.8400</price><drug id="09853812" insOH="Y" sec3="Y"><name>Novolin ge 30/70 Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>39.8400</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00930"><name>INSULIN (40% NEUTRAL &amp; 60% ISOPHANE) HUMAN BIOSYNTHETIC</name><pcgGroup><pcg9 id="682016022"><itemNumber>1433</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>40.8000</price><drug id="02024314" insOH="Y" sec3="Y"><name>Novolin ge 40/60 Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>40.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00933"><name>INSULIN (50% NEUTRAL &amp; 50% ISOPHANE) HUMAN BIOSYNTHETIC</name><pcgGroup><pcg9 id="682016025"><itemNumber>1434</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>40.8000</price><drug id="02024322" insOH="Y" sec3="Y"><name>Novolin ge 50/50 Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>40.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01757"><name>INSULIN ASPART 30% &amp; INSULIN ASPART PROTAMINE 70%</name><pcgGroup><pcg9 id="682016034"><itemNumber>1435</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>52.0300</price><drug id="02265435" insOH="Y" sec3="Y"><name>NovoMix 30 Penfill</name><manufacturerId>NOO</manufacturerId><individualPrice>52.0300</individualPrice><listingDate>2007-11-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00922"><name>INSULIN HUMAN BIOSYNTHETIC 30% &amp; ISOPHANE 70%</name><pcgGroup><pcg9 id="682016009"><itemNumber>1436</itemNumber><strength>1000U/10mL</strength><dosageForm>Inj Susp-10mL Pk</dosageForm><price>20.8000</price><drug id="00795879" insOH="Y" sec3="Y"><name>Humulin 30/70</name><manufacturerId>LIL</manufacturerId><individualPrice>20.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682016030"><itemNumber>1437</itemNumber><strength>100U/mL</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>40.8300</price><drug id="09853855" insOH="Y" sec3="Y"><name>Humulin 30/70</name><manufacturerId>LIL</manufacturerId><individualPrice>40.8300</individualPrice><listingDate>1998-12-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01440"><name>INSULIN LISPRO &amp; INSULIN LISPRO PROTAMINE</name><pcgGroup><pcg9 id="682016033"><itemNumber>1438</itemNumber><strength>25% &amp; 75%</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>53.7500</price><drug id="02240294" insOH="Y" sec3="Y"><name>Humalog Mix25</name><manufacturerId>LIL</manufacturerId><individualPrice>53.7500</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><pcg9 id="682016035"><itemNumber>1439</itemNumber><strength>50% &amp; 50%</strength><dosageForm>Inj Susp-5x3mL Pk</dosageForm><price>53.7500</price><drug id="02240297" dinStatus="N" insOH="Y" sec3="Y"><name>Humalog Mix50</name><manufacturerId>LIL</manufacturerId><individualPrice>53.7500</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682400000"><name>PARATHYROID AGENTS</name><genericName id="00935"><name>CALCITONIN (SALMON SYNTHETIC)</name><pcgGroup><pcg9 id="682400011"><itemNumber>1440</itemNumber><strength>100IU/mL</strength><dosageForm>Inj Sol-1mL Pk</dosageForm><price>7.8200</price><drug id="02007134" sec3="Y"><name>Caltine 100</name><manufacturerId>FEI</manufacturerId><individualPrice>7.8200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682400009"><itemNumber>1441</itemNumber><strength>400IU/2mL</strength><dosageForm>Inj Sol-2mL Pk</dosageForm><price>53.1800</price><drug id="01926691" sec3="Y"><name>Calcimar</name><manufacturerId>SAV</manufacturerId><individualPrice>53.1800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682400012"><itemNumber>1442</itemNumber><strength>200U/Metered Dose</strength><dosageForm>Nas Sp-2x14 Dose Pk</dosageForm><drug id="02240775" notABenefit="Y" sec3="Y"><name>Miacalcin</name><manufacturerId>NOV</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02261766" notABenefit="Y" sec3="Y"><name>Sandoz Calcitonin NS</name><manufacturerId>SDZ</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="682800000"><name>PITUITARY AGENTS</name><genericName id="00936"><name>DESMOPRESSIN ACETATE</name><pcgGroup><pcg9 id="682800005"><itemNumber>1443</itemNumber><strength>0.1mg/mL</strength><dosageForm>Nas Sol-2.5mL Pk</dosageForm><price>47.2000</price><drug id="00402516" sec3="Y"><name>DDAVP</name><manufacturerId>FEI</manufacturerId><individualPrice>47.2000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="682800012"><itemNumber>1444</itemNumber><strength>1.5mg/mL</strength><dosageForm>Nas Sp-2.5mL Pk</dosageForm><price>386.0000</price><drug id="02237860" sec3="Y"><name>Octostim</name><manufacturerId>FEI</manufacturerId><individualPrice>386.0000</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="682800006"><itemNumber>1445</itemNumber><strength>10mcg/Metered Dose</strength><dosageForm>Nas Sp-2.5mL Pk</dosageForm><price>35.4000</price><drug id="00836362" sec3="Y"><name>DDAVP</name><manufacturerId>FEI</manufacturerId><individualPrice>47.2000</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242465" sec3="Y"><name>Apo-Desmopressin</name><manufacturerId>APX</manufacturerId><individualPrice>35.4000</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="682800026"><itemNumber>1446</itemNumber><strength>60mcg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>.9913</price><drug id="02284995" sec3="Y"><name>DDAVP Melt</name><manufacturerId>FEI</manufacturerId><individualPrice>.9913</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="682800027"><itemNumber>1447</itemNumber><strength>120mcg</strength><dosageForm>Orally Disintegrating Tab</dosageForm><price>1.9826</price><drug id="02285002" sec3="Y"><name>DDAVP Melt</name><manufacturerId>FEI</manufacturerId><individualPrice>1.9826</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="682800010"><itemNumber>1448</itemNumber><strength>0.1mg</strength><dosageForm>Tab</dosageForm><price>.6609</price><drug id="00824305" sec3="Y"><name>DDAVP</name><manufacturerId>FEI</manufacturerId><individualPrice>1.3217</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02284030" sec3="Y"><name>Apo-Desmopressin</name><manufacturerId>APX</manufacturerId><individualPrice>.6609</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02287730" sec3="Y"><name>Novo-Desmopressin</name><manufacturerId>NOP</manufacturerId><individualPrice>.6609</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02304368" dinStatus="N" sec3="Y"><name>PMS-Desmopressin</name><manufacturerId>PMS</manufacturerId><individualPrice>.6609</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="682800011"><itemNumber>1449</itemNumber><strength>0.2mg</strength><dosageForm>Tab</dosageForm><price>1.3217</price><drug id="00824143" sec3="Y"><name>DDAVP</name><manufacturerId>FEI</manufacturerId><individualPrice>2.6434</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02284049" sec3="Y"><name>Apo-Desmopressin</name><manufacturerId>APX</manufacturerId><individualPrice>1.3217</individualPrice><listingDate>2007-04-02</listingDate></drug><drug id="02287749" sec3="Y"><name>Novo-Desmopressin</name><manufacturerId>NOP</manufacturerId><individualPrice>1.3217</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02304376" dinStatus="N" sec3="Y"><name>PMS-Desmopressin</name><manufacturerId>PMS</manufacturerId><individualPrice>1.3217</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01580"><name>THYROTROPIN ALFA</name><pcgGroup><pcg9 id="682800013"><itemNumber>1450</itemNumber><strength>0.9mg/mL</strength><dosageForm>Inj Pd-2x1.1mg Vial Pk</dosageForm><price>1363.7200</price><drug id="02246016" sec3="Y"><name>Thyrogen</name><manufacturerId>GZM</manufacturerId><individualPrice>1363.7200</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="683200000"><name>PROGESTOGENS AND ORAL CONTRACEPTIVES</name><genericName id="01388"><name>CYPROTERONE ACETATE &amp; ETHINYL ESTRADIOL</name><pcgGroup><pcg9 id="683200100"><itemNumber>1451</itemNumber><strength>2mg &amp; 0.035mg</strength><dosageForm>Tab-21 Pk</dosageForm><drug id="02233542" notABenefit="Y" sec3="Y"><name>Diane-35</name><manufacturerId>BAY</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02290308" notABenefit="Y" sec3="Y"><name>Cyestra-35</name><manufacturerId>PMS</manufacturerId><listingDate>2007-12-19</listingDate></drug><drug id="02309556" notABenefit="Y" sec3="Y"><name>Novo-Cyproterone/Ethinyl Estradiol</name><manufacturerId>NOP</manufacturerId><listingDate>2008-12-03</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00952"><name>DESOGESTREL &amp; ETHINYL ESTRADIOL</name><pcgGroup><pcg9 id="683200094"><itemNumber>1452</itemNumber><strength>0.15mg &amp; 0.03mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>9.1900</price><drug id="02042487" sec3="Y"><name>Marvelon 21</name><manufacturerId>ORG</manufacturerId><individualPrice>14.1578</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02317192" dinStatus="N" sec3="Y"><name>Apri 21</name><manufacturerId>APX</manufacturerId><individualPrice>9.1900</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="683200093"><itemNumber>1453</itemNumber><strength>0.15mg &amp; 0.03mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>9.1900</price><drug id="02042479" sec3="Y"><name>Marvelon 28</name><manufacturerId>ORG</manufacturerId><individualPrice>14.1578</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02317206" dinStatus="N" sec3="Y"><name>Apri 28</name><manufacturerId>APX</manufacturerId><individualPrice>9.1900</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="683200080"><itemNumber>1454</itemNumber><strength>0.15mg &amp; 0.03mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="02042533" sec3="Y"><name>Ortho-Cept</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01706"><name>DROSPIRENONE &amp; ETHINYL ESTRADIOL</name><pcgGroup><pcg9 id="683200107"><itemNumber>1455</itemNumber><strength>3.0mg &amp; 0.03mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>11.6000</price><drug id="02261723" sec3="Y"><name>Yasmin 21</name><manufacturerId>BAH</manufacturerId><individualPrice>11.6000</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9><pcg9 id="683200111"><itemNumber>1456</itemNumber><strength>3.0mg &amp; 0.02mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>14.5000</price><drug id="02321157" dinStatus="N" sec3="Y"><name>Yaz</name><manufacturerId>BAH</manufacturerId><individualPrice>14.5000</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><pcg9 id="683200108"><itemNumber>1457</itemNumber><strength>3.0mg &amp; 0.03mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>11.6000</price><drug id="02261731" sec3="Y"><name>Yasmin 28</name><manufacturerId>BAH</manufacturerId><individualPrice>11.6000</individualPrice><listingDate>2007-06-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00939"><name>ETHINYL ESTRADIOL &amp; ETHYNODIOL DIACETATE</name><pcgGroup><pcg9 id="683200051"><itemNumber>1458</itemNumber><strength>0.03mg &amp; 2mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>12.6152</price><drug id="00469327" sec3="Y"><name>Demulen 30</name><manufacturerId>PFI</manufacturerId><individualPrice>12.6152</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200052"><itemNumber>1459</itemNumber><strength>0.03mg &amp; 2mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>13.4992</price><drug id="00471526" sec3="Y"><name>Demulen 30</name><manufacturerId>PFI</manufacturerId><individualPrice>13.4992</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00945"><name>ETHINYL ESTRADIOL &amp; LEVONORGESTREL</name><pcgGroup><pcg9 id="683200102"><itemNumber>1460</itemNumber><strength>20mcg &amp; 100mcg</strength><dosageForm>Tab-21 Pk</dosageForm><price>9.7400</price><drug id="02236974" sec3="Y"><name>Alesse</name><manufacturerId>WAY</manufacturerId><individualPrice>13.8200</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02298538" sec3="Y"><name>Aviane 21</name><manufacturerId>BAR</manufacturerId><individualPrice>9.7400</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="683200064"><itemNumber>1461</itemNumber><strength>0.03mg &amp; 0.15mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>9.7400</price><drug id="02042320" sec3="Y"><name>Min-Ovral</name><manufacturerId>WAY</manufacturerId><individualPrice>13.8200</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02295946" sec3="Y"><name>Portia 21</name><manufacturerId>BAR</manufacturerId><individualPrice>9.7400</individualPrice><listingDate>2007-10-03</listingDate></drug></pcg9><pcg9 id="683200066"><itemNumber>1462</itemNumber><strength>3 Phase</strength><dosageForm>Tab-21 Pk</dosageForm><price>14.1500</price><drug id="00707600" sec3="Y"><name>Triquilar 21</name><manufacturerId>BAY</manufacturerId><individualPrice>14.1500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200103"><itemNumber>1463</itemNumber><strength>20mcg &amp; 100mcg</strength><dosageForm>Tab-28 Pk</dosageForm><price>9.7400</price><drug id="02236975" sec3="Y"><name>Alesse</name><manufacturerId>WAY</manufacturerId><individualPrice>13.8200</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02298546" sec3="Y"><name>Aviane 28</name><manufacturerId>BAR</manufacturerId><individualPrice>9.7400</individualPrice><listingDate>2008-01-15</listingDate></drug></pcg9><pcg9 id="683200065"><itemNumber>1464</itemNumber><strength>0.03mg &amp; 0.15mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>9.7400</price><drug id="02042339" sec3="Y"><name>Min-Ovral</name><manufacturerId>WAY</manufacturerId><individualPrice>13.8200</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02295954" sec3="Y"><name>Portia 28</name><manufacturerId>BAR</manufacturerId><individualPrice>9.7400</individualPrice><listingDate>2007-10-03</listingDate></drug></pcg9><pcg9 id="683200067"><itemNumber>1465</itemNumber><strength>3 Phase</strength><dosageForm>Tab-28 Pk</dosageForm><price>14.1500</price><drug id="00707503" sec3="Y"><name>Triquilar 28</name><manufacturerId>BAY</manufacturerId><individualPrice>14.1500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00944"><name>ETHINYL ESTRADIOL &amp; NORETHINDRONE</name><pcgGroup><pcg9 id="683200087"><itemNumber>1466</itemNumber><strength>0.035mg &amp; 0.5mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>16.3000</price><drug id="00317047" sec3="Y"><name>Ortho 0.5/35</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200089"><itemNumber>1467</itemNumber><strength>0.035mg &amp; 1mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>16.3000</price><drug id="00372846" sec3="Y"><name>Ortho 1/35</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200091"><itemNumber>1468</itemNumber><strength>3 Phase</strength><dosageForm>Tab-21 Pk</dosageForm><price>16.3000</price><drug id="00602957" sec3="Y"><name>Ortho 7/7/7</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200049"><itemNumber>1469</itemNumber><strength>0.035mg &amp; 0.5mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>11.5648</price><drug id="02187086" sec3="Y"><name>Brevicon</name><manufacturerId>PFI</manufacturerId><individualPrice>11.5648</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200053"><itemNumber>1470</itemNumber><strength>0.035mg &amp; 1mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>11.5648</price><drug id="02189054" sec3="Y"><name>Brevicon 1/35</name><manufacturerId>PFI</manufacturerId><individualPrice>11.5648</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200059"><itemNumber>1471</itemNumber><strength>3 Phase</strength><dosageForm>Tab-21 Pk</dosageForm><price>10.6288</price><drug id="02187108" sec3="Y"><name>Synphasic</name><manufacturerId>PFI</manufacturerId><individualPrice>10.6288</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200088"><itemNumber>1472</itemNumber><strength>0.035mg &amp; 0.5mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="00340731" sec3="Y"><name>Ortho 0.5/35</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200090"><itemNumber>1473</itemNumber><strength>0.035mg &amp; 1mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="00372838" sec3="Y"><name>Ortho 1/35</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200092"><itemNumber>1474</itemNumber><strength>3 Phase</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="00602965" sec3="Y"><name>Ortho 7/7/7</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200050"><itemNumber>1475</itemNumber><strength>0.035mg &amp; 0.5mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>11.5648</price><drug id="02187094" sec3="Y"><name>Brevicon</name><manufacturerId>PFI</manufacturerId><individualPrice>11.5648</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200054"><itemNumber>1476</itemNumber><strength>0.035mg &amp; 1mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>11.5648</price><drug id="02189062" sec3="Y"><name>Brevicon 1/35</name><manufacturerId>PFI</manufacturerId><individualPrice>11.5648</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200060"><itemNumber>1477</itemNumber><strength>3 Phase</strength><dosageForm>Tab-28 Pk</dosageForm><price>10.6288</price><drug id="02187116" sec3="Y"><name>Synphasic</name><manufacturerId>PFI</manufacturerId><individualPrice>10.6288</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00940"><name>ETHINYL ESTRADIOL &amp; NORETHINDRONE ACETATE</name><pcgGroup><pcg9 id="683200045"><itemNumber>1478</itemNumber><strength>0.02mg &amp; 1mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>12.7700</price><drug id="00315966" sec3="Y"><name>Minestrin 1/20</name><manufacturerId>PAL</manufacturerId><individualPrice>12.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200006"><itemNumber>1479</itemNumber><strength>0.03mg &amp; 1.5mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>12.7700</price><drug id="00297143" sec3="Y"><name>Loestrin 1.5/30</name><manufacturerId>PAL</manufacturerId><individualPrice>12.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200046"><itemNumber>1480</itemNumber><strength>0.02mg &amp; 1mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>12.7700</price><drug id="00343838" sec3="Y"><name>Minestrin 1/20</name><manufacturerId>PAL</manufacturerId><individualPrice>12.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200048"><itemNumber>1481</itemNumber><strength>0.03mg &amp; 1.5mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>12.7700</price><drug id="00353027" sec3="Y"><name>Loestrin 1.5/30</name><manufacturerId>PAL</manufacturerId><individualPrice>12.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00938"><name>ETHINYL ESTRADIOL &amp; NORGESTREL</name><pcgGroup><pcg9 id="683200001"><itemNumber>1482</itemNumber><strength>0.05mg &amp; 0.25mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>13.8200</price><drug id="02043033" sec3="Y"><name>Ovral</name><manufacturerId>WAY</manufacturerId><individualPrice>13.8200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00951"><name>LEVONORGESTREL</name><pcgGroup><pcg9 id="683200105"><itemNumber>1483</itemNumber><strength>52mg</strength><dosageForm>Insert</dosageForm><price>322.8300</price><drug id="02243005" sec3="Y"><name>Mirena</name><manufacturerId>BAY</manufacturerId><individualPrice>322.8300</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="683200104"><itemNumber>1484</itemNumber><strength>0.75mg</strength><dosageForm>Tab-2 Tabs Pk</dosageForm><price>17.2000</price><drug id="02241674" sec3="Y"><name>Plan B</name><manufacturerId>PAL</manufacturerId><individualPrice>17.2000</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00941"><name>MEDROXYPROGESTERONE ACETATE</name><pcgGroup><pcg9 id="683200084"><itemNumber>1485</itemNumber><strength>150mg/mL</strength><dosageForm>Inj</dosageForm><price>18.0000</price><drug id="00585092" sec3="Y"><name>Depo-Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>26.9880</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02322250" dinStatus="N" sec3="Y"><name>Medroxyprogesterone Acetate Inj Susp USP</name><manufacturerId>SDZ</manufacturerId><individualPrice>18.0000</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><pcg9 id="683200095"><itemNumber>1486</itemNumber><strength>50mg/mL</strength><dosageForm>Inj Sol-5mL Pk</dosageForm><price>25.1575</price><drug id="00030848" sec3="Y"><name>Depo-Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>25.1575</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200069"><itemNumber>1487</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.0630</price><drug id="00708917" sec3="Y"><name>Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>.1663</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02148552" dinStatus="E" sec3="Y"><name>Ratio-MPA</name><manufacturerId>RPH</manufacturerId><individualPrice>.0630</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02221284" sec3="Y"><name>Novo-Medrone</name><manufacturerId>NOP</manufacturerId><individualPrice>.0630</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02229838" dinStatus="E" sec3="Y"><name>Gen-Medroxy</name><manufacturerId>GEN</manufacturerId><individualPrice>.0630</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02244726" sec3="Y"><name>Apo-Medroxy</name><manufacturerId>APX</manufacturerId><individualPrice>.0630</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246627" sec3="Y"><name>PMS-Medroxyprogesterone</name><manufacturerId>PMS</manufacturerId><individualPrice>.0630</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="683200011"><itemNumber>1488</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.1246</price><drug id="00030937" sec3="Y"><name>Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>.3293</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02148560" dinStatus="E" sec3="Y"><name>Ratio-MPA</name><manufacturerId>RPH</manufacturerId><individualPrice>.1246</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02221292" sec3="Y"><name>Novo-Medrone</name><manufacturerId>NOP</manufacturerId><individualPrice>.1246</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02229839" sec3="Y"><name>Gen-Medroxy</name><manufacturerId>GEN</manufacturerId><individualPrice>.1246</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02244727" sec3="Y"><name>Apo-Medroxy</name><manufacturerId>APX</manufacturerId><individualPrice>.1246</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02246628" sec3="Y"><name>PMS-Medroxyprogesterone</name><manufacturerId>PMS</manufacturerId><individualPrice>.1246</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="683200061"><itemNumber>1489</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.2515</price><drug id="00729973" sec3="Y"><name>Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>.6681</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02148579" dinStatus="E" sec3="Y"><name>Ratio-MPA</name><manufacturerId>RPH</manufacturerId><individualPrice>.2516</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02221306" sec3="Y"><name>Novo-Medrone</name><manufacturerId>NOP</manufacturerId><individualPrice>.2516</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02229840" dinStatus="E" sec3="Y"><name>Gen-Medroxy</name><manufacturerId>GEN</manufacturerId><individualPrice>.2516</individualPrice><listingDate>1997-04-10</listingDate></drug><drug id="02246629" sec3="Y"><name>PMS-Medroxyprogesterone</name><manufacturerId>PMS</manufacturerId><individualPrice>.2516</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02277298" sec3="Y"><name>Apo-Medroxy</name><manufacturerId>APX</manufacturerId><individualPrice>.2515</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="683200077"><itemNumber>1490</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.6392</price><drug id="02010933" sec3="Y"><name>Provera-Pak</name><manufacturerId>PFI</manufacturerId><individualPrice>.6392</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200037"><itemNumber>1491</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.9153</price><drug id="00030945" sec3="Y"><name>Provera</name><manufacturerId>PFI</manufacturerId><individualPrice>1.2692</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02267640" sec3="Y"><name>Apo-Medroxy</name><manufacturerId>APX</manufacturerId><individualPrice>.9153</individualPrice><listingDate>2005-10-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00943"><name>NORETHINDRONE</name><pcgGroup><pcg9 id="683200031"><itemNumber>1492</itemNumber><strength>0.35mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="00037605" sec3="Y"><name>Micronor</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00949"><name>NORGESTIMATE &amp; ETHINYL ESTRADIOL</name><pcgGroup><pcg9 id="683200082"><itemNumber>1493</itemNumber><strength>3 Phase</strength><dosageForm>Tab-21 Pk</dosageForm><price>16.3000</price><drug id="02028700" sec3="Y"><name>Tri-Cyclen</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200109"><itemNumber>1494</itemNumber><strength>3 Phase</strength><dosageForm>Tab-21 Pk</dosageForm><price>12.2000</price><drug id="02258560" sec3="Y"><name>Tri-Cyclen Lo</name><manufacturerId>JNO</manufacturerId><individualPrice>12.2000</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="683200075"><itemNumber>1495</itemNumber><strength>0.25mg &amp; 0.035mg</strength><dosageForm>Tab-21 Pk</dosageForm><price>16.3000</price><drug id="01968440" sec3="Y"><name>Cyclen</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200083"><itemNumber>1496</itemNumber><strength>3 Phase</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="02029421" sec3="Y"><name>Tri-Cyclen</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683200110"><itemNumber>1497</itemNumber><strength>3 Phase</strength><dosageForm>Tab-28 Pk</dosageForm><price>12.2000</price><drug id="02258587" sec3="Y"><name>Tri-Cyclen Lo</name><manufacturerId>JNO</manufacturerId><individualPrice>12.2000</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="683200076"><itemNumber>1498</itemNumber><strength>0.25mg &amp; 0.035mg</strength><dosageForm>Tab-28 Pk</dosageForm><price>16.3000</price><drug id="01992872" sec3="Y"><name>Cyclen</name><manufacturerId>JNO</manufacturerId><individualPrice>16.3000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="683600000"><name>THYROIDS</name><genericName id="00953"><name>LEVOTHYROXINE (SODIUM)</name><pcgGroup><pcg9 id="683600016"><itemNumber>1499</itemNumber><strength>0.025mg</strength><dosageForm>Tab</dosageForm><price>.0865</price><drug id="02172062" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0865</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600004"><itemNumber>1500</itemNumber><strength>0.05mg</strength><dosageForm>Tab</dosageForm><price>.0280</price><drug id="02172070" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0594</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213192" sec3="Y"><name>Eltroxin</name><manufacturerId>GSK</manufacturerId><individualPrice>.0280</individualPrice><listingDate>1997-07-12</listingDate></drug></pcg9><pcg9 id="683600017"><itemNumber>1501</itemNumber><strength>0.075mg</strength><dosageForm>Tab</dosageForm><price>.0935</price><drug id="02172089" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0935</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600024"><itemNumber>1502</itemNumber><strength>0.088mg</strength><dosageForm>Tab</dosageForm><price>.0935</price><drug id="02172097" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0935</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="683600003"><itemNumber>1503</itemNumber><strength>0.1mg</strength><dosageForm>Tab</dosageForm><price>.0344</price><drug id="02172100" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0733</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213206" sec3="Y"><name>Eltroxin</name><manufacturerId>GSK</manufacturerId><individualPrice>.0344</individualPrice><listingDate>1997-07-12</listingDate></drug></pcg9><pcg9 id="683600018"><itemNumber>1504</itemNumber><strength>0.112mg</strength><dosageForm>Tab</dosageForm><price>.0989</price><drug id="02171228" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0989</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600019"><itemNumber>1505</itemNumber><strength>0.125mg</strength><dosageForm>Tab</dosageForm><price>.1000</price><drug id="02172119" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.1000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600011"><itemNumber>1506</itemNumber><strength>0.15mg</strength><dosageForm>Tab</dosageForm><price>.0381</price><drug id="02172127" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0788</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213214" sec3="Y"><name>Eltroxin</name><manufacturerId>GSK</manufacturerId><individualPrice>.0381</individualPrice><listingDate>1997-01-20</listingDate></drug></pcg9><pcg9 id="683600020"><itemNumber>1507</itemNumber><strength>0.175mg</strength><dosageForm>Tab</dosageForm><price>.1071</price><drug id="02172135" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.1071</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600002"><itemNumber>1508</itemNumber><strength>0.2mg</strength><dosageForm>Tab</dosageForm><price>.0404</price><drug id="02172143" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.0834</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213222" sec3="Y"><name>Eltroxin</name><manufacturerId>GSK</manufacturerId><individualPrice>.0404</individualPrice><listingDate>1997-01-20</listingDate></drug></pcg9><pcg9 id="683600001"><itemNumber>1509</itemNumber><strength>0.3mg</strength><dosageForm>Tab</dosageForm><price>.1154</price><drug id="02172151" sec3="Y"><name>Synthroid</name><manufacturerId>ABB</manufacturerId><individualPrice>.1154</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213230" notABenefit="Y" sec3="Y"><name>Eltroxin</name><manufacturerId>GLW</manufacturerId><listingDate>1997-01-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00955"><name>THYROID</name><pcgGroup><pcg9 id="683600010"><itemNumber>1510</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>.0663</price><drug id="00023949" sec3="Y"><name>Thyroid</name><manufacturerId>ERF</manufacturerId><individualPrice>.0663</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600009"><itemNumber>1511</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><price>.0816</price><drug id="00023957" sec3="Y"><name>Thyroid</name><manufacturerId>ERF</manufacturerId><individualPrice>.0816</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683600008"><itemNumber>1512</itemNumber><strength>125mg</strength><dosageForm>Tab</dosageForm><price>.1160</price><drug id="00023965" sec3="Y"><name>Thyroid</name><manufacturerId>ERF</manufacturerId><individualPrice>.1160</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="683800000"><name>ANTI-THYROIDS</name><genericName id="00959"><name>PROPYLTHIOURACIL</name><pcgGroup><pcg9 id="683800003"><itemNumber>1513</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.2118</price><drug id="00010200" sec3="Y"><name>Propyl-Thyracil</name><manufacturerId>PAL</manufacturerId><individualPrice>.2118</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="683800002"><itemNumber>1514</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.3314</price><drug id="00010219" sec3="Y"><name>Propyl-Thyracil</name><manufacturerId>PAL</manufacturerId><individualPrice>.3314</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="840000000"><name>SKIN AND MUCOUS MEMBRANE PREPARATIONS</name><pcg6 id="840404000"><name>ANTI-INFECTIVES ANTIBIOTICS</name><genericName id="01584"><name>CLINDAMYCIN PHOSPHATE &amp; BENZOYL PEROXIDE</name><pcgGroup><pcg9 id="840404028"><itemNumber>1515</itemNumber><strength>1% &amp; 5%</strength><dosageForm>Gel</dosageForm><price>.8878</price><drug id="02243158" sec3="Y"><name>Clindoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.8878</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="840404029"><itemNumber>1516</itemNumber><strength>1% &amp; 5%</strength><dosageForm>Top Gel</dosageForm><price>.8540</price><drug id="02248472" sec3="Y"><name>BenzaClin</name><manufacturerId>SAV</manufacturerId><individualPrice>.8540</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00097"><name>FUSIDIC ACID</name><pcgGroup><pcg9 id="840404006"><itemNumber>1517</itemNumber><strength>2%</strength><dosageForm>Cr</dosageForm><price>.5940</price><drug id="00586668" sec3="Y"><name>Fucidin</name><manufacturerId>LEO</manufacturerId><individualPrice>.5940</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00972"><name>MUPIROCIN</name><pcgGroup><pcg9 id="840404023"><itemNumber>1518</itemNumber><strength>2%</strength><dosageForm>Cr</dosageForm><price>.5233</price><drug id="02239757" sec3="Y"><name>Bactroban</name><manufacturerId>GSK</manufacturerId><individualPrice>.5233</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="840404008"><itemNumber>1519</itemNumber><strength>2%</strength><dosageForm>Oint</dosageForm><price>.3556</price><drug id="01916947" sec3="Y"><name>Bactroban</name><manufacturerId>GSK</manufacturerId><individualPrice>.5233</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02279983" sec3="Y"><name>Taro-Mupirocin</name><manufacturerId>TAR</manufacturerId><individualPrice>.3556</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00098"><name>SODIUM FUSIDATE</name><pcgGroup><pcg9 id="840404007"><itemNumber>1520</itemNumber><strength>2%</strength><dosageForm>Oint</dosageForm><price>.5940</price><drug id="00586676" sec3="Y"><name>Fucidin</name><manufacturerId>LEO</manufacturerId><individualPrice>.5940</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="840408000"><name>ANTI-INFECTIVES FUNGICIDES</name><note>Due to its efficacy and significantly lower cost, clotrimazole should be the first line of treatment for Tinea corporis and cruris. In Tinea pedis, topical terbinafine should be considered the first line of treatment due to its efficacy and lower rate of relapse.</note><genericName id="00981"><name>CLOTRIMAZOLE</name><pcgGroup><pcg9 id="840408012"><itemNumber>1521</itemNumber><strength>10mg/g</strength><dosageForm>Cr</dosageForm><price>.0884</price><drug id="00812382" sec3="Y"><name>Clotrimaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0884</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02150867" sec3="Y"><name>Canesten 1% Topical Cream</name><manufacturerId>BAY</manufacturerId><individualPrice>.0999</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408035"><itemNumber>1522</itemNumber><strength>500mg &amp; 1%</strength><dosageForm>Tab &amp; Cr</dosageForm><price>12.0800</price><drug id="02264102" sec3="Y"><name>Canesten 1 Comfortab Combi-Pak</name><manufacturerId>BAY</manufacturerId><individualPrice>12.0800</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="840408017"><itemNumber>1523</itemNumber><strength>10mg/g</strength><dosageForm>Vag Cr-App</dosageForm><price>.1750</price><drug id="00812366" sec3="Y"><name>Clotrimaderm Vaginal Cream</name><manufacturerId>TAR</manufacturerId><individualPrice>.1750</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02150891" sec3="Y"><name>Canesten 6 Cream</name><manufacturerId>BAY</manufacturerId><individualPrice>.2212</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408027"><itemNumber>1524</itemNumber><strength>20mg/g</strength><dosageForm>Vag Cr-App</dosageForm><price>.3500</price><drug id="00812374" sec3="Y"><name>Clotrimaderm Vaginal Cream</name><manufacturerId>TAR</manufacturerId><individualPrice>.3500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02150905" sec3="Y"><name>Canesten 3 Cream</name><manufacturerId>BAY</manufacturerId><individualPrice>.4424</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00983"><name>ECONAZOLE NITRATE</name><pcgGroup><pcg9 id="840408026"><itemNumber>1525</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.4407</price><drug id="02011948" dinStatus="E" sec3="Y"><name>Ecostatin</name><manufacturerId>BQU</manufacturerId><individualPrice>.4407</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408021"><itemNumber>1526</itemNumber><strength>150mg</strength><dosageForm>Vag Sup</dosageForm><price>5.9167</price><drug id="02010267" dinStatus="E" sec3="Y"><name>Ecostatin</name><manufacturerId>BQU</manufacturerId><individualPrice>5.9167</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00032"><name>FLUCONAZOLE</name><pcgGroup lccId="00116"><pcg9 id="840408048"><itemNumber>1527</itemNumber><strength>150mg</strength><dosageForm>Cap</dosageForm><price>7.2900</price><drug id="02141442" sec3="Y" sec12="Y"><name>Diflucan-150</name><manufacturerId>PFI</manufacturerId><individualPrice>15.7697</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02241895" sec3="Y" sec12="Y"><name>Apo-Fluconazole-150</name><manufacturerId>APX</manufacturerId><individualPrice>7.2900</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02245697" sec3="Y" sec12="Y"><name>Mylan-Fluconazole</name><manufacturerId>MYL</manufacturerId><individualPrice>7.2900</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02282348" sec3="Y" sec12="Y"><name>PMS-Fluconazole</name><manufacturerId>PMS</manufacturerId><individualPrice>7.2900</individualPrice><listingDate>2007-07-12</listingDate></drug><drug id="02323419" dinStatus="N" sec3="Y" sec12="Y"><name>Co Fluconazole-150</name><manufacturerId>COB</manufacturerId><individualPrice>7.2900</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="235">For the treatment of vaginal candidiasis. Dose: 150mg orally once daily for 1 day.</lccNote><lccNote seq="002" type="N">Repeats within a 25 day period will not be reimbursed.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="00027"><name>KETOCONAZOLE</name><pcgGroup><pcg9 id="840408034"><itemNumber>1528</itemNumber><strength>2%</strength><dosageForm>Cr</dosageForm><price>.3167</price><drug id="00703974" dinStatus="E" sec3="Y"><name>Nizoral</name><manufacturerId>JAN</manufacturerId><individualPrice>.4530</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245662" sec3="Y"><name>Ketoderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.3167</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00982"><name>MICONAZOLE NITRATE</name><pcgGroup><pcg9 id="840408015"><itemNumber>1529</itemNumber><strength>2%</strength><dosageForm>Cr</dosageForm><price>.2970</price><drug id="02085852" sec3="Y"><name>Micatin</name><manufacturerId>WEL</manufacturerId><individualPrice>.2970</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02126567" sec3="Y"><name>Monistat Derm</name><manufacturerId>OMC</manufacturerId><individualPrice>.2970</individualPrice><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="840408018"><itemNumber>1530</itemNumber><strength>2%</strength><dosageForm>Vag Cr-App 35g Pk</dosageForm><price>9.7800</price><drug id="02084309" sec3="Y"><name>Monistat 7</name><manufacturerId>MCL</manufacturerId><individualPrice>9.7800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408024"><itemNumber>1531</itemNumber><strength>400mg</strength><dosageForm>Vag Sup</dosageForm><price>3.2600</price><drug id="02126605" sec3="Y"><name>Monistat 3</name><manufacturerId>MCL</manufacturerId><individualPrice>3.2600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408031"><itemNumber>1532</itemNumber><strength>2% Cr-9g &amp; 400mg</strength><dosageForm>Vag Sup-3 Pk</dosageForm><price>11.2200</price><drug id="02126249" sec3="Y"><name>Monistat 3 Dual Pak</name><manufacturerId>MCL</manufacturerId><individualPrice>11.2200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00025"><name>NYSTATIN</name><pcgGroup><pcg9 id="840408004"><itemNumber>1533</itemNumber><strength>100000U/g</strength><dosageForm>Cr</dosageForm><price>.0700</price><drug id="00029092" notABenefit="Y" sec3="Y"><name>Mycostatin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716871" sec3="Y"><name>Nyaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02194236" sec3="Y"><name>Ratio-Nystatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.0700</individualPrice><listingDate>1997-10-31</listingDate></drug></pcg9><pcg9 id="840408005"><itemNumber>1534</itemNumber><strength>100000U/g</strength><dosageForm>Oint</dosageForm><price>.0903</price><note>Nystatin is not effective in the treatment of Dermatophyte infections or Tinea versicolor.</note><drug id="00029556" notABenefit="Y" sec3="Y"><name>Mycostatin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02194228" sec3="Y"><name>Ratio-Nystatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.0903</individualPrice><listingDate>1997-10-31</listingDate></drug></pcg9><pcg9 id="840408006"><itemNumber>1535</itemNumber><strength>25000U/g</strength><dosageForm>Vag Cr</dosageForm><price>.0492</price><drug id="00295973" notABenefit="Y" sec3="Y"><name>Mycostatin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716901" sec3="Y"><name>Nyaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0492</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840408010"><itemNumber>1536</itemNumber><strength>100000U/g</strength><dosageForm>Vag Cr</dosageForm><price>.2553</price><drug id="02194163" sec3="Y"><name>Ratio-Nystatin</name><manufacturerId>RPH</manufacturerId><individualPrice>.2553</individualPrice><listingDate>1997-10-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00030"><name>TERBINAFINE HCL</name><pcgGroup><pcg9 id="840408047"><itemNumber>1537</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.5090</price><drug id="02031094" sec3="Y"><name>Lamisil</name><manufacturerId>NOV</manufacturerId><individualPrice>.5090</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00985"><name>TERCONAZOLE</name><pcgGroup><pcg9 id="840408042"><itemNumber>1538</itemNumber><strength>0.4%</strength><dosageForm>Cr</dosageForm><price>.2726</price><drug id="00894729" sec3="Y"><name>Terazol 7</name><manufacturerId>JNO</manufacturerId><individualPrice>.4680</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02247651" sec3="Y"><name>Taro-Terconazole</name><manufacturerId>TAR</manufacturerId><individualPrice>.2726</individualPrice><listingDate>2005-06-13</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="840412000"><name>ANTI-INFECTIVES PARASITICIDES</name><note>All close contacts of patients with scabies should be treated regardless of symptoms to avoid reinfestation and unnecessary repeated treatments. The scabicide should be applied to all the skin from the neck down. Young children, the elderly and immunosuppressed patients may also require treatment of the head and scalp.</note><genericName id="01724"><name>ISOPROPYL MYRISTATE</name><pcgGroup><pcg9 id="840412018"><itemNumber>1539</itemNumber><strength>50%</strength><dosageForm>Top Sol-120mL Pk</dosageForm><price>12.2500</price><drug id="09857292" sec3="Y"><name>Resultz</name><manufacturerId>NYC</manufacturerId><individualPrice>12.2500</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9><pcg9 id="840412019"><itemNumber>1540</itemNumber><strength>50%</strength><dosageForm>Top Sol-240mL Pk</dosageForm><price>22.4200</price><drug id="02279592" sec3="Y"><name>Resultz</name><manufacturerId>NYC</manufacturerId><individualPrice>22.4200</individualPrice><listingDate>2008-02-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00989"><name>LINDANE (GAMMA BENZENE HEXACHLORIDE)</name><pcgGroup><pcg9 id="840412004"><itemNumber>1541</itemNumber><strength>1%</strength><dosageForm>Shampoo</dosageForm><drug id="00026220" notABenefit="Y" sec3="Y"><name>Kwellada</name><manufacturerId>RCA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00703605" notABenefit="Y" sec3="Y"><name>PMS-Lindane</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00993"><name>PERMETHRIN</name><pcgGroup lccId="00117"><pcg9 id="840412013"><itemNumber>1542</itemNumber><strength>5%</strength><dosageForm>Cr</dosageForm><price>.4736</price><drug id="02219905" sec3="Y" sec12="Y"><name>Nix Dermal Cream</name><manufacturerId>GSK</manufacturerId><individualPrice>.4736</individualPrice><listingDate>1998-10-21</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="311">For the treatment of patients who have failed on a less costly listed alternative.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup><pcgGroup><pcg9 id="840412010"><itemNumber>1543</itemNumber><strength>1%</strength><dosageForm>Cr Rinse</dosageForm><price>.0955</price><drug id="00771368" sec3="Y"><name>Nix</name><manufacturerId>BWE</manufacturerId><individualPrice>.0955</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840412015"><itemNumber>1544</itemNumber><strength>1%</strength><dosageForm>Cr Rinse</dosageForm><price>.0885</price><drug id="02231480" sec3="Y"><name>Kwellada-P</name><manufacturerId>GSK</manufacturerId><individualPrice>.0885</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="840412014"><itemNumber>1545</itemNumber><strength>5%</strength><dosageForm>Lot</dosageForm><price>.2560</price><drug id="02231348" sec3="Y"><name>Kwellada-P</name><manufacturerId>GSK</manufacturerId><individualPrice>.2560</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00992"><name>PYRETHRINS PIPERONYL BUTOXIDE &amp; PETROLEUM DISTILLATE</name><pcgGroup><pcg9 id="840412009"><itemNumber>1546</itemNumber><strength>0.3% &amp; 3% &amp; 1.2%</strength><dosageForm>Top Sol</dosageForm><price>.0819</price><drug id="02125447" sec3="Y"><name>R &amp; C Shampoo/Conditioner</name><manufacturerId>GSK</manufacturerId><individualPrice>.0819</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="840416000"><name>ANTI-INFECTIVES OTHER ANTI-INFECTIVES</name><genericName id="00029"><name>METRONIDAZOLE</name><pcgGroup><pcg9 id="840416038"><itemNumber>1547</itemNumber><strength>0.75%</strength><dosageForm>Cr</dosageForm><price>.6600</price><drug id="02226839" sec3="Y"><name>MetroCream</name><manufacturerId>GAC</manufacturerId><individualPrice>.6600</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="840416040"><itemNumber>1548</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.5083</price><drug id="02242919" sec3="Y"><name>Rosasol</name><manufacturerId>STI</manufacturerId><individualPrice>.5083</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="840416037"><itemNumber>1549</itemNumber><strength>1%</strength><dosageForm>Top Cr</dosageForm><price>.5180</price><drug id="02156091" sec3="Y"><name>Noritate</name><manufacturerId>SAV</manufacturerId><individualPrice>.5180</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="840416036"><itemNumber>1550</itemNumber><strength>0.75%</strength><dosageForm>Top Gel</dosageForm><price>.6600</price><drug id="02092832" sec3="Y"><name>Metrogel</name><manufacturerId>GAC</manufacturerId><individualPrice>.6600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840416043"><itemNumber>1551</itemNumber><strength>1%</strength><dosageForm>Top Gel</dosageForm><price>.6000</price><drug id="02297809" dinStatus="N" sec3="Y"><name>Metrogel</name><manufacturerId>GAC</manufacturerId><individualPrice>.6000</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="840416041"><itemNumber>1552</itemNumber><strength>0.75%</strength><dosageForm>Top Lot</dosageForm><price>.6600</price><drug id="02248206" sec3="Y"><name>MetroLotion</name><manufacturerId>GAC</manufacturerId><individualPrice>.6600</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="840416004"><itemNumber>1553</itemNumber><strength>10%</strength><dosageForm>Vag Cr-App</dosageForm><price>.2224</price><drug id="01926861" sec3="Y"><name>Flagyl</name><manufacturerId>SAV</manufacturerId><individualPrice>.2224</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00998"><name>METRONIDAZOLE &amp; NYSTATIN</name><pcgGroup><pcg9 id="840416018"><itemNumber>1554</itemNumber><strength>500mg &amp; 100000U/g</strength><dosageForm>Vag Cr-App</dosageForm><price>.5439</price><drug id="01926845" sec3="Y"><name>Flagystatin</name><manufacturerId>SAV</manufacturerId><individualPrice>.5439</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840416020"><itemNumber>1555</itemNumber><strength>500mg &amp; 100000U</strength><dosageForm>Vag Sup</dosageForm><price>2.9912</price><drug id="01926829" sec3="Y"><name>Flagystatin</name><manufacturerId>SAV</manufacturerId><individualPrice>2.9912</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00997"><name>POVIDONE - IODINE</name><pcgGroup><pcg9 id="840416007" suppliedBy="L"><itemNumber>1556</itemNumber><strength>10%</strength><dosageForm>Top Sol</dosageForm><drug id="00158348" notABenefit="Y" selfMed="Y" sec3="Y"><name>Betadine</name><manufacturerId>PFP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00172944" notABenefit="Y" selfMed="Y" sec3="Y"><name>Proviodine</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840416006"><itemNumber>1557</itemNumber><strength>10%</strength><dosageForm>Vag Gel</dosageForm><drug id="00026034" notABenefit="Y" sec3="Y"><name>Betadine</name><manufacturerId>PFP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00026611" notABenefit="Y" sec3="Y"><name>Proviodine</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840416008"><itemNumber>1558</itemNumber><strength>10%</strength><dosageForm>Vag Sol</dosageForm><drug id="00026093" notABenefit="Y" sec3="Y"><name>Betadine</name><manufacturerId>PFP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00252824" notABenefit="Y" sec3="Y"><name>Proviodine</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00999"><name>SILVER SULFADIAZINE</name><pcgGroup><pcg9 id="840416023"><itemNumber>1559</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.1320</price><drug id="00323098" sec3="Y"><name>Flamazine</name><manufacturerId>SNE</manufacturerId><individualPrice>.1320</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840416039"><itemNumber>1560</itemNumber><strength>1%</strength><dosageForm>Cr-50g Pk</dosageForm><price>10.9600</price><drug id="09854037" sec3="Y"><name>Flamazine</name><manufacturerId>SNE</manufacturerId><individualPrice>10.9600</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="840600000"><name>ANTI-INFLAMMATORY</name><genericName id="01020"><name>AMCINONIDE</name><pcgGroup><pcg9 id="840600064"><itemNumber>1561</itemNumber><strength>0.1%</strength><dosageForm>Cr</dosageForm><price>.1955</price><drug id="02192284" sec3="Y"><name>Cyclocort</name><manufacturerId>STI</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1998-03-17</listingDate></drug><drug id="02246714" sec3="Y"><name>Taro-Amcinonide</name><manufacturerId>TAR</manufacturerId><individualPrice>.1955</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02247098" sec3="Y"><name>Ratio-Amcinonide</name><manufacturerId>RPH</manufacturerId><individualPrice>.1955</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="840600076"><itemNumber>1562</itemNumber><strength>0.1%</strength><dosageForm>Lot</dosageForm><price>.2270</price><drug id="02192276" sec3="Y"><name>Cyclocort</name><manufacturerId>STI</manufacturerId><individualPrice>.3443</individualPrice><listingDate>1998-03-17</listingDate></drug><drug id="02247097" sec3="Y"><name>Ratio-Amcinonide</name><manufacturerId>RPH</manufacturerId><individualPrice>.2270</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="840600075"><itemNumber>1563</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>.2740</price><drug id="02192268" sec3="Y"><name>Cyclocort</name><manufacturerId>STI</manufacturerId><individualPrice>.4147</individualPrice><listingDate>1998-03-17</listingDate></drug><drug id="02247096" sec3="Y"><name>Ratio-Amcinonide</name><manufacturerId>RPH</manufacturerId><individualPrice>.2740</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00687"><name>BECLOMETHASONE DIPROPIONATE</name><pcgGroup><pcg9 id="840600001"><itemNumber>1564</itemNumber><strength>0.025%</strength><dosageForm>Cr</dosageForm><price>.4371</price><drug id="02089602" sec3="Y"><name>Propaderm</name><manufacturerId>PAL</manufacturerId><individualPrice>.4371</individualPrice><listingDate>1998-11-17</listingDate></drug></pcg9><pcg9 id="840600002"><itemNumber>1565</itemNumber><strength>0.025%</strength><dosageForm>Oint</dosageForm><price>.4038</price><drug id="01927957" sec3="Y"><name>Propaderm</name><manufacturerId>GLA</manufacturerId><individualPrice>.4038</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01015"><name>BETAMETHASONE DIPROPIONATE</name><pcgGroup><pcg9 id="840600042"><itemNumber>1566</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.2048</price><drug id="00323071" sec3="Y"><name>Diprosone</name><manufacturerId>SCH</manufacturerId><individualPrice>.2048</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01925350" sec3="Y"><name>Taro-Sone</name><manufacturerId>TAR</manufacturerId><individualPrice>.2048</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600048"><itemNumber>1567</itemNumber><strength>0.05%</strength><dosageForm>Lot</dosageForm><price>.1980</price><drug id="00417246" sec3="Y"><name>Diprosone</name><manufacturerId>SCH</manufacturerId><individualPrice>.1980</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00809187" sec3="Y"><name>Ratio-Topisone</name><manufacturerId>RPH</manufacturerId><individualPrice>.1980</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600047"><itemNumber>1568</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.2152</price><drug id="00344923" sec3="Y"><name>Diprosone</name><manufacturerId>SCH</manufacturerId><individualPrice>.2152</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00805009" sec3="Y"><name>Ratio-Topisone</name><manufacturerId>RPH</manufacturerId><individualPrice>.2152</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01026"><name>BETAMETHASONE DIPROPIONATE IN A BASE CONTAINING PROPYLENE GLYCOL</name><pcgGroup><pcg9 id="840600094"><itemNumber>1569</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.5186</price><note>No more than 50 grams per week of ultrapotent steroids for a maximum of 2 weeks is recommended.</note><drug id="00629367" sec3="Y"><name>Diprolene</name><manufacturerId>SCH</manufacturerId><individualPrice>.5186</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00849669" sec3="Y"><name>Ratio-Topilene</name><manufacturerId>RPH</manufacturerId><individualPrice>.5186</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01027"><name>BETAMETHASONE DIPROPIONATE IN PROPYLENE GLYCOL BASE</name><pcgGroup><pcg9 id="840600105"><itemNumber>1570</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.5186</price><note>No more than 50 grams per week of ultrapotent steroids for a maximum of 2 weeks is recommended.</note><drug id="00688622" sec3="Y"><name>Diprolene Glycol</name><manufacturerId>SCH</manufacturerId><individualPrice>.5186</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00849650" sec3="Y"><name>Ratio-Topilene</name><manufacturerId>RPH</manufacturerId><individualPrice>.5186</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01007"><name>BETAMETHASONE VALERATE</name><pcgGroup><pcg9 id="840600007"><itemNumber>1571</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.0611</price><drug id="00011916" notABenefit="Y" sec3="Y"><name>Betnovate-1/2</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00027898" notABenefit="Y" sec3="Y"><name>Celestoderm-V/2</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00535427" sec3="Y"><name>Ratio-Ectosone Mild</name><manufacturerId>RPH</manufacturerId><individualPrice>.0611</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00716618" notABenefit="Y" sec3="Y"><name>Betaderm</name><manufacturerId>TAR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600004"><itemNumber>1572</itemNumber><strength>0.1%</strength><dosageForm>Cr</dosageForm><price>.0911</price><drug id="00011924" notABenefit="Y" sec3="Y"><name>Betnovate</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00027901" notABenefit="Y" sec3="Y"><name>Celestoderm-V</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00535435" sec3="Y"><name>Ratio-Ectosone Regular</name><manufacturerId>RPH</manufacturerId><individualPrice>.0911</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00716626" notABenefit="Y" sec3="Y"><name>Betaderm</name><manufacturerId>TAR</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600009"><itemNumber>1573</itemNumber><strength>0.05%</strength><dosageForm>Lot</dosageForm><price>.1900</price><drug id="00653209" sec3="Y"><name>Ratio-Ectosone Mild</name><manufacturerId>RPH</manufacturerId><individualPrice>.1900</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100185" notABenefit="Y" sec3="Y"><name>Betnovate-1/2</name><manufacturerId>RBT</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600006"><itemNumber>1574</itemNumber><strength>0.1%</strength><dosageForm>Lot</dosageForm><price>.2500</price><drug id="00750050" sec3="Y"><name>Ratio-Ectosone Regular</name><manufacturerId>RPH</manufacturerId><individualPrice>.2500</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02100193" notABenefit="Y" sec3="Y"><name>Betnovate</name><manufacturerId>SHI</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600008"><itemNumber>1575</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.0606</price><drug id="00012378" notABenefit="Y" sec3="Y"><name>Betnovate-1/2</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00028355" notABenefit="Y" sec3="Y"><name>Celestoderm-V/2</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716642" sec3="Y"><name>Betaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0606</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600005"><itemNumber>1576</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>.0903</price><drug id="00012386" notABenefit="Y" sec3="Y"><name>Betnovate</name><manufacturerId>GLA</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00028363" notABenefit="Y" sec3="Y"><name>Celestoderm-V</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716650" sec3="Y"><name>Betaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0903</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600035"><itemNumber>1577</itemNumber><strength>0.1%</strength><dosageForm>Scalp Lot</dosageForm><price>.0853</price><drug id="00027944" sec3="Y"><name>Valisone</name><manufacturerId>VAE</manufacturerId><individualPrice>.0853</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00653217" sec3="Y"><name>Ratio-Ectosone</name><manufacturerId>RPH</manufacturerId><individualPrice>.0853</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00716634" sec3="Y"><name>Betaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0853</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01729"><name>CALCIPOTRIOL &amp; BETAMETHASONE DIPROPIONATE</name><pcgGroup><pcg9 id="840600151"><itemNumber>1578</itemNumber><strength>50mcg/g &amp; 0.5mg/g</strength><dosageForm>Oint</dosageForm><price>1.6000</price><note>Note: For use in patients with psoriasis who have failed 1st line topical steroids and Dovonex (calcipotriol) therapy.</note><drug id="02244126" sec3="Y"><name>Dovobet</name><manufacturerId>LEO</manufacturerId><individualPrice>1.6000</individualPrice><listingDate>2008-05-16</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01019"><name>CLOBETASOL PROPIONATE</name><note>No more than 50 grams per week of ultrapotent steroids for a maximum of 2 weeks is recommended.</note><pcgGroup><pcg9 id="840600061"><itemNumber>1579</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.3256</price><drug id="01910272" sec3="Y"><name>Ratio-Clobetasol</name><manufacturerId>RPH</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02024187" sec3="Y"><name>Gen-Clobetasol</name><manufacturerId>GEN</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02093162" sec3="Y"><name>Novo-Clobetasol</name><manufacturerId>NOP</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02213265" sec3="Y"><name>Dermovate</name><manufacturerId>TPH</manufacturerId><individualPrice>.6512</individualPrice><listingDate>1998-05-21</listingDate></drug><drug id="02232191" sec3="Y"><name>PMS-Clobetasol</name><manufacturerId>PMS</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02245523" sec3="Y"><name>Taro-Clobetasol Cream USP</name><manufacturerId>TAR</manufacturerId><individualPrice>.3256</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="840600062"><itemNumber>1580</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.3256</price><drug id="01910280" sec3="Y"><name>Ratio-Clobetasol</name><manufacturerId>RPH</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02026767" sec3="Y"><name>Gen-Clobetasol</name><manufacturerId>GEN</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02126192" sec3="Y"><name>Novo-Clobetasol</name><manufacturerId>NOP</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02213273" sec3="Y"><name>Dermovate</name><manufacturerId>TPH</manufacturerId><individualPrice>.6512</individualPrice><listingDate>1998-05-02</listingDate></drug><drug id="02232193" sec3="Y"><name>PMS-Clobetasol</name><manufacturerId>PMS</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02245524" sec3="Y"><name>Taro-Clobetasol Ointment USP</name><manufacturerId>TAR</manufacturerId><individualPrice>.3256</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="840600070"><itemNumber>1581</itemNumber><strength>0.05%</strength><dosageForm>Scalp Lot</dosageForm><price>.2843</price><drug id="01910299" sec3="Y"><name>Ratio-Clobetasol</name><manufacturerId>RPH</manufacturerId><individualPrice>.2843</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02213281" sec3="Y"><name>Dermovate</name><manufacturerId>TPH</manufacturerId><individualPrice>.5685</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02216213" sec3="Y"><name>Gen-Clobetasol</name><manufacturerId>GEN</manufacturerId><individualPrice>.2843</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02232195" sec3="Y"><name>PMS-Clobetasol</name><manufacturerId>PMS</manufacturerId><individualPrice>.2843</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02245522" sec3="Y"><name>Taro-Clobetasol Topical Solution USP</name><manufacturerId>TAR</manufacturerId><individualPrice>.2843</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01017"><name>CLOBETASONE BUTYRATE</name><pcgGroup><pcg9 id="840600056"><itemNumber>1582</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.3893</price><drug id="02214415" sec3="Y"><name>Eumovate</name><manufacturerId>GSK</manufacturerId><individualPrice>.3893</individualPrice><listingDate>1997-01-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01016"><name>DESONIDE</name><pcgGroup><pcg9 id="840600043"><itemNumber>1583</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.2610</price><drug id="02048639" dinStatus="E" sec3="Y"><name>Desocort</name><manufacturerId>GAC</manufacturerId><individualPrice>.2900</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02154862" notABenefit="Y" sec3="Y"><name>Tridesilon</name><manufacturerId>CPL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02229315" sec3="Y"><name>PMS-Desonide</name><manufacturerId>PMS</manufacturerId><individualPrice>.2610</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="840600138"><itemNumber>1584</itemNumber><strength>0.05%</strength><dosageForm>Lot</dosageForm><price>.1450</price><drug id="02115514" sec3="Y"><name>Desocort</name><manufacturerId>GAC</manufacturerId><individualPrice>.1450</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600045"><itemNumber>1585</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.2610</price><drug id="02115522" sec3="Y"><name>Desocort</name><manufacturerId>GAC</manufacturerId><individualPrice>.2900</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02154870" notABenefit="Y" sec3="Y"><name>Tridesilon</name><manufacturerId>CPL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02229323" sec3="Y"><name>PMS-Desonide</name><manufacturerId>PMS</manufacturerId><individualPrice>.2610</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01025"><name>DIFLUCORTOLONE VALERATE</name><pcgGroup><pcg9 id="840600091"><itemNumber>1586</itemNumber><strength>0.1%</strength><dosageForm>Cr</dosageForm><price>.3853</price><drug id="00587826" sec3="Y"><name>Nerisone</name><manufacturerId>STI</manufacturerId><individualPrice>.3853</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600092"><itemNumber>1587</itemNumber><strength>0.1%</strength><dosageForm>Oily Cr</dosageForm><price>.3853</price><drug id="00587818" sec3="Y"><name>Nerisone</name><manufacturerId>STI</manufacturerId><individualPrice>.3853</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600093"><itemNumber>1588</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>.3853</price><drug id="00587834" sec3="Y"><name>Nerisone</name><manufacturerId>STI</manufacturerId><individualPrice>.3853</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01009"><name>FLUOCINOLONE ACETONIDE</name><pcgGroup><pcg9 id="840600014"><itemNumber>1589</itemNumber><strength>0.01%</strength><dosageForm>Cr</dosageForm><price>.2387</price><drug id="00030414" dinStatus="E" sec3="Y"><name>Synalar Mild</name><manufacturerId>SYN</manufacturerId><individualPrice>.2387</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01010"><name>FLUOCINONIDE</name><pcgGroup><pcg9 id="840600017"><itemNumber>1590</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.2617</price><drug id="00716863" sec3="Y"><name>Lyderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.2617</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02161923" notABenefit="Y" sec3="Y"><name>Lidex</name><manufacturerId>MEC</manufacturerId><listingDate>1999-01-20</listingDate></drug></pcg9><pcg9 id="840600069"><itemNumber>1591</itemNumber><strength>0.05%</strength><dosageForm>Emol Cr</dosageForm><price>.2433</price><drug id="00598933" sec3="Y"><name>Tiamol</name><manufacturerId>TAR</manufacturerId><individualPrice>.2433</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02163152" notABenefit="Y" sec3="Y"><name>Lidemol</name><manufacturerId>MEC</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600044"><itemNumber>1592</itemNumber><strength>0.05%</strength><dosageForm>Gel</dosageForm><price>.3418</price><drug id="02161974" notABenefit="Y" sec3="Y"><name>Topsyn</name><manufacturerId>MEC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02236997" sec3="Y"><name>Lyderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.3418</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="840600100"><itemNumber>1593</itemNumber><strength>0.05%</strength><dosageForm>Oint</dosageForm><price>.3373</price><drug id="02161966" notABenefit="Y" sec3="Y"><name>Lidex</name><manufacturerId>MEC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02236996" sec3="Y"><name>Lyderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.3373</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01028"><name>FLUOCINONIDE &amp; PROCINONIDE &amp; CIPROCINONIDE</name><pcgGroup><pcg9 id="840600108"><itemNumber>1594</itemNumber><dosageForm>Emol Cr</dosageForm><price>.3256</price><drug id="00781371" dinStatus="E" sec3="Y"><name>Trisyn</name><manufacturerId>BAK</manufacturerId><individualPrice>.3256</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00823"><name>HYDROCORTISONE</name><pcgGroup><pcg9 id="840600054"><itemNumber>1595</itemNumber><strength>0.5%</strength><dosageForm>Cr</dosageForm><price>.1333</price><drug id="00513288" sec3="Y"><name>Cortate</name><manufacturerId>SCH</manufacturerId><individualPrice>.1333</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600025"><itemNumber>1596</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.1678</price><drug id="00192597" sec3="Y"><name>Emo-Cort</name><manufacturerId>STI</manufacturerId><individualPrice>.1678</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00502200" notABenefit="Y" sec3="Y"><name>Cortate</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600082"><itemNumber>1597</itemNumber><strength>2.5%</strength><dosageForm>Cr</dosageForm><price>.1949</price><drug id="00595799" sec3="Y"><name>Emo-Cort</name><manufacturerId>STI</manufacturerId><individualPrice>.1949</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600071"><itemNumber>1598</itemNumber><strength>1%</strength><dosageForm>Lot</dosageForm><price>.1550</price><drug id="00192600" sec3="Y"><name>Emo-Cort</name><manufacturerId>STI</manufacturerId><individualPrice>.1550</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600083"><itemNumber>1599</itemNumber><strength>2.5%</strength><dosageForm>Lot</dosageForm><price>.2050</price><drug id="00595802" sec3="Y"><name>Emo-Cort</name><manufacturerId>STI</manufacturerId><individualPrice>.2050</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600027"><itemNumber>1600</itemNumber><strength>0.5%</strength><dosageForm>Oint</dosageForm><price>.1333</price><drug id="00513261" sec3="Y"><name>Cortate</name><manufacturerId>SCH</manufacturerId><individualPrice>.1333</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00716685" dinStatus="E" sec3="Y"><name>Cortoderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.1400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600026"><itemNumber>1601</itemNumber><strength>1%</strength><dosageForm>Oint</dosageForm><price>.0390</price><drug id="00502197" notABenefit="Y" sec3="Y"><name>Cortate</name><manufacturerId>SCH</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716693" sec3="Y"><name>Cortoderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0390</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01023"><name>HYDROCORTISONE ACETATE</name><pcgGroup><pcg9 id="840600077"><itemNumber>1602</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>.0364</price><drug id="00477699" notABenefit="Y" sec3="Y"><name>Corticreme</name><manufacturerId>ROG</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716839" sec3="Y"><name>Hyderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0364</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01022"><name>HYDROCORTISONE ACETATE &amp; UREA</name><pcgGroup><pcg9 id="840600074"><itemNumber>1603</itemNumber><strength>1% &amp; 10%</strength><dosageForm>Cr</dosageForm><price>.1627</price><drug id="00503134" sec3="Y"><name>Uremol-HC</name><manufacturerId>STI</manufacturerId><individualPrice>.1627</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600079"><itemNumber>1604</itemNumber><strength>1% &amp; 10%</strength><dosageForm>Lot</dosageForm><price>.0948</price><drug id="00560022" sec3="Y"><name>Uremol-HC</name><manufacturerId>STI</manufacturerId><individualPrice>.0948</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01018"><name>HYDROCORTISONE VALERATE</name><pcgGroup><pcg9 id="840600060"><itemNumber>1605</itemNumber><strength>0.2%</strength><dosageForm>Cr</dosageForm><price>.1212</price><drug id="01910124" dinStatus="E" sec3="Y"><name>Westcort</name><manufacturerId>BQU</manufacturerId><individualPrice>.1212</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02242984" sec3="Y"><name>Hydroval</name><manufacturerId>TPH</manufacturerId><individualPrice>.1212</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="840600084"><itemNumber>1606</itemNumber><strength>0.2%</strength><dosageForm>Oint</dosageForm><price>.1212</price><drug id="02242985" sec3="Y"><name>Hydroval</name><manufacturerId>TPH</manufacturerId><individualPrice>.1212</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01029"><name>MOMETASONE FUROATE</name><pcgGroup><pcg9 id="840600109"><itemNumber>1607</itemNumber><strength>0.1%</strength><dosageForm>Cr</dosageForm><price>.7153</price><drug id="00851744" sec3="Y"><name>Elocom</name><manufacturerId>SCH</manufacturerId><individualPrice>.7153</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600111"><itemNumber>1608</itemNumber><strength>0.1%</strength><dosageForm>Lot</dosageForm><price>.4798</price><drug id="00871095" sec3="Y"><name>Elocom</name><manufacturerId>SCH</manufacturerId><individualPrice>.4798</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="840600110"><itemNumber>1609</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>.2771</price><drug id="00851736" sec3="Y"><name>Elocom</name><manufacturerId>SCH</manufacturerId><individualPrice>.6434</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02248130" sec3="Y"><name>Ratio-Mometasone</name><manufacturerId>RPH</manufacturerId><individualPrice>.2771</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02264749" sec3="Y"><name>Taro-Mometasone</name><manufacturerId>TAR</manufacturerId><individualPrice>.2771</individualPrice><listingDate>2005-12-06</listingDate></drug><drug id="02270862" sec3="Y"><name>PMS-Mometasone</name><manufacturerId>PMS</manufacturerId><individualPrice>.2771</individualPrice><listingDate>2006-08-24</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00695"><name>TRIAMCINOLONE ACETONIDE</name><pcgGroup><pcg9 id="840600029"><itemNumber>1610</itemNumber><strength>0.1%</strength><dosageForm>Cr</dosageForm><price>.0533</price><drug id="00029114" notABenefit="Y" sec3="Y"><name>Kenalog</name><manufacturerId>WSQ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00716960" sec3="Y"><name>Triaderm</name><manufacturerId>TAR</manufacturerId><individualPrice>.0533</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02194058" sec3="Y"><name>Aristocort R</name><manufacturerId>VAE</manufacturerId><individualPrice>.0533</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9><pcg9 id="840600030"><itemNumber>1611</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>.1300</price><drug id="01999796" notABenefit="Y" sec3="Y"><name>Kenalog</name><manufacturerId>WSQ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02194031" sec3="Y"><name>Aristocort R</name><manufacturerId>VAE</manufacturerId><individualPrice>.1300</individualPrice><listingDate>1998-03-17</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01012"><name>TRIAMCINOLONE ACETONIDE 0.1% IN ORABASE</name><pcgGroup><pcg9 id="840600034"><itemNumber>1612</itemNumber><dosageForm>Oral Top Oint</dosageForm><price>.9110</price><drug id="01964054" sec3="Y"><name>Oracort</name><manufacturerId>TAR</manufacturerId><individualPrice>.9110</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01999788" notABenefit="Y" sec3="Y"><name>Kenalog-Orabase</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="842800000"><name>KERATOLYTIC AGENTS</name><genericName id="01057"><name>BENZOYL PEROXIDE</name><pcgGroup><pcg9 id="842800002"><itemNumber>1613</itemNumber><strength>5%</strength><dosageForm>Lot</dosageForm><price>.1333</price><drug id="00236063" sec3="Y"><name>Benoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1333</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800006"><itemNumber>1614</itemNumber><strength>10%</strength><dosageForm>Lot</dosageForm><price>.1812</price><drug id="00370568" sec3="Y"><name>Benoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1812</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800001"><itemNumber>1615</itemNumber><strength>20%</strength><dosageForm>Lot</dosageForm><price>.2013</price><drug id="00187585" sec3="Y"><name>Benoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.2013</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01060"><name>BENZOYL PEROXIDE IN ACETONE-CONTAINING GEL</name><pcgGroup><pcg9 id="842800018"><itemNumber>1616</itemNumber><strength>5%</strength><dosageForm>Gel</dosageForm><price>.1158</price><drug id="00406821" dinStatus="E" sec3="Y"><name>AcetOxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1158</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800017"><itemNumber>1617</itemNumber><strength>10%</strength><dosageForm>Gel</dosageForm><price>.1375</price><drug id="00406848" dinStatus="E" sec3="Y"><name>AcetOxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1375</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01061"><name>BENZOYL PEROXIDE IN ALCOHOL-CONTAINING GEL</name><pcgGroup><pcg9 id="842800022"><itemNumber>1618</itemNumber><strength>5%</strength><dosageForm>Gel</dosageForm><price>.1243</price><drug id="00263702" sec3="Y"><name>Panoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1243</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800021"><itemNumber>1619</itemNumber><strength>10%</strength><dosageForm>Gel</dosageForm><price>.1458</price><drug id="00263699" sec3="Y"><name>Panoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1458</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800019"><itemNumber>1620</itemNumber><strength>20%</strength><dosageForm>Gel</dosageForm><price>.1900</price><drug id="00373036" sec3="Y"><name>Panoxyl</name><manufacturerId>STI</manufacturerId><individualPrice>.1900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01062"><name>BENZOYL PEROXIDE IN WATER-BASED GEL</name><pcgGroup><pcg9 id="842800024"><itemNumber>1621</itemNumber><strength>5%</strength><dosageForm>Gel</dosageForm><price>.1243</price><drug id="01908863" notABenefit="Y" sec3="Y"><name>Desquam-X5</name><manufacturerId>WSQ</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01925180" sec3="Y"><name>Benzac W5</name><manufacturerId>GAC</manufacturerId><individualPrice>.1250</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02214849" sec3="Y"><name>Panoxyl Aquagel</name><manufacturerId>STI</manufacturerId><individualPrice>.1243</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01058"><name>TRETINOIN</name><pcgGroup lccId="00118"><pcg9 id="842800045"><itemNumber>1622</itemNumber><strength>0.01%</strength><dosageForm>Cr</dosageForm><price>.2924</price><drug id="00657204" sec3="Y" sec12="Y"><name>Stieva-A</name><manufacturerId>STI</manufacturerId><individualPrice>.2924</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800038"><itemNumber>1623</itemNumber><strength>0.025%</strength><dosageForm>Cr</dosageForm><price>.2924</price><drug id="00578576" sec3="Y" sec12="Y"><name>Stieva-A</name><manufacturerId>STI</manufacturerId><individualPrice>.2924</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800013"><itemNumber>1624</itemNumber><strength>0.05%</strength><dosageForm>Cr</dosageForm><price>.2840</price><drug id="00518182" sec3="Y" sec12="Y"><name>Stieva-A</name><manufacturerId>STI</manufacturerId><individualPrice>.2924</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01926519" dinStatus="E" sec3="Y" sec12="Y"><name>Vitamin A Acid</name><manufacturerId>SAV</manufacturerId><individualPrice>.2840</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800031"><itemNumber>1625</itemNumber><strength>0.01%</strength><dosageForm>Gel</dosageForm><price>.2840</price><drug id="01926462" sec3="Y" sec12="Y"><name>Vitamin A Acid</name><manufacturerId>SAV</manufacturerId><individualPrice>.2840</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800037"><itemNumber>1626</itemNumber><strength>0.025%</strength><dosageForm>Gel</dosageForm><price>.2924</price><drug id="00587966" sec3="Y" sec12="Y"><name>Stieva-A</name><manufacturerId>STI</manufacturerId><individualPrice>.2924</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800010"><itemNumber>1627</itemNumber><strength>0.05%</strength><dosageForm>Gel</dosageForm><price>.2840</price><drug id="01926489" sec3="Y" sec12="Y"><name>Vitamin A Acid</name><manufacturerId>SAV</manufacturerId><individualPrice>.2840</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="842800039"><itemNumber>1628</itemNumber><strength>0.025%</strength><dosageForm>Sol</dosageForm><price>.1832</price><drug id="00578568" sec3="Y" sec12="Y"><name>Stieva-A</name><manufacturerId>STI</manufacturerId><individualPrice>.1832</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="269">For the treatment of acne vulgaris.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01064"><name>TRETINOIN &amp; ERYTHROMYCIN</name><pcgGroup><pcg9 id="842800047"><itemNumber>1629</itemNumber><strength>0.025% &amp; 4%</strength><dosageForm>Top Gel</dosageForm><price>.5356</price><drug id="01905112" sec3="Y"><name>Stievamycin Gel</name><manufacturerId>STI</manufacturerId><individualPrice>.5356</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="843600000"><name>MISCELLANEOUS SKIN AND MUCOUS MEMBRANE AGENTS</name><genericName id="01106"><name>ACITRETIN</name><note>This drug should be used with extreme caution in females of childbearing potential due to its teratogenicity. Effective contraception must be practised for at least 2 years following discontinuation.</note><pcgGroup><pcg9 id="843600067"><itemNumber>1630</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>1.7703</price><drug id="02070847" sec3="Y"><name>Soriatane</name><manufacturerId>AGP</manufacturerId><individualPrice>1.7703</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="843600068"><itemNumber>1631</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>3.1093</price><drug id="02070863" sec3="Y"><name>Soriatane</name><manufacturerId>AGP</manufacturerId><individualPrice>3.1093</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01089"><name>CALCIPOTRIOL</name><pcgGroup lccId="00119"><pcg9 id="843600069"><itemNumber>1632</itemNumber><strength>50mcg/g</strength><dosageForm>Cr</dosageForm><price>.7533</price><drug id="02150956" sec3="Y" sec12="Y"><name>Dovonex</name><manufacturerId>LEO</manufacturerId><individualPrice>.7533</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="843600044"><itemNumber>1633</itemNumber><strength>50mcg/g</strength><dosageForm>Oint</dosageForm><price>.7583</price><drug id="01976133" sec3="Y" sec12="Y"><name>Dovonex</name><manufacturerId>LEO</manufacturerId><individualPrice>.7583</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="191">For the treatment of psoriasis in patients who have failed topical corticosteroids alone, or are intolerant to topical corticosteroids.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00162"><name>FLUOROURACIL</name><pcgGroup><pcg9 id="843600014"><itemNumber>1634</itemNumber><strength>5%</strength><dosageForm>Cr</dosageForm><price>.8000</price><drug id="00330582" sec3="Y"><name>Efudex</name><manufacturerId>VAL</manufacturerId><individualPrice>.8000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01084"><name>ISOTRETINOIN</name><note>Isotretinoin is indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobata and recalcitrant acne that are unresponsive to conventional therapy including systemic antibiotics. Females of childbearing potential should have a negative pregnancy test within 2 weeks prior to starting treatment. Isotretinoin should be started the second or third day of the next normal menstrual period. Effective contraception should be used for at least 1 month prior to starting isotretinoin, during treatment and for at least 1 month following discontinuation of treatment.</note><pcgGroup><pcg9 id="843600035"><itemNumber>1635</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.9313</price><drug id="00582344" sec3="Y"><name>Accutane</name><manufacturerId>HLR</manufacturerId><individualPrice>.9313</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02257955" sec3="Y"><name>Clarus</name><manufacturerId>PRE</manufacturerId><individualPrice>.9313</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9><pcg9 id="843600034"><itemNumber>1636</itemNumber><strength>40mg</strength><dosageForm>Cap</dosageForm><price>1.9003</price><drug id="00582352" sec3="Y"><name>Accutane</name><manufacturerId>HLR</manufacturerId><individualPrice>1.9003</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02257963" sec3="Y"><name>Clarus</name><manufacturerId>PRE</manufacturerId><individualPrice>1.9003</individualPrice><listingDate>2006-07-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01086"><name>METHOXSALEN</name><pcgGroup><pcg9 id="843600039"><itemNumber>1637</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.5436</price><drug id="01946374" sec3="Y"><name>Oxsoralen</name><manufacturerId>VAL</manufacturerId><individualPrice>.5436</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="843600040"><itemNumber>1638</itemNumber><strength>10mg</strength><dosageForm>SG Cap</dosageForm><price>.4755</price><drug id="00646237" sec3="Y"><name>UltraMOP</name><manufacturerId>CDX</manufacturerId><individualPrice>.4755</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01605"><name>PIMECROLIMUS</name><pcgGroup lccId="00149"><pcg9 id="843600084"><itemNumber>1639</itemNumber><strength>1%</strength><dosageForm>Cr</dosageForm><price>2.1967</price><drug id="02247238" sec3="Y" sec12="Y"><name>Elidel</name><manufacturerId>NOV</manufacturerId><individualPrice>2.1967</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="383">For use in combination with moisturizers or oral antihistamines in patients with atopic dermatitis who have failed or are intolerant to an 8 week trial of an intermediate potency topical steroid.</lccNote><lccNote seq="002" type="R">Therapy should be reassessed at 6 months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01083"><name>ZINC SULFATE</name><pcgGroup><pcg9 id="843600033" suppliedBy="L"><itemNumber>1640</itemNumber><strength>0.5%</strength><dosageForm>Oint</dosageForm><price>.1033</price><drug id="00621447" selfMed="Y" sec3="Y"><name>Sandoz Anuzinc</name><manufacturerId>SDZ</manufacturerId><individualPrice>.1033</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="01945939" dinStatus="E" selfMed="Y" sec3="Y"><name>Anusol</name><manufacturerId>PFI</manufacturerId><individualPrice>.1320</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="843600020" suppliedBy="L"><itemNumber>1641</itemNumber><strength>10mg</strength><dosageForm>Sup</dosageForm><price>.3542</price><drug id="00621439" selfMed="Y" sec3="Y"><name>Anuzinc</name><manufacturerId>SDZ</manufacturerId><individualPrice>.3542</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="860000000"><name>SPASMOLYTICS</name><pcg6><genericName id="01110"><name>AMINOPHYLLINE</name><pcgGroup><pcg9 id="860000030"><itemNumber>1642</itemNumber><strength>225mg</strength><dosageForm>SR Tab</dosageForm><price>.2168</price><drug id="02014270" sec3="Y"><name>Phyllocontin</name><manufacturerId>PFP</manufacturerId><individualPrice>.2168</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="860000039"><itemNumber>1643</itemNumber><strength>350mg</strength><dosageForm>SR Tab</dosageForm><price>.2762</price><drug id="02014289" sec3="Y"><name>Phyllocontin-350</name><manufacturerId>PFP</manufacturerId><individualPrice>.2762</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01111"><name>OXTRIPHYLLINE</name><pcgGroup><pcg9 id="860000013"><itemNumber>1644</itemNumber><strength>20mg/mL</strength><dosageForm>O/L</dosageForm><price>.0229</price><drug id="00476366" sec3="Y"><name>Choledyl</name><manufacturerId>ERF</manufacturerId><individualPrice>.0360</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00792942" sec3="Y"><name>PMS-Oxtriphylline</name><manufacturerId>PMS</manufacturerId><individualPrice>.0229</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01112"><name>THEOPHYLLINE ANHYDROUS</name><pcgGroup><pcg9 id="860000059"><itemNumber>1645</itemNumber><strength>300mg</strength><dosageForm>LA Tab</dosageForm><price>.1400</price><drug id="00461008" notABenefit="Y" sec3="Y"><name>Theo-Dur</name><manufacturerId>AZC</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230087" sec3="Y"><name>Novo-Theophyl SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.1400</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="860000008"><itemNumber>1646</itemNumber><strength>5.3mg/mL</strength><dosageForm>O/L</dosageForm><price>.0252</price><drug id="01966219" sec3="Y"><name>Theolair Alcohol Free Oral Liquid</name><manufacturerId>GRA</manufacturerId><individualPrice>.0252</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="860000046"><itemNumber>1647</itemNumber><strength>400mg</strength><dosageForm>SR Tab</dosageForm><price>.4980</price><drug id="02014165" sec3="Y"><name>Uniphyl</name><manufacturerId>PFP</manufacturerId><individualPrice>.4980</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="860000047"><itemNumber>1648</itemNumber><strength>600mg</strength><dosageForm>SR Tab</dosageForm><price>.6032</price><drug id="02014181" sec3="Y"><name>Uniphyl</name><manufacturerId>PFP</manufacturerId><individualPrice>.6032</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="880000000"><name>VITAMINS</name><pcg6 id="880800000"><name>VITAMIN B</name><genericName id="01116"><name>CYANOCOBALAMIN</name><pcgGroup><pcg9 id="880800001" suppliedBy="L"><itemNumber>1649</itemNumber><strength>1mg/mL</strength><dosageForm>Inj Sol-10mL Pk</dosageForm><price>3.1000</price><drug id="00029165" notABenefit="Y" sec3="Y"><name>Rubramin</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00521515" selfMed="Y" sec3="Y"><name>Vitamin B12-1000mcg/mL</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.1000</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="01987003" selfMed="Y" sec3="Y"><name>Cyanocobalamin</name><manufacturerId>CYI</manufacturerId><individualPrice>3.1000</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01117"><name>FOLIC ACID</name><pcgGroup><pcg9 id="880800003"><itemNumber>1650</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.0259</price><drug id="00014966" notABenefit="Y" sec3="Y"><name>Folvite</name><manufacturerId>LED</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00426849" sec3="Y"><name>Apo-Folic</name><manufacturerId>APX</manufacturerId><individualPrice>.0259</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01121"><name>LEUCOVORIN CALCIUM</name><pcgGroup><pcg9 id="880800015"><itemNumber>1651</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>5.6953</price><drug id="02170493" sec3="Y"><name>Leucovorin Calcium</name><manufacturerId>WAY</manufacturerId><individualPrice>5.6953</individualPrice><listingDate>1999-01-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01118"><name>NICOTINIC ACID</name><note>Nicotinic acid is the most cost-effective therapy for hyperlipidemia and is tolerated in approximately 80% of patients with adequate warning about expected flushing which disappears after 5 days in most cases, and is significantly reduced with regular use of ASA.</note><pcgGroup><pcg9 id="880800007" dpp="Y"><itemNumber>1652</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="00268593" notABenefit="Y" sec3="Y"><name>Niacin-ICN</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00274496" notABenefit="Y" sec3="Y"><name>Novo-Niacin</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="880800006" dpp="Y"><itemNumber>1653</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.0295</price><drug id="00268585" dinStatus="E" sec3="Y"><name>Niacin-ICN</name><manufacturerId>VAL</manufacturerId><individualPrice>.0295</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01120"><name>THIAMINE HCL</name><pcgGroup><pcg9 id="880800012" dpp="Y"><itemNumber>1654</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><drug id="00268631" notABenefit="Y" sec3="Y"><name>Vitamin B1-ICN</name><manufacturerId>VAL</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00610267" notABenefit="Y" sec3="Y"><name>Vitamin B1</name><manufacturerId>LEA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="881200000"><name>VITAMIN C</name><genericName id="01131"><name>ASCORBIC ACID</name><pcgGroup><pcg9 id="881200003" suppliedBy="L"><itemNumber>1655</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><drug id="00021970" notABenefit="Y" sec3="Y"><name>Novo-C</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00466646" notABenefit="Y" sec3="Y"><name>Apo-C</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="881200002" suppliedBy="L"><itemNumber>1656</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><drug id="00021237" notABenefit="Y" sec3="Y"><name>Novo-C</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00036161" notABenefit="Y" sec3="Y"><name>Vitamin C</name><manufacturerId>RPR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00466638" notABenefit="Y" sec3="Y"><name>Apo-C</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="881200001" suppliedBy="L"><itemNumber>1657</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><drug id="00021997" notABenefit="Y" sec3="Y"><name>Novo-C</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00036188" notABenefit="Y" sec3="Y"><name>Vitamin C</name><manufacturerId>RPR</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00466611" notABenefit="Y" sec3="Y"><name>Apo-C</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="881200005"><itemNumber>1658</itemNumber><strength>1000mg</strength><dosageForm>Tab</dosageForm><drug id="00256862" notABenefit="Y" sec3="Y"><name>Vitamin C</name><manufacturerId>RPR</manufacturerId><listingDate>1996-07-15</listingDate></drug><drug id="00466603" notABenefit="Y" sec3="Y"><name>Apo-C</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00535907" notABenefit="Y" sec3="Y"><name>Novo-C</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="881600000"><name>VITAMIN D</name><genericName id="01136"><name>ALFACALCIDOL</name><pcgGroup><pcg9 id="881600007" dpp="Y"><itemNumber>1659</itemNumber><strength>0.25mcg</strength><dosageForm>Cap</dosageForm><price>.4255</price><drug id="00474517" sec3="Y"><name>One-Alpha</name><manufacturerId>LEO</manufacturerId><individualPrice>.4255</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="881600006" dpp="Y"><itemNumber>1660</itemNumber><strength>1mcg</strength><dosageForm>Cap</dosageForm><price>1.2738</price><drug id="00474525" sec3="Y"><name>One-Alpha</name><manufacturerId>LEO</manufacturerId><individualPrice>1.2738</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01135"><name>CALCITRIOL</name><pcgGroup><pcg9 id="881600005" dpp="Y"><itemNumber>1661</itemNumber><strength>0.25mcg</strength><dosageForm>Cap</dosageForm><price>.9280</price><drug id="00481823" sec3="Y"><name>Rocaltrol</name><manufacturerId>HLR</manufacturerId><individualPrice>.9280</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="881600004" dpp="Y"><itemNumber>1662</itemNumber><strength>0.5mcg</strength><dosageForm>Cap</dosageForm><price>1.4758</price><drug id="00481815" sec3="Y"><name>Rocaltrol</name><manufacturerId>HLR</manufacturerId><individualPrice>1.4758</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01133"><name>ERGOCALCIFEROL</name><pcgGroup><pcg9 id="881600002"><itemNumber>1663</itemNumber><strength>8288IU/mL</strength><dosageForm>O/L</dosageForm><price>.4268</price><drug id="02017598" sec3="Y"><name>Drisdol</name><manufacturerId>SAV</manufacturerId><individualPrice>.4268</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="882800000"><name>MULTIVITAMINS</name><genericName id="01143"><name>HEXAVITAMINS USP</name><pcgGroup><pcg9 id="882800001" suppliedBy="L"><itemNumber>1664</itemNumber><dosageForm>Tab</dosageForm><drug id="00269034" notABenefit="Y" sec3="Y"><name>Hexavitamins</name><manufacturerId>NOP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00701130" notABenefit="Y" sec3="Y"><name>Apo-Hexa</name><manufacturerId>APX</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="920000000"><name>UNCLASSIFIED THERAPEUTIC AGENTS</name><pcg6><genericName id="01633"><name>ADALIMUMAB</name><pcgGroup><pcg9 id="920000598"><itemNumber>1665</itemNumber><strength>40mg/0.8mL</strength><dosageForm>Inj Sol-Pref Pen Pk</dosageForm><price>708.0400</price><note>Note:  For the treatment of severe* plaque psoriasis in patients 18 years of age or older who have experienced failure, intolerance, or have a contraindication to adequate trials of several standard therapies**.

Claims for the first 6 months must be written by a dermatologist.

Monitoring of patients is required to determine if continuation of therapy beyond 12 weeks is required.  
Patients not responding adequately at 12 weeks should have treatment discontinued.

* Definition of severe plaque psoriasis:
Body Surface Area (BSA) involvement of at least 10%, or involvement of the face, hands, feet or genital regions, AND
Psoriasis Area and Severity Index (PASI) score of at least 10, (not required if there is involvemnet of the face, hands, feet or genital regions), AND 
Dermatology Life Quality Index (DLQI) score of at least 10.

** Definition of failure, intoleranace or contraindication to adequate trials of standard therapies:
           .   6 month trial of at least 3 topical agents including vitamin D                     analogues and steroids, AND
           .   12 week trial of phototherapy (unless not accessible), AND
           .   6 month trial of at least 2 systemic, oral agents used alone or in                 combination              
                       .    Methotrexate 15-30mg per week
                       .    Acitretin (could have been used with phototherapy)
                       .    Cyclosporine
                
 Maintenance/Renewal:

After 3 months of therapy, patients who respond to therapy should have:

       .   At least a 50% reduction in PASI, AND
       .   at least a 50% reduction in BSA involvement,  AND
       .   at least a 5 point reduction in DLQI  score

Dosing Approved by Health Canada
Approvals will only allow for standard dosing for Humira (adalimumab): the recommended dose is an initial 80mg administered subcutaneously, followed by 40mg subcutaneously given every other week starting one week after the initial dose. The Committee to Evaluate Drugs noted that this is the Manufacturer&apos;s recommended dosing regimen, as approved by Health Canada.  If the patient has not responded adequately after 12 weeks of treatment at the Health Canada approved dose, higher doses are not recommended and the physician should consider switching to an alternative biologic agent.

</note><drug id="09857327" dinStatus="N" sec3="Y"><name>Humira</name><manufacturerId>ABB</manufacturerId><individualPrice>708.0400</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9><pcg9 id="920000597"><itemNumber>1666</itemNumber><strength>40mg/0.8mL</strength><dosageForm>Inj Sol-Pref Syr Pk</dosageForm><price>708.0400</price><note>Note:  For the treatment of severe* plaque psoriasis in patients 18 years of age or older who have experienced failure, intolerance, or have a contraindication to adequate trials of several standard therapies**.

Claims for the first 6 months must be written by a dermatologist.

Monitoring of patients is required to determine if continuation of therapy beyond 12 weeks is required.  
Patients not responding adequately at 12 weeks should have treatment discontinued.

* Definition of severe plaque psoriasis:
Body Surface Area (BSA) involvement of at least 10%, or involvement of the face, hands, feet or genital regions, AND
Psoriasis Area and Severity Index (PASI) score of at least 10, (not required if there is involvemnet of the face, hands, feet or genital regions), AND 
Dermatology Life Quality Index (DLQI) score of at least 10.

** Definition of failure, intoleranace or contraindication to adequate trials of standard therapies:
           .   6 month trial of at least 3 topical agents including vitamin D                     analogues and steroids, AND
           .   12 week trial of phototherapy (unless not accessible), AND
           .   6 month trial of at least 2 systemic, oral agents used alone or in                 combination              
                       .    Methotrexate 15-30mg per week
                       .    Acitretin (could have been used with phototherapy)
                       .    Cyclosporine
                
 Maintenance/Renewal:

After 3 months of therapy, patients who respond to therapy should have:

       .   At least a 50% reduction in PASI, AND
       .   at least a 50% reduction in BSA involvement,  AND
       .   at least a 5 point reduction in DLQI  score

Dosing Approved by Health Canada
Approvals will only allow for standard dosing for Humira (adalimumab): the recommended dose is an initial 80mg administered subcutaneously, followed by 40mg subcutaneously given every other week starting one week after the initial dose. The Committee to Evaluate Drugs noted that this is the Manufacturer&apos;s recommended dosing regimen, as approved by Health Canada.  If the patient has not responded adequately after 12 weeks of treatment at the Health Canada approved dose, higher doses are not recommended and the physician should consider switching to an alternative biologic agent.

</note><drug id="09857326" dinStatus="N" sec3="Y"><name>Humira</name><manufacturerId>ABB</manufacturerId><individualPrice>708.0400</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01283"><name>ALENDRONATE</name><pcgGroup><pcg9 id="920000294"><itemNumber>1667</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><drug id="02233055" notABenefit="Y" sec3="Y"><name>Fosamax</name><manufacturerId>MFC</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02248251" notABenefit="Y" sec3="Y"><name>Novo-Alendronate</name><manufacturerId>NOP</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02248727" notABenefit="Y" sec3="Y"><name>Apo-Alendronate</name><manufacturerId>APX</manufacturerId><listingDate>2007-10-03</listingDate></drug><drug id="02270110" dinStatus="E" notABenefit="Y" sec3="Y"><name>Gen-Alendronate</name><manufacturerId>GEN</manufacturerId><listingDate>2007-11-10</listingDate></drug><drug id="02288079" notABenefit="Y" sec3="Y"><name>Sandoz Alendronate</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-10-03</listingDate></drug></pcg9><pcg9 id="920000232"><itemNumber>1668</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>.8775</price><drug id="02201011" sec3="Y"><name>Fosamax</name><manufacturerId>MFC</manufacturerId><individualPrice>1.9946</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02247373" sec3="Y"><name>Novo-Alendronate</name><manufacturerId>NOP</manufacturerId><individualPrice>.8775</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02248728" sec3="Y"><name>Apo-Alendronate</name><manufacturerId>APX</manufacturerId><individualPrice>.8775</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02270129" sec3="Y"><name>Gen-Alendronate</name><manufacturerId>GEN</manufacturerId><individualPrice>.8775</individualPrice><listingDate>2005-10-06</listingDate></drug><drug id="02288087" sec3="Y"><name>Sandoz Alendronate</name><manufacturerId>SDZ</manufacturerId><individualPrice>.8775</individualPrice><listingDate>2007-03-09</listingDate></drug></pcg9><pcg9 id="920000577"><itemNumber>1669</itemNumber><strength>40mg</strength><dosageForm>Tab</dosageForm><drug id="02201038" notABenefit="Y" sec3="Y"><name>Fosamax</name><manufacturerId>MFC</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02258102" notABenefit="Y" sec3="Y"><name>Co Alendronate</name><manufacturerId>COB</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9><pcg9 id="920000426"><itemNumber>1670</itemNumber><strength>70mg</strength><dosageForm>Tab</dosageForm><price>4.4250</price><drug id="02245329" sec3="Y"><name>Fosamax</name><manufacturerId>MFC</manufacturerId><individualPrice>10.0575</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02248730" sec3="Y"><name>Apo-Alendronate</name><manufacturerId>APX</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2005-07-14</listingDate></drug><drug id="02258110" sec3="Y"><name>Co-Alendronate</name><manufacturerId>COB</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2005-08-19</listingDate></drug><drug id="02261715" sec3="Y"><name>Novo-Alendronate</name><manufacturerId>NOP</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2005-08-19</listingDate></drug><drug id="02273179" sec3="Y"><name>PMS-Alendronate</name><manufacturerId>PMS</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2006-01-24</listingDate></drug><drug id="02275279" sec3="Y"><name>Ratio-Alendronate</name><manufacturerId>RPH</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2006-05-19</listingDate></drug><drug id="02284006" sec3="Y"><name>PMS-Alendronate-FC</name><manufacturerId>PMS</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02286335" sec3="Y"><name>Gen-Alendronate</name><manufacturerId>GEN</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02288109" sec3="Y"><name>Sandoz Alendronate</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2007-03-09</listingDate></drug><drug id="02299712" dinStatus="N" sec3="Y"><name>Phl-Alendronate-FC</name><manufacturerId>PHE</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2009-11-19</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01689"><name>ALENDRONATE &amp; CHOLECALCIFEROL</name><pcgGroup><pcg9 id="920000544"><itemNumber>1671</itemNumber><strength>70mg &amp; 70mcg</strength><dosageForm>Tab</dosageForm><price>4.4250</price><note>Note:  The recommended dose of Vitamin D for osteoporosis prevention and treatment in adults over 50 years old is at least 800 IU/day, in conjunction with calcium.  This product does not provide the total recommended daily intake of Vitamin D; supplemental Vitamin D may be required. The appropriate dosage of FOSAVANCE must be determined by the physician based on the patient&apos;s vitamin D requirement.</note><drug id="02276429" sec3="Y"><name>Fosavance</name><manufacturerId>MFC</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="920000596"><itemNumber>1672</itemNumber><strength>70mg &amp; 140mcg</strength><dosageForm>Tab</dosageForm><price>4.4250</price><drug id="02314940" dinStatus="N" sec3="Y"><name>Fosavance</name><manufacturerId>MFC</manufacturerId><individualPrice>4.4250</individualPrice><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01564"><name>ALFUZOSIN HYDROCHLORIDE</name><pcgGroup lccId="00121"><pcg9 id="920000421"><itemNumber>1673</itemNumber><strength>10mg</strength><dosageForm>Prolong-Rel Tab</dosageForm><price>.4966</price><drug id="02245565" sec3="Y" sec12="Y"><name>Xatral</name><manufacturerId>SAV</manufacturerId><individualPrice>.9933</individualPrice><listingDate>2003-01-30</listingDate></drug><drug id="02304678" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Alfuzosin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4966</individualPrice><listingDate>2008-11-04</listingDate></drug><drug id="02315866" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Alfuzosin</name><manufacturerId>APX</manufacturerId><individualPrice>.4966</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="351">For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g. doxazosin, terazosin) have been ineffective.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="352">For the management of benign prostatic hyperplasia where other formulary alpha blockers have produced intolerable side effects.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01170"><name>ALLOPURINOL</name><note>Reduce dose of mercaptopurine or azathioprine if used concomitantly. Adjust dose of allopurinol in patients with renal impairment. Allopurinol should not be used to treat patients with hyperuricemia when decreased uricosuria is the cause.</note><pcgGroup><pcg9 id="920000001"><itemNumber>1674</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.0780</price><drug id="00004588" notABenefit="Y" sec3="Y"><name>Zyloprim</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00364282" sec3="Y"><name>Novo-Purol</name><manufacturerId>NOP</manufacturerId><individualPrice>.0780</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00402818" sec3="Y"><name>Apo-Allopurinol</name><manufacturerId>APX</manufacturerId><individualPrice>.0780</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000028"><itemNumber>1675</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.1300</price><drug id="00479799" sec3="Y"><name>Apo-Allopurinol</name><manufacturerId>APX</manufacturerId><individualPrice>.1300</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00506370" notABenefit="Y" sec3="Y"><name>Zyloprim</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00565342" sec3="Y"><name>Novo-Purol</name><manufacturerId>NOP</manufacturerId><individualPrice>.1300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000013"><itemNumber>1676</itemNumber><strength>300mg</strength><dosageForm>Tab</dosageForm><price>.2125</price><drug id="00294322" notABenefit="Y" sec3="Y"><name>Zyloprim</name><manufacturerId>BWE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="00363693" sec3="Y"><name>Novo-Purol</name><manufacturerId>NOP</manufacturerId><individualPrice>.2125</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00402796" sec3="Y"><name>Apo-Allopurinol</name><manufacturerId>APX</manufacturerId><individualPrice>.2125</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01176"><name>AMANTADINE HCL</name><note>Amantadine increases central and peripheral effects of anticholinergic drugs.</note><pcgGroup><pcg9 id="920000021"><itemNumber>1677</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.5179</price><drug id="01914006" notABenefit="Y" sec3="Y"><name>Symmetrel</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="01990403" sec3="Y"><name>PMS-Amantadine HCL</name><manufacturerId>PMS</manufacturerId><individualPrice>.5179</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02139200" sec3="Y"><name>Mylan-Amantadine</name><manufacturerId>MYL</manufacturerId><individualPrice>.5179</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000032"><itemNumber>1678</itemNumber><strength>10mg/mL</strength><dosageForm>O/L</dosageForm><price>.0810</price><drug id="01913999" notABenefit="Y" sec3="Y"><name>Symmetrel</name><manufacturerId>BQU</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02022826" sec3="Y"><name>PMS-Amantadine</name><manufacturerId>PMS</manufacturerId><individualPrice>.0810</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01358"><name>ANAGRELIDE HCL</name><pcgGroup lccId="00164"><pcg9 id="920000521"><itemNumber>1679</itemNumber><strength>0.5mg</strength><dosageForm>Cap</dosageForm><price>3.3491</price><drug id="02260107" sec3="Y" sec12="Y"><name>Sandoz Anagrelide</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.3491</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="400">For the treatment of essential thrombocytosis in patients who are intolerant of or who have failed hydroxyurea therapy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 5 years.</lccNote></pcgGroup></genericName><genericName id="00196"><name>AZATHIOPRINE</name><pcgGroup><pcg9 id="920000003"><itemNumber>1680</itemNumber><strength>50mg</strength><dosageForm>Tab</dosageForm><price>.4300</price><note>Decrease dose of azathioprine to 25 -33% of initial dose if allopurinol used concomitantly.</note><drug id="00004596" sec3="Y"><name>Imuran</name><manufacturerId>GSK</manufacturerId><individualPrice>.9618</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231491" sec3="Y"><name>Gen-Azathioprine</name><manufacturerId>GEN</manufacturerId><individualPrice>.4300</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02236819" sec3="Y"><name>Novo-Azathioprine</name><manufacturerId>NOP</manufacturerId><individualPrice>.4300</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02242907" sec3="Y"><name>Apo-Azathioprine</name><manufacturerId>APX</manufacturerId><individualPrice>.4300</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01269"><name>BOTULINUM TOXIN TYPE A</name><pcgGroup lccId="00122"><pcg9 id="920000207"><itemNumber>1681</itemNumber><strength>100U/Vial</strength><dosageForm>Pd Inj-100U Vial Pk</dosageForm><price>357.0000</price><drug id="01981501" sec3="Y" sec12="Y"><name>Botox</name><manufacturerId>ALL</manufacturerId><individualPrice>357.0000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="10">For the treatment of strabismus and blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in patients 12 years of age or older.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="130">To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="412">For the management of focal spasticity, due to stroke or spinal cord 
injury in adults.</lccNote><lccNote seq="006" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="007" reasonForUseId="413">For the treatment of focal spasticity secondary to cerebral palsy in 
patients two years of age or older.</lccNote><lccNote seq="008" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="009" type="C">Note: Botox should be administered personally by a pediatrician, neurologist
or physical medicine specialist or a physician with equivalent post-graduate
training and experience with neuromuscular disorders.</lccNote></pcgGroup></genericName><genericName id="01179"><name>BROMOCRIPTINE</name><pcgGroup><pcg9 id="920000044"><itemNumber>1682</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.7708</price><drug id="00568643" notABenefit="Y" sec3="Y"><name>Parlodel</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02230454" sec3="Y"><name>Apo-Bromocriptine</name><manufacturerId>APX</manufacturerId><individualPrice>.7708</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02236949" sec3="Y"><name>PMS-Bromocriptine</name><manufacturerId>PMS</manufacturerId><individualPrice>.7708</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="920000029"><itemNumber>1683</itemNumber><strength>2.5mg</strength><dosageForm>Tab</dosageForm><price>.4328</price><drug id="00371033" notABenefit="Y" sec3="Y"><name>Parlodel</name><manufacturerId>NOV</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02087324" sec3="Y"><name>Apo-Bromocriptine</name><manufacturerId>APX</manufacturerId><individualPrice>.4328</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02231702" sec3="Y"><name>PMS-Bromocriptine</name><manufacturerId>PMS</manufacturerId><individualPrice>.4328</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01495"><name>CABERGOLINE</name><pcgGroup><pcg9 id="920000380"><itemNumber>1684</itemNumber><strength>0.5mg</strength><dosageForm>Tab</dosageForm><drug id="02242471" notABenefit="Y" sec3="Y"><name>Dostinex</name><manufacturerId>PMJ</manufacturerId><listingDate>2008-06-27</listingDate></drug><drug id="02301407" notABenefit="Y" sec3="Y"><name>Co Cabergoline</name><manufacturerId>COB</manufacturerId><listingDate>2008-06-27</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01239"><name>CLODRONATE DISODIUM</name><pcgGroup lccId="00124"><pcg9 id="920000212"><itemNumber>1685</itemNumber><strength>400mg</strength><dosageForm>Cap</dosageForm><price>1.2083</price><drug id="01927078" dinStatus="E" sec3="Y" sec12="Y"><name>Ostac</name><manufacturerId>HLR</manufacturerId><individualPrice>1.8137</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245828" sec3="Y" sec12="Y"><name>Clasteon</name><manufacturerId>ORY</manufacturerId><individualPrice>1.2083</individualPrice><listingDate>2004-10-14</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="280">For the control and prophylaxis of hypercalcemia of malignancy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="358">For the treatment of bony metastases in patients with breast cancer.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="359">For the prevention and treatment of osteolytic lesions in patients with multiple myeloma.</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01188"><name>CLODRONATE DISODIUM TETRAHYDRATE</name><pcgGroup lccId="00123"><pcg9 id="920000205"><itemNumber>1686</itemNumber><strength>400mg</strength><dosageForm>Cap</dosageForm><price>1.8710</price><drug id="01984845" sec3="Y" sec12="Y"><name>Bonefos</name><manufacturerId>BAY</manufacturerId><individualPrice>1.8710</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="280">For the control and prophylaxis of hypercalcemia of malignancy.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="358">For the treatment of bony metastases in patients with breast cancer.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="359">For the prevention and treatment of osteolytic lesions in patients with multiple myeloma.</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01403"><name>CLOPIDOGREL BISULFATE</name><pcgGroup lccId="00147"><pcg9 id="920000303"><itemNumber>1687</itemNumber><strength>75mg</strength><dosageForm>Tab</dosageForm><price>2.5775</price><drug id="02238682" sec3="Y" sec12="Y"><name>Plavix</name><manufacturerId>SAV</manufacturerId><individualPrice>2.5775</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="375">For patients immediately post-hospitalization for Acute Coronary Syndrome (ACS), in combination with ASA. ACS is defined as any myocardial infarction (MI) or  unstable angina (UA).</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="376">For patients immediately pre- or post-percutaneous coronary intervention (PCI).*
*Therapy may be initiated up to 10 days prior to PCI</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="005" reasonForUseId="411">For patients who experience a stroke or transient ischemic attack (TIA) while taking Aggrenox (dipyridamole and ASA) or ASA alone; or

For patients experiencing ongoing severe symptomatic peripheral vascular disease
(PVD) (i.e.with Ankle Brachial index &lt;0.5) after a vascular event while on ASA. ASA should not be used concomitantly; or

For patients requiring ASA with documented severe allergy to ASA, such as anaphylactic reaction or bronchospasm. Gastrointestinal events (GI), including GI bleeds, are excluded.</lccNote><lccNote seq="006" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01189"><name>CYCLOSPORINE</name><pcgGroup lccId="00125"><pcg9 id="920000324"><itemNumber>1688</itemNumber><strength>10mg</strength><dosageForm>Cap</dosageForm><price>.6238</price><drug id="02237671" sec3="Y" sec12="Y"><name>Neoral</name><manufacturerId>NOV</manufacturerId><individualPrice>.6238</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="920000166"><itemNumber>1689</itemNumber><strength>25mg</strength><dosageForm>Cap</dosageForm><price>.9952</price><drug id="02150689" sec3="Y" sec12="Y"><name>Neoral</name><manufacturerId>NOV</manufacturerId><individualPrice>1.4500</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02247073" sec3="Y" sec12="Y"><name>Sandoz Cyclosporine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9952</individualPrice><listingDate>2006-01-24</listingDate></drug></pcg9><pcg9 id="920000167"><itemNumber>1690</itemNumber><strength>50mg</strength><dosageForm>Cap</dosageForm><price>1.9400</price><drug id="02150662" sec3="Y" sec12="Y"><name>Neoral</name><manufacturerId>NOV</manufacturerId><individualPrice>2.8270</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02247074" sec3="Y" sec12="Y"><name>Sandoz Cyclosporine</name><manufacturerId>SDZ</manufacturerId><individualPrice>1.9400</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="920000169"><itemNumber>1691</itemNumber><strength>100mg</strength><dosageForm>Cap</dosageForm><price>3.8815</price><drug id="02150670" sec3="Y" sec12="Y"><name>Neoral</name><manufacturerId>NOV</manufacturerId><individualPrice>5.6560</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02242821" sec3="Y" sec12="Y"><name>Sandoz Cyclosporine</name><manufacturerId>SDZ</manufacturerId><individualPrice>3.8815</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="920000168"><itemNumber>1692</itemNumber><strength>100mg/mL</strength><dosageForm>O/L</dosageForm><price>3.7707</price><drug id="02150697" sec3="Y" sec12="Y"><name>Neoral</name><manufacturerId>NOV</manufacturerId><individualPrice>5.0276</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02244324" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Cyclosporine Oral Solution</name><manufacturerId>APX</manufacturerId><individualPrice>3.7707</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="177">For the treatment of psoriasis in patients who have failed, or are intolerant to, other systemic therapies, including methotrexate, acitretin or PUVA;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="178">For the treatment of rheumatoid arthritis in patients who have failed, or are intolerant to, other systemic therapies, including Disease-Modifying Antirheumatic Drugs (DMARDs).</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01644"><name>DUTASTERIDE</name><pcgGroup lccId="00166"><pcg9 id="920000524"><itemNumber>1693</itemNumber><strength>0.5mg</strength><dosageForm>Cap</dosageForm><price>1.6570</price><drug id="02247813" sec3="Y" sec12="Y"><name>Avodart</name><manufacturerId>GSK</manufacturerId><individualPrice>1.6570</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="384">For use in combination with an alpha blocker for the treatment of men with symptomatic* Benign Prostatic Hyperplasia.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="385">For monotherapy, as a second line agent in patients with symptomatic* Benign Prostatic Hyperplasia following treatment failure or intolerance to an alpha blocker.</lccNote><lccNote seq="004" type="R">* Symptomatic is defined as having moderate (about half the time) to severe (almost always) symptoms related to the prostate in at least 4 of the following domains:
1. feeling of incomplete emptying of the bladder after voiding
2. needing to urinate again less than 2 hours after previous void
3. stopping and starting urine several times while voiding
4. difficulty postponing urination
5. weak urinary stream
6. pushing or straining to begin voiding
7. the need to get up to void at least 3 times in the night.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01513"><name>ETANERCEPT</name><pcgGroup><pcg9 id="920000599"><itemNumber>1694</itemNumber><strength>50mg/mL</strength><dosageForm>Inj Pref Syr</dosageForm><price>364.2800</price><note>NOTE:  For the treatment of severe* plaque psoriasis in patients 18 years of age or older who have experienced failure, intolerance, or have a contraindication to adequate trials of several standard therapies**.

Claims for the first 6 months must be written by a dermatologist.

Monitoring of patients is required to determine if continuation of therapy beyond 12 weeks is required.  Patients not responding adequately at 12 weeks should have treatment discontinued.

* Definition of severe plaque psoriasis:
Body Surface Area (BSA) involvement of at least 10%, or involvement of the face, hands, feet or genital regions, AND
Psoriasis Area and Severity Index (PASI) score of at least 10, (not required if there is involvement of the face, hands, feet or genital regions), AND
Dermatology Life Quality Index (DLQI) score of at least 10.

** Definition of failure, intoleranace or contraindication to adequate trials of standard therapies:
      .  6 month trial of at least 3 topical agents including vitamin D analogues           and steroids, AND
      .  12 week trial of phototherapy (unless not accessible), AND
      .  6 month trial of at least 2 systemic, oral agents used alone or in                 combination

              .    Methotrexate 15-30mg per week
              .    Acitretin (could have been used with phototherapy)
              .    Cyclosporine

Maintenance/Renewal:
  
After 3 months of therapy, patients who respond to therapy should have:

                .   At least a 50% reduction in PASI, AND
                .   at least a 50% reduction in BSA involvement, AND
                .   at least a 5 point reduction in DLQI score

Dosing Approved by Health Canada

Approvals will only allow for standard dosing for Enbrel (Etanercept): the 
recommended dose is 50mg subcutaneous twice weekly for 12 weeks followed by maintenance therapy at 25-50mg subcutaneous once weekly. The Committee to Evaluate Drugs noted that this is the Manufacturer&apos;s recommended dosing regimen, as approved by Health Canada.  If the patient has not responded adequately after 12 weeks of treatment at the Health Canada approved dose, higher doses are not recommended and the physician should consider switching to an alternative biologic agent.</note><drug id="09857322" dinStatus="N" sec3="Y"><name>Enbrel</name><manufacturerId>IMU</manufacturerId><individualPrice>364.2800</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01180"><name>ETIDRONATE DISODIUM</name><pcgGroup lccId="00126"><pcg9 id="920000045"><itemNumber>1695</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.6554</price><drug id="01997629" notABenefit="Y" sec3="Y"><name>Didronel</name><manufacturerId>PGP</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02245330" sec3="Y" sec12="Y"><name>Mylan-Etidronate</name><manufacturerId>MYL</manufacturerId><individualPrice>.6554</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02248686" sec3="Y" sec12="Y"><name>Co-Etidronate</name><manufacturerId>COB</manufacturerId><individualPrice>.6554</individualPrice><listingDate>2005-01-25</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="236">For the treatment of Paget&apos;s disease;</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="237">For the management of hypercalcemia of malignancy.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01268"><name>ETIDRONATE DISODIUM/CALCIUM CARBONATE</name><pcgGroup><pcg9 id="920000206"><itemNumber>1696</itemNumber><strength>400mg/500mg</strength><dosageForm>Tab-90 Tablets Kit</dosageForm><price>19.9900</price><drug id="02176017" sec3="Y"><name>Didrocal</name><manufacturerId>PGP</manufacturerId><individualPrice>41.9800</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02247323" dinStatus="N" sec3="Y"><name>Mylan-Eti-Cal Carepac</name><manufacturerId>MYL</manufacturerId><individualPrice>19.9900</individualPrice><listingDate>2008-06-27</listingDate></drug><drug id="02263866" dinStatus="N" sec3="Y"><name>Co Etidrocal</name><manufacturerId>COB</manufacturerId><individualPrice>19.9900</individualPrice><listingDate>2008-06-27</listingDate></drug><drug id="02324199" dinStatus="N" sec3="Y"><name>Novo-Etidronatecal</name><manufacturerId>NOP</manufacturerId><individualPrice>19.9900</individualPrice><listingDate>2009-05-20</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01192"><name>FINASTERIDE</name><pcgGroup lccId="00155"><pcg9 id="920000067"><itemNumber>1697</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.9265</price><drug id="02010909" sec3="Y" sec12="Y"><name>Proscar</name><manufacturerId>MFC</manufacturerId><individualPrice>1.8530</individualPrice><listingDate>2004-07-20</listingDate></drug><drug id="02322579" dinStatus="N" sec3="Y" sec12="Y"><name>Sandoz Finasteride</name><manufacturerId>SDZ</manufacturerId><individualPrice>.9265</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="384">For use in combination with an alpha blocker for the treatment of men with symptomatic* Benign Prostatic Hyperplasia.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="385">For monotherapy, as a second line agent in patients with symptomatic* Benign Prostatic Hyperplasia following treatment failure or intolerance to an alpha blocker.</lccNote><lccNote seq="004" type="R">* Symptomatic is defined as having moderate (about half the time) to severe (almost always) symptoms related to the prostate in at least 4 of the following domains:
1. feeling of incomplete emptying of the bladder after voiding
2. needing to urinate again less than 2 hours after previous void
3. stopping and starting urine several times while voiding
4. difficulty postponing urination
5. weak urinary stream
6. pushing or straining to begin voiding
7. the need to get up to void at least 3 times in the night.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01273"><name>FLUNARIZINE HCL</name><pcgGroup lccId="00127"><pcg9 id="920000216"><itemNumber>1698</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>.5308</price><drug id="00846341" notABenefit="Y" sec3="Y"><name>Sibelium</name><manufacturerId>PMS</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02246082" sec3="Y" sec12="Y"><name>Apo-Flunarizine</name><manufacturerId>APX</manufacturerId><individualPrice>.5308</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="60">For patients with migraine headaches who have not responded to propranolol.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="003" reasonForUseId="61">For patients who have tried propranolol and experienced significant adverse effects.</lccNote><lccNote seq="004" type="R">LU Authorization Period: 1 year.</lccNote><lccNote seq="005" reasonForUseId="62">For patients in whom propranolol is contraindicated.</lccNote><lccNote seq="006" type="C">Contraindicated in patients with clinical depression and in patients with extrapyramidal disorders.</lccNote><lccNote seq="007" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01577"><name>GLUCAGON RDNA ORIGIN</name><pcgGroup><pcg9 id="920000419"><itemNumber>1699</itemNumber><strength>1mg/Vial</strength><dosageForm>Inj Pd-Vial Pk</dosageForm><price>86.3500</price><drug id="02243297" sec3="Y"><name>Glucagon</name><manufacturerId>LIL</manufacturerId><individualPrice>86.3500</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01737"><name>LANREOTIDE ACETATE</name><pcgGroup><pcg9 id="920000582"><itemNumber>1700</itemNumber><strength>60mg/0.3mL</strength><dosageForm>ER Pref Syr-0.3mL Pk</dosageForm><price>1102.0000</price><drug id="02283395" dinStatus="N" sec3="Y"><name>Somatuline Autogel</name><manufacturerId>IPS</manufacturerId><individualPrice>1102.0000</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="920000583"><itemNumber>1701</itemNumber><strength>90mg/0.3mL</strength><dosageForm>ER Pref Syr-0.3mL Pk</dosageForm><price>1470.0000</price><drug id="02283409" dinStatus="N" sec3="Y"><name>Somatuline Autogel</name><manufacturerId>IPS</manufacturerId><individualPrice>1470.0000</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9><pcg9 id="920000584"><itemNumber>1702</itemNumber><strength>120mg/0.5mL</strength><dosageForm>ER Pref Syr-0.5mL Pk</dosageForm><price>1840.0000</price><drug id="02283417" dinStatus="N" sec3="Y"><name>Somatuline Autogel</name><manufacturerId>IPS</manufacturerId><individualPrice>1840.0000</individualPrice><listingDate>2008-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01483"><name>LEFLUNOMIDE</name><pcgGroup lccId="00129"><pcg9 id="920000369"><itemNumber>1703</itemNumber><strength>10mg</strength><dosageForm>Tab</dosageForm><price>4.7950</price><drug id="02241888" sec3="Y" sec12="Y"><name>Arava</name><manufacturerId>SAV</manufacturerId><individualPrice>10.5730</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02256495" sec3="Y" sec12="Y"><name>Apo-Leflunomide</name><manufacturerId>APX</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2004-11-16</listingDate></drug><drug id="02261251" sec3="Y" sec12="Y"><name>Novo-Leflunomide</name><manufacturerId>NOP</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2005-01-25</listingDate></drug><drug id="02283964" sec3="Y" sec12="Y"><name>Sandoz Leflunomide</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02288265" sec3="Y" sec12="Y"><name>PMS-Leflunomide</name><manufacturerId>PMS</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02319225" dinStatus="N" sec3="Y" sec12="Y"><name>Gen-Leflunomide</name><manufacturerId>GEN</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><pcg9 id="920000370"><itemNumber>1704</itemNumber><strength>20mg</strength><dosageForm>Tab</dosageForm><price>4.7950</price><drug id="02241889" sec3="Y" sec12="Y"><name>Arava</name><manufacturerId>SAV</manufacturerId><individualPrice>10.5730</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02256509" sec3="Y" sec12="Y"><name>Apo-Leflunomide</name><manufacturerId>APX</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2004-11-16</listingDate></drug><drug id="02261278" sec3="Y" sec12="Y"><name>Novo-Leflunomide</name><manufacturerId>NOP</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2005-01-25</listingDate></drug><drug id="02283972" sec3="Y" sec12="Y"><name>Sandoz Leflunomide</name><manufacturerId>SDZ</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02288273" sec3="Y" sec12="Y"><name>PMS-Leflunomide</name><manufacturerId>PMS</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02319233" dinStatus="N" sec3="Y" sec12="Y"><name>Gen-Leflunomide</name><manufacturerId>GEN</manufacturerId><individualPrice>4.7950</individualPrice><listingDate>2009-01-30</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="331">For the treatment of rheumatoid arthritis in patients who have failed, or are intolerant to, one or more of the listed Disease- Modifying Anti-Rheumatic Drugs (DMARDS).</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01178"><name>LEVODOPA &amp; BENSERAZIDE</name><pcgGroup><pcg9 id="920000037"><itemNumber>1705</itemNumber><strength>50mg &amp; 12.5mg</strength><dosageForm>Cap</dosageForm><price>.2732</price><drug id="00522597" sec3="Y"><name>Prolopa 50-12.5</name><manufacturerId>HLR</manufacturerId><individualPrice>.2732</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000027"><itemNumber>1706</itemNumber><strength>100mg &amp; 25mg</strength><dosageForm>Cap</dosageForm><price>.4498</price><drug id="00386464" sec3="Y"><name>Prolopa 100-25</name><manufacturerId>HLR</manufacturerId><individualPrice>.4498</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000026"><itemNumber>1707</itemNumber><strength>200mg &amp; 50mg</strength><dosageForm>Cap</dosageForm><price>.7551</price><drug id="00386472" sec3="Y"><name>Prolopa 200-50</name><manufacturerId>HLR</manufacturerId><individualPrice>.7551</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01177"><name>LEVODOPA &amp; CARBIDOPA</name><pcgGroup><pcg9 id="920000030"><itemNumber>1708</itemNumber><strength>100mg &amp; 10mg</strength><dosageForm>Tab</dosageForm><price>.1877</price><drug id="00355658" sec3="Y"><name>Sinemet</name><manufacturerId>MFC</manufacturerId><individualPrice>.4348</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02182831" sec3="Y"><name>Nu-Levocarb</name><manufacturerId>NXP</manufacturerId><individualPrice>.1877</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02195933" sec3="Y"><name>Apo-Levocarb</name><manufacturerId>APX</manufacturerId><individualPrice>.1877</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02244494" sec3="Y"><name>Novo-Levocarbidopa</name><manufacturerId>NOP</manufacturerId><individualPrice>.1877</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="920000036"><itemNumber>1709</itemNumber><strength>100mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.2803</price><drug id="00513997" sec3="Y"><name>Sinemet</name><manufacturerId>MFC</manufacturerId><individualPrice>.6492</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02182823" sec3="Y"><name>Nu-Levocarb</name><manufacturerId>NXP</manufacturerId><individualPrice>.2803</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02195941" sec3="Y"><name>Apo-Levocarb</name><manufacturerId>APX</manufacturerId><individualPrice>.2803</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02244495" sec3="Y"><name>Novo-Levocarbidopa</name><manufacturerId>NOP</manufacturerId><individualPrice>.2803</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9></pcgGroup><pcgGroup lccId="00130"><pcg9 id="920000218"><itemNumber>1710</itemNumber><strength>100mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.5126</price><drug id="02028786" sec3="Y" sec12="Y"><name>Sinemet CR</name><manufacturerId>MFC</manufacturerId><individualPrice>.7040</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02272873" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Levocarb CR</name><manufacturerId>APX</manufacturerId><individualPrice>.5126</individualPrice><listingDate>2009-08-18</listingDate></drug></pcg9><pcg9 id="920000217"><itemNumber>1711</itemNumber><strength>200mg &amp; 50mg</strength><dosageForm>Tab</dosageForm><price>.9457</price><drug id="00870935" sec3="Y" sec12="Y"><name>Sinemet CR</name><manufacturerId>MFC</manufacturerId><individualPrice>1.2987</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02245211" sec3="Y" sec12="Y"><name>Apo-Levocarb CR</name><manufacturerId>APX</manufacturerId><individualPrice>.9457</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="64">For patients with Parkinson&apos;s disease who have been treated with conventional therapy (Prolopa or conventional Sinemet), and experienced adverse effects related to drug level fluctuations, such as ON/OFF or wearing off phenomena.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="65">For patients presently requiring anti-parkinsonian drug administration (levodopa/carbidopa) more than three times daily.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup><pcg9 id="920000022"><itemNumber>1712</itemNumber><strength>250mg &amp; 25mg</strength><dosageForm>Tab</dosageForm><price>.3129</price><drug id="00328219" sec3="Y"><name>Sinemet</name><manufacturerId>MFC</manufacturerId><individualPrice>.7247</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02182858" sec3="Y"><name>Nu-Levocarb</name><manufacturerId>NXP</manufacturerId><individualPrice>.3129</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02195968" sec3="Y"><name>Apo-Levocarb</name><manufacturerId>APX</manufacturerId><individualPrice>.3129</individualPrice><listingDate>1996-12-19</listingDate></drug><drug id="02244496" sec3="Y"><name>Novo-Levocarbidopa</name><manufacturerId>NOP</manufacturerId><individualPrice>.3129</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01750"><name>LEVODOPA &amp; CARBIDOPA &amp; ENTACAPONE</name><pcgGroup lccId="00199"><pcg9 id="920000588"><itemNumber>1713</itemNumber><strength>50 &amp; 12.5 &amp; 200mg</strength><dosageForm>Tab</dosageForm><price>1.5609</price><drug id="02305933" dinStatus="N" sec3="Y" sec12="Y"><name>Stalevo</name><manufacturerId>NOV</manufacturerId><individualPrice>1.5609</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="920000589"><itemNumber>1714</itemNumber><strength>100 &amp; 25 &amp; 200mg</strength><dosageForm>Tab</dosageForm><price>1.5609</price><drug id="02305941" dinStatus="N" sec3="Y" sec12="Y"><name>Stalevo</name><manufacturerId>NOV</manufacturerId><individualPrice>1.5609</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><pcg9 id="920000590"><itemNumber>1715</itemNumber><strength>150 &amp; 37.5 &amp; 200mg</strength><dosageForm>Tab</dosageForm><price>1.5609</price><drug id="02305968" dinStatus="N" sec3="Y" sec12="Y"><name>Stalevo</name><manufacturerId>NOV</manufacturerId><individualPrice>1.5609</individualPrice><listingDate>2009-03-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="367">For the treatment of patients with Parkinson&apos;s disease with 25% of the waking day in the off state despite maximally tolerated doses of levodopa.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01408"><name>MONTELUKAST SODIUM</name><pcgGroup lccId="00154"><pcg9 id="920000406"><itemNumber>1716</itemNumber><strength>4mg</strength><dosageForm>Chew Tab</dosageForm><price>1.4410</price><drug id="02243602" sec3="Y" sec12="Y"><name>Singulair</name><manufacturerId>MFC</manufacturerId><individualPrice>1.4410</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="382">For the treatment of asthma in patients aged 2-5 years old.</lccNote><lccNote seq="002" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01277"><name>MYCOPHENOLATE MOFETIL</name><pcgGroup lccId="00131"><pcg9 id="920000510"><itemNumber>1717</itemNumber><strength>200mg/mL</strength><dosageForm>Pd for Oral Susp-175mLPk</dosageForm><price>288.6800</price><drug id="02242145" sec3="Y" sec12="Y"><name>Cellcept</name><manufacturerId>HLR</manufacturerId><individualPrice>288.6800</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="920000223"><itemNumber>1718</itemNumber><strength>250mg</strength><dosageForm>SG Cap</dosageForm><price>2.0620</price><drug id="02192748" sec3="Y" sec12="Y"><name>CellCept</name><manufacturerId>HLR</manufacturerId><individualPrice>2.0620</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9><pcg9 id="920000339"><itemNumber>1719</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>4.1240</price><drug id="02237484" sec3="Y" sec12="Y"><name>CellCept</name><manufacturerId>HLR</manufacturerId><individualPrice>4.1240</individualPrice><listingDate>2000-04-17</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="190">For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01665"><name>MYCOPHENOLATE SODIUM</name><pcgGroup><pcg9 id="920000528"><itemNumber>1720</itemNumber><strength>180mg</strength><dosageForm>Ent Coated Tab</dosageForm><price>1.9977</price><drug id="02264560" sec3="Y"><name>Myfortic</name><manufacturerId>NOV</manufacturerId><individualPrice>1.9977</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><pcg9 id="920000529"><itemNumber>1721</itemNumber><strength>360mg</strength><dosageForm>Ent Coated Tab</dosageForm><price>3.9953</price><drug id="02264579" sec3="Y"><name>Myfortic</name><manufacturerId>NOV</manufacturerId><individualPrice>3.9953</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01199"><name>OCTREOTIDE</name><pcgGroup><pcg9 id="920000332"><itemNumber>1722</itemNumber><strength>10mg</strength><dosageForm>Inj Kit Pk</dosageForm><price>1261.4700</price><drug id="02239323" sec3="Y"><name>Sandostatin LAR</name><manufacturerId>NOV</manufacturerId><individualPrice>1261.4700</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="920000333"><itemNumber>1723</itemNumber><strength>20mg</strength><dosageForm>Inj Kit Pk</dosageForm><price>1629.7600</price><drug id="02239324" sec3="Y"><name>Sandostatin LAR</name><manufacturerId>NOV</manufacturerId><individualPrice>1629.7600</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="920000334"><itemNumber>1724</itemNumber><strength>30mg</strength><dosageForm>Inj Kit Pk</dosageForm><price>2090.9700</price><drug id="02239325" sec3="Y"><name>Sandostatin LAR</name><manufacturerId>NOV</manufacturerId><individualPrice>2090.9700</individualPrice><listingDate>2007-01-02</listingDate></drug></pcg9><pcg9 id="920000083"><itemNumber>1725</itemNumber><strength>50mcg/mL</strength><dosageForm>Inj Sol - 1mL Amp Pk</dosageForm><price>2.4950</price><drug id="00839191" sec3="Y"><name>Sandostatin</name><manufacturerId>NOV</manufacturerId><individualPrice>4.9900</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02248639" sec3="Y"><name>Octreotide Acetate Omega</name><manufacturerId>OMG</manufacturerId><individualPrice>2.4950</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="920000084"><itemNumber>1726</itemNumber><strength>100mcg/mL</strength><dosageForm>Inj Sol - 1mL Amp Pk</dosageForm><price>4.7100</price><drug id="00839205" sec3="Y"><name>Sandostatin</name><manufacturerId>NOV</manufacturerId><individualPrice>9.4200</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02248640" sec3="Y"><name>Octreotide Acetate Omega</name><manufacturerId>OMG</manufacturerId><individualPrice>4.7100</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="920000085"><itemNumber>1727</itemNumber><strength>500mcg/mL</strength><dosageForm>Inj Sol - 1mL Amp Pk</dosageForm><price>22.1350</price><drug id="00839213" sec3="Y"><name>Sandostatin</name><manufacturerId>NOV</manufacturerId><individualPrice>44.2700</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02248641" sec3="Y"><name>Octreotide Acetate Omega</name><manufacturerId>OMG</manufacturerId><individualPrice>22.1350</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9><pcg9 id="920000225"><itemNumber>1728</itemNumber><strength>200mcg/mL</strength><dosageForm>Inj Sol - 5mL Vial Pk</dosageForm><price>45.3000</price><drug id="02049392" sec3="Y"><name>Sandostatin</name><manufacturerId>NOV</manufacturerId><individualPrice>90.6000</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02248642" sec3="Y"><name>Octreotide Acetate Omega</name><manufacturerId>OMG</manufacturerId><individualPrice>45.3000</individualPrice><listingDate>2008-03-25</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01200"><name>PAMIDRONATE DISODIUM</name><pcgGroup><pcg9 id="920000562"><itemNumber>1729</itemNumber><strength>3mg/mL</strength><dosageForm>Inj Sol-10mL Vial</dosageForm><drug id="02059762" notABenefit="Y" sec3="Y"><name>Aredia</name><manufacturerId>NOV</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02245998" notABenefit="Y" sec3="Y"><name>PMS-Pamidronate</name><manufacturerId>PMS</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02264951" notABenefit="Y" sec3="Y"><name>Pamidronate Disodium</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-07-12</listingDate></drug></pcg9><pcg9 id="920000563"><itemNumber>1730</itemNumber><strength>6mg/mL</strength><dosageForm>Inj Sol-10mL Vial</dosageForm><drug id="02059770" notABenefit="Y" sec3="Y"><name>Aredia</name><manufacturerId>NOV</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02264978" notABenefit="Y" sec3="Y"><name>Pamidronate Disodium</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-07-12</listingDate></drug></pcg9><pcg9 id="920000564"><itemNumber>1731</itemNumber><strength>9mg/mL</strength><dosageForm>Inj Sol-10mL Vial</dosageForm><drug id="02059789" notABenefit="Y" sec3="Y"><name>Aredia</name><manufacturerId>NOV</manufacturerId><listingDate>2007-07-12</listingDate></drug><drug id="02245999" notABenefit="Y" sec3="Y"><name>PMS-Pamidronate</name><manufacturerId>PMS</manufacturerId><listingDate>2008-03-25</listingDate></drug><drug id="02264986" notABenefit="Y" sec3="Y"><name>Pamidronate Disodium</name><manufacturerId>SDZ</manufacturerId><listingDate>2007-07-12</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01183"><name>PHENAZOPYRIDINE HCL</name><note>There is no evidence that continuing treatment with phenazopyridine beyond the first 48 hours in urinary tract infections is beneficial.</note><pcgGroup><pcg9 id="920000053"><itemNumber>1732</itemNumber><strength>100mg</strength><dosageForm>Tab</dosageForm><price>.1180</price><drug id="00271489" dinStatus="E" sec3="Y"><name>Phenazo</name><manufacturerId>VAL</manufacturerId><individualPrice>.1180</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00476714" notABenefit="Y" sec3="Y"><name>Pyridium</name><manufacturerId>PDA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="920000054"><itemNumber>1733</itemNumber><strength>200mg</strength><dosageForm>Tab</dosageForm><price>.1636</price><drug id="00454583" sec3="Y"><name>Phenazo</name><manufacturerId>VAL</manufacturerId><individualPrice>.1636</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="00476722" notABenefit="Y" sec3="Y"><name>Pyridium</name><manufacturerId>PDA</manufacturerId><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01682"><name>QUINAGOLIDE HCL</name><pcgGroup lccId="00197"><pcg9 id="920000541"><itemNumber>1734</itemNumber><strength>0.075mg</strength><dosageForm>Tab</dosageForm><price>1.0900</price><drug id="02223767" sec3="Y" sec12="Y"><name>Norprolac</name><manufacturerId>FEI</manufacturerId><individualPrice>1.0900</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><pcg9 id="920000542"><itemNumber>1735</itemNumber><strength>0.15mg</strength><dosageForm>Tab</dosageForm><price>1.6300</price><drug id="02223775" sec3="Y" sec12="Y"><name>Norprolac</name><manufacturerId>FEI</manufacturerId><individualPrice>1.6300</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="405">For the treatment of hyperprolactinemia in patients who have:
 * Failed to respond to a greater than or equal to 3 month trial of bromocriptine;
   or
 * Failed to tolerate bromocriptine; or
 * Failed to shrink a prolactinoma by greater than 1 cm after 12 months of    bromocriptine therapy</lccNote><lccNote seq="002" type="R">LU Authorization Period: 5 years.</lccNote></pcgGroup></genericName><genericName id="01420"><name>RALOXIFENE HCL</name><pcgGroup lccId="00133"><pcg9 id="920000323"><itemNumber>1736</itemNumber><strength>60mg</strength><dosageForm>Tab</dosageForm><price>.9168</price><drug id="02239028" sec3="Y" sec12="Y"><name>Evista</name><manufacturerId>LIL</manufacturerId><individualPrice>1.8336</individualPrice><listingDate>2000-11-30</listingDate></drug><drug id="02279215" dinStatus="N" sec3="Y" sec12="Y"><name>Apo-Raloxifene</name><manufacturerId>APX</manufacturerId><individualPrice>.9168</individualPrice><listingDate>2009-05-20</listingDate></drug><drug id="02312298" dinStatus="N" sec3="Y" sec12="Y"><name>Novo-Raloxifene</name><manufacturerId>NOP</manufacturerId><individualPrice>.9168</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><lccNote seq="001" type="R">For the treatment of osteoporosis in postmenopausal women who have:</lccNote><lccNote seq="002" reasonForUseId="373">Failed or, experienced intractable side effects, or have a contraindication to, alendronate OR risedronate.</lccNote><lccNote seq="003" type="R">Failure is defined as: continued loss of bone mineral density (loss of more than 3%) after two years of therapy; or a new osteoporosis related fracture after one year of therapy.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01441"><name>RISEDRONATE SODIUM</name><pcgGroup><pcg9 id="920000372"><itemNumber>1737</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>.9107</price><drug id="02242518" sec3="Y"><name>Actonel</name><manufacturerId>PGP</manufacturerId><individualPrice>1.8214</individualPrice><listingDate>2001-03-07</listingDate></drug><drug id="02298376" dinStatus="N" sec3="Y"><name>Novo-Risedronate</name><manufacturerId>NOP</manufacturerId><individualPrice>.9107</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000340"><itemNumber>1738</itemNumber><strength>30mg</strength><dosageForm>Tab</dosageForm><price>5.9000</price><drug id="02239146" sec3="Y"><name>Actonel</name><manufacturerId>PGP</manufacturerId><individualPrice>11.8000</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02298384" dinStatus="N" sec3="Y"><name>Novo-Risedronate</name><manufacturerId>NOP</manufacturerId><individualPrice>5.9000</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000430"><itemNumber>1739</itemNumber><strength>35mg</strength><dosageForm>Tab</dosageForm><price>4.8575</price><drug id="02246896" sec3="Y"><name>Actonel</name><manufacturerId>PGP</manufacturerId><individualPrice>9.7150</individualPrice><listingDate>2003-04-16</listingDate></drug><drug id="02298392" dinStatus="N" sec3="Y"><name>Novo-Risedronate</name><manufacturerId>NOP</manufacturerId><individualPrice>4.8575</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000595"><itemNumber>1740</itemNumber><strength>150mg</strength><dosageForm>Tab</dosageForm><price>41.7800</price><drug id="02316838" dinStatus="N" sec3="Y"><name>Actonel</name><manufacturerId>PGP</manufacturerId><individualPrice>41.7800</individualPrice><listingDate>2009-06-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01354"><name>ROPINIROLE</name><pcgGroup><pcg9 id="920000289"><itemNumber>1741</itemNumber><strength>0.25mg</strength><dosageForm>Tab</dosageForm><price>.1419</price><drug id="02232565" sec3="Y"><name>ReQuip</name><manufacturerId>GSK</manufacturerId><individualPrice>.2838</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02314037" dinStatus="N" sec3="Y"><name>Ran-Ropinirole</name><manufacturerId>RAN</manufacturerId><individualPrice>.1419</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02316846" dinStatus="N" sec3="Y"><name>Co Ropinirole</name><manufacturerId>COB</manufacturerId><individualPrice>.1419</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02326590" dinStatus="N" sec3="Y"><name>PMS-Ropinirole</name><manufacturerId>PMS</manufacturerId><individualPrice>.1419</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02332361" dinStatus="N" sec3="Y"><name>Ropinirole Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.1419</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02337746" dinStatus="N" sec3="Y"><name>Apo-Ropinirole</name><manufacturerId>APX</manufacturerId><individualPrice>.1419</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000290"><itemNumber>1742</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.5676</price><drug id="02232567" sec3="Y"><name>ReQuip</name><manufacturerId>GSK</manufacturerId><individualPrice>1.1353</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02314053" dinStatus="N" sec3="Y"><name>Ran-Ropinirole</name><manufacturerId>RAN</manufacturerId><individualPrice>.5677</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02316854" dinStatus="N" sec3="Y"><name>Co Ropinirole</name><manufacturerId>COB</manufacturerId><individualPrice>.5677</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02326612" dinStatus="N" sec3="Y"><name>PMS-Ropinirole</name><manufacturerId>PMS</manufacturerId><individualPrice>.5677</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02332426" dinStatus="N" sec3="Y"><name>Ropinirole Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.5677</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02337762" dinStatus="N" sec3="Y"><name>Apo-Ropinirole</name><manufacturerId>APX</manufacturerId><individualPrice>.5676</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000291"><itemNumber>1743</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.6244</price><drug id="02232568" sec3="Y"><name>ReQuip</name><manufacturerId>GSK</manufacturerId><individualPrice>1.2489</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02314061" dinStatus="N" sec3="Y"><name>Ran-Ropinirole</name><manufacturerId>RAN</manufacturerId><individualPrice>.6245</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02316862" dinStatus="N" sec3="Y"><name>Co Ropinirole</name><manufacturerId>COB</manufacturerId><individualPrice>.6245</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02326620" dinStatus="N" sec3="Y"><name>PMS-Ropinirole</name><manufacturerId>PMS</manufacturerId><individualPrice>.6244</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02332434" dinStatus="N" sec3="Y"><name>Ropinirole Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>.6245</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02337770" dinStatus="N" sec3="Y"><name>Apo-Ropinirole</name><manufacturerId>APX</manufacturerId><individualPrice>.6244</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="920000292"><itemNumber>1744</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>1.7192</price><drug id="02232569" sec3="Y"><name>ReQuip</name><manufacturerId>GSK</manufacturerId><individualPrice>3.4384</individualPrice><listingDate>2000-04-17</listingDate></drug><drug id="02314088" dinStatus="N" sec3="Y"><name>Ran-Ropinirole</name><manufacturerId>RAN</manufacturerId><individualPrice>1.7192</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02316870" dinStatus="N" sec3="Y"><name>Co Ropinirole</name><manufacturerId>COB</manufacturerId><individualPrice>1.7192</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02326639" dinStatus="N" sec3="Y"><name>PMS-Ropinirole</name><manufacturerId>PMS</manufacturerId><individualPrice>1.7192</individualPrice><listingDate>2009-09-30</listingDate></drug><drug id="02332442" dinStatus="N" sec3="Y"><name>Ropinirole Tablets</name><manufacturerId>RAN</manufacturerId><individualPrice>1.7192</individualPrice><listingDate>2010-01-05</listingDate></drug><drug id="02337800" dinStatus="N" sec3="Y"><name>Apo-Ropinirole</name><manufacturerId>APX</manufacturerId><individualPrice>1.7192</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01184"><name>SELEGILINE HCL</name><pcgGroup><pcg9 id="920000056"><itemNumber>1745</itemNumber><strength>5mg</strength><dosageForm>Tab</dosageForm><price>1.0043</price><drug id="02068087" sec3="Y"><name>Novo-Selegiline</name><manufacturerId>NOP</manufacturerId><individualPrice>1.0043</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02123312" dinStatus="E" sec3="Y"><name>Eldepryl</name><manufacturerId>BJH</manufacturerId><individualPrice>2.0085</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02230641" sec3="Y"><name>Apo-Selegiline</name><manufacturerId>APX</manufacturerId><individualPrice>1.0043</individualPrice><listingDate>1997-08-28</listingDate></drug><drug id="02230717" sec3="Y"><name>Nu-Selegiline</name><manufacturerId>NXP</manufacturerId><individualPrice>1.0043</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02231036" sec3="Y"><name>Mylan-Selegiline</name><manufacturerId>MYL</manufacturerId><individualPrice>1.0043</individualPrice><listingDate>1998-12-31</listingDate></drug><drug id="02238102" sec3="Y"><name>PMS-Selegiline</name><manufacturerId>PMS</manufacturerId><individualPrice>1.0043</individualPrice><listingDate>2001-03-07</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01525"><name>SIROLIMUS</name><pcgGroup lccId="00163"><pcg9 id="920000403"><itemNumber>1746</itemNumber><strength>1mg/mL</strength><dosageForm>O/L</dosageForm><price>7.3693</price><drug id="02243237" sec3="Y" sec12="Y"><name>Rapamune</name><manufacturerId>WAY</manufacturerId><individualPrice>7.3693</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="920000450"><itemNumber>1747</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>7.3692</price><drug id="02247111" sec3="Y" sec12="Y"><name>Rapamune</name><manufacturerId>WAY</manufacturerId><individualPrice>7.3692</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="392">For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="00718"><name>SODIUM CROMOGLYCATE</name><pcgGroup><pcg9 id="920000038"><itemNumber>1748</itemNumber><strength>1%</strength><dosageForm>Inh Sol-2mL Pk</dosageForm><price>.4846</price><drug id="00534609" notABenefit="Y" sec3="Y"><name>Intal</name><manufacturerId>AVE</manufacturerId><listingDate>1996-10-01</listingDate></drug><drug id="02046113" sec3="Y"><name>PMS-Sodium Cromoglycate</name><manufacturerId>PMS</manufacturerId><individualPrice>.4846</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01276"><name>TACROLIMUS</name><pcgGroup lccId="00137"><pcg9 id="920000224"><itemNumber>1749</itemNumber><strength>5mg/mL</strength><dosageForm>Amp</dosageForm><price>124.5000</price><drug id="02176009" sec3="Y" sec12="Y"><name>Prograf</name><manufacturerId>ASE</manufacturerId><individualPrice>124.5000</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="920000391"><itemNumber>1750</itemNumber><strength>0.5mg</strength><dosageForm>Cap</dosageForm><price>1.9700</price><drug id="02243144" dinStatus="N" sec3="Y" sec12="Y"><name>Prograf</name><manufacturerId>ASE</manufacturerId><individualPrice>1.9700</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="920000221"><itemNumber>1751</itemNumber><strength>1mg</strength><dosageForm>Cap</dosageForm><price>2.5200</price><drug id="02175991" sec3="Y" sec12="Y"><name>Prograf</name><manufacturerId>ASE</manufacturerId><individualPrice>2.5200</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><pcg9 id="920000222"><itemNumber>1752</itemNumber><strength>5mg</strength><dosageForm>Cap</dosageForm><price>12.6200</price><drug id="02175983" sec3="Y" sec12="Y"><name>Prograf</name><manufacturerId>ASE</manufacturerId><individualPrice>12.6200</individualPrice><listingDate>1996-12-19</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="173">For solid organ transplant and bone marrow transplant.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00200"><pcg9 id="920000591"><itemNumber>1753</itemNumber><strength>0.5mg</strength><dosageForm>ER Cap</dosageForm><price>1.9700</price><drug id="02296462" dinStatus="N" sec3="Y" sec12="Y"><name>Advagraf</name><manufacturerId>ASE</manufacturerId><individualPrice>1.9700</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="920000592"><itemNumber>1754</itemNumber><strength>1mg</strength><dosageForm>ER Cap</dosageForm><price>2.5200</price><drug id="02296470" dinStatus="N" sec3="Y" sec12="Y"><name>Advagraf</name><manufacturerId>ASE</manufacturerId><individualPrice>2.5200</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><pcg9 id="920000593"><itemNumber>1755</itemNumber><strength>5mg</strength><dosageForm>ER Cap</dosageForm><price>12.6200</price><drug id="02296489" dinStatus="N" sec3="Y" sec12="Y"><name>Advagraf</name><manufacturerId>ASE</manufacturerId><individualPrice>12.6200</individualPrice><listingDate>2009-04-01</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="410">For prophylaxis of organ rejection in adult patients receiving allogeneic kidney transplants

</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00153"><pcg9 id="920000411"><itemNumber>1756</itemNumber><strength>0.03%</strength><dosageForm>Oint</dosageForm><price>2.1500</price><drug id="02244149" sec3="Y" sec12="Y"><name>Protopic</name><manufacturerId>ASE</manufacturerId><individualPrice>2.1500</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="920000402"><itemNumber>1757</itemNumber><strength>0.1%</strength><dosageForm>Oint</dosageForm><price>2.3000</price><drug id="02244148" sec3="Y" sec12="Y"><name>Protopic</name><manufacturerId>ASE</manufacturerId><individualPrice>2.3000</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="383">For use in combination with moisturizers or oral antihistamines in patients with atopic dermatitis who have failed or are intolerant to an 8 week trial of an intermediate potency topical steroid.</lccNote><lccNote seq="002" type="R">Therapy should be reassessed at 6 months.</lccNote><lccNote seq="003" type="R">LU Authorization Period: 1 year.</lccNote></pcgGroup></genericName><genericName id="01392"><name>TAMSULOSIN HCL</name><pcgGroup lccId="00138"><pcg9 id="920000534"><itemNumber>1758</itemNumber><strength>0.4mg</strength><price>.4500</price><note>Note: Randomized controlled trials have shown no significant differences in efficacy between daily doses of 0.4mg and 0.8mg of tamsulosin. Therefore, the daily tamsulosin dose should not exceed 0.4mg.</note><drug id="02270102" sec3="Y" sec12="Y"><name>Flomax CR Tab</name><manufacturerId>BOE</manufacturerId><individualPrice>.6000</individualPrice><listingDate>2006-06-15</listingDate></drug><drug id="09857334" dinStatus="N" sec3="Y" sec12="Y"><name>Ratio-Tamsulosin Cap</name><manufacturerId>RPH</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2009-09-30</listingDate></drug></pcg9><pcg9 id="920000298"><itemNumber>1759</itemNumber><strength>0.4mg</strength><dosageForm>Cap</dosageForm><price>.4500</price><note>Note:  Randomized controlled trials have shown no significant differences in
efficacy between daily doses of 0.4mg and 0.8mg of tamsulosin. Therefore,
the daily tamsulosin dose should not exceed 0.4mg.
</note><drug id="02238123" notABenefit="Y" sec3="Y"><name>Flomax</name><manufacturerId>BOE</manufacturerId><listingDate>2002-04-04</listingDate></drug><drug id="02281392" sec3="Y" sec12="Y"><name>Novo-Tamsulosin SR</name><manufacturerId>NOP</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-01-02</listingDate></drug><drug id="02294265" sec3="Y" sec12="Y"><name>Ratio-Tamsulosin</name><manufacturerId>RPH</manufacturerId><individualPrice>.4500</individualPrice><listingDate>2007-06-06</listingDate></drug><drug id="02294885" sec3="Y" sec12="Y"><name>Ran-Tamsulosin</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-12-19</listingDate></drug><drug id="02295121" sec3="Y" sec12="Y"><name>Sandoz Tamsulosin</name><manufacturerId>SDZ</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-09-04</listingDate></drug><drug id="02298570" sec3="Y" sec12="Y"><name>Gen-Tamsulosin</name><manufacturerId>GEN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2007-10-03</listingDate></drug><drug id="02331780" dinStatus="N" sec3="Y" sec12="Y"><name>Tamsulosin Capsules</name><manufacturerId>RAN</manufacturerId><individualPrice>.4750</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="351">For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g. doxazosin, terazosin) have been ineffective.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="352">For the management of benign prostatic hyperplasia where other formulary alpha blockers have produced intolerable side effects.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01275"><name>TICLOPIDINE HCL</name><pcgGroup lccId="00139"><pcg9 id="920000219"><itemNumber>1760</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.5464</price><drug id="02162776" dinStatus="E" sec3="Y" sec12="Y"><name>Ticlid</name><manufacturerId>HLR</manufacturerId><individualPrice>1.2564</individualPrice><listingDate>1996-10-01</listingDate></drug><drug id="02236848" sec3="Y" sec12="Y"><name>Novo-Ticlopidine</name><manufacturerId>NOP</manufacturerId><individualPrice>.5464</individualPrice><listingDate>2003-09-04</listingDate></drug><drug id="02237560" sec3="Y" sec12="Y"><name>Nu-Ticlopidine</name><manufacturerId>NXP</manufacturerId><individualPrice>.5464</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02237701" sec3="Y" sec12="Y"><name>Apo-Ticlopidine</name><manufacturerId>APX</manufacturerId><individualPrice>.5464</individualPrice><listingDate>1999-04-15</listingDate></drug><drug id="02239744" sec3="Y" sec12="Y"><name>Mylan-Ticlopidine</name><manufacturerId>MYL</manufacturerId><individualPrice>.5464</individualPrice><listingDate>1999-09-15</listingDate></drug><drug id="02243587" sec3="Y" sec12="Y"><name>Sandoz Ticlopidine</name><manufacturerId>SDZ</manufacturerId><individualPrice>.5464</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><lccNote seq="001" type="R">Ticlopidine is restricted to patients with transient cerebral ischemia. Ticlopidine may be somewhat more effective than ASA in preventing fatal and non-fatal strokes. However, it is associated with neutropenia in 0.8-2.4% of patients, a serious side-effect which may be fatal. Patients on ticlopidine require blood tests every two weeks for the first three months of therapy. There have been more than 60 cases of ticlopidine associated thrombotic thrombocytopenic purpura (TTP) with 33% mortality rate. As well, there are other side-effects such as diarrhea that occurs in 12.5% of patients. Ticlopidine should be used only after careful consideration. The appropriate use of ticlopidine in the management of patients with cerebral ischemic events (TIA or stroke) is based on the following:
(a) Determining that the symptoms are due to focal cerebral ischemia, and differentiating the symptoms of dizziness due to vestibular dysfunction, lightheadedness, or syncope from antihypertensive drugs or cardiac dysfunction, and from symptoms due to migraine, epilepsy, hypoglycemia, or other causes, such as tumor.
(b) If investigation demonstrates that the events are caused by emboli from the heart, the patient should be treated with anticoagulants, such as warfarin.
(c) If the events are due to artery-to-artery emboli from the carotid bifurcation with a severe stenosis, the patient should probably be treated with ASA and offered carotid endarterectomy if medically suitable (70% to 99% stenosis).
(d) ASA should be the first line of defense for patients with TIA and threatened stroke, and after an initial stroke of any severity.
(e) The only drugs other than ASA that are available as platelet inhibitors and which have been shown to be of value for such patients are ticlopidine and clopidogrel.
(f) Before abandoning ASA in favour of ticlopidine, efforts should be made to improve the tolerability of ASA by reducing the dose, taking it with food, and using enteric coated ASA.

Ticlopidine will be reimbursed for patients:</lccNote><lccNote seq="002" reasonForUseId="219">Who are known to be, or become, intolerant of ASA;</lccNote><lccNote seq="003" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="004" reasonForUseId="220">Where ASA is contraindicated;</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="006" reasonForUseId="221">Who continue to have TIA or stroke symptoms while being treated with ASA.</lccNote><lccNote seq="007" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01419"><name>TOLTERODINE L-TARTRATE</name><pcgGroup lccId="00140"><pcg9 id="920000451"><itemNumber>1761</itemNumber><strength>2mg</strength><dosageForm>SR Cap</dosageForm><price>1.8546</price><drug id="02244612" sec3="Y" sec12="Y"><name>Detrol LA</name><manufacturerId>PFI</manufacturerId><individualPrice>1.8546</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="920000452"><itemNumber>1762</itemNumber><strength>4mg</strength><dosageForm>SR Cap</dosageForm><price>1.8546</price><drug id="02244613" sec3="Y" sec12="Y"><name>Detrol LA</name><manufacturerId>PFI</manufacturerId><individualPrice>1.8546</individualPrice><listingDate>2004-04-06</listingDate></drug></pcg9><pcg9 id="920000318"><itemNumber>1763</itemNumber><strength>1mg</strength><dosageForm>Tab</dosageForm><price>.9273</price><drug id="02239064" sec3="Y" sec12="Y"><name>Detrol</name><manufacturerId>PFI</manufacturerId><individualPrice>.9273</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="920000319"><itemNumber>1764</itemNumber><strength>2mg</strength><dosageForm>Tab</dosageForm><price>.9273</price><drug id="02239065" sec3="Y" sec12="Y"><name>Detrol</name><manufacturerId>PFI</manufacturerId><individualPrice>.9273</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="290">For patients with urinary frequency, urgency or urge incontinence who have:</lccNote><lccNote seq="002" type="R">Failed to respond to behavioral techniques AND</lccNote><lccNote seq="003" type="R">An adequate trial of oxybutynin with gradual dose escalation has shown to be either ineffective or resulted in unacceptable side effects.</lccNote><lccNote seq="004" type="N">If after a trial of 2 weeks patients continue to experience similar side effects and no greater efficacy than oxybutynin, continued therapy with this more costly agent should be reassessed.</lccNote><lccNote seq="005" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01203"><name>URSODIOL</name><pcgGroup lccId="00141"><pcg9 id="920000308"><itemNumber>1765</itemNumber><strength>250mg</strength><dosageForm>Tab</dosageForm><price>.8635</price><drug id="02238984" sec3="Y" sec12="Y"><name>Urso</name><manufacturerId>BFI</manufacturerId><individualPrice>1.2561</individualPrice><listingDate>2000-01-17</listingDate></drug><drug id="02273497" sec3="Y" sec12="Y"><name>PMS-Ursodiol C</name><manufacturerId>PMS</manufacturerId><individualPrice>.8635</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="273">For the treatment of primary biliary cirrhosis.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup><pcgGroup lccId="00158"><pcg9 id="920000494"><itemNumber>1766</itemNumber><strength>500mg</strength><dosageForm>Tab</dosageForm><price>1.6380</price><drug id="02245894" sec3="Y" sec12="Y"><name>Urso DS</name><manufacturerId>BFI</manufacturerId><individualPrice>2.3826</individualPrice><listingDate>2004-04-06</listingDate></drug><drug id="02273500" sec3="Y" sec12="Y"><name>PMS-Ursodiol C</name><manufacturerId>PMS</manufacturerId><individualPrice>1.6380</individualPrice><listingDate>2007-04-02</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="273">For the treatment of primary biliary cirrhosis.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote><lccNote seq="003" reasonForUseId="386">For the treatment of primary sclerosing cholangitis.</lccNote><lccNote seq="004" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName><genericName id="01599"><name>ZOLEDRONIC ACID</name><pcgGroup lccId="00195"><pcg9 id="920000536"><itemNumber>1767</itemNumber><strength>5mg/100mL</strength><dosageForm>Inj Sol-100mL Pk</dosageForm><price>670.8000</price><drug id="02269198" sec3="Y" sec12="Y"><name>Aclasta</name><manufacturerId>NOV</manufacturerId><individualPrice>670.8000</individualPrice><listingDate>2006-10-23</listingDate></drug></pcg9><lccNote seq="001" reasonForUseId="319">For the treatment of Paget&apos;s disease.</lccNote><lccNote seq="002" type="R">LU Authorization Period: Indefinite.</lccNote></pcgGroup></genericName></pcg6></pcg2><pcg2 id="960000000"><name>MISCELLANEOUS</name><pcg6 id="960100000"><name>NUTRITION PRODUCTS</name><genericName id="01352"><name>NUTRITIONAL PRODUCT</name><pcgGroup><pcg9 id="960100125"><dosageForm>Liq-1000mL Pk</dosageForm><price>7.9700</price><drug id="09854231" additionalBenefitType="N" sec9="Y"><name>Compleat Modified</name><manufacturerId>NON</manufacturerId><individualPrice>7.9700</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100131"><dosageForm>Liq-1000mL Pk</dosageForm><price>11.4800</price><drug id="09854391" additionalBenefitType="N" sec9="Y"><name>Perative</name><manufacturerId>ROS</manufacturerId><individualPrice>11.4800</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960100133"><dosageForm>Liq-1000mL Pk</dosageForm><price>7.6800</price><drug id="09854393" additionalBenefitType="N" sec9="Y"><name>Glucerna Tube Feeding</name><manufacturerId>ABB</manufacturerId><individualPrice>7.6800</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960100139"><strength>1.06kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>5.3400</price><drug id="09854444" dinStatus="E" additionalBenefitType="N" sec9="Y"><name>Osmolite 1 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>5.3400</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100141"><strength>1.06kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>8.1400</price><drug id="09854460" additionalBenefitType="N" sec9="Y"><name>Jevity 1 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>8.1400</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100143"><strength>1.2kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>6.0500</price><drug id="09854487" dinStatus="E" additionalBenefitType="N" sec9="Y"><name>Osmolite 1.2 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>6.0500</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100145"><strength>1.2kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>9.1300</price><drug id="09857109" additionalBenefitType="N" sec9="Y"><name>Jevity 1.2 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>9.1300</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100159"><strength>1.5kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>41.0400</price><drug id="09857126" additionalBenefitType="N" sec9="Y"><name>Peptamen 1.5</name><manufacturerId>NES</manufacturerId><individualPrice>41.0400</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9><pcg9 id="960100163"><strength>1.5kcal/mL</strength><dosageForm>Liq-1000mL Pk</dosageForm><price>11.5200</price><drug id="09857310" additionalBenefitType="N" sec9="Y"><name>Jevity 1.5 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>11.5200</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="960100140"><strength>1.06kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>8.0100</price><drug id="09854452" additionalBenefitType="N" sec9="Y"><name>Osmolite 1 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>8.0100</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100142"><strength>1.06kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>12.2200</price><drug id="09854479" additionalBenefitType="N" sec9="Y"><name>Jevity 1 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>12.2200</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100144"><strength>1.2kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>9.0700</price><drug id="09857095" additionalBenefitType="N" sec9="Y"><name>Osmolite 1.2 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>9.0700</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100146"><strength>1.2kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>13.7000</price><drug id="09857117" additionalBenefitType="N" sec9="Y"><name>Jevity 1.2 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>13.7000</individualPrice><listingDate>2003-04-16</listingDate></drug></pcg9><pcg9 id="960100164"><strength>1.5kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>17.2800</price><drug id="09857312" additionalBenefitType="N" sec9="Y"><name>Jevity 1.5 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>17.2800</individualPrice><listingDate>2008-12-03</listingDate></drug></pcg9><pcg9 id="960100157"><strength>1kcal/mL</strength><dosageForm>Liq-1500mL Pk</dosageForm><price>42.6900</price><drug id="09857102" additionalBenefitType="N" sec9="Y"><name>Peptamen with Prebio</name><manufacturerId>NES</manufacturerId><individualPrice>42.6900</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="960100008"><dosageForm>Liq-235mL Pk</dosageForm><price>2.0000</price><drug id="97904317" additionalBenefitType="N" sec9="Y"><name>Ensure with Fibre</name><manufacturerId>ABB</manufacturerId><individualPrice>2.0000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100009"><dosageForm>Liq-235mL Pk</dosageForm><price>1.7900</price><drug id="97904333" additionalBenefitType="N" sec9="Y"><name>Ensure Plus</name><manufacturerId>ABB</manufacturerId><individualPrice>1.7900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100037"><dosageForm>Liq-235mL Pk</dosageForm><price>1.2600</price><drug id="97973165" dinStatus="E" additionalBenefitType="N" sec9="Y"><name>Osmolite HN</name><manufacturerId>ABB</manufacturerId><individualPrice>1.2600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100058"><dosageForm>Liq-235mL Pk</dosageForm><price>2.4700</price><drug id="97984370" additionalBenefitType="N" sec9="Y"><name>PediaSure</name><manufacturerId>ABB</manufacturerId><individualPrice>2.4700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100088"><dosageForm>Liq-235mL Pk</dosageForm><price>1.5300</price><drug id="09853154" additionalBenefitType="N" sec9="Y"><name>Boost Fruit Flavoured Beverage</name><manufacturerId>NES</manufacturerId><individualPrice>1.5300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100106"><dosageForm>Liq-235mL Pk</dosageForm><price>2.3700</price><drug id="09853723" additionalBenefitType="N" sec9="Y"><name>Nepro</name><manufacturerId>ABB</manufacturerId><individualPrice>2.3700</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="960100107"><dosageForm>Liq-235mL Pk</dosageForm><price>2.3700</price><drug id="09853731" additionalBenefitType="N" sec9="Y"><name>Suplena</name><manufacturerId>ABB</manufacturerId><individualPrice>2.3700</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="960100118"><dosageForm>Liq-235mL Pk</dosageForm><price>1.4400</price><drug id="09854169" dinStatus="E" additionalBenefitType="N" sec9="Y"><name>Osmolite HN Plus</name><manufacturerId>ABB</manufacturerId><individualPrice>1.4400</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100059"><strength>1.06kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>1.9200</price><drug id="97984060" additionalBenefitType="N" sec9="Y"><name>Jevity 1 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>1.9200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100108"><strength>1.2kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>2.1700</price><drug id="09854096" additionalBenefitType="N" sec9="Y"><name>Jevity 1.2 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>2.1700</individualPrice><listingDate>2000-01-17</listingDate></drug></pcg9><pcg9 id="960100149"><strength>1.5kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>2.7400</price><drug id="09857419" additionalBenefitType="N" sec9="Y"><name>Pediasure Plus with Fibre</name><manufacturerId>ROS</manufacturerId><individualPrice>2.7400</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="960100169"><strength>1.5kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>2.7025</price><drug id="09857344" additionalBenefitType="N" sec9="Y"><name>Jevity 1.5 Cal</name><manufacturerId>ABB</manufacturerId><individualPrice>2.7025</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9><pcg9 id="960100135"><strength>1kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>2.4700</price><drug id="09854371" additionalBenefitType="N" sec9="Y"><name>Pediasure with Fibre</name><manufacturerId>ROS</manufacturerId><individualPrice>2.4700</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="960100136"><strength>2kcal/mL</strength><dosageForm>Liq-235mL Pk</dosageForm><price>2.3688</price><drug id="09854380" additionalBenefitType="N" sec9="Y"><name>TwoCal HN</name><manufacturerId>ROS</manufacturerId><individualPrice>2.3688</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="960100132"><dosageForm>Liq-235mLPk</dosageForm><price>1.8000</price><drug id="09854392" additionalBenefitType="N" sec9="Y"><name>Glucerna Tube Feeding</name><manufacturerId>ABB</manufacturerId><individualPrice>1.8000</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960100111"><dosageForm>Liq-237mL Pk</dosageForm><price>2.0500</price><drug id="09853170" additionalBenefitType="N" sec9="Y"><name>Resource 2.0</name><manufacturerId>NES</manufacturerId><individualPrice>2.0500</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="960100127"><dosageForm>Liq-237mL Pk</dosageForm><price>2.0500</price><drug id="09854258" additionalBenefitType="N" sec9="Y"><name>NovaSource Renal</name><manufacturerId>NES</manufacturerId><individualPrice>2.0500</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100129"><dosageForm>Liq-237mL Pk</dosageForm><price>7.3000</price><drug id="09854274" additionalBenefitType="N" sec9="Y"><name>Optimental</name><manufacturerId>ABB</manufacturerId><individualPrice>7.3000</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="960100130"><dosageForm>Liq-237mL Pk</dosageForm><price>2.7200</price><drug id="09854390" additionalBenefitType="N" sec9="Y"><name>Perative</name><manufacturerId>ROS</manufacturerId><individualPrice>2.7200</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960100046"><strength>1.06kcal/mL</strength><dosageForm>Liq-237mL Pk</dosageForm><price>1.2300</price><drug id="97982580" additionalBenefitType="N" sec9="Y"><name>Boost 1.0 Standard</name><manufacturerId>NES</manufacturerId><individualPrice>1.2300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100047"><strength>1.5kcal/mL</strength><dosageForm>Liq-237mL Pk</dosageForm><price>1.5500</price><drug id="97982610" additionalBenefitType="N" sec9="Y"><name>Boost 1.5 Plus Calories</name><manufacturerId>NES</manufacturerId><individualPrice>1.5500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100160"><strength>1.5kcal/mL</strength><dosageForm>Liq-237mL Pk</dosageForm><price>2.3280</price><drug id="09857142" additionalBenefitType="N" sec9="Y"><name>Resource Just for Kids 1.5 Cal</name><manufacturerId>NES</manufacturerId><individualPrice>2.3280</individualPrice><listingDate>2005-09-27</listingDate></drug></pcg9><pcg9 id="960100165"><strength>1kcal/mL</strength><dosageForm>Liq-237mL Pk</dosageForm><price>6.3700</price><drug id="09857335" additionalBenefitType="N" sec9="Y"><name>E028 Splash (Grape Flavoured)</name><manufacturerId>SHL</manufacturerId><individualPrice>6.3700</individualPrice><listingDate>2009-11-13</listingDate></drug></pcg9><pcg9 id="960100166"><strength>1kcal/mL</strength><dosageForm>Liq-237mL Pk</dosageForm><price>6.3700</price><drug id="09857336" additionalBenefitType="N" sec9="Y"><name>E028 Splash (Orange-Pineapple Flavoured)</name><manufacturerId>SHL</manufacturerId><individualPrice>6.3700</individualPrice><listingDate>2009-11-13</listingDate></drug></pcg9><pcg9 id="960100006"><dosageForm>Liq-250mL Pk</dosageForm><price>2.0300</price><drug id="97983330" additionalBenefitType="N" sec9="Y"><name>Compleat Modified</name><manufacturerId>NES</manufacturerId><individualPrice>2.0300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100075"><dosageForm>Liq-250mL Pk</dosageForm><price>1.2000</price><drug id="97984663" additionalBenefitType="N" sec9="Y"><name>IsoSource HN</name><manufacturerId>NES</manufacturerId><individualPrice>1.2000</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100082"><dosageForm>Liq-250mL Pk</dosageForm><price>7.1200</price><drug id="97984779" additionalBenefitType="N" sec9="Y"><name>Peptamen</name><manufacturerId>NES</manufacturerId><individualPrice>7.1200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100091"><dosageForm>Liq-250mL Pk</dosageForm><price>1.2600</price><drug id="09853529" additionalBenefitType="N" sec9="Y"><name>NuBasic</name><manufacturerId>NES</manufacturerId><individualPrice>1.2600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100092"><dosageForm>Liq-250mL Pk</dosageForm><price>1.8900</price><drug id="09853537" additionalBenefitType="N" sec9="Y"><name>NuBasic Plus</name><manufacturerId>NES</manufacturerId><individualPrice>1.8900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100095"><dosageForm>Liq-250mL Pk</dosageForm><price>1.2700</price><drug id="09853553" additionalBenefitType="N" sec9="Y"><name>IsoSource VHN</name><manufacturerId>NES</manufacturerId><individualPrice>1.2700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100096"><dosageForm>Liq-250mL Pk</dosageForm><price>1.2800</price><drug id="09853561" additionalBenefitType="N" sec9="Y"><name>NuBasic VHP</name><manufacturerId>NES</manufacturerId><individualPrice>1.2800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100098"><dosageForm>Liq-250mL Pk</dosageForm><price>7.1200</price><drug id="09853588" additionalBenefitType="N" sec9="Y"><name>Peptamen Junior</name><manufacturerId>NES</manufacturerId><individualPrice>7.1200</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100128"><dosageForm>Liq-250mL Pk</dosageForm><price>1.8700</price><drug id="09854266" additionalBenefitType="N" sec9="Y"><name>IsoSource 1.5 Cal</name><manufacturerId>NES</manufacturerId><individualPrice>1.8700</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100134"><dosageForm>Liq-250mL Pk</dosageForm><price>1.8300</price><drug id="09854363" additionalBenefitType="N" sec9="Y"><name>IsoSource HN with Fibre</name><manufacturerId>NES</manufacturerId><individualPrice>1.8300</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960100150"><strength>1.06kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>1.7400</price><drug id="09857427" additionalBenefitType="N" sec9="Y"><name>Resource Diabetic</name><manufacturerId>NES</manufacturerId><individualPrice>1.7400</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="960100077"><strength>1.5kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>1.8900</price><drug id="97984698" additionalBenefitType="N" sec9="Y"><name>Nutren 1.5</name><manufacturerId>NES</manufacturerId><individualPrice>1.8900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100109"><strength>1.5kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>10.2600</price><drug id="09853090" additionalBenefitType="N" sec9="Y"><name>Peptamen 1.5</name><manufacturerId>NES</manufacturerId><individualPrice>10.2600</individualPrice><listingDate>2000-07-17</listingDate></drug></pcg9><pcg9 id="960100076"><strength>1kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>1.2600</price><drug id="97984671" additionalBenefitType="N" sec9="Y"><name>Nutren 1.0</name><manufacturerId>NES</manufacturerId><individualPrice>1.2600</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100123"><strength>1kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>1.6480</price><drug id="09854215" additionalBenefitType="N" sec9="Y"><name>Nutren Junior</name><manufacturerId>NES</manufacturerId><individualPrice>1.6480</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100124"><strength>1kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>1.6480</price><drug id="09854223" additionalBenefitType="N" sec9="Y"><name>Nutren Junior Fibre</name><manufacturerId>NES</manufacturerId><individualPrice>1.6480</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960100156"><strength>1kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>7.1200</price><drug id="09857101" additionalBenefitType="N" sec9="Y"><name>Peptamen with Prebio</name><manufacturerId>NES</manufacturerId><individualPrice>7.1200</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="960100162"><strength>1kcal/mL</strength><dosageForm>Liq-250mL Pk</dosageForm><price>2.5920</price><drug id="09857173" additionalBenefitType="N" sec9="Y"><name>Compleat Pediatric</name><manufacturerId>NES</manufacturerId><individualPrice>2.5920</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><pcg9 id="960100045"><dosageForm>Liq-384mL Pk</dosageForm><price>6.2700</price><drug id="97973084" additionalBenefitType="N" sec9="Y"><name>RCF</name><manufacturerId>ABB</manufacturerId><individualPrice>6.2700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100066"><dosageForm>Liq-4x237mL Pk</dosageForm><price>5.6500</price><drug id="97984558" additionalBenefitType="N" sec9="Y"><name>Alimentum</name><manufacturerId>ABB</manufacturerId><individualPrice>5.6500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100168"><strength>0.68kcal/mL</strength><dosageForm>Liq-945mL Pk</dosageForm><price>8.4373</price><drug id="09857347" additionalBenefitType="N" sec9="Y"><name>Nutramigen A+</name><manufacturerId>MJN</manufacturerId><individualPrice>8.4373</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="960100025"><strength>7.7kcal/mL</strength><dosageForm>Liq-946mL Pk</dosageForm><price>34.4900</price><drug id="97904473" additionalBenefitType="N" sec9="Y"><name>MCT Oil</name><manufacturerId>NES</manufacturerId><individualPrice>34.4900</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100161"><strength>22kcal/30mL</strength><dosageForm>Pd for Liq-363g Pk</dosageForm><price>15.2928</price><drug id="09857172" additionalBenefitType="N" sec9="Y"><name>Enfamil EnfaCare A+</name><manufacturerId>MJS</manufacturerId><individualPrice>15.2928</individualPrice><listingDate>2006-01-12</listingDate></drug></pcg9><pcg9 id="960100121"><dosageForm>Pd-10g Pouch</dosageForm><price>.6400</price><drug id="09854193" additionalBenefitType="N" sec9="Y"><name>HMS 90</name><manufacturerId>IMM</manufacturerId><individualPrice>.6400</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="960100001"><dosageForm>Pd-1Kg Pk</dosageForm><price>18.8300</price><drug id="97983250" additionalBenefitType="N" sec9="Y"><name>Caloreen</name><manufacturerId>NES</manufacturerId><individualPrice>18.8300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100137"><strength>7.2kcal/g</strength><dosageForm>Pd-300g Pk</dosageForm><price>30.0000</price><drug id="09854398" additionalBenefitType="N" sec9="Y"><name>KetoCal</name><manufacturerId>SHS</manufacturerId><individualPrice>30.0000</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="960100055"><dosageForm>Pd-350g Pk</dosageForm><price>6.2700</price><drug id="97972592" additionalBenefitType="N" sec9="Y"><name>Polycose</name><manufacturerId>ABB</manufacturerId><individualPrice>6.2700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100158"><strength>5.15kcal/g</strength><dosageForm>Pd-363g Pk</dosageForm><price>14.9900</price><drug id="09857124" additionalBenefitType="N" sec9="Y"><name>Similac Advance NeoSure</name><manufacturerId>ABB</manufacturerId><individualPrice>14.9900</individualPrice><listingDate>2004-07-20</listingDate></drug></pcg9><pcg9 id="960100114"><dosageForm>Pd-400g Pk</dosageForm><price>35.0000</price><drug id="09853510" additionalBenefitType="N" sec9="Y"><name>Neocate</name><manufacturerId>SHS</manufacturerId><individualPrice>35.0000</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="960100122"><strength>1kcal/mL</strength><dosageForm>Pd-400g Pk</dosageForm><price>37.5000</price><drug id="09854207" additionalBenefitType="N" sec9="Y"><name>Neocate Junior</name><manufacturerId>SHS</manufacturerId><individualPrice>37.5000</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="960100042"><dosageForm>Pd-454g Pk</dosageForm><price>18.3800</price><drug id="97982440" additionalBenefitType="N" sec9="Y"><name>Pregestimil</name><manufacturerId>MJN</manufacturerId><individualPrice>18.3800</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100138"><strength>1.02kcal/mL</strength><dosageForm>Pd-454g Pk</dosageForm><price>22.2300</price><drug id="09854401" additionalBenefitType="N" sec9="Y"><name>Portagen</name><manufacturerId>MJN</manufacturerId><individualPrice>22.2300</individualPrice><listingDate>2003-01-30</listingDate></drug></pcg9><pcg9 id="960100167"><strength>5kcal/g</strength><dosageForm>Pd-454g Pk</dosageForm><price>19.9412</price><drug id="09857345" additionalBenefitType="N" sec9="Y"><name>Nutramigen A+</name><manufacturerId>MJN</manufacturerId><individualPrice>19.9412</individualPrice><listingDate>2010-03-02</listingDate></drug></pcg9><pcg9 id="960100089"><dosageForm>Pd-48.7g Pk</dosageForm><price>7.0300</price><drug id="09853308" additionalBenefitType="N" sec9="Y"><name>Vivonex Pediatric</name><manufacturerId>NES</manufacturerId><individualPrice>7.0300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100002"><dosageForm>Pd-5Kg Pk</dosageForm><price>81.8500</price><drug id="97980390" additionalBenefitType="N" sec9="Y"><name>Caloreen</name><manufacturerId>NES</manufacturerId><individualPrice>81.8500</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100054"><dosageForm>Pd-79.5g Pk</dosageForm><price>7.0300</price><drug id="97982830" additionalBenefitType="N" sec9="Y"><name>Vivonex Plus</name><manufacturerId>NES</manufacturerId><individualPrice>7.0300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100053"><dosageForm>Pd-79g Pk</dosageForm><price>7.7700</price><drug id="97983500" additionalBenefitType="N" sec9="Y"><name>Vital HN</name><manufacturerId>ABB</manufacturerId><individualPrice>7.7700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100097"><dosageForm>Pd-80.4g Pk</dosageForm><price>7.0300</price><drug id="09853618" additionalBenefitType="N" sec9="Y"><name>Vivonex T.E.N.</name><manufacturerId>NES</manufacturerId><individualPrice>7.0300</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960100052"><dosageForm>Pd-80g Pk</dosageForm><price>4.1700</price><drug id="97982750" additionalBenefitType="N" sec9="Y"><name>Tolerex</name><manufacturerId>NES</manufacturerId><individualPrice>4.1700</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6><pcg6 id="960500000"><name>DIABETIC TESTING AGENTS</name><genericName id="01770"><name>GLUCOSE DEHYDROGENASE</name><pcgGroup><pcg9 id="960500032"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857127" additionalBenefitType="D" sec9="Y"><name>Contour</name><manufacturerId>BAY</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2004-11-04</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00590"><name>GLUCOSE OXIDASE REAGENT</name><pcgGroup><pcg9 id="960500002"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853162" additionalBenefitType="D" sec9="Y"><name>Accutrend</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500003"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853103" additionalBenefitType="D" sec9="Y"><name>Encore</name><manufacturerId>BAY</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500004"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853243" additionalBenefitType="D" sec9="Y"><name>One Touch</name><manufacturerId>LIF</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500005"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853146" additionalBenefitType="D" sec9="Y"><name>Precision Plus</name><manufacturerId>MED</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500006"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853081" additionalBenefitType="D" sec9="Y"><name>Accu-Chek Easy</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500007"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853219" additionalBenefitType="D" sec9="Y"><name>Exactech</name><manufacturerId>MED</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500008"><dosageForm>Strip</dosageForm><price>.7193</price><drug id="09853189" additionalBenefitType="D" sec9="Y"><name>Chemstrip bG</name><manufacturerId>ROD</manufacturerId><individualPrice>.7193</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500017"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853626" additionalBenefitType="D" sec9="Y"><name>Accu-Chek Advantage</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500018"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853634" additionalBenefitType="D" sec9="Y"><name>Surestep</name><manufacturerId>LIF</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="960500019"><dosageForm>Strip</dosageForm><price>.6067</price><drug id="09853677" additionalBenefitType="D" sec9="Y"><name>Prestige Smart System</name><manufacturerId>THR</manufacturerId><individualPrice>.6067</individualPrice><listingDate>1997-08-28</listingDate></drug></pcg9><pcg9 id="960500020"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09853693" additionalBenefitType="D" sec9="Y"><name>Ascensia Autodisc</name><manufacturerId>BAY</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9><pcg9 id="960500022"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854002" additionalBenefitType="D" sec9="Y"><name>Advantage Comfort</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="960500023"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854029" additionalBenefitType="D" sec9="Y"><name>FastTake</name><manufacturerId>LIF</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1999-04-15</listingDate></drug></pcg9><pcg9 id="960500024"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854088" dinStatus="E" additionalBenefitType="D" sec9="Y"><name>Elite</name><manufacturerId>BAL</manufacturerId><individualPrice>.7290</individualPrice><listingDate>1999-09-15</listingDate></drug></pcg9><pcg9 id="960500025"><dosageForm>Strip</dosageForm><price>.5222</price><drug id="09853480" additionalBenefitType="D" sec9="Y"><name>Novo-Glucose</name><manufacturerId>NOP</manufacturerId><individualPrice>.5222</individualPrice><listingDate>2000-11-30</listingDate></drug></pcg9><pcg9 id="960500026"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854070" additionalBenefitType="D" sec9="Y"><name>Precision Xtra</name><manufacturerId>ABB</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2001-10-11</listingDate></drug></pcg9><pcg9 id="960500027"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854282" additionalBenefitType="D" sec9="Y"><name>Accu-Chek Compact</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="960500028"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854290" additionalBenefitType="D" sec9="Y"><name>One Touch Ultra</name><manufacturerId>LIF</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2002-04-04</listingDate></drug></pcg9><pcg9 id="960500029"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09854304" additionalBenefitType="D" sec9="Y"><name>Sof-Tact</name><manufacturerId>ABB</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2002-07-29</listingDate></drug></pcg9><pcg9 id="960500030"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857141" additionalBenefitType="D" sec9="Y"><name>Freestyle</name><manufacturerId>TER</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="960500031"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857508" additionalBenefitType="D" sec9="Y"><name>Precision Easy</name><manufacturerId>ABB</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2003-09-04</listingDate></drug></pcg9><pcg9 id="960500033"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857132" additionalBenefitType="D" sec9="Y"><name>BD</name><manufacturerId>BED</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2005-02-22</listingDate></drug></pcg9><pcg9 id="960500034"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857178" additionalBenefitType="D" sec9="Y"><name>Accu-Chek Aviva</name><manufacturerId>ROD</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2006-04-19</listingDate></drug></pcg9><pcg9 id="960500035"><dosageForm>Strip</dosageForm><price>.4000</price><drug id="09857283" additionalBenefitType="D" sec9="Y"><name>TrueTrack Smart System</name><manufacturerId>HOM</manufacturerId><individualPrice>.4000</individualPrice><listingDate>2007-12-19</listingDate></drug></pcg9><pcg9 id="960500036"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857293" additionalBenefitType="D" sec9="Y"><name>Breeze 2</name><manufacturerId>BAH</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2008-04-09</listingDate></drug></pcg9><pcg9 id="960500038"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857313" additionalBenefitType="D" sec9="Y"><name>Nova Max</name><manufacturerId>NOB</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2008-12-23</listingDate></drug></pcg9><pcg9 id="960500039"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857340" additionalBenefitType="D" sec9="Y"><name>On Call Plus</name><manufacturerId>ACO</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2010-01-05</listingDate></drug></pcg9><pcg9 id="960500040"><dosageForm>Strip</dosageForm><price>.6804</price><drug id="09857348" additionalBenefitType="D" sec9="Y"><name>iTest</name><manufacturerId>AUT</manufacturerId><individualPrice>.6804</individualPrice><listingDate>2010-04-23</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01771"><name>PQQ GLUCOSE DEHYDROGENASE</name><pcgGroup><pcg9 id="960500037"><dosageForm>Strip</dosageForm><price>.7290</price><drug id="09857297" additionalBenefitType="D" sec9="Y"><name>Freestyle Lite</name><manufacturerId>ABB</manufacturerId><individualPrice>.7290</individualPrice><listingDate>2008-08-28</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2><pcg2 id="970000000"><name>FACILITATED ACCESS PRODUCTS</name><pcg6 id="970100000"><name>FACILITATED ACCESS PRODUCTS</name><genericName id="00146"><name>ATOVAQUONE</name><pcgGroup><pcg9 id="970100030"><strength>750mg/5mL</strength><dosageForm>O/L</dosageForm><price>2.5175</price><drug id="02217422" sec6="Y"><name>Mepron</name><manufacturerId>GLW</manufacturerId><individualPrice>2.5175</individualPrice><listingDate>1997-04-10</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01347"><name>DOXYCYCLINE</name><pcgGroup><pcg9 id="970100001"><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6720</price><drug id="00740713" sec6="Y"><name>Apo-Doxy</name><manufacturerId>APX</manufacturerId><individualPrice>.6720</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100005"><strength>100mg</strength><dosageForm>Cap</dosageForm><price>1.8442</price><drug id="00024368" sec6="Y"><name>Vibramycin</name><manufacturerId>PFI</manufacturerId><individualPrice>1.8442</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100014"><strength>100mg</strength><dosageForm>Cap</dosageForm><price>.6380</price><drug id="00725250" sec6="Y"><name>Novo-Doxylin</name><manufacturerId>NOP</manufacturerId><individualPrice>.6380</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00031"><name>ITRACONAZOLE</name><note>Recommended for the treatment of oral/esophageal candidiasis unresponsive to less expensive alternatives</note><pcgGroup><pcg9 id="970100017"><strength>100mg</strength><dosageForm>Cap</dosageForm><price>3.9747</price><drug id="02047454" sec6="Y"><name>Sporanox</name><manufacturerId>JNO</manufacturerId><individualPrice>3.9747</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100033"><strength>10mg/mL</strength><dosageForm>Oral Sol</dosageForm><price>.8705</price><drug id="02231347" sec6="Y"><name>Sporanox</name><manufacturerId>JNO</manufacturerId><individualPrice>.8705</individualPrice><listingDate>1998-12-31</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00149"><name>PAROMOMYCIN</name><note>Recommended for the treatment of cryptosporidium. Therapy should be discontinued if no benefits are observed after a three week trial.</note><pcgGroup><pcg9 id="970100019"><strength>250mg</strength><dosageForm>Cap</dosageForm><price>2.5872</price><drug id="02078759" sec6="Y"><name>Humatin</name><manufacturerId>PDA</manufacturerId><individualPrice>2.5872</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="01348"><name>PNEUMOCOCCAL VACCINE</name><pcgGroup><pcg9 id="970100003"><dosageForm>Inj-1 Dose Pk</dosageForm><price>15.1400</price><drug id="00431648" sec6="Y"><name>Pneumovax 23</name><manufacturerId>MSD</manufacturerId><individualPrice>15.1400</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00610"><name>POTASSIUM CHLORIDE</name><pcgGroup><pcg9 id="970100024"><strength>8meq</strength><dosageForm>LA Cap</dosageForm><price>.0944</price><drug id="02042304" sec6="Y"><name>Micro-K Extencaps</name><manufacturerId>WAY</manufacturerId><individualPrice>.0944</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100021"><strength>8meq</strength><dosageForm>LA Tab</dosageForm><price>.0749</price><drug id="00602884" sec6="Y"><name>Apo-K</name><manufacturerId>APX</manufacturerId><individualPrice>.0749</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100039"><strength>8meq</strength><dosageForm>LA Tab</dosageForm><price>.1017</price><drug id="00074225" selfMed="Y" sec6="Y"><name>Slow-K</name><manufacturerId>NOV</manufacturerId><individualPrice>.1017</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100022"><strength>10meq</strength><dosageForm>LA Tab</dosageForm><price>.0665</price><drug id="00471496" sec6="Y"><name>Kalium Durules</name><manufacturerId>AST</manufacturerId><individualPrice>.0665</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9><pcg9 id="970100023"><strength>20meq</strength><dosageForm>SR Tab</dosageForm><price>.2660</price><drug id="00713376" sec6="Y"><name>K-Dur</name><manufacturerId>KEY</manufacturerId><individualPrice>.2660</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName><genericName id="00121"><name>PYRIMETHAMINE</name><pcgGroup><pcg9 id="970100002"><strength>25mg</strength><dosageForm>Tab</dosageForm><price>1.2580</price><drug id="00004774" sec6="Y"><name>Daraprim</name><manufacturerId>GLW</manufacturerId><individualPrice>1.2580</individualPrice><listingDate>1996-10-01</listingDate></drug></pcg9></pcgGroup></genericName></pcg6></pcg2></formulary></extract>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              